data_5k5f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5k5f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.18 0.038 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.84 -42.44 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -76.04 -25.64 55.82 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.3 m -75.72 117.61 17.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.655 0.382 . . . . 0.0 110.022 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 m -116.0 156.64 17.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.556 1.142 . . . . 0.0 111.273 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.26 104.93 11.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -74.29 -33.07 63.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.97 -178.54 33.32 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.554 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -111.01 160.54 16.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.433 0.693 . . . . 0.0 109.926 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD23 HD23 ' A' ' 119' ' ' LEU . 29.7 tp -126.93 154.24 44.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 110.206 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.443 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -99.05 86.14 3.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.126 1.371 . . . . 0.0 108.128 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.98 87.28 0.87 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -70.98 80.6 0.65 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.848 0.859 . . . . 0.0 109.818 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.76 138.1 20.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.4 137.37 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 123.78 0.675 . . . . 0.0 109.654 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 142' ' ' PHE . . . -81.51 -31.17 34.28 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.219 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.5 tp -62.45 -18.81 62.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.978 0.911 . . . . 0.0 111.465 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 2.7 mmp_? -76.94 0.84 19.55 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.141 0.977 . . . . 0.0 112.582 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HA ' HG13 ' A' ' 76' ' ' VAL . 28.2 p90 -51.11 -34.22 29.64 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.436 1.095 . . . . 0.0 112.37 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -62.96 -34.51 77.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.394 1.078 . . . . 0.0 111.971 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.1 p -78.68 2.33 19.9 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 49.14 0.65 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.952 165.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.717 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 32.7 m -65.66 162.6 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.64 1.22 . . . . 0.0 111.366 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.08 166.5 8.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.92 0.888 . . . . 0.0 110.913 -170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -80.95 -170.83 2.89 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.797 0.839 . . . . 0.0 112.177 -170.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.11 145.86 55.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.995 0.918 . . . . 0.0 111.592 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 m120 66.25 10.17 6.94 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.326 1.45 . . . . 0.0 113.398 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.13 143.84 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.245 0.618 . . . . 0.0 110.141 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 80.6 mtp -96.65 142.0 29.22 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.5 m -126.2 145.81 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.361 1.064 . . . . 0.0 110.237 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . . . -105.79 153.56 21.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.101 0.96 . . . . 0.0 110.461 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.94 125.97 53.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.584 0.754 . . . . 0.0 109.691 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -140.8 112.86 7.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.718 0.807 . . . . 0.0 109.396 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 5.8 ppt_? -87.54 151.35 23.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.52 0.328 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 1.8 m-20 -90.88 149.61 40.57 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 123.59 0.756 . . . . 0.0 111.626 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.92 -43.11 57.35 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.609 2.206 . . . . 0.0 111.634 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -153.38 93.83 1.74 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.685 1.194 . . . . 0.0 108.962 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 1.3 t-20 -89.05 151.74 47.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.02 -29.43 44.56 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.618 2.879 . . . . 0.0 113.614 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.51 -51.63 22.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t0 172.1 162.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.366 1.467 . . . . 0.0 108.319 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -65.01 -15.09 61.93 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.64 1.176 . . . . 0.0 112.266 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -87.78 -15.92 35.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.364 0.666 . . . . 0.0 111.881 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.41 118.82 9.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.526 0.73 . . . . 0.0 111.665 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 63.1 mt -92.03 120.06 40.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.573 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.606 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 34.0 mtmm -81.14 123.4 28.39 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 164.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.27 126.16 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.459 ' OD1' ' HB2' ' A' ' 84' ' ' ALA . 6.5 p30 -115.29 173.76 6.35 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 124.598 1.159 . . . . 0.0 107.92 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -103.94 -170.38 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 118.666 0.666 . . . . 0.0 110.2 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -57.47 -33.06 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.57 -11.32 59.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.594 0.758 . . . . 0.0 111.564 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.16 14.57 78.81 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.521 -0.308 . . . . 0.0 112.888 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -78.5 120.57 23.4 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.95 0.9 . . . . 0.0 108.586 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.17 99.67 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.517 0.727 . . . . 0.0 109.499 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.717 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 23.0 m -71.77 -27.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.199 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.39 176.64 38.34 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.404 0.44 . . . . 0.0 113.41 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.606 ' HD2' ' HG2' ' A' ' 99' ' ' LYS . 31.6 m80 -92.46 133.96 35.41 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.459 HD11 ' HE3' ' A' ' 148' ' ' MET . 1.3 tt -66.35 -54.08 28.72 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.68 0.612 . . . . 0.0 110.307 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 53.9 mmtt 150.85 133.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 -160.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -70.86 -42.02 70.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.06 -52.03 65.59 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.128 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.84 -40.46 91.75 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.178 0.591 . . . . 0.0 110.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.03 69.85 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.239 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.79 -31.79 64.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.5 0.5 . . . . 0.0 113.125 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.58 5.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.552 0.741 . . . . 0.0 110.414 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.511 HD23 HD23 ' A' ' 63' ' ' LEU . 21.1 mt -73.3 -18.58 61.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -170.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.78 -29.7 65.97 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.412 0.685 . . . . 0.0 110.885 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.86 -35.33 64.74 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.411 HG21 ' HB2' ' A' ' 127' ' ' LEU . 58.8 mt -70.86 -33.64 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.275 0.63 . . . . 0.0 110.765 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.2 tpp -74.34 -56.2 5.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.419 1.088 . . . . 0.0 110.659 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.38 -44.78 62.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.267 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.33 5.07 32.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.695 0.398 . . . . 0.0 111.403 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 60.98 33.54 19.72 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.377 1.071 . . . . 0.0 112.592 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' HG21 ' A' ' 122' ' ' ILE . 64.2 mt -67.68 -38.56 83.89 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.662 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -166.67 145.89 5.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 111.173 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -78.26 116.87 19.0 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.998 0.919 . . . . 0.0 109.279 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -98.92 112.83 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.144 0.578 . . . . 0.0 109.812 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 10.9 pt-20 -83.41 167.66 17.29 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -143.27 152.34 23.98 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 35.5 t -149.16 128.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.475 1.11 . . . . 0.0 108.479 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.31 96.69 1.32 Allowed Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 123.646 0.778 . . . . 0.0 109.449 167.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.39 -31.34 9.22 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.591 2.194 . . . . 0.0 113.316 -176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.09 -20.94 12.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.989 0.916 . . . . 0.0 110.916 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.87 29.96 75.74 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.34 0.4 . . . . 0.0 113.468 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.79 3.24 12.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.953 0.901 . . . . 0.0 113.315 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -67.43 -26.63 66.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.171 0.589 . . . . 0.0 110.274 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.84 -37.46 73.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.694 0.797 . . . . 0.0 110.569 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.14 -55.23 9.92 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.695 0.798 . . . . 0.0 110.867 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.466 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 74.7 t80 -151.34 -77.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 p -158.3 165.76 33.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.012 1.725 . . . . 0.0 107.85 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.3 ptt? -167.12 152.37 7.15 Favored Pre-proline 0 C--O 1.246 0.921 0 O-C-N 123.43 0.456 . . . . 0.0 110.398 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.67 126.44 10.81 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.996 1.797 . . . . 0.0 110.339 162.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.59 156.23 16.9 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.984 0.514 . . . . 0.0 109.959 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.44 107.02 3.17 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.373 0.42 . . . . 0.0 110.305 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.459 ' HE3' HD11 ' A' ' 111' ' ' LEU . 65.4 mtt -104.07 160.26 14.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 131' ' ' GLU . 19.2 m -154.34 143.3 21.06 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.477 0.58 . . . . 0.0 110.029 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 76.6 m-85 -104.19 117.8 35.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.28 1.032 . . . . 0.0 109.851 -174.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -121.04 100.62 7.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.276 1.03 . . . . 0.0 108.811 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.52 167.67 33.07 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.528 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -65.69 147.87 52.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.12 -19.88 48.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.681 1.192 . . . . 0.0 114.046 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.0 -22.08 56.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -93.06 -0.19 57.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.083 0.553 . . . . 0.0 112.478 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 7.6 ppt_? -52.83 -38.11 60.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -79.98 -27.62 39.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.793 0.437 . . . . 0.0 110.79 -175.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.96 55.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.424 0.69 . . . . 0.0 110.752 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.83 -51.79 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.885 0.874 . . . . 0.0 110.133 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.3 p -65.89 -30.41 71.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.589 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -54.89 -42.54 72.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.898 0.879 . . . . 0.0 111.728 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -67.68 -34.41 76.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.299 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.28 -45.39 55.88 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.913 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -61.12 -31.73 71.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.03 1.332 . . . . 0.0 111.372 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -58.34 -42.35 86.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.804 1.242 . . . . 0.0 111.296 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -97.62 -15.05 20.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.099 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.32 19.18 31.06 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 113.585 0.194 . . . . 0.0 113.585 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 123.717 0.807 . . . . 0.0 110.997 171.24 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.655 0.264 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.53 -33.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.384 0.674 . . . . 0.0 109.561 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.38 -25.71 59.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.015 0.926 . . . . 0.0 110.411 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -72.47 134.83 45.53 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.071 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.5 158.53 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.384 1.073 . . . . 0.0 110.469 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.73 102.6 12.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.436 1.094 . . . . 0.0 108.292 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 41.8 m-85 -74.44 -23.24 58.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.108 0.563 . . . . 0.0 111.422 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.35 177.2 14.76 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.032 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -111.22 120.6 42.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.171 0.588 . . . . 0.0 110.267 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -86.76 137.71 32.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.539 1.136 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 100.73 4.13 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 115' ' ' LEU . . . -90.73 -170.84 43.43 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 166.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -165.43 127.04 2.0 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 100' ' ' VAL . 48.1 t -98.59 134.63 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 70' ' ' LEU . 23.7 t -69.98 143.93 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 O-C-N 123.92 0.763 . . . . 0.0 110.325 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.39 -22.52 78.58 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.233 0.333 . . . . 0.0 113.008 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.502 ' H ' HG13 ' A' ' 68' ' ' VAL . 35.0 tp -62.77 -18.15 62.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.429 1.092 . . . . 0.0 111.379 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 3.5 mmp_? -76.66 1.77 16.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.957 0.903 . . . . 0.0 112.823 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.698 ' HA ' HG21 ' A' ' 76' ' ' VAL . 86.7 t80 -48.69 -36.63 16.56 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.92 0.888 . . . . 0.0 112.546 174.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -62.44 -40.91 98.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.703 0.801 . . . . 0.0 111.609 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 p -78.51 -4.5 48.87 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.03 49.67 1.45 Allowed Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.698 HG21 ' HA ' ' A' ' 72' ' ' TYR . 17.4 m -53.55 164.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG23 HG23 ' A' ' 134' ' ' VAL . 14.8 m -114.6 163.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.792 -164.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -92.52 -166.37 1.53 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.996 1.318 . . . . 0.0 111.266 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.17 147.13 48.65 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.496 0.718 . . . . 0.0 111.6 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 63.98 8.87 4.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 0.0 113.637 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -77.04 136.91 38.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.977 0.418 . . . . 0.0 110.31 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.8 mtp -100.24 150.08 22.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.163 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 102' ' ' ASN . 29.8 m -135.11 174.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.537 1.135 . . . . 0.0 109.553 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.33 133.7 16.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 107.714 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.509 HD23 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -84.62 146.34 27.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.17 0.588 . . . . 0.0 109.986 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -151.2 130.31 12.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.141 0.977 . . . . 0.0 108.598 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.491 HH11 ' HB2' ' A' ' 95' ' ' LYS . 34.1 ptt85 -74.27 146.81 42.93 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -80.46 118.04 70.56 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.101 0.561 . . . . 0.0 110.894 -167.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 -32.63 24.86 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.14 2.56 . . . . 0.0 112.187 173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.75 33.95 2.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.913 0.885 . . . . 0.0 109.925 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -53.89 119.0 17.02 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.586 1.154 . . . . 0.0 112.987 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.88 -28.27 16.72 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.961 2.441 . . . . 0.0 113.155 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -116.45 -51.68 2.59 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.38 0.672 . . . . 0.0 111.328 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -167.67 155.64 8.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.841 0.456 . . . . 0.0 110.651 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.491 ' HB2' HH11 ' A' ' 87' ' ' ARG . 8.3 ptpp? -53.43 -23.17 9.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.179 1.791 . . . . 0.0 113.373 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.517 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 81.2 m-20 -78.98 18.86 0.58 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.775 0.83 . . . . 0.0 112.796 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.04 111.66 23.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 108.948 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 120' ' ' ALA . 29.7 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 123.592 0.757 . . . . 0.0 110.513 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -85.66 164.37 17.72 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.503 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 67' ' ' VAL . 60.7 t -117.27 117.34 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -110.25 131.39 55.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.936 0.894 . . . . 0.0 108.816 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.471 ' HA ' HG11 ' A' ' 83' ' ' VAL . 26.3 p-10 -75.71 -168.92 0.94 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 118.307 0.503 . . . . 0.0 111.507 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -52.11 -33.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 124.4 1.08 . . . . 0.0 112.96 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.24 -20.32 25.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.178 0.591 . . . . 0.0 111.553 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.53 4.2 54.92 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-N 116.447 -0.342 . . . . 0.0 112.843 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.15 127.46 31.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 110.061 175.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -77.3 92.16 3.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.925 0.89 . . . . 0.0 109.863 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.653 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 4.9 m -75.49 -14.89 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.231 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.24 -143.57 10.69 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 123.587 0.554 . . . . 0.0 112.426 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.83 166.75 22.57 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.407 1.083 . . . . 0.0 108.461 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' SD ' ' A' ' 148' ' ' MET . 5.2 mp -78.13 -53.13 7.71 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.557 0.694 . . . . 0.0 109.819 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 170.72 166.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 127.013 2.125 . . . . 0.0 106.771 -167.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -78.67 -44.98 22.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB3' ' NE2' ' A' ' 167' ' ' HIS . 19.5 mm-40 -66.74 -45.33 78.95 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.85 0.86 . . . . 0.0 111.935 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.479 HD13 ' HA2' ' A' ' 65' ' ' GLY . 1.5 tt -64.4 -44.03 92.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.525 0.73 . . . . 0.0 110.007 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.16 85.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.645 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -59.63 -30.33 68.6 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.97 0.793 . . . . 0.0 113.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -73.1 -61.29 1.87 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.394 0.678 . . . . 0.0 110.058 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.12 -15.79 63.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.932 0.893 . . . . 0.0 113.202 -171.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 98' ' ' ILE . . . -59.12 -39.55 82.63 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.413 1.085 . . . . 0.0 113.168 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.01 -32.95 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.079 0.552 . . . . 0.0 110.241 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.449 ' HA ' HD13 ' A' ' 127' ' ' LEU . 68.5 mt -66.78 -33.9 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.551 0.74 . . . . 0.0 110.081 174.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.4 tpp -78.01 -38.99 43.58 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.19 -47.66 34.21 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.196 0.998 . . . . 0.0 110.406 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -88.71 -1.49 58.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.099 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.87 31.45 18.24 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.264 1.025 . . . . 0.0 111.532 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 122' ' ' ILE . 77.6 mt -58.52 -43.62 89.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.157 0.983 . . . . 0.0 111.845 -174.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.72 131.53 11.6 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.972 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.17 107.19 13.76 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.494 1.118 . . . . 0.0 108.492 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.1 mt -93.35 111.36 24.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.236 0.615 . . . . 0.0 109.948 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.92 179.7 7.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.801 0.84 . . . . 0.0 109.156 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.26 156.34 27.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 82' ' ' MET . 38.8 t -141.76 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.949 0.9 . . . . 0.0 109.69 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 146' ' ' LEU . 1.7 m -103.73 94.99 6.83 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.447 1.099 . . . . 0.0 108.622 166.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.09 -48.76 3.27 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.537 2.158 . . . . 0.0 111.927 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.78 -27.79 40.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.604 0.762 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 134' ' ' VAL . . . 63.6 30.08 76.58 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 113.733 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.07 -1.25 19.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.14 0.976 . . . . 0.0 111.507 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.63 -26.93 66.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.724 0.81 . . . . 0.0 111.09 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.403 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 9.9 t-20 -69.07 -29.6 67.76 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.417 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.28 -49.24 4.77 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.646 0.778 . . . . 0.0 110.715 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.99 -162.46 1.25 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.845 1.258 . . . . 0.0 110.087 -170.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -103.09 114.5 28.85 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.9 ptm -112.29 157.11 40.91 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.063 0.545 . . . . 0.0 110.307 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.91 124.81 13.2 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.252 1.968 . . . . 0.0 110.898 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HG ' HG12 ' A' ' 134' ' ' VAL . 4.7 tt -109.1 121.21 44.67 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.64 110.3 16.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.932 0.493 . . . . 0.0 109.676 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.509 ' SD ' HD23 ' A' ' 85' ' ' LEU . 47.6 mtt -115.82 113.36 23.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.409 1.084 . . . . 0.0 110.53 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -103.97 129.41 51.55 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.134 0.574 . . . . 0.0 110.472 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 3.9 m-85 -88.4 125.51 34.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.094 0.958 . . . . 0.0 109.478 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -126.73 99.2 5.67 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.98 161.71 31.69 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.663 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -62.72 145.41 54.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.392 0.677 . . . . 0.0 112.282 -175.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.435 ' HB3' HH21 ' A' ' 157' ' ' ARG . 44.5 mt-10 -57.59 -31.74 66.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.253 1.021 . . . . 0.0 113.425 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.53 -23.77 66.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.28 2.41 56.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.261 0.624 . . . . 0.0 112.404 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.435 HH21 ' HB3' ' A' ' 154' ' ' GLU . 15.5 ptp180 -57.99 -37.97 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.844 0.457 . . . . 0.0 111.514 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.67 -43.42 89.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.226 1.01 . . . . 0.0 110.387 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.97 -36.29 67.08 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.358 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.39 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.848 0.859 . . . . 0.0 110.443 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.0 p -67.57 -26.78 66.46 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.086 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.13 -37.61 88.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.106 0.562 . . . . 0.0 110.951 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.1 mm100 -74.49 -38.43 62.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.012 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.68 -61.73 2.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.47 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.63 -21.99 66.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.749 1.219 . . . . 0.0 112.761 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -53.74 -52.34 60.47 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.882 0.873 . . . . 0.0 111.018 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.451 ' NE2' ' HB3' ' A' ' 114' ' ' GLU . 66.3 t-80 -96.25 -17.27 20.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.418 -177.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.1 34.32 5.43 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.734 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 . . . . . 0 N--CA 1.482 1.125 0 C-N-CA 123.609 0.764 . . . . 0.0 109.878 169.323 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.998 0.428 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.79 -30.96 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.684 0.794 . . . . 0.0 109.584 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -77.77 -18.07 56.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.767 0.827 . . . . 0.0 110.415 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.96 133.5 50.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.995 0.518 . . . . 0.0 110.879 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.2 m -132.62 162.77 39.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 125.015 1.326 . . . . 0.0 109.797 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 tp -83.89 111.58 19.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HE1' ' HB3' ' A' ' 128' ' ' ALA . 23.0 m-85 -73.51 -25.86 60.62 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.287 0.565 . . . . 0.0 110.611 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -144.25 14.41 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -132.52 179.74 5.95 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.635 0.774 . . . . 0.0 110.271 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 169' ' ' PHE . 49.2 tp -143.35 146.76 33.8 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.571 0.748 . . . . 0.0 109.516 172.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -71.24 81.81 0.73 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.221 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 67' ' ' VAL . . . -74.1 74.72 1.18 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -68.08 87.64 0.27 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG11 ' HA ' ' A' ' 111' ' ' LEU . 36.6 t -87.42 147.97 4.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.696 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 87.6 t -61.46 140.96 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.274 1.029 . . . . 0.0 110.727 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.59 -38.18 15.02 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -17.55 31.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.871 1.269 . . . . 0.0 113.248 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' NH1' HG21 ' A' ' 108' ' ' VAL . 13.1 ptt180 -69.22 -2.29 10.16 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.491 0.717 . . . . 0.0 112.506 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -51.93 -36.84 50.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.071 0.948 . . . . 0.0 112.928 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.08 -30.58 71.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.746 0.818 . . . . 0.0 111.535 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 m -74.38 -6.31 47.44 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.758 0.823 . . . . 0.0 111.786 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.02 45.77 1.24 Allowed Glycine 0 C--N 1.35 1.327 0 O-C-N 122.388 -0.195 . . . . 0.0 113.486 169.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.42 HG21 ' ND2' ' A' ' 140' ' ' ASN . 28.9 m -64.96 172.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 170.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.08 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.68 -146.26 0.4 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.247 0.619 . . . . 0.0 109.769 -172.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 150.91 41.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.286 1.034 . . . . 0.0 112.666 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 68.83 -5.44 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.592 1.557 . . . . 0.0 113.208 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.16 146.49 29.53 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.042 0.537 . . . . 0.0 110.622 -172.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.5 mtp -97.43 143.56 28.04 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.518 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.13 145.78 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.36 1.064 . . . . 0.0 108.912 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 101' ' ' ASN . . . -99.03 156.01 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.612 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -115.41 124.49 51.31 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -132.98 116.8 16.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.969 0.908 . . . . 0.0 109.679 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -67.91 119.21 12.21 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.616 ' HB3' HD22 ' A' ' 91' ' ' ASN . 18.5 t70 -66.6 132.65 94.16 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.571 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.79 -42.52 11.87 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.272 3.314 . . . . 0.0 114.079 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -167.38 106.95 0.58 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 123.138 0.273 . . . . 0.0 110.551 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.616 HD22 ' HB3' ' A' ' 88' ' ' ASP . 24.5 m-80 -96.7 146.26 30.99 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.05 -22.14 48.2 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.765 2.31 . . . . 0.0 114.003 -170.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -125.94 -46.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.713 0.405 . . . . 0.0 110.858 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.426 ' HB3' ' ND2' ' A' ' 96' ' ' ASN . 33.7 m-20 -117.14 92.7 3.93 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -55.86 -33.16 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.728 0.811 . . . . 0.0 111.686 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.498 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -72.3 -8.29 54.08 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 113.1 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 108.41 2.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.237 0.615 . . . . 0.0 111.375 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.32 125.95 45.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 124.081 0.952 . . . . 0.0 110.213 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 32.4 mmtp -86.8 123.91 32.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.106 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.61 112.67 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 2.0 m-20 -91.53 170.36 10.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.188 0.995 . . . . 0.0 108.849 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -108.11 -171.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.843 0.457 . . . . 0.0 110.248 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.69 -28.38 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.637 0.775 . . . . 0.0 112.24 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.9 -30.48 63.95 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.176 0.591 . . . . 0.0 110.357 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.19 -4.34 30.03 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.485 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.81 137.4 41.87 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.278 0.539 . . . . 0.0 110.026 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.78 95.37 0.89 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.554 HG21 ' NH1' ' A' ' 71' ' ' ARG . 27.8 m -86.95 16.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.861 0.865 . . . . 0.0 112.012 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 148.01 -175.72 27.19 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.925 169.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -102.68 148.83 25.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.11 0.964 . . . . 0.0 108.972 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HA ' HG11 ' A' ' 67' ' ' VAL . 3.2 tt -73.89 -56.09 5.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? 152.12 121.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -165.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -61.11 -49.47 77.13 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 118.802 0.728 . . . . 0.0 112.072 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.33 -41.56 93.81 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.821 0.7 . . . . 0.0 110.82 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.77 -40.08 66.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.831 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.32 -24.54 65.75 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.008 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.28 -33.82 88.29 Favored Glycine 0 C--N 1.351 1.361 0 O-C-N 123.603 0.565 . . . . 0.0 112.958 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -56.84 4.78 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.413 0.625 . . . . 0.0 109.802 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.417 HD22 HD22 ' A' ' 63' ' ' LEU . 22.5 mt -70.5 -18.12 62.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.506 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.96 67.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.881 0.873 . . . . 0.0 111.153 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -66.03 -35.5 80.72 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.184 0.928 . . . . 0.0 110.44 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 127' ' ' LEU . 83.9 mt -62.62 -44.55 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 0.0 110.585 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.515 ' HE1' ' HB3' ' A' ' 85' ' ' LEU . 30.1 ttm -81.19 -21.46 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.644 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.31 -51.05 10.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 0.0 109.72 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -89.71 4.16 50.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.224 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HB3' ' HZ1' ' A' ' 126' ' ' LYS . 2.7 mmmp? 59.71 36.63 22.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.533 1.133 . . . . 0.0 111.594 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 122' ' ' ILE . 66.0 mt -62.22 -40.83 97.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.44 1.096 . . . . 0.0 111.54 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . . . -162.15 140.86 9.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.13 0.572 . . . . 0.0 111.093 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -76.52 133.51 39.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.1 113.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.39 132.75 54.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.35 154.78 18.53 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.773 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 67.3 t -137.99 137.26 44.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.23 84.88 4.98 Favored Pre-proline 0 CA--C 1.555 1.17 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.47 -35.78 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.656 2.237 . . . . 0.0 111.74 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.25 -26.13 58.61 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.966 0.907 . . . . 0.0 110.59 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.76 -6.08 14.18 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 115.835 1.094 . . . . 0.0 115.835 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.12 1.8 30.22 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.481 0.641 . . . . 0.0 112.723 -172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.598 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 3.4 t-20 -75.32 -18.4 60.03 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.116 0.484 . . . . 0.0 110.315 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.42 ' ND2' HG21 ' A' ' 76' ' ' VAL . 20.6 t-20 -61.89 -34.23 75.66 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.092 0.957 . . . . 0.0 110.663 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.94 -56.39 2.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.828 0.851 . . . . 0.0 112.579 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -126.8 -178.25 4.32 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.542 1.137 . . . . 0.0 110.573 -161.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p -93.8 125.46 38.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.087 0.955 . . . . 0.0 109.631 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 139' ' ' ASN . 3.3 ppp? -156.61 160.93 30.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.172 0.989 . . . . 0.0 109.302 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.96 121.5 7.36 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.791 1.661 . . . . 0.0 111.147 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 67' ' ' VAL . 6.5 tt -100.34 124.88 46.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -74.33 108.84 7.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.612 ' SD ' HD21 ' A' ' 85' ' ' LEU . 58.5 mtt -116.05 121.74 43.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.76 0.824 . . . . 0.0 109.581 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -108.99 140.53 42.36 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.373 1.069 . . . . 0.0 110.206 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -104.15 121.01 42.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.923 0.889 . . . . 0.0 109.684 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -124.5 112.88 17.4 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.48 164.45 37.97 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -54.26 137.69 40.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.534 0.734 . . . . 0.0 110.541 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -53.93 -39.0 65.47 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 123.854 0.721 . . . . 0.0 112.551 -169.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.42 -18.03 35.67 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.319 1.048 . . . . 0.0 113.759 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -92.51 -8.22 45.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.79 -33.62 66.84 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.056 0.542 . . . . 0.0 112.398 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 46.7 pttt -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.674 0.789 . . . . 0.0 111.381 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 158' ' ' LYS . . . -68.65 -34.7 76.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.62 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.96 -44.24 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.657 0.783 . . . . 0.0 110.466 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -72.67 -25.97 61.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.543 0.737 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 32.7 t70 -58.77 -39.92 82.43 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.15 0.5 . . . . 0.0 110.286 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 166' ' ' LYS . 14.7 mm100 -73.19 -39.49 65.53 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.12 -175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.51 -57.54 4.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.32 -21.29 59.52 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.654 1.181 . . . . 0.0 112.484 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 163' ' ' GLN . 21.8 ttmm -56.23 -50.38 71.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.989 0.916 . . . . 0.0 111.177 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -111.59 18.7 18.82 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.174 0.59 . . . . 0.0 110.545 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.0 14.07 76.05 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' HB3' HD12 ' A' ' 63' ' ' LEU . 28.4 m-85 . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 123.883 0.873 . . . . 0.0 110.892 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.0 t -72.54 -31.44 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.4 t70 -77.4 -14.0 59.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.285 0.634 . . . . 0.0 111.126 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 m -70.66 109.29 4.82 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.464 0.65 . . . . 0.0 110.519 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 56' ' ' ASP . 16.9 m -116.61 162.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.853 1.261 . . . . 0.0 110.293 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.76 118.49 22.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 27.8 m-85 -83.31 -31.5 26.83 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.322 0.582 . . . . 0.0 110.167 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.1 -167.94 29.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.873 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 147' ' ' HIS . 77.6 p -125.58 138.98 53.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.889 0.476 . . . . 0.0 110.102 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.09 140.95 32.48 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 109.761 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -75.37 78.87 2.44 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.928 0.87 . . . . 0.0 110.486 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA2' HD12 ' A' ' 115' ' ' LEU . . . -71.68 141.23 31.66 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.419 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -122.01 100.72 7.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.45 0.7 . . . . 0.0 109.776 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.96 131.23 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.93 0.769 . . . . 0.0 108.974 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.66 142.32 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.741 0.816 . . . . 0.0 111.594 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.63 -27.29 57.35 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.64 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.85 -19.57 65.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.444 0.698 . . . . 0.0 110.072 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 4.1 mmp_? -78.1 0.27 25.39 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.47 1.108 . . . . 0.0 112.807 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.05 -36.66 65.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.473 0.709 . . . . 0.0 112.12 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.82 -32.23 73.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.701 0.8 . . . . 0.0 111.85 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 p -87.22 15.5 6.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.13 0.572 . . . . 0.0 112.399 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.04 49.95 1.41 Allowed Glycine 0 C--N 1.356 1.653 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 163.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.47 169.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.093 0.947 . . . . 0.0 111.585 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.552 HG21 HG11 ' A' ' 134' ' ' VAL . 27.6 m -115.64 158.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.769 0.828 . . . . 0.0 111.902 -164.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -173.95 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.136 0.974 . . . . 0.0 110.758 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -72.44 153.23 41.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.44 8.74 5.96 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 125.019 1.328 . . . . 0.0 112.229 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -88.11 145.41 25.96 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.7 -0.625 . . . . 0.0 111.553 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.56 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -95.36 147.37 23.58 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.123 177.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.82 142.09 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.556 1.142 . . . . 0.0 108.853 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -115.01 124.69 52.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.721 0.808 . . . . 0.0 109.56 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.9 mt -76.83 158.84 30.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.681 0.393 . . . . 0.0 110.707 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.03 121.59 4.89 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.425 0.69 . . . . 0.0 110.116 -174.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.28 134.61 56.14 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.471 0.708 . . . . 0.0 110.835 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' ND2' ' A' ' 91' ' ' ASN . 3.5 m-20 -68.74 118.28 59.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.319 0.647 . . . . 0.0 109.319 169.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.75 -29.57 90.07 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.918 2.412 . . . . 0.0 112.866 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -144.42 98.99 3.29 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.453 HD21 ' HB3' ' A' ' 97' ' ' ALA . 14.7 m120 -65.64 138.69 96.79 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.583 0.753 . . . . 0.0 110.632 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.46 -54.41 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.434 2.089 . . . . 0.0 113.139 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -128.61 -50.72 1.26 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.754 0.822 . . . . 0.0 109.768 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.71 101.25 13.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.019 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.25 -4.96 28.6 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.523 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 3.6 p-10 -99.37 -2.14 37.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.282 1.033 . . . . 0.0 111.784 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 91' ' ' ASN . . . -68.71 144.24 54.47 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.021 0.528 . . . . 0.0 111.384 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.19 126.18 55.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.145 0.978 . . . . 0.0 108.931 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.17 152.93 43.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.506 0.722 . . . . 0.0 111.209 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.31 134.08 64.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -121.05 166.48 13.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.429 1.091 . . . . 0.0 108.084 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -99.34 -172.64 2.3 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.11 -19.28 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.227 0.611 . . . . 0.0 112.582 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -84.92 -10.93 56.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.354 0.662 . . . . 0.0 110.919 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.3 19.9 59.77 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.648 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.88 127.68 35.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 109.762 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.01 110.49 3.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 110.239 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 4.3 m -84.3 -10.51 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.943 0.497 . . . . 0.0 110.643 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.96 -141.52 12.86 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -106.05 173.76 6.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.733 0.813 . . . . 0.0 110.072 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.437 HD12 ' SD ' ' A' ' 148' ' ' MET . 2.3 tt -84.71 -52.32 6.16 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 172.01 168.77 0.1 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -79.06 -63.77 1.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.26 -36.55 74.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 0.0 112.379 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.433 HD12 ' HA2' ' A' ' 65' ' ' GLY . 4.9 tt -73.05 -46.02 54.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.896 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.03 67.44 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.838 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -61.48 -40.04 98.14 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.592 0.558 . . . . 0.0 113.347 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -49.55 39.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.38 0.609 . . . . 0.0 109.86 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 122' ' ' ILE . 17.1 mt -69.31 -16.74 63.62 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.819 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.84 -57.95 9.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.381 1.072 . . . . 0.0 111.543 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -64.07 -31.0 72.03 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.909 0.756 . . . . 0.0 110.687 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.537 ' HA ' HD12 ' A' ' 127' ' ' LEU . 73.5 mt -67.34 -40.61 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.509 0.723 . . . . 0.0 111.203 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.7 ttm -80.36 -36.31 34.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.232 0.613 . . . . 0.0 110.971 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.13 -41.41 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.272 1.029 . . . . 0.0 111.101 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -99.67 7.98 44.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.648 0.779 . . . . 0.0 111.096 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 63.08 35.77 12.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.33 1.052 . . . . 0.0 111.762 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 122' ' ' ILE . 64.1 mt -69.5 -50.22 47.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.009 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -152.11 145.0 24.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.89 134.66 33.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 108.599 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.2 mt -121.4 117.42 52.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.721 0.296 . . . . 0.0 110.301 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -117.37 121.25 40.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.252 1.021 . . . . 0.0 108.451 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -90.14 155.52 24.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.582 -0.281 . . . . 0.0 112.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 82' ' ' MET . 53.3 t -138.68 128.02 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 77' ' ' VAL . 5.0 p -96.01 102.27 10.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.711 0.805 . . . . 0.0 109.301 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -53.56 0.18 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.296 1.997 . . . . 0.0 113.574 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -84.98 -27.59 26.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.035 0.534 . . . . 0.0 110.941 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.35 81.84 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 113.718 0.247 . . . . 0.0 113.718 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.662 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -75.93 -7.75 55.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.423 0.689 . . . . 0.0 112.277 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.78 -16.65 63.86 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.864 0.865 . . . . 0.0 110.973 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -73.12 -25.66 60.93 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.622 0.769 . . . . 0.0 111.29 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.07 -60.61 2.19 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -141.5 -83.49 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.1 m -157.5 140.62 15.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.662 ' HG2' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -153.06 149.38 21.69 Favored Pre-proline 0 C--O 1.243 0.758 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 173.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.75 124.4 14.49 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.326 2.017 . . . . 0.0 112.815 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.456 HD21 ' HB ' ' A' ' 134' ' ' VAL . 4.3 pp -117.77 146.25 43.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.043 0.937 . . . . 0.0 108.858 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.5 m80 -86.55 109.85 19.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.612 0.365 . . . . 0.0 111.139 -166.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.645 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 40.3 mtt -99.76 111.77 24.07 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.188 0.995 . . . . 0.0 109.468 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 49.5 p -93.99 128.22 40.21 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.154 0.982 . . . . 0.0 109.653 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -91.13 117.25 29.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.261 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -120.44 99.18 6.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.89 166.55 31.45 Favored Glycine 0 CA--C 1.501 -0.832 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.342 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.03 149.3 45.04 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.58 -48.02 7.51 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.78 1.632 . . . . 0.0 113.613 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.14 -9.89 55.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -171.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 127' ' ' LEU . 98.9 m-20 -107.62 -4.36 18.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.403 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 8.9 ptp85 -63.44 -29.24 70.56 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.216 0.916 . . . . 0.0 112.228 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.16 -42.52 86.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.67 0.788 . . . . 0.0 109.847 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.06 -34.12 29.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.467 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.89 -57.75 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.654 0.782 . . . . 0.0 110.517 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 m -62.95 -25.45 68.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.098 0.959 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.4 t70 -60.57 -48.65 80.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.526 0.33 . . . . 0.0 110.375 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.9 mm100 -64.06 -35.22 80.02 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.956 0.785 . . . . 0.0 111.155 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 -62.46 1.45 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.342 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -58.91 -26.98 64.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.497 0.719 . . . . 0.0 111.694 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 37.1 ttmt -56.06 -50.09 71.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.645 1.178 . . . . 0.0 111.793 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -87.15 -13.46 44.02 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.02 10.85 23.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.916 -0.38 . . . . 0.0 113.548 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 123.078 0.551 . . . . 0.0 110.106 171.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.92 -32.05 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.44 0.696 . . . . 0.0 109.605 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.97 -33.26 75.62 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.349 1.06 . . . . 0.0 110.48 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -78.53 127.49 32.22 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.753 0.821 . . . . 0.0 110.693 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.85 166.78 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.786 1.234 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.51 117.59 23.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.444 ' HE2' ' HB3' ' A' ' 128' ' ' ALA . 20.7 m-85 -81.12 -28.86 34.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.058 0.543 . . . . 0.0 110.648 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.93 -153.26 25.19 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -126.47 178.61 5.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.414 0.685 . . . . 0.0 110.559 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -150.96 141.56 22.62 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.913 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -71.74 84.14 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.494 0.718 . . . . 0.0 109.717 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.37 87.25 1.38 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.168 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 18.2 t60 -73.79 94.28 2.24 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.203 0.601 . . . . 0.0 110.213 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG11 ' HD2' ' A' ' 71' ' ' ARG . 38.3 t -82.22 142.68 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.431 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.74 154.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.892 0.877 . . . . 0.0 113.072 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.46 -19.95 72.85 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.387 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.3 tp -57.23 -23.85 50.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.973 1.309 . . . . 0.0 111.489 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.54 ' HD2' HG11 ' A' ' 67' ' ' VAL . 70.8 ttt180 -54.85 -21.83 12.62 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.241 1.416 . . . . 0.0 113.15 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -49.91 -49.6 49.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.165 0.986 . . . . 0.0 111.95 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -75.45 -25.94 57.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.056 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 m -80.46 -9.23 59.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.011 0.524 . . . . 0.0 110.53 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.31 50.18 0.73 Allowed Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.309 170.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.19 158.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.634 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 33.1 m -112.99 152.19 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.222 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.75 -76.84 0.11 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.338 0.399 . . . . 0.0 110.789 -164.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -164.07 159.22 20.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.065 0.946 . . . . 0.0 109.617 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 70.7 -7.6 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.486 1.114 . . . . 0.0 111.892 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 72.4 mm-40 -75.25 144.0 42.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.758 0.823 . . . . 0.0 111.965 -167.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.551 ' HG2' HG21 ' A' ' 133' ' ' VAL . 73.4 mtm -95.04 144.53 25.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.46 170.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.93 160.79 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.084 0.954 . . . . 0.0 109.083 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.68 25.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.613 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.6 mp -85.38 134.06 34.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.045 0.538 . . . . 0.0 109.575 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -142.78 130.7 21.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.3 0.64 . . . . 0.0 109.486 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -80.76 124.32 28.95 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -99.16 137.18 20.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.385 0.674 . . . . 0.0 111.446 -177.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.54 -28.7 6.51 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.622 2.215 . . . . 0.0 112.025 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -80.65 83.72 6.36 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -89.92 127.91 52.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.334 -166.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.47 -26.92 11.56 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.553 2.168 . . . . 0.0 112.408 171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -120.84 -53.38 2.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.254 0.621 . . . . 0.0 111.578 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -168.1 154.0 7.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.01 -13.38 2.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.162 0.985 . . . . 0.0 113.636 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.478 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 90.0 m-20 -95.19 27.68 3.15 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.065 0.946 . . . . 0.0 111.48 174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.7 34.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.057 0.543 . . . . 0.0 110.687 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mt -116.36 123.87 71.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 C-N-CA 123.967 0.907 . . . . 0.0 109.437 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HZ1' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -81.84 150.13 27.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.591 0.71 . . . . 0.0 110.465 170.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -101.11 109.95 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -89.91 167.73 12.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -107.1 -165.6 1.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.298 0.499 . . . . 0.0 110.482 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -59.04 -31.24 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.847 0.859 . . . . 0.0 112.034 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.08 -11.96 57.53 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.196 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.37 85.82 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 113.169 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 133.66 36.23 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 109.746 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -61.64 92.45 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 O-C-N 124.283 0.99 . . . . 0.0 110.816 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.92 -1.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.738 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 71' ' ' ARG . . . 172.76 -159.34 29.9 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.554 0.533 . . . . 0.0 113.83 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 11.6 p-80 -142.01 150.48 41.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.887 1.275 . . . . 0.0 107.632 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HG ' ' HE1' ' A' ' 148' ' ' MET . 2.7 tt -71.51 -53.84 12.53 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -178.47 -179.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.988 1.715 . . . . 0.0 108.104 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -81.0 -61.41 1.97 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 162.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.22 -39.21 23.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.712 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -67.08 -44.89 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.78 70.75 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.508 -1.223 . . . . 0.0 111.13 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -61.44 -42.82 99.86 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.876 0.735 . . . . 0.0 114.353 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.75 -47.95 67.82 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.389 0.614 . . . . 0.0 110.534 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.49 -18.97 63.74 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.55 87.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.117 0.967 . . . . 0.0 111.861 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -70.04 -32.87 71.21 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.699 0.625 . . . . 0.0 109.584 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.479 HD11 HG11 ' A' ' 160' ' ' VAL . 66.5 mt -67.63 -37.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.654 0.782 . . . . 0.0 110.782 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.91 -44.9 21.69 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.797 0.839 . . . . 0.0 111.075 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.74 -46.7 52.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.653 1.181 . . . . 0.0 110.791 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.97 6.86 33.81 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.806 0.443 . . . . 0.0 111.243 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 59.92 33.56 21.53 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.806 1.242 . . . . 0.0 111.733 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 122' ' ' ILE . 68.9 mt -65.71 -42.59 90.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.444 ' HB3' ' HE2' ' A' ' 60' ' ' PHE . . . -158.34 151.17 22.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -86.39 132.11 34.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -113.81 113.44 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -102.99 179.27 4.32 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.208 1.003 . . . . 0.0 108.481 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.33 164.38 31.47 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.551 HG21 ' HG2' ' A' ' 82' ' ' MET . 58.9 t -144.44 134.18 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.3 p -112.83 88.8 12.21 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.7 -22.88 8.73 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.489 2.126 . . . . 0.0 112.699 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.49 ' HB2' ' HE3' ' A' ' 144' ' ' MET . 64.8 m-85 -82.48 -28.45 31.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.923 0.489 . . . . 0.0 110.518 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.75 4.29 75.84 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -69.73 -9.05 52.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.301 0.64 . . . . 0.0 112.702 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -18.66 64.96 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.0 0.92 . . . . 0.0 113.221 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.62 -53.01 9.27 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 110.705 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.73 -34.35 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.169 0.588 . . . . 0.0 111.301 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -117.39 174.34 6.2 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.718 0.807 . . . . 0.0 110.819 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -98.92 111.02 23.54 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.493 ' SD ' ' HB2' ' A' ' 138' ' ' ALA . 19.6 ptm -125.8 158.74 64.36 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 121.921 -0.487 . . . . 0.0 110.644 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 2.5 Cg_endo -83.57 125.73 3.91 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.765 2.31 . . . . 0.0 110.826 164.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.22 154.75 22.95 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -74.76 111.21 9.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.053 0.541 . . . . 0.0 110.35 -171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.613 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -109.88 117.12 32.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.228 1.011 . . . . 0.0 110.328 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -107.49 135.23 49.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.505 1.122 . . . . 0.0 110.424 -167.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.2 118.95 35.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 109.424 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -123.62 103.49 8.45 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.47 169.47 36.99 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -62.95 138.06 58.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.011 0.525 . . . . 0.0 111.734 -176.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -52.48 -32.06 38.02 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.643 1.577 . . . . 0.0 113.071 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.34 -10.1 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.738 . . . . 0.0 112.697 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.57 4.13 20.05 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.841 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -61.06 -33.52 73.44 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.377 0.99 . . . . 0.0 111.756 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -33.19 69.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.239 0.616 . . . . 0.0 110.769 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -76.7 -38.31 54.61 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.615 0.766 . . . . 0.0 110.575 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.479 HG11 HD11 ' A' ' 122' ' ' ILE . 64.3 t -64.34 -47.65 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.141 0.976 . . . . 0.0 110.27 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.5 p -68.45 -29.87 68.61 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.881 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -43.13 99.38 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.38 0.672 . . . . 0.0 111.253 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 12.1 mm100 -63.15 -37.26 86.53 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.958 0.786 . . . . 0.0 110.485 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -48.38 51.01 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.223 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -66.07 -25.7 67.15 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.408 1.083 . . . . 0.0 111.611 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -67.04 -44.01 81.32 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.939 0.895 . . . . 0.0 111.293 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -110.09 3.94 20.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.903 0.481 . . . . 0.0 110.893 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.21 66.7 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 123.125 0.57 . . . . 0.0 110.373 173.132 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.85 -27.6 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 109.494 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.5 -16.97 60.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.642 0.777 . . . . 0.0 110.954 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -70.39 146.03 50.7 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.829 0.452 . . . . 0.0 109.976 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.0 m -141.14 161.13 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.932 1.293 . . . . 0.0 110.021 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.94 111.37 16.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.0 m-85 -74.02 -38.63 63.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.862 0.465 . . . . 0.0 110.905 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.8 -166.66 29.3 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.179 -169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.0 p -111.11 178.7 4.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.186 0.517 . . . . 0.0 111.474 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 47.6 tp -151.28 146.58 26.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.477 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -94.11 93.94 8.11 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.76 0.79 . . . . 0.0 109.399 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.83 102.85 2.61 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.829 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -78.66 105.7 10.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.363 0.581 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 HG11 ' HD2' ' A' ' 71' ' ' ARG . 10.8 t -89.56 147.33 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG11 ' HD3' ' A' ' 112' ' ' LYS . 31.4 m -80.62 167.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.26 -20.0 68.9 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.996 -1.002 . . . . 0.0 114.093 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.19 -17.78 30.62 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.468 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.721 ' HD3' ' HB2' ' A' ' 139' ' ' ASN . 68.7 ttt180 -56.26 -42.0 76.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.21 1.004 . . . . 0.0 112.98 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.538 ' HA ' HG11 ' A' ' 76' ' ' VAL . 16.0 p90 -75.06 -16.78 60.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.167 0.439 . . . . 0.0 111.583 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -83.44 -28.92 28.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.702 0.801 . . . . 0.0 110.289 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.1 m -75.22 -27.9 59.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.271 0.628 . . . . 0.0 111.152 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.54 53.98 0.31 Allowed Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.407 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 72' ' ' TYR . 3.3 m -41.45 169.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.6 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 9.2 m -115.53 -179.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.004 -176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.15 -166.7 0.52 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.559 1.144 . . . . 0.0 110.673 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -77.82 141.0 39.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.165 0.586 . . . . 0.0 110.894 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 8.0 t30 58.46 32.8 22.52 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.712 1.205 . . . . 0.0 112.447 170.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.6 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mm-40 -82.65 141.52 32.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.673 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.534 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.4 mtp -88.02 142.2 27.97 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 32.9 m -132.83 150.9 33.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.846 0.858 . . . . 0.0 110.246 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' HB1' ' OD1' ' A' ' 101' ' ' ASN . . . -107.69 157.15 18.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.264 1.026 . . . . 0.0 109.568 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.92 146.06 39.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.374 0.67 . . . . 0.0 110.003 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -155.35 130.61 9.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 13.2 ptm180 -66.89 146.03 54.83 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.11 0.481 . . . . 0.0 111.267 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -99.29 106.85 41.49 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.173 0.989 . . . . 0.0 108.445 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -83.7 3.56 7.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.802 2.335 . . . . 0.0 112.851 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -119.8 -11.21 9.4 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.661 0.784 . . . . 0.0 111.518 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 92' ' ' PRO . 5.1 t-20 -63.06 121.78 71.12 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.944 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 33.8 Cg_endo -59.49 -19.78 53.62 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.883 3.055 . . . . 0.0 114.355 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -72.14 -50.58 26.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.415 0.686 . . . . 0.0 110.524 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 96' ' ' ASN . 21.9 p-10 177.74 157.04 0.38 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.276 0.985 . . . . 0.0 110.66 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -64.03 -23.22 67.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.265 176.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 10.8 m-20 -75.61 -2.23 28.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.746 0.818 . . . . 0.0 112.499 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.5 33.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.499 0.32 . . . . 0.0 110.158 169.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.0 mt -133.75 126.34 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.024 0.929 . . . . 0.0 109.739 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.449 ' HB2' ' HZ1' ' A' ' 99' ' ' LYS . 4.4 ttmp? -82.27 134.08 35.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 168.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.58 134.85 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.287 0.635 . . . . 0.0 109.355 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.431 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 8.0 p30 -121.93 171.16 9.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.8 p30 -107.51 -169.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.482 1.037 . . . . 0.0 109.803 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.36 -29.89 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.47 -11.95 59.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.041 0.936 . . . . 0.0 111.692 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.17 -1.89 77.89 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 122.9 0.286 . . . . 0.0 113.382 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.479 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.8 t-20 -73.9 128.41 35.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.721 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.08 114.86 3.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.616 0.766 . . . . 0.0 110.409 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 106' ' ' ASN . 35.6 m -126.56 13.87 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.855 0.862 . . . . 0.0 111.974 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.36 -170.29 43.08 Favored Glycine 0 C--N 1.355 1.636 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.02 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -166.26 123.47 1.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.07 0.948 . . . . 0.0 109.123 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 115' ' ' LEU . 95.6 mt -80.34 7.26 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.1 0.96 . . . . 0.0 113.168 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 113' ' ' LYS . 16.1 tptm 64.08 -156.44 0.31 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.632 1.173 . . . . 0.0 109.972 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.546 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 16.5 ttmm -79.03 -48.61 14.1 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 118.987 0.812 . . . . 0.0 110.882 170.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.06 -59.47 4.71 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.073 0.858 . . . . 0.0 112.572 -162.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 111' ' ' LEU . 1.9 tm? -72.45 -46.54 54.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.618 0.723 . . . . 0.0 109.206 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -64.57 -29.47 70.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.713 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -65.71 -35.67 91.32 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 123.503 0.573 . . . . 0.0 112.63 -173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.71 -51.39 49.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.797 0.808 . . . . 0.0 109.486 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.68 -15.92 62.76 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.673 -1.148 . . . . 0.0 112.559 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.02 86.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.615 1.166 . . . . 0.0 112.689 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -73.76 -33.83 64.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 127' ' ' LEU . 56.8 mt -67.31 -33.5 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.419 0.688 . . . . 0.0 110.241 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.5 tpp -73.7 -43.36 59.5 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.005 1.322 . . . . 0.0 110.497 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.59 -50.47 30.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.803 -174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -91.05 2.03 56.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.483 -173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 56.03 44.13 25.98 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.714 1.205 . . . . 0.0 111.58 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.502 ' HB2' HG23 ' A' ' 122' ' ' ILE . 73.4 mt -70.18 -40.86 74.4 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.213 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.96 139.3 14.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.96 112.48 7.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.091 0.956 . . . . 0.0 109.529 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.14 120.33 48.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.38 166.8 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.88 150.36 21.94 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 82' ' ' MET . 64.8 t -142.08 116.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.26 92.74 0.93 Allowed Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 11.7 Cg_exo -69.65 -53.56 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.845 2.363 . . . . 0.0 113.498 -162.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.81 -26.31 57.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.631 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.99 79.43 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.939 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.78 -1.97 18.64 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.721 ' HB2' ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -63.17 -18.52 63.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.427 1.491 . . . . 0.0 113.84 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -82.22 -41.84 19.74 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.256 0.622 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.16 -58.42 3.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.809 0.444 . . . . 0.0 110.336 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -137.74 -163.15 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 110.294 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 p -95.2 127.02 40.92 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.6 ptm -129.36 151.29 77.61 Favored Pre-proline 0 C--O 1.249 1.059 0 C-N-CA 123.171 0.588 . . . . 0.0 109.51 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 139.82 25.92 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 121.968 1.778 . . . . 0.0 110.521 166.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -106.05 144.78 32.28 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -69.8 110.48 4.97 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.547 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 24.9 mtp -102.94 158.75 16.07 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -150.5 139.59 21.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 90.2 m-85 -101.83 133.2 46.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.078 0.951 . . . . 0.0 109.973 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -131.36 100.52 5.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.24 1.016 . . . . 0.0 108.805 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.56 169.39 37.82 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.66 ' HZ3' ' HB3' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -69.46 145.91 52.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.943 0.497 . . . . 0.0 111.715 -177.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.87 -28.5 67.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.035 0.934 . . . . 0.0 112.731 -172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.61 -21.83 62.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.877 0.471 . . . . 0.0 111.945 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -89.1 -8.6 53.52 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.046 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.278 0.49 . . . . 0.0 110.692 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -65.16 -34.83 79.33 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.297 0.373 . . . . 0.0 110.749 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.57 -33.58 28.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.621 0.769 . . . . 0.0 110.87 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.05 -49.99 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.457 0.703 . . . . 0.0 110.265 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.4 t -66.24 -29.75 70.06 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.648 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.85 -44.79 82.51 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.522 0.729 . . . . 0.0 109.957 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 17.8 mm100 -71.24 -38.54 71.96 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.876 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.58 -55.66 25.16 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.587 0.554 . . . . 0.0 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -64.35 -22.94 67.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.97 0.908 . . . . 0.0 112.13 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -62.31 -40.87 97.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.968 0.907 . . . . 0.0 110.907 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -107.36 -0.98 22.03 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 15.86 61.57 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 114.342 0.497 . . . . 0.0 114.342 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HB3' HD12 ' A' ' 63' ' ' LEU . 31.1 m-85 . . . . . 0 N--CA 1.482 1.166 0 C-N-CA 123.955 0.902 . . . . 0.0 112.126 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.765 0.317 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.89 -38.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.375 0.67 . . . . 0.0 109.372 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.31 -21.35 56.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.051 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -67.11 139.71 57.54 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.107 0.563 . . . . 0.0 110.724 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.45 169.0 17.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 109.144 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.26 126.64 35.59 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.39 -43.16 11.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.759 . . . . 0.0 110.053 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.58 -177.42 20.79 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.468 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -111.74 120.4 41.89 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.944 0.498 . . . . 0.0 110.219 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 169' ' ' PHE . 55.4 tp -77.14 148.16 36.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.835 1.254 . . . . 0.0 110.897 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -75.33 80.51 2.41 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.055 0.931 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.522 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -79.45 93.33 1.34 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.831 -171.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -70.56 92.37 0.84 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.34 138.33 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -71.07 144.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.17 74.82 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.395 -0.669 . . . . 0.0 114.006 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.91 -23.04 4.39 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.859 1.264 . . . . 0.0 112.965 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 108' ' ' VAL . 20.3 ptt85 -56.88 -6.63 0.36 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.889 1.676 . . . . 0.0 114.349 173.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -54.66 -35.88 63.99 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.11 0.564 . . . . 0.0 111.949 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.98 -26.81 60.66 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.919 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.9 m -75.64 -21.64 57.51 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.831 0.852 . . . . 0.0 111.32 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.69 50.1 0.45 Allowed Glycine 0 C--N 1.356 1.646 0 CA-C-O 119.865 -0.408 . . . . 0.0 113.981 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -52.84 171.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.9 m -114.04 176.85 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.559 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.23 -164.49 1.09 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.809 1.243 . . . . 0.0 110.247 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -82.7 157.37 23.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.314 0.645 . . . . 0.0 111.172 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 67.71 10.97 8.14 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.177 1.391 . . . . 0.0 112.463 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 29.6 mm-40 -84.11 149.37 26.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.499 0.72 . . . . 0.0 110.73 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.569 ' HG2' HG22 ' A' ' 133' ' ' VAL . 60.3 mtp -107.73 152.22 24.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.905 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.5 162.09 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.374 1.069 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.36 145.82 51.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.521 1.128 . . . . 0.0 108.924 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.04 135.13 42.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.187 0.595 . . . . 0.0 110.5 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.19 132.81 7.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.016 0.926 . . . . 0.0 108.697 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 2.5 ptp180 -57.1 147.39 24.67 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 112.086 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.18 127.33 59.59 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.512 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -20.09 65.61 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.248 2.632 . . . . 0.0 112.513 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -91.7 47.73 1.39 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.111 0.964 . . . . 0.0 109.147 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.1 p-10 -63.38 120.18 59.85 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.927 0.891 . . . . 0.0 111.365 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 18.2 Cg_exo -68.67 -50.89 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.912 2.408 . . . . 0.0 113.027 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.45 -50.33 4.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.202 0.601 . . . . 0.0 110.777 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -168.02 165.63 13.47 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' HB3' ' HZ1' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -56.26 -15.21 3.55 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.577 1.151 . . . . 0.0 113.062 177.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.518 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 29.5 p-10 -62.68 -21.92 66.09 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.687 0.795 . . . . 0.0 111.893 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.527 ' HB3' ' HE1' ' A' ' 110' ' ' HIS . . . -62.35 109.17 1.26 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.942 0.897 . . . . 0.0 109.926 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 98.7 mt -108.61 132.66 55.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 109.891 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.654 ' HZ2' ' HB3' ' A' ' 99' ' ' LYS . 5.1 ttpm? -98.68 146.58 25.72 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.503 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.6 124.86 63.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 109.593 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -110.63 153.83 24.64 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -90.54 -172.83 3.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.541 0.337 . . . . 0.0 110.13 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.52 -23.85 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.889 0.475 . . . . 0.0 112.066 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.191 0.596 . . . . 0.0 110.412 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.94 -0.83 86.54 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 122.778 0.228 . . . . 0.0 113.447 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -74.02 133.2 42.93 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.123 0.969 . . . . 0.0 108.975 175.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.435 ' N ' HD21 ' A' ' 106' ' ' ASN . 26.5 pt20 -64.3 106.38 1.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.674 0.75 . . . . 0.0 110.065 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.481 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 35.3 m -114.57 12.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.086 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.84 178.25 48.09 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 114.673 0.629 . . . . 0.0 114.673 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.527 ' HE1' ' HB3' ' A' ' 97' ' ' ALA . 78.9 t60 -161.34 113.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 86.2 mt -68.59 -13.13 62.14 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 83.0 tttt 70.71 149.18 0.08 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.124 0.97 . . . . 0.0 110.59 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -21.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.253 1.021 . . . . 0.0 112.476 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tp10 -56.74 -64.69 0.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.289 1.036 . . . . 0.0 111.461 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 HD21 ' A' ' 111' ' ' LEU . 59.9 tp -85.51 -49.66 7.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -60.04 -24.63 64.68 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.209 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.518 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.49 -34.36 89.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.456 0.472 . . . . 0.0 113.443 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.64 -45.08 26.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.438 0.695 . . . . 0.0 109.98 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.403 HD13 HD11 ' A' ' 111' ' ' LEU . 46.2 mt -70.73 -16.62 62.79 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.932 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.46 -53.91 32.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -68.9 -31.92 71.18 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.941 0.775 . . . . 0.0 110.761 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.23 -37.59 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.435 0.694 . . . . 0.0 110.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 44.9 ttm -79.32 -45.19 20.13 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.875 0.87 . . . . 0.0 110.962 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 87' ' ' ARG . 29.3 t70 -67.39 -46.62 72.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.067 0.947 . . . . 0.0 110.851 -172.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -92.18 1.36 57.26 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.09 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.18 37.95 17.13 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.376 1.07 . . . . 0.0 111.917 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.26 -42.5 93.2 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.818 0.847 . . . . 0.0 111.351 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.07 137.98 17.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.65 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.2 116.89 18.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.126 0.97 . . . . 0.0 108.642 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.35 123.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -107.07 178.66 4.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.76 155.04 25.92 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.5 t -142.67 141.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.269 1.028 . . . . 0.0 108.281 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 p -122.83 86.23 50.13 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.783 0.833 . . . . 0.0 109.153 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.52 -22.41 21.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.216 2.611 . . . . 0.0 113.9 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.633 ' HB2' ' HE3' ' A' ' 144' ' ' MET . 73.1 m-85 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.35 0.66 . . . . 0.0 110.797 -175.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 64.5 33.96 88.64 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 172.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -82.27 12.41 4.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.914 0.486 . . . . 0.0 111.446 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -52.85 -37.69 60.55 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.61 -44.7 63.95 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.423 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.86 3.56 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.374 0.669 . . . . 0.0 112.169 -168.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -122.51 170.73 9.69 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.544 0.738 . . . . 0.0 110.688 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 t -95.13 109.07 21.19 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.633 ' HE3' ' HB2' ' A' ' 136' ' ' PHE . 19.1 ptm -119.25 134.66 23.71 Favored Pre-proline 0 C--O 1.243 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 110.142 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.66 123.81 12.26 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.172 1.915 . . . . 0.0 110.795 164.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -98.12 156.64 16.57 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -82.12 107.49 14.86 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.522 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 11.8 mtp -105.16 112.54 25.7 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 m -101.79 120.41 40.32 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.077 0.551 . . . . 0.0 110.213 -163.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -94.89 124.19 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.056 0.942 . . . . 0.0 110.18 -172.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -124.29 111.56 15.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.574 1.15 . . . . 0.0 108.232 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.41 166.87 36.73 Favored Glycine 0 N--CA 1.463 0.485 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -68.89 146.88 52.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.021 0.528 . . . . 0.0 111.898 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.4 -24.75 67.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.274 1.029 . . . . 0.0 112.962 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.41 -13.39 59.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.669 0.387 . . . . 0.0 111.877 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.79 0.02 16.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -25.12 67.08 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.339 0.518 . . . . 0.0 112.165 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -36.43 83.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -80.47 -36.08 33.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.457 0.703 . . . . 0.0 110.923 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.79 -53.02 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.524 0.73 . . . . 0.0 109.799 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.9 t -70.71 -25.16 62.83 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.108 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.6 t70 -60.8 -49.53 77.1 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.0 mm100 -66.14 -38.51 88.31 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.159 0.912 . . . . 0.0 111.638 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.53 -62.66 1.39 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.715 0.635 . . . . 0.0 110.012 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.68 -19.1 65.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.38 1.072 . . . . 0.0 112.635 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 23.8 ttmm -51.39 -46.63 62.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.914 0.885 . . . . 0.0 110.889 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -95.94 -23.7 16.74 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.522 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 8.27 11.15 Favored Glycine 0 N--CA 1.475 1.263 0 N-CA-C 113.669 0.228 . . . . 0.0 113.669 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 63' ' ' LEU . 49.8 m-85 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -75.79 -31.51 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.057 0.943 . . . . 0.0 109.855 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.44 -44.29 68.16 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.312 1.445 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -85.7 122.64 30.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.47 165.02 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.816 1.246 . . . . 0.0 110.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 61' ' ' GLY . 5.9 tt -82.75 111.35 18.61 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -74.65 -36.02 62.86 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.491 0.717 . . . . 0.0 111.132 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' HD22 ' A' ' 59' ' ' LEU . . . 163.94 177.32 36.62 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.54 -171.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 p -112.83 149.32 33.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.303 0.641 . . . . 0.0 110.552 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.12 146.52 50.68 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.604 0.762 . . . . 0.0 110.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 145' ' ' PRO . 98.1 mtt180 -86.08 90.28 8.07 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.272 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.73 1.59 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.977 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -79.07 100.42 7.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.041 0.536 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.58 142.03 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 O-C-N 123.618 0.574 . . . . 0.0 109.541 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.04 154.23 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.944 0.898 . . . . 0.0 112.062 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.78 82.0 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.258 0.349 . . . . 0.0 113.66 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.09 -17.57 53.29 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.901 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.538 HH12 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -61.51 -14.49 29.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.363 1.065 . . . . 0.0 113.53 -177.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.76 ' HA ' HG13 ' A' ' 76' ' ' VAL . 44.9 p90 -60.21 -39.7 87.49 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.223 0.535 . . . . 0.0 111.509 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -71.71 -20.2 61.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.12 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 m -99.23 6.36 46.34 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.651 0.781 . . . . 0.0 111.502 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.27 55.84 0.59 Allowed Glycine 0 C--N 1.367 2.299 0 C-N-CA 120.362 -0.923 . . . . 0.0 115.398 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 ' HA ' ' A' ' 72' ' ' TYR . 8.1 m -40.46 155.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.476 HG21 HG23 ' A' ' 134' ' ' VAL . 19.5 m -115.57 159.78 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.335 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -85.27 -167.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.33 1.052 . . . . 0.0 111.659 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -73.83 151.65 40.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.305 0.642 . . . . 0.0 111.562 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 61.24 8.19 1.96 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.723 1.209 . . . . 0.0 113.595 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.68 133.29 40.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.59 0.756 . . . . 0.0 110.754 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.505 ' HG2' HG22 ' A' ' 133' ' ' VAL . 76.9 mtp -94.09 150.01 20.72 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.413 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.02 166.18 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.761 1.224 . . . . 0.0 109.354 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.68 140.88 48.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.635 1.174 . . . . 0.0 108.567 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.7 mp -97.12 132.41 42.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -150.32 133.36 16.15 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.6 ptt180 -69.98 145.27 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.097 0.475 . . . . 0.0 110.115 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -89.6 125.12 62.35 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.883 0.873 . . . . 0.0 111.288 -167.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.43 -19.84 24.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.203 2.602 . . . . 0.0 113.283 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -93.9 18.79 9.86 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.181 0.992 . . . . 0.0 110.315 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -51.37 137.06 30.82 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.142 1.377 . . . . 0.0 113.528 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.01 -41.22 0.23 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.471 2.114 . . . . 0.0 112.453 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.32 -53.1 4.23 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.981 0.512 . . . . 0.0 111.448 -168.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -173.3 159.69 3.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.379 1.072 . . . . 0.0 108.476 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 18.4 ptpt -57.68 -25.6 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.55 4.71 23.44 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.37 103.85 1.73 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 64.6 mt -82.91 121.6 36.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.043 -172.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 37.6 ttmt -100.09 127.93 46.24 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.092 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.18 130.68 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.058 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -120.87 154.41 35.87 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -90.1 -171.52 3.16 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.026 0.83 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.97 -34.07 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.814 0.846 . . . . 0.0 112.505 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -77.68 -22.79 49.99 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.933 0.893 . . . . 0.0 111.065 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.37 4.36 58.38 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.74 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.57 125.36 24.0 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.426 0.691 . . . . 0.0 110.013 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.581 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 75.8 mt-30 -71.0 100.86 2.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.021 0.928 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.538 ' HB ' HH12 ' A' ' 71' ' ' ARG . 34.1 m -91.71 -2.66 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.381 0.672 . . . . 0.0 112.188 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.75 165.68 12.21 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 123.239 0.337 . . . . 0.0 112.553 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.8 m-70 -76.21 150.4 37.08 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.812 0.445 . . . . 0.0 110.125 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -70.7 -52.99 17.44 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 5.0 tmtp? 162.54 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -30.17 68.9 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.609 0.763 . . . . 0.0 112.81 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 38.8 tt0 -75.04 -54.92 6.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.88 0.872 . . . . 0.0 110.852 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.578 0.751 . . . . 0.0 109.784 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.83 92.24 Favored 'General case' 0 C--O 1.208 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.665 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.52 -35.61 80.95 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 124.141 0.901 . . . . 0.0 113.89 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . . . -67.53 -50.15 60.03 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.199 0.523 . . . . 0.0 110.06 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -77.94 -14.03 59.68 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.4 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.76 -47.3 64.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.378 1.471 . . . . 0.0 113.23 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -68.83 -32.33 71.95 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.705 0.802 . . . . 0.0 110.548 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 160' ' ' VAL . 51.4 mt -66.03 -42.58 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.002 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.7 tpp -74.15 -37.55 64.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.678 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.95 -44.87 46.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.643 1.177 . . . . 0.0 110.863 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -99.07 5.45 46.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.057 0.543 . . . . 0.0 111.884 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 59.19 33.87 22.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.173 0.989 . . . . 0.0 112.057 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.23 -36.59 84.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.05 155.68 16.42 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.822 0.849 . . . . 0.0 110.833 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -82.01 139.44 34.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.779 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.53 125.16 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.76 148.46 43.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.205 1.002 . . . . 0.0 109.597 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -129.89 176.25 18.75 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 122.946 0.153 . . . . 0.0 113.381 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 ' HG2' ' A' ' 82' ' ' MET . 12.4 t -142.79 141.63 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.092 1.357 . . . . 0.0 108.121 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.476 HG23 HG21 ' A' ' 77' ' ' VAL . 6.5 m -103.98 86.06 1.17 Allowed Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.015 0.926 . . . . 0.0 108.977 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.24 -51.32 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.666 2.244 . . . . 0.0 113.408 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.504 ' HD2' ' HB3' ' A' ' 138' ' ' ALA . 37.7 t80 -70.86 -26.71 63.38 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.91 0.484 . . . . 0.0 110.501 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.67 19.53 79.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.513 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 136' ' ' PHE . . . -61.4 -17.48 54.35 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.283 0.633 . . . . 0.0 111.442 175.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -48.44 -31.8 6.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.012 1.725 . . . . 0.0 112.847 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.44 -44.96 81.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 0.0 111.002 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.17 -64.35 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.172 0.589 . . . . 0.0 111.529 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -119.54 143.59 47.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.267 1.027 . . . . 0.0 109.741 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 p -93.48 109.18 20.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.025 0.917 . . . . 0.0 109.129 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 165.84 12.68 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.343 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 20.2 Cg_exo -67.24 122.05 9.27 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 121.486 1.457 . . . . 0.0 110.676 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.96 149.9 22.97 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.582 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 58.2 mtt -103.34 164.08 11.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 0.0 109.524 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -148.79 144.59 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.301 1.04 . . . . 0.0 109.07 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -105.18 128.38 53.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.806 0.842 . . . . 0.0 109.394 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -129.06 102.81 6.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.379 1.072 . . . . 0.0 109.631 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.32 178.95 37.93 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.57 142.91 58.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 117.48 0.64 . . . . 0.0 111.895 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.64 -34.78 27.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 113.631 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.51 -26.72 61.01 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -85.55 2.86 43.16 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.845 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -34.89 79.09 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.981 0.355 . . . . 0.0 110.26 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -26.78 56.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.88 0.872 . . . . 0.0 111.309 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -73.7 -52.32 13.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 122' ' ' ILE . 49.9 t -57.02 -43.12 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.928 1.291 . . . . 0.0 111.777 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.6 p -64.95 -33.94 77.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.921 0.489 . . . . 0.0 111.385 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 20.5 t70 -67.26 -32.94 74.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.688 0.618 . . . . 0.0 110.48 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 8.1 mm100 -73.33 -25.81 60.78 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 95.9 mt -76.51 -39.51 52.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.531 0.733 . . . . 0.0 110.253 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 8.7 mtpm? -59.96 -22.22 62.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.297 1.039 . . . . 0.0 111.992 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 118' ' ' ALA . 40.2 ttmt -54.0 -49.95 67.7 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 111.24 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -100.18 0.1 39.84 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.686 0.394 . . . . 0.0 111.082 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.59 35.95 24.32 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 116.802 -0.181 . . . . 0.0 112.82 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 25.8 m-85 . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 123.576 0.75 . . . . 0.0 110.808 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.688 -0.116 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.04 -37.06 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.405 0.682 . . . . 0.0 109.809 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.65 -34.86 78.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.535 1.134 . . . . 0.0 111.018 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -79.39 130.32 35.31 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.234 0.614 . . . . 0.0 109.487 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.19 156.42 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.843 0.857 . . . . 0.0 111.873 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 61' ' ' GLY . 6.0 tt -81.08 105.6 12.42 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.7 m-85 -73.66 -30.36 62.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.943 0.497 . . . . 0.0 110.601 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 148.46 -170.61 28.96 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -175.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.402 ' HG ' HG23 ' A' ' 149' ' ' THR . 29.6 m -129.19 118.39 22.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.07 175.04 10.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -126.64 97.89 5.18 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.828 0.823 . . . . 0.0 108.848 174.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.08 124.81 7.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.691 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -88.6 119.41 29.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.741 0.817 . . . . 0.0 110.358 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.73 140.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 46.8 t -72.35 139.49 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.82 58.43 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.253 -0.43 . . . . 0.0 113.895 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -23.43 67.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 111.276 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 74' ' ' THR . 3.5 mpt_? -75.52 -1.2 23.17 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.28 1.032 . . . . 0.0 111.817 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -45.33 -32.9 2.21 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.16 -18.03 65.1 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.792 1.237 . . . . 0.0 112.565 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 71' ' ' ARG . 14.7 t -73.78 -20.62 60.43 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.122 0.569 . . . . 0.0 110.973 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.63 48.6 0.54 Allowed Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.55 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.14 165.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 121.489 0.662 . . . . 0.0 111.524 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.597 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 18.1 m -115.52 171.84 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.238 -171.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -104.83 -166.78 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -63.19 149.52 45.19 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.569 0.747 . . . . 0.0 111.446 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 77.17 -18.54 0.48 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.55 1.54 . . . . 0.0 112.337 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.597 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.3 mm-40 -62.56 141.78 58.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.477 ' HG2' HG21 ' A' ' 133' ' ' VAL . 85.4 mtp -105.06 143.74 32.82 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.969 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 18.2 m -129.57 132.32 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 109.795 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.42 142.25 28.75 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 109.686 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.614 HD13 ' SD ' ' A' ' 148' ' ' MET . 5.7 mp -90.68 121.14 32.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.858 0.863 . . . . 0.0 108.948 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -125.91 121.54 33.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 121.91 13.38 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -70.45 122.77 87.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.133 -163.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -20.35 36.71 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.693 2.262 . . . . 0.0 112.243 172.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -101.36 24.9 8.93 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.149 0.979 . . . . 0.0 110.667 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.81 126.75 72.74 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.588 0.755 . . . . 0.0 111.67 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.0 -24.17 6.03 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.462 2.108 . . . . 0.0 113.862 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.52 -56.08 1.99 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.228 -0.295 . . . . 0.0 111.362 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 6.4 m-20 -150.49 153.63 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.29 -14.65 57.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.863 0.865 . . . . 0.0 112.476 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.561 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 16.4 p-10 -70.3 -20.24 63.03 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.614 0.766 . . . . 0.0 111.638 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.99 109.38 3.44 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.293 0.637 . . . . 0.0 109.311 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -85.09 119.51 33.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.685 0.794 . . . . 0.0 109.867 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 7.6 ttpm? -83.48 116.53 22.58 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.419 HG11 ' HB ' ' A' ' 83' ' ' VAL . 10.3 t -85.56 128.56 39.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -122.98 143.15 50.11 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 28.3 p-10 -82.72 -167.94 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.248 0.931 . . . . 0.0 111.259 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.34 -31.18 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.464 1.106 . . . . 0.0 112.773 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -83.93 -27.41 28.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.532 0.733 . . . . 0.0 111.05 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.18 6.53 48.16 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.582 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -66.5 120.96 14.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.801 0.84 . . . . 0.0 110.26 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -60.18 107.42 0.64 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 110.833 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.58 2.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 0.0 111.449 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 134.13 -145.69 17.73 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 173.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.13 158.51 43.46 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.034 0.934 . . . . 0.0 109.862 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.477 HD12 ' HE3' ' A' ' 148' ' ' MET . 29.1 mt -87.89 8.46 26.0 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.813 0.845 . . . . 0.0 112.456 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 69.63 129.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.558 1.143 . . . . 0.0 110.074 -172.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -44.13 -39.16 4.1 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.188 1.395 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -62.22 -54.61 38.44 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.334 1.054 . . . . 0.0 112.281 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.413 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 10.4 tt -75.08 -47.81 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.444 0.64 . . . . 0.0 110.031 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.92 -34.47 63.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.579 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -55.07 -37.41 63.28 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.024 0.828 . . . . 0.0 115.004 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.74 -51.49 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.976 0.51 . . . . 0.0 110.523 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HA ' HD11 ' A' ' 122' ' ' ILE . 30.1 mt -73.77 -20.06 60.6 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.745 -172.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.43 64.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.766 0.826 . . . . 0.0 111.896 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.22 -36.77 77.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.493 HD13 HG12 ' A' ' 160' ' ' VAL . 64.1 mt -61.82 -37.11 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 110.763 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.3 ttm -79.23 -51.17 9.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.452 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.0 -39.38 69.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.379 1.072 . . . . 0.0 111.108 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -90.57 1.64 56.55 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 62.74 43.1 7.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.413 1.085 . . . . 0.0 111.768 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 122' ' ' ILE . 45.6 mt -76.75 -48.05 19.88 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.642 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.47 149.68 27.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.198 0.599 . . . . 0.0 110.721 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -89.45 106.69 18.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.045 0.938 . . . . 0.0 109.309 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -93.89 124.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.98 160.84 14.72 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.47 144.81 15.6 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' A' ' 82' ' ' MET . 40.3 t -137.7 126.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.65 90.42 5.04 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.82 -18.7 5.35 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.519 2.146 . . . . 0.0 113.003 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.447 ' HB2' ' HE1' ' A' ' 144' ' ' MET . 61.0 m-85 -79.44 -32.63 42.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.762 0.425 . . . . 0.0 110.816 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.85 17.07 20.31 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.853 0.721 . . . . 0.0 114.599 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.427 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -84.26 0.74 47.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.608 0.763 . . . . 0.0 111.384 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -64.11 -26.4 68.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.653 1.181 . . . . 0.0 110.878 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.51 -30.35 63.05 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.695 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.5 11.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.277 0.631 . . . . 0.0 111.718 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -158.35 -168.64 2.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.545 0.738 . . . . 0.0 110.289 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.8 p -94.55 120.6 35.04 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.516 0.727 . . . . 0.0 109.066 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.447 ' HE1' ' HB2' ' A' ' 136' ' ' PHE . 3.2 ppp? -147.45 156.88 45.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.006 0.922 . . . . 0.0 109.743 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.567 ' HB2' ' HB2' ' A' ' 64' ' ' ARG . 26.9 Cg_endo -92.84 144.36 2.37 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.516 2.144 . . . . 0.0 113.531 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -107.38 153.91 22.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -79.73 109.57 14.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.759 0.314 . . . . 0.0 111.223 -170.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.614 ' SD ' HD13 ' A' ' 85' ' ' LEU . 22.0 mmt -89.85 110.23 21.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.896 0.878 . . . . 0.0 108.837 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 62' ' ' SER . 7.0 m -103.46 125.25 49.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 31.5 m-85 -89.05 120.44 30.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 109.251 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.47 101.76 7.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.88 159.66 29.46 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.617 ' HB3' ' HZ2' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -60.19 145.58 46.6 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.267 0.627 . . . . 0.0 112.614 -175.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.45 -30.78 61.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.014 1.326 . . . . 0.0 113.468 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.34 -29.62 65.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.914 0.485 . . . . 0.0 111.472 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -88.66 9.8 22.92 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.285 0.634 . . . . 0.0 111.933 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 158' ' ' LYS . 11.7 ptp180 -54.93 -45.18 74.8 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.591 0.356 . . . . 0.0 111.601 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -78.94 -26.57 43.62 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.631 0.372 . . . . 0.0 111.333 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.24 89.76 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.041 0.536 . . . . 0.0 110.325 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 122' ' ' ILE . 70.1 t -70.45 -45.29 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.489 1.116 . . . . 0.0 110.726 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.496 ' HB3' ' HE3' ' A' ' 165' ' ' LYS . 67.2 m -64.52 -32.15 73.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.26 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.98 -42.43 76.3 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.774 0.83 . . . . 0.0 110.865 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.05 -38.23 78.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.857 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.11 -55.43 16.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.798 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 161' ' ' SER . 93.7 mttt -56.9 -29.04 62.66 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.749 1.22 . . . . 0.0 111.993 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.08 -41.02 97.75 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.855 0.862 . . . . 0.0 111.54 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.13 3.6 25.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.768 0.427 . . . . 0.0 110.615 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.95 20.65 77.55 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.932 -0.371 . . . . 0.0 113.364 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.413 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 32.2 m-85 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.939 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -70.55 -34.76 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 168.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -47.19 48.54 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.928 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.2 m -82.69 115.04 21.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.648 0.779 . . . . 0.0 111.005 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG22 ' HG2' ' A' ' 154' ' ' GLU . 14.3 m -107.71 162.94 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.256 1.022 . . . . 0.0 110.978 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.14 116.19 22.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.118 0.567 . . . . 0.0 109.793 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -79.43 -24.78 42.25 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.923 0.489 . . . . 0.0 110.567 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.03 -170.39 24.58 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.26 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' HG21 ' A' ' 149' ' ' THR . 22.5 p -123.1 121.35 35.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.073 0.549 . . . . 0.0 110.383 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.8 tp -80.12 145.87 32.15 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 109.876 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -76.16 85.87 3.01 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.96 54.61 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -141.32 91.75 2.41 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.529 1.165 . . . . 0.0 110.088 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 HG13 HG11 ' A' ' 108' ' ' VAL . 98.9 t -76.51 127.77 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 167.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 24.9 t -68.32 141.73 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 123.737 0.648 . . . . 0.0 110.542 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.79 -44.98 23.47 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.539 0.524 . . . . 0.0 113.747 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.85 -15.79 55.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.473 0.709 . . . . 0.0 112.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.487 ' HG2' ' HB ' ' A' ' 68' ' ' VAL . 36.6 mmt180 -73.81 -0.46 15.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.924 0.889 . . . . 0.0 112.54 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.488 ' HA ' HG11 ' A' ' 76' ' ' VAL . 42.5 p90 -50.72 -23.83 2.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.376 1.071 . . . . 0.0 113.843 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.72 -7.65 22.51 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.424 1.089 . . . . 0.0 112.71 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 p -73.23 -33.48 65.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.265 0.626 . . . . 0.0 109.912 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.59 48.05 0.52 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 72' ' ' TYR . 27.5 m -55.3 167.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.626 0.77 . . . . 0.0 112.268 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 m -114.12 163.88 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.27 0.628 . . . . 0.0 110.796 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -74.67 -172.19 1.47 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.312 1.045 . . . . 0.0 111.711 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -65.14 149.04 50.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.871 . . . . 0.0 111.95 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 64.88 10.75 6.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.957 1.303 . . . . 0.0 113.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.74 143.11 32.06 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.13 0.423 . . . . 0.0 111.154 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.503 ' HG2' HG23 ' A' ' 133' ' ' VAL . 83.2 mtp -83.08 145.5 29.23 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.705 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.401 HG23 HD12 ' A' ' 146' ' ' LEU . 29.4 m -134.27 145.0 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.017 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.98 125.02 53.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.675 0.79 . . . . 0.0 109.895 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.58 HD22 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -90.14 138.42 31.53 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.982 0.913 . . . . 0.0 109.749 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -147.73 138.7 23.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.6 ptm180 -67.09 158.33 31.4 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.579 0.228 . . . . 0.0 110.568 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -87.99 116.06 65.0 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 123.103 0.561 . . . . 0.0 110.647 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.28 -39.06 5.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.275 1.983 . . . . 0.0 110.493 168.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -88.88 71.14 8.63 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 170.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.44 134.49 86.7 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.34 -42.16 4.11 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.961 2.44 . . . . 0.0 112.519 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -126.3 -52.79 1.5 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.461 0.704 . . . . 0.0 110.014 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -146.85 165.74 28.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.704 0.802 . . . . 0.0 109.95 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.12 -5.49 18.08 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.237 1.015 . . . . 0.0 112.581 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.463 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 1.9 m-20 -77.13 9.69 2.88 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.594 1.158 . . . . 0.0 112.586 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -93.39 139.37 30.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.479 0.712 . . . . 0.0 110.208 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 54.5 mt -127.07 120.42 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.36 1.064 . . . . 0.0 109.133 175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -87.47 115.37 24.85 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.439 0.695 . . . . 0.0 109.854 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' HG ' ' A' ' 85' ' ' LEU . 53.0 t -87.1 126.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 14.9 m-80 -117.65 164.67 14.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -95.7 -170.77 2.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.69 -22.59 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -86.64 -3.08 58.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.219 1.008 . . . . 0.0 111.908 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.68 86.08 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 122.945 0.307 . . . . 0.0 113.491 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -76.84 134.17 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.633 0.773 . . . . 0.0 108.986 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.9 pt20 -71.58 127.42 32.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 122.303 1.049 . . . . 0.0 111.662 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 67' ' ' VAL . 93.0 t -78.06 -24.79 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.177 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.41 -168.19 28.48 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.99 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -117.23 148.97 41.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 148' ' ' MET . 52.2 mt -75.33 -6.29 49.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.233 0.613 . . . . 0.0 112.26 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 68.74 141.86 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.262 1.025 . . . . 0.0 110.229 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -21.29 3.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -62.57 -63.03 1.35 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.071 0.948 . . . . 0.0 110.702 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.1 tt -80.36 -50.56 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.094 0.557 . . . . 0.0 109.597 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 111' ' ' LEU . . . -52.8 -33.37 48.72 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.049 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -55.49 -43.48 85.43 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.105 0.878 . . . . 0.0 114.814 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.97 -48.74 72.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.23 0.538 . . . . 0.0 110.624 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.95 -18.24 60.91 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.625 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.48 91.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.12 0.968 . . . . 0.0 111.788 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -68.06 -40.78 82.7 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.549 0.531 . . . . 0.0 109.618 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.509 HD11 HG13 ' A' ' 160' ' ' VAL . 55.3 mt -63.79 -37.41 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.587 0.755 . . . . 0.0 110.75 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.6 tpp -70.75 -52.61 19.7 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.16 -32.51 73.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.619 1.567 . . . . 0.0 111.689 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.28 -2.57 36.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.026 0.531 . . . . 0.0 111.278 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 61.13 32.51 19.62 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.898 0.879 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.508 ' HB2' HG23 ' A' ' 122' ' ' ILE . 67.0 mt -63.39 -44.66 94.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.515 0.726 . . . . 0.0 110.145 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.45 142.23 21.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.288 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.03 107.85 5.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.479 1.112 . . . . 0.0 109.281 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.8 mt -99.36 104.83 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.4 178.72 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.21 168.76 32.01 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.466 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 82' ' ' MET . 63.9 t -141.36 125.73 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.43 100.66 2.43 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.688 ' HD2' ' HE1' ' A' ' 144' ' ' MET . 10.0 Cg_exo -69.46 -44.33 2.35 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.837 2.358 . . . . 0.0 113.812 -167.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.47 -23.9 14.96 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 0.0 111.285 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.48 27.66 71.2 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.304 0.377 . . . . 0.0 113.547 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.479 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -81.29 4.82 19.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.475 0.71 . . . . 0.0 112.174 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -63.43 -9.51 12.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.078 0.951 . . . . 0.0 112.004 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -64.42 -42.14 96.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.916 0.887 . . . . 0.0 111.008 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.8 -60.9 1.47 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.827 0.851 . . . . 0.0 111.147 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -139.48 -173.62 3.66 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.875 . . . . 0.0 109.444 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 t -93.04 134.91 34.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.688 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 4.4 ppp? -137.95 153.12 73.32 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.706 0.802 . . . . 0.0 109.96 -172.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.46 122.09 9.27 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.17 1.914 . . . . 0.0 112.637 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 83' ' ' VAL . 6.5 tt -100.91 124.54 46.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -80.17 110.16 15.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -172.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.602 ' HE1' HD21 ' A' ' 111' ' ' LEU . 59.6 mtt -112.81 116.32 29.88 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -171.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.421 HG21 ' HB3' ' A' ' 62' ' ' SER . 37.8 p -102.71 133.68 47.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.95 1.3 . . . . 0.0 110.306 -165.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -100.95 117.76 35.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.834 0.853 . . . . 0.0 109.166 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -119.19 99.05 6.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.417 0.687 . . . . 0.0 109.508 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 163.44 31.73 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.512 ' HB3' ' HZ2' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -56.46 146.47 24.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 111.655 178.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 58' ' ' VAL . 44.6 mt-10 -58.97 -18.78 37.09 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.36 -32.31 43.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.087 0.403 . . . . 0.0 111.296 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -77.9 -6.92 55.88 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -57.95 -27.79 63.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.219 0.463 . . . . 0.0 110.791 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.78 -53.2 59.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.12 0.968 . . . . 0.0 109.138 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.88 -30.97 65.96 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.97 0.908 . . . . 0.0 112.081 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 122' ' ' ILE . 56.1 t -71.13 -55.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.157 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.2 t -66.1 -22.69 66.41 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.903 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.22 -44.56 92.3 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.085 0.554 . . . . 0.0 110.307 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -79.51 -30.14 41.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.237 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.69 -61.01 2.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.85 -21.1 65.7 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.752 1.221 . . . . 0.0 112.101 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -53.45 -46.51 69.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.653 0.781 . . . . 0.0 110.493 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -99.72 -16.91 17.98 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.129 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.47 16.77 21.61 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 116.554 -0.294 . . . . 0.0 113.177 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 122.825 0.45 . . . . 0.0 110.095 170.792 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.952 0.406 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.42 -22.16 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.642 0.777 . . . . 0.0 110.444 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -72.94 -46.65 51.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.271 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -80.19 113.88 18.69 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 154' ' ' GLU . 13.8 m -107.19 156.43 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.148 0.979 . . . . 0.0 111.327 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.79 109.6 14.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.445 0.698 . . . . 0.0 109.762 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -74.38 -36.23 63.53 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 110.972 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.64 -176.03 36.44 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.769 0.668 . . . . 0.0 112.558 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 148' ' ' MET . 49.4 p -115.92 122.35 45.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.119 0.968 . . . . 0.0 110.532 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.86 137.46 38.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.941 0.496 . . . . 0.0 109.711 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -90.78 83.98 5.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -75.21 153.07 44.43 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.469 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -116.47 111.05 19.43 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.832 1.316 . . . . 0.0 109.978 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 111' ' ' LEU . 2.5 t -94.68 157.32 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.083 0.953 . . . . 0.0 109.118 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 m -76.05 161.94 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.83 -17.74 74.34 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.326 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.7 -18.42 30.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.308 1.043 . . . . 0.0 111.431 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.671 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 63.8 mtp180 -49.86 -33.31 16.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.394 1.078 . . . . 0.0 113.204 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.27 -43.87 92.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.217 0.607 . . . . 0.0 110.628 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -71.62 -35.49 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.457 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -74.95 -16.93 60.62 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.089 0.555 . . . . 0.0 111.798 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.76 54.3 0.54 Allowed Glycine 0 C--N 1.357 1.713 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.282 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.3 m -40.9 164.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 19.3 m -114.51 167.16 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.527 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.38 -79.27 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.309 0.644 . . . . 0.0 111.825 -170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.6 154.15 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.789 0.835 . . . . 0.0 110.308 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.79 28.56 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.943 1.297 . . . . 0.0 111.83 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 49.8 mm-40 -87.25 142.82 27.62 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.327 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 78.0 mtp -99.76 127.88 45.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 102' ' ' ASN . 35.6 m -118.04 163.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.294 1.038 . . . . 0.0 108.997 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.48 128.41 47.98 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' A' ' 98' ' ' ILE . 12.8 mt -80.18 112.01 17.09 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -123.78 115.12 20.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 108.316 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 37.2 ptt180 -57.03 133.82 55.28 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 121.106 0.479 . . . . 0.0 110.925 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.2 118.94 57.86 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.138 -161.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.667 2.245 . . . . 0.0 112.039 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -111.08 32.38 5.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.422 1.089 . . . . 0.0 109.73 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.41 127.3 65.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.877 0.871 . . . . 0.0 111.773 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.37 -48.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.033 1.822 . . . . 0.0 113.011 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -99.04 -50.5 4.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.792 0.437 . . . . 0.0 110.524 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -159.59 156.57 28.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.17 0.588 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.579 ' HZ2' ' HB3' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -65.33 -7.26 12.63 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.519 1.528 . . . . 0.0 113.559 -178.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.563 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 26.1 p-10 -64.13 -30.7 71.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.003 0.521 . . . . 0.0 111.584 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.06 125.85 25.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.892 0.745 . . . . 0.0 109.239 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 70.5 mt -113.2 127.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 109.647 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 151.17 32.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 172.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.1 t -110.58 120.46 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.748 1.219 . . . . 0.0 107.854 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -119.06 127.46 53.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HA ' HG13 ' A' ' 83' ' ' VAL . 35.4 p-10 -71.93 -173.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.392 0.677 . . . . 0.0 112.385 -175.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.78 -31.9 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 C-N-CA 124.147 0.979 . . . . 0.0 112.293 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.73 -31.83 63.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.642 0.777 . . . . 0.0 111.053 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.68 -3.38 42.32 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.342 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -67.72 136.54 54.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.117 0.967 . . . . 0.0 110.836 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.5 pm0 -67.1 117.74 9.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.19 -2.38 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.385 0.674 . . . . 0.0 111.644 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.671 ' HA3' ' HG2' ' A' ' 71' ' ' ARG . . . 152.59 -177.15 30.48 Favored Glycine 0 C--N 1.36 1.913 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 172.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -108.95 151.32 26.46 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.584 ' HA ' HG12 ' A' ' 67' ' ' VAL . 52.0 mt -72.58 -55.03 7.54 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.581 0.628 . . . . 0.0 112.386 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 147.31 143.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.241 1.816 . . . . 0.0 106.104 -162.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HG2' HD22 ' A' ' 96' ' ' ASN . 5.5 tmmm? -65.83 -41.41 91.83 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.861 0.464 . . . . 0.0 109.97 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.63 -52.67 42.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.802 0.841 . . . . 0.0 111.384 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 111' ' ' LEU . 62.6 tp -59.78 -57.12 14.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.12 70.15 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.994 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -60.69 -42.54 99.38 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.631 0.582 . . . . 0.0 113.307 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.73 71.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.36 0.664 . . . . 0.0 110.163 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 130' ' ' ILE . 61.3 mt -71.79 -17.79 62.15 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.17 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.33 77.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.372 1.069 . . . . 0.0 112.042 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.07 -35.76 64.28 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.063 0.545 . . . . 0.0 109.629 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.507 HG21 ' HB2' ' A' ' 127' ' ' LEU . 51.6 mt -65.1 -36.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.39 0.614 . . . . 0.0 110.02 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 41.1 tpp -70.23 -44.21 69.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.913 1.285 . . . . 0.0 111.099 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.65 -48.71 24.73 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.263 -173.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -91.05 5.83 47.32 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.619 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 60.62 34.66 20.11 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.048 0.939 . . . . 0.0 111.641 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 122' ' ' ILE . 81.8 mt -65.92 -41.56 91.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.583 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.66 141.39 8.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 110.269 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.23 107.48 14.06 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 119' ' ' LEU . 18.6 mt -92.49 117.82 36.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -85.79 166.21 16.25 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -130.53 143.86 15.21 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 170.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.85 130.85 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.687 HG21 ' SD ' ' A' ' 144' ' ' MET . 2.4 p -118.15 85.71 24.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.48 -38.68 0.67 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.642 2.228 . . . . 0.0 113.535 -171.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.38 -29.73 65.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.964 0.506 . . . . 0.0 110.384 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.31 17.23 68.1 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.57 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.99 9.94 4.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.111 0.965 . . . . 0.0 112.39 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.512 HD21 ' N ' ' A' ' 140' ' ' ASN . 0.2 OUTLIER -66.0 -21.27 66.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.699 0.799 . . . . 0.0 111.547 172.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 139' ' ' ASN . 5.3 t30 -75.66 -46.74 29.66 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 110.014 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.82 12.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.336 0.655 . . . . 0.0 111.663 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.11 -166.26 1.74 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.171 0.988 . . . . 0.0 110.129 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p -96.11 117.8 31.44 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.687 ' SD ' HG21 ' A' ' 134' ' ' VAL . 22.3 ptm -115.56 157.56 43.94 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.838 0.455 . . . . 0.0 111.27 -173.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.7 Cg_endo -71.1 124.84 10.87 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.319 2.012 . . . . 0.0 112.835 173.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.405 HD22 ' HE2' ' A' ' 148' ' ' MET . 24.6 tp -85.9 117.62 24.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.324 1.05 . . . . 0.0 108.792 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -75.33 107.77 7.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 62' ' ' SER . 64.4 mtt -106.23 137.74 43.65 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.964 0.906 . . . . 0.0 109.961 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.6 p -126.35 116.9 21.92 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -85.4 118.6 25.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.795 0.838 . . . . 0.0 109.292 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -122.68 101.41 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.665 0.786 . . . . 0.0 109.139 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.62 31.21 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.799 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.54 ' HB3' ' HZ2' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -52.82 138.43 29.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.588 1.155 . . . . 0.0 112.427 174.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.454 ' HG2' HG23 ' A' ' 58' ' ' VAL . 42.0 mt-10 -58.92 -22.17 59.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 112.988 -175.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.34 -18.03 64.99 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.195 0.598 . . . . 0.0 112.056 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -44.0 75.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -167.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -24.64 51.32 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.578 0.351 . . . . 0.0 111.211 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.11 -35.21 61.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.839 0.455 . . . . 0.0 110.52 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.0 -50.63 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.032 0.933 . . . . 0.0 110.375 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p -66.94 -31.82 72.66 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.153 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.46 -39.7 67.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.215 0.606 . . . . 0.0 111.531 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -69.25 -37.35 77.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.946 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.2 mt -69.33 -55.48 10.3 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.587 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -54.64 -32.57 59.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.258 1.423 . . . . 0.0 112.134 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.08 -44.34 83.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -98.66 -15.3 19.47 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.434 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.31 9.48 50.89 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.332 0.653 . . . . 0.0 110.713 175.811 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 -30.69 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.39 -26.93 52.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.665 1.186 . . . . 0.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -61.78 149.39 40.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.787 0.835 . . . . 0.0 112.142 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.23 162.63 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.603 1.161 . . . . 0.0 110.064 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 tp -85.81 117.13 24.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.948 0.499 . . . . 0.0 110.22 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HE1' ' HB1' ' A' ' 128' ' ' ALA . 24.8 m-85 -82.18 -34.03 29.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.994 0.518 . . . . 0.0 110.71 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.93 -166.63 33.04 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.932 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.9 p -115.1 169.22 9.27 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.666 0.787 . . . . 0.0 110.837 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 tp -147.8 139.04 23.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.293 0.637 . . . . 0.0 109.394 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -76.35 93.73 3.51 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.077 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.409 ' HA3' ' HE1' ' A' ' 148' ' ' MET . . . -77.43 81.3 1.23 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.484 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -71.75 114.32 9.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -107.45 135.61 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.915 0.886 . . . . 0.0 109.189 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.82 151.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 124.506 1.122 . . . . 0.0 111.277 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.87 -21.7 31.26 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.19 -16.52 45.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.873 0.869 . . . . 0.0 112.067 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.716 HH12 HG21 ' A' ' 143' ' ' THR . 34.1 ptt-85 -49.74 -27.94 5.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.777 1.631 . . . . 0.0 113.227 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -63.31 -48.53 77.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.864 0.466 . . . . 0.0 110.262 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.26 -28.98 67.68 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.575 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.6 m -74.66 -24.86 58.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.811 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.88 53.76 0.33 Allowed Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.483 -0.62 . . . . 0.0 114.583 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -43.71 165.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.2 m -115.96 178.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.756 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -94.91 -82.05 0.38 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.872 0.469 . . . . 0.0 109.757 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -159.34 165.29 33.65 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.948 0.899 . . . . 0.0 109.732 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.461 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 1.9 m-20 64.38 7.6 3.71 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.875 1.27 . . . . 0.0 112.293 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.583 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.7 mm-40 -84.87 124.25 31.4 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.332 0.653 . . . . 0.0 110.788 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.6 mtm -88.16 130.35 35.07 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 25.3 m -125.26 126.53 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.753 0.821 . . . . 0.0 110.78 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.66 136.62 33.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.263 1.025 . . . . 0.0 110.229 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD23 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -87.57 141.56 28.52 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.49 0.716 . . . . 0.0 109.596 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -154.05 133.5 12.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 26.9 ptt180 -60.24 131.6 51.3 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 15.5 t70 -84.64 125.1 72.23 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.04 -37.55 75.15 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.307 2.671 . . . . 0.0 113.523 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.92 36.59 4.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.626 0.77 . . . . 0.0 109.732 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' A' ' 88' ' ' ASP . 21.5 t-20 -63.41 127.73 91.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.95 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.25 -23.32 33.24 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.9 2.4 . . . . 0.0 113.636 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -79.62 -52.15 8.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.7 t70 177.98 156.77 0.39 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.427 1.091 . . . . 0.0 109.951 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -57.14 -33.48 67.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.865 1.266 . . . . 0.0 113.599 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.4 -12.99 58.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.296 0.639 . . . . 0.0 111.883 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.1 128.77 37.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.176 0.591 . . . . 0.0 111.315 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.1 mt -92.95 125.04 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.991 0.917 . . . . 0.0 110.532 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -96.38 126.18 41.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.428 HG12 ' HB ' ' A' ' 83' ' ' VAL . 14.3 t -93.89 143.4 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -127.86 147.3 50.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.629 1.172 . . . . 0.0 108.111 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 p-10 -78.8 169.03 18.86 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.047 0.84 . . . . 0.0 110.051 170.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.67 -10.47 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.488 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.1 t-20 -73.12 -22.84 60.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 110.374 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 40.93 5.1 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -122.41 133.09 54.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.788 0.835 . . . . 0.0 109.788 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -63.47 131.35 47.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.332 0.653 . . . . 0.0 110.791 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.29 -32.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.399 0.68 . . . . 0.0 111.817 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.53 -171.65 44.73 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -128.65 139.78 52.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.022 0.929 . . . . 0.0 109.861 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.491 HD11 ' HE3' ' A' ' 148' ' ' MET . 91.5 mt -92.44 1.98 56.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.499 0.72 . . . . 0.0 111.8 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 67.74 -176.88 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.545 1.138 . . . . 0.0 110.382 -167.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -39.86 45.24 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -51.48 -63.25 1.19 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.279 0.987 . . . . 0.0 112.325 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.21 -39.08 88.9 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.518 0.675 . . . . 0.0 110.748 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.15 -21.62 63.99 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.348 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.22 -15.53 70.06 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.191 0.424 . . . . 0.0 113.412 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.11 -51.99 6.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.931 0.872 . . . . 0.0 109.062 165.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.44 -17.46 63.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.72 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.71 90.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.276 1.03 . . . . 0.0 111.895 -173.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -75.07 -33.73 61.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.949 0.5 . . . . 0.0 109.9 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.452 HD12 HG11 ' A' ' 160' ' ' VAL . 31.6 mt -70.15 -31.73 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.074 0.549 . . . . 0.0 110.115 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.9 tpp -79.43 -43.3 23.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.026 1.33 . . . . 0.0 110.798 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.25 -50.29 28.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.811 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -88.97 -0.62 57.57 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.427 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 59.59 32.45 21.59 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.653 1.181 . . . . 0.0 111.846 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.12 -39.39 82.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.142 0.977 . . . . 0.0 111.405 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.413 ' HB1' ' HE1' ' A' ' 60' ' ' PHE . . . -154.08 132.33 11.89 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.599 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.27 105.64 2.6 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.991 0.916 . . . . 0.0 109.266 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.83 108.22 19.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.44 146.12 36.44 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -123.31 162.66 17.11 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -149.2 140.59 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.517 1.127 . . . . 0.0 108.033 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.06 87.31 34.0 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 57.4 Cg_endo -88.6 0.2 6.52 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.045 2.496 . . . . 0.0 112.907 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.25 -31.3 20.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.977 0.511 . . . . 0.0 112.009 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.58 -6.52 23.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.64 9.03 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.028 0.914 . . . . 0.0 112.715 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.48 -15.59 61.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.674 1.19 . . . . 0.0 111.367 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.29 -55.19 5.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.945 0.898 . . . . 0.0 111.071 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.71 -61.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.452 0.701 . . . . 0.0 111.641 -171.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 -178.63 3.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.538 0.735 . . . . 0.0 109.823 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.716 HG21 HH12 ' A' ' 71' ' ' ARG . 15.9 p -92.29 109.05 20.42 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -112.24 120.44 41.59 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.716 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.58 125.12 8.73 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.025 1.816 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.37 146.94 24.34 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -73.36 107.36 5.62 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.127 0.571 . . . . 0.0 110.611 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.539 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 63.2 mtt -97.82 166.81 11.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.751 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.8 p -154.36 146.52 23.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.23 1.012 . . . . 0.0 109.634 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -109.19 120.39 42.39 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.134 0.974 . . . . 0.0 109.477 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -123.87 98.78 5.96 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.637 0.775 . . . . 0.0 109.647 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.31 162.46 30.63 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -55.57 142.57 33.0 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.647 0.779 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.34 -37.9 17.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.774 1.23 . . . . 0.0 113.465 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.413 ' O ' ' HE3' ' A' ' 158' ' ' LYS . 12.7 pt-20 -65.94 -29.78 70.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.213 0.605 . . . . 0.0 112.171 -174.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.22 4.19 13.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -61.71 -40.5 95.25 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 118.156 0.435 . . . . 0.0 111.31 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -69.31 -25.45 64.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.43 0.692 . . . . 0.0 111.192 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.6 -45.61 15.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.58 0.752 . . . . 0.0 110.567 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.452 HG11 HD12 ' A' ' 122' ' ' ILE . 67.6 t -65.95 -45.68 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.449 1.1 . . . . 0.0 110.983 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.5 p -66.94 -32.01 72.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.151 0.58 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.46 -47.11 82.73 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.599 0.562 . . . . 0.0 110.838 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.0 mm100 -63.28 -44.27 95.57 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.37 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.23 -52.81 29.93 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.775 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.44 -22.69 66.79 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.798 0.839 . . . . 0.0 112.193 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -53.02 -46.56 68.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.157 0.983 . . . . 0.0 111.141 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -108.24 -11.9 15.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.114 0.966 . . . . 0.0 111.247 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.87 30.58 25.87 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.885 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.759 0.314 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.59 -31.62 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.801 0.84 . . . . 0.0 109.645 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.92 -12.13 57.61 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.056 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.7 m -63.7 133.39 53.5 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.135 0.493 . . . . 0.0 110.717 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.2 m -129.18 163.62 33.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 124.84 1.256 . . . . 0.0 109.061 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 149' ' ' THR . 40.3 tp -86.82 117.31 25.48 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -82.72 -31.42 28.48 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.65 -151.89 23.83 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.464 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -132.49 178.96 6.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.484 0.713 . . . . 0.0 110.684 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 39.0 tp -159.01 154.37 25.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.264 0.626 . . . . 0.0 110.186 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 94.69 5.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.978 0.911 . . . . 0.0 108.729 174.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.64 121.33 5.83 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -93.24 100.4 12.77 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.169 0.984 . . . . 0.0 109.751 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 7.9 p -82.88 145.68 8.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.368 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.8 m -65.72 156.02 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.18 0.992 . . . . 0.0 111.472 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 143' ' ' THR . . . -73.18 -23.42 77.6 Favored Glycine 0 N--CA 1.47 0.915 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.091 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt -51.29 -18.2 0.9 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.37 1.468 . . . . 0.0 112.678 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.596 HH12 HG22 ' A' ' 134' ' ' VAL . 13.8 ttt180 -47.19 -32.63 4.56 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.155 1.782 . . . . 0.0 112.755 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -63.22 -41.03 99.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.288 0.566 . . . . 0.0 110.933 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -69.53 -27.85 65.52 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.577 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 107' ' ' GLN . 6.0 m -101.48 -4.11 27.39 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.825 -170.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.32 52.56 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.965 172.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -44.42 156.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.2 175.88 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.087 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.78 -173.77 4.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.85 0.86 . . . . 0.0 111.157 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.3 151.45 39.82 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.933 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.57 -0.57 1.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.01 1.324 . . . . 0.0 113.883 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -73.33 128.48 35.61 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.272 0.487 . . . . 0.0 112.303 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.446 ' HG2' HG22 ' A' ' 133' ' ' VAL . 77.4 mtp -79.63 148.22 31.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.719 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 102' ' ' ASN . 23.1 m -143.74 146.82 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.617 1.167 . . . . 0.0 108.8 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB1' ' OD1' ' A' ' 101' ' ' ASN . . . -97.5 156.07 16.66 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.177 0.991 . . . . 0.0 110.084 175.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 130' ' ' ILE . 27.7 mt -89.0 161.58 16.51 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.535 . . . . 0.0 109.636 168.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.56 144.88 18.45 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -80.68 123.28 28.04 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -60.53 109.0 1.68 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.79 -15.17 46.5 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.789 2.326 . . . . 0.0 113.123 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.54 90.81 3.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.03 115.88 22.83 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.12 -51.56 5.43 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.976 2.451 . . . . 0.0 112.624 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.8 -47.28 1.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.68 0.792 . . . . 0.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -122.98 137.92 54.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.522 0.729 . . . . 0.0 109.736 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -57.82 -27.12 62.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.792 1.237 . . . . 0.0 113.232 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.4 ' HB2' ' HB1' ' A' ' 120' ' ' ALA . 28.3 p-10 -84.86 -1.79 56.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.424 0.689 . . . . 0.0 112.827 -173.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.92 111.08 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.876 0.87 . . . . 0.0 111.19 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.0 mt -96.03 108.62 21.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 C-N-CA 123.259 0.624 . . . . 0.0 110.118 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 32.2 ttpt -88.91 142.16 27.89 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.393 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.96 143.87 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.761 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.41 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 5.7 p30 -130.0 150.98 51.04 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.089 1.356 . . . . 0.0 107.878 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HA ' HG11 ' A' ' 83' ' ' VAL . 28.6 p-10 -90.51 -176.92 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.854 0.752 . . . . 0.0 111.04 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 m -57.83 -29.18 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.581 0.753 . . . . 0.0 112.649 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.84 -18.04 41.82 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.947 0.499 . . . . 0.0 111.245 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.04 50.17 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.042 0.353 . . . . 0.0 113.556 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.38 114.53 4.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.958 0.903 . . . . 0.0 109.174 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.412 ' O ' HG21 ' A' ' 74' ' ' THR . 22.9 pt20 -59.85 105.15 0.35 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.34 -17.81 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.392 0.677 . . . . 0.0 111.376 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.14 158.5 9.94 Favored Glycine 0 N--CA 1.473 1.107 0 O-C-N 122.954 0.159 . . . . 0.0 112.957 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 6.9 p-80 -81.86 154.59 25.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.3 0.64 . . . . 0.0 112.666 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 45.9 mt -70.73 -51.44 27.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.907 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 24.4 ttmm 156.65 145.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.642 1.577 . . . . 0.0 107.204 -166.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -23.59 55.33 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.755 0.707 . . . . 0.0 111.196 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 37.5 tt0 -74.24 -42.39 59.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.937 0.495 . . . . 0.0 110.569 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -47.54 85.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.93 67.61 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.866 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -53.86 -37.57 57.95 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.139 0.4 . . . . 0.0 113.746 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.05 -55.54 4.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.125 0.57 . . . . 0.0 110.475 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.7 mt -68.16 -17.38 64.32 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.249 -171.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' A' ' 96' ' ' ASN . . . -56.16 -54.35 46.16 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.556 1.142 . . . . 0.0 111.62 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.54 -29.11 69.12 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.183 0.927 . . . . 0.0 110.76 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.434 HD12 HG11 ' A' ' 160' ' ' VAL . 48.3 mt -68.59 -40.35 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.332 0.653 . . . . 0.0 110.143 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 52.0 ttm -80.1 -28.13 39.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.638 0.775 . . . . 0.0 111.446 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.96 -48.61 20.47 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.536 0.734 . . . . 0.0 110.614 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -95.43 5.25 52.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.547 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 57.45 37.26 27.76 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.44 1.096 . . . . 0.0 111.344 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 70.6 mt -61.01 -52.77 63.59 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.332 -177.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.407 ' HB1' HG22 ' A' ' 160' ' ' VAL . . . -146.14 161.49 40.08 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.615 0.766 . . . . 0.0 111.023 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -101.18 107.28 18.64 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.129 0.972 . . . . 0.0 108.556 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 85' ' ' LEU . 27.7 mt -96.56 112.11 28.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -93.4 173.55 7.65 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.74 154.82 24.53 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 82' ' ' MET . 93.7 t -141.87 129.58 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.596 HG22 HH12 ' A' ' 71' ' ' ARG . 61.7 t -99.62 87.16 0.64 Allowed Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 4.5 Cg_exo -76.25 -51.11 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.52 -165.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -71.81 -27.16 62.74 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.798 0.839 . . . . 0.0 110.844 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.76 18.45 72.28 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.356 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.64 1.95 27.8 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.834 0.853 . . . . 0.0 112.134 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.441 HD21 ' N ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -57.5 -25.73 60.24 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.53 1.532 . . . . 0.0 114.304 -176.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -86.65 -38.65 16.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.606 0.762 . . . . 0.0 111.386 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.65 -20.15 21.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.534 0.734 . . . . 0.0 112.039 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.73 173.08 16.58 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.297 0.639 . . . . 0.0 109.717 -167.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 69' ' ' GLY . 44.7 p -94.36 109.68 21.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.0 ptm -113.73 155.72 44.66 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 122.935 0.494 . . . . 0.0 111.004 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.89 127.53 4.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.349 2.033 . . . . 0.0 111.369 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -92.75 143.23 26.5 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -69.9 107.41 3.55 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 16.3 mtp -94.78 150.24 20.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.472 HG22 HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.09 130.38 22.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 113.7 25.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.391 0.676 . . . . 0.0 109.574 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.22 100.6 6.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.6 160.35 28.44 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -53.65 143.88 19.14 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.676 0.79 . . . . 0.0 112.496 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 2.3 tm-20 -50.77 -46.4 59.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.128 1.371 . . . . 0.0 111.454 -173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -58.94 -18.28 32.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 127' ' ' LEU . 1.4 t-20 -100.51 0.22 39.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -166.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.481 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 3.4 ppt_? -52.17 -37.28 54.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -171.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -81.72 -30.18 32.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.58 0.352 . . . . 0.0 111.366 -177.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.83 -43.31 46.59 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.086 0.554 . . . . 0.0 111.237 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.434 HG11 HD12 ' A' ' 122' ' ' ILE . 61.9 t -62.7 -42.64 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.851 0.86 . . . . 0.0 110.73 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.0 t -64.24 -35.38 80.62 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.02 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -57.0 -41.16 77.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.959 0.904 . . . . 0.0 110.934 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.44 -36.32 78.86 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.723 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.4 mt -68.71 -44.35 74.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.021 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -59.37 -27.71 66.21 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.611 1.164 . . . . 0.0 111.879 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -54.62 -52.17 63.08 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 111.954 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -93.59 -23.68 18.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.472 0.709 . . . . 0.0 110.34 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.89 16.82 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.528 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 123.463 0.705 . . . . 0.0 110.53 174.366 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.55 -29.4 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.133 0.973 . . . . 0.0 109.811 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.94 -24.9 43.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 0.0 111.004 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -78.69 122.77 26.41 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.203 0.601 . . . . 0.0 109.822 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.461 HG23 ' HG2' ' A' ' 154' ' ' GLU . 27.0 m -124.16 175.87 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.873 1.269 . . . . 0.0 110.196 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.43 121.41 30.79 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -85.26 -40.3 16.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.097 0.559 . . . . 0.0 110.042 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.19 -151.54 23.4 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.605 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.9 p -123.56 -179.82 4.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.914 0.886 . . . . 0.0 111.073 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.584 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 26.7 tp -156.28 155.78 32.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -93.53 90.59 6.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.962 0.905 . . . . 0.0 108.72 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.21 88.89 1.37 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -70.31 93.9 0.89 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.174 0.487 . . . . 0.0 110.398 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 32.4 t -95.14 143.48 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 109.723 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.07 143.2 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.162 0.585 . . . . 0.0 111.563 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.457 ' H ' HG21 ' A' ' 143' ' ' THR . . . -80.44 -19.91 67.8 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 113.051 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.1 tp -59.94 -22.62 62.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.23 1.012 . . . . 0.0 112.146 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HE ' HG21 ' A' ' 108' ' ' VAL . 13.9 ptt-85 -74.4 0.26 15.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.493 1.117 . . . . 0.0 112.567 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -42.56 -40.3 2.62 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.483 1.513 . . . . 0.0 114.094 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -56.85 -24.78 53.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.408 1.083 . . . . 0.0 113.218 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 m -75.56 -7.16 53.49 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.749 0.82 . . . . 0.0 111.626 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.3 2.74 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 140' ' ' ASN . 31.6 m -62.54 169.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.612 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 28.2 m -114.29 149.32 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.932 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -97.17 -97.14 0.2 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -107.94 144.11 35.66 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.192 0.597 . . . . 0.0 111.606 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 t30 59.19 10.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.39 1.476 . . . . 0.0 112.634 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.612 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 68.3 mm-40 -79.83 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 122.782 0.433 . . . . 0.0 110.611 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.532 ' HG2' HG21 ' A' ' 133' ' ' VAL . 85.1 mtp -88.43 117.62 27.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 23.2 m -113.86 135.06 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.142 0.977 . . . . 0.0 109.923 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.1 55.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.688 0.795 . . . . 0.0 109.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.3 mp -81.88 141.06 33.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.629 0.771 . . . . 0.0 109.216 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -151.55 148.47 28.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.127 0.571 . . . . 0.0 109.929 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -58.81 144.41 44.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.186 0.994 . . . . 0.0 112.144 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.36 93.03 22.88 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.39 -24.62 12.05 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.708 2.272 . . . . 0.0 112.978 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.68 59.02 2.79 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.21 1.005 . . . . 0.0 110.469 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 97' ' ' ALA . 37.4 m-80 -108.32 143.09 26.74 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.768 164.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.58 -19.15 32.6 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.379 2.053 . . . . 0.0 111.156 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -77.59 -53.32 7.72 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.269 0.628 . . . . 0.0 110.467 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.04 152.04 0.87 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.815 0.697 . . . . 0.0 109.444 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.38 -19.14 64.61 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.331 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.37 -1.81 31.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.575 1.15 . . . . 0.0 113.006 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . . . -72.86 138.68 46.44 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.98 123.69 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.934 0.894 . . . . 0.0 109.838 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 7.8 ttpm? -86.18 116.58 24.46 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.748 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.48 131.85 33.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -119.05 165.69 13.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 107.645 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.2 p-10 -98.29 -165.5 1.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.321 0.51 . . . . 0.0 110.056 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.69 -32.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.164 0.586 . . . . 0.0 112.109 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.755 0.822 . . . . 0.0 110.934 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -0.27 82.13 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.89 118.02 9.1 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.032 0.933 . . . . 0.0 109.155 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -62.27 122.16 14.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.8 0.687 . . . . 0.0 110.377 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 HG21 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -89.08 -12.79 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.097 173.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.93 -164.84 24.41 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -84.21 157.37 21.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.174 0.59 . . . . 0.0 110.015 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 4.0 tt -80.71 -55.27 4.95 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 158.21 127.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -163.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -58.22 9.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.369 0.668 . . . . 0.0 110.707 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -54.3 -48.38 71.36 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.376 1.071 . . . . 0.0 112.291 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.37 -40.24 77.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.83 -34.05 76.52 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.705 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.33 -32.28 80.29 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.913 0.758 . . . . 0.0 113.539 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.06 -59.16 2.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.397 0.618 . . . . 0.0 109.962 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.6 -15.04 63.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.38 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.82 72.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.116 1.366 . . . . 0.0 112.631 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -69.25 -32.95 72.5 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.586 0.554 . . . . 0.0 110.02 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 127' ' ' LEU . 50.3 mt -70.72 -34.29 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.461 0.705 . . . . 0.0 110.336 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 39.0 tpp -80.25 -39.36 29.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.612 1.165 . . . . 0.0 111.268 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -83.04 -37.43 23.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.194 0.998 . . . . 0.0 110.426 -171.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.55 6.31 47.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 53.58 39.2 29.77 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.509 1.124 . . . . 0.0 112.724 171.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.414 ' HB2' HG22 ' A' ' 122' ' ' ILE . 75.6 mt -66.06 -40.98 91.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.893 0.877 . . . . 0.0 111.09 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.62 138.11 18.62 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.102 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -77.23 107.03 9.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.604 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.29 110.95 24.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.25 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.57 179.0 4.99 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.586 0.754 . . . . 0.0 109.34 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -160.18 160.62 31.84 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.532 HG21 ' HG2' ' A' ' 82' ' ' MET . 61.0 t -142.66 120.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 2.4 p -95.08 100.48 5.69 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.173 0.589 . . . . 0.0 109.901 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.74 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.832 2.355 . . . . 0.0 113.397 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.65 -27.63 45.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.587 0.755 . . . . 0.0 111.833 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.95 79.34 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.066 0.387 . . . . 0.0 114.066 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.514 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -75.92 -15.17 60.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.017 0.527 . . . . 0.0 111.348 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -9.57 33.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.588 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.8 m-20 -73.64 -56.92 4.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.818 0.447 . . . . 0.0 110.664 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.94 -42.38 7.16 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.169 0.587 . . . . 0.0 111.082 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.24 161.38 13.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.086 0.954 . . . . 0.0 111.468 -171.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 69' ' ' GLY . 67.1 p -95.73 109.02 21.38 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.514 ' SD ' ' HB1' ' A' ' 138' ' ' ALA . 22.8 ptm -131.75 151.0 77.82 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 122.59 0.356 . . . . 0.0 111.168 -169.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.06 129.13 4.53 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.618 2.212 . . . . 0.0 111.592 164.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -114.24 156.29 24.59 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -75.56 107.68 7.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.799 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.575 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 61.3 mtt -97.84 160.12 14.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.357 1.063 . . . . 0.0 109.008 173.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.27 135.03 30.24 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -169.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.584 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 96.9 m-85 -100.76 120.41 40.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.923 0.889 . . . . 0.0 110.144 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.89 110.17 12.75 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.9 39.98 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -64.19 141.31 58.82 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.955 0.502 . . . . 0.0 111.768 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 58' ' ' VAL . 34.2 mt-10 -55.14 -31.05 61.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -171.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.49 -20.89 66.15 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.275 0.63 . . . . 0.0 112.199 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.09 -1.0 46.19 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.087 -0.959 . . . . 0.0 113.151 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -64.92 -29.73 70.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 119.593 1.088 . . . . 0.0 111.118 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -29.56 65.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.389 0.676 . . . . 0.0 111.082 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.63 -42.58 19.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.292 0.637 . . . . 0.0 110.271 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.46 -47.15 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.769 1.227 . . . . 0.0 110.83 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.5 t -61.85 -39.93 93.58 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.2 t70 -56.28 -41.29 75.64 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.837 0.71 . . . . 0.0 111.248 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.1 mm100 -72.0 -35.6 69.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.643 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.35 -51.64 34.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.106 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.95 -33.23 72.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.613 1.165 . . . . 0.0 111.717 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HZ1' HE22 ' A' ' 163' ' ' GLN . 29.4 ttmt -54.8 -44.87 74.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.06 1.344 . . . . 0.0 111.43 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 -17.71 17.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.217 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.83 30.77 16.97 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.882 -0.399 . . . . 0.0 113.916 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' HB3' HD13 ' A' ' 63' ' ' LEU . 53.7 m-85 . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 117.402 0.601 . . . . 0.0 109.532 172.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.94 -29.99 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.941 0.496 . . . . 0.0 110.125 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.09 -9.46 27.97 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.425 0.69 . . . . 0.0 110.937 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -71.28 116.06 11.16 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.41 165.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.774 1.229 . . . . 0.0 110.421 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.44 117.44 23.07 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.161 0.584 . . . . 0.0 110.087 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.68 -24.79 28.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.53 -158.7 27.07 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.472 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.2 p -112.22 178.78 4.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.327 0.651 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 37.3 tp -152.91 147.93 26.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.074 0.549 . . . . 0.0 109.844 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -84.27 87.5 7.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.709 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.36 93.83 0.91 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.926 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -67.42 111.91 4.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.749 0.82 . . . . 0.0 110.965 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG13 HD23 ' A' ' 111' ' ' LEU . 19.6 m -113.24 145.81 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.689 0.796 . . . . 0.0 109.119 172.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.429 ' HA ' HG21 ' A' ' 143' ' ' THR . 26.2 m -96.58 153.33 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.173 0.589 . . . . 0.0 111.447 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.07 -19.88 68.81 Favored Glycine 0 N--CA 1.477 1.41 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.29 -17.57 58.99 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.504 0.669 . . . . 0.0 112.028 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.544 ' NH2' HG21 ' A' ' 108' ' ' VAL . 15.3 mtp180 -69.48 -2.38 11.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.38 1.472 . . . . 0.0 113.611 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -52.05 -42.84 63.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.6 0.76 . . . . 0.0 112.493 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -83.46 -6.47 59.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.862 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -75.17 -26.14 58.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 109.695 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.96 49.79 0.45 Allowed Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.389 -0.369 . . . . 0.0 112.704 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.556 ' HB ' ' ND2' ' A' ' 139' ' ' ASN . 15.7 m -59.79 170.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 6.0 m -115.54 178.56 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.657 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -85.03 -165.95 1.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.658 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -82.48 159.93 22.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.17 0.588 . . . . 0.0 110.411 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.8 OUTLIER 63.47 9.02 3.88 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.083 1.353 . . . . 0.0 112.912 -179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 28.4 mm-40 -84.33 144.27 28.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.139 0.576 . . . . 0.0 110.731 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.438 ' HG2' HG23 ' A' ' 133' ' ' VAL . 72.1 mtm -92.84 132.88 36.61 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.89 152.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.993 0.917 . . . . 0.0 110.116 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.76 157.1 30.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.517 0.727 . . . . 0.0 110.489 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 130' ' ' ILE . 8.4 mp -100.43 134.65 43.07 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.304 0.642 . . . . 0.0 110.037 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -139.73 110.78 6.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.441 1.097 . . . . 0.0 108.238 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 127.37 32.93 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -118.18 96.64 49.99 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.892 -169.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.14 -24.88 76.76 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.993 2.462 . . . . 0.0 112.821 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.824 0.85 . . . . 0.0 111.826 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.501 HD21 ' HB1' ' A' ' 97' ' ' ALA . 66.0 t30 -57.83 117.89 22.37 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.735 0.814 . . . . 0.0 111.375 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.34 -14.13 22.87 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.964 2.443 . . . . 0.0 112.516 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.47 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 28.9 t80 -73.11 -49.48 28.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.114 0.966 . . . . 0.0 109.713 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 16.2 t70 -173.09 138.27 0.74 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.626 0.771 . . . . 0.0 109.829 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -69.54 -30.43 68.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.37 0.668 . . . . 0.0 111.62 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -83.95 -12.88 54.68 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.012 0.525 . . . . 0.0 110.508 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' A' ' 91' ' ' ASN . . . -59.77 109.14 0.86 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 124.267 0.979 . . . . 0.0 109.826 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.41 ' HB ' HD12 ' A' ' 111' ' ' LEU . 73.2 mt -72.38 104.33 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.99 -172.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 39.6 ttmt -61.94 110.9 1.7 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.516 168.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.82 110.87 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.68 173.94 6.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.056 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -105.67 -167.87 1.38 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.02 -29.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.48 -31.69 63.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.781 0.832 . . . . 0.0 110.81 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.88 -2.34 41.47 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.191 -172.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.52 122.89 18.25 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.844 0.858 . . . . 0.0 109.45 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.434 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 18.5 pm0 -62.07 111.26 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.091 0.869 . . . . 0.0 109.761 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.544 HG21 ' NH2' ' A' ' 71' ' ' ARG . 16.0 m -91.36 -0.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.35 -148.68 20.21 Favored Glycine 0 C--N 1.366 2.228 0 C-N-CA 123.535 0.588 . . . . 0.0 113.513 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -137.28 146.13 44.33 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.085 1.354 . . . . 0.0 108.732 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.557 HD11 HD13 ' A' ' 115' ' ' LEU . 43.4 mt -63.63 -57.1 11.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 117.955 0.343 . . . . 0.0 111.609 -176.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 173.98 169.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 128.078 2.551 . . . . 0.0 105.033 -167.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 -27.25 33.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 119.292 0.951 . . . . 0.0 109.327 160.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HG2' ' HZ ' ' A' ' 169' ' ' PHE . 28.9 tt0 -69.7 -59.93 2.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.756 1.222 . . . . 0.0 111.085 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -58.2 -40.14 80.8 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.167 0.987 . . . . 0.0 109.044 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.99 97.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.831 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.17 -36.0 35.09 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 124.215 0.947 . . . . 0.0 113.928 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -61.34 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.444 0.698 . . . . 0.0 111.548 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 mt -71.38 -18.92 62.33 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.583 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.55 81.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.902 0.881 . . . . 0.0 110.417 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -65.4 -36.51 84.18 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.182 0.926 . . . . 0.0 110.331 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.98 -42.06 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.0 -32.2 51.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.249 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -48.78 11.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.916 0.887 . . . . 0.0 111.021 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.93 7.01 25.92 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.141 0.576 . . . . 0.0 111.231 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 63.14 32.36 15.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.445 ' HA ' HD21 ' A' ' 156' ' ' ASN . 56.7 mt -67.5 -44.17 79.12 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.895 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.33 150.38 25.21 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -77.77 134.92 37.95 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 ' HB ' HD21 ' A' ' 85' ' ' LEU . 31.3 mt -127.73 129.55 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.1 168.13 18.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.544 1.137 . . . . 0.0 108.516 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -137.02 166.96 24.8 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 82' ' ' MET . 62.6 t -147.91 131.35 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.45 99.27 12.56 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.169 0.588 . . . . 0.0 110.251 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.11 -27.58 4.4 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.761 2.308 . . . . 0.0 112.766 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -75.23 -31.29 60.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.066 0.546 . . . . 0.0 111.784 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.18 11.69 40.49 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 114.222 0.449 . . . . 0.0 114.222 -172.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -88.92 5.63 43.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.674 0.789 . . . . 0.0 111.397 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.556 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 3.6 p-10 -63.69 -19.42 64.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.597 1.159 . . . . 0.0 112.188 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -69.71 -60.73 2.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.744 0.818 . . . . 0.0 111.146 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.56 -32.04 11.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -171.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -113.58 162.56 16.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 112.196 -167.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 68' ' ' VAL . 72.9 p -97.51 109.71 22.41 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.456 ' HG2' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -149.75 158.43 37.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -167.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.66 127.18 1.9 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.772 2.314 . . . . 0.0 113.035 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.442 ' HB3' ' HE3' ' A' ' 144' ' ' MET . 3.7 pp -94.23 152.16 18.9 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -73.26 108.82 6.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.594 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.458 ' HE2' HD13 ' A' ' 111' ' ' LEU . 47.7 mtt -99.03 166.39 11.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.692 0.797 . . . . 0.0 110.346 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.4 p -143.69 156.17 44.46 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.304 1.042 . . . . 0.0 109.707 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 81.1 m-85 -117.41 117.24 28.94 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.715 0.806 . . . . 0.0 108.856 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -124.26 100.37 6.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.78 167.06 29.86 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -73.55 145.25 45.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.599 0.36 . . . . 0.0 111.307 -171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.34 -30.34 66.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 113.874 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.04 -6.51 54.8 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 127' ' ' LEU . 4.0 m-20 -118.24 7.55 12.1 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.248 0.619 . . . . 0.0 110.543 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -37.04 86.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.144 0.578 . . . . 0.0 112.11 -169.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -26.03 61.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.157 0.286 . . . . 0.0 110.765 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -77.93 -34.59 51.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.072 0.549 . . . . 0.0 110.335 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.8 -50.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.33 0.652 . . . . 0.0 109.993 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.4 p -66.36 -32.21 73.45 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.735 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.26 -43.31 82.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.296 0.638 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 9.8 mm100 -70.05 -30.84 68.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.786 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.15 -52.34 35.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.19 0.596 . . . . 0.0 110.103 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.04 -25.07 67.67 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.447 1.099 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.929 1.292 . . . . 0.0 111.805 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -103.77 -28.37 11.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.293 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.11 29.88 5.3 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.552 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.596 ' HZ ' ' HG2' ' A' ' 114' ' ' GLU . 62.5 m-85 . . . . . 0 N--CA 1.483 1.19 0 CA-C-N 117.733 0.766 . . . . 0.0 110.858 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -35.3 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.925 0.89 . . . . 0.0 109.726 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -84.83 -15.44 44.75 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.749 1.219 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -80.42 143.39 33.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.523 0.729 . . . . 0.0 111.704 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.31 161.31 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.296 1.438 . . . . 0.0 110.474 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.7 tp -85.36 110.89 19.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -73.17 -39.22 65.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.341 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.57 -160.86 30.56 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.1 p -111.79 179.14 4.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.516 0.726 . . . . 0.0 110.858 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 169' ' ' PHE . 33.7 tp -154.73 153.39 31.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.371 0.668 . . . . 0.0 109.983 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -87.29 92.71 9.17 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.64 125.21 8.39 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.401 ' H ' ' HG ' ' A' ' 115' ' ' LEU . 77.0 m80 -114.65 109.95 19.01 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.606 0.762 . . . . 0.0 110.286 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.39 139.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 66.4 t -71.97 142.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.998 0.519 . . . . 0.0 110.397 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.88 -44.45 68.68 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.727 -0.67 . . . . 0.0 114.328 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.1 -17.77 42.24 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.067 0.947 . . . . 0.0 112.065 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' HD3' ' HB ' ' A' ' 68' ' ' VAL . 2.3 mpt_? -74.35 1.4 11.72 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.452 1.101 . . . . 0.0 111.739 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -57.25 -28.83 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.845 0.458 . . . . 0.0 110.611 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.66 -31.89 72.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.051 0.94 . . . . 0.0 111.015 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -74.46 -27.06 60.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.392 0.677 . . . . 0.0 110.207 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.8 46.63 0.51 Allowed Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.756 -0.656 . . . . 0.0 114.288 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.673 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 93.7 t -56.49 154.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 122.816 0.446 . . . . 0.0 110.452 171.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.54 159.4 7.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.538 0.735 . . . . 0.0 111.061 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -96.02 -115.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.07 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -93.96 139.94 30.31 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.63 0.772 . . . . 0.0 111.745 -163.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 74.03 -22.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.37 1.468 . . . . 0.0 113.656 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.02 129.69 43.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.52 1.128 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.513 ' HG2' HG21 ' A' ' 133' ' ' VAL . 74.7 mtp -94.25 142.74 27.06 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 30.0 m -114.64 147.04 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.101 0.56 . . . . 0.0 110.463 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.76 53.75 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.042 0.937 . . . . 0.0 108.803 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -88.37 151.32 22.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.405 0.682 . . . . 0.0 110.319 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -159.76 153.68 23.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.073 0.949 . . . . 0.0 109.101 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -71.88 137.13 47.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.703 0.401 . . . . 0.0 110.334 172.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.78 117.17 67.61 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.4 0.68 . . . . 0.0 109.813 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.4 -29.76 53.68 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.781 2.321 . . . . 0.0 112.797 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.33 52.49 2.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.431 0.693 . . . . 0.0 109.599 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.25 108.16 1.06 Allowed Pre-proline 0 CA--C 1.566 1.564 0 C-N-CA 124.579 1.151 . . . . 0.0 112.498 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.86 -34.94 70.32 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 123.284 2.656 . . . . 0.0 113.543 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -126.0 -44.04 1.79 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.412 0.685 . . . . 0.0 111.197 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -162.94 162.7 26.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.142 0.577 . . . . 0.0 109.924 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.23 -14.52 26.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.417 1.087 . . . . 0.0 112.53 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.463 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 47.3 m-80 -73.33 4.08 5.09 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.74 116.96 18.68 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.248 0.619 . . . . 0.0 109.955 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.465 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 44.9 mt -97.98 118.79 45.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 C-N-CA 123.614 0.766 . . . . 0.0 109.649 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.726 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 17.3 ttmm -71.53 140.04 49.74 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.288 165.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 t -109.84 124.62 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -108.09 168.65 9.14 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -108.4 -165.77 1.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.988 0.515 . . . . 0.0 110.217 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.75 -33.14 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.742 . . . . 0.0 111.537 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -76.14 -19.99 58.0 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.991 0.916 . . . . 0.0 111.112 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.04 6.88 78.41 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -69.96 135.09 49.06 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 109.62 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.726 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 26.1 mp0 -73.81 98.64 3.0 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.825 0.85 . . . . 0.0 109.0 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.673 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 11.8 m -79.77 -25.82 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.51 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.7 -142.18 8.36 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 121.587 -0.34 . . . . 0.0 112.914 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -140.32 157.4 45.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.334 1.054 . . . . 0.0 109.571 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 115' ' ' LEU . 65.9 mt -81.64 -5.06 57.71 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.422 176.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? 71.6 151.5 0.11 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 109.937 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -37.42 -42.06 0.48 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.41 -56.12 5.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.383 0.273 . . . . 0.0 111.122 -170.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -72.43 -44.46 62.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -175.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -58.6 -51.6 69.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.412 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -60.44 -27.4 65.73 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.497 0.498 . . . . 0.0 114.071 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -61.59 1.73 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.954 0.502 . . . . 0.0 109.918 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 130' ' ' ILE . 18.1 mt -69.88 -16.07 63.18 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.971 -172.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.11 -24.15 65.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.967 0.907 . . . . 0.0 113.231 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -76.32 -35.87 58.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.535 HG22 ' HB2' ' A' ' 127' ' ' LEU . 48.1 mt -67.64 -29.65 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.92 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.2 tpp -79.08 -41.71 28.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.463 1.105 . . . . 0.0 110.558 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.66 -50.8 56.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.53 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -93.54 1.16 56.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.849 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 54.52 44.65 28.44 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.015 0.926 . . . . 0.0 111.642 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' A' ' 122' ' ' ILE . 62.3 mt -68.79 -40.18 79.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.992 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.58 135.38 12.72 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.261 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -68.21 114.43 6.69 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 119' ' ' LEU . 13.7 mt -101.08 124.03 54.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.07 139.6 44.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.815 0.846 . . . . 0.0 108.944 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -116.95 168.16 12.74 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.343 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.513 HG21 ' HG2' ' A' ' 82' ' ' MET . 44.1 t -138.94 133.6 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.34 94.12 5.47 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.17 -56.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.179 1.92 . . . . 0.0 112.951 -172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.547 ' HB2' ' HE1' ' A' ' 144' ' ' MET . 84.4 m-85 -75.8 -30.99 59.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.943 0.497 . . . . 0.0 110.976 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 49.47 34.62 19.91 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 124.0 0.812 . . . . 0.0 114.435 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -89.89 17.77 6.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.753 0.821 . . . . 0.0 112.278 -168.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -52.14 -36.46 51.47 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.293 1.037 . . . . 0.0 112.094 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -53.92 -49.14 69.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.819 0.848 . . . . 0.0 111.397 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.85 -51.59 11.01 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.722 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -157.49 166.42 33.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.416 1.087 . . . . 0.0 109.555 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.8 p -94.59 110.71 22.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.547 ' HE1' ' HB2' ' A' ' 136' ' ' PHE . 0.9 OUTLIER -114.03 141.49 26.36 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 124.245 1.018 . . . . 0.0 110.562 -174.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.29 130.26 18.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.951 2.434 . . . . 0.0 112.261 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.52 152.97 21.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -91.13 110.73 22.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 122.1 -0.375 . . . . 0.0 110.502 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.568 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 54.7 mtt -92.5 169.45 10.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.217 1.007 . . . . 0.0 111.065 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 p -149.72 147.53 28.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.702 1.201 . . . . 0.0 109.062 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 91.8 m-85 -109.34 120.56 42.89 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.847 0.859 . . . . 0.0 109.515 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -124.17 97.68 5.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.22 166.34 35.73 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.75 139.76 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.373 0.669 . . . . 0.0 111.942 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -51.07 -37.28 44.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.753 1.221 . . . . 0.0 112.997 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.46 -12.29 59.92 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.679 0.791 . . . . 0.0 113.133 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -97.22 -0.98 45.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -30.24 69.61 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -33.59 71.62 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.16 0.505 . . . . 0.0 110.929 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.74 -33.97 30.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.48 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.37 -48.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.878 0.871 . . . . 0.0 110.777 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 72.9 p -64.34 -34.41 78.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 111.555 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.61 -42.76 75.35 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.674 0.609 . . . . 0.0 111.394 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mm100 -66.8 -38.94 87.46 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.326 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -70.17 -53.18 18.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.525 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.94 -25.61 68.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.888 0.875 . . . . 0.0 112.074 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.37 -48.12 82.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 111.389 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -102.89 -1.1 30.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.601 0.761 . . . . 0.0 111.046 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.73 63.65 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.368 0.418 . . . . 0.0 113.988 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' HB3' HD12 ' A' ' 63' ' ' LEU . 24.8 m-85 . . . . . 0 N--CA 1.481 1.106 0 C-N-CA 123.372 0.669 . . . . 0.0 111.05 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.99 -31.94 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.827 0.851 . . . . 0.0 109.625 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.38 -13.73 42.6 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.715 0.806 . . . . 0.0 110.788 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.4 m -74.41 113.94 12.22 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 122.997 0.519 . . . . 0.0 110.497 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.29 158.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 0.0 110.898 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 tt -81.27 114.92 20.39 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.76 0.824 . . . . 0.0 108.962 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.05 -36.03 59.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.188 0.595 . . . . 0.0 110.062 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.48 175.9 38.98 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.756 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 p -110.67 155.23 22.73 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.106 0.962 . . . . 0.0 108.735 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.01 147.05 52.58 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.774 0.429 . . . . 0.0 110.285 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 78.56 4.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.797 0.808 . . . . 0.0 109.118 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.642 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -70.43 143.06 36.57 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.186 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -132.79 105.58 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.192 0.597 . . . . 0.0 109.546 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG13 ' HG3' ' A' ' 71' ' ' ARG . 3.8 t -78.65 159.56 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.7 m -63.49 152.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.174 -0.329 . . . . 0.0 111.312 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' HB ' ' A' ' 143' ' ' THR . . . -65.1 -35.56 91.92 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.03 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.34 -15.07 3.44 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.212 1.405 . . . . 0.0 113.269 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.657 HH12 HG22 ' A' ' 77' ' ' VAL . 1.9 tmm_? -56.95 -17.59 10.22 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.206 1.003 . . . . 0.0 112.42 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.4 ' HA ' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -59.07 -41.31 87.68 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 123.062 0.545 . . . . 0.0 110.859 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -72.0 -31.18 65.99 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.251 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 71' ' ' ARG . 46.4 p -95.82 3.56 53.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.793 0.437 . . . . 0.0 111.561 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.9 52.2 0.51 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 140' ' ' ASN . 3.1 m -48.91 152.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 118.334 1.067 . . . . 0.0 113.186 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.657 HG22 HH12 ' A' ' 71' ' ' ARG . 28.8 m -114.47 164.7 10.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.884 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -84.39 -169.17 2.48 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.548 0.739 . . . . 0.0 111.231 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.66 157.89 37.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.64 0.776 . . . . 0.0 111.279 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 67.88 8.08 6.2 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.122 0.969 . . . . 0.0 112.186 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.635 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.6 mm-40 -76.93 140.63 40.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.482 0.658 . . . . 0.0 111.132 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.473 ' HG2' HG21 ' A' ' 133' ' ' VAL . 78.9 mtp -107.2 149.49 27.65 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 132' ' ' GLY . 13.4 m -132.04 163.5 37.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.248 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.38 125.71 23.3 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.76 160.38 26.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -157.05 126.75 6.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.002 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' A' ' 95' ' ' LYS . 64.7 ttp85 -67.34 130.76 44.11 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.2 117.6 21.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 123.628 0.58 . . . . 0.0 110.733 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.35 -39.88 34.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.33 2.02 . . . . 0.0 110.237 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.26 76.1 3.42 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 7.5 p30 -67.4 127.9 93.54 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.968 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.54 -39.39 28.22 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.998 2.465 . . . . 0.0 113.021 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -127.35 -50.97 1.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.764 0.426 . . . . 0.0 110.43 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 8.8 p30 -150.38 170.58 18.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 110.031 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -64.9 -8.24 14.67 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.459 1.103 . . . . 0.0 113.09 -173.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.26 -12.25 39.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.587 0.755 . . . . 0.0 112.567 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 109.4 7.57 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.049 0.54 . . . . 0.0 110.303 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.7 mt -118.8 115.82 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.408 ' HZ1' ' HB3' ' A' ' 107' ' ' GLN . 19.2 pttp -85.22 163.21 18.82 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.467 0.651 . . . . 0.0 110.223 172.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.53 121.32 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.5 1.12 . . . . 0.0 109.237 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -109.76 130.97 55.46 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -75.85 -170.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.932 0.787 . . . . 0.0 110.994 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.43 -33.78 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.894 0.878 . . . . 0.0 112.87 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.13 -31.62 34.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.818 0.447 . . . . 0.0 110.885 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.49 6.4 25.34 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 116.323 -0.399 . . . . 0.0 113.266 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -66.7 119.25 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.858 0.863 . . . . 0.0 110.251 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.408 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 15.3 pt20 -72.8 90.16 1.41 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.828 0.823 . . . . 0.0 110.279 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.5 -14.19 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.988 1.315 . . . . 0.0 113.307 -172.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.13 -157.4 27.62 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 118.024 0.375 . . . . 0.0 112.363 -176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -132.15 149.43 52.4 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.47 0.708 . . . . 0.0 110.269 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.622 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . 71.5 mt -76.23 -0.85 23.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.685 0.794 . . . . 0.0 113.004 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.5 tttt 71.45 130.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -19.21 5.99 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.597 1.159 . . . . 0.0 113.865 -170.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.461 ' HG3' ' HE1' ' A' ' 167' ' ' HIS . 12.2 tp10 -67.01 -55.09 15.9 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.481 0.713 . . . . 0.0 111.395 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.69 -44.97 12.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.354 0.662 . . . . 0.0 110.184 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -61.89 -24.28 66.84 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.179 0.991 . . . . 0.0 111.967 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.64 64.62 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.17 0.294 . . . . 0.0 113.538 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -65.97 -44.5 84.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.53 -16.41 56.02 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.742 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.475 ' HA ' HD13 ' A' ' 98' ' ' ILE . . . -56.53 -44.75 81.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 112.053 -174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -70.58 -32.74 70.25 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.09 0.869 . . . . 0.0 110.298 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 160' ' ' VAL . 62.5 mt -65.36 -41.63 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.194 0.598 . . . . 0.0 110.02 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.45 -37.93 50.5 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.918 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.35 -42.9 58.6 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.485 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -98.02 6.38 47.7 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.396 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.37 34.72 20.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.702 1.201 . . . . 0.0 111.654 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.0 -43.44 95.66 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.484 0.714 . . . . 0.0 111.231 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.2 159.93 26.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.071 0.549 . . . . 0.0 111.109 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.8 mt -129.69 118.5 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.47 166.18 18.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.96 102.37 0.24 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.473 HG21 ' HG2' ' A' ' 82' ' ' MET . 43.0 t -103.58 114.96 44.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.552 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.9 p -101.3 91.29 2.01 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.263 1.025 . . . . 0.0 108.71 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 2.7 Cg_exo -78.54 -23.92 8.03 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.128 2.552 . . . . 0.0 112.93 -172.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.414 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 81.1 m-85 -89.26 -28.82 19.66 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.21 0.604 . . . . 0.0 110.926 -176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.56 62.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 113.863 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.08 -2.38 33.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.631 0.772 . . . . 0.0 112.347 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -24.69 65.44 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.441 ' HA ' HG23 ' A' ' 76' ' ' VAL . 55.6 t30 -57.28 -34.3 68.52 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.056 0.942 . . . . 0.0 111.262 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.78 53.25 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.133 0.573 . . . . 0.0 110.816 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -167.99 -66.3 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.46 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 8.9 t -160.32 169.06 23.92 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.693 0.797 . . . . 0.0 110.17 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.552 ' SD ' HG23 ' A' ' 134' ' ' VAL . 5.5 ppp? -167.34 156.28 9.16 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.289 1.036 . . . . 0.0 109.484 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.1 Cg_endo -76.63 120.45 5.55 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.418 1.412 . . . . 0.0 112.063 170.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -102.73 149.4 24.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -85.39 108.2 17.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -171.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.642 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 38.1 mtp -107.36 116.38 31.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.316 0.646 . . . . 0.0 109.873 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.7 p -113.06 126.49 55.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.763 0.425 . . . . 0.0 110.008 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -92.19 115.32 27.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.685 0.794 . . . . 0.0 109.537 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -114.54 110.97 20.63 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.503 1.121 . . . . 0.0 109.724 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.52 168.74 38.29 Favored Glycine 0 C--O 1.236 0.235 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -63.47 152.25 38.92 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.207 1.003 . . . . 0.0 111.304 -178.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.72 -27.78 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.065 0.946 . . . . 0.0 113.511 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 153' ' ' LYS . 12.8 pt-20 -78.08 -28.21 48.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.89 -5.02 46.74 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.797 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -59.01 -41.91 88.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.754 0.422 . . . . 0.0 110.228 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -70.49 -27.75 64.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.444 0.697 . . . . 0.0 111.738 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.71 -45.03 60.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.589 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 122' ' ' ILE . 70.4 t -64.41 -40.97 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.31 1.044 . . . . 0.0 111.14 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.4 m -58.58 -45.07 89.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.075 0.95 . . . . 0.0 110.62 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.14 -41.4 71.71 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.878 0.871 . . . . 0.0 111.542 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.2 mm100 -75.34 -27.26 59.15 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.038 -174.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 76.1 mt -73.0 -44.26 61.22 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.824 173.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.46 -28.63 67.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.404 1.082 . . . . 0.0 111.356 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.57 -50.12 70.9 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.094 0.958 . . . . 0.0 111.34 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . 0.461 ' HE1' ' HG3' ' A' ' 114' ' ' GLU . 20.6 t60 -81.43 -28.14 34.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.363 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.49 12.02 10.01 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-O 119.87 -0.406 . . . . 0.0 113.332 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.592 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 46.8 m-85 . . . . . 0 CA--C 1.558 1.274 0 C-N-CA 123.231 0.612 . . . . 0.0 111.331 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.7 0.286 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.88 -35.3 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.601 0.761 . . . . 0.0 109.474 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.35 -17.58 63.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.194 0.997 . . . . 0.0 111.104 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -73.71 116.66 14.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.313 0.645 . . . . 0.0 109.863 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.86 165.83 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.526 1.13 . . . . 0.0 110.859 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 149' ' ' THR . 24.6 tp -82.13 121.67 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.873 0.469 . . . . 0.0 110.177 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.429 ' HE2' ' HB1' ' A' ' 128' ' ' ALA . 19.7 m-85 -86.87 -38.58 16.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.169 0.588 . . . . 0.0 110.088 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 -172.18 28.92 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.724 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -112.6 166.5 11.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.464 0.706 . . . . 0.0 111.363 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HB2' ' HE2' ' A' ' 150' ' ' PHE . 33.8 tp -145.32 150.6 36.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.933 0.893 . . . . 0.0 109.319 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -75.94 98.36 4.22 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.418 0.628 . . . . 0.0 109.964 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.09 73.98 2.5 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 52.9 t-80 -65.62 85.82 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.981 0.912 . . . . 0.0 110.351 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 111' ' ' LEU . 14.4 m -81.61 144.33 10.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.166 173.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.3 m -65.61 148.07 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.39 175.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.86 -22.12 62.15 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -61.85 -19.12 62.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.929 1.292 . . . . 0.0 111.804 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.465 HH21 HG21 ' A' ' 67' ' ' VAL . 34.4 ptt85 -72.52 0.14 11.18 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.387 1.075 . . . . 0.0 112.549 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -53.85 -35.63 61.71 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.811 0.844 . . . . 0.0 112.658 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -67.86 -23.23 65.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.884 0.874 . . . . 0.0 111.641 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -73.02 -24.18 60.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.072 0.549 . . . . 0.0 111.023 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.82 49.11 0.52 Allowed Glycine 0 C--N 1.354 1.533 0 O-C-N 122.309 -0.244 . . . . 0.0 113.49 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.624 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 43.4 t -63.47 160.09 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.634 0.774 . . . . 0.0 111.747 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.06 157.05 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.454 1.102 . . . . 0.0 109.3 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -78.91 -164.64 0.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.989 0.916 . . . . 0.0 113.024 -165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -67.05 145.89 54.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.691 0.797 . . . . 0.0 110.825 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 73.72 -15.52 0.57 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.198 1.399 . . . . 0.0 112.713 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -73.2 130.02 39.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.57 0.748 . . . . 0.0 111.113 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 79.7 mtp -84.77 149.42 25.76 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.068 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.75 -170.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.709 1.204 . . . . 0.0 109.836 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.92 154.5 22.08 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.595 1.158 . . . . 0.0 108.432 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.49 HD22 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -99.15 146.83 25.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.909 0.385 . . . . 0.0 110.817 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -155.83 127.77 7.49 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 108.845 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -63.05 142.23 58.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 174.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.24 110.79 2.83 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.753 0.821 . . . . 0.0 110.347 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -31.61 44.84 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.488 2.125 . . . . 0.0 111.271 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.27 68.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 170.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 6.9 p30 -74.85 119.03 74.82 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.059 0.544 . . . . 0.0 110.551 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 15.4 Cg_exo -69.61 -38.68 7.79 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 0.0 113.554 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -119.88 -51.39 2.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.304 0.641 . . . . 0.0 111.677 -167.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.25 146.82 35.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.375 0.67 . . . . 0.0 109.792 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HB2' HH21 ' A' ' 87' ' ' ARG . 14.7 ptmm? -74.05 -5.1 39.47 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.932 0.893 . . . . 0.0 111.1 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 85.9 m-20 -76.63 -6.03 50.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.204 1.002 . . . . 0.0 111.98 171.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -71.03 125.56 27.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.081 0.952 . . . . 0.0 110.646 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.9 mt -123.65 120.18 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.64 0.776 . . . . 0.0 110.657 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 39.5 mttp -77.7 162.79 26.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.554 1.141 . . . . 0.0 111.009 167.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.3 t -123.3 127.02 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -122.32 144.22 49.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.622 1.169 . . . . 0.0 108.737 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -74.29 179.01 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.883 0.765 . . . . 0.0 112.285 177.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.85 -25.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.167 0.987 . . . . 0.0 113.492 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -73.16 -17.2 61.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.376 0.67 . . . . 0.0 110.968 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.81 37.25 10.49 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.825 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.466 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.8 t-20 -121.99 131.47 54.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.573 0.749 . . . . 0.0 109.185 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.92 104.76 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 124.167 0.917 . . . . 0.0 111.16 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 28.8 m -87.5 -0.24 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.012 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 151.89 -159.24 28.21 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.457 -0.338 . . . . 0.0 113.057 170.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 64.0 t60 -122.83 150.11 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.3 tt -75.07 -57.07 4.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.122 0.169 . . . . 0.0 111.006 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.3 tptt 142.53 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -162.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -22.5 62.43 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.777 1.171 . . . . 0.0 112.192 -175.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.78 -47.56 68.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.289 1.035 . . . . 0.0 110.571 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.9 tt -72.04 -48.69 42.66 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.434 0.694 . . . . 0.0 109.273 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -21.91 65.9 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.041 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.8 -28.36 60.3 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 123.296 0.373 . . . . 0.0 113.691 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.13 -56.26 4.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.315 0.646 . . . . 0.0 109.896 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.67 -16.5 61.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.059 0.944 . . . . 0.0 112.396 -175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -54.32 -51.22 65.36 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.518 1.527 . . . . 0.0 112.046 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -70.07 -30.55 67.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.35 1.031 . . . . 0.0 110.618 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.49 ' HA ' HD13 ' A' ' 127' ' ' LEU . 60.2 mt -67.79 -34.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.22 0.608 . . . . 0.0 110.143 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -80.8 -33.22 34.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.068 0.947 . . . . 0.0 110.723 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.85 -40.34 54.92 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.505 1.122 . . . . 0.0 111.467 -173.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.08 -2.38 40.27 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.221 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 57.84 41.58 24.6 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.236 1.015 . . . . 0.0 111.03 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 122' ' ' ILE . 82.1 mt -61.3 -43.95 98.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.436 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.429 ' HB1' ' HE2' ' A' ' 60' ' ' PHE . . . -149.66 138.37 20.93 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.246 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.92 105.24 5.86 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.59 104.69 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.11 176.28 9.34 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.589 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.59 158.97 27.89 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.61 -0.268 . . . . 0.0 112.522 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 55.6 t -148.38 129.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.552 HG22 HD23 ' A' ' 146' ' ' LEU . 21.8 t -96.68 93.41 1.36 Allowed Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 7.1 Cg_exo -74.25 -49.24 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.404 2.069 . . . . 0.0 112.24 -171.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.88 -27.48 33.44 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.563 0.745 . . . . 0.0 111.263 -172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.66 60.64 Favored Glycine 0 C--N 1.354 1.551 0 O-C-N 123.465 0.478 . . . . 0.0 114.27 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.99 9.27 10.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.415 0.686 . . . . 0.0 112.694 -170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.71 -20.5 66.36 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.611 0.765 . . . . 0.0 111.659 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.23 -47.96 82.07 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 0.0 110.077 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.61 -53.99 4.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.492 0.717 . . . . 0.0 111.747 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -146.88 -165.77 2.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.665 0.786 . . . . 0.0 111.504 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -95.94 122.73 39.06 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.809 0.844 . . . . 0.0 109.662 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -131.66 147.02 64.37 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.271 0.628 . . . . 0.0 111.223 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 88.2 Cg_endo -79.2 125.5 6.47 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.52 2.146 . . . . 0.0 112.252 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.552 HD23 HG22 ' A' ' 134' ' ' VAL . 3.3 pp -100.37 154.59 18.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.21 107.48 4.24 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.333 0.653 . . . . 0.0 110.559 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.49 ' SD ' HD22 ' A' ' 85' ' ' LEU . 62.3 mtt -107.12 149.66 27.41 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.404 HG21 HD13 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -144.34 135.97 25.83 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -171.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.473 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 83.1 m-85 -99.53 123.56 43.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.241 1.016 . . . . 0.0 110.655 -174.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.68 105.25 7.69 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.1 0.96 . . . . 0.0 108.561 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.78 166.76 35.09 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -58.37 143.13 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.77 -41.04 61.33 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.068 0.947 . . . . 0.0 113.135 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.57 -21.11 66.61 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.37 -3.51 56.66 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.731 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -61.65 -32.25 72.4 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.146 0.885 . . . . 0.0 111.162 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.37 -46.68 85.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.751 0.82 . . . . 0.0 109.754 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.44 -30.59 60.06 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.652 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.418 HG12 HD13 ' A' ' 122' ' ' ILE . 53.7 t -67.01 -49.71 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.535 0.734 . . . . 0.0 109.235 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.6 t -61.45 -34.14 74.93 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.449 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.1 t70 -55.54 -47.84 75.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.17 0.588 . . . . 0.0 110.43 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -66.89 -41.27 87.48 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 124.774 1.296 . . . . 0.0 111.578 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -62.39 1.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.797 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -57.05 -33.4 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.321 1.048 . . . . 0.0 111.846 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 20.9 ttmm -55.55 -53.3 58.1 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.333 1.053 . . . . 0.0 111.394 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.97 -16.29 38.83 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.435 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.79 26.76 7.83 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.626 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 123.536 0.734 . . . . 0.0 110.126 168.667 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -72.34 -27.48 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.446 1.098 . . . . 0.0 110.038 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -85.93 -26.12 25.72 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.426 1.09 . . . . 0.0 110.645 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 153' ' ' LYS . 70.2 m -82.15 135.36 35.29 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 110.835 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.13 164.17 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.08 1.352 . . . . 0.0 110.763 -172.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.408 HD11 HG23 ' A' ' 149' ' ' THR . 18.7 tp -87.55 112.62 22.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.082 0.553 . . . . 0.0 110.362 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 24.6 m-85 -78.17 -37.83 44.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.518 0.727 . . . . 0.0 111.408 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.85 -154.3 25.42 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -133.8 179.89 5.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.327 0.651 . . . . 0.0 111.176 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.57 150.75 21.57 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.614 1.165 . . . . 0.0 108.887 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -87.27 101.82 13.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.33 85.81 0.51 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.265 175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -70.35 99.3 1.54 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.52 0.728 . . . . 0.0 109.286 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG22 ' HD3' ' A' ' 71' ' ' ARG . 7.1 p -119.24 131.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.681 0.792 . . . . 0.0 109.825 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 70' ' ' LEU . 65.1 t -56.93 143.41 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.774 1.23 . . . . 0.0 111.719 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.45 66.25 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.496 ' H ' HG12 ' A' ' 68' ' ' VAL . 42.0 tp -61.56 -17.82 56.62 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.069 0.947 . . . . 0.0 111.803 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HD3' HG22 ' A' ' 67' ' ' VAL . 28.6 ptt-85 -63.89 -5.17 4.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.673 1.189 . . . . 0.0 113.442 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -53.33 -35.88 60.69 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.611 0.764 . . . . 0.0 112.616 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.44 -24.83 65.67 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 111.511 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -77.36 -6.57 53.77 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.952 0.901 . . . . 0.0 111.6 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.86 53.2 0.86 Allowed Glycine 0 C--N 1.359 1.834 0 O-C-N 121.81 -0.556 . . . . 0.0 113.301 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.597 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 29.0 m -68.41 171.38 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 24.1 m -114.71 162.1 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.411 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -89.96 -87.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.874 0.469 . . . . 0.0 111.811 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.92 149.23 36.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.847 0.459 . . . . 0.0 111.41 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.0 9.46 3.07 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.31 1.444 . . . . 0.0 113.141 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 56.6 mm-40 -82.11 132.52 35.25 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.904 0.383 . . . . 0.0 111.481 -174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.7 mtm -80.31 132.81 35.87 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.604 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 102' ' ' ASN . 27.0 m -131.66 163.35 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 124.098 0.959 . . . . 0.0 109.141 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.25 24.7 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.892 0.877 . . . . 0.0 108.735 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -85.23 148.79 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.478 0.711 . . . . 0.0 110.026 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.472 ' HA ' ' SD ' ' A' ' 123' ' ' MET . 52.5 tp60 -159.89 137.86 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.842 0.857 . . . . 0.0 108.776 175.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 22.5 ptt85 -66.92 152.48 45.6 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.237 0.541 . . . . 0.0 110.085 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 32.1 t70 -102.33 116.59 62.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.825 -168.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.92 -18.0 41.23 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.855 2.37 . . . . 0.0 112.808 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.03 15.64 4.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.259 0.623 . . . . 0.0 110.644 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -53.98 128.22 55.5 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.643 0.777 . . . . 0.0 111.461 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.37 -26.89 1.24 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.326 2.018 . . . . 0.0 113.793 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -108.68 -52.18 2.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.136 0.574 . . . . 0.0 110.934 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -166.67 157.56 12.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.307 0.643 . . . . 0.0 109.671 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HB2' HH11 ' A' ' 87' ' ' ARG . 16.5 ptpt -62.35 -7.79 4.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.228 1.411 . . . . 0.0 112.81 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -54.04 -32.48 54.59 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.278 1.031 . . . . 0.0 112.232 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.89 109.15 1.36 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.402 0.439 . . . . 0.0 110.181 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.5 mt -107.92 149.59 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.634 1.174 . . . . 0.0 108.231 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -122.29 144.44 48.99 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.53 0.681 . . . . 0.0 110.972 171.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -77.83 130.38 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.155 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 23.2 m-80 -114.95 144.14 44.05 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.603 0.761 . . . . 0.0 109.124 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -77.31 -169.69 1.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.445 0.566 . . . . 0.0 111.123 177.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.85 -25.87 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.188 0.595 . . . . 0.0 112.468 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 24.8 t-20 -74.58 -21.1 59.66 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.213 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.26 5.0 64.05 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.601 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.5 125.51 31.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.128 0.971 . . . . 0.0 108.781 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 12.0 pt20 -67.26 126.68 30.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.175 0.512 . . . . 0.0 111.701 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 16.9 m -89.47 -23.13 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.968 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 71' ' ' ARG . . . 165.06 165.27 22.07 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 99' ' ' LYS . 23.1 m170 -92.0 150.87 20.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.091 0.956 . . . . 0.0 111.403 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' HE2' ' A' ' 148' ' ' MET . 29.8 mt -96.37 29.78 2.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.602 1.561 . . . . 0.0 112.316 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 65.09 -172.1 0.18 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.775 0.83 . . . . 0.0 110.737 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -80.42 -49.35 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.944 0.498 . . . . 0.0 110.839 171.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.38 -57.35 9.56 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.817 -166.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 169' ' ' PHE . 10.1 tt -67.67 -47.15 70.32 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.859 0.838 . . . . 0.0 109.314 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.591 -1.641 . . . . 0.0 111.675 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.9 -38.85 94.65 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.544 0.527 . . . . 0.0 114.078 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -51.97 49.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.225 0.536 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.11 -16.83 64.17 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.928 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -61.32 -38.44 86.87 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.378 1.071 . . . . 0.0 112.887 -177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -71.36 -33.71 69.81 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.485 HD12 HG11 ' A' ' 160' ' ' VAL . 44.2 mt -68.66 -34.95 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.484 0.714 . . . . 0.0 110.322 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . 0.472 ' SD ' ' HA ' ' A' ' 86' ' ' GLN . 38.4 tpp -79.84 -52.26 8.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.095 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.54 -45.17 91.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.679 1.192 . . . . 0.0 110.654 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.86 2.76 54.6 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.59 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 126' ' ' LYS . 3.0 mmmp? 56.35 36.93 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.308 1.043 . . . . 0.0 111.886 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.9 mt -65.86 -43.93 86.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.837 0.855 . . . . 0.0 111.322 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.71 140.27 23.5 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.477 0.711 . . . . 0.0 110.603 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.97 102.91 6.62 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -89.07 106.22 16.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.14 179.84 5.46 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.875 0.87 . . . . 0.0 109.382 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -162.96 172.97 39.11 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.634 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 78.0 t -149.28 138.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 107.512 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.36 90.76 1.49 Allowed Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.76 -23.53 2.59 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.054 1.836 . . . . 0.0 113.871 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -77.87 -28.73 50.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.379 0.672 . . . . 0.0 112.49 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.12 31.2 75.9 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 123.229 0.33 . . . . 0.0 113.771 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 144' ' ' MET . . . -85.6 17.13 3.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.04 0.936 . . . . 0.0 111.655 -178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.3 -26.24 68.31 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.624 1.17 . . . . 0.0 111.72 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.01 -37.0 69.88 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.553 0.741 . . . . 0.0 110.914 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.07 -64.64 0.82 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.652 0.381 . . . . 0.0 110.362 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 37.6 t80 171.75 -89.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.304 1.442 . . . . 0.0 108.497 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.6 m -103.24 144.64 31.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.184 0.994 . . . . 0.0 109.852 -175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 1.4 pmm? -147.79 148.56 30.76 Favored Pre-proline 0 C--O 1.243 0.741 0 C-N-CA 123.308 0.643 . . . . 0.0 109.747 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.7 124.71 4.66 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.023 1.815 . . . . 0.0 109.985 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.2 145.58 27.88 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -74.79 106.81 6.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 85' ' ' LEU . 60.3 mtt -95.67 161.07 14.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.019 0.928 . . . . 0.0 109.554 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.408 HG23 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -150.73 132.4 14.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -171.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 82.3 m-85 -97.66 117.27 31.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.744 0.817 . . . . 0.0 109.911 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -124.31 115.78 21.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.53 168.41 40.55 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -65.83 147.01 54.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.435 0.636 . . . . 0.0 112.693 -173.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -53.64 -32.5 51.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.406 1.482 . . . . 0.0 114.083 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.43 -23.93 60.18 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.902 0.481 . . . . 0.0 111.608 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -92.55 3.26 55.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.294 0.637 . . . . 0.0 111.722 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.37 76.48 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.091 0.556 . . . . 0.0 111.919 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -35.36 69.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.25 0.62 . . . . 0.0 110.872 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -78.11 -41.14 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.443 0.697 . . . . 0.0 110.63 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.485 HG11 HD12 ' A' ' 122' ' ' ILE . 78.1 t -61.12 -47.97 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.834 0.854 . . . . 0.0 110.347 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.4 m -73.11 -24.26 60.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.675 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.52 -39.81 95.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.83 0.452 . . . . 0.0 110.5 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.3 mm100 -64.47 -35.11 79.86 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.666 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.18 -40.23 59.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.653 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.492 ' HB2' ' HZ2' ' A' ' 165' ' ' LYS . 10.3 mtmp? -67.06 -38.43 85.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.851 0.461 . . . . 0.0 110.908 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -59.47 -43.11 93.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.118 0.967 . . . . 0.0 111.691 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -96.78 -26.73 15.03 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.13 21.65 10.7 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.259 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 115' ' ' LEU . 67.3 m-85 . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.662 . . . . 0.0 110.462 171.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.479 0.181 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.52 -35.09 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.535 0.734 . . . . 0.0 109.619 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.5 t70 -76.4 -12.53 60.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.718 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -67.64 114.89 6.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.303 0.641 . . . . 0.0 111.685 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 56' ' ' ASP . 23.9 m -119.5 160.95 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.996 1.318 . . . . 0.0 110.821 -174.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.4 tp -81.37 112.41 18.63 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 22.2 m-85 -74.39 -29.12 61.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.96 0.504 . . . . 0.0 110.584 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.4 -176.75 29.71 Favored Glycine 0 C--O 1.246 0.851 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.703 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.7 p -110.81 119.83 40.38 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -100.84 133.21 45.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -73.09 96.21 2.16 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -76.48 -179.83 47.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 173.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -139.18 110.32 6.88 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.245 1.023 . . . . 0.0 109.942 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.65 132.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' HA ' HG21 ' A' ' 143' ' ' THR . 93.2 t -82.84 141.27 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.317 0.647 . . . . 0.0 109.608 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.31 69.11 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.432 0.458 . . . . 0.0 113.609 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.418 ' H ' HG13 ' A' ' 68' ' ' VAL . 70.8 mt -64.13 -18.69 64.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.005 0.922 . . . . 0.0 111.367 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HD2' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.15 0.65 18.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.828 1.251 . . . . 0.0 112.295 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 140' ' ' ASN . 11.1 p90 -55.98 -31.02 62.64 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.252 0.621 . . . . 0.0 111.762 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.36 -20.4 63.84 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.127 0.971 . . . . 0.0 111.91 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -74.97 -25.01 58.54 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.875 0.47 . . . . 0.0 110.059 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.55 50.41 0.45 Allowed Glycine 0 C--N 1.355 1.597 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.487 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.762 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 27.7 m -57.28 168.4 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.55 0.69 . . . . 0.0 112.673 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 m -114.41 166.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.543 -171.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.1 156.85 11.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.609 ' HB3' ' HA3' ' A' ' 137' ' ' GLY . 12.2 p30 -68.14 69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.157 1.383 . . . . 0.0 111.674 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -178.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.396 1.078 . . . . 0.0 109.37 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -65.18 149.41 49.96 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.121 -164.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 81.4 mtp -89.17 149.77 22.99 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.802 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.0 m -121.06 151.64 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.729 0.811 . . . . 0.0 110.933 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 101' ' ' ASN . . . -108.12 166.45 10.73 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.498 1.119 . . . . 0.0 109.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.465 HD11 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -122.68 119.41 30.64 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.564 0.746 . . . . 0.0 109.336 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.01 135.83 50.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.255 1.022 . . . . 0.0 108.985 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.445 HH21 ' HG3' ' A' ' 95' ' ' LYS . 69.1 ttt180 -77.49 125.33 29.17 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.157 0.583 . . . . 0.0 109.882 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' HB3' HD22 ' A' ' 91' ' ' ASN . 15.7 t70 -108.02 115.58 58.35 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 49.7 Cg_endo -83.55 -2.75 10.56 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.948 2.432 . . . . 0.0 114.26 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -107.53 21.63 17.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.267 0.627 . . . . 0.0 111.749 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.509 HD22 ' HB3' ' A' ' 88' ' ' ASP . 50.9 m-80 -86.28 142.22 35.49 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 121.609 -0.682 . . . . 0.0 111.313 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.67 -12.55 33.3 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.063 2.509 . . . . 0.0 112.284 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -77.76 -53.4 7.57 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.131 0.572 . . . . 0.0 109.528 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 170.78 163.91 0.08 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.874 1.359 . . . . 0.0 109.784 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 89' ' ' PRO . 8.3 ptpp? -59.41 -22.55 61.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.345 1.458 . . . . 0.0 113.243 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -78.44 -12.3 60.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.495 0.718 . . . . 0.0 112.885 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.18 110.44 3.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.838 0.455 . . . . 0.0 110.72 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.4 mt -75.86 120.8 26.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 124.012 0.925 . . . . 0.0 110.657 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 5.5 tppp? -75.07 117.14 16.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.02 167.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 111' ' ' LEU . 15.1 t -77.18 130.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 12.8 m120 -112.62 175.73 5.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.01 173.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.9 p30 -110.54 -167.9 1.24 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.713 0.688 . . . . 0.0 109.92 169.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.48 -27.28 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.409 0.683 . . . . 0.0 112.525 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -73.31 -21.86 60.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.723 0.809 . . . . 0.0 110.641 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 -5.58 60.68 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.837 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 131.84 37.49 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.187 0.595 . . . . 0.0 110.746 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.554 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -57.44 127.47 32.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.613 1.165 . . . . 0.0 112.042 177.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.762 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 30.3 m -113.27 -19.52 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 111.228 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.96 -145.93 9.58 Favored Glycine 0 C--N 1.358 1.786 0 C-N-CA 121.594 -0.336 . . . . 0.0 113.756 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -139.96 156.53 46.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.526 1.13 . . . . 0.0 109.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.536 ' HG ' HG22 ' A' ' 100' ' ' VAL . 53.9 mt -93.54 4.84 53.32 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.976 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 69.15 146.3 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.707 1.203 . . . . 0.0 110.815 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.53 17.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.89 -59.43 5.14 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.135 0.974 . . . . 0.0 111.702 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 111' ' ' LEU . 3.9 pp -85.6 -22.03 28.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.615 0.366 . . . . 0.0 111.358 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.8 88.77 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.48 0.712 . . . . 0.0 111.763 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.14 -29.48 74.51 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.851 0.72 . . . . 0.0 112.906 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.58 5.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 109.632 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.26 -15.92 63.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.977 0.911 . . . . 0.0 112.348 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -52.72 -44.92 66.71 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.41 1.084 . . . . 0.0 113.042 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -70.98 -32.23 69.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.911 0.386 . . . . 0.0 110.207 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.36 -35.44 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.421 0.689 . . . . 0.0 110.334 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.6 tpp -79.8 -33.53 40.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.671 1.188 . . . . 0.0 111.065 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.67 -51.14 10.27 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.169 0.988 . . . . 0.0 110.097 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -88.21 2.06 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.845 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 59.42 34.5 22.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.641 1.177 . . . . 0.0 111.354 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.54 -40.65 95.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.915 0.886 . . . . 0.0 111.894 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB1' ' HE1' ' A' ' 60' ' ' PHE . . . -154.73 134.88 13.13 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.474 0.71 . . . . 0.0 110.311 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.67 104.49 12.11 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.08 123.07 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.724 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.05 149.3 42.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.35 174.71 19.2 Favored Glycine 0 C--O 1.239 0.438 0 O-C-N 123.486 0.491 . . . . 0.0 112.869 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 14.4 p -151.18 143.58 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.869 0.868 . . . . 0.0 110.107 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.81 84.66 32.08 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.716 0.807 . . . . 0.0 110.029 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.62 -17.69 12.47 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.87 2.38 . . . . 0.0 112.647 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -83.22 -30.66 27.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.188 0.595 . . . . 0.0 111.174 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 79' ' ' ASN . . . 57.46 34.18 68.17 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.772 0.67 . . . . 0.0 114.339 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.16 0.31 57.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 0.0 110.548 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.87 -9.12 57.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.059 1.344 . . . . 0.0 112.582 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 72' ' ' TYR . 9.4 p30 -102.51 -22.25 14.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.327 0.651 . . . . 0.0 111.206 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.66 -41.53 7.66 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.629 0.772 . . . . 0.0 112.619 -167.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -160.0 -178.3 6.92 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 -164.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 68' ' ' VAL . 22.5 p -90.19 108.75 19.94 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 ptm -112.06 148.87 39.96 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.97 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 96.6 Cg_endo -78.77 146.62 21.1 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.925 1.75 . . . . 0.0 110.14 160.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -137.36 155.61 49.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.022 0.439 . . . . 0.0 110.134 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -74.22 108.08 6.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.118 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 85' ' ' LEU . 24.8 mmt -102.48 153.59 19.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -143.24 124.72 14.78 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.034 0.934 . . . . 0.0 108.853 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.06 117.53 30.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.814 0.846 . . . . 0.0 109.665 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -119.76 100.62 7.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.83 157.28 27.2 Favored Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -61.42 144.44 54.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.751 0.42 . . . . 0.0 111.487 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.32 -34.38 57.19 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.83 -30.31 70.75 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.144 0.429 . . . . 0.0 111.961 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -85.74 -9.84 56.51 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.422 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.9 ppt_? -60.69 -29.25 69.2 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 118.899 0.772 . . . . 0.0 112.152 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.99 -37.76 86.03 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.097 0.559 . . . . 0.0 110.536 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.493 ' N ' ' HD2' ' A' ' 158' ' ' LYS . . . -82.68 -46.17 13.56 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.829 0.852 . . . . 0.0 110.505 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.54 -50.61 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.38 1.072 . . . . 0.0 111.458 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.9 p -65.0 -39.25 93.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.905 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.94 -38.9 76.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.981 0.912 . . . . 0.0 111.632 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.5 mm100 -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.377 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.58 -56.72 7.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.189 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -55.03 -32.16 61.63 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.336 1.454 . . . . 0.0 112.128 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.15 -39.03 77.75 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -107.16 -11.52 15.59 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.429 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.75 42.17 6.51 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.639 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.455 0.702 . . . . 0.0 110.104 171.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -76.83 -18.04 58.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.45 0.7 . . . . 0.0 111.482 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.42 -22.59 66.97 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.952 0.901 . . . . 0.0 111.643 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.79 -41.48 91.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.43 0.692 . . . . 0.0 111.793 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -74.62 -23.78 58.75 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.682 0.219 . . . . 0.0 111.034 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.84 -42.44 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -76.04 -25.64 55.82 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.3 m -75.72 117.61 17.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.655 0.382 . . . . 0.0 110.022 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 m -116.0 156.64 17.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.556 1.142 . . . . 0.0 111.273 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.26 104.93 11.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -74.29 -33.07 63.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.577 ' HA3' ' HE2' ' A' ' 170' ' ' LYS . . . 156.97 -178.54 33.32 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.554 -173.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -111.01 160.54 16.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.433 0.693 . . . . 0.0 109.926 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD23 HD23 ' A' ' 119' ' ' LEU . 29.7 tp -126.93 154.24 44.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 110.206 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.443 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -99.05 86.14 3.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.126 1.371 . . . . 0.0 108.128 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.98 87.28 0.87 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -70.98 80.6 0.65 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.848 0.859 . . . . 0.0 109.818 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.76 138.1 20.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.4 137.37 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 123.78 0.675 . . . . 0.0 109.654 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 142' ' ' PHE . . . -81.51 -31.17 34.28 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.219 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.5 tp -62.45 -18.81 62.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.978 0.911 . . . . 0.0 111.465 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 2.7 mmp_? -76.94 0.84 19.55 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.141 0.977 . . . . 0.0 112.582 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HA ' HG13 ' A' ' 76' ' ' VAL . 28.2 p90 -51.11 -34.22 29.64 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.436 1.095 . . . . 0.0 112.37 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -62.96 -34.51 77.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.394 1.078 . . . . 0.0 111.971 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.1 p -78.68 2.33 19.9 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 49.14 0.65 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.952 165.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.717 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 32.7 m -65.66 162.6 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.64 1.22 . . . . 0.0 111.366 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.08 166.5 8.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.92 0.888 . . . . 0.0 110.913 -170.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -80.95 -170.83 2.89 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.797 0.839 . . . . 0.0 112.177 -170.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.11 145.86 55.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.995 0.918 . . . . 0.0 111.592 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 m120 66.25 10.17 6.94 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.326 1.45 . . . . 0.0 113.398 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.13 143.84 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.245 0.618 . . . . 0.0 110.141 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 80.6 mtp -96.65 142.0 29.22 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.5 m -126.2 145.81 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.361 1.064 . . . . 0.0 110.237 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . . . -105.79 153.56 21.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.101 0.96 . . . . 0.0 110.461 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.94 125.97 53.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.584 0.754 . . . . 0.0 109.691 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -140.8 112.86 7.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.718 0.807 . . . . 0.0 109.396 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 5.8 ppt_? -87.54 151.35 23.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.52 0.328 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 1.8 m-20 -90.88 149.61 40.57 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 123.59 0.756 . . . . 0.0 111.626 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.92 -43.11 57.35 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.609 2.206 . . . . 0.0 111.634 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -153.38 93.83 1.74 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.685 1.194 . . . . 0.0 108.962 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 1.3 t-20 -89.05 151.74 47.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.02 -29.43 44.56 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.618 2.879 . . . . 0.0 113.614 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.51 -51.63 22.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t0 172.1 162.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.366 1.467 . . . . 0.0 108.319 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -65.01 -15.09 61.93 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.64 1.176 . . . . 0.0 112.266 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -87.78 -15.92 35.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.364 0.666 . . . . 0.0 111.881 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.41 118.82 9.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.526 0.73 . . . . 0.0 111.665 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 63.1 mt -92.03 120.06 40.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.573 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.606 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 34.0 mtmm -81.14 123.4 28.39 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 164.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.27 126.16 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.459 ' OD1' ' HB2' ' A' ' 84' ' ' ALA . 6.5 p30 -115.29 173.76 6.35 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 124.598 1.159 . . . . 0.0 107.92 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -103.94 -170.38 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 118.666 0.666 . . . . 0.0 110.2 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -57.47 -33.06 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.57 -11.32 59.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.594 0.758 . . . . 0.0 111.564 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.16 14.57 78.81 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.521 -0.308 . . . . 0.0 112.888 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -78.5 120.57 23.4 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.95 0.9 . . . . 0.0 108.586 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.17 99.67 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.517 0.727 . . . . 0.0 109.499 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.717 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 23.0 m -71.77 -27.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.199 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.39 176.64 38.34 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.404 0.44 . . . . 0.0 113.41 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.606 ' HD2' ' HG2' ' A' ' 99' ' ' LYS . 31.6 m80 -92.46 133.96 35.41 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.459 HD11 ' HE3' ' A' ' 148' ' ' MET . 1.3 tt -66.35 -54.08 28.72 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.68 0.612 . . . . 0.0 110.307 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 53.9 mmtt 150.85 133.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 -160.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -70.86 -42.02 70.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.06 -52.03 65.59 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.128 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.84 -40.46 91.75 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.178 0.591 . . . . 0.0 110.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.03 69.85 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.239 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.79 -31.79 64.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.5 0.5 . . . . 0.0 113.125 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.58 5.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.552 0.741 . . . . 0.0 110.414 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.511 HD23 HD23 ' A' ' 63' ' ' LEU . 21.1 mt -73.3 -18.58 61.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -170.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.78 -29.7 65.97 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.412 0.685 . . . . 0.0 110.885 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.86 -35.33 64.74 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.411 HG21 ' HB2' ' A' ' 127' ' ' LEU . 58.8 mt -70.86 -33.64 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.275 0.63 . . . . 0.0 110.765 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.2 tpp -74.34 -56.2 5.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.419 1.088 . . . . 0.0 110.659 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.38 -44.78 62.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.267 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.33 5.07 32.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.695 0.398 . . . . 0.0 111.403 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 60.98 33.54 19.72 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.377 1.071 . . . . 0.0 112.592 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' HG21 ' A' ' 122' ' ' ILE . 64.2 mt -67.68 -38.56 83.89 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.662 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -166.67 145.89 5.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 111.173 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -78.26 116.87 19.0 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.998 0.919 . . . . 0.0 109.279 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -98.92 112.83 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.144 0.578 . . . . 0.0 109.812 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.401 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 10.9 pt-20 -83.41 167.66 17.29 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -143.27 152.34 23.98 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 35.5 t -149.16 128.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.475 1.11 . . . . 0.0 108.479 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.31 96.69 1.32 Allowed Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 123.646 0.778 . . . . 0.0 109.449 167.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.39 -31.34 9.22 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.591 2.194 . . . . 0.0 113.316 -176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.09 -20.94 12.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.989 0.916 . . . . 0.0 110.916 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.87 29.96 75.74 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.34 0.4 . . . . 0.0 113.468 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.79 3.24 12.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.953 0.901 . . . . 0.0 113.315 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -67.43 -26.63 66.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.171 0.589 . . . . 0.0 110.274 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.84 -37.46 73.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.694 0.797 . . . . 0.0 110.569 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.14 -55.23 9.92 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.695 0.798 . . . . 0.0 110.867 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.466 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 74.7 t80 -151.34 -77.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 p -158.3 165.76 33.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.012 1.725 . . . . 0.0 107.85 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.3 ptt? -167.12 152.37 7.15 Favored Pre-proline 0 C--O 1.246 0.921 0 O-C-N 123.43 0.456 . . . . 0.0 110.398 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.67 126.44 10.81 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.996 1.797 . . . . 0.0 110.339 162.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.59 156.23 16.9 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.984 0.514 . . . . 0.0 109.959 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.44 107.02 3.17 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.373 0.42 . . . . 0.0 110.305 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.459 ' HE3' HD11 ' A' ' 111' ' ' LEU . 65.4 mtt -104.07 160.26 14.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 131' ' ' GLU . 19.2 m -154.34 143.3 21.06 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.477 0.58 . . . . 0.0 110.029 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 76.6 m-85 -104.19 117.8 35.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.28 1.032 . . . . 0.0 109.851 -174.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -121.04 100.62 7.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.276 1.03 . . . . 0.0 108.811 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.52 167.67 33.07 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.528 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -65.69 147.87 52.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.12 -19.88 48.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.681 1.192 . . . . 0.0 114.046 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.0 -22.08 56.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -93.06 -0.19 57.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.083 0.553 . . . . 0.0 112.478 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 7.6 ppt_? -52.83 -38.11 60.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -79.98 -27.62 39.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.793 0.437 . . . . 0.0 110.79 -175.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.96 55.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.424 0.69 . . . . 0.0 110.752 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.83 -51.79 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.885 0.874 . . . . 0.0 110.133 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.3 p -65.89 -30.41 71.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.589 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -54.89 -42.54 72.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.898 0.879 . . . . 0.0 111.728 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -67.68 -34.41 76.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.299 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.28 -45.39 55.88 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.913 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -61.12 -31.73 71.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.03 1.332 . . . . 0.0 111.372 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -58.34 -42.35 86.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.804 1.242 . . . . 0.0 111.296 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -97.62 -15.05 20.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.099 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.32 19.18 31.06 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 113.585 0.194 . . . . 0.0 113.585 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.43 165.94 22.76 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.717 0.807 . . . . 0.0 110.997 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.577 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -57.61 147.77 26.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.03 0.932 . . . . 0.0 110.82 170.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 124.681 1.192 . . . . 0.0 110.451 -176.765 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -61.19 -37.11 81.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.631 0.772 . . . . 0.0 111.732 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.68 -29.83 22.17 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.014 0.525 . . . . 0.0 111.015 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.38 -39.51 90.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.969 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.31 -27.16 61.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.892 0.477 . . . . 0.0 111.286 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.53 -33.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.384 0.674 . . . . 0.0 109.561 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.38 -25.71 59.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.015 0.926 . . . . 0.0 110.411 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -72.47 134.83 45.53 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.071 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.5 158.53 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.384 1.073 . . . . 0.0 110.469 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.73 102.6 12.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.436 1.094 . . . . 0.0 108.292 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 41.8 m-85 -74.44 -23.24 58.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.108 0.563 . . . . 0.0 111.422 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.35 177.2 14.76 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.032 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -111.22 120.6 42.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.171 0.588 . . . . 0.0 110.267 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -86.76 137.71 32.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.539 1.136 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 100.73 4.13 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 115' ' ' LEU . . . -90.73 -170.84 43.43 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 166.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -165.43 127.04 2.0 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 100' ' ' VAL . 48.1 t -98.59 134.63 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 70' ' ' LEU . 23.7 t -69.98 143.93 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 O-C-N 123.92 0.763 . . . . 0.0 110.325 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.39 -22.52 78.58 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.233 0.333 . . . . 0.0 113.008 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.502 ' H ' HG13 ' A' ' 68' ' ' VAL . 35.0 tp -62.77 -18.15 62.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.429 1.092 . . . . 0.0 111.379 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 3.5 mmp_? -76.66 1.77 16.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.957 0.903 . . . . 0.0 112.823 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.698 ' HA ' HG21 ' A' ' 76' ' ' VAL . 86.7 t80 -48.69 -36.63 16.56 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.92 0.888 . . . . 0.0 112.546 174.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -62.44 -40.91 98.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.703 0.801 . . . . 0.0 111.609 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 p -78.51 -4.5 48.87 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.03 49.67 1.45 Allowed Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.698 HG21 ' HA ' ' A' ' 72' ' ' TYR . 17.4 m -53.55 164.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG23 HG23 ' A' ' 134' ' ' VAL . 14.8 m -114.6 163.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.792 -164.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -92.52 -166.37 1.53 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.996 1.318 . . . . 0.0 111.266 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.17 147.13 48.65 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.496 0.718 . . . . 0.0 111.6 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 63.98 8.87 4.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 0.0 113.637 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -77.04 136.91 38.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.977 0.418 . . . . 0.0 110.31 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.8 mtp -100.24 150.08 22.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.163 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 102' ' ' ASN . 29.8 m -135.11 174.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.537 1.135 . . . . 0.0 109.553 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.33 133.7 16.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 107.714 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.509 HD23 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -84.62 146.34 27.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.17 0.588 . . . . 0.0 109.986 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -151.2 130.31 12.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.141 0.977 . . . . 0.0 108.598 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.491 HH11 ' HB2' ' A' ' 95' ' ' LYS . 34.1 ptt85 -74.27 146.81 42.93 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -80.46 118.04 70.56 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.101 0.561 . . . . 0.0 110.894 -167.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 -32.63 24.86 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.14 2.56 . . . . 0.0 112.187 173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.75 33.95 2.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.913 0.885 . . . . 0.0 109.925 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -53.89 119.0 17.02 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.586 1.154 . . . . 0.0 112.987 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.88 -28.27 16.72 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.961 2.441 . . . . 0.0 113.155 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -116.45 -51.68 2.59 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.38 0.672 . . . . 0.0 111.328 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -167.67 155.64 8.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.841 0.456 . . . . 0.0 110.651 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.491 ' HB2' HH11 ' A' ' 87' ' ' ARG . 8.3 ptpp? -53.43 -23.17 9.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.179 1.791 . . . . 0.0 113.373 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.517 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 81.2 m-20 -78.98 18.86 0.58 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.775 0.83 . . . . 0.0 112.796 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.04 111.66 23.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 108.948 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 120' ' ' ALA . 29.7 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 123.592 0.757 . . . . 0.0 110.513 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -85.66 164.37 17.72 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.503 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 67' ' ' VAL . 60.7 t -117.27 117.34 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -110.25 131.39 55.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.936 0.894 . . . . 0.0 108.816 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.471 ' HA ' HG11 ' A' ' 83' ' ' VAL . 26.3 p-10 -75.71 -168.92 0.94 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 118.307 0.503 . . . . 0.0 111.507 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -52.11 -33.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 124.4 1.08 . . . . 0.0 112.96 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.24 -20.32 25.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.178 0.591 . . . . 0.0 111.553 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.53 4.2 54.92 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-N 116.447 -0.342 . . . . 0.0 112.843 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.15 127.46 31.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 110.061 175.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -77.3 92.16 3.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.925 0.89 . . . . 0.0 109.863 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.653 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 4.9 m -75.49 -14.89 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.231 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.24 -143.57 10.69 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 123.587 0.554 . . . . 0.0 112.426 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -135.83 166.75 22.57 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.407 1.083 . . . . 0.0 108.461 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' SD ' ' A' ' 148' ' ' MET . 5.2 mp -78.13 -53.13 7.71 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.557 0.694 . . . . 0.0 109.819 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 170.72 166.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 127.013 2.125 . . . . 0.0 106.771 -167.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -78.67 -44.98 22.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB3' ' NE2' ' A' ' 167' ' ' HIS . 19.5 mm-40 -66.74 -45.33 78.95 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.85 0.86 . . . . 0.0 111.935 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.479 HD13 ' HA2' ' A' ' 65' ' ' GLY . 1.5 tt -64.4 -44.03 92.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.525 0.73 . . . . 0.0 110.007 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.16 85.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.645 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -59.63 -30.33 68.6 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.97 0.793 . . . . 0.0 113.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -73.1 -61.29 1.87 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.394 0.678 . . . . 0.0 110.058 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.12 -15.79 63.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.932 0.893 . . . . 0.0 113.202 -171.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 98' ' ' ILE . . . -59.12 -39.55 82.63 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.413 1.085 . . . . 0.0 113.168 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.01 -32.95 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.079 0.552 . . . . 0.0 110.241 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.449 ' HA ' HD13 ' A' ' 127' ' ' LEU . 68.5 mt -66.78 -33.9 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.551 0.74 . . . . 0.0 110.081 174.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.4 tpp -78.01 -38.99 43.58 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.19 -47.66 34.21 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.196 0.998 . . . . 0.0 110.406 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -88.71 -1.49 58.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.099 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.87 31.45 18.24 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.264 1.025 . . . . 0.0 111.532 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 122' ' ' ILE . 77.6 mt -58.52 -43.62 89.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.157 0.983 . . . . 0.0 111.845 -174.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.72 131.53 11.6 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.972 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.17 107.19 13.76 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.494 1.118 . . . . 0.0 108.492 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.1 mt -93.35 111.36 24.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.236 0.615 . . . . 0.0 109.948 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.92 179.7 7.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.801 0.84 . . . . 0.0 109.156 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.26 156.34 27.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 82' ' ' MET . 38.8 t -141.76 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.949 0.9 . . . . 0.0 109.69 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 146' ' ' LEU . 1.7 m -103.73 94.99 6.83 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.447 1.099 . . . . 0.0 108.622 166.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.09 -48.76 3.27 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.537 2.158 . . . . 0.0 111.927 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.78 -27.79 40.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.604 0.762 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' ' HB ' ' A' ' 134' ' ' VAL . . . 63.6 30.08 76.58 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 113.733 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.07 -1.25 19.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.14 0.976 . . . . 0.0 111.507 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.63 -26.93 66.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.724 0.81 . . . . 0.0 111.09 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.403 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 9.9 t-20 -69.07 -29.6 67.76 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.417 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.28 -49.24 4.77 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.646 0.778 . . . . 0.0 110.715 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.99 -162.46 1.25 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.845 1.258 . . . . 0.0 110.087 -170.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -103.09 114.5 28.85 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.9 ptm -112.29 157.11 40.91 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.063 0.545 . . . . 0.0 110.307 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.91 124.81 13.2 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.252 1.968 . . . . 0.0 110.898 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HG ' HG12 ' A' ' 134' ' ' VAL . 4.7 tt -109.1 121.21 44.67 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.64 110.3 16.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.932 0.493 . . . . 0.0 109.676 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.509 ' SD ' HD23 ' A' ' 85' ' ' LEU . 47.6 mtt -115.82 113.36 23.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.409 1.084 . . . . 0.0 110.53 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -103.97 129.41 51.55 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.134 0.574 . . . . 0.0 110.472 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 3.9 m-85 -88.4 125.51 34.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.094 0.958 . . . . 0.0 109.478 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -126.73 99.2 5.67 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.98 161.71 31.69 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.663 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -62.72 145.41 54.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.392 0.677 . . . . 0.0 112.282 -175.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.435 ' HB3' HH21 ' A' ' 157' ' ' ARG . 44.5 mt-10 -57.59 -31.74 66.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.253 1.021 . . . . 0.0 113.425 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.53 -23.77 66.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.28 2.41 56.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.261 0.624 . . . . 0.0 112.404 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.435 HH21 ' HB3' ' A' ' 154' ' ' GLU . 15.5 ptp180 -57.99 -37.97 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.844 0.457 . . . . 0.0 111.514 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.67 -43.42 89.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.226 1.01 . . . . 0.0 110.387 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.97 -36.29 67.08 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.358 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.39 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.848 0.859 . . . . 0.0 110.443 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.0 p -67.57 -26.78 66.46 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.086 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.13 -37.61 88.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.106 0.562 . . . . 0.0 110.951 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.1 mm100 -74.49 -38.43 62.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.012 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.68 -61.73 2.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.47 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.63 -21.99 66.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.749 1.219 . . . . 0.0 112.761 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -53.74 -52.34 60.47 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.882 0.873 . . . . 0.0 111.018 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.451 ' NE2' ' HB3' ' A' ' 114' ' ' GLU . 66.3 t-80 -96.25 -17.27 20.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.418 -177.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.1 34.32 5.43 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.734 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.16 152.15 20.68 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.609 0.764 . . . . 0.0 109.878 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -166.41 150.31 7.44 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.798 0.839 . . . . 0.0 109.753 -177.641 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -85.12 36.33 0.62 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.92 0.888 . . . . 0.0 111.93 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.23 -30.64 64.77 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.104 0.962 . . . . 0.0 112.264 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -66.82 -13.01 61.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.813 1.245 . . . . 0.0 113.588 -177.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.55 -28.73 69.54 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.555 0.742 . . . . 0.0 111.18 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.79 -30.96 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.684 0.794 . . . . 0.0 109.584 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -77.77 -18.07 56.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.767 0.827 . . . . 0.0 110.415 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.96 133.5 50.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.995 0.518 . . . . 0.0 110.879 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.2 m -132.62 162.77 39.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 125.015 1.326 . . . . 0.0 109.797 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 tp -83.89 111.58 19.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HE1' ' HB3' ' A' ' 128' ' ' ALA . 23.0 m-85 -73.51 -25.86 60.62 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.287 0.565 . . . . 0.0 110.611 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -144.25 14.41 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -132.52 179.74 5.95 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.635 0.774 . . . . 0.0 110.271 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 169' ' ' PHE . 49.2 tp -143.35 146.76 33.8 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.571 0.748 . . . . 0.0 109.516 172.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -71.24 81.81 0.73 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.221 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 67' ' ' VAL . . . -74.1 74.72 1.18 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -68.08 87.64 0.27 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG11 ' HA ' ' A' ' 111' ' ' LEU . 36.6 t -87.42 147.97 4.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.696 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 87.6 t -61.46 140.96 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.274 1.029 . . . . 0.0 110.727 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.59 -38.18 15.02 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -17.55 31.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.871 1.269 . . . . 0.0 113.248 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' NH1' HG21 ' A' ' 108' ' ' VAL . 13.1 ptt180 -69.22 -2.29 10.16 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.491 0.717 . . . . 0.0 112.506 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -51.93 -36.84 50.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.071 0.948 . . . . 0.0 112.928 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.08 -30.58 71.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.746 0.818 . . . . 0.0 111.535 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 m -74.38 -6.31 47.44 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.758 0.823 . . . . 0.0 111.786 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.02 45.77 1.24 Allowed Glycine 0 C--N 1.35 1.327 0 O-C-N 122.388 -0.195 . . . . 0.0 113.486 169.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.42 HG21 ' ND2' ' A' ' 140' ' ' ASN . 28.9 m -64.96 172.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 170.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.08 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.68 -146.26 0.4 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.247 0.619 . . . . 0.0 109.769 -172.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 150.91 41.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.286 1.034 . . . . 0.0 112.666 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 68.83 -5.44 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.592 1.557 . . . . 0.0 113.208 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.16 146.49 29.53 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.042 0.537 . . . . 0.0 110.622 -172.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.5 mtp -97.43 143.56 28.04 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.518 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.13 145.78 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.36 1.064 . . . . 0.0 108.912 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 101' ' ' ASN . . . -99.03 156.01 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.612 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -115.41 124.49 51.31 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -132.98 116.8 16.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.969 0.908 . . . . 0.0 109.679 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -67.91 119.21 12.21 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.616 ' HB3' HD22 ' A' ' 91' ' ' ASN . 18.5 t70 -66.6 132.65 94.16 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.571 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.79 -42.52 11.87 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.272 3.314 . . . . 0.0 114.079 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -167.38 106.95 0.58 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 123.138 0.273 . . . . 0.0 110.551 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.616 HD22 ' HB3' ' A' ' 88' ' ' ASP . 24.5 m-80 -96.7 146.26 30.99 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.05 -22.14 48.2 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.765 2.31 . . . . 0.0 114.003 -170.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -125.94 -46.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.713 0.405 . . . . 0.0 110.858 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.426 ' HB3' ' ND2' ' A' ' 96' ' ' ASN . 33.7 m-20 -117.14 92.7 3.93 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -55.86 -33.16 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.728 0.811 . . . . 0.0 111.686 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.498 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -72.3 -8.29 54.08 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 113.1 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 108.41 2.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.237 0.615 . . . . 0.0 111.375 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.32 125.95 45.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 124.081 0.952 . . . . 0.0 110.213 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 32.4 mmtp -86.8 123.91 32.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.106 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.61 112.67 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.503 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 2.0 m-20 -91.53 170.36 10.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.188 0.995 . . . . 0.0 108.849 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -108.11 -171.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.843 0.457 . . . . 0.0 110.248 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.69 -28.38 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.637 0.775 . . . . 0.0 112.24 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.9 -30.48 63.95 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.176 0.591 . . . . 0.0 110.357 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.19 -4.34 30.03 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.485 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.81 137.4 41.87 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.278 0.539 . . . . 0.0 110.026 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.78 95.37 0.89 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.554 HG21 ' NH1' ' A' ' 71' ' ' ARG . 27.8 m -86.95 16.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.861 0.865 . . . . 0.0 112.012 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 148.01 -175.72 27.19 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.925 169.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -102.68 148.83 25.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.11 0.964 . . . . 0.0 108.972 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HA ' HG11 ' A' ' 67' ' ' VAL . 3.2 tt -73.89 -56.09 5.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? 152.12 121.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -165.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -61.11 -49.47 77.13 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 118.802 0.728 . . . . 0.0 112.072 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.33 -41.56 93.81 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.821 0.7 . . . . 0.0 110.82 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.77 -40.08 66.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.831 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.32 -24.54 65.75 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.008 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.28 -33.82 88.29 Favored Glycine 0 C--N 1.351 1.361 0 O-C-N 123.603 0.565 . . . . 0.0 112.958 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -56.84 4.78 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.413 0.625 . . . . 0.0 109.802 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.417 HD22 HD22 ' A' ' 63' ' ' LEU . 22.5 mt -70.5 -18.12 62.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.506 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.96 67.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.881 0.873 . . . . 0.0 111.153 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -66.03 -35.5 80.72 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.184 0.928 . . . . 0.0 110.44 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 127' ' ' LEU . 83.9 mt -62.62 -44.55 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 0.0 110.585 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.515 ' HE1' ' HB3' ' A' ' 85' ' ' LEU . 30.1 ttm -81.19 -21.46 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.644 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.31 -51.05 10.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 0.0 109.72 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -89.71 4.16 50.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.224 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HB3' ' HZ1' ' A' ' 126' ' ' LYS . 2.7 mmmp? 59.71 36.63 22.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.533 1.133 . . . . 0.0 111.594 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 122' ' ' ILE . 66.0 mt -62.22 -40.83 97.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.44 1.096 . . . . 0.0 111.54 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . . . -162.15 140.86 9.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.13 0.572 . . . . 0.0 111.093 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -76.52 133.51 39.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.1 113.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.39 132.75 54.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.35 154.78 18.53 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.773 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 67.3 t -137.99 137.26 44.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.23 84.88 4.98 Favored Pre-proline 0 CA--C 1.555 1.17 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.47 -35.78 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.656 2.237 . . . . 0.0 111.74 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.25 -26.13 58.61 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.966 0.907 . . . . 0.0 110.59 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.76 -6.08 14.18 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 115.835 1.094 . . . . 0.0 115.835 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.12 1.8 30.22 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.481 0.641 . . . . 0.0 112.723 -172.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.598 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 3.4 t-20 -75.32 -18.4 60.03 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.116 0.484 . . . . 0.0 110.315 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.42 ' ND2' HG21 ' A' ' 76' ' ' VAL . 20.6 t-20 -61.89 -34.23 75.66 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.092 0.957 . . . . 0.0 110.663 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.94 -56.39 2.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.828 0.851 . . . . 0.0 112.579 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -126.8 -178.25 4.32 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.542 1.137 . . . . 0.0 110.573 -161.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p -93.8 125.46 38.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.087 0.955 . . . . 0.0 109.631 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 139' ' ' ASN . 3.3 ppp? -156.61 160.93 30.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.172 0.989 . . . . 0.0 109.302 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.96 121.5 7.36 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.791 1.661 . . . . 0.0 111.147 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 67' ' ' VAL . 6.5 tt -100.34 124.88 46.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -74.33 108.84 7.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.612 ' SD ' HD21 ' A' ' 85' ' ' LEU . 58.5 mtt -116.05 121.74 43.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.76 0.824 . . . . 0.0 109.581 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -108.99 140.53 42.36 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.373 1.069 . . . . 0.0 110.206 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -104.15 121.01 42.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.923 0.889 . . . . 0.0 109.684 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -124.5 112.88 17.4 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.48 164.45 37.97 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 7.9 ptpp? -54.26 137.69 40.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.534 0.734 . . . . 0.0 110.541 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -53.93 -39.0 65.47 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 123.854 0.721 . . . . 0.0 112.551 -169.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.42 -18.03 35.67 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.319 1.048 . . . . 0.0 113.759 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -92.51 -8.22 45.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.79 -33.62 66.84 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.056 0.542 . . . . 0.0 112.398 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 46.7 pttt -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.674 0.789 . . . . 0.0 111.381 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' H ' ' HG3' ' A' ' 158' ' ' LYS . . . -68.65 -34.7 76.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.62 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.96 -44.24 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.657 0.783 . . . . 0.0 110.466 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -72.67 -25.97 61.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.543 0.737 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 32.7 t70 -58.77 -39.92 82.43 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.15 0.5 . . . . 0.0 110.286 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.458 ' HA ' ' HE2' ' A' ' 166' ' ' LYS . 14.7 mm100 -73.19 -39.49 65.53 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.12 -175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.51 -57.54 4.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.32 -21.29 59.52 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.654 1.181 . . . . 0.0 112.484 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 163' ' ' GLN . 21.8 ttmm -56.23 -50.38 71.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.989 0.916 . . . . 0.0 111.177 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -111.59 18.7 18.82 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.174 0.59 . . . . 0.0 110.545 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.0 14.07 76.05 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' HB3' HD12 ' A' ' 63' ' ' LEU . 28.4 m-85 -66.1 137.55 57.13 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.883 0.873 . . . . 0.0 110.892 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -166.54 151.0 7.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.467 1.107 . . . . 0.0 108.022 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.561 HD21 ' H ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.435 0.694 . . . . 0.0 111.628 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 120.096 -0.28 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -60.31 -35.5 75.74 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.246 1.019 . . . . 0.0 111.372 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -73.73 -40.09 63.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.196 0.598 . . . . 0.0 110.874 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.62 -42.05 82.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.101 0.961 . . . . 0.0 111.588 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.39 -36.78 71.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.328 0.651 . . . . 0.0 111.993 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.0 t -72.54 -31.44 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.4 t70 -77.4 -14.0 59.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.285 0.634 . . . . 0.0 111.126 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 m -70.66 109.29 4.82 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.464 0.65 . . . . 0.0 110.519 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 56' ' ' ASP . 16.9 m -116.61 162.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.853 1.261 . . . . 0.0 110.293 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.76 118.49 22.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 27.8 m-85 -83.31 -31.5 26.83 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.322 0.582 . . . . 0.0 110.167 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.1 -167.94 29.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.873 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 147' ' ' HIS . 77.6 p -125.58 138.98 53.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.889 0.476 . . . . 0.0 110.102 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.09 140.95 32.48 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 109.761 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -75.37 78.87 2.44 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.928 0.87 . . . . 0.0 110.486 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA2' HD12 ' A' ' 115' ' ' LEU . . . -71.68 141.23 31.66 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.419 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -122.01 100.72 7.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.45 0.7 . . . . 0.0 109.776 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.96 131.23 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.93 0.769 . . . . 0.0 108.974 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.66 142.32 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.741 0.816 . . . . 0.0 111.594 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.63 -27.29 57.35 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.64 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.85 -19.57 65.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.444 0.698 . . . . 0.0 110.072 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 4.1 mmp_? -78.1 0.27 25.39 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.47 1.108 . . . . 0.0 112.807 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.05 -36.66 65.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.473 0.709 . . . . 0.0 112.12 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.82 -32.23 73.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.701 0.8 . . . . 0.0 111.85 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 p -87.22 15.5 6.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.13 0.572 . . . . 0.0 112.399 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.04 49.95 1.41 Allowed Glycine 0 C--N 1.356 1.653 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 163.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.47 169.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.093 0.947 . . . . 0.0 111.585 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.552 HG21 HG11 ' A' ' 134' ' ' VAL . 27.6 m -115.64 158.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.769 0.828 . . . . 0.0 111.902 -164.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.32 -173.95 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.136 0.974 . . . . 0.0 110.758 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -72.44 153.23 41.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.44 8.74 5.96 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 125.019 1.328 . . . . 0.0 112.229 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -88.11 145.41 25.96 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.7 -0.625 . . . . 0.0 111.553 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.56 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -95.36 147.37 23.58 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.123 177.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.82 142.09 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.556 1.142 . . . . 0.0 108.853 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -115.01 124.69 52.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.721 0.808 . . . . 0.0 109.56 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.9 mt -76.83 158.84 30.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.681 0.393 . . . . 0.0 110.707 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.03 121.59 4.89 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.425 0.69 . . . . 0.0 110.116 -174.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.28 134.61 56.14 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.471 0.708 . . . . 0.0 110.835 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' ND2' ' A' ' 91' ' ' ASN . 3.5 m-20 -68.74 118.28 59.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.319 0.647 . . . . 0.0 109.319 169.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.75 -29.57 90.07 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.918 2.412 . . . . 0.0 112.866 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -144.42 98.99 3.29 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.453 HD21 ' HB3' ' A' ' 97' ' ' ALA . 14.7 m120 -65.64 138.69 96.79 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.583 0.753 . . . . 0.0 110.632 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.46 -54.41 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.434 2.089 . . . . 0.0 113.139 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -128.61 -50.72 1.26 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.754 0.822 . . . . 0.0 109.768 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.71 101.25 13.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.019 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.25 -4.96 28.6 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.523 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 3.6 p-10 -99.37 -2.14 37.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.282 1.033 . . . . 0.0 111.784 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 91' ' ' ASN . . . -68.71 144.24 54.47 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.021 0.528 . . . . 0.0 111.384 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.19 126.18 55.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.145 0.978 . . . . 0.0 108.931 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.17 152.93 43.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.506 0.722 . . . . 0.0 111.209 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.31 134.08 64.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -121.05 166.48 13.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.429 1.091 . . . . 0.0 108.084 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -99.34 -172.64 2.3 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.11 -19.28 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.227 0.611 . . . . 0.0 112.582 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -84.92 -10.93 56.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.354 0.662 . . . . 0.0 110.919 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.3 19.9 59.77 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.648 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.88 127.68 35.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 109.762 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.01 110.49 3.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 110.239 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 4.3 m -84.3 -10.51 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.943 0.497 . . . . 0.0 110.643 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.96 -141.52 12.86 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -106.05 173.76 6.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.733 0.813 . . . . 0.0 110.072 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD12 ' SD ' ' A' ' 148' ' ' MET . 2.3 tt -84.71 -52.32 6.16 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 172.01 168.77 0.1 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -79.06 -63.77 1.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.26 -36.55 74.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 0.0 112.379 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.433 HD12 ' HA2' ' A' ' 65' ' ' GLY . 4.9 tt -73.05 -46.02 54.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.896 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.03 67.44 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.838 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -61.48 -40.04 98.14 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.592 0.558 . . . . 0.0 113.347 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -49.55 39.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.38 0.609 . . . . 0.0 109.86 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 122' ' ' ILE . 17.1 mt -69.31 -16.74 63.62 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.819 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.84 -57.95 9.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.381 1.072 . . . . 0.0 111.543 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -64.07 -31.0 72.03 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.909 0.756 . . . . 0.0 110.687 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.537 ' HA ' HD12 ' A' ' 127' ' ' LEU . 73.5 mt -67.34 -40.61 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.509 0.723 . . . . 0.0 111.203 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.7 ttm -80.36 -36.31 34.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.232 0.613 . . . . 0.0 110.971 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.13 -41.41 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.272 1.029 . . . . 0.0 111.101 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -99.67 7.98 44.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.648 0.779 . . . . 0.0 111.096 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 63.08 35.77 12.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.33 1.052 . . . . 0.0 111.762 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 122' ' ' ILE . 64.1 mt -69.5 -50.22 47.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.009 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -152.11 145.0 24.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.89 134.66 33.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 108.599 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.2 mt -121.4 117.42 52.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.721 0.296 . . . . 0.0 110.301 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -117.37 121.25 40.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.252 1.021 . . . . 0.0 108.451 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -90.14 155.52 24.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.582 -0.281 . . . . 0.0 112.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 82' ' ' MET . 53.3 t -138.68 128.02 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 77' ' ' VAL . 5.0 p -96.01 102.27 10.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.711 0.805 . . . . 0.0 109.301 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -53.56 0.18 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.296 1.997 . . . . 0.0 113.574 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -84.98 -27.59 26.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.035 0.534 . . . . 0.0 110.941 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.35 81.84 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 113.718 0.247 . . . . 0.0 113.718 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.662 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -75.93 -7.75 55.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.423 0.689 . . . . 0.0 112.277 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.78 -16.65 63.86 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.864 0.865 . . . . 0.0 110.973 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -73.12 -25.66 60.93 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.622 0.769 . . . . 0.0 111.29 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.07 -60.61 2.19 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -141.5 -83.49 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.1 m -157.5 140.62 15.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.662 ' HG2' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -153.06 149.38 21.69 Favored Pre-proline 0 C--O 1.243 0.758 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 173.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.75 124.4 14.49 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.326 2.017 . . . . 0.0 112.815 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.456 HD21 ' HB ' ' A' ' 134' ' ' VAL . 4.3 pp -117.77 146.25 43.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.043 0.937 . . . . 0.0 108.858 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.5 m80 -86.55 109.85 19.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.612 0.365 . . . . 0.0 111.139 -166.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.645 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 40.3 mtt -99.76 111.77 24.07 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.188 0.995 . . . . 0.0 109.468 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 49.5 p -93.99 128.22 40.21 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.154 0.982 . . . . 0.0 109.653 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -91.13 117.25 29.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.261 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -120.44 99.18 6.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.89 166.55 31.45 Favored Glycine 0 CA--C 1.501 -0.832 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.342 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.03 149.3 45.04 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.58 -48.02 7.51 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.78 1.632 . . . . 0.0 113.613 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.14 -9.89 55.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -171.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 127' ' ' LEU . 98.9 m-20 -107.62 -4.36 18.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.403 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 8.9 ptp85 -63.44 -29.24 70.56 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.216 0.916 . . . . 0.0 112.228 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.16 -42.52 86.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.67 0.788 . . . . 0.0 109.847 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.06 -34.12 29.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.467 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.89 -57.75 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.654 0.782 . . . . 0.0 110.517 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 m -62.95 -25.45 68.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.098 0.959 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.4 t70 -60.57 -48.65 80.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.526 0.33 . . . . 0.0 110.375 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.9 mm100 -64.06 -35.22 80.02 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.956 0.785 . . . . 0.0 111.155 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.455 HD12 ' HZ3' ' A' ' 170' ' ' LYS . 94.7 mt -73.05 -62.46 1.45 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -58.91 -26.98 64.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.497 0.719 . . . . 0.0 111.694 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 37.1 ttmt -56.06 -50.09 71.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.645 1.178 . . . . 0.0 111.793 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -87.15 -13.46 44.02 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.02 10.85 23.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.916 -0.38 . . . . 0.0 113.548 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -73.71 168.97 18.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.078 0.551 . . . . 0.0 110.106 171.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' HZ3' HD12 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -68.23 151.48 46.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.67 0.388 . . . . 0.0 110.216 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.431 HD21 ' H ' ' A' ' 171' ' ' LEU . 1.8 pt? . . . . . 0 CA--C 1.565 1.542 0 C-N-CA 123.019 0.528 . . . . 0.0 110.153 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 t -65.68 -35.2 80.1 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.724 0.809 . . . . 0.0 110.464 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.78 -28.01 69.29 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.386 1.474 . . . . 0.0 113.742 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 15.8 pt-20 -70.4 -31.25 68.39 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.755 0.422 . . . . 0.0 111.82 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -27.56 21.51 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.768 0.427 . . . . 0.0 110.471 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.92 -32.05 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.44 0.696 . . . . 0.0 109.605 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.97 -33.26 75.62 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.349 1.06 . . . . 0.0 110.48 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -78.53 127.49 32.22 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.753 0.821 . . . . 0.0 110.693 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.85 166.78 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.786 1.234 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.51 117.59 23.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.444 ' HE2' ' HB3' ' A' ' 128' ' ' ALA . 20.7 m-85 -81.12 -28.86 34.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.058 0.543 . . . . 0.0 110.648 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.93 -153.26 25.19 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -126.47 178.61 5.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.414 0.685 . . . . 0.0 110.559 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -150.96 141.56 22.62 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.913 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -71.74 84.14 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.494 0.718 . . . . 0.0 109.717 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.37 87.25 1.38 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.168 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 18.2 t60 -73.79 94.28 2.24 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.203 0.601 . . . . 0.0 110.213 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG11 ' HD2' ' A' ' 71' ' ' ARG . 38.3 t -82.22 142.68 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.431 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.74 154.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.892 0.877 . . . . 0.0 113.072 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.46 -19.95 72.85 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.387 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.3 tp -57.23 -23.85 50.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.973 1.309 . . . . 0.0 111.489 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.54 ' HD2' HG11 ' A' ' 67' ' ' VAL . 70.8 ttt180 -54.85 -21.83 12.62 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.241 1.416 . . . . 0.0 113.15 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -49.91 -49.6 49.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.165 0.986 . . . . 0.0 111.95 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -75.45 -25.94 57.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.056 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 m -80.46 -9.23 59.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.011 0.524 . . . . 0.0 110.53 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.31 50.18 0.73 Allowed Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.309 170.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.19 158.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.634 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 33.1 m -112.99 152.19 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.222 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.75 -76.84 0.11 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.338 0.399 . . . . 0.0 110.789 -164.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -164.07 159.22 20.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.065 0.946 . . . . 0.0 109.617 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 70.7 -7.6 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.486 1.114 . . . . 0.0 111.892 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 72.4 mm-40 -75.25 144.0 42.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.758 0.823 . . . . 0.0 111.965 -167.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.551 ' HG2' HG21 ' A' ' 133' ' ' VAL . 73.4 mtm -95.04 144.53 25.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.46 170.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.93 160.79 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.084 0.954 . . . . 0.0 109.083 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.68 25.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.613 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.6 mp -85.38 134.06 34.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.045 0.538 . . . . 0.0 109.575 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -142.78 130.7 21.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.3 0.64 . . . . 0.0 109.486 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -80.76 124.32 28.95 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -99.16 137.18 20.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.385 0.674 . . . . 0.0 111.446 -177.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.54 -28.7 6.51 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.622 2.215 . . . . 0.0 112.025 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -80.65 83.72 6.36 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -89.92 127.91 52.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.334 -166.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.47 -26.92 11.56 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.553 2.168 . . . . 0.0 112.408 171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -120.84 -53.38 2.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.254 0.621 . . . . 0.0 111.578 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -168.1 154.0 7.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.01 -13.38 2.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.162 0.985 . . . . 0.0 113.636 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.478 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 90.0 m-20 -95.19 27.68 3.15 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.065 0.946 . . . . 0.0 111.48 174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.7 34.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.057 0.543 . . . . 0.0 110.687 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mt -116.36 123.87 71.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 C-N-CA 123.967 0.907 . . . . 0.0 109.437 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HZ1' ' HB3' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -81.84 150.13 27.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.591 0.71 . . . . 0.0 110.465 170.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -101.11 109.95 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -89.91 167.73 12.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -107.1 -165.6 1.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.298 0.499 . . . . 0.0 110.482 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -59.04 -31.24 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.847 0.859 . . . . 0.0 112.034 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.08 -11.96 57.53 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.196 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.37 85.82 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 113.169 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 133.66 36.23 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 109.746 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -61.64 92.45 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 O-C-N 124.283 0.99 . . . . 0.0 110.816 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.92 -1.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.738 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 71' ' ' ARG . . . 172.76 -159.34 29.9 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.554 0.533 . . . . 0.0 113.83 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 11.6 p-80 -142.01 150.48 41.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.887 1.275 . . . . 0.0 107.632 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HG ' ' HE1' ' A' ' 148' ' ' MET . 2.7 tt -71.51 -53.84 12.53 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -173.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -178.47 -179.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.988 1.715 . . . . 0.0 108.104 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -81.0 -61.41 1.97 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 162.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.22 -39.21 23.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.712 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -67.08 -44.89 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.78 70.75 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.508 -1.223 . . . . 0.0 111.13 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -61.44 -42.82 99.86 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.876 0.735 . . . . 0.0 114.353 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.75 -47.95 67.82 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.389 0.614 . . . . 0.0 110.534 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.49 -18.97 63.74 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.55 87.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.117 0.967 . . . . 0.0 111.861 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -70.04 -32.87 71.21 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.699 0.625 . . . . 0.0 109.584 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.479 HD11 HG11 ' A' ' 160' ' ' VAL . 66.5 mt -67.63 -37.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.654 0.782 . . . . 0.0 110.782 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.91 -44.9 21.69 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.797 0.839 . . . . 0.0 111.075 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.74 -46.7 52.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.653 1.181 . . . . 0.0 110.791 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.97 6.86 33.81 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.806 0.443 . . . . 0.0 111.243 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 59.92 33.56 21.53 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.806 1.242 . . . . 0.0 111.733 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 122' ' ' ILE . 68.9 mt -65.71 -42.59 90.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.444 ' HB3' ' HE2' ' A' ' 60' ' ' PHE . . . -158.34 151.17 22.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -86.39 132.11 34.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -113.81 113.44 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -102.99 179.27 4.32 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.208 1.003 . . . . 0.0 108.481 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.33 164.38 31.47 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.551 HG21 ' HG2' ' A' ' 82' ' ' MET . 58.9 t -144.44 134.18 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.3 p -112.83 88.8 12.21 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.7 -22.88 8.73 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.489 2.126 . . . . 0.0 112.699 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.49 ' HB2' ' HE3' ' A' ' 144' ' ' MET . 64.8 m-85 -82.48 -28.45 31.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.923 0.489 . . . . 0.0 110.518 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.75 4.29 75.84 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -69.73 -9.05 52.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.301 0.64 . . . . 0.0 112.702 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -18.66 64.96 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.0 0.92 . . . . 0.0 113.221 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.62 -53.01 9.27 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 110.705 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.73 -34.35 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.169 0.588 . . . . 0.0 111.301 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -117.39 174.34 6.2 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.718 0.807 . . . . 0.0 110.819 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -98.92 111.02 23.54 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.493 ' SD ' ' HB2' ' A' ' 138' ' ' ALA . 19.6 ptm -125.8 158.74 64.36 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 121.921 -0.487 . . . . 0.0 110.644 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 2.5 Cg_endo -83.57 125.73 3.91 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.765 2.31 . . . . 0.0 110.826 164.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.22 154.75 22.95 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -74.76 111.21 9.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.053 0.541 . . . . 0.0 110.35 -171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.613 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -109.88 117.12 32.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.228 1.011 . . . . 0.0 110.328 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -107.49 135.23 49.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.505 1.122 . . . . 0.0 110.424 -167.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.2 118.95 35.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 109.424 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -123.62 103.49 8.45 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.47 169.47 36.99 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.506 ' HZ1' ' HB3' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -62.95 138.06 58.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.011 0.525 . . . . 0.0 111.734 -176.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -52.48 -32.06 38.02 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.643 1.577 . . . . 0.0 113.071 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.34 -10.1 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.738 . . . . 0.0 112.697 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.57 4.13 20.05 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.841 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -61.06 -33.52 73.44 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.377 0.99 . . . . 0.0 111.756 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -33.19 69.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.239 0.616 . . . . 0.0 110.769 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -76.7 -38.31 54.61 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.615 0.766 . . . . 0.0 110.575 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.479 HG11 HD11 ' A' ' 122' ' ' ILE . 64.3 t -64.34 -47.65 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.141 0.976 . . . . 0.0 110.27 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.5 p -68.45 -29.87 68.61 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.881 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -43.13 99.38 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.38 0.672 . . . . 0.0 111.253 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 12.1 mm100 -63.15 -37.26 86.53 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.958 0.786 . . . . 0.0 110.485 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -48.38 51.01 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.223 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -66.07 -25.7 67.15 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.408 1.083 . . . . 0.0 111.611 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -67.04 -44.01 81.32 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.939 0.895 . . . . 0.0 111.293 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -110.09 3.94 20.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.903 0.481 . . . . 0.0 110.893 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.21 66.7 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.24 140.2 41.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.125 0.57 . . . . 0.0 110.373 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -169.57 145.78 3.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.326 0 C-N-CA 123.533 0.733 . . . . 0.0 110.133 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.446 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -62.29 -43.57 98.52 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.111 0.964 . . . . 0.0 111.528 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.23 -37.2 76.92 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.687 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HG2' ' HZ2' ' A' ' 153' ' ' LYS . 1.0 OUTLIER -68.08 -48.02 66.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -177.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -77.32 -22.96 51.11 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.984 0.514 . . . . 0.0 112.286 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.85 -27.6 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 109.494 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.5 -16.97 60.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.642 0.777 . . . . 0.0 110.954 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -70.39 146.03 50.7 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.829 0.452 . . . . 0.0 109.976 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.0 m -141.14 161.13 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.932 1.293 . . . . 0.0 110.021 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.94 111.37 16.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.0 m-85 -74.02 -38.63 63.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.862 0.465 . . . . 0.0 110.905 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.8 -166.66 29.3 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.179 -169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.0 p -111.11 178.7 4.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.186 0.517 . . . . 0.0 111.474 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 47.6 tp -151.28 146.58 26.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.477 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -94.11 93.94 8.11 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.76 0.79 . . . . 0.0 109.399 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.83 102.85 2.61 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.829 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -78.66 105.7 10.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.363 0.581 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 HG11 ' HD2' ' A' ' 71' ' ' ARG . 10.8 t -89.56 147.33 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG11 ' HD3' ' A' ' 112' ' ' LYS . 31.4 m -80.62 167.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.26 -20.0 68.9 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.996 -1.002 . . . . 0.0 114.093 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.19 -17.78 30.62 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.468 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.721 ' HD3' ' HB2' ' A' ' 139' ' ' ASN . 68.7 ttt180 -56.26 -42.0 76.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.21 1.004 . . . . 0.0 112.98 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.538 ' HA ' HG11 ' A' ' 76' ' ' VAL . 16.0 p90 -75.06 -16.78 60.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.167 0.439 . . . . 0.0 111.583 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -83.44 -28.92 28.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.702 0.801 . . . . 0.0 110.289 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.1 m -75.22 -27.9 59.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.271 0.628 . . . . 0.0 111.152 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.54 53.98 0.31 Allowed Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.407 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 72' ' ' TYR . 3.3 m -41.45 169.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.6 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 9.2 m -115.53 -179.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.004 -176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.15 -166.7 0.52 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.559 1.144 . . . . 0.0 110.673 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -77.82 141.0 39.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.165 0.586 . . . . 0.0 110.894 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 8.0 t30 58.46 32.8 22.52 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.712 1.205 . . . . 0.0 112.447 170.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.6 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mm-40 -82.65 141.52 32.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.673 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.534 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.4 mtp -88.02 142.2 27.97 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 32.9 m -132.83 150.9 33.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.846 0.858 . . . . 0.0 110.246 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' HB1' ' OD1' ' A' ' 101' ' ' ASN . . . -107.69 157.15 18.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.264 1.026 . . . . 0.0 109.568 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.92 146.06 39.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.374 0.67 . . . . 0.0 110.003 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -155.35 130.61 9.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 13.2 ptm180 -66.89 146.03 54.83 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.11 0.481 . . . . 0.0 111.267 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -99.29 106.85 41.49 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.173 0.989 . . . . 0.0 108.445 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -83.7 3.56 7.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.802 2.335 . . . . 0.0 112.851 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -119.8 -11.21 9.4 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.661 0.784 . . . . 0.0 111.518 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 92' ' ' PRO . 5.1 t-20 -63.06 121.78 71.12 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.944 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 33.8 Cg_endo -59.49 -19.78 53.62 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.883 3.055 . . . . 0.0 114.355 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -72.14 -50.58 26.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.415 0.686 . . . . 0.0 110.524 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 96' ' ' ASN . 21.9 p-10 177.74 157.04 0.38 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.276 0.985 . . . . 0.0 110.66 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -64.03 -23.22 67.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.265 176.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 10.8 m-20 -75.61 -2.23 28.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.746 0.818 . . . . 0.0 112.499 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.5 33.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.499 0.32 . . . . 0.0 110.158 169.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.0 mt -133.75 126.34 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.024 0.929 . . . . 0.0 109.739 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.449 ' HB2' ' HZ1' ' A' ' 99' ' ' LYS . 4.4 ttmp? -82.27 134.08 35.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 168.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.58 134.85 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.287 0.635 . . . . 0.0 109.355 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.431 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 8.0 p30 -121.93 171.16 9.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.8 p30 -107.51 -169.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.482 1.037 . . . . 0.0 109.803 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.36 -29.89 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.47 -11.95 59.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.041 0.936 . . . . 0.0 111.692 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.17 -1.89 77.89 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 122.9 0.286 . . . . 0.0 113.382 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.479 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.8 t-20 -73.9 128.41 35.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.721 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.08 114.86 3.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.616 0.766 . . . . 0.0 110.409 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 106' ' ' ASN . 35.6 m -126.56 13.87 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.855 0.862 . . . . 0.0 111.974 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.36 -170.29 43.08 Favored Glycine 0 C--N 1.355 1.636 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.02 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -166.26 123.47 1.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.07 0.948 . . . . 0.0 109.123 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 115' ' ' LEU . 95.6 mt -80.34 7.26 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.1 0.96 . . . . 0.0 113.168 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 113' ' ' LYS . 16.1 tptm 64.08 -156.44 0.31 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.632 1.173 . . . . 0.0 109.972 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.546 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 16.5 ttmm -79.03 -48.61 14.1 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 118.987 0.812 . . . . 0.0 110.882 170.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.06 -59.47 4.71 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.073 0.858 . . . . 0.0 112.572 -162.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD11 HD11 ' A' ' 111' ' ' LEU . 1.9 tm? -72.45 -46.54 54.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.618 0.723 . . . . 0.0 109.206 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -64.57 -29.47 70.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.713 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -65.71 -35.67 91.32 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 123.503 0.573 . . . . 0.0 112.63 -173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.71 -51.39 49.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.797 0.808 . . . . 0.0 109.486 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.68 -15.92 62.76 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.673 -1.148 . . . . 0.0 112.559 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.02 86.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.615 1.166 . . . . 0.0 112.689 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -73.76 -33.83 64.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 127' ' ' LEU . 56.8 mt -67.31 -33.5 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.419 0.688 . . . . 0.0 110.241 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.5 tpp -73.7 -43.36 59.5 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.005 1.322 . . . . 0.0 110.497 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.59 -50.47 30.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.803 -174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -91.05 2.03 56.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.483 -173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 56.03 44.13 25.98 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.714 1.205 . . . . 0.0 111.58 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.502 ' HB2' HG23 ' A' ' 122' ' ' ILE . 73.4 mt -70.18 -40.86 74.4 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.213 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.96 139.3 14.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.96 112.48 7.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.091 0.956 . . . . 0.0 109.529 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.14 120.33 48.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.38 166.8 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.88 150.36 21.94 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.534 HG22 ' HG2' ' A' ' 82' ' ' MET . 64.8 t -142.08 116.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.26 92.74 0.93 Allowed Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 11.7 Cg_exo -69.65 -53.56 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.845 2.363 . . . . 0.0 113.498 -162.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.81 -26.31 57.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.631 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.99 79.43 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.939 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.78 -1.97 18.64 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.721 ' HB2' ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -63.17 -18.52 63.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.427 1.491 . . . . 0.0 113.84 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -82.22 -41.84 19.74 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.256 0.622 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.16 -58.42 3.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.809 0.444 . . . . 0.0 110.336 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -137.74 -163.15 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 110.294 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 p -95.2 127.02 40.92 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.6 ptm -129.36 151.29 77.61 Favored Pre-proline 0 C--O 1.249 1.059 0 C-N-CA 123.171 0.588 . . . . 0.0 109.51 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 139.82 25.92 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 121.968 1.778 . . . . 0.0 110.521 166.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -106.05 144.78 32.28 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -69.8 110.48 4.97 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.547 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 24.9 mtp -102.94 158.75 16.07 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -150.5 139.59 21.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 90.2 m-85 -101.83 133.2 46.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.078 0.951 . . . . 0.0 109.973 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -131.36 100.52 5.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.24 1.016 . . . . 0.0 108.805 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.56 169.39 37.82 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.66 ' HZ3' ' HB3' ' A' ' 153' ' ' LYS . 0.7 OUTLIER -69.46 145.91 52.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.943 0.497 . . . . 0.0 111.715 -177.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.87 -28.5 67.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.035 0.934 . . . . 0.0 112.731 -172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.61 -21.83 62.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.877 0.471 . . . . 0.0 111.945 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -89.1 -8.6 53.52 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.046 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.278 0.49 . . . . 0.0 110.692 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -65.16 -34.83 79.33 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.297 0.373 . . . . 0.0 110.749 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.57 -33.58 28.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.621 0.769 . . . . 0.0 110.87 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.05 -49.99 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.457 0.703 . . . . 0.0 110.265 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.4 t -66.24 -29.75 70.06 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.648 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.85 -44.79 82.51 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.522 0.729 . . . . 0.0 109.957 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 17.8 mm100 -71.24 -38.54 71.96 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.876 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.58 -55.66 25.16 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.587 0.554 . . . . 0.0 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -64.35 -22.94 67.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.97 0.908 . . . . 0.0 112.13 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -62.31 -40.87 97.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.968 0.907 . . . . 0.0 110.907 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -107.36 -0.98 22.03 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 15.86 61.57 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 114.342 0.497 . . . . 0.0 114.342 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HB3' HD12 ' A' ' 63' ' ' LEU . 31.1 m-85 -75.03 161.14 29.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.955 0.902 . . . . 0.0 112.126 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -170.06 153.82 4.82 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.811 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.566 1.564 0 C-N-CA 123.55 0.74 . . . . 0.0 112.946 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 p -84.84 -0.63 54.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.072 0.549 . . . . 0.0 112.425 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.29 -16.93 38.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.905 0.482 . . . . 0.0 111.448 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.65 -38.33 86.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.232 0.613 . . . . 0.0 110.924 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.72 -28.46 67.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.545 0.738 . . . . 0.0 111.625 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.89 -38.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.375 0.67 . . . . 0.0 109.372 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.31 -21.35 56.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.051 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -67.11 139.71 57.54 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.107 0.563 . . . . 0.0 110.724 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.45 169.0 17.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 109.144 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.26 126.64 35.59 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.39 -43.16 11.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.759 . . . . 0.0 110.053 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.58 -177.42 20.79 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.468 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -111.74 120.4 41.89 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.944 0.498 . . . . 0.0 110.219 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 169' ' ' PHE . 55.4 tp -77.14 148.16 36.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.835 1.254 . . . . 0.0 110.897 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -75.33 80.51 2.41 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.055 0.931 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.522 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -79.45 93.33 1.34 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.831 -171.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -70.56 92.37 0.84 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.34 138.33 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -71.07 144.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.17 74.82 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.395 -0.669 . . . . 0.0 114.006 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.91 -23.04 4.39 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.859 1.264 . . . . 0.0 112.965 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 108' ' ' VAL . 20.3 ptt85 -56.88 -6.63 0.36 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.889 1.676 . . . . 0.0 114.349 173.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -54.66 -35.88 63.99 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.11 0.564 . . . . 0.0 111.949 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.98 -26.81 60.66 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.919 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.9 m -75.64 -21.64 57.51 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.831 0.852 . . . . 0.0 111.32 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.69 50.1 0.45 Allowed Glycine 0 C--N 1.356 1.646 0 CA-C-O 119.865 -0.408 . . . . 0.0 113.981 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -52.84 171.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.9 m -114.04 176.85 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.559 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.23 -164.49 1.09 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.809 1.243 . . . . 0.0 110.247 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -82.7 157.37 23.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.314 0.645 . . . . 0.0 111.172 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 67.71 10.97 8.14 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.177 1.391 . . . . 0.0 112.463 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 29.6 mm-40 -84.11 149.37 26.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.499 0.72 . . . . 0.0 110.73 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.569 ' HG2' HG22 ' A' ' 133' ' ' VAL . 60.3 mtp -107.73 152.22 24.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.905 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.5 162.09 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.374 1.069 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.36 145.82 51.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.521 1.128 . . . . 0.0 108.924 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.04 135.13 42.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.187 0.595 . . . . 0.0 110.5 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.19 132.81 7.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.016 0.926 . . . . 0.0 108.697 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 2.5 ptp180 -57.1 147.39 24.67 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 112.086 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.18 127.33 59.59 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.512 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -20.09 65.61 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.248 2.632 . . . . 0.0 112.513 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -91.7 47.73 1.39 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.111 0.964 . . . . 0.0 109.147 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.1 p-10 -63.38 120.18 59.85 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.927 0.891 . . . . 0.0 111.365 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 18.2 Cg_exo -68.67 -50.89 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.912 2.408 . . . . 0.0 113.027 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.45 -50.33 4.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.202 0.601 . . . . 0.0 110.777 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -168.02 165.63 13.47 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' HB3' ' HZ1' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -56.26 -15.21 3.55 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.577 1.151 . . . . 0.0 113.062 177.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.518 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 29.5 p-10 -62.68 -21.92 66.09 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.687 0.795 . . . . 0.0 111.893 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' HB3' ' HE1' ' A' ' 110' ' ' HIS . . . -62.35 109.17 1.26 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.942 0.897 . . . . 0.0 109.926 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 98.7 mt -108.61 132.66 55.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 109.891 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.654 ' HZ2' ' HB3' ' A' ' 99' ' ' LYS . 5.1 ttpm? -98.68 146.58 25.72 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.503 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.6 124.86 63.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 109.593 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -110.63 153.83 24.64 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -90.54 -172.83 3.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.541 0.337 . . . . 0.0 110.13 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.52 -23.85 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.889 0.475 . . . . 0.0 112.066 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.191 0.596 . . . . 0.0 110.412 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.94 -0.83 86.54 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 122.778 0.228 . . . . 0.0 113.447 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -74.02 133.2 42.93 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.123 0.969 . . . . 0.0 108.975 175.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.435 ' N ' HD21 ' A' ' 106' ' ' ASN . 26.5 pt20 -64.3 106.38 1.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.674 0.75 . . . . 0.0 110.065 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.481 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 35.3 m -114.57 12.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.086 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.84 178.25 48.09 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 114.673 0.629 . . . . 0.0 114.673 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.527 ' HE1' ' HB3' ' A' ' 97' ' ' ALA . 78.9 t60 -161.34 113.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 86.2 mt -68.59 -13.13 62.14 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 83.0 tttt 70.71 149.18 0.08 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.124 0.97 . . . . 0.0 110.59 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -21.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.253 1.021 . . . . 0.0 112.476 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tp10 -56.74 -64.69 0.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.289 1.036 . . . . 0.0 111.461 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 HD21 ' A' ' 111' ' ' LEU . 59.9 tp -85.51 -49.66 7.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -60.04 -24.63 64.68 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.209 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.518 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.49 -34.36 89.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.456 0.472 . . . . 0.0 113.443 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.64 -45.08 26.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.438 0.695 . . . . 0.0 109.98 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.403 HD13 HD11 ' A' ' 111' ' ' LEU . 46.2 mt -70.73 -16.62 62.79 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.932 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.46 -53.91 32.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -68.9 -31.92 71.18 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.941 0.775 . . . . 0.0 110.761 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.23 -37.59 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.435 0.694 . . . . 0.0 110.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 44.9 ttm -79.32 -45.19 20.13 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.875 0.87 . . . . 0.0 110.962 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 87' ' ' ARG . 29.3 t70 -67.39 -46.62 72.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.067 0.947 . . . . 0.0 110.851 -172.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -92.18 1.36 57.26 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.09 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.18 37.95 17.13 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.376 1.07 . . . . 0.0 111.917 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.26 -42.5 93.2 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.818 0.847 . . . . 0.0 111.351 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.07 137.98 17.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.65 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.2 116.89 18.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.126 0.97 . . . . 0.0 108.642 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.35 123.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -107.07 178.66 4.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.76 155.04 25.92 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.5 t -142.67 141.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.269 1.028 . . . . 0.0 108.281 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 p -122.83 86.23 50.13 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.783 0.833 . . . . 0.0 109.153 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.52 -22.41 21.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.216 2.611 . . . . 0.0 113.9 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.633 ' HB2' ' HE3' ' A' ' 144' ' ' MET . 73.1 m-85 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.35 0.66 . . . . 0.0 110.797 -175.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 64.5 33.96 88.64 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 172.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -82.27 12.41 4.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.914 0.486 . . . . 0.0 111.446 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -52.85 -37.69 60.55 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.61 -44.7 63.95 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.423 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.86 3.56 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.374 0.669 . . . . 0.0 112.169 -168.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -122.51 170.73 9.69 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.544 0.738 . . . . 0.0 110.688 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 t -95.13 109.07 21.19 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.633 ' HE3' ' HB2' ' A' ' 136' ' ' PHE . 19.1 ptm -119.25 134.66 23.71 Favored Pre-proline 0 C--O 1.243 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 110.142 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.66 123.81 12.26 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.172 1.915 . . . . 0.0 110.795 164.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -98.12 156.64 16.57 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -82.12 107.49 14.86 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.522 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 11.8 mtp -105.16 112.54 25.7 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 m -101.79 120.41 40.32 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.077 0.551 . . . . 0.0 110.213 -163.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -94.89 124.19 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.056 0.942 . . . . 0.0 110.18 -172.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -124.29 111.56 15.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.574 1.15 . . . . 0.0 108.232 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.41 166.87 36.73 Favored Glycine 0 N--CA 1.463 0.485 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -68.89 146.88 52.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.021 0.528 . . . . 0.0 111.898 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.4 -24.75 67.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.274 1.029 . . . . 0.0 112.962 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.41 -13.39 59.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.669 0.387 . . . . 0.0 111.877 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.79 0.02 16.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -25.12 67.08 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.339 0.518 . . . . 0.0 112.165 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -36.43 83.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -80.47 -36.08 33.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.457 0.703 . . . . 0.0 110.923 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.79 -53.02 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.524 0.73 . . . . 0.0 109.799 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.9 t -70.71 -25.16 62.83 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.108 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.6 t70 -60.8 -49.53 77.1 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.0 mm100 -66.14 -38.51 88.31 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.159 0.912 . . . . 0.0 111.638 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.53 -62.66 1.39 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.715 0.635 . . . . 0.0 110.012 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.68 -19.1 65.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.38 1.072 . . . . 0.0 112.635 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 23.8 ttmm -51.39 -46.63 62.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.914 0.885 . . . . 0.0 110.889 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -95.94 -23.7 16.74 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.522 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 8.27 11.15 Favored Glycine 0 N--CA 1.475 1.263 0 N-CA-C 113.669 0.228 . . . . 0.0 113.669 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 63' ' ' LEU . 49.8 m-85 -75.57 142.93 42.63 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -159.3 136.6 9.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 CA--C 1.555 1.148 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.418 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.0 p -65.53 -15.24 62.48 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.393 1.077 . . . . 0.0 112.582 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.01 -49.6 74.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.941 0.497 . . . . 0.0 110.448 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.68 -32.36 73.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.233 1.013 . . . . 0.0 113.374 -167.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.11 -37.72 72.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.135 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -75.79 -31.51 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.057 0.943 . . . . 0.0 109.855 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.44 -44.29 68.16 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.312 1.445 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -85.7 122.64 30.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.47 165.02 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.816 1.246 . . . . 0.0 110.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 61' ' ' GLY . 5.9 tt -82.75 111.35 18.61 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -74.65 -36.02 62.86 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.491 0.717 . . . . 0.0 111.132 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' HD22 ' A' ' 59' ' ' LEU . . . 163.94 177.32 36.62 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.54 -171.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 p -112.83 149.32 33.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.303 0.641 . . . . 0.0 110.552 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.12 146.52 50.68 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.604 0.762 . . . . 0.0 110.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 145' ' ' PRO . 98.1 mtt180 -86.08 90.28 8.07 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.272 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.73 1.59 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.977 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -79.07 100.42 7.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.041 0.536 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.58 142.03 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 O-C-N 123.618 0.574 . . . . 0.0 109.541 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.04 154.23 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.944 0.898 . . . . 0.0 112.062 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.78 82.0 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.258 0.349 . . . . 0.0 113.66 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.09 -17.57 53.29 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.901 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.538 HH12 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -61.51 -14.49 29.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.363 1.065 . . . . 0.0 113.53 -177.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.76 ' HA ' HG13 ' A' ' 76' ' ' VAL . 44.9 p90 -60.21 -39.7 87.49 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.223 0.535 . . . . 0.0 111.509 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -71.71 -20.2 61.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.12 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 m -99.23 6.36 46.34 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.651 0.781 . . . . 0.0 111.502 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.27 55.84 0.59 Allowed Glycine 0 C--N 1.367 2.299 0 C-N-CA 120.362 -0.923 . . . . 0.0 115.398 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.76 HG13 ' HA ' ' A' ' 72' ' ' TYR . 8.1 m -40.46 155.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.476 HG21 HG23 ' A' ' 134' ' ' VAL . 19.5 m -115.57 159.78 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.335 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -85.27 -167.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.33 1.052 . . . . 0.0 111.659 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -73.83 151.65 40.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.305 0.642 . . . . 0.0 111.562 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 61.24 8.19 1.96 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.723 1.209 . . . . 0.0 113.595 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.68 133.29 40.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.59 0.756 . . . . 0.0 110.754 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.505 ' HG2' HG22 ' A' ' 133' ' ' VAL . 76.9 mtp -94.09 150.01 20.72 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.413 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.02 166.18 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.761 1.224 . . . . 0.0 109.354 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.68 140.88 48.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.635 1.174 . . . . 0.0 108.567 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.7 mp -97.12 132.41 42.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -150.32 133.36 16.15 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.6 ptt180 -69.98 145.27 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.097 0.475 . . . . 0.0 110.115 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -89.6 125.12 62.35 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.883 0.873 . . . . 0.0 111.288 -167.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.43 -19.84 24.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.203 2.602 . . . . 0.0 113.283 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -93.9 18.79 9.86 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.181 0.992 . . . . 0.0 110.315 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -51.37 137.06 30.82 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.142 1.377 . . . . 0.0 113.528 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.01 -41.22 0.23 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.471 2.114 . . . . 0.0 112.453 172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.32 -53.1 4.23 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.981 0.512 . . . . 0.0 111.448 -168.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -173.3 159.69 3.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.379 1.072 . . . . 0.0 108.476 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 18.4 ptpt -57.68 -25.6 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.55 4.71 23.44 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.37 103.85 1.73 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 64.6 mt -82.91 121.6 36.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.043 -172.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 37.6 ttmt -100.09 127.93 46.24 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.092 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.18 130.68 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.058 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -120.87 154.41 35.87 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -90.1 -171.52 3.16 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.026 0.83 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.97 -34.07 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.814 0.846 . . . . 0.0 112.505 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -77.68 -22.79 49.99 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.933 0.893 . . . . 0.0 111.065 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.37 4.36 58.38 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.74 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.57 125.36 24.0 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.426 0.691 . . . . 0.0 110.013 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.581 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 75.8 mt-30 -71.0 100.86 2.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.021 0.928 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.538 ' HB ' HH12 ' A' ' 71' ' ' ARG . 34.1 m -91.71 -2.66 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.381 0.672 . . . . 0.0 112.188 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.75 165.68 12.21 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 123.239 0.337 . . . . 0.0 112.553 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.8 m-70 -76.21 150.4 37.08 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.812 0.445 . . . . 0.0 110.125 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -70.7 -52.99 17.44 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 5.0 tmtp? 162.54 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -30.17 68.9 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.609 0.763 . . . . 0.0 112.81 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 38.8 tt0 -75.04 -54.92 6.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.88 0.872 . . . . 0.0 110.852 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.578 0.751 . . . . 0.0 109.784 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.83 92.24 Favored 'General case' 0 C--O 1.208 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.665 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.52 -35.61 80.95 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 124.141 0.901 . . . . 0.0 113.89 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . . . -67.53 -50.15 60.03 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.199 0.523 . . . . 0.0 110.06 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -77.94 -14.03 59.68 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.4 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.76 -47.3 64.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.378 1.471 . . . . 0.0 113.23 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -68.83 -32.33 71.95 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.705 0.802 . . . . 0.0 110.548 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 160' ' ' VAL . 51.4 mt -66.03 -42.58 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.002 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.7 tpp -74.15 -37.55 64.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.678 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.95 -44.87 46.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.643 1.177 . . . . 0.0 110.863 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -99.07 5.45 46.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.057 0.543 . . . . 0.0 111.884 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 59.19 33.87 22.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.173 0.989 . . . . 0.0 112.057 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.23 -36.59 84.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.05 155.68 16.42 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.822 0.849 . . . . 0.0 110.833 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -82.01 139.44 34.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.779 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.53 125.16 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.76 148.46 43.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.205 1.002 . . . . 0.0 109.597 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -129.89 176.25 18.75 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 122.946 0.153 . . . . 0.0 113.381 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 ' HG2' ' A' ' 82' ' ' MET . 12.4 t -142.79 141.63 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.092 1.357 . . . . 0.0 108.121 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.476 HG23 HG21 ' A' ' 77' ' ' VAL . 6.5 m -103.98 86.06 1.17 Allowed Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.015 0.926 . . . . 0.0 108.977 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.24 -51.32 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.666 2.244 . . . . 0.0 113.408 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.504 ' HD2' ' HB3' ' A' ' 138' ' ' ALA . 37.7 t80 -70.86 -26.71 63.38 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.91 0.484 . . . . 0.0 110.501 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.67 19.53 79.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.513 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 136' ' ' PHE . . . -61.4 -17.48 54.35 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.283 0.633 . . . . 0.0 111.442 175.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -48.44 -31.8 6.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.012 1.725 . . . . 0.0 112.847 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.44 -44.96 81.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 0.0 111.002 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.17 -64.35 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.172 0.589 . . . . 0.0 111.529 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -119.54 143.59 47.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.267 1.027 . . . . 0.0 109.741 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 p -93.48 109.18 20.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.025 0.917 . . . . 0.0 109.129 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 165.84 12.68 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.343 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 20.2 Cg_exo -67.24 122.05 9.27 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 121.486 1.457 . . . . 0.0 110.676 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.96 149.9 22.97 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.582 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 58.2 mtt -103.34 164.08 11.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 0.0 109.524 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -148.79 144.59 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.301 1.04 . . . . 0.0 109.07 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -105.18 128.38 53.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.806 0.842 . . . . 0.0 109.394 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -129.06 102.81 6.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.379 1.072 . . . . 0.0 109.631 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.32 178.95 37.93 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.57 142.91 58.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 117.48 0.64 . . . . 0.0 111.895 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.64 -34.78 27.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 113.631 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.51 -26.72 61.01 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -85.55 2.86 43.16 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.845 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -34.89 79.09 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.981 0.355 . . . . 0.0 110.26 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -26.78 56.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.88 0.872 . . . . 0.0 111.309 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -73.7 -52.32 13.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 122' ' ' ILE . 49.9 t -57.02 -43.12 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.928 1.291 . . . . 0.0 111.777 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.6 p -64.95 -33.94 77.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.921 0.489 . . . . 0.0 111.385 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 20.5 t70 -67.26 -32.94 74.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.688 0.618 . . . . 0.0 110.48 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 8.1 mm100 -73.33 -25.81 60.78 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 95.9 mt -76.51 -39.51 52.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.531 0.733 . . . . 0.0 110.253 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 8.7 mtpm? -59.96 -22.22 62.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.297 1.039 . . . . 0.0 111.992 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 118' ' ' ALA . 40.2 ttmt -54.0 -49.95 67.7 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 111.24 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -100.18 0.1 39.84 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.686 0.394 . . . . 0.0 111.082 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.59 35.95 24.32 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 116.802 -0.181 . . . . 0.0 112.82 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 25.8 m-85 -79.54 174.63 11.38 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.576 0.75 . . . . 0.0 110.808 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.88 152.64 23.42 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.442 1.097 . . . . 0.0 110.253 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.939 177.135 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.288 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 p -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.02 0.928 . . . . 0.0 111.876 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.5 -41.61 72.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.248 0.619 . . . . 0.0 110.213 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.62 -30.15 59.43 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.688 0.795 . . . . 0.0 112.396 -171.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.38 -36.32 74.04 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.075 0.234 . . . . 0.0 110.688 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.04 -37.06 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.405 0.682 . . . . 0.0 109.809 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.65 -34.86 78.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.535 1.134 . . . . 0.0 111.018 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -79.39 130.32 35.31 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.234 0.614 . . . . 0.0 109.487 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.19 156.42 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.843 0.857 . . . . 0.0 111.873 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 61' ' ' GLY . 6.0 tt -81.08 105.6 12.42 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.7 m-85 -73.66 -30.36 62.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.943 0.497 . . . . 0.0 110.601 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 148.46 -170.61 28.96 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -175.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.402 ' HG ' HG23 ' A' ' 149' ' ' THR . 29.6 m -129.19 118.39 22.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.07 175.04 10.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -126.64 97.89 5.18 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.828 0.823 . . . . 0.0 108.848 174.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.08 124.81 7.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.691 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -88.6 119.41 29.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.741 0.817 . . . . 0.0 110.358 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.73 140.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 46.8 t -72.35 139.49 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.82 58.43 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.253 -0.43 . . . . 0.0 113.895 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -23.43 67.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 111.276 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 74' ' ' THR . 3.5 mpt_? -75.52 -1.2 23.17 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.28 1.032 . . . . 0.0 111.817 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -45.33 -32.9 2.21 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.16 -18.03 65.1 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.792 1.237 . . . . 0.0 112.565 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 71' ' ' ARG . 14.7 t -73.78 -20.62 60.43 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.122 0.569 . . . . 0.0 110.973 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.63 48.6 0.54 Allowed Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.55 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.14 165.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 121.489 0.662 . . . . 0.0 111.524 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.597 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 18.1 m -115.52 171.84 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.238 -171.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -104.83 -166.78 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -63.19 149.52 45.19 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.569 0.747 . . . . 0.0 111.446 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 77.17 -18.54 0.48 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.55 1.54 . . . . 0.0 112.337 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.597 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.3 mm-40 -62.56 141.78 58.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.477 ' HG2' HG21 ' A' ' 133' ' ' VAL . 85.4 mtp -105.06 143.74 32.82 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.969 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 18.2 m -129.57 132.32 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 109.795 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.42 142.25 28.75 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 109.686 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.614 HD13 ' SD ' ' A' ' 148' ' ' MET . 5.7 mp -90.68 121.14 32.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.858 0.863 . . . . 0.0 108.948 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -125.91 121.54 33.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 121.91 13.38 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -70.45 122.77 87.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.133 -163.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -20.35 36.71 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.693 2.262 . . . . 0.0 112.243 172.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -101.36 24.9 8.93 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.149 0.979 . . . . 0.0 110.667 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.81 126.75 72.74 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.588 0.755 . . . . 0.0 111.67 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.0 -24.17 6.03 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.462 2.108 . . . . 0.0 113.862 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.52 -56.08 1.99 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.228 -0.295 . . . . 0.0 111.362 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 6.4 m-20 -150.49 153.63 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.29 -14.65 57.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.863 0.865 . . . . 0.0 112.476 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.561 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 16.4 p-10 -70.3 -20.24 63.03 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.614 0.766 . . . . 0.0 111.638 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.99 109.38 3.44 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.293 0.637 . . . . 0.0 109.311 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -85.09 119.51 33.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.685 0.794 . . . . 0.0 109.867 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 7.6 ttpm? -83.48 116.53 22.58 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.419 HG11 ' HB ' ' A' ' 83' ' ' VAL . 10.3 t -85.56 128.56 39.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -122.98 143.15 50.11 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 28.3 p-10 -82.72 -167.94 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.248 0.931 . . . . 0.0 111.259 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.34 -31.18 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.464 1.106 . . . . 0.0 112.773 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -83.93 -27.41 28.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.532 0.733 . . . . 0.0 111.05 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.18 6.53 48.16 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.582 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -66.5 120.96 14.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.801 0.84 . . . . 0.0 110.26 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -60.18 107.42 0.64 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 110.833 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.58 2.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 0.0 111.449 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 134.13 -145.69 17.73 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 173.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.13 158.51 43.46 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.034 0.934 . . . . 0.0 109.862 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.477 HD12 ' HE3' ' A' ' 148' ' ' MET . 29.1 mt -87.89 8.46 26.0 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.813 0.845 . . . . 0.0 112.456 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 69.63 129.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.558 1.143 . . . . 0.0 110.074 -172.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -44.13 -39.16 4.1 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.188 1.395 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -62.22 -54.61 38.44 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.334 1.054 . . . . 0.0 112.281 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.413 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 10.4 tt -75.08 -47.81 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.444 0.64 . . . . 0.0 110.031 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.92 -34.47 63.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.579 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -55.07 -37.41 63.28 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.024 0.828 . . . . 0.0 115.004 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.74 -51.49 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.976 0.51 . . . . 0.0 110.523 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HA ' HD11 ' A' ' 122' ' ' ILE . 30.1 mt -73.77 -20.06 60.6 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.745 -172.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.43 64.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.766 0.826 . . . . 0.0 111.896 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.22 -36.77 77.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.493 HD13 HG12 ' A' ' 160' ' ' VAL . 64.1 mt -61.82 -37.11 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 110.763 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.3 ttm -79.23 -51.17 9.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.452 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.0 -39.38 69.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.379 1.072 . . . . 0.0 111.108 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -90.57 1.64 56.55 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 62.74 43.1 7.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.413 1.085 . . . . 0.0 111.768 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 122' ' ' ILE . 45.6 mt -76.75 -48.05 19.88 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.642 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.47 149.68 27.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.198 0.599 . . . . 0.0 110.721 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -89.45 106.69 18.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.045 0.938 . . . . 0.0 109.309 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -93.89 124.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.98 160.84 14.72 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.47 144.81 15.6 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.477 HG21 ' HG2' ' A' ' 82' ' ' MET . 40.3 t -137.7 126.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.65 90.42 5.04 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.82 -18.7 5.35 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.519 2.146 . . . . 0.0 113.003 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.447 ' HB2' ' HE1' ' A' ' 144' ' ' MET . 61.0 m-85 -79.44 -32.63 42.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.762 0.425 . . . . 0.0 110.816 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.85 17.07 20.31 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.853 0.721 . . . . 0.0 114.599 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.427 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -84.26 0.74 47.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.608 0.763 . . . . 0.0 111.384 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -64.11 -26.4 68.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.653 1.181 . . . . 0.0 110.878 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.51 -30.35 63.05 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.695 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.5 11.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.277 0.631 . . . . 0.0 111.718 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -158.35 -168.64 2.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.545 0.738 . . . . 0.0 110.289 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.8 p -94.55 120.6 35.04 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.516 0.727 . . . . 0.0 109.066 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.447 ' HE1' ' HB2' ' A' ' 136' ' ' PHE . 3.2 ppp? -147.45 156.88 45.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.006 0.922 . . . . 0.0 109.743 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.567 ' HB2' ' HB2' ' A' ' 64' ' ' ARG . 26.9 Cg_endo -92.84 144.36 2.37 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.516 2.144 . . . . 0.0 113.531 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -107.38 153.91 22.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -79.73 109.57 14.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.759 0.314 . . . . 0.0 111.223 -170.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.614 ' SD ' HD13 ' A' ' 85' ' ' LEU . 22.0 mmt -89.85 110.23 21.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.896 0.878 . . . . 0.0 108.837 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 62' ' ' SER . 7.0 m -103.46 125.25 49.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 31.5 m-85 -89.05 120.44 30.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 109.251 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.47 101.76 7.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.88 159.66 29.46 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.617 ' HB3' ' HZ2' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -60.19 145.58 46.6 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.267 0.627 . . . . 0.0 112.614 -175.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.45 -30.78 61.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.014 1.326 . . . . 0.0 113.468 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.34 -29.62 65.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.914 0.485 . . . . 0.0 111.472 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -88.66 9.8 22.92 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.285 0.634 . . . . 0.0 111.933 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 158' ' ' LYS . 11.7 ptp180 -54.93 -45.18 74.8 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.591 0.356 . . . . 0.0 111.601 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -78.94 -26.57 43.62 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.631 0.372 . . . . 0.0 111.333 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.24 89.76 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.041 0.536 . . . . 0.0 110.325 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 122' ' ' ILE . 70.1 t -70.45 -45.29 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.489 1.116 . . . . 0.0 110.726 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.496 ' HB3' ' HE3' ' A' ' 165' ' ' LYS . 67.2 m -64.52 -32.15 73.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.26 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.98 -42.43 76.3 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.774 0.83 . . . . 0.0 110.865 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.05 -38.23 78.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.857 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.11 -55.43 16.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.798 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 161' ' ' SER . 93.7 mttt -56.9 -29.04 62.66 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.749 1.22 . . . . 0.0 111.993 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.08 -41.02 97.75 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.855 0.862 . . . . 0.0 111.54 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.13 3.6 25.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.768 0.427 . . . . 0.0 110.615 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.95 20.65 77.55 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.932 -0.371 . . . . 0.0 113.364 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.413 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 32.2 m-85 -67.82 146.08 54.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.939 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -156.21 139.38 15.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.48 170.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.407 HD22 ' HA3' ' A' ' 61' ' ' GLY . 2.1 pp . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 124.324 1.049 . . . . 0.0 111.317 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.062 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' HG21 ' A' ' 55' ' ' VAL . 37.6 m -64.38 -14.08 54.49 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.618 0.767 . . . . 0.0 112.439 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.46 -31.47 61.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.725 1.21 . . . . 0.0 111.955 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.14 -40.78 67.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.848 0.459 . . . . 0.0 111.363 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -84.86 -15.59 44.18 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.708 0.403 . . . . 0.0 111.639 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 51' ' ' SER . 85.3 t -70.55 -34.76 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 168.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -47.19 48.54 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.928 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.2 m -82.69 115.04 21.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.648 0.779 . . . . 0.0 111.005 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG22 ' HG2' ' A' ' 154' ' ' GLU . 14.3 m -107.71 162.94 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.256 1.022 . . . . 0.0 110.978 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.14 116.19 22.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.118 0.567 . . . . 0.0 109.793 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -79.43 -24.78 42.25 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.923 0.489 . . . . 0.0 110.567 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.03 -170.39 24.58 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.26 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' HG21 ' A' ' 149' ' ' THR . 22.5 p -123.1 121.35 35.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.073 0.549 . . . . 0.0 110.383 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.8 tp -80.12 145.87 32.15 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 109.876 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -76.16 85.87 3.01 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.96 54.61 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -141.32 91.75 2.41 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.529 1.165 . . . . 0.0 110.088 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 HG13 HG11 ' A' ' 108' ' ' VAL . 98.9 t -76.51 127.77 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 167.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 24.9 t -68.32 141.73 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 123.737 0.648 . . . . 0.0 110.542 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.79 -44.98 23.47 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.539 0.524 . . . . 0.0 113.747 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.85 -15.79 55.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.473 0.709 . . . . 0.0 112.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.487 ' HG2' ' HB ' ' A' ' 68' ' ' VAL . 36.6 mmt180 -73.81 -0.46 15.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.924 0.889 . . . . 0.0 112.54 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' HA ' HG11 ' A' ' 76' ' ' VAL . 42.5 p90 -50.72 -23.83 2.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.376 1.071 . . . . 0.0 113.843 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.72 -7.65 22.51 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.424 1.089 . . . . 0.0 112.71 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 p -73.23 -33.48 65.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.265 0.626 . . . . 0.0 109.912 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.59 48.05 0.52 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 72' ' ' TYR . 27.5 m -55.3 167.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.626 0.77 . . . . 0.0 112.268 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 m -114.12 163.88 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.27 0.628 . . . . 0.0 110.796 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -74.67 -172.19 1.47 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.312 1.045 . . . . 0.0 111.711 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -65.14 149.04 50.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.871 . . . . 0.0 111.95 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 64.88 10.75 6.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.957 1.303 . . . . 0.0 113.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.74 143.11 32.06 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.13 0.423 . . . . 0.0 111.154 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.503 ' HG2' HG23 ' A' ' 133' ' ' VAL . 83.2 mtp -83.08 145.5 29.23 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.705 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.401 HG23 HD12 ' A' ' 146' ' ' LEU . 29.4 m -134.27 145.0 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.017 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.98 125.02 53.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.675 0.79 . . . . 0.0 109.895 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.58 HD22 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -90.14 138.42 31.53 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.982 0.913 . . . . 0.0 109.749 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -147.73 138.7 23.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.6 ptm180 -67.09 158.33 31.4 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.579 0.228 . . . . 0.0 110.568 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -87.99 116.06 65.0 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 123.103 0.561 . . . . 0.0 110.647 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.28 -39.06 5.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.275 1.983 . . . . 0.0 110.493 168.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -88.88 71.14 8.63 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 170.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.44 134.49 86.7 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.34 -42.16 4.11 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.961 2.44 . . . . 0.0 112.519 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -126.3 -52.79 1.5 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.461 0.704 . . . . 0.0 110.014 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -146.85 165.74 28.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.704 0.802 . . . . 0.0 109.95 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.12 -5.49 18.08 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.237 1.015 . . . . 0.0 112.581 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.463 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 1.9 m-20 -77.13 9.69 2.88 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.594 1.158 . . . . 0.0 112.586 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -93.39 139.37 30.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.479 0.712 . . . . 0.0 110.208 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 54.5 mt -127.07 120.42 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.36 1.064 . . . . 0.0 109.133 175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -87.47 115.37 24.85 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.439 0.695 . . . . 0.0 109.854 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.49 HG22 ' HG ' ' A' ' 85' ' ' LEU . 53.0 t -87.1 126.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 14.9 m-80 -117.65 164.67 14.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -95.7 -170.77 2.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.69 -22.59 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -86.64 -3.08 58.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.219 1.008 . . . . 0.0 111.908 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.68 86.08 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 122.945 0.307 . . . . 0.0 113.491 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -76.84 134.17 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.633 0.773 . . . . 0.0 108.986 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.9 pt20 -71.58 127.42 32.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 122.303 1.049 . . . . 0.0 111.662 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 67' ' ' VAL . 93.0 t -78.06 -24.79 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.177 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.41 -168.19 28.48 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.99 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -117.23 148.97 41.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 148' ' ' MET . 52.2 mt -75.33 -6.29 49.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.233 0.613 . . . . 0.0 112.26 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 68.74 141.86 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.262 1.025 . . . . 0.0 110.229 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -21.29 3.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -62.57 -63.03 1.35 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.071 0.948 . . . . 0.0 110.702 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.1 tt -80.36 -50.56 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.094 0.557 . . . . 0.0 109.597 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 111' ' ' LEU . . . -52.8 -33.37 48.72 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.049 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -55.49 -43.48 85.43 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.105 0.878 . . . . 0.0 114.814 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.97 -48.74 72.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.23 0.538 . . . . 0.0 110.624 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.95 -18.24 60.91 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.625 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.48 91.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.12 0.968 . . . . 0.0 111.788 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -68.06 -40.78 82.7 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.549 0.531 . . . . 0.0 109.618 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.509 HD11 HG13 ' A' ' 160' ' ' VAL . 55.3 mt -63.79 -37.41 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.587 0.755 . . . . 0.0 110.75 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.6 tpp -70.75 -52.61 19.7 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.16 -32.51 73.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.619 1.567 . . . . 0.0 111.689 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.28 -2.57 36.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.026 0.531 . . . . 0.0 111.278 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 61.13 32.51 19.62 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.898 0.879 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.508 ' HB2' HG23 ' A' ' 122' ' ' ILE . 67.0 mt -63.39 -44.66 94.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.515 0.726 . . . . 0.0 110.145 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.45 142.23 21.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.288 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.03 107.85 5.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.479 1.112 . . . . 0.0 109.281 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.8 mt -99.36 104.83 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.4 178.72 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.21 168.76 32.01 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.466 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.503 HG23 ' HG2' ' A' ' 82' ' ' MET . 63.9 t -141.36 125.73 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.43 100.66 2.43 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.688 ' HD2' ' HE1' ' A' ' 144' ' ' MET . 10.0 Cg_exo -69.46 -44.33 2.35 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.837 2.358 . . . . 0.0 113.812 -167.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.47 -23.9 14.96 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 0.0 111.285 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.48 27.66 71.2 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.304 0.377 . . . . 0.0 113.547 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.479 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -81.29 4.82 19.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.475 0.71 . . . . 0.0 112.174 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -63.43 -9.51 12.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.078 0.951 . . . . 0.0 112.004 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -64.42 -42.14 96.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.916 0.887 . . . . 0.0 111.008 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.8 -60.9 1.47 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.827 0.851 . . . . 0.0 111.147 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -139.48 -173.62 3.66 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.875 . . . . 0.0 109.444 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 t -93.04 134.91 34.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.688 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 4.4 ppp? -137.95 153.12 73.32 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.706 0.802 . . . . 0.0 109.96 -172.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.46 122.09 9.27 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.17 1.914 . . . . 0.0 112.637 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.401 HD12 HG23 ' A' ' 83' ' ' VAL . 6.5 tt -100.91 124.54 46.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -80.17 110.16 15.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -172.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.602 ' HE1' HD21 ' A' ' 111' ' ' LEU . 59.6 mtt -112.81 116.32 29.88 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -171.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.421 HG21 ' HB3' ' A' ' 62' ' ' SER . 37.8 p -102.71 133.68 47.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.95 1.3 . . . . 0.0 110.306 -165.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -100.95 117.76 35.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.834 0.853 . . . . 0.0 109.166 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -119.19 99.05 6.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.417 0.687 . . . . 0.0 109.508 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 163.44 31.73 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.512 ' HB3' ' HZ2' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -56.46 146.47 24.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 111.655 178.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 58' ' ' VAL . 44.6 mt-10 -58.97 -18.78 37.09 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.36 -32.31 43.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.087 0.403 . . . . 0.0 111.296 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -77.9 -6.92 55.88 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -57.95 -27.79 63.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.219 0.463 . . . . 0.0 110.791 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.78 -53.2 59.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.12 0.968 . . . . 0.0 109.138 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.88 -30.97 65.96 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.97 0.908 . . . . 0.0 112.081 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 122' ' ' ILE . 56.1 t -71.13 -55.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.157 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.2 t -66.1 -22.69 66.41 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.903 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.22 -44.56 92.3 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.085 0.554 . . . . 0.0 110.307 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -79.51 -30.14 41.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.237 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.69 -61.01 2.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.85 -21.1 65.7 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.752 1.221 . . . . 0.0 112.101 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -53.45 -46.51 69.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.653 0.781 . . . . 0.0 110.493 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -99.72 -16.91 17.98 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.129 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.47 16.77 21.61 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 116.554 -0.294 . . . . 0.0 113.177 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -79.52 145.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.825 0.45 . . . . 0.0 110.095 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -172.81 138.56 0.82 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 108.755 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.548 175.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 p -68.07 -47.96 66.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.081 0.953 . . . . 0.0 111.806 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.39 -14.54 60.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.819 0.847 . . . . 0.0 112.144 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -62.58 -45.4 93.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.946 0.898 . . . . 0.0 112.186 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.56 -29.66 67.27 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.432 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.42 -22.16 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.642 0.777 . . . . 0.0 110.444 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -72.94 -46.65 51.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.271 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -80.19 113.88 18.69 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 154' ' ' GLU . 13.8 m -107.19 156.43 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.148 0.979 . . . . 0.0 111.327 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.79 109.6 14.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.445 0.698 . . . . 0.0 109.762 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -74.38 -36.23 63.53 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 110.972 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.64 -176.03 36.44 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.769 0.668 . . . . 0.0 112.558 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 148' ' ' MET . 49.4 p -115.92 122.35 45.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.119 0.968 . . . . 0.0 110.532 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.2 tp -99.86 137.46 38.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.941 0.496 . . . . 0.0 109.711 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -90.78 83.98 5.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -75.21 153.07 44.43 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.469 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -116.47 111.05 19.43 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.832 1.316 . . . . 0.0 109.978 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 111' ' ' LEU . 2.5 t -94.68 157.32 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.083 0.953 . . . . 0.0 109.118 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 m -76.05 161.94 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.83 -17.74 74.34 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.326 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.7 -18.42 30.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.308 1.043 . . . . 0.0 111.431 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.671 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 63.8 mtp180 -49.86 -33.31 16.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.394 1.078 . . . . 0.0 113.204 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.27 -43.87 92.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.217 0.607 . . . . 0.0 110.628 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -71.62 -35.49 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.457 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -74.95 -16.93 60.62 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.089 0.555 . . . . 0.0 111.798 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.76 54.3 0.54 Allowed Glycine 0 C--N 1.357 1.713 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.282 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.3 m -40.9 164.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 19.3 m -114.51 167.16 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.527 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.38 -79.27 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.309 0.644 . . . . 0.0 111.825 -170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.6 154.15 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.789 0.835 . . . . 0.0 110.308 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.79 28.56 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.943 1.297 . . . . 0.0 111.83 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 49.8 mm-40 -87.25 142.82 27.62 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.327 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 78.0 mtp -99.76 127.88 45.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 102' ' ' ASN . 35.6 m -118.04 163.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.294 1.038 . . . . 0.0 108.997 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.48 128.41 47.98 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' A' ' 98' ' ' ILE . 12.8 mt -80.18 112.01 17.09 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -123.78 115.12 20.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 108.316 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 37.2 ptt180 -57.03 133.82 55.28 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 121.106 0.479 . . . . 0.0 110.925 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.2 118.94 57.86 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.138 -161.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.667 2.245 . . . . 0.0 112.039 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -111.08 32.38 5.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.422 1.089 . . . . 0.0 109.73 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.41 127.3 65.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.877 0.871 . . . . 0.0 111.773 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.37 -48.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.033 1.822 . . . . 0.0 113.011 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -99.04 -50.5 4.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.792 0.437 . . . . 0.0 110.524 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -159.59 156.57 28.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.17 0.588 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.579 ' HZ2' ' HB3' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -65.33 -7.26 12.63 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.519 1.528 . . . . 0.0 113.559 -178.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.563 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 26.1 p-10 -64.13 -30.7 71.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.003 0.521 . . . . 0.0 111.584 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.06 125.85 25.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.892 0.745 . . . . 0.0 109.239 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 70.5 mt -113.2 127.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 109.647 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 151.17 32.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 172.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.1 t -110.58 120.46 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.748 1.219 . . . . 0.0 107.854 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -119.06 127.46 53.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HA ' HG13 ' A' ' 83' ' ' VAL . 35.4 p-10 -71.93 -173.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.392 0.677 . . . . 0.0 112.385 -175.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.78 -31.9 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 C-N-CA 124.147 0.979 . . . . 0.0 112.293 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.73 -31.83 63.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.642 0.777 . . . . 0.0 111.053 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.68 -3.38 42.32 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.342 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -67.72 136.54 54.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.117 0.967 . . . . 0.0 110.836 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.5 pm0 -67.1 117.74 9.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.19 -2.38 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.385 0.674 . . . . 0.0 111.644 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.671 ' HA3' ' HG2' ' A' ' 71' ' ' ARG . . . 152.59 -177.15 30.48 Favored Glycine 0 C--N 1.36 1.913 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 172.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -108.95 151.32 26.46 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.584 ' HA ' HG12 ' A' ' 67' ' ' VAL . 52.0 mt -72.58 -55.03 7.54 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.581 0.628 . . . . 0.0 112.386 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 147.31 143.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.241 1.816 . . . . 0.0 106.104 -162.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HG2' HD22 ' A' ' 96' ' ' ASN . 5.5 tmmm? -65.83 -41.41 91.83 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.861 0.464 . . . . 0.0 109.97 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.63 -52.67 42.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.802 0.841 . . . . 0.0 111.384 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 111' ' ' LEU . 62.6 tp -59.78 -57.12 14.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.12 70.15 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.994 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -60.69 -42.54 99.38 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.631 0.582 . . . . 0.0 113.307 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.73 71.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.36 0.664 . . . . 0.0 110.163 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 130' ' ' ILE . 61.3 mt -71.79 -17.79 62.15 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.17 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.33 77.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.372 1.069 . . . . 0.0 112.042 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.07 -35.76 64.28 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.063 0.545 . . . . 0.0 109.629 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.507 HG21 ' HB2' ' A' ' 127' ' ' LEU . 51.6 mt -65.1 -36.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.39 0.614 . . . . 0.0 110.02 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 41.1 tpp -70.23 -44.21 69.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.913 1.285 . . . . 0.0 111.099 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.65 -48.71 24.73 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.263 -173.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -91.05 5.83 47.32 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.619 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 60.62 34.66 20.11 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.048 0.939 . . . . 0.0 111.641 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' A' ' 122' ' ' ILE . 81.8 mt -65.92 -41.56 91.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.583 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.66 141.39 8.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 110.269 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.23 107.48 14.06 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 119' ' ' LEU . 18.6 mt -92.49 117.82 36.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -85.79 166.21 16.25 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -130.53 143.86 15.21 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 170.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.85 130.85 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.687 HG21 ' SD ' ' A' ' 144' ' ' MET . 2.4 p -118.15 85.71 24.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.48 -38.68 0.67 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.642 2.228 . . . . 0.0 113.535 -171.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.38 -29.73 65.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.964 0.506 . . . . 0.0 110.384 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.31 17.23 68.1 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.57 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.99 9.94 4.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.111 0.965 . . . . 0.0 112.39 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.512 HD21 ' N ' ' A' ' 140' ' ' ASN . 0.2 OUTLIER -66.0 -21.27 66.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.699 0.799 . . . . 0.0 111.547 172.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 139' ' ' ASN . 5.3 t30 -75.66 -46.74 29.66 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 110.014 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.82 12.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.336 0.655 . . . . 0.0 111.663 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.11 -166.26 1.74 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.171 0.988 . . . . 0.0 110.129 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p -96.11 117.8 31.44 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.687 ' SD ' HG21 ' A' ' 134' ' ' VAL . 22.3 ptm -115.56 157.56 43.94 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.838 0.455 . . . . 0.0 111.27 -173.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.7 Cg_endo -71.1 124.84 10.87 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.319 2.012 . . . . 0.0 112.835 173.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.405 HD22 ' HE2' ' A' ' 148' ' ' MET . 24.6 tp -85.9 117.62 24.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.324 1.05 . . . . 0.0 108.792 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -75.33 107.77 7.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 62' ' ' SER . 64.4 mtt -106.23 137.74 43.65 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.964 0.906 . . . . 0.0 109.961 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.6 p -126.35 116.9 21.92 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -85.4 118.6 25.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.795 0.838 . . . . 0.0 109.292 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -122.68 101.41 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.665 0.786 . . . . 0.0 109.139 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.62 31.21 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.799 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.54 ' HB3' ' HZ2' ' A' ' 153' ' ' LYS . 0.5 OUTLIER -52.82 138.43 29.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.588 1.155 . . . . 0.0 112.427 174.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.454 ' HG2' HG23 ' A' ' 58' ' ' VAL . 42.0 mt-10 -58.92 -22.17 59.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 112.988 -175.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.34 -18.03 64.99 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.195 0.598 . . . . 0.0 112.056 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -44.0 75.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -167.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -24.64 51.32 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.578 0.351 . . . . 0.0 111.211 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.11 -35.21 61.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.839 0.455 . . . . 0.0 110.52 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.0 -50.63 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.032 0.933 . . . . 0.0 110.375 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p -66.94 -31.82 72.66 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.153 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.46 -39.7 67.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.215 0.606 . . . . 0.0 111.531 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -69.25 -37.35 77.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.946 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.2 mt -69.33 -55.48 10.3 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.587 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -54.64 -32.57 59.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.258 1.423 . . . . 0.0 112.134 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.08 -44.34 83.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -98.66 -15.3 19.47 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.434 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.31 9.48 50.89 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -63.95 133.33 53.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.332 0.653 . . . . 0.0 110.713 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -166.0 152.89 9.71 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.187 0.595 . . . . 0.0 110.638 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 CA-C-O 120.067 -0.296 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 m -68.61 -17.0 64.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.088 0.955 . . . . 0.0 112.21 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.46 -20.43 65.48 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.911 0.485 . . . . 0.0 111.663 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.56 -43.97 97.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.711 0.804 . . . . 0.0 111.658 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.54 -25.24 57.0 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.208 0.603 . . . . 0.0 111.501 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 -30.69 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.39 -26.93 52.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.665 1.186 . . . . 0.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -61.78 149.39 40.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.787 0.835 . . . . 0.0 112.142 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.23 162.63 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.603 1.161 . . . . 0.0 110.064 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 tp -85.81 117.13 24.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.948 0.499 . . . . 0.0 110.22 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.413 ' HE1' ' HB1' ' A' ' 128' ' ' ALA . 24.8 m-85 -82.18 -34.03 29.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.994 0.518 . . . . 0.0 110.71 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.93 -166.63 33.04 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.932 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.9 p -115.1 169.22 9.27 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.666 0.787 . . . . 0.0 110.837 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 tp -147.8 139.04 23.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.293 0.637 . . . . 0.0 109.394 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -76.35 93.73 3.51 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.077 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.409 ' HA3' ' HE1' ' A' ' 148' ' ' MET . . . -77.43 81.3 1.23 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.484 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -71.75 114.32 9.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -107.45 135.61 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.915 0.886 . . . . 0.0 109.189 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.82 151.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 124.506 1.122 . . . . 0.0 111.277 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.87 -21.7 31.26 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.19 -16.52 45.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.873 0.869 . . . . 0.0 112.067 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.716 HH12 HG21 ' A' ' 143' ' ' THR . 34.1 ptt-85 -49.74 -27.94 5.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.777 1.631 . . . . 0.0 113.227 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -63.31 -48.53 77.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.864 0.466 . . . . 0.0 110.262 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.26 -28.98 67.68 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.575 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.6 m -74.66 -24.86 58.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.811 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.88 53.76 0.33 Allowed Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.483 -0.62 . . . . 0.0 114.583 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -43.71 165.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.2 m -115.96 178.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.756 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -94.91 -82.05 0.38 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.872 0.469 . . . . 0.0 109.757 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -159.34 165.29 33.65 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.948 0.899 . . . . 0.0 109.732 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.461 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 1.9 m-20 64.38 7.6 3.71 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.875 1.27 . . . . 0.0 112.293 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.583 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.7 mm-40 -84.87 124.25 31.4 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.332 0.653 . . . . 0.0 110.788 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.6 mtm -88.16 130.35 35.07 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 25.3 m -125.26 126.53 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.753 0.821 . . . . 0.0 110.78 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.66 136.62 33.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.263 1.025 . . . . 0.0 110.229 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD23 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -87.57 141.56 28.52 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.49 0.716 . . . . 0.0 109.596 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -154.05 133.5 12.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 26.9 ptt180 -60.24 131.6 51.3 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 15.5 t70 -84.64 125.1 72.23 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.04 -37.55 75.15 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.307 2.671 . . . . 0.0 113.523 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.92 36.59 4.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.626 0.77 . . . . 0.0 109.732 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' A' ' 88' ' ' ASP . 21.5 t-20 -63.41 127.73 91.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.95 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.25 -23.32 33.24 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.9 2.4 . . . . 0.0 113.636 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -79.62 -52.15 8.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.7 t70 177.98 156.77 0.39 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.427 1.091 . . . . 0.0 109.951 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -57.14 -33.48 67.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.865 1.266 . . . . 0.0 113.599 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.4 -12.99 58.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.296 0.639 . . . . 0.0 111.883 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.1 128.77 37.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.176 0.591 . . . . 0.0 111.315 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.1 mt -92.95 125.04 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.991 0.917 . . . . 0.0 110.532 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -96.38 126.18 41.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.428 HG12 ' HB ' ' A' ' 83' ' ' VAL . 14.3 t -93.89 143.4 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -127.86 147.3 50.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.629 1.172 . . . . 0.0 108.111 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 p-10 -78.8 169.03 18.86 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.047 0.84 . . . . 0.0 110.051 170.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.67 -10.47 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.488 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.1 t-20 -73.12 -22.84 60.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 110.374 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 40.93 5.1 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -122.41 133.09 54.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.788 0.835 . . . . 0.0 109.788 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -63.47 131.35 47.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.332 0.653 . . . . 0.0 110.791 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.29 -32.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.399 0.68 . . . . 0.0 111.817 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.53 -171.65 44.73 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -128.65 139.78 52.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.022 0.929 . . . . 0.0 109.861 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.491 HD11 ' HE3' ' A' ' 148' ' ' MET . 91.5 mt -92.44 1.98 56.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.499 0.72 . . . . 0.0 111.8 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 67.74 -176.88 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.545 1.138 . . . . 0.0 110.382 -167.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -39.86 45.24 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -51.48 -63.25 1.19 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.279 0.987 . . . . 0.0 112.325 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.21 -39.08 88.9 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.518 0.675 . . . . 0.0 110.748 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.15 -21.62 63.99 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.348 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.22 -15.53 70.06 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.191 0.424 . . . . 0.0 113.412 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.11 -51.99 6.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.931 0.872 . . . . 0.0 109.062 165.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.44 -17.46 63.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.72 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.71 90.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.276 1.03 . . . . 0.0 111.895 -173.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -75.07 -33.73 61.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.949 0.5 . . . . 0.0 109.9 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.452 HD12 HG11 ' A' ' 160' ' ' VAL . 31.6 mt -70.15 -31.73 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.074 0.549 . . . . 0.0 110.115 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.9 tpp -79.43 -43.3 23.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.026 1.33 . . . . 0.0 110.798 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.25 -50.29 28.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.811 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -88.97 -0.62 57.57 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.427 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 59.59 32.45 21.59 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.653 1.181 . . . . 0.0 111.846 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -59.12 -39.39 82.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.142 0.977 . . . . 0.0 111.405 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.413 ' HB1' ' HE1' ' A' ' 60' ' ' PHE . . . -154.08 132.33 11.89 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.599 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.27 105.64 2.6 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.991 0.916 . . . . 0.0 109.266 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.83 108.22 19.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.44 146.12 36.44 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -123.31 162.66 17.11 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -149.2 140.59 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.517 1.127 . . . . 0.0 108.033 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.06 87.31 34.0 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 57.4 Cg_endo -88.6 0.2 6.52 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.045 2.496 . . . . 0.0 112.907 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.25 -31.3 20.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.977 0.511 . . . . 0.0 112.009 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.58 -6.52 23.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.64 9.03 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.028 0.914 . . . . 0.0 112.715 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.48 -15.59 61.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.674 1.19 . . . . 0.0 111.367 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.29 -55.19 5.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.945 0.898 . . . . 0.0 111.071 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.71 -61.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.452 0.701 . . . . 0.0 111.641 -171.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 -178.63 3.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.538 0.735 . . . . 0.0 109.823 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.716 HG21 HH12 ' A' ' 71' ' ' ARG . 15.9 p -92.29 109.05 20.42 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -112.24 120.44 41.59 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.716 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.58 125.12 8.73 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.025 1.816 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.37 146.94 24.34 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -73.36 107.36 5.62 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.127 0.571 . . . . 0.0 110.611 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.539 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 63.2 mtt -97.82 166.81 11.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.751 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.8 p -154.36 146.52 23.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.23 1.012 . . . . 0.0 109.634 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -109.19 120.39 42.39 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.134 0.974 . . . . 0.0 109.477 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -123.87 98.78 5.96 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.637 0.775 . . . . 0.0 109.647 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.31 162.46 30.63 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -55.57 142.57 33.0 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.647 0.779 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.34 -37.9 17.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.774 1.23 . . . . 0.0 113.465 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.413 ' O ' ' HE3' ' A' ' 158' ' ' LYS . 12.7 pt-20 -65.94 -29.78 70.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.213 0.605 . . . . 0.0 112.171 -174.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.22 4.19 13.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -61.71 -40.5 95.25 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 118.156 0.435 . . . . 0.0 111.31 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -69.31 -25.45 64.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.43 0.692 . . . . 0.0 111.192 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.6 -45.61 15.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.58 0.752 . . . . 0.0 110.567 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.452 HG11 HD12 ' A' ' 122' ' ' ILE . 67.6 t -65.95 -45.68 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.449 1.1 . . . . 0.0 110.983 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.5 p -66.94 -32.01 72.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.151 0.58 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.46 -47.11 82.73 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.599 0.562 . . . . 0.0 110.838 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.0 mm100 -63.28 -44.27 95.57 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.37 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.23 -52.81 29.93 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.775 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.44 -22.69 66.79 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.798 0.839 . . . . 0.0 112.193 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -53.02 -46.56 68.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.157 0.983 . . . . 0.0 111.141 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -108.24 -11.9 15.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.114 0.966 . . . . 0.0 111.247 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.87 30.58 25.87 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.885 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -77.55 126.62 31.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -172.3 147.53 1.99 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 CA--C 1.554 1.12 0 O-C-N 123.498 0.499 . . . . 0.0 110.881 -179.457 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 -0.22 23.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.652 0.781 . . . . 0.0 112.012 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.66 -43.55 22.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.571 0.348 . . . . 0.0 110.567 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.58 -31.97 71.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.899 0.479 . . . . 0.0 111.936 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.74 -32.53 69.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.96 0.504 . . . . 0.0 111.265 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.59 -31.62 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.801 0.84 . . . . 0.0 109.645 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.92 -12.13 57.61 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.056 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.7 m -63.7 133.39 53.5 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.135 0.493 . . . . 0.0 110.717 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.2 m -129.18 163.62 33.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 124.84 1.256 . . . . 0.0 109.061 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 149' ' ' THR . 40.3 tp -86.82 117.31 25.48 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -82.72 -31.42 28.48 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.65 -151.89 23.83 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.464 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -132.49 178.96 6.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.484 0.713 . . . . 0.0 110.684 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 39.0 tp -159.01 154.37 25.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.264 0.626 . . . . 0.0 110.186 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 94.69 5.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.978 0.911 . . . . 0.0 108.729 174.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.64 121.33 5.83 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -93.24 100.4 12.77 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.169 0.984 . . . . 0.0 109.751 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 7.9 p -82.88 145.68 8.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.368 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.8 m -65.72 156.02 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.18 0.992 . . . . 0.0 111.472 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 143' ' ' THR . . . -73.18 -23.42 77.6 Favored Glycine 0 N--CA 1.47 0.915 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.091 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt -51.29 -18.2 0.9 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.37 1.468 . . . . 0.0 112.678 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.596 HH12 HG22 ' A' ' 134' ' ' VAL . 13.8 ttt180 -47.19 -32.63 4.56 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.155 1.782 . . . . 0.0 112.755 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -63.22 -41.03 99.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.288 0.566 . . . . 0.0 110.933 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -69.53 -27.85 65.52 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.577 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 107' ' ' GLN . 6.0 m -101.48 -4.11 27.39 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.825 -170.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.32 52.56 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.965 172.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -44.42 156.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.2 175.88 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.087 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.78 -173.77 4.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.85 0.86 . . . . 0.0 111.157 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.3 151.45 39.82 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.933 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.57 -0.57 1.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.01 1.324 . . . . 0.0 113.883 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -73.33 128.48 35.61 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.272 0.487 . . . . 0.0 112.303 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.446 ' HG2' HG22 ' A' ' 133' ' ' VAL . 77.4 mtp -79.63 148.22 31.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.719 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 102' ' ' ASN . 23.1 m -143.74 146.82 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.617 1.167 . . . . 0.0 108.8 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB1' ' OD1' ' A' ' 101' ' ' ASN . . . -97.5 156.07 16.66 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.177 0.991 . . . . 0.0 110.084 175.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 130' ' ' ILE . 27.7 mt -89.0 161.58 16.51 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.535 . . . . 0.0 109.636 168.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.56 144.88 18.45 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -80.68 123.28 28.04 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -60.53 109.0 1.68 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.79 -15.17 46.5 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.789 2.326 . . . . 0.0 113.123 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.54 90.81 3.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.03 115.88 22.83 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.12 -51.56 5.43 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.976 2.451 . . . . 0.0 112.624 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.8 -47.28 1.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.68 0.792 . . . . 0.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -122.98 137.92 54.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.522 0.729 . . . . 0.0 109.736 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -57.82 -27.12 62.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.792 1.237 . . . . 0.0 113.232 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.4 ' HB2' ' HB1' ' A' ' 120' ' ' ALA . 28.3 p-10 -84.86 -1.79 56.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.424 0.689 . . . . 0.0 112.827 -173.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.92 111.08 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.876 0.87 . . . . 0.0 111.19 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.0 mt -96.03 108.62 21.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 C-N-CA 123.259 0.624 . . . . 0.0 110.118 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 32.2 ttpt -88.91 142.16 27.89 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.393 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.96 143.87 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.761 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.41 ' OD1' ' HB1' ' A' ' 84' ' ' ALA . 5.7 p30 -130.0 150.98 51.04 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.089 1.356 . . . . 0.0 107.878 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' HA ' HG11 ' A' ' 83' ' ' VAL . 28.6 p-10 -90.51 -176.92 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.854 0.752 . . . . 0.0 111.04 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 m -57.83 -29.18 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.581 0.753 . . . . 0.0 112.649 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.84 -18.04 41.82 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.947 0.499 . . . . 0.0 111.245 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.04 50.17 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.042 0.353 . . . . 0.0 113.556 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.38 114.53 4.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.958 0.903 . . . . 0.0 109.174 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.412 ' O ' HG21 ' A' ' 74' ' ' THR . 22.9 pt20 -59.85 105.15 0.35 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.34 -17.81 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.392 0.677 . . . . 0.0 111.376 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.14 158.5 9.94 Favored Glycine 0 N--CA 1.473 1.107 0 O-C-N 122.954 0.159 . . . . 0.0 112.957 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 6.9 p-80 -81.86 154.59 25.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.3 0.64 . . . . 0.0 112.666 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 45.9 mt -70.73 -51.44 27.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.907 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 24.4 ttmm 156.65 145.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.642 1.577 . . . . 0.0 107.204 -166.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -23.59 55.33 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.755 0.707 . . . . 0.0 111.196 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 37.5 tt0 -74.24 -42.39 59.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.937 0.495 . . . . 0.0 110.569 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -47.54 85.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.93 67.61 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.866 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -53.86 -37.57 57.95 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.139 0.4 . . . . 0.0 113.746 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.05 -55.54 4.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.125 0.57 . . . . 0.0 110.475 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 122' ' ' ILE . 11.7 mt -68.16 -17.38 64.32 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.249 -171.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' A' ' 96' ' ' ASN . . . -56.16 -54.35 46.16 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.556 1.142 . . . . 0.0 111.62 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.54 -29.11 69.12 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.183 0.927 . . . . 0.0 110.76 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.434 HD12 HG11 ' A' ' 160' ' ' VAL . 48.3 mt -68.59 -40.35 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.332 0.653 . . . . 0.0 110.143 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 52.0 ttm -80.1 -28.13 39.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.638 0.775 . . . . 0.0 111.446 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.96 -48.61 20.47 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.536 0.734 . . . . 0.0 110.614 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -95.43 5.25 52.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.547 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 57.45 37.26 27.76 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.44 1.096 . . . . 0.0 111.344 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 70.6 mt -61.01 -52.77 63.59 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.332 -177.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.407 ' HB1' HG22 ' A' ' 160' ' ' VAL . . . -146.14 161.49 40.08 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.615 0.766 . . . . 0.0 111.023 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -101.18 107.28 18.64 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.129 0.972 . . . . 0.0 108.556 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 85' ' ' LEU . 27.7 mt -96.56 112.11 28.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -93.4 173.55 7.65 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.74 154.82 24.53 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 82' ' ' MET . 93.7 t -141.87 129.58 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.596 HG22 HH12 ' A' ' 71' ' ' ARG . 61.7 t -99.62 87.16 0.64 Allowed Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 4.5 Cg_exo -76.25 -51.11 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.52 -165.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -71.81 -27.16 62.74 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.798 0.839 . . . . 0.0 110.844 -174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.76 18.45 72.28 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.356 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.64 1.95 27.8 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.834 0.853 . . . . 0.0 112.134 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.441 HD21 ' N ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -57.5 -25.73 60.24 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.53 1.532 . . . . 0.0 114.304 -176.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -86.65 -38.65 16.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.606 0.762 . . . . 0.0 111.386 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.65 -20.15 21.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.534 0.734 . . . . 0.0 112.039 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.73 173.08 16.58 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.297 0.639 . . . . 0.0 109.717 -167.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 69' ' ' GLY . 44.7 p -94.36 109.68 21.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.0 ptm -113.73 155.72 44.66 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 122.935 0.494 . . . . 0.0 111.004 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.89 127.53 4.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.349 2.033 . . . . 0.0 111.369 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -92.75 143.23 26.5 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -69.9 107.41 3.55 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 16.3 mtp -94.78 150.24 20.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.472 HG22 HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.09 130.38 22.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 113.7 25.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.391 0.676 . . . . 0.0 109.574 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.22 100.6 6.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.6 160.35 28.44 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -53.65 143.88 19.14 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.676 0.79 . . . . 0.0 112.496 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 2.3 tm-20 -50.77 -46.4 59.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.128 1.371 . . . . 0.0 111.454 -173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -58.94 -18.28 32.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 127' ' ' LEU . 1.4 t-20 -100.51 0.22 39.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -166.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.481 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 3.4 ppt_? -52.17 -37.28 54.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -171.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -81.72 -30.18 32.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.58 0.352 . . . . 0.0 111.366 -177.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.83 -43.31 46.59 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.086 0.554 . . . . 0.0 111.237 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.434 HG11 HD12 ' A' ' 122' ' ' ILE . 61.9 t -62.7 -42.64 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.851 0.86 . . . . 0.0 110.73 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.0 t -64.24 -35.38 80.62 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.02 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -57.0 -41.16 77.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.959 0.904 . . . . 0.0 110.934 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.44 -36.32 78.86 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.723 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.4 mt -68.71 -44.35 74.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.021 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -59.37 -27.71 66.21 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.611 1.164 . . . . 0.0 111.879 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -54.62 -52.17 63.08 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 111.954 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -93.59 -23.68 18.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.472 0.709 . . . . 0.0 110.34 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.89 16.82 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.528 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.42 144.22 54.78 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.463 0.705 . . . . 0.0 110.53 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -176.42 152.66 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.716 1.206 . . . . 0.0 107.782 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.559 1.289 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 42.0 m -69.36 -7.78 40.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.403 0.681 . . . . 0.0 112.078 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.17 -31.42 63.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.357 1.063 . . . . 0.0 111.254 173.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 47.5 mt-10 -60.09 -23.97 64.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.978 . . . . 0.0 113.463 -175.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 51' ' ' SER . 13.0 pt-20 -70.25 -32.89 70.94 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.918 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.55 -29.4 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.133 0.973 . . . . 0.0 109.811 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 32.6 t70 -78.94 -24.9 43.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 0.0 111.004 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -78.69 122.77 26.41 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.203 0.601 . . . . 0.0 109.822 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.461 HG23 ' HG2' ' A' ' 154' ' ' GLU . 27.0 m -124.16 175.87 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.873 1.269 . . . . 0.0 110.196 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.43 121.41 30.79 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -85.26 -40.3 16.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.097 0.559 . . . . 0.0 110.042 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.19 -151.54 23.4 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.605 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.466 ' H ' HD11 ' A' ' 171' ' ' LEU . 73.9 p -123.56 -179.82 4.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.914 0.886 . . . . 0.0 111.073 -174.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.584 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 26.7 tp -156.28 155.78 32.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -93.53 90.59 6.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.962 0.905 . . . . 0.0 108.72 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.21 88.89 1.37 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -70.31 93.9 0.89 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.174 0.487 . . . . 0.0 110.398 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 32.4 t -95.14 143.48 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 109.723 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.07 143.2 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.162 0.585 . . . . 0.0 111.563 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.457 ' H ' HG21 ' A' ' 143' ' ' THR . . . -80.44 -19.91 67.8 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 113.051 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.1 tp -59.94 -22.62 62.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.23 1.012 . . . . 0.0 112.146 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HE ' HG21 ' A' ' 108' ' ' VAL . 13.9 ptt-85 -74.4 0.26 15.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.493 1.117 . . . . 0.0 112.567 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -42.56 -40.3 2.62 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.483 1.513 . . . . 0.0 114.094 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -56.85 -24.78 53.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.408 1.083 . . . . 0.0 113.218 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 m -75.56 -7.16 53.49 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.749 0.82 . . . . 0.0 111.626 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.3 2.74 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 140' ' ' ASN . 31.6 m -62.54 169.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.612 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 28.2 m -114.29 149.32 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.932 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -97.17 -97.14 0.2 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -107.94 144.11 35.66 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.192 0.597 . . . . 0.0 111.606 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 t30 59.19 10.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.39 1.476 . . . . 0.0 112.634 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.612 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 68.3 mm-40 -79.83 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 122.782 0.433 . . . . 0.0 110.611 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.532 ' HG2' HG21 ' A' ' 133' ' ' VAL . 85.1 mtp -88.43 117.62 27.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 23.2 m -113.86 135.06 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.142 0.977 . . . . 0.0 109.923 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.1 55.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.688 0.795 . . . . 0.0 109.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.3 mp -81.88 141.06 33.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.629 0.771 . . . . 0.0 109.216 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -151.55 148.47 28.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.127 0.571 . . . . 0.0 109.929 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -58.81 144.41 44.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.186 0.994 . . . . 0.0 112.144 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.36 93.03 22.88 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.39 -24.62 12.05 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.708 2.272 . . . . 0.0 112.978 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.68 59.02 2.79 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.21 1.005 . . . . 0.0 110.469 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 97' ' ' ALA . 37.4 m-80 -108.32 143.09 26.74 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.768 164.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.58 -19.15 32.6 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.379 2.053 . . . . 0.0 111.156 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -77.59 -53.32 7.72 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.269 0.628 . . . . 0.0 110.467 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.04 152.04 0.87 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.815 0.697 . . . . 0.0 109.444 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.38 -19.14 64.61 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.331 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.37 -1.81 31.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.575 1.15 . . . . 0.0 113.006 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.452 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . . . -72.86 138.68 46.44 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.98 123.69 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.934 0.894 . . . . 0.0 109.838 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 7.8 ttpm? -86.18 116.58 24.46 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.748 171.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.48 131.85 33.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -119.05 165.69 13.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 107.645 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.2 p-10 -98.29 -165.5 1.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.321 0.51 . . . . 0.0 110.056 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.69 -32.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.164 0.586 . . . . 0.0 112.109 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.755 0.822 . . . . 0.0 110.934 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -0.27 82.13 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.89 118.02 9.1 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.032 0.933 . . . . 0.0 109.155 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -62.27 122.16 14.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.8 0.687 . . . . 0.0 110.377 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 HG21 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -89.08 -12.79 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.097 173.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.93 -164.84 24.41 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -84.21 157.37 21.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.174 0.59 . . . . 0.0 110.015 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 4.0 tt -80.71 -55.27 4.95 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 158.21 127.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -163.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -58.22 9.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.369 0.668 . . . . 0.0 110.707 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -54.3 -48.38 71.36 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.376 1.071 . . . . 0.0 112.291 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.37 -40.24 77.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.83 -34.05 76.52 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.705 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.33 -32.28 80.29 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.913 0.758 . . . . 0.0 113.539 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.06 -59.16 2.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.397 0.618 . . . . 0.0 109.962 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.6 -15.04 63.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.38 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.82 72.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.116 1.366 . . . . 0.0 112.631 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -69.25 -32.95 72.5 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.586 0.554 . . . . 0.0 110.02 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 127' ' ' LEU . 50.3 mt -70.72 -34.29 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.461 0.705 . . . . 0.0 110.336 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 39.0 tpp -80.25 -39.36 29.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.612 1.165 . . . . 0.0 111.268 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -83.04 -37.43 23.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.194 0.998 . . . . 0.0 110.426 -171.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.55 6.31 47.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 53.58 39.2 29.77 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.509 1.124 . . . . 0.0 112.724 171.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.414 ' HB2' HG22 ' A' ' 122' ' ' ILE . 75.6 mt -66.06 -40.98 91.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.893 0.877 . . . . 0.0 111.09 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.62 138.11 18.62 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.102 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -77.23 107.03 9.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.604 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.29 110.95 24.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.25 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.57 179.0 4.99 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.586 0.754 . . . . 0.0 109.34 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -160.18 160.62 31.84 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.532 HG21 ' HG2' ' A' ' 82' ' ' MET . 61.0 t -142.66 120.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 2.4 p -95.08 100.48 5.69 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.173 0.589 . . . . 0.0 109.901 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.74 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.832 2.355 . . . . 0.0 113.397 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.65 -27.63 45.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.587 0.755 . . . . 0.0 111.833 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.95 79.34 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.066 0.387 . . . . 0.0 114.066 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.514 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -75.92 -15.17 60.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.017 0.527 . . . . 0.0 111.348 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -9.57 33.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.588 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.8 m-20 -73.64 -56.92 4.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.818 0.447 . . . . 0.0 110.664 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.94 -42.38 7.16 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.169 0.587 . . . . 0.0 111.082 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.24 161.38 13.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.086 0.954 . . . . 0.0 111.468 -171.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 69' ' ' GLY . 67.1 p -95.73 109.02 21.38 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.514 ' SD ' ' HB1' ' A' ' 138' ' ' ALA . 22.8 ptm -131.75 151.0 77.82 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 122.59 0.356 . . . . 0.0 111.168 -169.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.06 129.13 4.53 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.618 2.212 . . . . 0.0 111.592 164.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -114.24 156.29 24.59 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -75.56 107.68 7.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.799 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.575 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 61.3 mtt -97.84 160.12 14.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.357 1.063 . . . . 0.0 109.008 173.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.27 135.03 30.24 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -169.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.584 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 96.9 m-85 -100.76 120.41 40.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.923 0.889 . . . . 0.0 110.144 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.89 110.17 12.75 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.9 39.98 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -64.19 141.31 58.82 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.955 0.502 . . . . 0.0 111.768 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 58' ' ' VAL . 34.2 mt-10 -55.14 -31.05 61.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -171.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.49 -20.89 66.15 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.275 0.63 . . . . 0.0 112.199 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.09 -1.0 46.19 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.087 -0.959 . . . . 0.0 113.151 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -64.92 -29.73 70.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 119.593 1.088 . . . . 0.0 111.118 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -29.56 65.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.389 0.676 . . . . 0.0 111.082 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.63 -42.58 19.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.292 0.637 . . . . 0.0 110.271 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.46 -47.15 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.769 1.227 . . . . 0.0 110.83 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.5 t -61.85 -39.93 93.58 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.2 t70 -56.28 -41.29 75.64 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.837 0.71 . . . . 0.0 111.248 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.1 mm100 -72.0 -35.6 69.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.643 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.35 -51.64 34.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.106 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.95 -33.23 72.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.613 1.165 . . . . 0.0 111.717 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HZ1' HE22 ' A' ' 163' ' ' GLN . 29.4 ttmt -54.8 -44.87 74.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.06 1.344 . . . . 0.0 111.43 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 -17.71 17.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.217 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.83 30.77 16.97 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.882 -0.399 . . . . 0.0 113.916 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' HB3' HD13 ' A' ' 63' ' ' LEU . 53.7 m-85 -88.63 126.74 35.44 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.402 0.601 . . . . 0.0 109.532 172.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -131.38 150.11 52.28 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 108.967 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 171' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.251 1.181 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.882 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.1 t -80.47 -8.87 59.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.086 0.954 . . . . 0.0 112.143 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 7.2 p-10 -58.3 -19.17 32.55 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.512 1.125 . . . . 0.0 113.411 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -59.82 -61.04 2.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.258 0.623 . . . . 0.0 110.13 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.9 -17.62 55.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.536 0.734 . . . . 0.0 111.724 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 74.2 t -70.94 -29.99 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.941 0.496 . . . . 0.0 110.125 170.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.09 -9.46 27.97 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.425 0.69 . . . . 0.0 110.937 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -71.28 116.06 11.16 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.41 165.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.774 1.229 . . . . 0.0 110.421 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.44 117.44 23.07 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.161 0.584 . . . . 0.0 110.087 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.68 -24.79 28.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.53 -158.7 27.07 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.472 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.2 p -112.22 178.78 4.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.327 0.651 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 37.3 tp -152.91 147.93 26.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.074 0.549 . . . . 0.0 109.844 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -84.27 87.5 7.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.709 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.36 93.83 0.91 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.926 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -67.42 111.91 4.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.749 0.82 . . . . 0.0 110.965 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG13 HD23 ' A' ' 111' ' ' LEU . 19.6 m -113.24 145.81 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.689 0.796 . . . . 0.0 109.119 172.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.429 ' HA ' HG21 ' A' ' 143' ' ' THR . 26.2 m -96.58 153.33 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.173 0.589 . . . . 0.0 111.447 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.07 -19.88 68.81 Favored Glycine 0 N--CA 1.477 1.41 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.29 -17.57 58.99 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.504 0.669 . . . . 0.0 112.028 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.544 ' NH2' HG21 ' A' ' 108' ' ' VAL . 15.3 mtp180 -69.48 -2.38 11.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.38 1.472 . . . . 0.0 113.611 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -52.05 -42.84 63.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.6 0.76 . . . . 0.0 112.493 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -83.46 -6.47 59.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.862 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -75.17 -26.14 58.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 109.695 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.96 49.79 0.45 Allowed Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.389 -0.369 . . . . 0.0 112.704 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.556 ' HB ' ' ND2' ' A' ' 139' ' ' ASN . 15.7 m -59.79 170.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 6.0 m -115.54 178.56 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.657 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -85.03 -165.95 1.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.658 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -82.48 159.93 22.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.17 0.588 . . . . 0.0 110.411 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.8 OUTLIER 63.47 9.02 3.88 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.083 1.353 . . . . 0.0 112.912 -179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 28.4 mm-40 -84.33 144.27 28.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.139 0.576 . . . . 0.0 110.731 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.438 ' HG2' HG23 ' A' ' 133' ' ' VAL . 72.1 mtm -92.84 132.88 36.61 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.89 152.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.993 0.917 . . . . 0.0 110.116 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.76 157.1 30.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.517 0.727 . . . . 0.0 110.489 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 130' ' ' ILE . 8.4 mp -100.43 134.65 43.07 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.304 0.642 . . . . 0.0 110.037 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -139.73 110.78 6.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.441 1.097 . . . . 0.0 108.238 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 127.37 32.93 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -118.18 96.64 49.99 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.892 -169.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.14 -24.88 76.76 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.993 2.462 . . . . 0.0 112.821 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.824 0.85 . . . . 0.0 111.826 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.501 HD21 ' HB1' ' A' ' 97' ' ' ALA . 66.0 t30 -57.83 117.89 22.37 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.735 0.814 . . . . 0.0 111.375 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.34 -14.13 22.87 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.964 2.443 . . . . 0.0 112.516 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.47 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 28.9 t80 -73.11 -49.48 28.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.114 0.966 . . . . 0.0 109.713 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 16.2 t70 -173.09 138.27 0.74 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.626 0.771 . . . . 0.0 109.829 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -69.54 -30.43 68.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.37 0.668 . . . . 0.0 111.62 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -83.95 -12.88 54.68 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.012 0.525 . . . . 0.0 110.508 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' A' ' 91' ' ' ASN . . . -59.77 109.14 0.86 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 124.267 0.979 . . . . 0.0 109.826 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.41 ' HB ' HD12 ' A' ' 111' ' ' LEU . 73.2 mt -72.38 104.33 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.99 -172.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 39.6 ttmt -61.94 110.9 1.7 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.516 168.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.82 110.87 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.68 173.94 6.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.056 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -105.67 -167.87 1.38 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.02 -29.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.48 -31.69 63.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.781 0.832 . . . . 0.0 110.81 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.88 -2.34 41.47 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.191 -172.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.52 122.89 18.25 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.844 0.858 . . . . 0.0 109.45 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.434 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 18.5 pm0 -62.07 111.26 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.091 0.869 . . . . 0.0 109.761 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.544 HG21 ' NH2' ' A' ' 71' ' ' ARG . 16.0 m -91.36 -0.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.35 -148.68 20.21 Favored Glycine 0 C--N 1.366 2.228 0 C-N-CA 123.535 0.588 . . . . 0.0 113.513 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -137.28 146.13 44.33 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.085 1.354 . . . . 0.0 108.732 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.557 HD11 HD13 ' A' ' 115' ' ' LEU . 43.4 mt -63.63 -57.1 11.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 117.955 0.343 . . . . 0.0 111.609 -176.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 173.98 169.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 128.078 2.551 . . . . 0.0 105.033 -167.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 -27.25 33.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 119.292 0.951 . . . . 0.0 109.327 160.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HG2' ' HZ ' ' A' ' 169' ' ' PHE . 28.9 tt0 -69.7 -59.93 2.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.756 1.222 . . . . 0.0 111.085 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -58.2 -40.14 80.8 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.167 0.987 . . . . 0.0 109.044 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.99 97.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.831 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.17 -36.0 35.09 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 124.215 0.947 . . . . 0.0 113.928 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -61.34 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.444 0.698 . . . . 0.0 111.548 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 mt -71.38 -18.92 62.33 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.583 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.55 81.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.902 0.881 . . . . 0.0 110.417 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -65.4 -36.51 84.18 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.182 0.926 . . . . 0.0 110.331 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.98 -42.06 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.0 -32.2 51.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.249 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -48.78 11.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.916 0.887 . . . . 0.0 111.021 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.93 7.01 25.92 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.141 0.576 . . . . 0.0 111.231 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 63.14 32.36 15.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.445 ' HA ' HD21 ' A' ' 156' ' ' ASN . 56.7 mt -67.5 -44.17 79.12 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.895 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.33 150.38 25.21 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -77.77 134.92 37.95 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 ' HB ' HD21 ' A' ' 85' ' ' LEU . 31.3 mt -127.73 129.55 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.1 168.13 18.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.544 1.137 . . . . 0.0 108.516 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -137.02 166.96 24.8 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 82' ' ' MET . 62.6 t -147.91 131.35 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.45 99.27 12.56 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.169 0.588 . . . . 0.0 110.251 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.11 -27.58 4.4 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.761 2.308 . . . . 0.0 112.766 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -75.23 -31.29 60.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.066 0.546 . . . . 0.0 111.784 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.18 11.69 40.49 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 114.222 0.449 . . . . 0.0 114.222 -172.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 144' ' ' MET . . . -88.92 5.63 43.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.674 0.789 . . . . 0.0 111.397 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.556 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 3.6 p-10 -63.69 -19.42 64.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.597 1.159 . . . . 0.0 112.188 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -69.71 -60.73 2.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.744 0.818 . . . . 0.0 111.146 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.56 -32.04 11.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -171.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -113.58 162.56 16.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 112.196 -167.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 68' ' ' VAL . 72.9 p -97.51 109.71 22.41 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.456 ' HG2' ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -149.75 158.43 37.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -167.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.66 127.18 1.9 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.772 2.314 . . . . 0.0 113.035 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.442 ' HB3' ' HE3' ' A' ' 144' ' ' MET . 3.7 pp -94.23 152.16 18.9 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -73.26 108.82 6.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.594 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.458 ' HE2' HD13 ' A' ' 111' ' ' LEU . 47.7 mtt -99.03 166.39 11.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.692 0.797 . . . . 0.0 110.346 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.4 p -143.69 156.17 44.46 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.304 1.042 . . . . 0.0 109.707 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 81.1 m-85 -117.41 117.24 28.94 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.715 0.806 . . . . 0.0 108.856 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -124.26 100.37 6.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.78 167.06 29.86 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -73.55 145.25 45.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.599 0.36 . . . . 0.0 111.307 -171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.34 -30.34 66.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 113.874 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.04 -6.51 54.8 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 127' ' ' LEU . 4.0 m-20 -118.24 7.55 12.1 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.248 0.619 . . . . 0.0 110.543 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -37.04 86.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.144 0.578 . . . . 0.0 112.11 -169.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -26.03 61.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.157 0.286 . . . . 0.0 110.765 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -77.93 -34.59 51.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.072 0.549 . . . . 0.0 110.335 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.8 -50.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.33 0.652 . . . . 0.0 109.993 174.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.4 p -66.36 -32.21 73.45 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.735 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.26 -43.31 82.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.296 0.638 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 9.8 mm100 -70.05 -30.84 68.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.786 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.15 -52.34 35.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.19 0.596 . . . . 0.0 110.103 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.04 -25.07 67.67 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.447 1.099 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.929 1.292 . . . . 0.0 111.805 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -103.77 -28.37 11.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.293 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.11 29.88 5.3 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.552 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.596 ' HZ ' ' HG2' ' A' ' 114' ' ' GLU . 62.5 m-85 -78.17 129.93 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.733 0.766 . . . . 0.0 110.858 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HZ3' HD22 ' A' ' 171' ' ' LEU . 21.2 tptp -153.4 146.58 24.68 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.339 0 C-N-CA 123.709 0.804 . . . . 0.0 110.794 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 112.884 -0.086 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.1 t -66.69 -21.74 66.09 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.006 0.922 . . . . 0.0 111.646 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.9 -14.23 62.63 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.643 1.177 . . . . 0.0 112.483 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.19 -48.61 70.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.615 0.766 . . . . 0.0 112.021 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -15.29 59.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.196 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -35.3 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.925 0.89 . . . . 0.0 109.726 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -84.83 -15.44 44.75 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.749 1.219 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -80.42 143.39 33.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.523 0.729 . . . . 0.0 111.704 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.31 161.31 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.296 1.438 . . . . 0.0 110.474 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.7 tp -85.36 110.89 19.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -73.17 -39.22 65.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.341 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.57 -160.86 30.56 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.1 p -111.79 179.14 4.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.516 0.726 . . . . 0.0 110.858 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 169' ' ' PHE . 33.7 tp -154.73 153.39 31.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.371 0.668 . . . . 0.0 109.983 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -87.29 92.71 9.17 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.64 125.21 8.39 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.401 ' H ' ' HG ' ' A' ' 115' ' ' LEU . 77.0 m80 -114.65 109.95 19.01 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.606 0.762 . . . . 0.0 110.286 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.39 139.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 66.4 t -71.97 142.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.998 0.519 . . . . 0.0 110.397 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.88 -44.45 68.68 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.727 -0.67 . . . . 0.0 114.328 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.1 -17.77 42.24 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.067 0.947 . . . . 0.0 112.065 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' HD3' ' HB ' ' A' ' 68' ' ' VAL . 2.3 mpt_? -74.35 1.4 11.72 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.452 1.101 . . . . 0.0 111.739 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -57.25 -28.83 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.845 0.458 . . . . 0.0 110.611 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.66 -31.89 72.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.051 0.94 . . . . 0.0 111.015 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -74.46 -27.06 60.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.392 0.677 . . . . 0.0 110.207 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.8 46.63 0.51 Allowed Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.756 -0.656 . . . . 0.0 114.288 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.673 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 93.7 t -56.49 154.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 122.816 0.446 . . . . 0.0 110.452 171.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.54 159.4 7.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.538 0.735 . . . . 0.0 111.061 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -96.02 -115.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.07 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -93.96 139.94 30.31 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.63 0.772 . . . . 0.0 111.745 -163.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 74.03 -22.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.37 1.468 . . . . 0.0 113.656 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.02 129.69 43.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.52 1.128 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.513 ' HG2' HG21 ' A' ' 133' ' ' VAL . 74.7 mtp -94.25 142.74 27.06 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 30.0 m -114.64 147.04 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.101 0.56 . . . . 0.0 110.463 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.76 53.75 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.042 0.937 . . . . 0.0 108.803 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -88.37 151.32 22.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.405 0.682 . . . . 0.0 110.319 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -159.76 153.68 23.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.073 0.949 . . . . 0.0 109.101 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -71.88 137.13 47.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.703 0.401 . . . . 0.0 110.334 172.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.78 117.17 67.61 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.4 0.68 . . . . 0.0 109.813 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.4 -29.76 53.68 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.781 2.321 . . . . 0.0 112.797 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.33 52.49 2.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.431 0.693 . . . . 0.0 109.599 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.25 108.16 1.06 Allowed Pre-proline 0 CA--C 1.566 1.564 0 C-N-CA 124.579 1.151 . . . . 0.0 112.498 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.86 -34.94 70.32 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 123.284 2.656 . . . . 0.0 113.543 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -126.0 -44.04 1.79 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.412 0.685 . . . . 0.0 111.197 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -162.94 162.7 26.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.142 0.577 . . . . 0.0 109.924 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.23 -14.52 26.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.417 1.087 . . . . 0.0 112.53 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.463 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 47.3 m-80 -73.33 4.08 5.09 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.74 116.96 18.68 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.248 0.619 . . . . 0.0 109.955 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.465 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 44.9 mt -97.98 118.79 45.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 C-N-CA 123.614 0.766 . . . . 0.0 109.649 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.726 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 17.3 ttmm -71.53 140.04 49.74 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.288 165.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 t -109.84 124.62 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -108.09 168.65 9.14 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -108.4 -165.77 1.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.988 0.515 . . . . 0.0 110.217 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.75 -33.14 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.742 . . . . 0.0 111.537 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -76.14 -19.99 58.0 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.991 0.916 . . . . 0.0 111.112 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.04 6.88 78.41 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -69.96 135.09 49.06 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 109.62 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.726 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 26.1 mp0 -73.81 98.64 3.0 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.825 0.85 . . . . 0.0 109.0 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.673 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 11.8 m -79.77 -25.82 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.51 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.7 -142.18 8.36 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 121.587 -0.34 . . . . 0.0 112.914 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -140.32 157.4 45.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.334 1.054 . . . . 0.0 109.571 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 115' ' ' LEU . 65.9 mt -81.64 -5.06 57.71 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.422 176.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? 71.6 151.5 0.11 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 109.937 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -37.42 -42.06 0.48 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.41 -56.12 5.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.383 0.273 . . . . 0.0 111.122 -170.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -72.43 -44.46 62.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -175.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.465 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -58.6 -51.6 69.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.412 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -60.44 -27.4 65.73 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.497 0.498 . . . . 0.0 114.071 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -61.59 1.73 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.954 0.502 . . . . 0.0 109.918 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.401 HD13 HG23 ' A' ' 130' ' ' ILE . 18.1 mt -69.88 -16.07 63.18 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.971 -172.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.11 -24.15 65.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.967 0.907 . . . . 0.0 113.231 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -76.32 -35.87 58.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.535 HG22 ' HB2' ' A' ' 127' ' ' LEU . 48.1 mt -67.64 -29.65 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.92 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.2 tpp -79.08 -41.71 28.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.463 1.105 . . . . 0.0 110.558 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.66 -50.8 56.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.53 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -93.54 1.16 56.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.849 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 54.52 44.65 28.44 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.015 0.926 . . . . 0.0 111.642 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' HB2' HG22 ' A' ' 122' ' ' ILE . 62.3 mt -68.79 -40.18 79.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.992 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.58 135.38 12.72 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.261 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -68.21 114.43 6.69 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 119' ' ' LEU . 13.7 mt -101.08 124.03 54.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.07 139.6 44.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.815 0.846 . . . . 0.0 108.944 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -116.95 168.16 12.74 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.343 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.513 HG21 ' HG2' ' A' ' 82' ' ' MET . 44.1 t -138.94 133.6 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.34 94.12 5.47 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.17 -56.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.179 1.92 . . . . 0.0 112.951 -172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.547 ' HB2' ' HE1' ' A' ' 144' ' ' MET . 84.4 m-85 -75.8 -30.99 59.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.943 0.497 . . . . 0.0 110.976 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 49.47 34.62 19.91 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 124.0 0.812 . . . . 0.0 114.435 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -89.89 17.77 6.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.753 0.821 . . . . 0.0 112.278 -168.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -52.14 -36.46 51.47 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.293 1.037 . . . . 0.0 112.094 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -53.92 -49.14 69.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.819 0.848 . . . . 0.0 111.397 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.85 -51.59 11.01 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.722 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -157.49 166.42 33.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.416 1.087 . . . . 0.0 109.555 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.8 p -94.59 110.71 22.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.547 ' HE1' ' HB2' ' A' ' 136' ' ' PHE . 0.9 OUTLIER -114.03 141.49 26.36 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 124.245 1.018 . . . . 0.0 110.562 -174.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.29 130.26 18.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.951 2.434 . . . . 0.0 112.261 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.52 152.97 21.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -91.13 110.73 22.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 122.1 -0.375 . . . . 0.0 110.502 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.568 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 54.7 mtt -92.5 169.45 10.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.217 1.007 . . . . 0.0 111.065 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 p -149.72 147.53 28.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.702 1.201 . . . . 0.0 109.062 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 91.8 m-85 -109.34 120.56 42.89 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.847 0.859 . . . . 0.0 109.515 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -124.17 97.68 5.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.22 166.34 35.73 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.75 139.76 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.373 0.669 . . . . 0.0 111.942 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -51.07 -37.28 44.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.753 1.221 . . . . 0.0 112.997 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.46 -12.29 59.92 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.679 0.791 . . . . 0.0 113.133 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -97.22 -0.98 45.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -30.24 69.61 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -33.59 71.62 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.16 0.505 . . . . 0.0 110.929 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.74 -33.97 30.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.48 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.37 -48.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.878 0.871 . . . . 0.0 110.777 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 72.9 p -64.34 -34.41 78.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 111.555 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.61 -42.76 75.35 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.674 0.609 . . . . 0.0 111.394 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mm100 -66.8 -38.94 87.46 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.326 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -70.17 -53.18 18.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.525 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.94 -25.61 68.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.888 0.875 . . . . 0.0 112.074 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.37 -48.12 82.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 111.389 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -102.89 -1.1 30.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.601 0.761 . . . . 0.0 111.046 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.73 63.65 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.368 0.418 . . . . 0.0 113.988 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' HB3' HD12 ' A' ' 63' ' ' LEU . 24.8 m-85 -74.54 147.54 41.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.372 0.669 . . . . 0.0 111.05 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -164.16 152.58 13.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.787 0.835 . . . . 0.0 109.709 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 123.76 0.824 . . . . 0.0 112.882 174.456 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.0 p -80.35 -17.21 52.63 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.814 0.446 . . . . 0.0 111.913 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.07 -41.26 71.3 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.453 1.101 . . . . 0.0 111.537 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.86 -47.06 66.88 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.18 -22.01 60.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.387 0.275 . . . . 0.0 111.488 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.99 -31.94 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.827 0.851 . . . . 0.0 109.625 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.38 -13.73 42.6 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.715 0.806 . . . . 0.0 110.788 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.4 m -74.41 113.94 12.22 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 122.997 0.519 . . . . 0.0 110.497 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.29 158.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 0.0 110.898 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 tt -81.27 114.92 20.39 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.76 0.824 . . . . 0.0 108.962 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.05 -36.03 59.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.188 0.595 . . . . 0.0 110.062 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.48 175.9 38.98 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.756 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 p -110.67 155.23 22.73 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.106 0.962 . . . . 0.0 108.735 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.01 147.05 52.58 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.774 0.429 . . . . 0.0 110.285 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.42 78.56 4.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.797 0.808 . . . . 0.0 109.118 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.642 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -70.43 143.06 36.57 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.186 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -132.79 105.58 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.192 0.597 . . . . 0.0 109.546 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG13 ' HG3' ' A' ' 71' ' ' ARG . 3.8 t -78.65 159.56 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.7 m -63.49 152.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.174 -0.329 . . . . 0.0 111.312 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' HB ' ' A' ' 143' ' ' THR . . . -65.1 -35.56 91.92 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.03 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.34 -15.07 3.44 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.212 1.405 . . . . 0.0 113.269 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.657 HH12 HG22 ' A' ' 77' ' ' VAL . 1.9 tmm_? -56.95 -17.59 10.22 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.206 1.003 . . . . 0.0 112.42 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.4 ' HA ' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -59.07 -41.31 87.68 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 123.062 0.545 . . . . 0.0 110.859 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -72.0 -31.18 65.99 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.251 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 71' ' ' ARG . 46.4 p -95.82 3.56 53.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.793 0.437 . . . . 0.0 111.561 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.9 52.2 0.51 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG23 ' HA ' ' A' ' 140' ' ' ASN . 3.1 m -48.91 152.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 118.334 1.067 . . . . 0.0 113.186 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.657 HG22 HH12 ' A' ' 71' ' ' ARG . 28.8 m -114.47 164.7 10.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.884 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -84.39 -169.17 2.48 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.548 0.739 . . . . 0.0 111.231 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.66 157.89 37.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.64 0.776 . . . . 0.0 111.279 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 67.88 8.08 6.2 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.122 0.969 . . . . 0.0 112.186 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.635 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.6 mm-40 -76.93 140.63 40.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.482 0.658 . . . . 0.0 111.132 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.473 ' HG2' HG21 ' A' ' 133' ' ' VAL . 78.9 mtp -107.2 149.49 27.65 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 132' ' ' GLY . 13.4 m -132.04 163.5 37.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.248 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.38 125.71 23.3 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.76 160.38 26.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -157.05 126.75 6.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.002 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' A' ' 95' ' ' LYS . 64.7 ttp85 -67.34 130.76 44.11 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.2 117.6 21.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 123.628 0.58 . . . . 0.0 110.733 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.35 -39.88 34.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.33 2.02 . . . . 0.0 110.237 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.26 76.1 3.42 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 7.5 p30 -67.4 127.9 93.54 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.968 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.54 -39.39 28.22 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.998 2.465 . . . . 0.0 113.021 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -127.35 -50.97 1.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.764 0.426 . . . . 0.0 110.43 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 8.8 p30 -150.38 170.58 18.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 110.031 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -64.9 -8.24 14.67 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.459 1.103 . . . . 0.0 113.09 -173.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.26 -12.25 39.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.587 0.755 . . . . 0.0 112.567 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 109.4 7.57 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.049 0.54 . . . . 0.0 110.303 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.7 mt -118.8 115.82 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' HZ1' ' HB3' ' A' ' 107' ' ' GLN . 19.2 pttp -85.22 163.21 18.82 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.467 0.651 . . . . 0.0 110.223 172.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.53 121.32 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.5 1.12 . . . . 0.0 109.237 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -109.76 130.97 55.46 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -75.85 -170.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.932 0.787 . . . . 0.0 110.994 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.43 -33.78 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.894 0.878 . . . . 0.0 112.87 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.13 -31.62 34.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.818 0.447 . . . . 0.0 110.885 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.49 6.4 25.34 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 116.323 -0.399 . . . . 0.0 113.266 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -66.7 119.25 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.858 0.863 . . . . 0.0 110.251 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.408 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 15.3 pt20 -72.8 90.16 1.41 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.828 0.823 . . . . 0.0 110.279 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.5 -14.19 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.988 1.315 . . . . 0.0 113.307 -172.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.13 -157.4 27.62 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 118.024 0.375 . . . . 0.0 112.363 -176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -132.15 149.43 52.4 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.47 0.708 . . . . 0.0 110.269 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.622 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . 71.5 mt -76.23 -0.85 23.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.685 0.794 . . . . 0.0 113.004 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.5 tttt 71.45 130.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -19.21 5.99 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.597 1.159 . . . . 0.0 113.865 -170.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.461 ' HG3' ' HE1' ' A' ' 167' ' ' HIS . 12.2 tp10 -67.01 -55.09 15.9 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.481 0.713 . . . . 0.0 111.395 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.69 -44.97 12.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.354 0.662 . . . . 0.0 110.184 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' A' ' 111' ' ' LEU . . . -61.89 -24.28 66.84 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.179 0.991 . . . . 0.0 111.967 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.64 64.62 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.17 0.294 . . . . 0.0 113.538 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -65.97 -44.5 84.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.53 -16.41 56.02 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.742 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.475 ' HA ' HD13 ' A' ' 98' ' ' ILE . . . -56.53 -44.75 81.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 112.053 -174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -70.58 -32.74 70.25 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.09 0.869 . . . . 0.0 110.298 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 160' ' ' VAL . 62.5 mt -65.36 -41.63 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.194 0.598 . . . . 0.0 110.02 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.45 -37.93 50.5 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.918 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.35 -42.9 58.6 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.485 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -98.02 6.38 47.7 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.396 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.37 34.72 20.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.702 1.201 . . . . 0.0 111.654 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.0 -43.44 95.66 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.484 0.714 . . . . 0.0 111.231 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.2 159.93 26.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.071 0.549 . . . . 0.0 111.109 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.8 mt -129.69 118.5 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.47 166.18 18.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.96 102.37 0.24 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.473 HG21 ' HG2' ' A' ' 82' ' ' MET . 43.0 t -103.58 114.96 44.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.552 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.9 p -101.3 91.29 2.01 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.263 1.025 . . . . 0.0 108.71 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 2.7 Cg_exo -78.54 -23.92 8.03 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.128 2.552 . . . . 0.0 112.93 -172.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.414 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 81.1 m-85 -89.26 -28.82 19.66 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.21 0.604 . . . . 0.0 110.926 -176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.56 62.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 113.863 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.08 -2.38 33.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.631 0.772 . . . . 0.0 112.347 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -24.69 65.44 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.441 ' HA ' HG23 ' A' ' 76' ' ' VAL . 55.6 t30 -57.28 -34.3 68.52 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.056 0.942 . . . . 0.0 111.262 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.78 53.25 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.133 0.573 . . . . 0.0 110.816 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -167.99 -66.3 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.46 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 8.9 t -160.32 169.06 23.92 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.693 0.797 . . . . 0.0 110.17 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.552 ' SD ' HG23 ' A' ' 134' ' ' VAL . 5.5 ppp? -167.34 156.28 9.16 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.289 1.036 . . . . 0.0 109.484 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.1 Cg_endo -76.63 120.45 5.55 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.418 1.412 . . . . 0.0 112.063 170.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -102.73 149.4 24.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -85.39 108.2 17.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -171.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.642 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 38.1 mtp -107.36 116.38 31.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.316 0.646 . . . . 0.0 109.873 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.7 p -113.06 126.49 55.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.763 0.425 . . . . 0.0 110.008 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -92.19 115.32 27.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.685 0.794 . . . . 0.0 109.537 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -114.54 110.97 20.63 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.503 1.121 . . . . 0.0 109.724 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.52 168.74 38.29 Favored Glycine 0 C--O 1.236 0.235 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -63.47 152.25 38.92 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.207 1.003 . . . . 0.0 111.304 -178.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.72 -27.78 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.065 0.946 . . . . 0.0 113.511 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 153' ' ' LYS . 12.8 pt-20 -78.08 -28.21 48.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.89 -5.02 46.74 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.797 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -59.01 -41.91 88.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.754 0.422 . . . . 0.0 110.228 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -70.49 -27.75 64.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.444 0.697 . . . . 0.0 111.738 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.71 -45.03 60.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.589 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 122' ' ' ILE . 70.4 t -64.41 -40.97 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.31 1.044 . . . . 0.0 111.14 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.4 m -58.58 -45.07 89.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.075 0.95 . . . . 0.0 110.62 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.14 -41.4 71.71 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.878 0.871 . . . . 0.0 111.542 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.2 mm100 -75.34 -27.26 59.15 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.038 -174.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 76.1 mt -73.0 -44.26 61.22 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.824 173.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.46 -28.63 67.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.404 1.082 . . . . 0.0 111.356 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.57 -50.12 70.9 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.094 0.958 . . . . 0.0 111.34 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . 0.461 ' HE1' ' HG3' ' A' ' 114' ' ' GLU . 20.6 t60 -81.43 -28.14 34.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.363 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.49 12.02 10.01 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-O 119.87 -0.406 . . . . 0.0 113.332 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.592 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 46.8 m-85 -70.09 168.23 16.01 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.231 0.612 . . . . 0.0 111.331 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 160.45 23.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.619 1.168 . . . . 0.0 112.475 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 126.941 2.097 . . . . 0.0 109.111 178.047 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 p -70.44 -34.66 72.72 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.081 0.552 . . . . 0.0 110.752 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -65.41 -24.06 67.11 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.242 1.017 . . . . 0.0 111.563 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.389 1.076 . . . . 0.0 112.528 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.41 -33.24 73.36 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.555 0.342 . . . . 0.0 111.246 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.88 -35.3 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.601 0.761 . . . . 0.0 109.474 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.35 -17.58 63.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.194 0.997 . . . . 0.0 111.104 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -73.71 116.66 14.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.313 0.645 . . . . 0.0 109.863 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.86 165.83 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.526 1.13 . . . . 0.0 110.859 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 149' ' ' THR . 24.6 tp -82.13 121.67 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.873 0.469 . . . . 0.0 110.177 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.429 ' HE2' ' HB1' ' A' ' 128' ' ' ALA . 19.7 m-85 -86.87 -38.58 16.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.169 0.588 . . . . 0.0 110.088 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 -172.18 28.92 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.724 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -112.6 166.5 11.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.464 0.706 . . . . 0.0 111.363 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HB2' ' HE2' ' A' ' 150' ' ' PHE . 33.8 tp -145.32 150.6 36.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.933 0.893 . . . . 0.0 109.319 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -75.94 98.36 4.22 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.418 0.628 . . . . 0.0 109.964 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.09 73.98 2.5 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 52.9 t-80 -65.62 85.82 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.981 0.912 . . . . 0.0 110.351 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 111' ' ' LEU . 14.4 m -81.61 144.33 10.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.166 173.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.3 m -65.61 148.07 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.39 175.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.86 -22.12 62.15 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -61.85 -19.12 62.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.929 1.292 . . . . 0.0 111.804 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.465 HH21 HG21 ' A' ' 67' ' ' VAL . 34.4 ptt85 -72.52 0.14 11.18 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.387 1.075 . . . . 0.0 112.549 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -53.85 -35.63 61.71 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.811 0.844 . . . . 0.0 112.658 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -67.86 -23.23 65.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.884 0.874 . . . . 0.0 111.641 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -73.02 -24.18 60.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.072 0.549 . . . . 0.0 111.023 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.82 49.11 0.52 Allowed Glycine 0 C--N 1.354 1.533 0 O-C-N 122.309 -0.244 . . . . 0.0 113.49 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.624 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 43.4 t -63.47 160.09 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.634 0.774 . . . . 0.0 111.747 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.06 157.05 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.454 1.102 . . . . 0.0 109.3 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -78.91 -164.64 0.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.989 0.916 . . . . 0.0 113.024 -165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -67.05 145.89 54.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.691 0.797 . . . . 0.0 110.825 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 73.72 -15.52 0.57 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.198 1.399 . . . . 0.0 112.713 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -73.2 130.02 39.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.57 0.748 . . . . 0.0 111.113 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 79.7 mtp -84.77 149.42 25.76 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.068 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.4 m -134.75 -170.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.709 1.204 . . . . 0.0 109.836 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.92 154.5 22.08 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.595 1.158 . . . . 0.0 108.432 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.49 HD22 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -99.15 146.83 25.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.909 0.385 . . . . 0.0 110.817 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -155.83 127.77 7.49 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 108.845 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -63.05 142.23 58.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 174.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.24 110.79 2.83 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.753 0.821 . . . . 0.0 110.347 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -31.61 44.84 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.488 2.125 . . . . 0.0 111.271 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.27 68.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 170.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 6.9 p30 -74.85 119.03 74.82 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.059 0.544 . . . . 0.0 110.551 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 15.4 Cg_exo -69.61 -38.68 7.79 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 0.0 113.554 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -119.88 -51.39 2.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.304 0.641 . . . . 0.0 111.677 -167.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.25 146.82 35.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.375 0.67 . . . . 0.0 109.792 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HB2' HH21 ' A' ' 87' ' ' ARG . 14.7 ptmm? -74.05 -5.1 39.47 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.932 0.893 . . . . 0.0 111.1 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 85.9 m-20 -76.63 -6.03 50.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.204 1.002 . . . . 0.0 111.98 171.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -71.03 125.56 27.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.081 0.952 . . . . 0.0 110.646 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.9 mt -123.65 120.18 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.64 0.776 . . . . 0.0 110.657 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 39.5 mttp -77.7 162.79 26.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.554 1.141 . . . . 0.0 111.009 167.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.3 t -123.3 127.02 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -122.32 144.22 49.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.622 1.169 . . . . 0.0 108.737 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -74.29 179.01 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.883 0.765 . . . . 0.0 112.285 177.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.85 -25.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.167 0.987 . . . . 0.0 113.492 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -73.16 -17.2 61.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.376 0.67 . . . . 0.0 110.968 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.81 37.25 10.49 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.825 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.466 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.8 t-20 -121.99 131.47 54.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.573 0.749 . . . . 0.0 109.185 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.92 104.76 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 124.167 0.917 . . . . 0.0 111.16 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 28.8 m -87.5 -0.24 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.012 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 151.89 -159.24 28.21 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.457 -0.338 . . . . 0.0 113.057 170.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 64.0 t60 -122.83 150.11 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.3 tt -75.07 -57.07 4.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.122 0.169 . . . . 0.0 111.006 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.3 tptt 142.53 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -162.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -22.5 62.43 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.777 1.171 . . . . 0.0 112.192 -175.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.78 -47.56 68.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.289 1.035 . . . . 0.0 110.571 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.9 tt -72.04 -48.69 42.66 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.434 0.694 . . . . 0.0 109.273 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -21.91 65.9 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.041 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.8 -28.36 60.3 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 123.296 0.373 . . . . 0.0 113.691 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.13 -56.26 4.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.315 0.646 . . . . 0.0 109.896 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.67 -16.5 61.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.059 0.944 . . . . 0.0 112.396 -175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 96' ' ' ASN . . . -54.32 -51.22 65.36 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.518 1.527 . . . . 0.0 112.046 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -70.07 -30.55 67.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.35 1.031 . . . . 0.0 110.618 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.49 ' HA ' HD13 ' A' ' 127' ' ' LEU . 60.2 mt -67.79 -34.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.22 0.608 . . . . 0.0 110.143 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -80.8 -33.22 34.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.068 0.947 . . . . 0.0 110.723 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.85 -40.34 54.92 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.505 1.122 . . . . 0.0 111.467 -173.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.08 -2.38 40.27 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.221 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 57.84 41.58 24.6 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.236 1.015 . . . . 0.0 111.03 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 122' ' ' ILE . 82.1 mt -61.3 -43.95 98.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.436 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.429 ' HB1' ' HE2' ' A' ' 60' ' ' PHE . . . -149.66 138.37 20.93 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.246 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.92 105.24 5.86 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.59 104.69 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.11 176.28 9.34 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.589 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.59 158.97 27.89 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.61 -0.268 . . . . 0.0 112.522 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 55.6 t -148.38 129.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.552 HG22 HD23 ' A' ' 146' ' ' LEU . 21.8 t -96.68 93.41 1.36 Allowed Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 7.1 Cg_exo -74.25 -49.24 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.404 2.069 . . . . 0.0 112.24 -171.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.88 -27.48 33.44 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.563 0.745 . . . . 0.0 111.263 -172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.66 60.64 Favored Glycine 0 C--N 1.354 1.551 0 O-C-N 123.465 0.478 . . . . 0.0 114.27 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.99 9.27 10.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.415 0.686 . . . . 0.0 112.694 -170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.71 -20.5 66.36 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.611 0.765 . . . . 0.0 111.659 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.23 -47.96 82.07 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 0.0 110.077 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.61 -53.99 4.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.492 0.717 . . . . 0.0 111.747 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -146.88 -165.77 2.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.665 0.786 . . . . 0.0 111.504 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -95.94 122.73 39.06 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.809 0.844 . . . . 0.0 109.662 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -131.66 147.02 64.37 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.271 0.628 . . . . 0.0 111.223 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 88.2 Cg_endo -79.2 125.5 6.47 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.52 2.146 . . . . 0.0 112.252 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.552 HD23 HG22 ' A' ' 134' ' ' VAL . 3.3 pp -100.37 154.59 18.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.21 107.48 4.24 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.333 0.653 . . . . 0.0 110.559 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.49 ' SD ' HD22 ' A' ' 85' ' ' LEU . 62.3 mtt -107.12 149.66 27.41 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.404 HG21 HD13 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -144.34 135.97 25.83 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -171.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.473 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 83.1 m-85 -99.53 123.56 43.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.241 1.016 . . . . 0.0 110.655 -174.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.68 105.25 7.69 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.1 0.96 . . . . 0.0 108.561 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.78 166.76 35.09 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -58.37 143.13 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.77 -41.04 61.33 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.068 0.947 . . . . 0.0 113.135 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.57 -21.11 66.61 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.37 -3.51 56.66 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.731 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -61.65 -32.25 72.4 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.146 0.885 . . . . 0.0 111.162 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.37 -46.68 85.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.751 0.82 . . . . 0.0 109.754 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.44 -30.59 60.06 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.652 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG12 HD13 ' A' ' 122' ' ' ILE . 53.7 t -67.01 -49.71 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.535 0.734 . . . . 0.0 109.235 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.6 t -61.45 -34.14 74.93 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.449 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.1 t70 -55.54 -47.84 75.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.17 0.588 . . . . 0.0 110.43 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -66.89 -41.27 87.48 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 124.774 1.296 . . . . 0.0 111.578 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -62.39 1.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.797 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -57.05 -33.4 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.321 1.048 . . . . 0.0 111.846 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 20.9 ttmm -55.55 -53.3 58.1 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.333 1.053 . . . . 0.0 111.394 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.97 -16.29 38.83 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.435 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.79 26.76 7.83 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.626 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -78.61 177.78 8.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.536 0.734 . . . . 0.0 110.126 168.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -48.03 145.34 3.11 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.211 1.004 . . . . 0.0 110.672 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.526 HD21 ' H ' ' A' ' 171' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.576 1.959 0 C-N-CA 124.987 1.315 . . . . 0.0 113.23 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 m -75.22 -0.94 21.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.16 0.984 . . . . 0.0 112.221 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -74.86 -24.85 58.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.248 1.019 . . . . 0.0 111.529 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -60.88 -44.78 96.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.577 0.751 . . . . 0.0 112.296 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.18 -33.32 74.23 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.116 0.566 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -72.34 -27.48 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.446 1.098 . . . . 0.0 110.038 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -85.93 -26.12 25.72 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.426 1.09 . . . . 0.0 110.645 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 153' ' ' LYS . 70.2 m -82.15 135.36 35.29 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 110.835 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.13 164.17 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.08 1.352 . . . . 0.0 110.763 -172.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.408 HD11 HG23 ' A' ' 149' ' ' THR . 18.7 tp -87.55 112.62 22.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.082 0.553 . . . . 0.0 110.362 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 24.6 m-85 -78.17 -37.83 44.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.518 0.727 . . . . 0.0 111.408 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.85 -154.3 25.42 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -133.8 179.89 5.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.327 0.651 . . . . 0.0 111.176 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 171' ' ' LEU . 50.1 tp -158.57 150.75 21.57 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.614 1.165 . . . . 0.0 108.887 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -87.27 101.82 13.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.33 85.81 0.51 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.265 175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -70.35 99.3 1.54 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.52 0.728 . . . . 0.0 109.286 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG22 ' HD3' ' A' ' 71' ' ' ARG . 7.1 p -119.24 131.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.681 0.792 . . . . 0.0 109.825 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 70' ' ' LEU . 65.1 t -56.93 143.41 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.774 1.23 . . . . 0.0 111.719 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.45 66.25 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.496 ' H ' HG12 ' A' ' 68' ' ' VAL . 42.0 tp -61.56 -17.82 56.62 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.069 0.947 . . . . 0.0 111.803 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HD3' HG22 ' A' ' 67' ' ' VAL . 28.6 ptt-85 -63.89 -5.17 4.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.673 1.189 . . . . 0.0 113.442 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -53.33 -35.88 60.69 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.611 0.764 . . . . 0.0 112.616 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.44 -24.83 65.67 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 111.511 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -77.36 -6.57 53.77 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.952 0.901 . . . . 0.0 111.6 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.86 53.2 0.86 Allowed Glycine 0 C--N 1.359 1.834 0 O-C-N 121.81 -0.556 . . . . 0.0 113.301 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.597 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 29.0 m -68.41 171.38 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 24.1 m -114.71 162.1 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.411 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -89.96 -87.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.874 0.469 . . . . 0.0 111.811 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.92 149.23 36.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.847 0.459 . . . . 0.0 111.41 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.0 9.46 3.07 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.31 1.444 . . . . 0.0 113.141 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 56.6 mm-40 -82.11 132.52 35.25 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.904 0.383 . . . . 0.0 111.481 -174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.7 mtm -80.31 132.81 35.87 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.604 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 102' ' ' ASN . 27.0 m -131.66 163.35 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 124.098 0.959 . . . . 0.0 109.141 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.25 24.7 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.892 0.877 . . . . 0.0 108.735 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -85.23 148.79 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.478 0.711 . . . . 0.0 110.026 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.472 ' HA ' ' SD ' ' A' ' 123' ' ' MET . 52.5 tp60 -159.89 137.86 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.842 0.857 . . . . 0.0 108.776 175.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 22.5 ptt85 -66.92 152.48 45.6 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.237 0.541 . . . . 0.0 110.085 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 32.1 t70 -102.33 116.59 62.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.825 -168.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.92 -18.0 41.23 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.855 2.37 . . . . 0.0 112.808 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.03 15.64 4.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.259 0.623 . . . . 0.0 110.644 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -53.98 128.22 55.5 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.643 0.777 . . . . 0.0 111.461 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.37 -26.89 1.24 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.326 2.018 . . . . 0.0 113.793 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -108.68 -52.18 2.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.136 0.574 . . . . 0.0 110.934 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -166.67 157.56 12.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.307 0.643 . . . . 0.0 109.671 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HB2' HH11 ' A' ' 87' ' ' ARG . 16.5 ptpt -62.35 -7.79 4.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.228 1.411 . . . . 0.0 112.81 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -54.04 -32.48 54.59 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.278 1.031 . . . . 0.0 112.232 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.89 109.15 1.36 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.402 0.439 . . . . 0.0 110.181 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.5 mt -107.92 149.59 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.634 1.174 . . . . 0.0 108.231 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -122.29 144.44 48.99 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.53 0.681 . . . . 0.0 110.972 171.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -77.83 130.38 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.155 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 23.2 m-80 -114.95 144.14 44.05 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.603 0.761 . . . . 0.0 109.124 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -77.31 -169.69 1.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.445 0.566 . . . . 0.0 111.123 177.006 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.85 -25.87 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.188 0.595 . . . . 0.0 112.468 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 24.8 t-20 -74.58 -21.1 59.66 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.213 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.26 5.0 64.05 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.601 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.5 125.51 31.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.128 0.971 . . . . 0.0 108.781 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 12.0 pt20 -67.26 126.68 30.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.175 0.512 . . . . 0.0 111.701 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 16.9 m -89.47 -23.13 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.968 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 71' ' ' ARG . . . 165.06 165.27 22.07 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 99' ' ' LYS . 23.1 m170 -92.0 150.87 20.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.091 0.956 . . . . 0.0 111.403 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' HE2' ' A' ' 148' ' ' MET . 29.8 mt -96.37 29.78 2.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.602 1.561 . . . . 0.0 112.316 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 65.09 -172.1 0.18 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.775 0.83 . . . . 0.0 110.737 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -80.42 -49.35 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.944 0.498 . . . . 0.0 110.839 171.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.38 -57.35 9.56 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.817 -166.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 169' ' ' PHE . 10.1 tt -67.67 -47.15 70.32 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.859 0.838 . . . . 0.0 109.314 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.55 70.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.591 -1.641 . . . . 0.0 111.675 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.9 -38.85 94.65 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.544 0.527 . . . . 0.0 114.078 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -51.97 49.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.225 0.536 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.11 -16.83 64.17 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.928 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -61.32 -38.44 86.87 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.378 1.071 . . . . 0.0 112.887 -177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -71.36 -33.71 69.81 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.485 HD12 HG11 ' A' ' 160' ' ' VAL . 44.2 mt -68.66 -34.95 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.484 0.714 . . . . 0.0 110.322 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . 0.472 ' SD ' ' HA ' ' A' ' 86' ' ' GLN . 38.4 tpp -79.84 -52.26 8.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.095 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.54 -45.17 91.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.679 1.192 . . . . 0.0 110.654 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.86 2.76 54.6 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.59 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 126' ' ' LYS . 3.0 mmmp? 56.35 36.93 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.308 1.043 . . . . 0.0 111.886 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.9 mt -65.86 -43.93 86.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.837 0.855 . . . . 0.0 111.322 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -148.71 140.27 23.5 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.477 0.711 . . . . 0.0 110.603 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.97 102.91 6.62 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -89.07 106.22 16.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.14 179.84 5.46 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.875 0.87 . . . . 0.0 109.382 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -162.96 172.97 39.11 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.634 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 78.0 t -149.28 138.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 107.512 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.36 90.76 1.49 Allowed Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.76 -23.53 2.59 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.054 1.836 . . . . 0.0 113.871 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -77.87 -28.73 50.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.379 0.672 . . . . 0.0 112.49 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.12 31.2 75.9 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 123.229 0.33 . . . . 0.0 113.771 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 144' ' ' MET . . . -85.6 17.13 3.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.04 0.936 . . . . 0.0 111.655 -178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.3 -26.24 68.31 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.624 1.17 . . . . 0.0 111.72 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.01 -37.0 69.88 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.553 0.741 . . . . 0.0 110.914 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.07 -64.64 0.82 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.652 0.381 . . . . 0.0 110.362 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 37.6 t80 171.75 -89.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.304 1.442 . . . . 0.0 108.497 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 62.6 m -103.24 144.64 31.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.184 0.994 . . . . 0.0 109.852 -175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 1.4 pmm? -147.79 148.56 30.76 Favored Pre-proline 0 C--O 1.243 0.741 0 C-N-CA 123.308 0.643 . . . . 0.0 109.747 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.7 124.71 4.66 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.023 1.815 . . . . 0.0 109.985 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.2 145.58 27.88 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -74.79 106.81 6.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 85' ' ' LEU . 60.3 mtt -95.67 161.07 14.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.019 0.928 . . . . 0.0 109.554 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.408 HG23 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -150.73 132.4 14.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -171.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 82.3 m-85 -97.66 117.27 31.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.744 0.817 . . . . 0.0 109.911 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -124.31 115.78 21.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.53 168.41 40.55 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -65.83 147.01 54.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.435 0.636 . . . . 0.0 112.693 -173.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -53.64 -32.5 51.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.406 1.482 . . . . 0.0 114.083 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.43 -23.93 60.18 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.902 0.481 . . . . 0.0 111.608 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -92.55 3.26 55.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.294 0.637 . . . . 0.0 111.722 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.37 76.48 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.091 0.556 . . . . 0.0 111.919 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -35.36 69.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.25 0.62 . . . . 0.0 110.872 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -78.11 -41.14 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.443 0.697 . . . . 0.0 110.63 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.485 HG11 HD12 ' A' ' 122' ' ' ILE . 78.1 t -61.12 -47.97 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.834 0.854 . . . . 0.0 110.347 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.4 m -73.11 -24.26 60.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.675 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.52 -39.81 95.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.83 0.452 . . . . 0.0 110.5 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.3 mm100 -64.47 -35.11 79.86 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.666 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.18 -40.23 59.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.653 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.492 ' HB2' ' HZ2' ' A' ' 165' ' ' LYS . 10.3 mtmp? -67.06 -38.43 85.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.851 0.461 . . . . 0.0 110.908 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -59.47 -43.11 93.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.118 0.967 . . . . 0.0 111.691 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -96.78 -26.73 15.03 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.13 21.65 10.7 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.259 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 115' ' ' LEU . 67.3 m-85 -66.65 144.36 56.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.662 . . . . 0.0 110.462 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.0 152.89 28.68 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.968 173.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 28.2 m -85.99 -13.49 47.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.233 0.613 . . . . 0.0 111.888 173.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.24 -14.37 55.18 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.693 0.797 . . . . 0.0 112.982 -174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HG3' ' HZ3' ' A' ' 153' ' ' LYS . 3.0 mp0 -55.25 -47.59 75.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.275 1.03 . . . . 0.0 111.629 171.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 51' ' ' SER . 11.1 pt-20 -72.76 -27.81 62.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.26 0.224 . . . . 0.0 111.338 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.52 -35.09 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.535 0.734 . . . . 0.0 109.619 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.5 t70 -76.4 -12.53 60.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.718 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -67.64 114.89 6.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.303 0.641 . . . . 0.0 111.685 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 56' ' ' ASP . 23.9 m -119.5 160.95 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.996 1.318 . . . . 0.0 110.821 -174.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.4 tp -81.37 112.41 18.63 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 22.2 m-85 -74.39 -29.12 61.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.96 0.504 . . . . 0.0 110.584 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.4 -176.75 29.71 Favored Glycine 0 C--O 1.246 0.851 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.703 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.7 p -110.81 119.83 40.38 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -100.84 133.21 45.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -73.09 96.21 2.16 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -76.48 -179.83 47.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 173.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -139.18 110.32 6.88 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.245 1.023 . . . . 0.0 109.942 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.65 132.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' HA ' HG21 ' A' ' 143' ' ' THR . 93.2 t -82.84 141.27 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.317 0.647 . . . . 0.0 109.608 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.31 69.11 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.432 0.458 . . . . 0.0 113.609 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.418 ' H ' HG13 ' A' ' 68' ' ' VAL . 70.8 mt -64.13 -18.69 64.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.005 0.922 . . . . 0.0 111.367 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HD2' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.15 0.65 18.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.828 1.251 . . . . 0.0 112.295 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' A' ' 140' ' ' ASN . 11.1 p90 -55.98 -31.02 62.64 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.252 0.621 . . . . 0.0 111.762 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.36 -20.4 63.84 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.127 0.971 . . . . 0.0 111.91 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -74.97 -25.01 58.54 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.875 0.47 . . . . 0.0 110.059 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.55 50.41 0.45 Allowed Glycine 0 C--N 1.355 1.597 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.487 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.762 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 27.7 m -57.28 168.4 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.55 0.69 . . . . 0.0 112.673 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 m -114.41 166.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.543 -171.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.1 156.85 11.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.609 ' HB3' ' HA3' ' A' ' 137' ' ' GLY . 12.2 p30 -68.14 69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.157 1.383 . . . . 0.0 111.674 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -178.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.396 1.078 . . . . 0.0 109.37 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -65.18 149.41 49.96 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.121 -164.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 81.4 mtp -89.17 149.77 22.99 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.802 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.0 m -121.06 151.64 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.729 0.811 . . . . 0.0 110.933 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 101' ' ' ASN . . . -108.12 166.45 10.73 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.498 1.119 . . . . 0.0 109.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.465 HD11 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -122.68 119.41 30.64 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.564 0.746 . . . . 0.0 109.336 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.01 135.83 50.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.255 1.022 . . . . 0.0 108.985 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.445 HH21 ' HG3' ' A' ' 95' ' ' LYS . 69.1 ttt180 -77.49 125.33 29.17 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.157 0.583 . . . . 0.0 109.882 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' HB3' HD22 ' A' ' 91' ' ' ASN . 15.7 t70 -108.02 115.58 58.35 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 49.7 Cg_endo -83.55 -2.75 10.56 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.948 2.432 . . . . 0.0 114.26 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -107.53 21.63 17.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.267 0.627 . . . . 0.0 111.749 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.509 HD22 ' HB3' ' A' ' 88' ' ' ASP . 50.9 m-80 -86.28 142.22 35.49 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 121.609 -0.682 . . . . 0.0 111.313 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.67 -12.55 33.3 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.063 2.509 . . . . 0.0 112.284 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -77.76 -53.4 7.57 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.131 0.572 . . . . 0.0 109.528 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 170.78 163.91 0.08 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.874 1.359 . . . . 0.0 109.784 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 89' ' ' PRO . 8.3 ptpp? -59.41 -22.55 61.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.345 1.458 . . . . 0.0 113.243 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -78.44 -12.3 60.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.495 0.718 . . . . 0.0 112.885 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.18 110.44 3.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.838 0.455 . . . . 0.0 110.72 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.4 mt -75.86 120.8 26.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 124.012 0.925 . . . . 0.0 110.657 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 5.5 tppp? -75.07 117.14 16.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.02 167.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 111' ' ' LEU . 15.1 t -77.18 130.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 12.8 m120 -112.62 175.73 5.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.01 173.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.9 p30 -110.54 -167.9 1.24 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.713 0.688 . . . . 0.0 109.92 169.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.48 -27.28 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.409 0.683 . . . . 0.0 112.525 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -73.31 -21.86 60.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.723 0.809 . . . . 0.0 110.641 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 -5.58 60.68 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.837 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 131.84 37.49 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.187 0.595 . . . . 0.0 110.746 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.554 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -57.44 127.47 32.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.613 1.165 . . . . 0.0 112.042 177.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.762 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 30.3 m -113.27 -19.52 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 111.228 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.96 -145.93 9.58 Favored Glycine 0 C--N 1.358 1.786 0 C-N-CA 121.594 -0.336 . . . . 0.0 113.756 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -139.96 156.53 46.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.526 1.13 . . . . 0.0 109.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.536 ' HG ' HG22 ' A' ' 100' ' ' VAL . 53.9 mt -93.54 4.84 53.32 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.976 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 69.15 146.3 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.707 1.203 . . . . 0.0 110.815 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.53 17.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.89 -59.43 5.14 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.135 0.974 . . . . 0.0 111.702 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 111' ' ' LEU . 3.9 pp -85.6 -22.03 28.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.615 0.366 . . . . 0.0 111.358 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.8 88.77 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.48 0.712 . . . . 0.0 111.763 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.14 -29.48 74.51 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.851 0.72 . . . . 0.0 112.906 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.58 5.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 109.632 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.26 -15.92 63.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.977 0.911 . . . . 0.0 112.348 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -52.72 -44.92 66.71 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.41 1.084 . . . . 0.0 113.042 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -70.98 -32.23 69.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.911 0.386 . . . . 0.0 110.207 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.36 -35.44 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.421 0.689 . . . . 0.0 110.334 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.6 tpp -79.8 -33.53 40.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.671 1.188 . . . . 0.0 111.065 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.67 -51.14 10.27 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.169 0.988 . . . . 0.0 110.097 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -88.21 2.06 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.845 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 59.42 34.5 22.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.641 1.177 . . . . 0.0 111.354 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.54 -40.65 95.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.915 0.886 . . . . 0.0 111.894 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB1' ' HE1' ' A' ' 60' ' ' PHE . . . -154.73 134.88 13.13 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.474 0.71 . . . . 0.0 110.311 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.67 104.49 12.11 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.08 123.07 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.724 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.05 149.3 42.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.35 174.71 19.2 Favored Glycine 0 C--O 1.239 0.438 0 O-C-N 123.486 0.491 . . . . 0.0 112.869 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 14.4 p -151.18 143.58 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.869 0.868 . . . . 0.0 110.107 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.81 84.66 32.08 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.716 0.807 . . . . 0.0 110.029 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.62 -17.69 12.47 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.87 2.38 . . . . 0.0 112.647 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -83.22 -30.66 27.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.188 0.595 . . . . 0.0 111.174 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 79' ' ' ASN . . . 57.46 34.18 68.17 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.772 0.67 . . . . 0.0 114.339 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.16 0.31 57.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 0.0 110.548 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.87 -9.12 57.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.059 1.344 . . . . 0.0 112.582 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 72' ' ' TYR . 9.4 p30 -102.51 -22.25 14.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.327 0.651 . . . . 0.0 111.206 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.66 -41.53 7.66 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.629 0.772 . . . . 0.0 112.619 -167.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -160.0 -178.3 6.92 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 -164.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 68' ' ' VAL . 22.5 p -90.19 108.75 19.94 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 ptm -112.06 148.87 39.96 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.97 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 96.6 Cg_endo -78.77 146.62 21.1 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.925 1.75 . . . . 0.0 110.14 160.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -137.36 155.61 49.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.022 0.439 . . . . 0.0 110.134 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -74.22 108.08 6.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.118 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 85' ' ' LEU . 24.8 mmt -102.48 153.59 19.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -143.24 124.72 14.78 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.034 0.934 . . . . 0.0 108.853 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.06 117.53 30.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.814 0.846 . . . . 0.0 109.665 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -119.76 100.62 7.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.83 157.28 27.2 Favored Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.498 ' HZ3' ' HG3' ' A' ' 53' ' ' GLU . 13.1 ptmt -61.42 144.44 54.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.751 0.42 . . . . 0.0 111.487 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.32 -34.38 57.19 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.83 -30.31 70.75 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.144 0.429 . . . . 0.0 111.961 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -85.74 -9.84 56.51 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.422 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.9 ppt_? -60.69 -29.25 69.2 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 118.899 0.772 . . . . 0.0 112.152 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.99 -37.76 86.03 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.097 0.559 . . . . 0.0 110.536 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.493 ' N ' ' HD2' ' A' ' 158' ' ' LYS . . . -82.68 -46.17 13.56 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.829 0.852 . . . . 0.0 110.505 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.54 -50.61 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.38 1.072 . . . . 0.0 111.458 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.9 p -65.0 -39.25 93.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.905 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.94 -38.9 76.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.981 0.912 . . . . 0.0 111.632 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.5 mm100 -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.377 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.58 -56.72 7.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.189 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -55.03 -32.16 61.63 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.336 1.454 . . . . 0.0 112.128 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.15 -39.03 77.75 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -107.16 -11.52 15.59 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.429 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.75 42.17 6.51 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.639 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.83 137.21 38.61 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.455 0.702 . . . . 0.0 110.104 171.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -168.18 151.42 5.73 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 123.631 0.772 . . . . 0.0 111.88 177.879 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.18 0.038 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.84 -42.44 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -76.04 -25.64 55.82 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.3 m -75.72 117.61 17.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.655 0.382 . . . . 0.0 110.022 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 m -116.0 156.64 17.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.556 1.142 . . . . 0.0 111.273 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.26 104.93 11.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -74.29 -33.07 63.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.97 -178.54 33.32 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.554 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -111.01 160.54 16.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.433 0.693 . . . . 0.0 109.926 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.507 HD22 HD21 ' A' ' 119' ' ' LEU . 29.7 tp -126.93 154.24 44.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 110.206 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -99.05 86.14 3.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.126 1.371 . . . . 0.0 108.128 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.98 87.28 0.87 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -70.98 80.6 0.65 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.848 0.859 . . . . 0.0 109.818 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.76 138.1 20.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.4 137.37 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 123.78 0.675 . . . . 0.0 109.654 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 142' ' ' PHE . . . -81.51 -31.17 34.28 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.219 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.5 tp -62.45 -18.81 62.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.978 0.911 . . . . 0.0 111.465 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.488 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 2.7 mmp_? -76.94 0.84 19.55 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.141 0.977 . . . . 0.0 112.582 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HA ' HG13 ' A' ' 76' ' ' VAL . 28.2 p90 -51.11 -34.22 29.64 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.436 1.095 . . . . 0.0 112.37 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -62.96 -34.51 77.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.394 1.078 . . . . 0.0 111.971 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.1 p -78.68 2.33 19.9 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 49.14 0.65 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.952 165.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.729 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 32.7 m -65.66 162.6 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.64 1.22 . . . . 0.0 111.366 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.08 166.5 8.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.92 0.888 . . . . 0.0 110.913 -170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.95 -170.83 2.89 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.797 0.839 . . . . 0.0 112.177 -170.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.11 145.86 55.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.995 0.918 . . . . 0.0 111.592 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 m120 66.25 10.17 6.94 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.326 1.45 . . . . 0.0 113.398 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.13 143.84 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.245 0.618 . . . . 0.0 110.141 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 80.6 mtp -96.65 142.0 29.22 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.5 m -126.2 145.81 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.361 1.064 . . . . 0.0 110.237 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -105.79 153.56 21.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.101 0.96 . . . . 0.0 110.461 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.94 125.97 53.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.584 0.754 . . . . 0.0 109.691 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -140.8 112.86 7.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.718 0.807 . . . . 0.0 109.396 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' HB3' HG12 ' A' ' 98' ' ' ILE . 5.8 ppt_? -87.54 151.35 23.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.52 0.328 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 1.8 m-20 -90.88 149.61 40.57 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 123.59 0.756 . . . . 0.0 111.626 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.92 -43.11 57.35 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.609 2.206 . . . . 0.0 111.634 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -153.38 93.83 1.74 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.685 1.194 . . . . 0.0 108.962 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 13.6 t30 -89.05 151.74 47.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.02 -29.43 44.56 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.618 2.879 . . . . 0.0 113.614 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.51 -51.63 22.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t0 172.1 162.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.366 1.467 . . . . 0.0 108.319 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -65.01 -15.09 61.93 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.64 1.176 . . . . 0.0 112.266 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -87.78 -15.92 35.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.364 0.666 . . . . 0.0 111.881 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.41 118.82 9.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.526 0.73 . . . . 0.0 111.665 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 87' ' ' ARG . 63.1 mt -92.03 120.06 40.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.573 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 34.0 mtmm -81.14 123.4 28.39 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 164.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.27 126.16 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 6.5 p30 -115.29 173.76 6.35 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 124.598 1.159 . . . . 0.0 107.92 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -103.94 -170.38 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 118.666 0.666 . . . . 0.0 110.2 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -57.47 -33.06 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.57 -11.32 59.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.594 0.758 . . . . 0.0 111.564 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.16 14.57 78.81 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.521 -0.308 . . . . 0.0 112.888 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -78.5 120.57 23.4 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.95 0.9 . . . . 0.0 108.586 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.17 99.67 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.517 0.727 . . . . 0.0 109.499 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 23.0 m -71.77 -27.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.199 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.39 176.64 38.34 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.404 0.44 . . . . 0.0 113.41 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.602 ' HD2' ' HG2' ' A' ' 99' ' ' LYS . 31.6 m80 -92.46 133.96 35.41 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 1.3 tt -66.35 -54.08 28.72 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.68 0.612 . . . . 0.0 110.307 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 53.9 mmtt 150.85 133.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 -160.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -70.86 -42.02 70.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.06 -52.03 65.59 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.128 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.84 -40.46 91.75 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.178 0.591 . . . . 0.0 110.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.03 69.85 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.239 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.79 -31.79 64.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.5 0.5 . . . . 0.0 113.125 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.58 5.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.552 0.741 . . . . 0.0 110.414 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 63' ' ' LEU . 21.1 mt -73.3 -18.58 61.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -170.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.78 -29.7 65.97 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.412 0.685 . . . . 0.0 110.885 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.86 -35.33 64.74 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 127' ' ' LEU . 58.8 mt -70.86 -33.64 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.275 0.63 . . . . 0.0 110.765 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.2 tpp -74.34 -56.2 5.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.419 1.088 . . . . 0.0 110.659 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.38 -44.78 62.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.267 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.33 5.07 32.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.695 0.398 . . . . 0.0 111.403 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 60.98 33.54 19.72 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.377 1.071 . . . . 0.0 112.592 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HB2' HG23 ' A' ' 122' ' ' ILE . 64.2 mt -67.68 -38.56 83.89 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.662 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -166.67 145.89 5.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 111.173 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -78.26 116.87 19.0 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.998 0.919 . . . . 0.0 109.279 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -98.92 112.83 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.144 0.578 . . . . 0.0 109.812 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 10.9 pt-20 -83.41 167.66 17.29 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -143.27 152.34 23.98 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 35.5 t -149.16 128.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.475 1.11 . . . . 0.0 108.479 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.31 96.69 1.32 Allowed Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 123.646 0.778 . . . . 0.0 109.449 167.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.39 -31.34 9.22 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.591 2.194 . . . . 0.0 113.316 -176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.09 -20.94 12.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.989 0.916 . . . . 0.0 110.916 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.87 29.96 75.74 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.34 0.4 . . . . 0.0 113.468 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -76.79 3.24 12.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.953 0.901 . . . . 0.0 113.315 -170.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -67.43 -26.63 66.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.171 0.589 . . . . 0.0 110.274 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.84 -37.46 73.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.694 0.797 . . . . 0.0 110.569 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.14 -55.23 9.92 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.695 0.798 . . . . 0.0 110.867 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 74.7 t80 -151.34 -77.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 p -158.3 165.76 33.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.012 1.725 . . . . 0.0 107.85 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 14.3 ptt? -167.12 152.37 7.15 Favored Pre-proline 0 C--O 1.246 0.921 0 O-C-N 123.43 0.456 . . . . 0.0 110.398 168.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.67 126.44 10.81 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.996 1.797 . . . . 0.0 110.339 162.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.59 156.23 16.9 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.984 0.514 . . . . 0.0 109.959 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.44 107.02 3.17 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.373 0.42 . . . . 0.0 110.305 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.463 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 65.4 mtt -104.07 160.26 14.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 131' ' ' GLU . 19.2 m -154.34 143.3 21.06 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.477 0.58 . . . . 0.0 110.029 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 76.6 m-85 -104.19 117.8 35.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.28 1.032 . . . . 0.0 109.851 -174.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -121.04 100.62 7.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.276 1.03 . . . . 0.0 108.811 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.52 167.67 33.07 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -65.69 147.87 52.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.12 -19.88 48.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.681 1.192 . . . . 0.0 114.046 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.0 -22.08 56.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -93.06 -0.19 57.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.083 0.553 . . . . 0.0 112.478 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 7.6 ppt_? -52.83 -38.11 60.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -79.98 -27.62 39.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.793 0.437 . . . . 0.0 110.79 -175.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.96 55.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.424 0.69 . . . . 0.0 110.752 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.83 -51.79 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.885 0.874 . . . . 0.0 110.133 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.3 p -65.89 -30.41 71.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.589 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -54.89 -42.54 72.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.898 0.879 . . . . 0.0 111.728 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -67.68 -34.41 76.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.299 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.28 -45.39 55.88 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.913 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -61.12 -31.73 71.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.03 1.332 . . . . 0.0 111.372 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -58.34 -42.35 86.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.804 1.242 . . . . 0.0 111.296 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -97.62 -15.05 20.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.099 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.32 19.18 31.06 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 113.585 0.194 . . . . 0.0 113.585 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 123.717 0.807 . . . . 0.0 110.997 171.24 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.655 0.264 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.53 -33.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.384 0.674 . . . . 0.0 109.561 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.38 -25.71 59.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.015 0.926 . . . . 0.0 110.411 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -72.47 134.83 45.53 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.071 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.5 158.53 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.384 1.073 . . . . 0.0 110.469 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.73 102.6 12.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.436 1.094 . . . . 0.0 108.292 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 41.8 m-85 -74.44 -23.24 58.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.108 0.563 . . . . 0.0 111.422 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.35 177.2 14.76 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.032 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -111.22 120.6 42.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.171 0.588 . . . . 0.0 110.267 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -86.76 137.71 32.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.539 1.136 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 100.73 4.13 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -90.73 -170.84 43.43 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 166.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -165.43 127.04 2.0 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 100' ' ' VAL . 48.1 t -98.59 134.63 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 70' ' ' LEU . 23.7 t -69.98 143.93 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 O-C-N 123.92 0.763 . . . . 0.0 110.325 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.39 -22.52 78.58 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.233 0.333 . . . . 0.0 113.008 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' H ' HG12 ' A' ' 68' ' ' VAL . 35.0 tp -62.77 -18.15 62.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.429 1.092 . . . . 0.0 111.379 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 3.5 mmp_? -76.66 1.77 16.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.957 0.903 . . . . 0.0 112.823 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 76' ' ' VAL . 86.7 t80 -48.69 -36.63 16.56 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.92 0.888 . . . . 0.0 112.546 174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -62.44 -40.91 98.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.703 0.801 . . . . 0.0 111.609 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 p -78.51 -4.5 48.87 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.03 49.67 1.45 Allowed Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 72' ' ' TYR . 17.4 m -53.55 164.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG23 HG21 ' A' ' 134' ' ' VAL . 14.8 m -114.6 163.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.792 -164.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -92.52 -166.37 1.53 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.996 1.318 . . . . 0.0 111.266 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.17 147.13 48.65 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.496 0.718 . . . . 0.0 111.6 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 63.98 8.87 4.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 0.0 113.637 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -77.04 136.91 38.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.977 0.418 . . . . 0.0 110.31 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.541 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.8 mtp -100.24 150.08 22.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.163 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 102' ' ' ASN . 29.8 m -135.11 174.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.537 1.135 . . . . 0.0 109.553 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.33 133.7 16.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 107.714 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -84.62 146.34 27.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.17 0.588 . . . . 0.0 109.986 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -151.2 130.31 12.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.141 0.977 . . . . 0.0 108.598 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' A' ' 95' ' ' LYS . 34.1 ptt85 -74.27 146.81 42.93 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -80.46 118.04 70.56 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.101 0.561 . . . . 0.0 110.894 -167.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 -32.63 24.86 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.14 2.56 . . . . 0.0 112.187 173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.75 33.95 2.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.913 0.885 . . . . 0.0 109.925 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -53.89 119.0 17.02 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.586 1.154 . . . . 0.0 112.987 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.88 -28.27 16.72 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.961 2.441 . . . . 0.0 113.155 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -116.45 -51.68 2.59 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.38 0.672 . . . . 0.0 111.328 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -167.67 155.64 8.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.841 0.456 . . . . 0.0 110.651 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HB2' HH11 ' A' ' 87' ' ' ARG . 8.3 ptpp? -53.43 -23.17 9.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.179 1.791 . . . . 0.0 113.373 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 81.2 m-20 -78.98 18.86 0.58 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.775 0.83 . . . . 0.0 112.796 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.04 111.66 23.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 108.948 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 120' ' ' ALA . 29.7 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 123.592 0.757 . . . . 0.0 110.513 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 16.5 ptpt -85.66 164.37 17.72 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.503 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 67' ' ' VAL . 60.7 t -117.27 117.34 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -110.25 131.39 55.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.936 0.894 . . . . 0.0 108.816 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' HG12 ' A' ' 83' ' ' VAL . 26.3 p-10 -75.71 -168.92 0.94 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 118.307 0.503 . . . . 0.0 111.507 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -52.11 -33.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 124.4 1.08 . . . . 0.0 112.96 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.24 -20.32 25.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.178 0.591 . . . . 0.0 111.553 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.53 4.2 54.92 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-N 116.447 -0.342 . . . . 0.0 112.843 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -63.15 127.46 31.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 110.061 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -77.3 92.16 3.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.925 0.89 . . . . 0.0 109.863 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 4.9 m -75.49 -14.89 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.231 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.24 -143.57 10.69 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 123.587 0.554 . . . . 0.0 112.426 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 51.9 m80 -135.83 166.75 22.57 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.407 1.083 . . . . 0.0 108.461 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 148' ' ' MET . 5.2 mp -78.13 -53.13 7.71 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.557 0.694 . . . . 0.0 109.819 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 170.72 166.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 127.013 2.125 . . . . 0.0 106.771 -167.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -78.67 -44.98 22.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HB3' ' NE2' ' A' ' 167' ' ' HIS . 19.5 mm-40 -66.74 -45.33 78.95 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.85 0.86 . . . . 0.0 111.935 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 65' ' ' GLY . 1.5 tt -64.4 -44.03 92.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.525 0.73 . . . . 0.0 110.007 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.16 85.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.645 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -59.63 -30.33 68.6 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.97 0.793 . . . . 0.0 113.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -73.1 -61.29 1.87 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.394 0.678 . . . . 0.0 110.058 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.12 -15.79 63.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.932 0.893 . . . . 0.0 113.202 -171.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -59.12 -39.55 82.63 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.413 1.085 . . . . 0.0 113.168 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.01 -32.95 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.079 0.552 . . . . 0.0 110.241 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.449 ' HA ' HD12 ' A' ' 127' ' ' LEU . 68.5 mt -66.78 -33.9 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.551 0.74 . . . . 0.0 110.081 174.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.4 tpp -78.01 -38.99 43.58 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.19 -47.66 34.21 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.196 0.998 . . . . 0.0 110.406 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.71 -1.49 58.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.099 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.87 31.45 18.24 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.264 1.025 . . . . 0.0 111.532 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 122' ' ' ILE . 77.6 mt -58.52 -43.62 89.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.157 0.983 . . . . 0.0 111.845 -174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.72 131.53 11.6 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.972 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.17 107.19 13.76 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.494 1.118 . . . . 0.0 108.492 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.1 mt -93.35 111.36 24.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.236 0.615 . . . . 0.0 109.948 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.92 179.7 7.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.801 0.84 . . . . 0.0 109.156 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.26 156.34 27.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 82' ' ' MET . 38.8 t -141.76 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.949 0.9 . . . . 0.0 109.69 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.521 HG13 ' HG ' ' A' ' 146' ' ' LEU . 1.7 m -103.73 94.99 6.83 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.447 1.099 . . . . 0.0 108.622 166.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.09 -48.76 3.27 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.537 2.158 . . . . 0.0 111.927 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.78 -27.79 40.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.604 0.762 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' ' HB ' ' A' ' 134' ' ' VAL . . . 63.6 30.08 76.58 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 113.733 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.07 -1.25 19.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.14 0.976 . . . . 0.0 111.507 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.63 -26.93 66.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.724 0.81 . . . . 0.0 111.09 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 9.9 t-20 -69.07 -29.6 67.76 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.417 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.28 -49.24 4.77 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.646 0.778 . . . . 0.0 110.715 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.99 -162.46 1.25 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.845 1.258 . . . . 0.0 110.087 -170.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -103.09 114.5 28.85 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.9 ptm -112.29 157.11 40.91 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.063 0.545 . . . . 0.0 110.307 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.91 124.81 13.2 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.252 1.968 . . . . 0.0 110.898 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HG ' HG13 ' A' ' 134' ' ' VAL . 4.7 tt -109.1 121.21 44.67 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.64 110.3 16.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.932 0.493 . . . . 0.0 109.676 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.52 ' SD ' HD21 ' A' ' 85' ' ' LEU . 47.6 mtt -115.82 113.36 23.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.409 1.084 . . . . 0.0 110.53 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -103.97 129.41 51.55 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.134 0.574 . . . . 0.0 110.472 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 3.9 m-85 -88.4 125.51 34.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.094 0.958 . . . . 0.0 109.478 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -126.73 99.2 5.67 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.98 161.71 31.69 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.72 145.41 54.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.392 0.677 . . . . 0.0 112.282 -175.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 157' ' ' ARG . 44.5 mt-10 -57.59 -31.74 66.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.253 1.021 . . . . 0.0 113.425 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.53 -23.77 66.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.28 2.41 56.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.261 0.624 . . . . 0.0 112.404 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.444 HH21 ' HB3' ' A' ' 154' ' ' GLU . 15.5 ptp180 -57.99 -37.97 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.844 0.457 . . . . 0.0 111.514 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.67 -43.42 89.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.226 1.01 . . . . 0.0 110.387 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.97 -36.29 67.08 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.358 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.39 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.848 0.859 . . . . 0.0 110.443 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.0 p -67.57 -26.78 66.46 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.086 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.13 -37.61 88.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.106 0.562 . . . . 0.0 110.951 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.1 mm100 -74.49 -38.43 62.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.012 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.68 -61.73 2.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.47 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.63 -21.99 66.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.749 1.219 . . . . 0.0 112.761 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -53.74 -52.34 60.47 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.882 0.873 . . . . 0.0 111.018 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' HIS . . . . . 0.449 ' NE2' ' HB3' ' A' ' 114' ' ' GLU . 66.3 t-80 -96.25 -17.27 20.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.418 -177.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.1 34.32 5.43 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.734 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 . . . . . 0 N--CA 1.482 1.125 0 C-N-CA 123.609 0.764 . . . . 0.0 109.878 169.323 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.998 0.428 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.79 -30.96 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.684 0.794 . . . . 0.0 109.584 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -77.77 -18.07 56.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.767 0.827 . . . . 0.0 110.415 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.96 133.5 50.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.995 0.518 . . . . 0.0 110.879 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.2 m -132.62 162.77 39.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 125.015 1.326 . . . . 0.0 109.797 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 tp -83.89 111.58 19.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 23.0 m-85 -73.51 -25.86 60.62 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.287 0.565 . . . . 0.0 110.611 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -144.25 14.41 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -132.52 179.74 5.95 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.635 0.774 . . . . 0.0 110.271 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 169' ' ' PHE . 49.2 tp -143.35 146.76 33.8 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.571 0.748 . . . . 0.0 109.516 172.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -71.24 81.81 0.73 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.221 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -74.1 74.72 1.18 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -68.08 87.64 0.27 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 111' ' ' LEU . 36.6 t -87.42 147.97 4.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.696 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 87.6 t -61.46 140.96 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.274 1.029 . . . . 0.0 110.727 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.59 -38.18 15.02 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -17.55 31.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.871 1.269 . . . . 0.0 113.248 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.562 ' NH1' HG23 ' A' ' 108' ' ' VAL . 13.1 ptt180 -69.22 -2.29 10.16 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.491 0.717 . . . . 0.0 112.506 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -51.93 -36.84 50.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.071 0.948 . . . . 0.0 112.928 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.08 -30.58 71.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.746 0.818 . . . . 0.0 111.535 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 m -74.38 -6.31 47.44 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.758 0.823 . . . . 0.0 111.786 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.02 45.77 1.24 Allowed Glycine 0 C--N 1.35 1.327 0 O-C-N 122.388 -0.195 . . . . 0.0 113.486 169.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.96 172.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 170.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.08 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.68 -146.26 0.4 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.247 0.619 . . . . 0.0 109.769 -172.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -73.17 150.91 41.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.286 1.034 . . . . 0.0 112.666 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 68.83 -5.44 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.592 1.557 . . . . 0.0 113.208 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.16 146.49 29.53 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.042 0.537 . . . . 0.0 110.622 -172.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.469 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.5 mtp -97.43 143.56 28.04 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.518 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.13 145.78 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.36 1.064 . . . . 0.0 108.912 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -99.03 156.01 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -115.41 124.49 51.31 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -132.98 116.8 16.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.969 0.908 . . . . 0.0 109.679 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -67.91 119.21 12.21 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.451 ' HB2' ' HG2' ' A' ' 99' ' ' LYS . 18.5 t70 -66.6 132.65 94.16 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.571 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.79 -42.52 11.87 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.272 3.314 . . . . 0.0 114.079 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -167.38 106.95 0.58 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 123.138 0.273 . . . . 0.0 110.551 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.7 146.26 30.99 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.05 -22.14 48.2 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.765 2.31 . . . . 0.0 114.003 -170.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -125.94 -46.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.713 0.405 . . . . 0.0 110.858 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.428 ' HB3' ' ND2' ' A' ' 96' ' ' ASN . 33.7 m-20 -117.14 92.7 3.93 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -55.86 -33.16 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.728 0.811 . . . . 0.0 111.686 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.585 ' H ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -72.3 -8.29 54.08 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 113.1 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 108.41 2.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.237 0.615 . . . . 0.0 111.375 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.32 125.95 45.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 124.081 0.952 . . . . 0.0 110.213 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 32.4 mmtp -86.8 123.91 32.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.106 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.61 112.67 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.0 m-20 -91.53 170.36 10.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.188 0.995 . . . . 0.0 108.849 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -108.11 -171.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.843 0.457 . . . . 0.0 110.248 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.69 -28.38 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.637 0.775 . . . . 0.0 112.24 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.9 -30.48 63.95 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.176 0.591 . . . . 0.0 110.357 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.19 -4.34 30.03 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.485 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -74.81 137.4 41.87 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.278 0.539 . . . . 0.0 110.026 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.78 95.37 0.89 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.562 HG23 ' NH1' ' A' ' 71' ' ' ARG . 27.8 m -86.95 16.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.861 0.865 . . . . 0.0 112.012 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 148.01 -175.72 27.19 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.925 169.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -102.68 148.83 25.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.11 0.964 . . . . 0.0 108.972 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.2 tt -73.89 -56.09 5.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? 152.12 121.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -165.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -61.11 -49.47 77.13 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 118.802 0.728 . . . . 0.0 112.072 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.33 -41.56 93.81 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.821 0.7 . . . . 0.0 110.82 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.77 -40.08 66.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.831 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.32 -24.54 65.75 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.008 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.28 -33.82 88.29 Favored Glycine 0 C--N 1.351 1.361 0 O-C-N 123.603 0.565 . . . . 0.0 112.958 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -56.84 4.78 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.413 0.625 . . . . 0.0 109.802 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 63' ' ' LEU . 22.5 mt -70.5 -18.12 62.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.506 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.96 67.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.881 0.873 . . . . 0.0 111.153 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -66.03 -35.5 80.72 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.184 0.928 . . . . 0.0 110.44 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.507 ' HA ' HD12 ' A' ' 127' ' ' LEU . 83.9 mt -62.62 -44.55 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 0.0 110.585 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 85' ' ' LEU . 30.1 ttm -81.19 -21.46 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.644 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.31 -51.05 10.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 0.0 109.72 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -89.71 4.16 50.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.224 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 59.71 36.63 22.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.533 1.133 . . . . 0.0 111.594 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 122' ' ' ILE . 66.0 mt -62.22 -40.83 97.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.44 1.096 . . . . 0.0 111.54 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.504 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.15 140.86 9.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.13 0.572 . . . . 0.0 111.093 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -76.52 133.51 39.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.1 113.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.39 132.75 54.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.35 154.78 18.53 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.773 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 82' ' ' MET . 67.3 t -137.99 137.26 44.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.23 84.88 4.98 Favored Pre-proline 0 CA--C 1.555 1.17 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.47 -35.78 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.656 2.237 . . . . 0.0 111.74 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.25 -26.13 58.61 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.966 0.907 . . . . 0.0 110.59 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.76 -6.08 14.18 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 115.835 1.094 . . . . 0.0 115.835 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.12 1.8 30.22 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.481 0.641 . . . . 0.0 112.723 -172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.602 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 3.4 t-20 -75.32 -18.4 60.03 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.116 0.484 . . . . 0.0 110.315 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.89 -34.23 75.66 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.092 0.957 . . . . 0.0 110.663 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.94 -56.39 2.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.828 0.851 . . . . 0.0 112.579 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -126.8 -178.25 4.32 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.542 1.137 . . . . 0.0 110.573 -161.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p -93.8 125.46 38.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.087 0.955 . . . . 0.0 109.631 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 139' ' ' ASN . 3.3 ppp? -156.61 160.93 30.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.172 0.989 . . . . 0.0 109.302 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.96 121.5 7.36 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.791 1.661 . . . . 0.0 111.147 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 67' ' ' VAL . 6.5 tt -100.34 124.88 46.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -74.33 108.84 7.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.627 ' SD ' HD21 ' A' ' 85' ' ' LEU . 58.5 mtt -116.05 121.74 43.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.76 0.824 . . . . 0.0 109.581 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -108.99 140.53 42.36 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.373 1.069 . . . . 0.0 110.206 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 43.5 m-85 -104.15 121.01 42.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.923 0.889 . . . . 0.0 109.684 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -124.5 112.88 17.4 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.48 164.45 37.97 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -54.26 137.69 40.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.534 0.734 . . . . 0.0 110.541 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -53.93 -39.0 65.47 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 123.854 0.721 . . . . 0.0 112.551 -169.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.42 -18.03 35.67 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.319 1.048 . . . . 0.0 113.759 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -92.51 -8.22 45.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.79 -33.62 66.84 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.056 0.542 . . . . 0.0 112.398 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 46.7 pttt -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.674 0.789 . . . . 0.0 111.381 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -68.65 -34.7 76.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.62 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.96 -44.24 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.657 0.783 . . . . 0.0 110.466 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -72.67 -25.97 61.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.543 0.737 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 32.7 t70 -58.77 -39.92 82.43 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.15 0.5 . . . . 0.0 110.286 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 166' ' ' LYS . 14.7 mm100 -73.19 -39.49 65.53 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.12 -175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.51 -57.54 4.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.32 -21.29 59.52 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.654 1.181 . . . . 0.0 112.484 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 163' ' ' GLN . 21.8 ttmm -56.23 -50.38 71.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.989 0.916 . . . . 0.0 111.177 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -111.59 18.7 18.82 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.174 0.59 . . . . 0.0 110.545 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.0 14.07 76.05 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.584 ' HB3' HD11 ' A' ' 63' ' ' LEU . 28.4 m-85 . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 123.883 0.873 . . . . 0.0 110.892 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.0 t -72.54 -31.44 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.4 t70 -77.4 -14.0 59.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.285 0.634 . . . . 0.0 111.126 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 m -70.66 109.29 4.82 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.464 0.65 . . . . 0.0 110.519 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 56' ' ' ASP . 16.9 m -116.61 162.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.853 1.261 . . . . 0.0 110.293 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.76 118.49 22.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 27.8 m-85 -83.31 -31.5 26.83 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.322 0.582 . . . . 0.0 110.167 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.1 -167.94 29.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.873 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 147' ' ' HIS . 77.6 p -125.58 138.98 53.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.889 0.476 . . . . 0.0 110.102 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 33.6 tp -99.09 140.95 32.48 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 109.761 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -75.37 78.87 2.44 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.928 0.87 . . . . 0.0 110.486 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -71.68 141.23 31.66 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.419 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -122.01 100.72 7.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.45 0.7 . . . . 0.0 109.776 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.96 131.23 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.93 0.769 . . . . 0.0 108.974 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.66 142.32 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.741 0.816 . . . . 0.0 111.594 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.63 -27.29 57.35 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.64 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.85 -19.57 65.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.444 0.698 . . . . 0.0 110.072 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 4.1 mmp_? -78.1 0.27 25.39 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.47 1.108 . . . . 0.0 112.807 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.05 -36.66 65.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.473 0.709 . . . . 0.0 112.12 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.82 -32.23 73.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.701 0.8 . . . . 0.0 111.85 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 p -87.22 15.5 6.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.13 0.572 . . . . 0.0 112.399 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.04 49.95 1.41 Allowed Glycine 0 C--N 1.356 1.653 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 163.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.47 169.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.093 0.947 . . . . 0.0 111.585 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 HG11 ' A' ' 134' ' ' VAL . 27.6 m -115.64 158.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.769 0.828 . . . . 0.0 111.902 -164.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.32 -173.95 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.136 0.974 . . . . 0.0 110.758 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -72.44 153.23 41.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.44 8.74 5.96 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 125.019 1.328 . . . . 0.0 112.229 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -88.11 145.41 25.96 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.7 -0.625 . . . . 0.0 111.553 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.578 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -95.36 147.37 23.58 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.123 177.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.82 142.09 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.556 1.142 . . . . 0.0 108.853 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -115.01 124.69 52.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.721 0.808 . . . . 0.0 109.56 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.9 mt -76.83 158.84 30.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.681 0.393 . . . . 0.0 110.707 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.03 121.59 4.89 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.425 0.69 . . . . 0.0 110.116 -174.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.28 134.61 56.14 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.471 0.708 . . . . 0.0 110.835 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.74 118.28 59.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.319 0.647 . . . . 0.0 109.319 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.75 -29.57 90.07 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.918 2.412 . . . . 0.0 112.866 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -144.42 98.99 3.29 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -65.64 138.69 96.79 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.583 0.753 . . . . 0.0 110.632 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.46 -54.41 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.434 2.089 . . . . 0.0 113.139 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -128.61 -50.72 1.26 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.754 0.822 . . . . 0.0 109.768 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.71 101.25 13.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.019 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.25 -4.96 28.6 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 3.6 p-10 -99.37 -2.14 37.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.282 1.033 . . . . 0.0 111.784 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.71 144.24 54.47 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.021 0.528 . . . . 0.0 111.384 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.19 126.18 55.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.145 0.978 . . . . 0.0 108.931 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.17 152.93 43.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.506 0.722 . . . . 0.0 111.209 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.31 134.08 64.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -121.05 166.48 13.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.429 1.091 . . . . 0.0 108.084 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -99.34 -172.64 2.3 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.11 -19.28 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.227 0.611 . . . . 0.0 112.582 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -84.92 -10.93 56.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.354 0.662 . . . . 0.0 110.919 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.3 19.9 59.77 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.648 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -87.88 127.68 35.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 109.762 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.01 110.49 3.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 110.239 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 4.3 m -84.3 -10.51 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.943 0.497 . . . . 0.0 110.643 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.96 -141.52 12.86 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -106.05 173.76 6.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.733 0.813 . . . . 0.0 110.072 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.431 HD11 ' SD ' ' A' ' 148' ' ' MET . 2.3 tt -84.71 -52.32 6.16 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 172.01 168.77 0.1 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -79.06 -63.77 1.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.26 -36.55 74.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 0.0 112.379 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.483 HD11 ' HA2' ' A' ' 65' ' ' GLY . 4.9 tt -73.05 -46.02 54.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.896 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.03 67.44 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.838 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -61.48 -40.04 98.14 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.592 0.558 . . . . 0.0 113.347 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -49.55 39.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.38 0.609 . . . . 0.0 109.86 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 122' ' ' ILE . 17.1 mt -69.31 -16.74 63.62 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.819 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.84 -57.95 9.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.381 1.072 . . . . 0.0 111.543 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -64.07 -31.0 72.03 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.909 0.756 . . . . 0.0 110.687 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 127' ' ' LEU . 73.5 mt -67.34 -40.61 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.509 0.723 . . . . 0.0 111.203 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.7 ttm -80.36 -36.31 34.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.232 0.613 . . . . 0.0 110.971 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.13 -41.41 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.272 1.029 . . . . 0.0 111.101 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -99.67 7.98 44.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.648 0.779 . . . . 0.0 111.096 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 63.08 35.77 12.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.33 1.052 . . . . 0.0 111.762 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 122' ' ' ILE . 64.1 mt -69.5 -50.22 47.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.009 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -152.11 145.0 24.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.89 134.66 33.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 108.599 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.2 mt -121.4 117.42 52.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.721 0.296 . . . . 0.0 110.301 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -117.37 121.25 40.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.252 1.021 . . . . 0.0 108.451 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -90.14 155.52 24.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.582 -0.281 . . . . 0.0 112.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 82' ' ' MET . 53.3 t -138.68 128.02 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG23 ' A' ' 77' ' ' VAL . 5.0 p -96.01 102.27 10.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.711 0.805 . . . . 0.0 109.301 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -53.56 0.18 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.296 1.997 . . . . 0.0 113.574 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -84.98 -27.59 26.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.035 0.534 . . . . 0.0 110.941 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.35 81.84 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 113.718 0.247 . . . . 0.0 113.718 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.652 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -75.93 -7.75 55.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.423 0.689 . . . . 0.0 112.277 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.78 -16.65 63.86 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.864 0.865 . . . . 0.0 110.973 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -73.12 -25.66 60.93 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.622 0.769 . . . . 0.0 111.29 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.07 -60.61 2.19 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -141.5 -83.49 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.1 m -157.5 140.62 15.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.652 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -153.06 149.38 21.69 Favored Pre-proline 0 C--O 1.243 0.758 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 173.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.75 124.4 14.49 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.326 2.017 . . . . 0.0 112.815 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.485 HD22 ' HB ' ' A' ' 134' ' ' VAL . 4.3 pp -117.77 146.25 43.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.043 0.937 . . . . 0.0 108.858 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.5 m80 -86.55 109.85 19.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.612 0.365 . . . . 0.0 111.139 -166.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.649 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 40.3 mtt -99.76 111.77 24.07 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.188 0.995 . . . . 0.0 109.468 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 49.5 p -93.99 128.22 40.21 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.154 0.982 . . . . 0.0 109.653 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 24.7 m-85 -91.13 117.25 29.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.261 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -120.44 99.18 6.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.89 166.55 31.45 Favored Glycine 0 CA--C 1.501 -0.832 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.342 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.03 149.3 45.04 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.58 -48.02 7.51 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.78 1.632 . . . . 0.0 113.613 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.14 -9.89 55.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -171.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 127' ' ' LEU . 98.9 m-20 -107.62 -4.36 18.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 8.9 ptp85 -63.44 -29.24 70.56 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.216 0.916 . . . . 0.0 112.228 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.16 -42.52 86.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.67 0.788 . . . . 0.0 109.847 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.06 -34.12 29.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.467 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.89 -57.75 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.654 0.782 . . . . 0.0 110.517 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 m -62.95 -25.45 68.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.098 0.959 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.4 t70 -60.57 -48.65 80.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.526 0.33 . . . . 0.0 110.375 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.9 mm100 -64.06 -35.22 80.02 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.956 0.785 . . . . 0.0 111.155 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 -62.46 1.45 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.342 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -58.91 -26.98 64.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.497 0.719 . . . . 0.0 111.694 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 37.1 ttmt -56.06 -50.09 71.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.645 1.178 . . . . 0.0 111.793 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -87.15 -13.46 44.02 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.02 10.85 23.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.916 -0.38 . . . . 0.0 113.548 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 123.078 0.551 . . . . 0.0 110.106 171.885 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.92 -32.05 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.44 0.696 . . . . 0.0 109.605 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.97 -33.26 75.62 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.349 1.06 . . . . 0.0 110.48 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -78.53 127.49 32.22 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.753 0.821 . . . . 0.0 110.693 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.85 166.78 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.786 1.234 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.51 117.59 23.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.497 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 20.7 m-85 -81.12 -28.86 34.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.058 0.543 . . . . 0.0 110.648 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.93 -153.26 25.19 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -126.47 178.61 5.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.414 0.685 . . . . 0.0 110.559 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -150.96 141.56 22.62 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.913 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -71.74 84.14 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.494 0.718 . . . . 0.0 109.717 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.513 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.37 87.25 1.38 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.168 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 18.2 t60 -73.79 94.28 2.24 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.203 0.601 . . . . 0.0 110.213 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.55 HG11 ' HD2' ' A' ' 71' ' ' ARG . 38.3 t -82.22 142.68 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.431 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.74 154.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.892 0.877 . . . . 0.0 113.072 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.46 -19.95 72.85 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.387 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.3 tp -57.23 -23.85 50.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.973 1.309 . . . . 0.0 111.489 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.55 ' HD2' HG11 ' A' ' 67' ' ' VAL . 70.8 ttt180 -54.85 -21.83 12.62 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.241 1.416 . . . . 0.0 113.15 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -49.91 -49.6 49.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.165 0.986 . . . . 0.0 111.95 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -75.45 -25.94 57.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.056 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 m -80.46 -9.23 59.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.011 0.524 . . . . 0.0 110.53 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.31 50.18 0.73 Allowed Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.309 170.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.19 158.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 33.1 m -112.99 152.19 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.222 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.75 -76.84 0.11 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.338 0.399 . . . . 0.0 110.789 -164.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -164.07 159.22 20.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.065 0.946 . . . . 0.0 109.617 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 70.7 -7.6 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.486 1.114 . . . . 0.0 111.892 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.648 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 72.4 mm-40 -75.25 144.0 42.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.758 0.823 . . . . 0.0 111.965 -167.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.568 ' HG2' HG22 ' A' ' 133' ' ' VAL . 73.4 mtm -95.04 144.53 25.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.46 170.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.93 160.79 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.084 0.954 . . . . 0.0 109.083 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.68 25.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.6 mp -85.38 134.06 34.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.045 0.538 . . . . 0.0 109.575 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -142.78 130.7 21.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.3 0.64 . . . . 0.0 109.486 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -80.76 124.32 28.95 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -99.16 137.18 20.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.385 0.674 . . . . 0.0 111.446 -177.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.54 -28.7 6.51 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.622 2.215 . . . . 0.0 112.025 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -80.65 83.72 6.36 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 3.9 p-10 -89.92 127.91 52.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.334 -166.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 10.1 Cg_exo -74.47 -26.92 11.56 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.553 2.168 . . . . 0.0 112.408 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -120.84 -53.38 2.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.254 0.621 . . . . 0.0 111.578 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -168.1 154.0 7.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.01 -13.38 2.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.162 0.985 . . . . 0.0 113.636 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 90.0 m-20 -95.19 27.68 3.15 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.065 0.946 . . . . 0.0 111.48 174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.7 34.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.057 0.543 . . . . 0.0 110.687 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mt -116.36 123.87 71.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 C-N-CA 123.967 0.907 . . . . 0.0 109.437 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -81.84 150.13 27.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.591 0.71 . . . . 0.0 110.465 170.306 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -101.11 109.95 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -89.91 167.73 12.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -107.1 -165.6 1.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.298 0.499 . . . . 0.0 110.482 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -59.04 -31.24 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.847 0.859 . . . . 0.0 112.034 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.08 -11.96 57.53 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.196 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.37 85.82 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 113.169 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.92 133.66 36.23 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 109.746 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -61.64 92.45 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 O-C-N 124.283 0.99 . . . . 0.0 110.816 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.92 -1.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.738 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HG3' ' A' ' 71' ' ' ARG . . . 172.76 -159.34 29.9 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.554 0.533 . . . . 0.0 113.83 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 11.6 p-80 -142.01 150.48 41.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.887 1.275 . . . . 0.0 107.632 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.51 -53.84 12.53 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -178.47 -179.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.988 1.715 . . . . 0.0 108.104 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -81.0 -61.41 1.97 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 162.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.22 -39.21 23.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.712 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -67.08 -44.89 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.78 70.75 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.508 -1.223 . . . . 0.0 111.13 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -61.44 -42.82 99.86 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.876 0.735 . . . . 0.0 114.353 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.75 -47.95 67.82 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.389 0.614 . . . . 0.0 110.534 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.49 -18.97 63.74 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.55 87.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.117 0.967 . . . . 0.0 111.861 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -70.04 -32.87 71.21 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.699 0.625 . . . . 0.0 109.584 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 160' ' ' VAL . 66.5 mt -67.63 -37.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.654 0.782 . . . . 0.0 110.782 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.91 -44.9 21.69 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.797 0.839 . . . . 0.0 111.075 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.74 -46.7 52.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.653 1.181 . . . . 0.0 110.791 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.97 6.86 33.81 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.806 0.443 . . . . 0.0 111.243 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 59.92 33.56 21.53 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.806 1.242 . . . . 0.0 111.733 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 122' ' ' ILE . 68.9 mt -65.71 -42.59 90.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -158.34 151.17 22.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -86.39 132.11 34.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -113.81 113.44 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -102.99 179.27 4.32 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.208 1.003 . . . . 0.0 108.481 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.33 164.38 31.47 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.9 t -144.44 134.18 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.3 p -112.83 88.8 12.21 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.7 -22.88 8.73 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.489 2.126 . . . . 0.0 112.699 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -82.48 -28.45 31.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.923 0.489 . . . . 0.0 110.518 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 75.75 4.29 75.84 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -69.73 -9.05 52.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.301 0.64 . . . . 0.0 112.702 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -18.66 64.96 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.0 0.92 . . . . 0.0 113.221 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.62 -53.01 9.27 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 110.705 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.73 -34.35 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.169 0.588 . . . . 0.0 111.301 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -117.39 174.34 6.2 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.718 0.807 . . . . 0.0 110.819 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -98.92 111.02 23.54 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.512 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.6 ptm -125.8 158.74 64.36 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 121.921 -0.487 . . . . 0.0 110.644 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 2.5 Cg_endo -83.57 125.73 3.91 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.765 2.31 . . . . 0.0 110.826 164.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.22 154.75 22.95 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -74.76 111.21 9.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.053 0.541 . . . . 0.0 110.35 -171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -109.88 117.12 32.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.228 1.011 . . . . 0.0 110.328 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -107.49 135.23 49.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.505 1.122 . . . . 0.0 110.424 -167.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.2 118.95 35.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 109.424 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -123.62 103.49 8.45 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.47 169.47 36.99 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 138.06 58.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.011 0.525 . . . . 0.0 111.734 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -52.48 -32.06 38.02 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.643 1.577 . . . . 0.0 113.071 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.34 -10.1 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.738 . . . . 0.0 112.697 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.57 4.13 20.05 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.841 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -61.06 -33.52 73.44 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.377 0.99 . . . . 0.0 111.756 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -33.19 69.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.239 0.616 . . . . 0.0 110.769 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -76.7 -38.31 54.61 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.615 0.766 . . . . 0.0 110.575 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 122' ' ' ILE . 64.3 t -64.34 -47.65 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.141 0.976 . . . . 0.0 110.27 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.5 p -68.45 -29.87 68.61 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.881 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -43.13 99.38 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.38 0.672 . . . . 0.0 111.253 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 12.1 mm100 -63.15 -37.26 86.53 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.958 0.786 . . . . 0.0 110.485 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -48.38 51.01 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.223 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -66.07 -25.7 67.15 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.408 1.083 . . . . 0.0 111.611 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -67.04 -44.01 81.32 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.939 0.895 . . . . 0.0 111.293 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -110.09 3.94 20.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.903 0.481 . . . . 0.0 110.893 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.21 66.7 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 123.125 0.57 . . . . 0.0 110.373 173.132 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.85 -27.6 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 109.494 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.5 -16.97 60.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.642 0.777 . . . . 0.0 110.954 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -70.39 146.03 50.7 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.829 0.452 . . . . 0.0 109.976 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG21 ' HG2' ' A' ' 154' ' ' GLU . 24.0 m -141.14 161.13 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.932 1.293 . . . . 0.0 110.021 -174.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.94 111.37 16.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.0 m-85 -74.02 -38.63 63.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.862 0.465 . . . . 0.0 110.905 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.8 -166.66 29.3 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.179 -169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.0 p -111.11 178.7 4.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.186 0.517 . . . . 0.0 111.474 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 47.6 tp -151.28 146.58 26.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.477 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -94.11 93.94 8.11 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.76 0.79 . . . . 0.0 109.399 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.83 102.85 2.61 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.829 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -78.66 105.7 10.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.363 0.581 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG11 ' HD2' ' A' ' 71' ' ' ARG . 10.8 t -89.56 147.33 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 112' ' ' LYS . 31.4 m -80.62 167.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.26 -20.0 68.9 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.996 -1.002 . . . . 0.0 114.093 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.19 -17.78 30.62 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.468 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.73 ' HD3' ' HB2' ' A' ' 139' ' ' ASN . 68.7 ttt180 -56.26 -42.0 76.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.21 1.004 . . . . 0.0 112.98 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.557 ' HA ' HG13 ' A' ' 76' ' ' VAL . 16.0 p90 -75.06 -16.78 60.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.167 0.439 . . . . 0.0 111.583 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -83.44 -28.92 28.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.702 0.801 . . . . 0.0 110.289 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.1 m -75.22 -27.9 59.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.271 0.628 . . . . 0.0 111.152 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.54 53.98 0.31 Allowed Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.407 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 72' ' ' TYR . 3.3 m -41.45 169.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.599 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 9.2 m -115.53 -179.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.004 -176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.15 -166.7 0.52 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.559 1.144 . . . . 0.0 110.673 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -77.82 141.0 39.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.165 0.586 . . . . 0.0 110.894 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 8.0 t30 58.46 32.8 22.52 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.712 1.205 . . . . 0.0 112.447 170.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mm-40 -82.65 141.52 32.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.673 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.553 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.4 mtp -88.02 142.2 27.97 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 32.9 m -132.83 150.9 33.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.846 0.858 . . . . 0.0 110.246 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -107.69 157.15 18.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.264 1.026 . . . . 0.0 109.568 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.92 146.06 39.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.374 0.67 . . . . 0.0 110.003 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -155.35 130.61 9.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 13.2 ptm180 -66.89 146.03 54.83 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.11 0.481 . . . . 0.0 111.267 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -99.29 106.85 41.49 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.173 0.989 . . . . 0.0 108.445 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -83.7 3.56 7.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.802 2.335 . . . . 0.0 112.851 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -119.8 -11.21 9.4 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.661 0.784 . . . . 0.0 111.518 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 92' ' ' PRO . 5.1 t-20 -63.06 121.78 71.12 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.944 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 33.8 Cg_endo -59.49 -19.78 53.62 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.883 3.055 . . . . 0.0 114.355 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -72.14 -50.58 26.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.415 0.686 . . . . 0.0 110.524 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 96' ' ' ASN . 21.9 p-10 177.74 157.04 0.38 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.276 0.985 . . . . 0.0 110.66 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -64.03 -23.22 67.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.265 176.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 10.8 m-20 -75.61 -2.23 28.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.746 0.818 . . . . 0.0 112.499 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.5 33.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.499 0.32 . . . . 0.0 110.158 169.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.0 mt -133.75 126.34 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.024 0.929 . . . . 0.0 109.739 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -82.27 134.08 35.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 168.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.58 134.85 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.287 0.635 . . . . 0.0 109.355 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.0 p30 -121.93 171.16 9.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.8 p30 -107.51 -169.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.482 1.037 . . . . 0.0 109.803 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.36 -29.89 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -78.47 -11.95 59.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.041 0.936 . . . . 0.0 111.692 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.17 -1.89 77.89 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 122.9 0.286 . . . . 0.0 113.382 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.8 t-20 -73.9 128.41 35.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.721 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.08 114.86 3.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.616 0.766 . . . . 0.0 110.409 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' ASN . 35.6 m -126.56 13.87 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.855 0.862 . . . . 0.0 111.974 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.36 -170.29 43.08 Favored Glycine 0 C--N 1.355 1.636 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.02 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -166.26 123.47 1.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.07 0.948 . . . . 0.0 109.123 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 115' ' ' LEU . 95.6 mt -80.34 7.26 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.1 0.96 . . . . 0.0 113.168 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HG3' ' H ' ' A' ' 113' ' ' LYS . 16.1 tptm 64.08 -156.44 0.31 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.632 1.173 . . . . 0.0 109.972 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 16.5 ttmm -79.03 -48.61 14.1 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 118.987 0.812 . . . . 0.0 110.882 170.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.06 -59.47 4.71 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.073 0.858 . . . . 0.0 112.572 -162.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 HD13 ' A' ' 111' ' ' LEU . 1.9 tm? -72.45 -46.54 54.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.618 0.723 . . . . 0.0 109.206 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -64.57 -29.47 70.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.713 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -65.71 -35.67 91.32 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 123.503 0.573 . . . . 0.0 112.63 -173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.71 -51.39 49.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.797 0.808 . . . . 0.0 109.486 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.68 -15.92 62.76 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.673 -1.148 . . . . 0.0 112.559 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.02 86.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.615 1.166 . . . . 0.0 112.689 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -73.76 -33.83 64.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 127' ' ' LEU . 56.8 mt -67.31 -33.5 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.419 0.688 . . . . 0.0 110.241 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.5 tpp -73.7 -43.36 59.5 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.005 1.322 . . . . 0.0 110.497 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.59 -50.47 30.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.803 -174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -91.05 2.03 56.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.483 -173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 56.03 44.13 25.98 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.714 1.205 . . . . 0.0 111.58 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.527 ' HB2' HG23 ' A' ' 122' ' ' ILE . 73.4 mt -70.18 -40.86 74.4 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.213 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.96 139.3 14.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.96 112.48 7.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.091 0.956 . . . . 0.0 109.529 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.14 120.33 48.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.38 166.8 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.88 150.36 21.94 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 82' ' ' MET . 64.8 t -142.08 116.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.26 92.74 0.93 Allowed Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 11.7 Cg_exo -69.65 -53.56 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.845 2.363 . . . . 0.0 113.498 -162.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.81 -26.31 57.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.631 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.99 79.43 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.939 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.78 -1.97 18.64 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.73 ' HB2' ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -63.17 -18.52 63.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.427 1.491 . . . . 0.0 113.84 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -82.22 -41.84 19.74 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.256 0.622 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.16 -58.42 3.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.809 0.444 . . . . 0.0 110.336 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -137.74 -163.15 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 110.294 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 p -95.2 127.02 40.92 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.6 ptm -129.36 151.29 77.61 Favored Pre-proline 0 C--O 1.249 1.059 0 C-N-CA 123.171 0.588 . . . . 0.0 109.51 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 139.82 25.92 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 121.968 1.778 . . . . 0.0 110.521 166.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -106.05 144.78 32.28 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -69.8 110.48 4.97 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 24.9 mtp -102.94 158.75 16.07 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -150.5 139.59 21.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 90.2 m-85 -101.83 133.2 46.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.078 0.951 . . . . 0.0 109.973 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -131.36 100.52 5.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.24 1.016 . . . . 0.0 108.805 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.56 169.39 37.82 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.46 145.91 52.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.943 0.497 . . . . 0.0 111.715 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' HG21 ' A' ' 58' ' ' VAL . 37.6 mt-10 -59.87 -28.5 67.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.035 0.934 . . . . 0.0 112.731 -172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.61 -21.83 62.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.877 0.471 . . . . 0.0 111.945 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -89.1 -8.6 53.52 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.046 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.278 0.49 . . . . 0.0 110.692 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.4 pptp? -65.16 -34.83 79.33 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.297 0.373 . . . . 0.0 110.749 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.57 -33.58 28.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.621 0.769 . . . . 0.0 110.87 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.05 -49.99 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.457 0.703 . . . . 0.0 110.265 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.4 t -66.24 -29.75 70.06 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.648 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 26.7 t70 -56.85 -44.79 82.51 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.522 0.729 . . . . 0.0 109.957 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 17.8 mm100 -71.24 -38.54 71.96 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.876 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.58 -55.66 25.16 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.587 0.554 . . . . 0.0 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -64.35 -22.94 67.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.97 0.908 . . . . 0.0 112.13 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -62.31 -40.87 97.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.968 0.907 . . . . 0.0 110.907 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -107.36 -0.98 22.03 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 15.86 61.57 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 114.342 0.497 . . . . 0.0 114.342 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 63' ' ' LEU . 31.1 m-85 . . . . . 0 N--CA 1.482 1.166 0 C-N-CA 123.955 0.902 . . . . 0.0 112.126 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.765 0.317 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.89 -38.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.375 0.67 . . . . 0.0 109.372 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.31 -21.35 56.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.051 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -67.11 139.71 57.54 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.107 0.563 . . . . 0.0 110.724 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.45 169.0 17.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 109.144 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.26 126.64 35.59 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.39 -43.16 11.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.759 . . . . 0.0 110.053 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.58 -177.42 20.79 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.468 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -111.74 120.4 41.89 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.944 0.498 . . . . 0.0 110.219 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 169' ' ' PHE . 55.4 tp -77.14 148.16 36.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.835 1.254 . . . . 0.0 110.897 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -75.33 80.51 2.41 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.055 0.931 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -79.45 93.33 1.34 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.831 -171.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -70.56 92.37 0.84 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.34 138.33 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 70' ' ' LEU . 39.9 t -71.07 144.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.17 74.82 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.395 -0.669 . . . . 0.0 114.006 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.45 ' H ' HG12 ' A' ' 68' ' ' VAL . 39.2 tp -51.91 -23.04 4.39 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.859 1.264 . . . . 0.0 112.965 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 108' ' ' VAL . 20.3 ptt85 -56.88 -6.63 0.36 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.889 1.676 . . . . 0.0 114.349 173.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -54.66 -35.88 63.99 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.11 0.564 . . . . 0.0 111.949 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.98 -26.81 60.66 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.919 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.9 m -75.64 -21.64 57.51 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.831 0.852 . . . . 0.0 111.32 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.69 50.1 0.45 Allowed Glycine 0 C--N 1.356 1.646 0 CA-C-O 119.865 -0.408 . . . . 0.0 113.981 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -52.84 171.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.9 m -114.04 176.85 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.559 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.23 -164.49 1.09 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.809 1.243 . . . . 0.0 110.247 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -82.7 157.37 23.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.314 0.645 . . . . 0.0 111.172 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 67.71 10.97 8.14 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.177 1.391 . . . . 0.0 112.463 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 29.6 mm-40 -84.11 149.37 26.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.499 0.72 . . . . 0.0 110.73 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.593 ' HG2' HG22 ' A' ' 133' ' ' VAL . 60.3 mtp -107.73 152.22 24.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.905 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.5 162.09 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.374 1.069 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.36 145.82 51.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.521 1.128 . . . . 0.0 108.924 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HE1' ' A' ' 148' ' ' MET . 6.9 mp -101.04 135.13 42.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.187 0.595 . . . . 0.0 110.5 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.19 132.81 7.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.016 0.926 . . . . 0.0 108.697 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.737 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 2.5 ptp180 -57.1 147.39 24.67 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 112.086 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.18 127.33 59.59 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.512 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -20.09 65.61 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.248 2.632 . . . . 0.0 112.513 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -91.7 47.73 1.39 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.111 0.964 . . . . 0.0 109.147 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.1 p-10 -63.38 120.18 59.85 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.927 0.891 . . . . 0.0 111.365 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 18.2 Cg_exo -68.67 -50.89 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.912 2.408 . . . . 0.0 113.027 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.45 -50.33 4.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.202 0.601 . . . . 0.0 110.777 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -168.02 165.63 13.47 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -15.21 3.55 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.577 1.151 . . . . 0.0 113.062 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 29.5 p-10 -62.68 -21.92 66.09 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.687 0.795 . . . . 0.0 111.893 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.35 109.17 1.26 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.942 0.897 . . . . 0.0 109.926 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.737 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 98.7 mt -108.61 132.66 55.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 109.891 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 5.1 ttpm? -98.68 146.58 25.72 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.503 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.6 124.86 63.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 109.593 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -110.63 153.83 24.64 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -90.54 -172.83 3.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.541 0.337 . . . . 0.0 110.13 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.52 -23.85 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.889 0.475 . . . . 0.0 112.066 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.191 0.596 . . . . 0.0 110.412 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.94 -0.83 86.54 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 122.778 0.228 . . . . 0.0 113.447 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.02 133.2 42.93 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.123 0.969 . . . . 0.0 108.975 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -64.3 106.38 1.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.674 0.75 . . . . 0.0 110.065 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 35.3 m -114.57 12.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.086 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.84 178.25 48.09 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 114.673 0.629 . . . . 0.0 114.673 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -161.34 113.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 86.2 mt -68.59 -13.13 62.14 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 83.0 tttt 70.71 149.18 0.08 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.124 0.97 . . . . 0.0 110.59 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -21.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.253 1.021 . . . . 0.0 112.476 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.506 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tp10 -56.74 -64.69 0.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.289 1.036 . . . . 0.0 111.461 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 111' ' ' LEU . 59.9 tp -85.51 -49.66 7.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -60.04 -24.63 64.68 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.209 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.49 -34.36 89.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.456 0.472 . . . . 0.0 113.443 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.64 -45.08 26.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.438 0.695 . . . . 0.0 109.98 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.42 HD12 HD13 ' A' ' 111' ' ' LEU . 46.2 mt -70.73 -16.62 62.79 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.932 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.46 -53.91 32.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -68.9 -31.92 71.18 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.941 0.775 . . . . 0.0 110.761 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.23 -37.59 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.435 0.694 . . . . 0.0 110.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 44.9 ttm -79.32 -45.19 20.13 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.875 0.87 . . . . 0.0 110.962 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB2' HH22 ' A' ' 87' ' ' ARG . 29.3 t70 -67.39 -46.62 72.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.067 0.947 . . . . 0.0 110.851 -172.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -92.18 1.36 57.26 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.09 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.18 37.95 17.13 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.376 1.07 . . . . 0.0 111.917 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.26 -42.5 93.2 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.818 0.847 . . . . 0.0 111.351 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.07 137.98 17.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.65 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.2 116.89 18.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.126 0.97 . . . . 0.0 108.642 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.35 123.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -107.07 178.66 4.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.76 155.04 25.92 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.5 t -142.67 141.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.269 1.028 . . . . 0.0 108.281 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 137' ' ' GLY . 3.8 p -122.83 86.23 50.13 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.783 0.833 . . . . 0.0 109.153 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.52 -22.41 21.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.216 2.611 . . . . 0.0 113.9 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.35 0.66 . . . . 0.0 110.797 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 64.5 33.96 88.64 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.514 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -82.27 12.41 4.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.914 0.486 . . . . 0.0 111.446 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -52.85 -37.69 60.55 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.61 -44.7 63.95 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.423 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.86 3.56 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.374 0.669 . . . . 0.0 112.169 -168.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -122.51 170.73 9.69 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.544 0.738 . . . . 0.0 110.688 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 t -95.13 109.07 21.19 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.1 ptm -119.25 134.66 23.71 Favored Pre-proline 0 C--O 1.243 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 110.142 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.66 123.81 12.26 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.172 1.915 . . . . 0.0 110.795 164.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -98.12 156.64 16.57 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -82.12 107.49 14.86 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.547 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 11.8 mtp -105.16 112.54 25.7 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 m -101.79 120.41 40.32 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.077 0.551 . . . . 0.0 110.213 -163.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -94.89 124.19 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.056 0.942 . . . . 0.0 110.18 -172.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -124.29 111.56 15.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.574 1.15 . . . . 0.0 108.232 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.41 166.87 36.73 Favored Glycine 0 N--CA 1.463 0.485 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -68.89 146.88 52.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.021 0.528 . . . . 0.0 111.898 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.4 -24.75 67.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.274 1.029 . . . . 0.0 112.962 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.41 -13.39 59.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.669 0.387 . . . . 0.0 111.877 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.79 0.02 16.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -25.12 67.08 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.339 0.518 . . . . 0.0 112.165 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -36.43 83.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -80.47 -36.08 33.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.457 0.703 . . . . 0.0 110.923 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.79 -53.02 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.524 0.73 . . . . 0.0 109.799 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.9 t -70.71 -25.16 62.83 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.108 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.6 t70 -60.8 -49.53 77.1 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.0 mm100 -66.14 -38.51 88.31 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.159 0.912 . . . . 0.0 111.638 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.53 -62.66 1.39 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.715 0.635 . . . . 0.0 110.012 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.68 -19.1 65.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.38 1.072 . . . . 0.0 112.635 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 23.8 ttmm -51.39 -46.63 62.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.914 0.885 . . . . 0.0 110.889 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -95.94 -23.7 16.74 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.522 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 8.27 11.15 Favored Glycine 0 N--CA 1.475 1.263 0 N-CA-C 113.669 0.228 . . . . 0.0 113.669 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB3' HD11 ' A' ' 63' ' ' LEU . 49.8 m-85 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -75.79 -31.51 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.057 0.943 . . . . 0.0 109.855 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.44 -44.29 68.16 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.312 1.445 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -85.7 122.64 30.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.47 165.02 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.816 1.246 . . . . 0.0 110.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' GLY . 5.9 tt -82.75 111.35 18.61 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -74.65 -36.02 62.86 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.491 0.717 . . . . 0.0 111.132 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 163.94 177.32 36.62 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.54 -171.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 p -112.83 149.32 33.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.303 0.641 . . . . 0.0 110.552 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.12 146.52 50.68 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.604 0.762 . . . . 0.0 110.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' PRO . 98.1 mtt180 -86.08 90.28 8.07 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.272 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.73 1.59 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.977 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -79.07 100.42 7.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.041 0.536 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.58 142.03 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 O-C-N 123.618 0.574 . . . . 0.0 109.541 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.04 154.23 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.944 0.898 . . . . 0.0 112.062 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.78 82.0 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.258 0.349 . . . . 0.0 113.66 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.09 -17.57 53.29 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.901 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.549 HH12 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -61.51 -14.49 29.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.363 1.065 . . . . 0.0 113.53 -177.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.777 ' HA ' HG13 ' A' ' 76' ' ' VAL . 44.9 p90 -60.21 -39.7 87.49 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.223 0.535 . . . . 0.0 111.509 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -71.71 -20.2 61.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.12 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 m -99.23 6.36 46.34 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.651 0.781 . . . . 0.0 111.502 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.27 55.84 0.59 Allowed Glycine 0 C--N 1.367 2.299 0 C-N-CA 120.362 -0.923 . . . . 0.0 115.398 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 72' ' ' TYR . 8.1 m -40.46 155.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 134' ' ' VAL . 19.5 m -115.57 159.78 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.335 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -85.27 -167.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.33 1.052 . . . . 0.0 111.659 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -73.83 151.65 40.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.305 0.642 . . . . 0.0 111.562 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 61.24 8.19 1.96 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.723 1.209 . . . . 0.0 113.595 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.68 133.29 40.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.59 0.756 . . . . 0.0 110.754 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 76.9 mtp -94.09 150.01 20.72 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.413 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.02 166.18 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.761 1.224 . . . . 0.0 109.354 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.68 140.88 48.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.635 1.174 . . . . 0.0 108.567 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.486 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.7 mp -97.12 132.41 42.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -150.32 133.36 16.15 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.6 ptt180 -69.98 145.27 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.097 0.475 . . . . 0.0 110.115 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -89.6 125.12 62.35 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.883 0.873 . . . . 0.0 111.288 -167.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.43 -19.84 24.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.203 2.602 . . . . 0.0 113.283 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -93.9 18.79 9.86 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.181 0.992 . . . . 0.0 110.315 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.6 p30 -51.37 137.06 30.82 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.142 1.377 . . . . 0.0 113.528 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 2.9 Cg_exo -79.01 -41.22 0.23 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.471 2.114 . . . . 0.0 112.453 172.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.32 -53.1 4.23 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.981 0.512 . . . . 0.0 111.448 -168.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -173.3 159.69 3.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.379 1.072 . . . . 0.0 108.476 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 18.4 ptpt -57.68 -25.6 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.55 4.71 23.44 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.37 103.85 1.73 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 64.6 mt -82.91 121.6 36.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.043 -172.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 37.6 ttmt -100.09 127.93 46.24 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.092 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.18 130.68 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.058 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -120.87 154.41 35.87 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -90.1 -171.52 3.16 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.026 0.83 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.97 -34.07 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.814 0.846 . . . . 0.0 112.505 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -77.68 -22.79 49.99 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.933 0.893 . . . . 0.0 111.065 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.37 4.36 58.38 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.74 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.57 125.36 24.0 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.426 0.691 . . . . 0.0 110.013 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.576 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 75.8 mt-30 -71.0 100.86 2.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.021 0.928 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.549 ' HB ' HH12 ' A' ' 71' ' ' ARG . 34.1 m -91.71 -2.66 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.381 0.672 . . . . 0.0 112.188 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.75 165.68 12.21 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 123.239 0.337 . . . . 0.0 112.553 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.8 m-70 -76.21 150.4 37.08 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.812 0.445 . . . . 0.0 110.125 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -70.7 -52.99 17.44 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 5.0 tmtp? 162.54 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -30.17 68.9 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.609 0.763 . . . . 0.0 112.81 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 38.8 tt0 -75.04 -54.92 6.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.88 0.872 . . . . 0.0 110.852 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.578 0.751 . . . . 0.0 109.784 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.83 92.24 Favored 'General case' 0 C--O 1.208 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.665 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.52 -35.61 80.95 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 124.141 0.901 . . . . 0.0 113.89 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.49 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . . . -67.53 -50.15 60.03 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.199 0.523 . . . . 0.0 110.06 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -77.94 -14.03 59.68 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.4 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.76 -47.3 64.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.378 1.471 . . . . 0.0 113.23 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -68.83 -32.33 71.95 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.705 0.802 . . . . 0.0 110.548 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.456 HD13 HG13 ' A' ' 160' ' ' VAL . 51.4 mt -66.03 -42.58 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.002 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.7 tpp -74.15 -37.55 64.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.678 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.95 -44.87 46.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.643 1.177 . . . . 0.0 110.863 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -99.07 5.45 46.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.057 0.543 . . . . 0.0 111.884 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 59.19 33.87 22.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.173 0.989 . . . . 0.0 112.057 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.23 -36.59 84.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.05 155.68 16.42 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.822 0.849 . . . . 0.0 110.833 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -82.01 139.44 34.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.779 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.53 125.16 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.76 148.46 43.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.205 1.002 . . . . 0.0 109.597 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -129.89 176.25 18.75 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 122.946 0.153 . . . . 0.0 113.381 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 12.4 t -142.79 141.63 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.092 1.357 . . . . 0.0 108.121 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 77' ' ' VAL . 6.5 m -103.98 86.06 1.17 Allowed Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.015 0.926 . . . . 0.0 108.977 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.24 -51.32 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.666 2.244 . . . . 0.0 113.408 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 138' ' ' ALA . 37.7 t80 -70.86 -26.71 63.38 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.91 0.484 . . . . 0.0 110.501 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.67 19.53 79.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.513 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' ' HD2' ' A' ' 136' ' ' PHE . . . -61.4 -17.48 54.35 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.283 0.633 . . . . 0.0 111.442 175.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 77' ' ' VAL . 5.2 t30 -48.44 -31.8 6.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.012 1.725 . . . . 0.0 112.847 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.44 -44.96 81.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 0.0 111.002 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.17 -64.35 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.172 0.589 . . . . 0.0 111.529 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -119.54 143.59 47.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.267 1.027 . . . . 0.0 109.741 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 p -93.48 109.18 20.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.025 0.917 . . . . 0.0 109.129 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 165.84 12.68 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.343 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 20.2 Cg_exo -67.24 122.05 9.27 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 121.486 1.457 . . . . 0.0 110.676 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.96 149.9 22.97 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.586 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 58.2 mtt -103.34 164.08 11.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 0.0 109.524 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -148.79 144.59 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.301 1.04 . . . . 0.0 109.07 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -105.18 128.38 53.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.806 0.842 . . . . 0.0 109.394 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -129.06 102.81 6.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.379 1.072 . . . . 0.0 109.631 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.32 178.95 37.93 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.57 142.91 58.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 117.48 0.64 . . . . 0.0 111.895 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.64 -34.78 27.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 113.631 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.51 -26.72 61.01 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -85.55 2.86 43.16 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.845 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -34.89 79.09 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.981 0.355 . . . . 0.0 110.26 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -26.78 56.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.88 0.872 . . . . 0.0 111.309 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -73.7 -52.32 13.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 122' ' ' ILE . 49.9 t -57.02 -43.12 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.928 1.291 . . . . 0.0 111.777 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.6 p -64.95 -33.94 77.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.921 0.489 . . . . 0.0 111.385 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 20.5 t70 -67.26 -32.94 74.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.688 0.618 . . . . 0.0 110.48 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 8.1 mm100 -73.33 -25.81 60.78 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 95.9 mt -76.51 -39.51 52.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.531 0.733 . . . . 0.0 110.253 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 8.7 mtpm? -59.96 -22.22 62.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.297 1.039 . . . . 0.0 111.992 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 118' ' ' ALA . 40.2 ttmt -54.0 -49.95 67.7 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 111.24 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -100.18 0.1 39.84 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.686 0.394 . . . . 0.0 111.082 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.59 35.95 24.32 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 116.802 -0.181 . . . . 0.0 112.82 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 25.8 m-85 . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 123.576 0.75 . . . . 0.0 110.808 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.688 -0.116 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.04 -37.06 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.405 0.682 . . . . 0.0 109.809 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.65 -34.86 78.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.535 1.134 . . . . 0.0 111.018 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -79.39 130.32 35.31 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.234 0.614 . . . . 0.0 109.487 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.19 156.42 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.843 0.857 . . . . 0.0 111.873 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 61' ' ' GLY . 6.0 tt -81.08 105.6 12.42 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.7 m-85 -73.66 -30.36 62.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.943 0.497 . . . . 0.0 110.601 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 148.46 -170.61 28.96 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -175.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.6 m -129.19 118.39 22.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.07 175.04 10.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HB2' ' HB2' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -126.64 97.89 5.18 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.828 0.823 . . . . 0.0 108.848 174.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.08 124.81 7.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.691 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -88.6 119.41 29.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.741 0.817 . . . . 0.0 110.358 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.73 140.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 46.8 t -72.35 139.49 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.82 58.43 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.253 -0.43 . . . . 0.0 113.895 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -23.43 67.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 111.276 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' THR . 3.5 mpt_? -75.52 -1.2 23.17 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.28 1.032 . . . . 0.0 111.817 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -45.33 -32.9 2.21 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.16 -18.03 65.1 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.792 1.237 . . . . 0.0 112.565 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 71' ' ' ARG . 14.7 t -73.78 -20.62 60.43 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.122 0.569 . . . . 0.0 110.973 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.63 48.6 0.54 Allowed Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.55 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.14 165.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 121.489 0.662 . . . . 0.0 111.524 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 18.1 m -115.52 171.84 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.238 -171.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.83 -166.78 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -63.19 149.52 45.19 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.569 0.747 . . . . 0.0 111.446 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 8.6 t30 77.17 -18.54 0.48 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.55 1.54 . . . . 0.0 112.337 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.3 mm-40 -62.56 141.78 58.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.4 mtp -105.06 143.74 32.82 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.969 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 18.2 m -129.57 132.32 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 109.795 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.42 142.25 28.75 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 109.686 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.624 HD11 ' SD ' ' A' ' 148' ' ' MET . 5.7 mp -90.68 121.14 32.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.858 0.863 . . . . 0.0 108.948 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -125.91 121.54 33.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -60.62 121.91 13.38 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -70.45 122.77 87.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.133 -163.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -20.35 36.71 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.693 2.262 . . . . 0.0 112.243 172.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -101.36 24.9 8.93 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.149 0.979 . . . . 0.0 110.667 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.81 126.75 72.74 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.588 0.755 . . . . 0.0 111.67 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.0 -24.17 6.03 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.462 2.108 . . . . 0.0 113.862 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.52 -56.08 1.99 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.228 -0.295 . . . . 0.0 111.362 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 6.4 m-20 -150.49 153.63 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.29 -14.65 57.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.863 0.865 . . . . 0.0 112.476 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.574 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 16.4 p-10 -70.3 -20.24 63.03 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.614 0.766 . . . . 0.0 111.638 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.99 109.38 3.44 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.293 0.637 . . . . 0.0 109.311 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 86.7 mt -85.09 119.51 33.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.685 0.794 . . . . 0.0 109.867 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -83.48 116.53 22.58 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG12 ' HB ' ' A' ' 83' ' ' VAL . 10.3 t -85.56 128.56 39.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -122.98 143.15 50.11 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 28.3 p-10 -82.72 -167.94 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.248 0.931 . . . . 0.0 111.259 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.34 -31.18 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.464 1.106 . . . . 0.0 112.773 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -83.93 -27.41 28.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.532 0.733 . . . . 0.0 111.05 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.18 6.53 48.16 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.582 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -66.5 120.96 14.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.801 0.84 . . . . 0.0 110.26 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -60.18 107.42 0.64 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 110.833 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.58 2.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 0.0 111.449 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 134.13 -145.69 17.73 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 173.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.13 158.51 43.46 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.034 0.934 . . . . 0.0 109.862 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD11 ' HE3' ' A' ' 148' ' ' MET . 29.1 mt -87.89 8.46 26.0 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.813 0.845 . . . . 0.0 112.456 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 69.63 129.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.558 1.143 . . . . 0.0 110.074 -172.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -44.13 -39.16 4.1 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.188 1.395 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -62.22 -54.61 38.44 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.334 1.054 . . . . 0.0 112.281 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.424 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 10.4 tt -75.08 -47.81 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.444 0.64 . . . . 0.0 110.031 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.437 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -54.92 -34.47 63.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.579 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -55.07 -37.41 63.28 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.024 0.828 . . . . 0.0 115.004 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.74 -51.49 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.976 0.51 . . . . 0.0 110.523 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 122' ' ' ILE . 30.1 mt -73.77 -20.06 60.6 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.745 -172.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.43 64.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.766 0.826 . . . . 0.0 111.896 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.22 -36.77 77.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.493 HD13 HG13 ' A' ' 160' ' ' VAL . 64.1 mt -61.82 -37.11 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 110.763 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.3 ttm -79.23 -51.17 9.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.452 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.0 -39.38 69.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.379 1.072 . . . . 0.0 111.108 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -90.57 1.64 56.55 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 62.74 43.1 7.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.413 1.085 . . . . 0.0 111.768 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 122' ' ' ILE . 45.6 mt -76.75 -48.05 19.88 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.642 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.47 149.68 27.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.198 0.599 . . . . 0.0 110.721 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -89.45 106.69 18.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.045 0.938 . . . . 0.0 109.309 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -93.89 124.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.98 160.84 14.72 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.47 144.81 15.6 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.3 t -137.7 126.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.65 90.42 5.04 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 64.9 Cg_endo -83.82 -18.7 5.35 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.519 2.146 . . . . 0.0 113.003 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -79.44 -32.63 42.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.762 0.425 . . . . 0.0 110.816 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.85 17.07 20.31 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.853 0.721 . . . . 0.0 114.599 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -84.26 0.74 47.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.608 0.763 . . . . 0.0 111.384 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -64.11 -26.4 68.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.653 1.181 . . . . 0.0 110.878 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -73.51 -30.35 63.05 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.695 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.5 11.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.277 0.631 . . . . 0.0 111.718 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -158.35 -168.64 2.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.545 0.738 . . . . 0.0 110.289 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.8 p -94.55 120.6 35.04 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.516 0.727 . . . . 0.0 109.066 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 ppp? -147.45 156.88 45.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.006 0.922 . . . . 0.0 109.743 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.581 ' HB2' ' HB2' ' A' ' 64' ' ' ARG . 26.9 Cg_endo -92.84 144.36 2.37 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.516 2.144 . . . . 0.0 113.531 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -107.38 153.91 22.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -79.73 109.57 14.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.759 0.314 . . . . 0.0 111.223 -170.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.624 ' SD ' HD11 ' A' ' 85' ' ' LEU . 22.0 mmt -89.85 110.23 21.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.896 0.878 . . . . 0.0 108.837 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m -103.46 125.25 49.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 31.5 m-85 -89.05 120.44 30.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 109.251 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.47 101.76 7.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.88 159.66 29.46 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.19 145.58 46.6 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.267 0.627 . . . . 0.0 112.614 -175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.45 -30.78 61.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.014 1.326 . . . . 0.0 113.468 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.34 -29.62 65.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.914 0.485 . . . . 0.0 111.472 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -88.66 9.8 22.92 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.285 0.634 . . . . 0.0 111.933 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 158' ' ' LYS . 11.7 ptp180 -54.93 -45.18 74.8 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.591 0.356 . . . . 0.0 111.601 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -78.94 -26.57 43.62 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.631 0.372 . . . . 0.0 111.333 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.24 89.76 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.041 0.536 . . . . 0.0 110.325 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 HD13 ' A' ' 122' ' ' ILE . 70.1 t -70.45 -45.29 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.489 1.116 . . . . 0.0 110.726 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.515 ' HB3' ' HE3' ' A' ' 165' ' ' LYS . 67.2 m -64.52 -32.15 73.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.26 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.98 -42.43 76.3 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.774 0.83 . . . . 0.0 110.865 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.05 -38.23 78.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.857 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.11 -55.43 16.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.798 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 161' ' ' SER . 93.7 mttt -56.9 -29.04 62.66 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.749 1.22 . . . . 0.0 111.993 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.08 -41.02 97.75 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.855 0.862 . . . . 0.0 111.54 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.13 3.6 25.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.768 0.427 . . . . 0.0 110.615 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.95 20.65 77.55 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.932 -0.371 . . . . 0.0 113.364 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.424 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 32.2 m-85 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.939 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -70.55 -34.76 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 168.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -47.19 48.54 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.928 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.2 m -82.69 115.04 21.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.648 0.779 . . . . 0.0 111.005 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 154' ' ' GLU . 14.3 m -107.71 162.94 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.256 1.022 . . . . 0.0 110.978 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.14 116.19 22.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.118 0.567 . . . . 0.0 109.793 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -79.43 -24.78 42.25 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.923 0.489 . . . . 0.0 110.567 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.03 -170.39 24.58 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.26 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.44 ' HB3' HG22 ' A' ' 149' ' ' THR . 22.5 p -123.1 121.35 35.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.073 0.549 . . . . 0.0 110.383 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.8 tp -80.12 145.87 32.15 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 109.876 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -76.16 85.87 3.01 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -74.2 163.96 54.61 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -141.32 91.75 2.41 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.529 1.165 . . . . 0.0 110.088 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 108' ' ' VAL . 98.9 t -76.51 127.77 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 167.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 24.9 t -68.32 141.73 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 123.737 0.648 . . . . 0.0 110.542 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.79 -44.98 23.47 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.539 0.524 . . . . 0.0 113.747 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.85 -15.79 55.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.473 0.709 . . . . 0.0 112.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HG2' ' HB ' ' A' ' 68' ' ' VAL . 36.6 mmt180 -73.81 -0.46 15.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.924 0.889 . . . . 0.0 112.54 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.484 ' HA ' HG13 ' A' ' 76' ' ' VAL . 42.5 p90 -50.72 -23.83 2.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.376 1.071 . . . . 0.0 113.843 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.72 -7.65 22.51 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.424 1.089 . . . . 0.0 112.71 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 p -73.23 -33.48 65.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.265 0.626 . . . . 0.0 109.912 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.59 48.05 0.52 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 72' ' ' TYR . 27.5 m -55.3 167.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.626 0.77 . . . . 0.0 112.268 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 m -114.12 163.88 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.27 0.628 . . . . 0.0 110.796 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -74.67 -172.19 1.47 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.312 1.045 . . . . 0.0 111.711 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -65.14 149.04 50.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.871 . . . . 0.0 111.95 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 64.88 10.75 6.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.957 1.303 . . . . 0.0 113.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.74 143.11 32.06 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.13 0.423 . . . . 0.0 111.154 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.2 mtp -83.08 145.5 29.23 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.705 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 146' ' ' LEU . 29.4 m -134.27 145.0 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.017 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.98 125.02 53.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.675 0.79 . . . . 0.0 109.895 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -90.14 138.42 31.53 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.982 0.913 . . . . 0.0 109.749 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -147.73 138.7 23.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.6 ptm180 -67.09 158.33 31.4 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.579 0.228 . . . . 0.0 110.568 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -87.99 116.06 65.0 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 123.103 0.561 . . . . 0.0 110.647 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.28 -39.06 5.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.275 1.983 . . . . 0.0 110.493 168.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -88.88 71.14 8.63 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 170.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.44 134.49 86.7 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.34 -42.16 4.11 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.961 2.44 . . . . 0.0 112.519 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -126.3 -52.79 1.5 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.461 0.704 . . . . 0.0 110.014 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -146.85 165.74 28.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.704 0.802 . . . . 0.0 109.95 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.12 -5.49 18.08 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.237 1.015 . . . . 0.0 112.581 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 1.9 m-20 -77.13 9.69 2.88 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.594 1.158 . . . . 0.0 112.586 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -93.39 139.37 30.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.479 0.712 . . . . 0.0 110.208 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 54.5 mt -127.07 120.42 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.36 1.064 . . . . 0.0 109.133 175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -87.47 115.37 24.85 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.439 0.695 . . . . 0.0 109.854 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' HG ' ' A' ' 85' ' ' LEU . 53.0 t -87.1 126.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 14.9 m-80 -117.65 164.67 14.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -95.7 -170.77 2.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.69 -22.59 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -86.64 -3.08 58.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.219 1.008 . . . . 0.0 111.908 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.68 86.08 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 122.945 0.307 . . . . 0.0 113.491 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -76.84 134.17 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.633 0.773 . . . . 0.0 108.986 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.9 pt20 -71.58 127.42 32.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 122.303 1.049 . . . . 0.0 111.662 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 67' ' ' VAL . 93.0 t -78.06 -24.79 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.177 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.41 -168.19 28.48 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.99 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -117.23 148.97 41.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 52.2 mt -75.33 -6.29 49.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.233 0.613 . . . . 0.0 112.26 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 68.74 141.86 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.262 1.025 . . . . 0.0 110.229 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -21.29 3.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -62.57 -63.03 1.35 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.071 0.948 . . . . 0.0 110.702 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.1 tt -80.36 -50.56 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.094 0.557 . . . . 0.0 109.597 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -52.8 -33.37 48.72 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.049 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -55.49 -43.48 85.43 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.105 0.878 . . . . 0.0 114.814 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.97 -48.74 72.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.23 0.538 . . . . 0.0 110.624 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.95 -18.24 60.91 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.625 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.48 91.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.12 0.968 . . . . 0.0 111.788 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -68.06 -40.78 82.7 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.549 0.531 . . . . 0.0 109.618 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 127' ' ' LEU . 55.3 mt -63.79 -37.41 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.587 0.755 . . . . 0.0 110.75 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.6 tpp -70.75 -52.61 19.7 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.16 -32.51 73.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.619 1.567 . . . . 0.0 111.689 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -99.28 -2.57 36.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.026 0.531 . . . . 0.0 111.278 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 61.13 32.51 19.62 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.898 0.879 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 122' ' ' ILE . 67.0 mt -63.39 -44.66 94.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.515 0.726 . . . . 0.0 110.145 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.45 142.23 21.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.288 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.03 107.85 5.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.479 1.112 . . . . 0.0 109.281 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.8 mt -99.36 104.83 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.4 178.72 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.21 168.76 32.01 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.466 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 63.9 t -141.36 125.73 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.43 100.66 2.43 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.46 -44.33 2.35 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.837 2.358 . . . . 0.0 113.812 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.47 -23.9 14.96 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 0.0 111.285 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.48 27.66 71.2 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.304 0.377 . . . . 0.0 113.547 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -81.29 4.82 19.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.475 0.71 . . . . 0.0 112.174 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 93.4 m-20 -63.43 -9.51 12.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.078 0.951 . . . . 0.0 112.004 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -64.42 -42.14 96.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.916 0.887 . . . . 0.0 111.008 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.8 -60.9 1.47 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.827 0.851 . . . . 0.0 111.147 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 84.6 m-85 -139.48 -173.62 3.66 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.875 . . . . 0.0 109.444 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 t -93.04 134.91 34.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 4.4 ppp? -137.95 153.12 73.32 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.706 0.802 . . . . 0.0 109.96 -172.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 21.4 Cg_exo -67.46 122.09 9.27 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.17 1.914 . . . . 0.0 112.637 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.496 HD22 ' HE2' ' A' ' 148' ' ' MET . 6.5 tt -100.91 124.54 46.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -80.17 110.16 15.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -172.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.597 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -112.81 116.32 29.88 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -171.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 62' ' ' SER . 37.8 p -102.71 133.68 47.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.95 1.3 . . . . 0.0 110.306 -165.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -100.95 117.76 35.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.834 0.853 . . . . 0.0 109.166 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -119.19 99.05 6.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.417 0.687 . . . . 0.0 109.508 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 163.44 31.73 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 146.47 24.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 111.655 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG2' HG21 ' A' ' 58' ' ' VAL . 44.6 mt-10 -58.97 -18.78 37.09 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.36 -32.31 43.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.087 0.403 . . . . 0.0 111.296 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -77.9 -6.92 55.88 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -57.95 -27.79 63.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.219 0.463 . . . . 0.0 110.791 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.78 -53.2 59.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.12 0.968 . . . . 0.0 109.138 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.88 -30.97 65.96 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.97 0.908 . . . . 0.0 112.081 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD13 ' A' ' 122' ' ' ILE . 56.1 t -71.13 -55.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.157 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.2 t -66.1 -22.69 66.41 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.903 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.22 -44.56 92.3 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.085 0.554 . . . . 0.0 110.307 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -79.51 -30.14 41.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.237 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.69 -61.01 2.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.85 -21.1 65.7 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.752 1.221 . . . . 0.0 112.101 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -53.45 -46.51 69.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.653 0.781 . . . . 0.0 110.493 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -99.72 -16.91 17.98 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.129 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.47 16.77 21.61 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 116.554 -0.294 . . . . 0.0 113.177 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 122.825 0.45 . . . . 0.0 110.095 170.792 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.952 0.406 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.42 -22.16 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.642 0.777 . . . . 0.0 110.444 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -72.94 -46.65 51.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.271 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -80.19 113.88 18.69 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 154' ' ' GLU . 13.8 m -107.19 156.43 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.148 0.979 . . . . 0.0 111.327 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.79 109.6 14.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.445 0.698 . . . . 0.0 109.762 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 26.6 m-85 -74.38 -36.23 63.53 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 110.972 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.64 -176.03 36.44 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.769 0.668 . . . . 0.0 112.558 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 148' ' ' MET . 49.4 p -115.92 122.35 45.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.119 0.968 . . . . 0.0 110.532 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 169' ' ' PHE . 48.2 tp -99.86 137.46 38.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.941 0.496 . . . . 0.0 109.711 173.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -90.78 83.98 5.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -75.21 153.07 44.43 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.469 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -116.47 111.05 19.43 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.832 1.316 . . . . 0.0 109.978 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 111' ' ' LEU . 2.5 t -94.68 157.32 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.083 0.953 . . . . 0.0 109.118 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' HIS . 30.5 m -76.05 161.94 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.83 -17.74 74.34 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.326 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.7 -18.42 30.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.308 1.043 . . . . 0.0 111.431 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.683 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 63.8 mtp180 -49.86 -33.31 16.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.394 1.078 . . . . 0.0 113.204 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.27 -43.87 92.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.217 0.607 . . . . 0.0 110.628 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -71.62 -35.49 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.457 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -74.95 -16.93 60.62 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.089 0.555 . . . . 0.0 111.798 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.76 54.3 0.54 Allowed Glycine 0 C--N 1.357 1.713 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.282 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.3 m -40.9 164.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 19.3 m -114.51 167.16 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.527 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.38 -79.27 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.309 0.644 . . . . 0.0 111.825 -170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.6 154.15 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.789 0.835 . . . . 0.0 110.308 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.79 28.56 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.943 1.297 . . . . 0.0 111.83 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 49.8 mm-40 -87.25 142.82 27.62 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.327 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 78.0 mtp -99.76 127.88 45.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 102' ' ' ASN . 35.6 m -118.04 163.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.294 1.038 . . . . 0.0 108.997 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.48 128.41 47.98 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' A' ' 98' ' ' ILE . 12.8 mt -80.18 112.01 17.09 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -123.78 115.12 20.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 108.316 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 37.2 ptt180 -57.03 133.82 55.28 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 121.106 0.479 . . . . 0.0 110.925 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.2 118.94 57.86 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.138 -161.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.667 2.245 . . . . 0.0 112.039 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -111.08 32.38 5.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.422 1.089 . . . . 0.0 109.73 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.41 127.3 65.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.877 0.871 . . . . 0.0 111.773 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.37 -48.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.033 1.822 . . . . 0.0 113.011 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -99.04 -50.5 4.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.792 0.437 . . . . 0.0 110.524 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -159.59 156.57 28.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.17 0.588 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -7.26 12.63 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.519 1.528 . . . . 0.0 113.559 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.582 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 26.1 p-10 -64.13 -30.7 71.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.003 0.521 . . . . 0.0 111.584 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.06 125.85 25.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.892 0.745 . . . . 0.0 109.239 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 70.5 mt -113.2 127.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 109.647 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 151.17 32.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 172.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.1 t -110.58 120.46 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.748 1.219 . . . . 0.0 107.854 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -119.06 127.46 53.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HA ' HG12 ' A' ' 83' ' ' VAL . 35.4 p-10 -71.93 -173.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.392 0.677 . . . . 0.0 112.385 -175.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.78 -31.9 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 C-N-CA 124.147 0.979 . . . . 0.0 112.293 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.73 -31.83 63.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.642 0.777 . . . . 0.0 111.053 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.68 -3.38 42.32 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.342 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -67.72 136.54 54.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.117 0.967 . . . . 0.0 110.836 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.5 pm0 -67.1 117.74 9.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.19 -2.38 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.385 0.674 . . . . 0.0 111.644 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 71' ' ' ARG . . . 152.59 -177.15 30.48 Favored Glycine 0 C--N 1.36 1.913 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 172.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 68' ' ' VAL . 55.6 m-70 -108.95 151.32 26.46 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HA ' HG13 ' A' ' 67' ' ' VAL . 52.0 mt -72.58 -55.03 7.54 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.581 0.628 . . . . 0.0 112.386 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 147.31 143.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.241 1.816 . . . . 0.0 106.104 -162.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.506 ' HG2' HD21 ' A' ' 96' ' ' ASN . 5.5 tmmm? -65.83 -41.41 91.83 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.861 0.464 . . . . 0.0 109.97 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.63 -52.67 42.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.802 0.841 . . . . 0.0 111.384 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 111' ' ' LEU . 62.6 tp -59.78 -57.12 14.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.12 70.15 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.994 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -60.69 -42.54 99.38 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.631 0.582 . . . . 0.0 113.307 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.73 71.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.36 0.664 . . . . 0.0 110.163 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 130' ' ' ILE . 61.3 mt -71.79 -17.79 62.15 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.17 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.33 77.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.372 1.069 . . . . 0.0 112.042 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.07 -35.76 64.28 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.063 0.545 . . . . 0.0 109.629 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 127' ' ' LEU . 51.6 mt -65.1 -36.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.39 0.614 . . . . 0.0 110.02 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 123' ' ' MET . 41.1 tpp -70.23 -44.21 69.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.913 1.285 . . . . 0.0 111.099 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.65 -48.71 24.73 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.263 -173.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -91.05 5.83 47.32 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.619 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 60.62 34.66 20.11 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.048 0.939 . . . . 0.0 111.641 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' HB2' HG23 ' A' ' 122' ' ' ILE . 81.8 mt -65.92 -41.56 91.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.583 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.66 141.39 8.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 110.269 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.23 107.48 14.06 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 HD22 ' A' ' 119' ' ' LEU . 18.6 mt -92.49 117.82 36.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -85.79 166.21 16.25 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -130.53 143.86 15.21 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 170.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.85 130.85 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.697 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.4 p -118.15 85.71 24.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.48 -38.68 0.67 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.642 2.228 . . . . 0.0 113.535 -171.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.38 -29.73 65.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.964 0.506 . . . . 0.0 110.384 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.31 17.23 68.1 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.57 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.99 9.94 4.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.111 0.965 . . . . 0.0 112.39 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 140' ' ' ASN . 0.2 OUTLIER -66.0 -21.27 66.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.699 0.799 . . . . 0.0 111.547 172.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 139' ' ' ASN . 5.3 t30 -75.66 -46.74 29.66 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 110.014 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.82 12.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.336 0.655 . . . . 0.0 111.663 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.11 -166.26 1.74 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.171 0.988 . . . . 0.0 110.129 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p -96.11 117.8 31.44 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.697 ' SD ' HG23 ' A' ' 134' ' ' VAL . 22.3 ptm -115.56 157.56 43.94 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.838 0.455 . . . . 0.0 111.27 -173.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.7 Cg_endo -71.1 124.84 10.87 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.319 2.012 . . . . 0.0 112.835 173.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.416 HD23 ' HE2' ' A' ' 148' ' ' MET . 24.6 tp -85.9 117.62 24.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.324 1.05 . . . . 0.0 108.792 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -75.33 107.77 7.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' SER . 64.4 mtt -106.23 137.74 43.65 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.964 0.906 . . . . 0.0 109.961 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.6 p -126.35 116.9 21.92 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -85.4 118.6 25.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.795 0.838 . . . . 0.0 109.292 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -122.68 101.41 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.665 0.786 . . . . 0.0 109.139 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.62 31.21 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.799 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 138.43 29.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.588 1.155 . . . . 0.0 112.427 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.471 ' HG2' HG21 ' A' ' 58' ' ' VAL . 42.0 mt-10 -58.92 -22.17 59.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 112.988 -175.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.34 -18.03 64.99 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.195 0.598 . . . . 0.0 112.056 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -44.0 75.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -167.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -24.64 51.32 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.578 0.351 . . . . 0.0 111.211 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.11 -35.21 61.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.839 0.455 . . . . 0.0 110.52 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.0 -50.63 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.032 0.933 . . . . 0.0 110.375 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p -66.94 -31.82 72.66 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.153 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.46 -39.7 67.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.215 0.606 . . . . 0.0 111.531 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -69.25 -37.35 77.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.946 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.2 mt -69.33 -55.48 10.3 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.587 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -54.64 -32.57 59.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.258 1.423 . . . . 0.0 112.134 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.08 -44.34 83.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -98.66 -15.3 19.47 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.434 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.31 9.48 50.89 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.8 m-85 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.332 0.653 . . . . 0.0 110.713 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 -30.69 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.39 -26.93 52.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.665 1.186 . . . . 0.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -61.78 149.39 40.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.787 0.835 . . . . 0.0 112.142 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.23 162.63 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.603 1.161 . . . . 0.0 110.064 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 tp -85.81 117.13 24.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.948 0.499 . . . . 0.0 110.22 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 24.8 m-85 -82.18 -34.03 29.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.994 0.518 . . . . 0.0 110.71 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.93 -166.63 33.04 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.932 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.9 p -115.1 169.22 9.27 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.666 0.787 . . . . 0.0 110.837 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 tp -147.8 139.04 23.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.293 0.637 . . . . 0.0 109.394 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -76.35 93.73 3.51 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.077 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.43 81.3 1.23 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.484 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -71.75 114.32 9.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -107.45 135.61 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.915 0.886 . . . . 0.0 109.189 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.82 151.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 124.506 1.122 . . . . 0.0 111.277 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.87 -21.7 31.26 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.19 -16.52 45.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.873 0.869 . . . . 0.0 112.067 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.746 HH12 HG22 ' A' ' 143' ' ' THR . 34.1 ptt-85 -49.74 -27.94 5.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.777 1.631 . . . . 0.0 113.227 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -63.31 -48.53 77.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.864 0.466 . . . . 0.0 110.262 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.26 -28.98 67.68 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.575 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.6 m -74.66 -24.86 58.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.811 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.88 53.76 0.33 Allowed Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.483 -0.62 . . . . 0.0 114.583 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -43.71 165.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.595 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.2 m -115.96 178.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.756 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.91 -82.05 0.38 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.872 0.469 . . . . 0.0 109.757 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -159.34 165.29 33.65 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.948 0.899 . . . . 0.0 109.732 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.581 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 1.9 m-20 64.38 7.6 3.71 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.875 1.27 . . . . 0.0 112.293 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.7 mm-40 -84.87 124.25 31.4 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.332 0.653 . . . . 0.0 110.788 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.6 mtm -88.16 130.35 35.07 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 25.3 m -125.26 126.53 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.753 0.821 . . . . 0.0 110.78 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.66 136.62 33.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.263 1.025 . . . . 0.0 110.229 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.544 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -87.57 141.56 28.52 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.49 0.716 . . . . 0.0 109.596 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -154.05 133.5 12.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 26.9 ptt180 -60.24 131.6 51.3 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 15.5 t70 -84.64 125.1 72.23 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' ASP . 37.6 Cg_exo -61.04 -37.55 75.15 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.307 2.671 . . . . 0.0 113.523 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.92 36.59 4.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.626 0.77 . . . . 0.0 109.732 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 88' ' ' ASP . 21.5 t-20 -63.41 127.73 91.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.95 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.25 -23.32 33.24 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.9 2.4 . . . . 0.0 113.636 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -79.62 -52.15 8.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.7 t70 177.98 156.77 0.39 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.427 1.091 . . . . 0.0 109.951 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -57.14 -33.48 67.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.865 1.266 . . . . 0.0 113.599 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.4 -12.99 58.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.296 0.639 . . . . 0.0 111.883 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.1 128.77 37.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.176 0.591 . . . . 0.0 111.315 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.1 mt -92.95 125.04 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.991 0.917 . . . . 0.0 110.532 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -96.38 126.18 41.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.432 HG12 ' HB ' ' A' ' 83' ' ' VAL . 14.3 t -93.89 143.4 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -127.86 147.3 50.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.629 1.172 . . . . 0.0 108.111 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p-10 -78.8 169.03 18.86 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.047 0.84 . . . . 0.0 110.051 170.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.67 -10.47 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.499 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.1 t-20 -73.12 -22.84 60.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 110.374 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 40.93 5.1 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -122.41 133.09 54.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.788 0.835 . . . . 0.0 109.788 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -63.47 131.35 47.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.332 0.653 . . . . 0.0 110.791 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.29 -32.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.399 0.68 . . . . 0.0 111.817 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.53 -171.65 44.73 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -128.65 139.78 52.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.022 0.929 . . . . 0.0 109.861 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.44 1.98 56.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.499 0.72 . . . . 0.0 111.8 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 67.74 -176.88 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.545 1.138 . . . . 0.0 110.382 -167.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -39.86 45.24 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -51.48 -63.25 1.19 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.279 0.987 . . . . 0.0 112.325 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.21 -39.08 88.9 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.518 0.675 . . . . 0.0 110.748 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.15 -21.62 63.99 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.348 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.22 -15.53 70.06 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.191 0.424 . . . . 0.0 113.412 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.11 -51.99 6.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.931 0.872 . . . . 0.0 109.062 165.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.4 HD22 HD13 ' A' ' 130' ' ' ILE . 60.2 mt -70.44 -17.46 63.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.72 -169.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.71 90.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.276 1.03 . . . . 0.0 111.895 -173.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -75.07 -33.73 61.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.949 0.5 . . . . 0.0 109.9 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.455 HD13 HG13 ' A' ' 160' ' ' VAL . 31.6 mt -70.15 -31.73 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.074 0.549 . . . . 0.0 110.115 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.9 tpp -79.43 -43.3 23.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.026 1.33 . . . . 0.0 110.798 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.25 -50.29 28.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.811 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -88.97 -0.62 57.57 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.427 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 59.59 32.45 21.59 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.653 1.181 . . . . 0.0 111.846 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 122' ' ' ILE . 68.0 mt -59.12 -39.39 82.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.142 0.977 . . . . 0.0 111.405 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.08 132.33 11.89 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.599 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.27 105.64 2.6 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.991 0.916 . . . . 0.0 109.266 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.4 HD13 HD22 ' A' ' 119' ' ' LEU . 12.2 mt -89.83 108.22 19.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.44 146.12 36.44 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -123.31 162.66 17.11 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -149.2 140.59 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.517 1.127 . . . . 0.0 108.033 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.06 87.31 34.0 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 57.4 Cg_endo -88.6 0.2 6.52 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.045 2.496 . . . . 0.0 112.907 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.25 -31.3 20.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.977 0.511 . . . . 0.0 112.009 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.58 -6.52 23.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.64 9.03 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.028 0.914 . . . . 0.0 112.715 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.48 -15.59 61.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.674 1.19 . . . . 0.0 111.367 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.29 -55.19 5.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.945 0.898 . . . . 0.0 111.071 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.71 -61.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.452 0.701 . . . . 0.0 111.641 -171.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 -178.63 3.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.538 0.735 . . . . 0.0 109.823 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.746 HG22 HH12 ' A' ' 71' ' ' ARG . 15.9 p -92.29 109.05 20.42 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -112.24 120.44 41.59 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.716 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.58 125.12 8.73 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.025 1.816 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 148' ' ' MET . 4.5 pp -89.37 146.94 24.34 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -73.36 107.36 5.62 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.127 0.571 . . . . 0.0 110.611 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.546 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 63.2 mtt -97.82 166.81 11.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.751 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.8 p -154.36 146.52 23.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.23 1.012 . . . . 0.0 109.634 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -109.19 120.39 42.39 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.134 0.974 . . . . 0.0 109.477 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -123.87 98.78 5.96 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.637 0.775 . . . . 0.0 109.647 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.31 162.46 30.63 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -55.57 142.57 33.0 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.647 0.779 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.34 -37.9 17.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.774 1.23 . . . . 0.0 113.465 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 158' ' ' LYS . 12.7 pt-20 -65.94 -29.78 70.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.213 0.605 . . . . 0.0 112.171 -174.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.22 4.19 13.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -61.71 -40.5 95.25 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 118.156 0.435 . . . . 0.0 111.31 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -69.31 -25.45 64.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.43 0.692 . . . . 0.0 111.192 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.6 -45.61 15.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.58 0.752 . . . . 0.0 110.567 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 122' ' ' ILE . 67.6 t -65.95 -45.68 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.449 1.1 . . . . 0.0 110.983 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.5 p -66.94 -32.01 72.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.151 0.58 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.46 -47.11 82.73 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.599 0.562 . . . . 0.0 110.838 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.0 mm100 -63.28 -44.27 95.57 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.37 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.23 -52.81 29.93 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.775 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.44 -22.69 66.79 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.798 0.839 . . . . 0.0 112.193 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -53.02 -46.56 68.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.157 0.983 . . . . 0.0 111.141 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -108.24 -11.9 15.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.114 0.966 . . . . 0.0 111.247 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.87 30.58 25.87 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.885 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.707 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.759 0.314 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.59 -31.62 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.801 0.84 . . . . 0.0 109.645 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.92 -12.13 57.61 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.056 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.7 m -63.7 133.39 53.5 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.135 0.493 . . . . 0.0 110.717 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.2 m -129.18 163.62 33.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 124.84 1.256 . . . . 0.0 109.061 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.524 HD11 HG22 ' A' ' 149' ' ' THR . 40.3 tp -86.82 117.31 25.48 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -82.72 -31.42 28.48 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.65 -151.89 23.83 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.464 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -132.49 178.96 6.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.484 0.713 . . . . 0.0 110.684 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 39.0 tp -159.01 154.37 25.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.264 0.626 . . . . 0.0 110.186 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 94.69 5.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.978 0.911 . . . . 0.0 108.729 174.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.64 121.33 5.83 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -93.24 100.4 12.77 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.169 0.984 . . . . 0.0 109.751 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 7.9 p -82.88 145.68 8.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.368 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.8 m -65.72 156.02 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.18 0.992 . . . . 0.0 111.472 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 143' ' ' THR . . . -73.18 -23.42 77.6 Favored Glycine 0 N--CA 1.47 0.915 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.091 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt -51.29 -18.2 0.9 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.37 1.468 . . . . 0.0 112.678 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.628 HH12 HG21 ' A' ' 134' ' ' VAL . 13.8 ttt180 -47.19 -32.63 4.56 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.155 1.782 . . . . 0.0 112.755 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 26.0 p90 -63.22 -41.03 99.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.288 0.566 . . . . 0.0 110.933 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -69.53 -27.85 65.52 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.577 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 107' ' ' GLN . 6.0 m -101.48 -4.11 27.39 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.825 -170.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.32 52.56 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.965 172.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -44.42 156.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.2 175.88 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.087 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.78 -173.77 4.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.85 0.86 . . . . 0.0 111.157 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.3 151.45 39.82 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.933 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.57 -0.57 1.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.01 1.324 . . . . 0.0 113.883 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -73.33 128.48 35.61 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.272 0.487 . . . . 0.0 112.303 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.46 ' HG2' HG22 ' A' ' 133' ' ' VAL . 77.4 mtp -79.63 148.22 31.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.719 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.49 HG11 HH22 ' A' ' 71' ' ' ARG . 23.1 m -143.74 146.82 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.617 1.167 . . . . 0.0 108.8 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -97.5 156.07 16.66 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.177 0.991 . . . . 0.0 110.084 175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD12 ' HB ' ' A' ' 130' ' ' ILE . 27.7 mt -89.0 161.58 16.51 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.535 . . . . 0.0 109.636 168.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.56 144.88 18.45 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -80.68 123.28 28.04 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -60.53 109.0 1.68 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.79 -15.17 46.5 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.789 2.326 . . . . 0.0 113.123 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.54 90.81 3.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.03 115.88 22.83 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.12 -51.56 5.43 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.976 2.451 . . . . 0.0 112.624 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.8 -47.28 1.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.68 0.792 . . . . 0.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -122.98 137.92 54.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.522 0.729 . . . . 0.0 109.736 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -57.82 -27.12 62.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.792 1.237 . . . . 0.0 113.232 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.433 HD22 ' HA2' ' A' ' 117' ' ' GLY . 28.3 p-10 -84.86 -1.79 56.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.424 0.689 . . . . 0.0 112.827 -173.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.92 111.08 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.876 0.87 . . . . 0.0 111.19 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 119' ' ' LEU . 66.0 mt -96.03 108.62 21.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 C-N-CA 123.259 0.624 . . . . 0.0 110.118 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 32.2 ttpt -88.91 142.16 27.89 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.393 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.96 143.87 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.761 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 5.7 p30 -130.0 150.98 51.04 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.089 1.356 . . . . 0.0 107.878 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HA ' HG12 ' A' ' 83' ' ' VAL . 28.6 p-10 -90.51 -176.92 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.854 0.752 . . . . 0.0 111.04 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 m -57.83 -29.18 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.581 0.753 . . . . 0.0 112.649 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.84 -18.04 41.82 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.947 0.499 . . . . 0.0 111.245 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.04 50.17 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.042 0.353 . . . . 0.0 113.556 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.38 114.53 4.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.958 0.903 . . . . 0.0 109.174 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 74' ' ' THR . 22.9 pt20 -59.85 105.15 0.35 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.34 -17.81 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.392 0.677 . . . . 0.0 111.376 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.14 158.5 9.94 Favored Glycine 0 N--CA 1.473 1.107 0 O-C-N 122.954 0.159 . . . . 0.0 112.957 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 6.9 p-80 -81.86 154.59 25.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.3 0.64 . . . . 0.0 112.666 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 45.9 mt -70.73 -51.44 27.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.907 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 24.4 ttmm 156.65 145.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.642 1.577 . . . . 0.0 107.204 -166.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -23.59 55.33 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.755 0.707 . . . . 0.0 111.196 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.528 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 37.5 tt0 -74.24 -42.39 59.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.937 0.495 . . . . 0.0 110.569 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -47.54 85.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.93 67.61 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.866 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA2' HD22 ' A' ' 96' ' ' ASN . . . -53.86 -37.57 57.95 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.139 0.4 . . . . 0.0 113.746 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.05 -55.54 4.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.125 0.57 . . . . 0.0 110.475 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 122' ' ' ILE . 11.7 mt -68.16 -17.38 64.32 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.249 -171.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 96' ' ' ASN . . . -56.16 -54.35 46.16 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.556 1.142 . . . . 0.0 111.62 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.54 -29.11 69.12 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.183 0.927 . . . . 0.0 110.76 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 HG13 ' A' ' 160' ' ' VAL . 48.3 mt -68.59 -40.35 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.332 0.653 . . . . 0.0 110.143 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 52.0 ttm -80.1 -28.13 39.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.638 0.775 . . . . 0.0 111.446 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.96 -48.61 20.47 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.536 0.734 . . . . 0.0 110.614 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -95.43 5.25 52.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.547 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 57.45 37.26 27.76 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.44 1.096 . . . . 0.0 111.344 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 70.6 mt -61.01 -52.77 63.59 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.332 -177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 160' ' ' VAL . . . -146.14 161.49 40.08 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.615 0.766 . . . . 0.0 111.023 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -101.18 107.28 18.64 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.129 0.972 . . . . 0.0 108.556 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HD12 ' A' ' 85' ' ' LEU . 27.7 mt -96.56 112.11 28.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -93.4 173.55 7.65 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.74 154.82 24.53 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 82' ' ' MET . 93.7 t -141.87 129.58 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.628 HG21 HH12 ' A' ' 71' ' ' ARG . 61.7 t -99.62 87.16 0.64 Allowed Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 4.5 Cg_exo -76.25 -51.11 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.52 -165.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.416 ' HD2' ' HE3' ' A' ' 144' ' ' MET . 22.7 m-85 -71.81 -27.16 62.74 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.798 0.839 . . . . 0.0 110.844 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.76 18.45 72.28 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.356 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.64 1.95 27.8 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.834 0.853 . . . . 0.0 112.134 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -57.5 -25.73 60.24 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.53 1.532 . . . . 0.0 114.304 -176.199 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -86.65 -38.65 16.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.606 0.762 . . . . 0.0 111.386 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.65 -20.15 21.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.534 0.734 . . . . 0.0 112.039 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.73 173.08 16.58 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.297 0.639 . . . . 0.0 109.717 -167.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 69' ' ' GLY . 44.7 p -94.36 109.68 21.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE3' ' HD2' ' A' ' 136' ' ' PHE . 23.0 ptm -113.73 155.72 44.66 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 122.935 0.494 . . . . 0.0 111.004 -170.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.89 127.53 4.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.349 2.033 . . . . 0.0 111.369 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -92.75 143.23 26.5 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -69.9 107.41 3.55 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 16.3 mtp -94.78 150.24 20.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.09 130.38 22.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 113.7 25.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.391 0.676 . . . . 0.0 109.574 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.22 100.6 6.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.6 160.35 28.44 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -53.65 143.88 19.14 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.676 0.79 . . . . 0.0 112.496 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 2.3 tm-20 -50.77 -46.4 59.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.128 1.371 . . . . 0.0 111.454 -173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -58.94 -18.28 32.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 127' ' ' LEU . 1.4 t-20 -100.51 0.22 39.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -166.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 3.4 ppt_? -52.17 -37.28 54.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -171.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -81.72 -30.18 32.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.58 0.352 . . . . 0.0 111.366 -177.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.83 -43.31 46.59 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.086 0.554 . . . . 0.0 111.237 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 122' ' ' ILE . 61.9 t -62.7 -42.64 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.851 0.86 . . . . 0.0 110.73 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.0 t -64.24 -35.38 80.62 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.02 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -57.0 -41.16 77.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.959 0.904 . . . . 0.0 110.934 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.44 -36.32 78.86 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.723 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.4 mt -68.71 -44.35 74.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.021 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -59.37 -27.71 66.21 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.611 1.164 . . . . 0.0 111.879 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -54.62 -52.17 63.08 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 111.954 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -93.59 -23.68 18.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.472 0.709 . . . . 0.0 110.34 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.89 16.82 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.528 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 123.463 0.705 . . . . 0.0 110.53 174.366 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.55 -29.4 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.133 0.973 . . . . 0.0 109.811 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.94 -24.9 43.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 0.0 111.004 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -78.69 122.77 26.41 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.203 0.601 . . . . 0.0 109.822 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 154' ' ' GLU . 27.0 m -124.16 175.87 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.873 1.269 . . . . 0.0 110.196 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.43 121.41 30.79 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.426 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.0 m-85 -85.26 -40.3 16.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.097 0.559 . . . . 0.0 110.042 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.19 -151.54 23.4 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.605 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.9 p -123.56 -179.82 4.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.914 0.886 . . . . 0.0 111.073 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 26.7 tp -156.28 155.78 32.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -93.53 90.59 6.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.962 0.905 . . . . 0.0 108.72 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.21 88.89 1.37 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -70.31 93.9 0.89 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.174 0.487 . . . . 0.0 110.398 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 32.4 t -95.14 143.48 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 109.723 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.07 143.2 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.162 0.585 . . . . 0.0 111.563 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 143' ' ' THR . . . -80.44 -19.91 67.8 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 113.051 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.1 tp -59.94 -22.62 62.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.23 1.012 . . . . 0.0 112.146 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.463 ' HE ' HG23 ' A' ' 108' ' ' VAL . 13.9 ptt-85 -74.4 0.26 15.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.493 1.117 . . . . 0.0 112.567 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -42.56 -40.3 2.62 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.483 1.513 . . . . 0.0 114.094 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -56.85 -24.78 53.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.408 1.083 . . . . 0.0 113.218 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 m -75.56 -7.16 53.49 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.749 0.82 . . . . 0.0 111.626 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.3 2.74 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 140' ' ' ASN . 31.6 m -62.54 169.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 28.2 m -114.29 149.32 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.932 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -97.17 -97.14 0.2 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -107.94 144.11 35.66 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.192 0.597 . . . . 0.0 111.606 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 t30 59.19 10.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.39 1.476 . . . . 0.0 112.634 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.614 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 68.3 mm-40 -79.83 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 122.782 0.433 . . . . 0.0 110.611 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -88.43 117.62 27.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 23.2 m -113.86 135.06 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.142 0.977 . . . . 0.0 109.923 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.1 55.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.688 0.795 . . . . 0.0 109.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.3 mp -81.88 141.06 33.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.629 0.771 . . . . 0.0 109.216 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -151.55 148.47 28.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.127 0.571 . . . . 0.0 109.929 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -58.81 144.41 44.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.186 0.994 . . . . 0.0 112.144 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.36 93.03 22.88 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.39 -24.62 12.05 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.708 2.272 . . . . 0.0 112.978 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.68 59.02 2.79 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.21 1.005 . . . . 0.0 110.469 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 15.1 m120 -108.32 143.09 26.74 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.768 164.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.58 -19.15 32.6 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.379 2.053 . . . . 0.0 111.156 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -77.59 -53.32 7.72 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.269 0.628 . . . . 0.0 110.467 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 4.8 t70 -177.04 152.04 0.87 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.815 0.697 . . . . 0.0 109.444 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.38 -19.14 64.61 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.331 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -77.37 -1.81 31.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.575 1.15 . . . . 0.0 113.006 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 138.68 46.44 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.98 123.69 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.934 0.894 . . . . 0.0 109.838 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.18 116.58 24.46 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.748 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.48 131.85 33.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -119.05 165.69 13.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 107.645 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.2 p-10 -98.29 -165.5 1.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.321 0.51 . . . . 0.0 110.056 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.69 -32.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.164 0.586 . . . . 0.0 112.109 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.755 0.822 . . . . 0.0 110.934 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -0.27 82.13 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.89 118.02 9.1 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.032 0.933 . . . . 0.0 109.155 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -62.27 122.16 14.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.8 0.687 . . . . 0.0 110.377 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG23 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -89.08 -12.79 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.097 173.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.93 -164.84 24.41 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -84.21 157.37 21.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.174 0.59 . . . . 0.0 110.015 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 4.0 tt -80.71 -55.27 4.95 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 158.21 127.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -163.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -58.22 9.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.369 0.668 . . . . 0.0 110.707 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -54.3 -48.38 71.36 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.376 1.071 . . . . 0.0 112.291 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.37 -40.24 77.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.83 -34.05 76.52 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.705 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.33 -32.28 80.29 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.913 0.758 . . . . 0.0 113.539 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.06 -59.16 2.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.397 0.618 . . . . 0.0 109.962 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.6 -15.04 63.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.38 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.82 72.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.116 1.366 . . . . 0.0 112.631 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -69.25 -32.95 72.5 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.586 0.554 . . . . 0.0 110.02 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 127' ' ' LEU . 50.3 mt -70.72 -34.29 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.461 0.705 . . . . 0.0 110.336 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 39.0 tpp -80.25 -39.36 29.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.612 1.165 . . . . 0.0 111.268 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -83.04 -37.43 23.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.194 0.998 . . . . 0.0 110.426 -171.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.55 6.31 47.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 53.58 39.2 29.77 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.509 1.124 . . . . 0.0 112.724 171.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.433 ' HB2' HG23 ' A' ' 122' ' ' ILE . 75.6 mt -66.06 -40.98 91.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.893 0.877 . . . . 0.0 111.09 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -151.62 138.11 18.62 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.102 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -77.23 107.03 9.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.604 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.29 110.95 24.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.25 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.57 179.0 4.99 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.586 0.754 . . . . 0.0 109.34 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -160.18 160.62 31.84 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 82' ' ' MET . 61.0 t -142.66 120.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 2.4 p -95.08 100.48 5.69 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.173 0.589 . . . . 0.0 109.901 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.74 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.832 2.355 . . . . 0.0 113.397 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.65 -27.63 45.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.587 0.755 . . . . 0.0 111.833 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.95 79.34 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.066 0.387 . . . . 0.0 114.066 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -75.92 -15.17 60.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.017 0.527 . . . . 0.0 111.348 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -9.57 33.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.594 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.8 m-20 -73.64 -56.92 4.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.818 0.447 . . . . 0.0 110.664 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.94 -42.38 7.16 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.169 0.587 . . . . 0.0 111.082 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.24 161.38 13.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.086 0.954 . . . . 0.0 111.468 -171.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 69' ' ' GLY . 67.1 p -95.73 109.02 21.38 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 22.8 ptm -131.75 151.0 77.82 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 122.59 0.356 . . . . 0.0 111.168 -169.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.06 129.13 4.53 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.618 2.212 . . . . 0.0 111.592 164.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -114.24 156.29 24.59 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.135 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -75.56 107.68 7.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.799 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.585 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 61.3 mtt -97.84 160.12 14.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.357 1.063 . . . . 0.0 109.008 173.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.27 135.03 30.24 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -169.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.594 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 96.9 m-85 -100.76 120.41 40.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.923 0.889 . . . . 0.0 110.144 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.89 110.17 12.75 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.9 39.98 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -64.19 141.31 58.82 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.955 0.502 . . . . 0.0 111.768 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.2 mt-10 -55.14 -31.05 61.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -171.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.49 -20.89 66.15 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.275 0.63 . . . . 0.0 112.199 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.09 -1.0 46.19 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.087 -0.959 . . . . 0.0 113.151 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -64.92 -29.73 70.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 119.593 1.088 . . . . 0.0 111.118 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -29.56 65.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.389 0.676 . . . . 0.0 111.082 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.63 -42.58 19.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.292 0.637 . . . . 0.0 110.271 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.46 -47.15 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.769 1.227 . . . . 0.0 110.83 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.5 t -61.85 -39.93 93.58 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.2 t70 -56.28 -41.29 75.64 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.837 0.71 . . . . 0.0 111.248 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 72.8 mm-40 -72.0 -35.6 69.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.643 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.35 -51.64 34.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.106 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.95 -33.23 72.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.613 1.165 . . . . 0.0 111.717 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 29.4 ttmt -54.8 -44.87 74.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.06 1.344 . . . . 0.0 111.43 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 -17.71 17.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.217 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.83 30.77 16.97 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.882 -0.399 . . . . 0.0 113.916 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' LEU . 53.7 m-85 . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 117.402 0.601 . . . . 0.0 109.532 172.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.94 -29.99 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.941 0.496 . . . . 0.0 110.125 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.09 -9.46 27.97 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.425 0.69 . . . . 0.0 110.937 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -71.28 116.06 11.16 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.41 165.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.774 1.229 . . . . 0.0 110.421 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.44 117.44 23.07 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.161 0.584 . . . . 0.0 110.087 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.416 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.1 m-85 -84.68 -24.79 28.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.53 -158.7 27.07 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.472 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.2 p -112.22 178.78 4.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.327 0.651 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 37.3 tp -152.91 147.93 26.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.074 0.549 . . . . 0.0 109.844 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -84.27 87.5 7.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.709 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.36 93.83 0.91 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.926 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -67.42 111.91 4.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.749 0.82 . . . . 0.0 110.965 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG12 HD23 ' A' ' 111' ' ' LEU . 19.6 m -113.24 145.81 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.689 0.796 . . . . 0.0 109.119 172.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 143' ' ' THR . 26.2 m -96.58 153.33 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.173 0.589 . . . . 0.0 111.447 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.07 -19.88 68.81 Favored Glycine 0 N--CA 1.477 1.41 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.29 -17.57 58.99 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.504 0.669 . . . . 0.0 112.028 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.558 ' NH2' HG23 ' A' ' 108' ' ' VAL . 15.3 mtp180 -69.48 -2.38 11.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.38 1.472 . . . . 0.0 113.611 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -52.05 -42.84 63.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.6 0.76 . . . . 0.0 112.493 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -83.46 -6.47 59.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.862 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -75.17 -26.14 58.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 109.695 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.96 49.79 0.45 Allowed Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.389 -0.369 . . . . 0.0 112.704 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' ND2' ' A' ' 139' ' ' ASN . 15.7 m -59.79 170.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.46 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 6.0 m -115.54 178.56 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.657 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -85.03 -165.95 1.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.658 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.48 159.93 22.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.17 0.588 . . . . 0.0 110.411 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.47 9.02 3.88 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.083 1.353 . . . . 0.0 112.912 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 28.4 mm-40 -84.33 144.27 28.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.139 0.576 . . . . 0.0 110.731 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.441 ' HG2' HG22 ' A' ' 133' ' ' VAL . 72.1 mtm -92.84 132.88 36.61 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.89 152.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.993 0.917 . . . . 0.0 110.116 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.76 157.1 30.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.517 0.727 . . . . 0.0 110.489 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 98' ' ' ILE . 8.4 mp -100.43 134.65 43.07 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.304 0.642 . . . . 0.0 110.037 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -139.73 110.78 6.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.441 1.097 . . . . 0.0 108.238 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 127.37 32.93 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -118.18 96.64 49.99 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.892 -169.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.14 -24.88 76.76 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.993 2.462 . . . . 0.0 112.821 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.824 0.85 . . . . 0.0 111.826 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 5.7 t-20 -57.83 117.89 22.37 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.735 0.814 . . . . 0.0 111.375 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.34 -14.13 22.87 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.964 2.443 . . . . 0.0 112.516 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -73.11 -49.48 28.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.114 0.966 . . . . 0.0 109.713 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 16.2 t70 -173.09 138.27 0.74 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.626 0.771 . . . . 0.0 109.829 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -69.54 -30.43 68.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.37 0.668 . . . . 0.0 111.62 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.95 -12.88 54.68 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.012 0.525 . . . . 0.0 110.508 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -59.77 109.14 0.86 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 124.267 0.979 . . . . 0.0 109.826 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 111' ' ' LEU . 73.2 mt -72.38 104.33 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.99 -172.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 39.6 ttmt -61.94 110.9 1.7 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.516 168.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.82 110.87 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.68 173.94 6.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.056 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -105.67 -167.87 1.38 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.02 -29.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.48 -31.69 63.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.781 0.832 . . . . 0.0 110.81 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.88 -2.34 41.47 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.191 -172.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.52 122.89 18.25 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.844 0.858 . . . . 0.0 109.45 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 18.5 pm0 -62.07 111.26 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.091 0.869 . . . . 0.0 109.761 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.558 HG23 ' NH2' ' A' ' 71' ' ' ARG . 16.0 m -91.36 -0.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.35 -148.68 20.21 Favored Glycine 0 C--N 1.366 2.228 0 C-N-CA 123.535 0.588 . . . . 0.0 113.513 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -137.28 146.13 44.33 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.085 1.354 . . . . 0.0 108.732 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 115' ' ' LEU . 43.4 mt -63.63 -57.1 11.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 117.955 0.343 . . . . 0.0 111.609 -176.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 115' ' ' LEU . 32.1 mmmt 173.98 169.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 128.078 2.551 . . . . 0.0 105.033 -167.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 -27.25 33.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 119.292 0.951 . . . . 0.0 109.327 160.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 169' ' ' PHE . 28.9 tt0 -69.7 -59.93 2.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.756 1.222 . . . . 0.0 111.085 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 HD13 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -58.2 -40.14 80.8 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.167 0.987 . . . . 0.0 109.044 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.99 97.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.831 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.17 -36.0 35.09 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 124.215 0.947 . . . . 0.0 113.928 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -61.34 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.444 0.698 . . . . 0.0 111.548 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 mt -71.38 -18.92 62.33 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.583 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.55 81.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.902 0.881 . . . . 0.0 110.417 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -65.4 -36.51 84.18 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.182 0.926 . . . . 0.0 110.331 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.401 HG23 ' HB2' ' A' ' 127' ' ' LEU . 67.5 mt -65.98 -42.06 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.0 -32.2 51.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.249 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -48.78 11.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.916 0.887 . . . . 0.0 111.021 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -85.93 7.01 25.92 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.141 0.576 . . . . 0.0 111.231 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 63.14 32.36 15.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 156' ' ' ASN . 56.7 mt -67.5 -44.17 79.12 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.895 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -156.33 150.38 25.21 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -77.77 134.92 37.95 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.409 ' HB ' HD22 ' A' ' 85' ' ' LEU . 31.3 mt -127.73 129.55 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.1 168.13 18.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.544 1.137 . . . . 0.0 108.516 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -137.02 166.96 24.8 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 82' ' ' MET . 62.6 t -147.91 131.35 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 137' ' ' GLY . 2.5 p -102.45 99.27 12.56 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.169 0.588 . . . . 0.0 110.251 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.11 -27.58 4.4 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.761 2.308 . . . . 0.0 112.766 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -75.23 -31.29 60.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.066 0.546 . . . . 0.0 111.784 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 63.18 11.69 40.49 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 114.222 0.449 . . . . 0.0 114.222 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -88.92 5.63 43.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.674 0.789 . . . . 0.0 111.397 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 3.6 p-10 -63.69 -19.42 64.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.597 1.159 . . . . 0.0 112.188 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -69.71 -60.73 2.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.744 0.818 . . . . 0.0 111.146 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.56 -32.04 11.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -171.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -113.58 162.56 16.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 112.196 -167.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 72.9 p -97.51 109.71 22.41 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE1' ' HB3' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -149.75 158.43 37.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -167.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.66 127.18 1.9 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.772 2.314 . . . . 0.0 113.035 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.482 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 3.7 pp -94.23 152.16 18.9 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -73.26 108.82 6.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.594 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.49 ' HE3' HD21 ' A' ' 111' ' ' LEU . 47.7 mtt -99.03 166.39 11.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.692 0.797 . . . . 0.0 110.346 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.4 p -143.69 156.17 44.46 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.304 1.042 . . . . 0.0 109.707 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 81.1 m-85 -117.41 117.24 28.94 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.715 0.806 . . . . 0.0 108.856 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -124.26 100.37 6.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.78 167.06 29.86 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -73.55 145.25 45.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.599 0.36 . . . . 0.0 111.307 -171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.34 -30.34 66.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 113.874 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.04 -6.51 54.8 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 127' ' ' LEU . 4.0 m-20 -118.24 7.55 12.1 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.248 0.619 . . . . 0.0 110.543 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -37.04 86.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.144 0.578 . . . . 0.0 112.11 -169.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -26.03 61.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.157 0.286 . . . . 0.0 110.765 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -77.93 -34.59 51.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.072 0.549 . . . . 0.0 110.335 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 156' ' ' ASN . 66.0 t -62.8 -50.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.33 0.652 . . . . 0.0 109.993 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.4 p -66.36 -32.21 73.45 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.735 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.26 -43.31 82.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.296 0.638 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 9.8 mm100 -70.05 -30.84 68.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.786 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.15 -52.34 35.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.19 0.596 . . . . 0.0 110.103 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.04 -25.07 67.67 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.447 1.099 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.929 1.292 . . . . 0.0 111.805 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -103.77 -28.37 11.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.293 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.11 29.88 5.3 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.552 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 114' ' ' GLU . 62.5 m-85 . . . . . 0 N--CA 1.483 1.19 0 CA-C-N 117.733 0.766 . . . . 0.0 110.858 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -35.3 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.925 0.89 . . . . 0.0 109.726 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -84.83 -15.44 44.75 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.749 1.219 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -80.42 143.39 33.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.523 0.729 . . . . 0.0 111.704 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.31 161.31 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.296 1.438 . . . . 0.0 110.474 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.7 tp -85.36 110.89 19.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 34.7 m-85 -73.17 -39.22 65.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.341 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.57 -160.86 30.56 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.1 p -111.79 179.14 4.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.516 0.726 . . . . 0.0 110.858 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 169' ' ' PHE . 33.7 tp -154.73 153.39 31.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.371 0.668 . . . . 0.0 109.983 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -87.29 92.71 9.17 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.64 125.21 8.39 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.456 ' H ' ' HG ' ' A' ' 115' ' ' LEU . 77.0 m80 -114.65 109.95 19.01 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.606 0.762 . . . . 0.0 110.286 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.39 139.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 66.4 t -71.97 142.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.998 0.519 . . . . 0.0 110.397 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.88 -44.45 68.68 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.727 -0.67 . . . . 0.0 114.328 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.1 -17.77 42.24 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.067 0.947 . . . . 0.0 112.065 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' A' ' 68' ' ' VAL . 2.3 mpt_? -74.35 1.4 11.72 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.452 1.101 . . . . 0.0 111.739 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -57.25 -28.83 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.845 0.458 . . . . 0.0 110.611 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.66 -31.89 72.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.051 0.94 . . . . 0.0 111.015 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -74.46 -27.06 60.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.392 0.677 . . . . 0.0 110.207 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.8 46.63 0.51 Allowed Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.756 -0.656 . . . . 0.0 114.288 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.676 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 93.7 t -56.49 154.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 122.816 0.446 . . . . 0.0 110.452 171.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.54 159.4 7.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.538 0.735 . . . . 0.0 111.061 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -96.02 -115.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.07 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -93.96 139.94 30.31 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.63 0.772 . . . . 0.0 111.745 -163.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 74.03 -22.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.37 1.468 . . . . 0.0 113.656 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.02 129.69 43.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.52 1.128 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.525 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.7 mtp -94.25 142.74 27.06 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 30.0 m -114.64 147.04 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.101 0.56 . . . . 0.0 110.463 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.76 53.75 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.042 0.937 . . . . 0.0 108.803 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -88.37 151.32 22.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.405 0.682 . . . . 0.0 110.319 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -159.76 153.68 23.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.073 0.949 . . . . 0.0 109.101 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.402 HH22 ' HB2' ' A' ' 124' ' ' ASP . 32.9 ttm180 -71.88 137.13 47.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.703 0.401 . . . . 0.0 110.334 172.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.78 117.17 67.61 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.4 0.68 . . . . 0.0 109.813 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.4 -29.76 53.68 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.781 2.321 . . . . 0.0 112.797 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.33 52.49 2.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.431 0.693 . . . . 0.0 109.599 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.25 108.16 1.06 Allowed Pre-proline 0 CA--C 1.566 1.564 0 C-N-CA 124.579 1.151 . . . . 0.0 112.498 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.86 -34.94 70.32 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 123.284 2.656 . . . . 0.0 113.543 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -126.0 -44.04 1.79 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.412 0.685 . . . . 0.0 111.197 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -162.94 162.7 26.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.142 0.577 . . . . 0.0 109.924 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.23 -14.52 26.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.417 1.087 . . . . 0.0 112.53 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.477 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 47.3 m-80 -73.33 4.08 5.09 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.74 116.96 18.68 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.248 0.619 . . . . 0.0 109.955 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.537 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 44.9 mt -97.98 118.79 45.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 C-N-CA 123.614 0.766 . . . . 0.0 109.649 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.731 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 17.3 ttmm -71.53 140.04 49.74 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.288 165.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 t -109.84 124.62 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -108.09 168.65 9.14 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -108.4 -165.77 1.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.988 0.515 . . . . 0.0 110.217 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.75 -33.14 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.742 . . . . 0.0 111.537 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -76.14 -19.99 58.0 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.991 0.916 . . . . 0.0 111.112 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.04 6.88 78.41 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.96 135.09 49.06 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 109.62 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.731 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 26.1 mp0 -73.81 98.64 3.0 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.825 0.85 . . . . 0.0 109.0 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 11.8 m -79.77 -25.82 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.51 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.7 -142.18 8.36 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 121.587 -0.34 . . . . 0.0 112.914 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -140.32 157.4 45.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.334 1.054 . . . . 0.0 109.571 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.58 HD13 HD12 ' A' ' 115' ' ' LEU . 65.9 mt -81.64 -5.06 57.71 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.422 176.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? 71.6 151.5 0.11 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 109.937 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -37.42 -42.06 0.48 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.41 -56.12 5.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.383 0.273 . . . . 0.0 111.122 -170.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.58 HD12 HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -72.43 -44.46 62.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -175.216 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.537 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -58.6 -51.6 69.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.412 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -60.44 -27.4 65.73 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.497 0.498 . . . . 0.0 114.071 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -61.59 1.73 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.954 0.502 . . . . 0.0 109.918 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 130' ' ' ILE . 18.1 mt -69.88 -16.07 63.18 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.971 -172.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.11 -24.15 65.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.967 0.907 . . . . 0.0 113.231 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -76.32 -35.87 58.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 127' ' ' LEU . 48.1 mt -67.64 -29.65 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.92 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.2 tpp -79.08 -41.71 28.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.463 1.105 . . . . 0.0 110.558 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HH22 ' A' ' 87' ' ' ARG . 20.7 t70 -67.66 -50.8 56.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.53 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -93.54 1.16 56.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.849 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 54.52 44.65 28.44 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.015 0.926 . . . . 0.0 111.642 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 122' ' ' ILE . 62.3 mt -68.79 -40.18 79.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.992 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -155.58 135.38 12.72 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.261 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -68.21 114.43 6.69 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 119' ' ' LEU . 13.7 mt -101.08 124.03 54.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.07 139.6 44.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.815 0.846 . . . . 0.0 108.944 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -116.95 168.16 12.74 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.343 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 82' ' ' MET . 44.1 t -138.94 133.6 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 146' ' ' LEU . 11.0 t -103.34 94.12 5.47 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.17 -56.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.179 1.92 . . . . 0.0 112.951 -172.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -75.8 -30.99 59.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.943 0.497 . . . . 0.0 110.976 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 49.47 34.62 19.91 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 124.0 0.812 . . . . 0.0 114.435 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -89.89 17.77 6.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.753 0.821 . . . . 0.0 112.278 -168.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -52.14 -36.46 51.47 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.293 1.037 . . . . 0.0 112.094 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -53.92 -49.14 69.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.819 0.848 . . . . 0.0 111.397 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.85 -51.59 11.01 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.722 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -157.49 166.42 33.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.416 1.087 . . . . 0.0 109.555 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.8 p -94.59 110.71 22.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.03 141.49 26.36 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 124.245 1.018 . . . . 0.0 110.562 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.29 130.26 18.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.951 2.434 . . . . 0.0 112.261 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.418 HD22 HG22 ' A' ' 134' ' ' VAL . 4.5 pp -87.52 152.97 21.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -91.13 110.73 22.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 122.1 -0.375 . . . . 0.0 110.502 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.572 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 54.7 mtt -92.5 169.45 10.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.217 1.007 . . . . 0.0 111.065 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 p -149.72 147.53 28.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.702 1.201 . . . . 0.0 109.062 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 91.8 m-85 -109.34 120.56 42.89 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.847 0.859 . . . . 0.0 109.515 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -124.17 97.68 5.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.22 166.34 35.73 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.75 139.76 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.373 0.669 . . . . 0.0 111.942 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -51.07 -37.28 44.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.753 1.221 . . . . 0.0 112.997 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.46 -12.29 59.92 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.679 0.791 . . . . 0.0 113.133 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -97.22 -0.98 45.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -30.24 69.61 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -33.59 71.62 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.16 0.505 . . . . 0.0 110.929 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.74 -33.97 30.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.48 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.37 -48.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.878 0.871 . . . . 0.0 110.777 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 72.9 p -64.34 -34.41 78.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 111.555 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.61 -42.76 75.35 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.674 0.609 . . . . 0.0 111.394 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mm100 -66.8 -38.94 87.46 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.326 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -70.17 -53.18 18.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.525 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.94 -25.61 68.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.888 0.875 . . . . 0.0 112.074 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.37 -48.12 82.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 111.389 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -102.89 -1.1 30.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.601 0.761 . . . . 0.0 111.046 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.73 63.65 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.368 0.418 . . . . 0.0 113.988 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 63' ' ' LEU . 24.8 m-85 . . . . . 0 N--CA 1.481 1.106 0 C-N-CA 123.372 0.669 . . . . 0.0 111.05 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.99 -31.94 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.827 0.851 . . . . 0.0 109.625 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.38 -13.73 42.6 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.715 0.806 . . . . 0.0 110.788 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.4 m -74.41 113.94 12.22 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 122.997 0.519 . . . . 0.0 110.497 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.29 158.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 0.0 110.898 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 tt -81.27 114.92 20.39 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.76 0.824 . . . . 0.0 108.962 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.05 -36.03 59.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.188 0.595 . . . . 0.0 110.062 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.48 175.9 38.98 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.756 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 p -110.67 155.23 22.73 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.106 0.962 . . . . 0.0 108.735 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.01 147.05 52.58 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.774 0.429 . . . . 0.0 110.285 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -78.42 78.56 4.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.797 0.808 . . . . 0.0 109.118 171.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -70.43 143.06 36.57 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.186 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -132.79 105.58 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.192 0.597 . . . . 0.0 109.546 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 71' ' ' ARG . 3.8 t -78.65 159.56 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.7 m -63.49 152.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.174 -0.329 . . . . 0.0 111.312 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 143' ' ' THR . . . -65.1 -35.56 91.92 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.03 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.34 -15.07 3.44 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.212 1.405 . . . . 0.0 113.269 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.691 HH12 HG22 ' A' ' 77' ' ' VAL . 1.9 tmm_? -56.95 -17.59 10.22 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.206 1.003 . . . . 0.0 112.42 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HA ' HG13 ' A' ' 76' ' ' VAL . 40.6 p90 -59.07 -41.31 87.68 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 123.062 0.545 . . . . 0.0 110.859 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -72.0 -31.18 65.99 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.251 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 71' ' ' ARG . 46.4 p -95.82 3.56 53.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.793 0.437 . . . . 0.0 111.561 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.9 52.2 0.51 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 140' ' ' ASN . 3.1 m -48.91 152.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 118.334 1.067 . . . . 0.0 113.186 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.691 HG22 HH12 ' A' ' 71' ' ' ARG . 28.8 m -114.47 164.7 10.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.884 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -84.39 -169.17 2.48 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.548 0.739 . . . . 0.0 111.231 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.66 157.89 37.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.64 0.776 . . . . 0.0 111.279 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 67.88 8.08 6.2 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.122 0.969 . . . . 0.0 112.186 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.6 mm-40 -76.93 140.63 40.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.482 0.658 . . . . 0.0 111.132 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.475 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.9 mtp -107.2 149.49 27.65 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 132' ' ' GLY . 13.4 m -132.04 163.5 37.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.248 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.38 125.71 23.3 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.76 160.38 26.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -157.05 126.75 6.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.002 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HD2' ' HB2' ' A' ' 95' ' ' LYS . 64.7 ttp85 -67.34 130.76 44.11 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.2 117.6 21.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 123.628 0.58 . . . . 0.0 110.733 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.35 -39.88 34.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.33 2.02 . . . . 0.0 110.237 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -95.26 76.1 3.42 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 7.5 p30 -67.4 127.9 93.54 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.968 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.54 -39.39 28.22 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.998 2.465 . . . . 0.0 113.021 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -127.35 -50.97 1.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.764 0.426 . . . . 0.0 110.43 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 8.8 p30 -150.38 170.58 18.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 110.031 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -64.9 -8.24 14.67 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.459 1.103 . . . . 0.0 113.09 -173.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.26 -12.25 39.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.587 0.755 . . . . 0.0 112.567 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 109.4 7.57 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.049 0.54 . . . . 0.0 110.303 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 120' ' ' ALA . 59.7 mt -118.8 115.82 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -85.22 163.21 18.82 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.467 0.651 . . . . 0.0 110.223 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.53 121.32 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.5 1.12 . . . . 0.0 109.237 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -109.76 130.97 55.46 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -75.85 -170.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.932 0.787 . . . . 0.0 110.994 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.43 -33.78 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.894 0.878 . . . . 0.0 112.87 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.13 -31.62 34.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.818 0.447 . . . . 0.0 110.885 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.49 6.4 25.34 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 116.323 -0.399 . . . . 0.0 113.266 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -66.7 119.25 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.858 0.863 . . . . 0.0 110.251 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -72.8 90.16 1.41 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.828 0.823 . . . . 0.0 110.279 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.5 -14.19 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.988 1.315 . . . . 0.0 113.307 -172.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.13 -157.4 27.62 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 118.024 0.375 . . . . 0.0 112.363 -176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -132.15 149.43 52.4 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.47 0.708 . . . . 0.0 110.269 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 71.5 mt -76.23 -0.85 23.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.685 0.794 . . . . 0.0 113.004 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.5 tttt 71.45 130.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -19.21 5.99 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.597 1.159 . . . . 0.0 113.865 -170.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -67.01 -55.09 15.9 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.481 0.713 . . . . 0.0 111.395 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.69 -44.97 12.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.354 0.662 . . . . 0.0 110.184 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -61.89 -24.28 66.84 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.179 0.991 . . . . 0.0 111.967 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.64 64.62 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.17 0.294 . . . . 0.0 113.538 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -65.97 -44.5 84.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.53 -16.41 56.02 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.742 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.496 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -56.53 -44.75 81.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 112.053 -174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -70.58 -32.74 70.25 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.09 0.869 . . . . 0.0 110.298 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 160' ' ' VAL . 62.5 mt -65.36 -41.63 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.194 0.598 . . . . 0.0 110.02 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.45 -37.93 50.5 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.918 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.35 -42.9 58.6 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.485 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -98.02 6.38 47.7 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.396 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.37 34.72 20.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.702 1.201 . . . . 0.0 111.654 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD13 ' HB1' ' A' ' 159' ' ' ALA . 75.8 mt -64.0 -43.44 95.66 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.484 0.714 . . . . 0.0 111.231 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.2 159.93 26.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.071 0.549 . . . . 0.0 111.109 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.8 mt -129.69 118.5 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.47 166.18 18.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.96 102.37 0.24 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' HG2' ' A' ' 82' ' ' MET . 43.0 t -103.58 114.96 44.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.9 p -101.3 91.29 2.01 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.263 1.025 . . . . 0.0 108.71 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 2.7 Cg_exo -78.54 -23.92 8.03 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.128 2.552 . . . . 0.0 112.93 -172.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.26 -28.82 19.66 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.21 0.604 . . . . 0.0 110.926 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.56 62.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 113.863 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.08 -2.38 33.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.631 0.772 . . . . 0.0 112.347 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -24.69 65.44 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.448 ' HA ' HG21 ' A' ' 76' ' ' VAL . 55.6 t30 -57.28 -34.3 68.52 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.056 0.942 . . . . 0.0 111.262 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.78 53.25 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.133 0.573 . . . . 0.0 110.816 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -167.99 -66.3 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.474 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 8.9 t -160.32 169.06 23.92 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.693 0.797 . . . . 0.0 110.17 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.581 ' SD ' HG23 ' A' ' 134' ' ' VAL . 5.5 ppp? -167.34 156.28 9.16 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.289 1.036 . . . . 0.0 109.484 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.1 Cg_endo -76.63 120.45 5.55 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.418 1.412 . . . . 0.0 112.063 170.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 146' ' ' LEU . 2.6 pt? -102.73 149.4 24.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -85.39 108.2 17.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -171.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 38.1 mtp -107.36 116.38 31.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.316 0.646 . . . . 0.0 109.873 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.7 p -113.06 126.49 55.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.763 0.425 . . . . 0.0 110.008 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -92.19 115.32 27.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.685 0.794 . . . . 0.0 109.537 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -114.54 110.97 20.63 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.503 1.121 . . . . 0.0 109.724 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.52 168.74 38.29 Favored Glycine 0 C--O 1.236 0.235 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -63.47 152.25 38.92 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.207 1.003 . . . . 0.0 111.304 -178.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.72 -27.78 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.065 0.946 . . . . 0.0 113.511 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 153' ' ' LYS . 12.8 pt-20 -78.08 -28.21 48.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.89 -5.02 46.74 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.797 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -59.01 -41.91 88.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.754 0.422 . . . . 0.0 110.228 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -70.49 -27.75 64.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.444 0.697 . . . . 0.0 111.738 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.71 -45.03 60.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.589 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 122' ' ' ILE . 70.4 t -64.41 -40.97 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.31 1.044 . . . . 0.0 111.14 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.4 m -58.58 -45.07 89.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.075 0.95 . . . . 0.0 110.62 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.14 -41.4 71.71 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.878 0.871 . . . . 0.0 111.542 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 49.6 mm-40 -75.34 -27.26 59.15 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.038 -174.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 76.1 mt -73.0 -44.26 61.22 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.824 173.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.46 -28.63 67.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.404 1.082 . . . . 0.0 111.356 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.57 -50.12 70.9 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.094 0.958 . . . . 0.0 111.34 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -81.43 -28.14 34.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.363 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.49 12.02 10.01 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-O 119.87 -0.406 . . . . 0.0 113.332 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.602 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 46.8 m-85 . . . . . 0 CA--C 1.558 1.274 0 C-N-CA 123.231 0.612 . . . . 0.0 111.331 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.7 0.286 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.88 -35.3 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.601 0.761 . . . . 0.0 109.474 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.35 -17.58 63.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.194 0.997 . . . . 0.0 111.104 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -73.71 116.66 14.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.313 0.645 . . . . 0.0 109.863 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.86 165.83 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.526 1.13 . . . . 0.0 110.859 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 149' ' ' THR . 24.6 tp -82.13 121.67 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.873 0.469 . . . . 0.0 110.177 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 19.7 m-85 -86.87 -38.58 16.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.169 0.588 . . . . 0.0 110.088 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 -172.18 28.92 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.724 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -112.6 166.5 11.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.464 0.706 . . . . 0.0 111.363 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.481 ' HB2' ' HE2' ' A' ' 150' ' ' PHE . 33.8 tp -145.32 150.6 36.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.933 0.893 . . . . 0.0 109.319 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -75.94 98.36 4.22 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.418 0.628 . . . . 0.0 109.964 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.09 73.98 2.5 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 52.9 t-80 -65.62 85.82 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.981 0.912 . . . . 0.0 110.351 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 111' ' ' LEU . 14.4 m -81.61 144.33 10.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.166 173.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.3 m -65.61 148.07 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.39 175.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.86 -22.12 62.15 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -61.85 -19.12 62.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.929 1.292 . . . . 0.0 111.804 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 34.4 ptt85 -72.52 0.14 11.18 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.387 1.075 . . . . 0.0 112.549 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -53.85 -35.63 61.71 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.811 0.844 . . . . 0.0 112.658 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -67.86 -23.23 65.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.884 0.874 . . . . 0.0 111.641 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -73.02 -24.18 60.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.072 0.549 . . . . 0.0 111.023 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.82 49.11 0.52 Allowed Glycine 0 C--N 1.354 1.533 0 O-C-N 122.309 -0.244 . . . . 0.0 113.49 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 43.4 t -63.47 160.09 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.634 0.774 . . . . 0.0 111.747 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.06 157.05 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.454 1.102 . . . . 0.0 109.3 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -78.91 -164.64 0.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.989 0.916 . . . . 0.0 113.024 -165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -67.05 145.89 54.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.691 0.797 . . . . 0.0 110.825 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 73.72 -15.52 0.57 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.198 1.399 . . . . 0.0 112.713 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -73.2 130.02 39.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.57 0.748 . . . . 0.0 111.113 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 79.7 mtp -84.77 149.42 25.76 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.068 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 16.4 m -134.75 -170.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.709 1.204 . . . . 0.0 109.836 177.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.92 154.5 22.08 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.595 1.158 . . . . 0.0 108.432 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -99.15 146.83 25.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.909 0.385 . . . . 0.0 110.817 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -155.83 127.77 7.49 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 108.845 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -63.05 142.23 58.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 174.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.24 110.79 2.83 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.753 0.821 . . . . 0.0 110.347 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -31.61 44.84 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.488 2.125 . . . . 0.0 111.271 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.27 68.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 170.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 6.9 p30 -74.85 119.03 74.82 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.059 0.544 . . . . 0.0 110.551 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 15.4 Cg_exo -69.61 -38.68 7.79 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 0.0 113.554 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -119.88 -51.39 2.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.304 0.641 . . . . 0.0 111.677 -167.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.25 146.82 35.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.375 0.67 . . . . 0.0 109.792 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.506 ' HB2' HH21 ' A' ' 87' ' ' ARG . 14.7 ptmm? -74.05 -5.1 39.47 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.932 0.893 . . . . 0.0 111.1 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -76.63 -6.03 50.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.204 1.002 . . . . 0.0 111.98 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.03 125.56 27.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.081 0.952 . . . . 0.0 110.646 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.9 mt -123.65 120.18 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.64 0.776 . . . . 0.0 110.657 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 39.5 mttp -77.7 162.79 26.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.554 1.141 . . . . 0.0 111.009 167.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.3 t -123.3 127.02 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -122.32 144.22 49.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.622 1.169 . . . . 0.0 108.737 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 29.6 p30 -74.29 179.01 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.883 0.765 . . . . 0.0 112.285 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.85 -25.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.167 0.987 . . . . 0.0 113.492 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -73.16 -17.2 61.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.376 0.67 . . . . 0.0 110.968 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.81 37.25 10.49 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.825 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.99 131.47 54.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.573 0.749 . . . . 0.0 109.185 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.92 104.76 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 124.167 0.917 . . . . 0.0 111.16 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 28.8 m -87.5 -0.24 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.012 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 151.89 -159.24 28.21 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.457 -0.338 . . . . 0.0 113.057 170.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 56.6 t-80 -122.83 150.11 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.3 tt -75.07 -57.07 4.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.122 0.169 . . . . 0.0 111.006 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.3 tptt 142.53 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -162.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -22.5 62.43 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.777 1.171 . . . . 0.0 112.192 -175.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.78 -47.56 68.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.289 1.035 . . . . 0.0 110.571 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 8.9 tt -72.04 -48.69 42.66 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.434 0.694 . . . . 0.0 109.273 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -21.91 65.9 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.041 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.8 -28.36 60.3 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 123.296 0.373 . . . . 0.0 113.691 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.13 -56.26 4.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.315 0.646 . . . . 0.0 109.896 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 122' ' ' ILE . 31.3 mt -63.67 -16.5 61.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.059 0.944 . . . . 0.0 112.396 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.22 65.36 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.518 1.527 . . . . 0.0 112.046 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -70.07 -30.55 67.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.35 1.031 . . . . 0.0 110.618 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.488 ' HA ' HD12 ' A' ' 127' ' ' LEU . 60.2 mt -67.79 -34.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.22 0.608 . . . . 0.0 110.143 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -80.8 -33.22 34.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.068 0.947 . . . . 0.0 110.723 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.85 -40.34 54.92 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.505 1.122 . . . . 0.0 111.467 -173.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.08 -2.38 40.27 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 57.84 41.58 24.6 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.236 1.015 . . . . 0.0 111.03 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.1 mt -61.3 -43.95 98.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.436 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -149.66 138.37 20.93 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.246 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.92 105.24 5.86 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.59 104.69 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.11 176.28 9.34 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.589 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.59 158.97 27.89 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.61 -0.268 . . . . 0.0 112.522 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 55.6 t -148.38 129.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 146' ' ' LEU . 21.8 t -96.68 93.41 1.36 Allowed Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 7.1 Cg_exo -74.25 -49.24 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.404 2.069 . . . . 0.0 112.24 -171.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.88 -27.48 33.44 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.563 0.745 . . . . 0.0 111.263 -172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.66 60.64 Favored Glycine 0 C--N 1.354 1.551 0 O-C-N 123.465 0.478 . . . . 0.0 114.27 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.99 9.27 10.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.415 0.686 . . . . 0.0 112.694 -170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.71 -20.5 66.36 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.611 0.765 . . . . 0.0 111.659 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.23 -47.96 82.07 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 0.0 110.077 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.61 -53.99 4.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.492 0.717 . . . . 0.0 111.747 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -146.88 -165.77 2.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.665 0.786 . . . . 0.0 111.504 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -95.94 122.73 39.06 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.809 0.844 . . . . 0.0 109.662 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -131.66 147.02 64.37 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.271 0.628 . . . . 0.0 111.223 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 88.2 Cg_endo -79.2 125.5 6.47 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.52 2.146 . . . . 0.0 112.252 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.581 HD22 HG22 ' A' ' 134' ' ' VAL . 3.3 pp -100.37 154.59 18.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.21 107.48 4.24 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.333 0.653 . . . . 0.0 110.559 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 85' ' ' LEU . 62.3 mtt -107.12 149.66 27.41 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -144.34 135.97 25.83 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -171.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 83.1 m-85 -99.53 123.56 43.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.241 1.016 . . . . 0.0 110.655 -174.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.68 105.25 7.69 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.1 0.96 . . . . 0.0 108.561 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.78 166.76 35.09 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -58.37 143.13 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.77 -41.04 61.33 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.068 0.947 . . . . 0.0 113.135 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.57 -21.11 66.61 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.37 -3.51 56.66 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.731 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -61.65 -32.25 72.4 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.146 0.885 . . . . 0.0 111.162 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.37 -46.68 85.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.751 0.82 . . . . 0.0 109.754 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -75.44 -30.59 60.06 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.652 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 122' ' ' ILE . 53.7 t -67.01 -49.71 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.535 0.734 . . . . 0.0 109.235 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.6 t -61.45 -34.14 74.93 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.449 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.1 t70 -55.54 -47.84 75.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.17 0.588 . . . . 0.0 110.43 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.8 mm100 -66.89 -41.27 87.48 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 124.774 1.296 . . . . 0.0 111.578 -176.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -62.39 1.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.797 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -57.05 -33.4 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.321 1.048 . . . . 0.0 111.846 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 20.9 ttmm -55.55 -53.3 58.1 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.333 1.053 . . . . 0.0 111.394 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.97 -16.29 38.83 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.435 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.79 26.76 7.83 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.626 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 74.4 m-85 . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 123.536 0.734 . . . . 0.0 110.126 168.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -72.34 -27.48 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.446 1.098 . . . . 0.0 110.038 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -85.93 -26.12 25.72 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.426 1.09 . . . . 0.0 110.645 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LYS . 70.2 m -82.15 135.36 35.29 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 110.835 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.13 164.17 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.08 1.352 . . . . 0.0 110.763 -172.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.428 HD11 HG22 ' A' ' 149' ' ' THR . 18.7 tp -87.55 112.62 22.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.082 0.553 . . . . 0.0 110.362 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 24.6 m-85 -78.17 -37.83 44.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.518 0.727 . . . . 0.0 111.408 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.85 -154.3 25.42 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -133.8 179.89 5.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.327 0.651 . . . . 0.0 111.176 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.57 150.75 21.57 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.614 1.165 . . . . 0.0 108.887 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -87.27 101.82 13.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 148' ' ' MET . . . -72.33 85.81 0.51 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.265 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -70.35 99.3 1.54 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.52 0.728 . . . . 0.0 109.286 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 71' ' ' ARG . 7.1 p -119.24 131.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.681 0.792 . . . . 0.0 109.825 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 70' ' ' LEU . 65.1 t -56.93 143.41 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.774 1.23 . . . . 0.0 111.719 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.45 66.25 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.532 ' H ' HG12 ' A' ' 68' ' ' VAL . 42.0 tp -61.56 -17.82 56.62 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.069 0.947 . . . . 0.0 111.803 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 67' ' ' VAL . 28.6 ptt-85 -63.89 -5.17 4.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.673 1.189 . . . . 0.0 113.442 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -53.33 -35.88 60.69 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.611 0.764 . . . . 0.0 112.616 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.44 -24.83 65.67 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 111.511 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -77.36 -6.57 53.77 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.952 0.901 . . . . 0.0 111.6 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.86 53.2 0.86 Allowed Glycine 0 C--N 1.359 1.834 0 O-C-N 121.81 -0.556 . . . . 0.0 113.301 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 29.0 m -68.41 171.38 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 24.1 m -114.71 162.1 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.411 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -89.96 -87.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.874 0.469 . . . . 0.0 111.811 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.92 149.23 36.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.847 0.459 . . . . 0.0 111.41 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.0 9.46 3.07 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.31 1.444 . . . . 0.0 113.141 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 56.6 mm-40 -82.11 132.52 35.25 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.904 0.383 . . . . 0.0 111.481 -174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.7 mtm -80.31 132.81 35.87 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.604 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 102' ' ' ASN . 27.0 m -131.66 163.35 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 124.098 0.959 . . . . 0.0 109.141 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.25 24.7 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.892 0.877 . . . . 0.0 108.735 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -85.23 148.79 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.478 0.711 . . . . 0.0 110.026 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.458 ' HA ' ' SD ' ' A' ' 123' ' ' MET . 52.5 tp60 -159.89 137.86 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.842 0.857 . . . . 0.0 108.776 175.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 22.5 ptt85 -66.92 152.48 45.6 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.237 0.541 . . . . 0.0 110.085 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 32.1 t70 -102.33 116.59 62.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.825 -168.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.92 -18.0 41.23 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.855 2.37 . . . . 0.0 112.808 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.03 15.64 4.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.259 0.623 . . . . 0.0 110.644 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -53.98 128.22 55.5 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.643 0.777 . . . . 0.0 111.461 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.37 -26.89 1.24 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.326 2.018 . . . . 0.0 113.793 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -108.68 -52.18 2.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.136 0.574 . . . . 0.0 110.934 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -166.67 157.56 12.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.307 0.643 . . . . 0.0 109.671 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' HH11 ' A' ' 87' ' ' ARG . 16.5 ptpt -62.35 -7.79 4.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.228 1.411 . . . . 0.0 112.81 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -54.04 -32.48 54.59 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.278 1.031 . . . . 0.0 112.232 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.89 109.15 1.36 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.402 0.439 . . . . 0.0 110.181 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.5 mt -107.92 149.59 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.634 1.174 . . . . 0.0 108.231 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -122.29 144.44 48.99 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.53 0.681 . . . . 0.0 110.972 171.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -77.83 130.38 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.155 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 23.2 m-80 -114.95 144.14 44.05 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.603 0.761 . . . . 0.0 109.124 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HA ' HG12 ' A' ' 83' ' ' VAL . 22.3 p30 -77.31 -169.69 1.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.445 0.566 . . . . 0.0 111.123 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.85 -25.87 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.188 0.595 . . . . 0.0 112.468 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -74.58 -21.1 59.66 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.213 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.26 5.0 64.05 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.601 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.5 125.51 31.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.128 0.971 . . . . 0.0 108.781 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 12.0 pt20 -67.26 126.68 30.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.175 0.512 . . . . 0.0 111.701 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 16.9 m -89.47 -23.13 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.968 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 71' ' ' ARG . . . 165.06 165.27 22.07 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' A' ' 99' ' ' LYS . 23.1 m170 -92.0 150.87 20.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.091 0.956 . . . . 0.0 111.403 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 115' ' ' LEU . 29.8 mt -96.37 29.78 2.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.602 1.561 . . . . 0.0 112.316 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 65.09 -172.1 0.18 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.775 0.83 . . . . 0.0 110.737 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -80.42 -49.35 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.944 0.498 . . . . 0.0 110.839 171.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.38 -57.35 9.56 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.817 -166.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 111' ' ' LEU . 10.1 tt -67.67 -47.15 70.32 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.859 0.838 . . . . 0.0 109.314 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -62.34 -29.55 70.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.591 -1.641 . . . . 0.0 111.675 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.9 -38.85 94.65 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.544 0.527 . . . . 0.0 114.078 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -51.97 49.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.225 0.536 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.11 -16.83 64.17 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.928 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -61.32 -38.44 86.87 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.378 1.071 . . . . 0.0 112.887 -177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -71.36 -33.71 69.81 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.488 HD13 HG13 ' A' ' 160' ' ' VAL . 44.2 mt -68.66 -34.95 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.484 0.714 . . . . 0.0 110.322 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 86' ' ' GLN . 38.4 tpp -79.84 -52.26 8.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.095 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.54 -45.17 91.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.679 1.192 . . . . 0.0 110.654 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.86 2.76 54.6 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.59 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 56.35 36.93 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.308 1.043 . . . . 0.0 111.886 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.9 mt -65.86 -43.93 86.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.837 0.855 . . . . 0.0 111.322 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -148.71 140.27 23.5 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.477 0.711 . . . . 0.0 110.603 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.97 102.91 6.62 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -89.07 106.22 16.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.14 179.84 5.46 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.875 0.87 . . . . 0.0 109.382 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -162.96 172.97 39.11 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.634 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 78.0 t -149.28 138.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 107.512 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.36 90.76 1.49 Allowed Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.76 -23.53 2.59 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.054 1.836 . . . . 0.0 113.871 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -77.87 -28.73 50.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.379 0.672 . . . . 0.0 112.49 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.12 31.2 75.9 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 123.229 0.33 . . . . 0.0 113.771 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -85.6 17.13 3.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.04 0.936 . . . . 0.0 111.655 -178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.3 -26.24 68.31 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.624 1.17 . . . . 0.0 111.72 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.01 -37.0 69.88 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.553 0.741 . . . . 0.0 110.914 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.07 -64.64 0.82 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.652 0.381 . . . . 0.0 110.362 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 37.6 t80 171.75 -89.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.304 1.442 . . . . 0.0 108.497 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 67' ' ' VAL . 62.6 m -103.24 144.64 31.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.184 0.994 . . . . 0.0 109.852 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 1.4 pmm? -147.79 148.56 30.76 Favored Pre-proline 0 C--O 1.243 0.741 0 C-N-CA 123.308 0.643 . . . . 0.0 109.747 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.7 124.71 4.66 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.023 1.815 . . . . 0.0 109.985 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.2 145.58 27.88 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -74.79 106.81 6.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.6 ' SD ' HD21 ' A' ' 85' ' ' LEU . 60.3 mtt -95.67 161.07 14.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.019 0.928 . . . . 0.0 109.554 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -150.73 132.4 14.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -171.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 82.3 m-85 -97.66 117.27 31.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.744 0.817 . . . . 0.0 109.911 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -124.31 115.78 21.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.53 168.41 40.55 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -65.83 147.01 54.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.435 0.636 . . . . 0.0 112.693 -173.665 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -53.64 -32.5 51.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.406 1.482 . . . . 0.0 114.083 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.43 -23.93 60.18 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.902 0.481 . . . . 0.0 111.608 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -92.55 3.26 55.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.294 0.637 . . . . 0.0 111.722 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.37 76.48 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.091 0.556 . . . . 0.0 111.919 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -35.36 69.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.25 0.62 . . . . 0.0 110.872 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -78.11 -41.14 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.443 0.697 . . . . 0.0 110.63 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.488 HG13 HD13 ' A' ' 122' ' ' ILE . 78.1 t -61.12 -47.97 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.834 0.854 . . . . 0.0 110.347 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.4 m -73.11 -24.26 60.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.675 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 35.6 t70 -63.52 -39.81 95.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.83 0.452 . . . . 0.0 110.5 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.3 mm100 -64.47 -35.11 79.86 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.666 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.18 -40.23 59.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.653 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 10.3 mtmp? -67.06 -38.43 85.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.851 0.461 . . . . 0.0 110.908 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -59.47 -43.11 93.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.118 0.967 . . . . 0.0 111.691 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -96.78 -26.73 15.03 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.13 21.65 10.7 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.259 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 115' ' ' LEU . 67.3 m-85 . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.662 . . . . 0.0 110.462 171.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.479 0.181 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.52 -35.09 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.535 0.734 . . . . 0.0 109.619 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.5 t70 -76.4 -12.53 60.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.718 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -67.64 114.89 6.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.303 0.641 . . . . 0.0 111.685 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 56' ' ' ASP . 23.9 m -119.5 160.95 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.996 1.318 . . . . 0.0 110.821 -174.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.4 tp -81.37 112.41 18.63 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 22.2 m-85 -74.39 -29.12 61.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.96 0.504 . . . . 0.0 110.584 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.4 -176.75 29.71 Favored Glycine 0 C--O 1.246 0.851 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.703 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.7 p -110.81 119.83 40.38 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -100.84 133.21 45.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -73.09 96.21 2.16 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -76.48 -179.83 47.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 173.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -139.18 110.32 6.88 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.245 1.023 . . . . 0.0 109.942 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 146' ' ' LEU . 96.8 t -103.65 132.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 70' ' ' LEU . 93.2 t -82.84 141.27 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.317 0.647 . . . . 0.0 109.608 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.31 69.11 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.432 0.458 . . . . 0.0 113.609 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' H ' HG12 ' A' ' 68' ' ' VAL . 70.8 mt -64.13 -18.69 64.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.005 0.922 . . . . 0.0 111.367 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.444 ' HD2' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.15 0.65 18.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.828 1.251 . . . . 0.0 112.295 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 140' ' ' ASN . 11.1 p90 -55.98 -31.02 62.64 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.252 0.621 . . . . 0.0 111.762 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.36 -20.4 63.84 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.127 0.971 . . . . 0.0 111.91 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -74.97 -25.01 58.54 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.875 0.47 . . . . 0.0 110.059 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.55 50.41 0.45 Allowed Glycine 0 C--N 1.355 1.597 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.487 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.771 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 27.7 m -57.28 168.4 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.55 0.69 . . . . 0.0 112.673 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 m -114.41 166.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.543 -171.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.1 156.85 11.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.619 ' HB3' ' HA3' ' A' ' 137' ' ' GLY . 12.2 p30 -68.14 69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.157 1.383 . . . . 0.0 111.674 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -178.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.396 1.078 . . . . 0.0 109.37 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -65.18 149.41 49.96 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.121 -164.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 81.4 mtp -89.17 149.77 22.99 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.802 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.0 m -121.06 151.64 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.729 0.811 . . . . 0.0 110.933 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -108.12 166.45 10.73 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.498 1.119 . . . . 0.0 109.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -122.68 119.41 30.64 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.564 0.746 . . . . 0.0 109.336 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.01 135.83 50.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.255 1.022 . . . . 0.0 108.985 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.459 HH21 ' HG3' ' A' ' 95' ' ' LYS . 69.1 ttt180 -77.49 125.33 29.17 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.157 0.583 . . . . 0.0 109.882 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 91' ' ' ASN . 15.7 t70 -108.02 115.58 58.35 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 49.7 Cg_endo -83.55 -2.75 10.56 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.948 2.432 . . . . 0.0 114.26 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -107.53 21.63 17.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.267 0.627 . . . . 0.0 111.749 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 88' ' ' ASP . 50.9 m-80 -86.28 142.22 35.49 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 121.609 -0.682 . . . . 0.0 111.313 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.67 -12.55 33.3 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.063 2.509 . . . . 0.0 112.284 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -77.76 -53.4 7.57 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.131 0.572 . . . . 0.0 109.528 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 170.78 163.91 0.08 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.874 1.359 . . . . 0.0 109.784 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 89' ' ' PRO . 8.3 ptpp? -59.41 -22.55 61.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.345 1.458 . . . . 0.0 113.243 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -78.44 -12.3 60.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.495 0.718 . . . . 0.0 112.885 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.18 110.44 3.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.838 0.455 . . . . 0.0 110.72 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.4 mt -75.86 120.8 26.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 124.012 0.925 . . . . 0.0 110.657 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 5.5 tppp? -75.07 117.14 16.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.02 167.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 111' ' ' LEU . 15.1 t -77.18 130.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 12.8 m120 -112.62 175.73 5.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.01 173.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.9 p30 -110.54 -167.9 1.24 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.713 0.688 . . . . 0.0 109.92 169.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.48 -27.28 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.409 0.683 . . . . 0.0 112.525 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.31 -21.86 60.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.723 0.809 . . . . 0.0 110.641 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 -5.58 60.68 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.837 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -78.05 131.84 37.49 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.187 0.595 . . . . 0.0 110.746 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -57.44 127.47 32.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.613 1.165 . . . . 0.0 112.042 177.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.771 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 30.3 m -113.27 -19.52 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 111.228 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.96 -145.93 9.58 Favored Glycine 0 C--N 1.358 1.786 0 C-N-CA 121.594 -0.336 . . . . 0.0 113.756 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -139.96 156.53 46.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.526 1.13 . . . . 0.0 109.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 100' ' ' VAL . 53.9 mt -93.54 4.84 53.32 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.976 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 69.15 146.3 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.707 1.203 . . . . 0.0 110.815 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -56.12 -20.53 17.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.364 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.89 -59.43 5.14 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.135 0.974 . . . . 0.0 111.702 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 111' ' ' LEU . 3.9 pp -85.6 -22.03 28.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.615 0.366 . . . . 0.0 111.358 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -64.18 -37.8 88.77 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.48 0.712 . . . . 0.0 111.763 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.14 -29.48 74.51 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.851 0.72 . . . . 0.0 112.906 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.58 5.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 109.632 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.26 -15.92 63.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.977 0.911 . . . . 0.0 112.348 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -52.72 -44.92 66.71 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.41 1.084 . . . . 0.0 113.042 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -70.98 -32.23 69.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.911 0.386 . . . . 0.0 110.207 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.36 -35.44 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.421 0.689 . . . . 0.0 110.334 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.6 tpp -79.8 -33.53 40.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.671 1.188 . . . . 0.0 111.065 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.67 -51.14 10.27 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.169 0.988 . . . . 0.0 110.097 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -88.21 2.06 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.845 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 59.42 34.5 22.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.641 1.177 . . . . 0.0 111.354 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.54 -40.65 95.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.915 0.886 . . . . 0.0 111.894 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.73 134.88 13.13 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.474 0.71 . . . . 0.0 110.311 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.67 104.49 12.11 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.08 123.07 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.724 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.05 149.3 42.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.35 174.71 19.2 Favored Glycine 0 C--O 1.239 0.438 0 O-C-N 123.486 0.491 . . . . 0.0 112.869 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 14.4 p -151.18 143.58 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.869 0.868 . . . . 0.0 110.107 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.81 84.66 32.08 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.716 0.807 . . . . 0.0 110.029 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.62 -17.69 12.47 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.87 2.38 . . . . 0.0 112.647 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -83.22 -30.66 27.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.188 0.595 . . . . 0.0 111.174 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 79' ' ' ASN . . . 57.46 34.18 68.17 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.772 0.67 . . . . 0.0 114.339 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.16 0.31 57.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 0.0 110.548 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.87 -9.12 57.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.059 1.344 . . . . 0.0 112.582 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 72' ' ' TYR . 9.4 p30 -102.51 -22.25 14.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.327 0.651 . . . . 0.0 111.206 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.66 -41.53 7.66 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.629 0.772 . . . . 0.0 112.619 -167.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -160.0 -178.3 6.92 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 -164.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 22.5 p -90.19 108.75 19.94 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 ptm -112.06 148.87 39.96 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.97 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 96.6 Cg_endo -78.77 146.62 21.1 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.925 1.75 . . . . 0.0 110.14 160.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 67' ' ' VAL . 2.6 pt? -137.36 155.61 49.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.022 0.439 . . . . 0.0 110.134 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -74.22 108.08 6.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.118 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' ' 85' ' ' LEU . 24.8 mmt -102.48 153.59 19.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -143.24 124.72 14.78 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.034 0.934 . . . . 0.0 108.853 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.06 117.53 30.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.814 0.846 . . . . 0.0 109.665 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -119.76 100.62 7.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.83 157.28 27.2 Favored Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -61.42 144.44 54.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.751 0.42 . . . . 0.0 111.487 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.32 -34.38 57.19 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.83 -30.31 70.75 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.144 0.429 . . . . 0.0 111.961 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -85.74 -9.84 56.51 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.431 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.9 ppt_? -60.69 -29.25 69.2 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 118.899 0.772 . . . . 0.0 112.152 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.99 -37.76 86.03 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.097 0.559 . . . . 0.0 110.536 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 158' ' ' LYS . . . -82.68 -46.17 13.56 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.829 0.852 . . . . 0.0 110.505 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.54 -50.61 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.38 1.072 . . . . 0.0 111.458 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.9 p -65.0 -39.25 93.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.905 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.94 -38.9 76.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.981 0.912 . . . . 0.0 111.632 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.5 mm100 -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.377 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.58 -56.72 7.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.189 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -55.03 -32.16 61.63 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.336 1.454 . . . . 0.0 112.128 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.15 -39.03 77.75 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -107.16 -11.52 15.59 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.429 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.75 42.17 6.51 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.639 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.455 0.702 . . . . 0.0 110.104 171.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -76.83 -18.04 58.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.45 0.7 . . . . 0.0 111.482 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.42 -22.59 66.97 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.952 0.901 . . . . 0.0 111.643 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.79 -41.48 91.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.43 0.692 . . . . 0.0 111.793 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -74.62 -23.78 58.75 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.682 0.219 . . . . 0.0 111.034 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.84 -42.44 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -76.04 -25.64 55.82 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.3 m -75.72 117.61 17.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.655 0.382 . . . . 0.0 110.022 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 m -116.0 156.64 17.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.556 1.142 . . . . 0.0 111.273 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.26 104.93 11.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -74.29 -33.07 63.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HE2' ' A' ' 170' ' ' LYS . . . 156.97 -178.54 33.32 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.554 -173.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -111.01 160.54 16.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.433 0.693 . . . . 0.0 109.926 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.507 HD22 HD21 ' A' ' 119' ' ' LEU . 29.7 tp -126.93 154.24 44.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 110.206 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -99.05 86.14 3.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.126 1.371 . . . . 0.0 108.128 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.98 87.28 0.87 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -70.98 80.6 0.65 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.848 0.859 . . . . 0.0 109.818 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.76 138.1 20.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.4 137.37 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 123.78 0.675 . . . . 0.0 109.654 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 142' ' ' PHE . . . -81.51 -31.17 34.28 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.219 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.5 tp -62.45 -18.81 62.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.978 0.911 . . . . 0.0 111.465 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.488 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 2.7 mmp_? -76.94 0.84 19.55 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.141 0.977 . . . . 0.0 112.582 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HA ' HG13 ' A' ' 76' ' ' VAL . 28.2 p90 -51.11 -34.22 29.64 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.436 1.095 . . . . 0.0 112.37 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -62.96 -34.51 77.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.394 1.078 . . . . 0.0 111.971 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.1 p -78.68 2.33 19.9 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 49.14 0.65 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.952 165.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.729 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 32.7 m -65.66 162.6 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.64 1.22 . . . . 0.0 111.366 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.08 166.5 8.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.92 0.888 . . . . 0.0 110.913 -170.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.95 -170.83 2.89 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.797 0.839 . . . . 0.0 112.177 -170.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.11 145.86 55.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.995 0.918 . . . . 0.0 111.592 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 m120 66.25 10.17 6.94 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.326 1.45 . . . . 0.0 113.398 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.13 143.84 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.245 0.618 . . . . 0.0 110.141 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 80.6 mtp -96.65 142.0 29.22 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.5 m -126.2 145.81 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.361 1.064 . . . . 0.0 110.237 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -105.79 153.56 21.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.101 0.96 . . . . 0.0 110.461 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.94 125.97 53.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.584 0.754 . . . . 0.0 109.691 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -140.8 112.86 7.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.718 0.807 . . . . 0.0 109.396 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' HB3' HG12 ' A' ' 98' ' ' ILE . 5.8 ppt_? -87.54 151.35 23.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.52 0.328 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 1.8 m-20 -90.88 149.61 40.57 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 123.59 0.756 . . . . 0.0 111.626 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.92 -43.11 57.35 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.609 2.206 . . . . 0.0 111.634 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -153.38 93.83 1.74 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.685 1.194 . . . . 0.0 108.962 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 13.6 t30 -89.05 151.74 47.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.02 -29.43 44.56 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.618 2.879 . . . . 0.0 113.614 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.51 -51.63 22.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t0 172.1 162.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.366 1.467 . . . . 0.0 108.319 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -65.01 -15.09 61.93 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.64 1.176 . . . . 0.0 112.266 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -87.78 -15.92 35.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.364 0.666 . . . . 0.0 111.881 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.41 118.82 9.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.526 0.73 . . . . 0.0 111.665 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 87' ' ' ARG . 63.1 mt -92.03 120.06 40.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.573 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 34.0 mtmm -81.14 123.4 28.39 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 164.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.27 126.16 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 6.5 p30 -115.29 173.76 6.35 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 124.598 1.159 . . . . 0.0 107.92 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -103.94 -170.38 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 118.666 0.666 . . . . 0.0 110.2 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -57.47 -33.06 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.57 -11.32 59.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.594 0.758 . . . . 0.0 111.564 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.16 14.57 78.81 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.521 -0.308 . . . . 0.0 112.888 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -78.5 120.57 23.4 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.95 0.9 . . . . 0.0 108.586 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.17 99.67 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.517 0.727 . . . . 0.0 109.499 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 23.0 m -71.77 -27.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.199 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.39 176.64 38.34 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.404 0.44 . . . . 0.0 113.41 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.602 ' HD2' ' HG2' ' A' ' 99' ' ' LYS . 31.6 m80 -92.46 133.96 35.41 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 1.3 tt -66.35 -54.08 28.72 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.68 0.612 . . . . 0.0 110.307 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 53.9 mmtt 150.85 133.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 -160.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -70.86 -42.02 70.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.06 -52.03 65.59 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.128 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.84 -40.46 91.75 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.178 0.591 . . . . 0.0 110.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.03 69.85 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.239 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.79 -31.79 64.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.5 0.5 . . . . 0.0 113.125 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.58 5.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.552 0.741 . . . . 0.0 110.414 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 63' ' ' LEU . 21.1 mt -73.3 -18.58 61.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -170.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.78 -29.7 65.97 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.412 0.685 . . . . 0.0 110.885 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.86 -35.33 64.74 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 127' ' ' LEU . 58.8 mt -70.86 -33.64 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.275 0.63 . . . . 0.0 110.765 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.2 tpp -74.34 -56.2 5.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.419 1.088 . . . . 0.0 110.659 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.38 -44.78 62.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.267 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.33 5.07 32.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.695 0.398 . . . . 0.0 111.403 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 60.98 33.54 19.72 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.377 1.071 . . . . 0.0 112.592 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HB2' HG23 ' A' ' 122' ' ' ILE . 64.2 mt -67.68 -38.56 83.89 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.662 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -166.67 145.89 5.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 111.173 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -78.26 116.87 19.0 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.998 0.919 . . . . 0.0 109.279 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -98.92 112.83 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.144 0.578 . . . . 0.0 109.812 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 10.9 pt-20 -83.41 167.66 17.29 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -143.27 152.34 23.98 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 35.5 t -149.16 128.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.475 1.11 . . . . 0.0 108.479 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.31 96.69 1.32 Allowed Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 123.646 0.778 . . . . 0.0 109.449 167.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.39 -31.34 9.22 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.591 2.194 . . . . 0.0 113.316 -176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.09 -20.94 12.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.989 0.916 . . . . 0.0 110.916 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.87 29.96 75.74 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.34 0.4 . . . . 0.0 113.468 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -76.79 3.24 12.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.953 0.901 . . . . 0.0 113.315 -170.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -67.43 -26.63 66.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.171 0.589 . . . . 0.0 110.274 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.84 -37.46 73.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.694 0.797 . . . . 0.0 110.569 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.14 -55.23 9.92 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.695 0.798 . . . . 0.0 110.867 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 74.7 t80 -151.34 -77.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 p -158.3 165.76 33.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.012 1.725 . . . . 0.0 107.85 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 14.3 ptt? -167.12 152.37 7.15 Favored Pre-proline 0 C--O 1.246 0.921 0 O-C-N 123.43 0.456 . . . . 0.0 110.398 168.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.67 126.44 10.81 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.996 1.797 . . . . 0.0 110.339 162.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.59 156.23 16.9 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.984 0.514 . . . . 0.0 109.959 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.44 107.02 3.17 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.373 0.42 . . . . 0.0 110.305 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.463 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 65.4 mtt -104.07 160.26 14.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 131' ' ' GLU . 19.2 m -154.34 143.3 21.06 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.477 0.58 . . . . 0.0 110.029 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 76.6 m-85 -104.19 117.8 35.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.28 1.032 . . . . 0.0 109.851 -174.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -121.04 100.62 7.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.276 1.03 . . . . 0.0 108.811 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.52 167.67 33.07 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -65.69 147.87 52.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.12 -19.88 48.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.681 1.192 . . . . 0.0 114.046 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.0 -22.08 56.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -93.06 -0.19 57.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.083 0.553 . . . . 0.0 112.478 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 7.6 ppt_? -52.83 -38.11 60.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -79.98 -27.62 39.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.793 0.437 . . . . 0.0 110.79 -175.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.96 55.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.424 0.69 . . . . 0.0 110.752 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.83 -51.79 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.885 0.874 . . . . 0.0 110.133 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.3 p -65.89 -30.41 71.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.589 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -54.89 -42.54 72.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.898 0.879 . . . . 0.0 111.728 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -67.68 -34.41 76.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.299 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.28 -45.39 55.88 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.913 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -61.12 -31.73 71.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.03 1.332 . . . . 0.0 111.372 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -58.34 -42.35 86.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.804 1.242 . . . . 0.0 111.296 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -97.62 -15.05 20.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.099 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.32 19.18 31.06 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 113.585 0.194 . . . . 0.0 113.585 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.43 165.94 22.76 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.717 0.807 . . . . 0.0 110.997 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -57.61 147.77 26.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.03 0.932 . . . . 0.0 110.82 170.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 124.681 1.192 . . . . 0.0 110.451 -176.765 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -61.19 -37.11 81.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.631 0.772 . . . . 0.0 111.732 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.68 -29.83 22.17 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.014 0.525 . . . . 0.0 111.015 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.38 -39.51 90.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.969 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.31 -27.16 61.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.892 0.477 . . . . 0.0 111.286 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.53 -33.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.384 0.674 . . . . 0.0 109.561 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.38 -25.71 59.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.015 0.926 . . . . 0.0 110.411 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -72.47 134.83 45.53 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.071 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.5 158.53 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.384 1.073 . . . . 0.0 110.469 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.73 102.6 12.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.436 1.094 . . . . 0.0 108.292 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 41.8 m-85 -74.44 -23.24 58.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.108 0.563 . . . . 0.0 111.422 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.35 177.2 14.76 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.032 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -111.22 120.6 42.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.171 0.588 . . . . 0.0 110.267 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -86.76 137.71 32.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.539 1.136 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 100.73 4.13 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -90.73 -170.84 43.43 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 166.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -165.43 127.04 2.0 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 100' ' ' VAL . 48.1 t -98.59 134.63 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 70' ' ' LEU . 23.7 t -69.98 143.93 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 O-C-N 123.92 0.763 . . . . 0.0 110.325 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.39 -22.52 78.58 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.233 0.333 . . . . 0.0 113.008 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' H ' HG12 ' A' ' 68' ' ' VAL . 35.0 tp -62.77 -18.15 62.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.429 1.092 . . . . 0.0 111.379 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 3.5 mmp_? -76.66 1.77 16.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.957 0.903 . . . . 0.0 112.823 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 76' ' ' VAL . 86.7 t80 -48.69 -36.63 16.56 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.92 0.888 . . . . 0.0 112.546 174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -62.44 -40.91 98.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.703 0.801 . . . . 0.0 111.609 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 p -78.51 -4.5 48.87 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.03 49.67 1.45 Allowed Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 72' ' ' TYR . 17.4 m -53.55 164.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG23 HG21 ' A' ' 134' ' ' VAL . 14.8 m -114.6 163.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.792 -164.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -92.52 -166.37 1.53 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.996 1.318 . . . . 0.0 111.266 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.17 147.13 48.65 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.496 0.718 . . . . 0.0 111.6 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 63.98 8.87 4.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 0.0 113.637 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -77.04 136.91 38.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.977 0.418 . . . . 0.0 110.31 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.541 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.8 mtp -100.24 150.08 22.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.163 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 102' ' ' ASN . 29.8 m -135.11 174.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.537 1.135 . . . . 0.0 109.553 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.33 133.7 16.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 107.714 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -84.62 146.34 27.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.17 0.588 . . . . 0.0 109.986 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -151.2 130.31 12.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.141 0.977 . . . . 0.0 108.598 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' A' ' 95' ' ' LYS . 34.1 ptt85 -74.27 146.81 42.93 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -80.46 118.04 70.56 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.101 0.561 . . . . 0.0 110.894 -167.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 -32.63 24.86 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.14 2.56 . . . . 0.0 112.187 173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.75 33.95 2.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.913 0.885 . . . . 0.0 109.925 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -53.89 119.0 17.02 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.586 1.154 . . . . 0.0 112.987 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.88 -28.27 16.72 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.961 2.441 . . . . 0.0 113.155 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -116.45 -51.68 2.59 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.38 0.672 . . . . 0.0 111.328 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -167.67 155.64 8.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.841 0.456 . . . . 0.0 110.651 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HB2' HH11 ' A' ' 87' ' ' ARG . 8.3 ptpp? -53.43 -23.17 9.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.179 1.791 . . . . 0.0 113.373 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 81.2 m-20 -78.98 18.86 0.58 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.775 0.83 . . . . 0.0 112.796 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.04 111.66 23.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 108.948 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 120' ' ' ALA . 29.7 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 123.592 0.757 . . . . 0.0 110.513 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 16.5 ptpt -85.66 164.37 17.72 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.503 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 67' ' ' VAL . 60.7 t -117.27 117.34 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -110.25 131.39 55.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.936 0.894 . . . . 0.0 108.816 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' HG12 ' A' ' 83' ' ' VAL . 26.3 p-10 -75.71 -168.92 0.94 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 118.307 0.503 . . . . 0.0 111.507 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -52.11 -33.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 124.4 1.08 . . . . 0.0 112.96 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -88.24 -20.32 25.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.178 0.591 . . . . 0.0 111.553 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.53 4.2 54.92 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-N 116.447 -0.342 . . . . 0.0 112.843 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -63.15 127.46 31.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 110.061 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -77.3 92.16 3.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.925 0.89 . . . . 0.0 109.863 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 4.9 m -75.49 -14.89 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.231 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.24 -143.57 10.69 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 123.587 0.554 . . . . 0.0 112.426 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 51.9 m80 -135.83 166.75 22.57 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.407 1.083 . . . . 0.0 108.461 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 148' ' ' MET . 5.2 mp -78.13 -53.13 7.71 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.557 0.694 . . . . 0.0 109.819 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 170.72 166.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 127.013 2.125 . . . . 0.0 106.771 -167.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -78.67 -44.98 22.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HB3' ' NE2' ' A' ' 167' ' ' HIS . 19.5 mm-40 -66.74 -45.33 78.95 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.85 0.86 . . . . 0.0 111.935 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 65' ' ' GLY . 1.5 tt -64.4 -44.03 92.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.525 0.73 . . . . 0.0 110.007 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.16 85.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.645 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -59.63 -30.33 68.6 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.97 0.793 . . . . 0.0 113.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -73.1 -61.29 1.87 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.394 0.678 . . . . 0.0 110.058 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.12 -15.79 63.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.932 0.893 . . . . 0.0 113.202 -171.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -59.12 -39.55 82.63 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.413 1.085 . . . . 0.0 113.168 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.01 -32.95 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.079 0.552 . . . . 0.0 110.241 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.449 ' HA ' HD12 ' A' ' 127' ' ' LEU . 68.5 mt -66.78 -33.9 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.551 0.74 . . . . 0.0 110.081 174.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.4 tpp -78.01 -38.99 43.58 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.19 -47.66 34.21 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.196 0.998 . . . . 0.0 110.406 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.71 -1.49 58.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.099 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.87 31.45 18.24 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.264 1.025 . . . . 0.0 111.532 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 122' ' ' ILE . 77.6 mt -58.52 -43.62 89.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.157 0.983 . . . . 0.0 111.845 -174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.72 131.53 11.6 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.972 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.17 107.19 13.76 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.494 1.118 . . . . 0.0 108.492 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.1 mt -93.35 111.36 24.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.236 0.615 . . . . 0.0 109.948 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.92 179.7 7.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.801 0.84 . . . . 0.0 109.156 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.26 156.34 27.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 82' ' ' MET . 38.8 t -141.76 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.949 0.9 . . . . 0.0 109.69 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.521 HG13 ' HG ' ' A' ' 146' ' ' LEU . 1.7 m -103.73 94.99 6.83 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.447 1.099 . . . . 0.0 108.622 166.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.09 -48.76 3.27 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.537 2.158 . . . . 0.0 111.927 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.78 -27.79 40.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.604 0.762 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' ' HB ' ' A' ' 134' ' ' VAL . . . 63.6 30.08 76.58 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 113.733 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.07 -1.25 19.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.14 0.976 . . . . 0.0 111.507 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.63 -26.93 66.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.724 0.81 . . . . 0.0 111.09 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 9.9 t-20 -69.07 -29.6 67.76 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.417 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.28 -49.24 4.77 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.646 0.778 . . . . 0.0 110.715 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.99 -162.46 1.25 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.845 1.258 . . . . 0.0 110.087 -170.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -103.09 114.5 28.85 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.9 ptm -112.29 157.11 40.91 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.063 0.545 . . . . 0.0 110.307 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.91 124.81 13.2 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.252 1.968 . . . . 0.0 110.898 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HG ' HG13 ' A' ' 134' ' ' VAL . 4.7 tt -109.1 121.21 44.67 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.64 110.3 16.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.932 0.493 . . . . 0.0 109.676 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.52 ' SD ' HD21 ' A' ' 85' ' ' LEU . 47.6 mtt -115.82 113.36 23.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.409 1.084 . . . . 0.0 110.53 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -103.97 129.41 51.55 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.134 0.574 . . . . 0.0 110.472 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 3.9 m-85 -88.4 125.51 34.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.094 0.958 . . . . 0.0 109.478 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -126.73 99.2 5.67 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.98 161.71 31.69 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.72 145.41 54.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.392 0.677 . . . . 0.0 112.282 -175.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 157' ' ' ARG . 44.5 mt-10 -57.59 -31.74 66.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.253 1.021 . . . . 0.0 113.425 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.53 -23.77 66.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.28 2.41 56.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.261 0.624 . . . . 0.0 112.404 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.444 HH21 ' HB3' ' A' ' 154' ' ' GLU . 15.5 ptp180 -57.99 -37.97 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.844 0.457 . . . . 0.0 111.514 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.67 -43.42 89.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.226 1.01 . . . . 0.0 110.387 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.97 -36.29 67.08 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.358 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.39 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.848 0.859 . . . . 0.0 110.443 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.0 p -67.57 -26.78 66.46 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.086 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.13 -37.61 88.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.106 0.562 . . . . 0.0 110.951 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.1 mm100 -74.49 -38.43 62.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.012 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.68 -61.73 2.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.47 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.63 -21.99 66.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.749 1.219 . . . . 0.0 112.761 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -53.74 -52.34 60.47 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.882 0.873 . . . . 0.0 111.018 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . 0.449 ' NE2' ' HB3' ' A' ' 114' ' ' GLU . 66.3 t-80 -96.25 -17.27 20.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.418 -177.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.1 34.32 5.43 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.734 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.16 152.15 20.68 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.609 0.764 . . . . 0.0 109.878 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -166.41 150.31 7.44 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.798 0.839 . . . . 0.0 109.753 -177.641 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -85.12 36.33 0.62 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.92 0.888 . . . . 0.0 111.93 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.23 -30.64 64.77 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.104 0.962 . . . . 0.0 112.264 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -66.82 -13.01 61.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.813 1.245 . . . . 0.0 113.588 -177.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.55 -28.73 69.54 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.555 0.742 . . . . 0.0 111.18 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.79 -30.96 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.684 0.794 . . . . 0.0 109.584 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -77.77 -18.07 56.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.767 0.827 . . . . 0.0 110.415 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.96 133.5 50.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.995 0.518 . . . . 0.0 110.879 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.2 m -132.62 162.77 39.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 125.015 1.326 . . . . 0.0 109.797 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 tp -83.89 111.58 19.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 23.0 m-85 -73.51 -25.86 60.62 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.287 0.565 . . . . 0.0 110.611 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -144.25 14.41 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -132.52 179.74 5.95 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.635 0.774 . . . . 0.0 110.271 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 169' ' ' PHE . 49.2 tp -143.35 146.76 33.8 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.571 0.748 . . . . 0.0 109.516 172.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -71.24 81.81 0.73 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.221 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -74.1 74.72 1.18 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -68.08 87.64 0.27 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 111' ' ' LEU . 36.6 t -87.42 147.97 4.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.696 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 87.6 t -61.46 140.96 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.274 1.029 . . . . 0.0 110.727 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.59 -38.18 15.02 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -17.55 31.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.871 1.269 . . . . 0.0 113.248 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.562 ' NH1' HG23 ' A' ' 108' ' ' VAL . 13.1 ptt180 -69.22 -2.29 10.16 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.491 0.717 . . . . 0.0 112.506 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -51.93 -36.84 50.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.071 0.948 . . . . 0.0 112.928 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.08 -30.58 71.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.746 0.818 . . . . 0.0 111.535 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 m -74.38 -6.31 47.44 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.758 0.823 . . . . 0.0 111.786 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.02 45.77 1.24 Allowed Glycine 0 C--N 1.35 1.327 0 O-C-N 122.388 -0.195 . . . . 0.0 113.486 169.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.96 172.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 170.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.08 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.68 -146.26 0.4 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.247 0.619 . . . . 0.0 109.769 -172.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -73.17 150.91 41.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.286 1.034 . . . . 0.0 112.666 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 68.83 -5.44 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.592 1.557 . . . . 0.0 113.208 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.16 146.49 29.53 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.042 0.537 . . . . 0.0 110.622 -172.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.469 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.5 mtp -97.43 143.56 28.04 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.518 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.13 145.78 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.36 1.064 . . . . 0.0 108.912 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -99.03 156.01 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -115.41 124.49 51.31 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -132.98 116.8 16.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.969 0.908 . . . . 0.0 109.679 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -67.91 119.21 12.21 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.451 ' HB2' ' HG2' ' A' ' 99' ' ' LYS . 18.5 t70 -66.6 132.65 94.16 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.571 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.79 -42.52 11.87 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.272 3.314 . . . . 0.0 114.079 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -167.38 106.95 0.58 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 123.138 0.273 . . . . 0.0 110.551 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.7 146.26 30.99 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.05 -22.14 48.2 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.765 2.31 . . . . 0.0 114.003 -170.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -125.94 -46.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.713 0.405 . . . . 0.0 110.858 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.428 ' HB3' ' ND2' ' A' ' 96' ' ' ASN . 33.7 m-20 -117.14 92.7 3.93 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -55.86 -33.16 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.728 0.811 . . . . 0.0 111.686 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.585 ' H ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -72.3 -8.29 54.08 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 113.1 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 108.41 2.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.237 0.615 . . . . 0.0 111.375 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.32 125.95 45.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 124.081 0.952 . . . . 0.0 110.213 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 32.4 mmtp -86.8 123.91 32.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.106 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.61 112.67 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.0 m-20 -91.53 170.36 10.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.188 0.995 . . . . 0.0 108.849 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -108.11 -171.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.843 0.457 . . . . 0.0 110.248 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.69 -28.38 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.637 0.775 . . . . 0.0 112.24 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.9 -30.48 63.95 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.176 0.591 . . . . 0.0 110.357 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.19 -4.34 30.03 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.485 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -74.81 137.4 41.87 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.278 0.539 . . . . 0.0 110.026 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.78 95.37 0.89 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.562 HG23 ' NH1' ' A' ' 71' ' ' ARG . 27.8 m -86.95 16.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.861 0.865 . . . . 0.0 112.012 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 148.01 -175.72 27.19 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.925 169.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -102.68 148.83 25.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.11 0.964 . . . . 0.0 108.972 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.2 tt -73.89 -56.09 5.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? 152.12 121.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -165.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -61.11 -49.47 77.13 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 118.802 0.728 . . . . 0.0 112.072 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.33 -41.56 93.81 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.821 0.7 . . . . 0.0 110.82 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.77 -40.08 66.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.831 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.32 -24.54 65.75 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.008 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.28 -33.82 88.29 Favored Glycine 0 C--N 1.351 1.361 0 O-C-N 123.603 0.565 . . . . 0.0 112.958 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -56.84 4.78 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.413 0.625 . . . . 0.0 109.802 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 63' ' ' LEU . 22.5 mt -70.5 -18.12 62.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.506 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.96 67.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.881 0.873 . . . . 0.0 111.153 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -66.03 -35.5 80.72 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.184 0.928 . . . . 0.0 110.44 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.507 ' HA ' HD12 ' A' ' 127' ' ' LEU . 83.9 mt -62.62 -44.55 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 0.0 110.585 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 85' ' ' LEU . 30.1 ttm -81.19 -21.46 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.644 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.31 -51.05 10.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 0.0 109.72 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -89.71 4.16 50.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.224 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 59.71 36.63 22.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.533 1.133 . . . . 0.0 111.594 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 122' ' ' ILE . 66.0 mt -62.22 -40.83 97.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.44 1.096 . . . . 0.0 111.54 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.504 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.15 140.86 9.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.13 0.572 . . . . 0.0 111.093 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -76.52 133.51 39.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.1 113.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.39 132.75 54.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.35 154.78 18.53 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.773 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 82' ' ' MET . 67.3 t -137.99 137.26 44.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.23 84.88 4.98 Favored Pre-proline 0 CA--C 1.555 1.17 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.47 -35.78 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.656 2.237 . . . . 0.0 111.74 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.25 -26.13 58.61 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.966 0.907 . . . . 0.0 110.59 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.76 -6.08 14.18 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 115.835 1.094 . . . . 0.0 115.835 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.12 1.8 30.22 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.481 0.641 . . . . 0.0 112.723 -172.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.602 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 3.4 t-20 -75.32 -18.4 60.03 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.116 0.484 . . . . 0.0 110.315 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.89 -34.23 75.66 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.092 0.957 . . . . 0.0 110.663 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.94 -56.39 2.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.828 0.851 . . . . 0.0 112.579 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -126.8 -178.25 4.32 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.542 1.137 . . . . 0.0 110.573 -161.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p -93.8 125.46 38.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.087 0.955 . . . . 0.0 109.631 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 139' ' ' ASN . 3.3 ppp? -156.61 160.93 30.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.172 0.989 . . . . 0.0 109.302 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.96 121.5 7.36 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.791 1.661 . . . . 0.0 111.147 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 67' ' ' VAL . 6.5 tt -100.34 124.88 46.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -74.33 108.84 7.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.627 ' SD ' HD21 ' A' ' 85' ' ' LEU . 58.5 mtt -116.05 121.74 43.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.76 0.824 . . . . 0.0 109.581 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -108.99 140.53 42.36 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.373 1.069 . . . . 0.0 110.206 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 43.5 m-85 -104.15 121.01 42.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.923 0.889 . . . . 0.0 109.684 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -124.5 112.88 17.4 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.48 164.45 37.97 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 7.9 ptpp? -54.26 137.69 40.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.534 0.734 . . . . 0.0 110.541 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -53.93 -39.0 65.47 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 123.854 0.721 . . . . 0.0 112.551 -169.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.42 -18.03 35.67 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.319 1.048 . . . . 0.0 113.759 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -92.51 -8.22 45.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.79 -33.62 66.84 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.056 0.542 . . . . 0.0 112.398 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 46.7 pttt -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.674 0.789 . . . . 0.0 111.381 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -68.65 -34.7 76.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.62 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.96 -44.24 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.657 0.783 . . . . 0.0 110.466 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -72.67 -25.97 61.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.543 0.737 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 32.7 t70 -58.77 -39.92 82.43 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.15 0.5 . . . . 0.0 110.286 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 166' ' ' LYS . 14.7 mm100 -73.19 -39.49 65.53 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.12 -175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.51 -57.54 4.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.32 -21.29 59.52 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.654 1.181 . . . . 0.0 112.484 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 163' ' ' GLN . 21.8 ttmm -56.23 -50.38 71.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.989 0.916 . . . . 0.0 111.177 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -111.59 18.7 18.82 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.174 0.59 . . . . 0.0 110.545 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.0 14.07 76.05 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.584 ' HB3' HD11 ' A' ' 63' ' ' LEU . 28.4 m-85 -66.1 137.55 57.13 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.883 0.873 . . . . 0.0 110.892 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -166.54 151.0 7.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.467 1.107 . . . . 0.0 108.022 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.435 0.694 . . . . 0.0 111.628 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 120.096 -0.28 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -60.31 -35.5 75.74 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.246 1.019 . . . . 0.0 111.372 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -73.73 -40.09 63.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.196 0.598 . . . . 0.0 110.874 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.62 -42.05 82.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.101 0.961 . . . . 0.0 111.588 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.39 -36.78 71.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.328 0.651 . . . . 0.0 111.993 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.0 t -72.54 -31.44 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.4 t70 -77.4 -14.0 59.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.285 0.634 . . . . 0.0 111.126 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 m -70.66 109.29 4.82 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.464 0.65 . . . . 0.0 110.519 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 56' ' ' ASP . 16.9 m -116.61 162.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.853 1.261 . . . . 0.0 110.293 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.76 118.49 22.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 27.8 m-85 -83.31 -31.5 26.83 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.322 0.582 . . . . 0.0 110.167 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.1 -167.94 29.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.873 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 147' ' ' HIS . 77.6 p -125.58 138.98 53.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.889 0.476 . . . . 0.0 110.102 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 33.6 tp -99.09 140.95 32.48 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 109.761 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -75.37 78.87 2.44 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.928 0.87 . . . . 0.0 110.486 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -71.68 141.23 31.66 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.419 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -122.01 100.72 7.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.45 0.7 . . . . 0.0 109.776 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.96 131.23 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.93 0.769 . . . . 0.0 108.974 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.66 142.32 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.741 0.816 . . . . 0.0 111.594 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.63 -27.29 57.35 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.64 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.85 -19.57 65.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.444 0.698 . . . . 0.0 110.072 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 4.1 mmp_? -78.1 0.27 25.39 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.47 1.108 . . . . 0.0 112.807 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.05 -36.66 65.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.473 0.709 . . . . 0.0 112.12 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.82 -32.23 73.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.701 0.8 . . . . 0.0 111.85 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 p -87.22 15.5 6.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.13 0.572 . . . . 0.0 112.399 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.04 49.95 1.41 Allowed Glycine 0 C--N 1.356 1.653 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 163.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.47 169.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.093 0.947 . . . . 0.0 111.585 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 HG11 ' A' ' 134' ' ' VAL . 27.6 m -115.64 158.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.769 0.828 . . . . 0.0 111.902 -164.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.32 -173.95 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.136 0.974 . . . . 0.0 110.758 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -72.44 153.23 41.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.44 8.74 5.96 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 125.019 1.328 . . . . 0.0 112.229 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -88.11 145.41 25.96 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.7 -0.625 . . . . 0.0 111.553 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.578 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -95.36 147.37 23.58 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.123 177.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.82 142.09 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.556 1.142 . . . . 0.0 108.853 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -115.01 124.69 52.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.721 0.808 . . . . 0.0 109.56 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.9 mt -76.83 158.84 30.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.681 0.393 . . . . 0.0 110.707 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.03 121.59 4.89 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.425 0.69 . . . . 0.0 110.116 -174.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.28 134.61 56.14 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.471 0.708 . . . . 0.0 110.835 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.74 118.28 59.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.319 0.647 . . . . 0.0 109.319 169.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.75 -29.57 90.07 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.918 2.412 . . . . 0.0 112.866 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -144.42 98.99 3.29 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -65.64 138.69 96.79 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.583 0.753 . . . . 0.0 110.632 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.46 -54.41 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.434 2.089 . . . . 0.0 113.139 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -128.61 -50.72 1.26 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.754 0.822 . . . . 0.0 109.768 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.71 101.25 13.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.019 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.25 -4.96 28.6 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 3.6 p-10 -99.37 -2.14 37.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.282 1.033 . . . . 0.0 111.784 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.71 144.24 54.47 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.021 0.528 . . . . 0.0 111.384 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.19 126.18 55.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.145 0.978 . . . . 0.0 108.931 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.17 152.93 43.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.506 0.722 . . . . 0.0 111.209 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.31 134.08 64.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -121.05 166.48 13.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.429 1.091 . . . . 0.0 108.084 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -99.34 -172.64 2.3 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.11 -19.28 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.227 0.611 . . . . 0.0 112.582 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -84.92 -10.93 56.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.354 0.662 . . . . 0.0 110.919 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.3 19.9 59.77 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.648 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -87.88 127.68 35.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 109.762 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.01 110.49 3.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 110.239 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 4.3 m -84.3 -10.51 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.943 0.497 . . . . 0.0 110.643 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.96 -141.52 12.86 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -106.05 173.76 6.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.733 0.813 . . . . 0.0 110.072 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.431 HD11 ' SD ' ' A' ' 148' ' ' MET . 2.3 tt -84.71 -52.32 6.16 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 172.01 168.77 0.1 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -79.06 -63.77 1.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.26 -36.55 74.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 0.0 112.379 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.483 HD11 ' HA2' ' A' ' 65' ' ' GLY . 4.9 tt -73.05 -46.02 54.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.896 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.03 67.44 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.838 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -61.48 -40.04 98.14 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.592 0.558 . . . . 0.0 113.347 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -49.55 39.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.38 0.609 . . . . 0.0 109.86 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 122' ' ' ILE . 17.1 mt -69.31 -16.74 63.62 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.819 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.84 -57.95 9.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.381 1.072 . . . . 0.0 111.543 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -64.07 -31.0 72.03 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.909 0.756 . . . . 0.0 110.687 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 127' ' ' LEU . 73.5 mt -67.34 -40.61 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.509 0.723 . . . . 0.0 111.203 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.7 ttm -80.36 -36.31 34.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.232 0.613 . . . . 0.0 110.971 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.13 -41.41 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.272 1.029 . . . . 0.0 111.101 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -99.67 7.98 44.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.648 0.779 . . . . 0.0 111.096 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 63.08 35.77 12.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.33 1.052 . . . . 0.0 111.762 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 122' ' ' ILE . 64.1 mt -69.5 -50.22 47.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.009 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -152.11 145.0 24.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.89 134.66 33.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 108.599 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.2 mt -121.4 117.42 52.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.721 0.296 . . . . 0.0 110.301 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -117.37 121.25 40.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.252 1.021 . . . . 0.0 108.451 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -90.14 155.52 24.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.582 -0.281 . . . . 0.0 112.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 82' ' ' MET . 53.3 t -138.68 128.02 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG23 ' A' ' 77' ' ' VAL . 5.0 p -96.01 102.27 10.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.711 0.805 . . . . 0.0 109.301 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -53.56 0.18 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.296 1.997 . . . . 0.0 113.574 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -84.98 -27.59 26.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.035 0.534 . . . . 0.0 110.941 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.35 81.84 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 113.718 0.247 . . . . 0.0 113.718 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.652 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -75.93 -7.75 55.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.423 0.689 . . . . 0.0 112.277 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.78 -16.65 63.86 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.864 0.865 . . . . 0.0 110.973 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -73.12 -25.66 60.93 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.622 0.769 . . . . 0.0 111.29 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.07 -60.61 2.19 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -141.5 -83.49 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.1 m -157.5 140.62 15.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.652 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -153.06 149.38 21.69 Favored Pre-proline 0 C--O 1.243 0.758 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 173.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.75 124.4 14.49 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.326 2.017 . . . . 0.0 112.815 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.485 HD22 ' HB ' ' A' ' 134' ' ' VAL . 4.3 pp -117.77 146.25 43.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.043 0.937 . . . . 0.0 108.858 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.5 m80 -86.55 109.85 19.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.612 0.365 . . . . 0.0 111.139 -166.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.649 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 40.3 mtt -99.76 111.77 24.07 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.188 0.995 . . . . 0.0 109.468 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 49.5 p -93.99 128.22 40.21 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.154 0.982 . . . . 0.0 109.653 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 24.7 m-85 -91.13 117.25 29.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.261 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -120.44 99.18 6.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.89 166.55 31.45 Favored Glycine 0 CA--C 1.501 -0.832 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.342 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.03 149.3 45.04 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.58 -48.02 7.51 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.78 1.632 . . . . 0.0 113.613 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.14 -9.89 55.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -171.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 127' ' ' LEU . 98.9 m-20 -107.62 -4.36 18.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 8.9 ptp85 -63.44 -29.24 70.56 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.216 0.916 . . . . 0.0 112.228 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.16 -42.52 86.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.67 0.788 . . . . 0.0 109.847 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.06 -34.12 29.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.467 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.89 -57.75 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.654 0.782 . . . . 0.0 110.517 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 m -62.95 -25.45 68.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.098 0.959 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.4 t70 -60.57 -48.65 80.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.526 0.33 . . . . 0.0 110.375 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.9 mm100 -64.06 -35.22 80.02 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.956 0.785 . . . . 0.0 111.155 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 -62.46 1.45 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.342 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -58.91 -26.98 64.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.497 0.719 . . . . 0.0 111.694 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 37.1 ttmt -56.06 -50.09 71.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.645 1.178 . . . . 0.0 111.793 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -87.15 -13.46 44.02 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.02 10.85 23.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.916 -0.38 . . . . 0.0 113.548 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -73.71 168.97 18.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.078 0.551 . . . . 0.0 110.106 171.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 151.48 46.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.67 0.388 . . . . 0.0 110.216 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 171' ' ' LEU . 1.8 pt? . . . . . 0 CA--C 1.565 1.542 0 C-N-CA 123.019 0.528 . . . . 0.0 110.153 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 t -65.68 -35.2 80.1 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.724 0.809 . . . . 0.0 110.464 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.78 -28.01 69.29 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.386 1.474 . . . . 0.0 113.742 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 15.8 pt-20 -70.4 -31.25 68.39 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.755 0.422 . . . . 0.0 111.82 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -27.56 21.51 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.768 0.427 . . . . 0.0 110.471 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.92 -32.05 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.44 0.696 . . . . 0.0 109.605 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.97 -33.26 75.62 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.349 1.06 . . . . 0.0 110.48 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -78.53 127.49 32.22 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.753 0.821 . . . . 0.0 110.693 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.85 166.78 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.786 1.234 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.51 117.59 23.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.497 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 20.7 m-85 -81.12 -28.86 34.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.058 0.543 . . . . 0.0 110.648 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.93 -153.26 25.19 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 171' ' ' LEU . 35.0 p -126.47 178.61 5.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.414 0.685 . . . . 0.0 110.559 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -150.96 141.56 22.62 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.913 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -71.74 84.14 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.494 0.718 . . . . 0.0 109.717 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.37 87.25 1.38 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.168 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 18.2 t60 -73.79 94.28 2.24 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.203 0.601 . . . . 0.0 110.213 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.55 HG11 ' HD2' ' A' ' 71' ' ' ARG . 38.3 t -82.22 142.68 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.431 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.74 154.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.892 0.877 . . . . 0.0 113.072 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.46 -19.95 72.85 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.387 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.3 tp -57.23 -23.85 50.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.973 1.309 . . . . 0.0 111.489 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.55 ' HD2' HG11 ' A' ' 67' ' ' VAL . 70.8 ttt180 -54.85 -21.83 12.62 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.241 1.416 . . . . 0.0 113.15 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -49.91 -49.6 49.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.165 0.986 . . . . 0.0 111.95 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -75.45 -25.94 57.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.056 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 m -80.46 -9.23 59.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.011 0.524 . . . . 0.0 110.53 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.31 50.18 0.73 Allowed Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.309 170.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.19 158.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 33.1 m -112.99 152.19 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.222 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.75 -76.84 0.11 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.338 0.399 . . . . 0.0 110.789 -164.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -164.07 159.22 20.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.065 0.946 . . . . 0.0 109.617 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 70.7 -7.6 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.486 1.114 . . . . 0.0 111.892 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.648 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 72.4 mm-40 -75.25 144.0 42.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.758 0.823 . . . . 0.0 111.965 -167.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.568 ' HG2' HG22 ' A' ' 133' ' ' VAL . 73.4 mtm -95.04 144.53 25.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.46 170.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.93 160.79 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.084 0.954 . . . . 0.0 109.083 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.68 25.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.6 mp -85.38 134.06 34.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.045 0.538 . . . . 0.0 109.575 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -142.78 130.7 21.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.3 0.64 . . . . 0.0 109.486 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -80.76 124.32 28.95 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -99.16 137.18 20.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.385 0.674 . . . . 0.0 111.446 -177.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.54 -28.7 6.51 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.622 2.215 . . . . 0.0 112.025 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -80.65 83.72 6.36 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 3.9 p-10 -89.92 127.91 52.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.334 -166.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 10.1 Cg_exo -74.47 -26.92 11.56 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.553 2.168 . . . . 0.0 112.408 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -120.84 -53.38 2.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.254 0.621 . . . . 0.0 111.578 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -168.1 154.0 7.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.01 -13.38 2.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.162 0.985 . . . . 0.0 113.636 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 90.0 m-20 -95.19 27.68 3.15 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.065 0.946 . . . . 0.0 111.48 174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.7 34.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.057 0.543 . . . . 0.0 110.687 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mt -116.36 123.87 71.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 C-N-CA 123.967 0.907 . . . . 0.0 109.437 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -81.84 150.13 27.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.591 0.71 . . . . 0.0 110.465 170.306 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -101.11 109.95 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -89.91 167.73 12.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -107.1 -165.6 1.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.298 0.499 . . . . 0.0 110.482 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -59.04 -31.24 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.847 0.859 . . . . 0.0 112.034 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.08 -11.96 57.53 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.196 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.37 85.82 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 113.169 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.92 133.66 36.23 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 109.746 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -61.64 92.45 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 O-C-N 124.283 0.99 . . . . 0.0 110.816 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.92 -1.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.738 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HG3' ' A' ' 71' ' ' ARG . . . 172.76 -159.34 29.9 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.554 0.533 . . . . 0.0 113.83 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 11.6 p-80 -142.01 150.48 41.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.887 1.275 . . . . 0.0 107.632 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.51 -53.84 12.53 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -178.47 -179.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.988 1.715 . . . . 0.0 108.104 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -81.0 -61.41 1.97 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 162.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.22 -39.21 23.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.712 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -67.08 -44.89 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.78 70.75 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.508 -1.223 . . . . 0.0 111.13 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -61.44 -42.82 99.86 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.876 0.735 . . . . 0.0 114.353 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.75 -47.95 67.82 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.389 0.614 . . . . 0.0 110.534 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.49 -18.97 63.74 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.55 87.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.117 0.967 . . . . 0.0 111.861 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -70.04 -32.87 71.21 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.699 0.625 . . . . 0.0 109.584 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 160' ' ' VAL . 66.5 mt -67.63 -37.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.654 0.782 . . . . 0.0 110.782 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.91 -44.9 21.69 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.797 0.839 . . . . 0.0 111.075 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.74 -46.7 52.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.653 1.181 . . . . 0.0 110.791 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.97 6.86 33.81 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.806 0.443 . . . . 0.0 111.243 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 59.92 33.56 21.53 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.806 1.242 . . . . 0.0 111.733 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 122' ' ' ILE . 68.9 mt -65.71 -42.59 90.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -158.34 151.17 22.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -86.39 132.11 34.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -113.81 113.44 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -102.99 179.27 4.32 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.208 1.003 . . . . 0.0 108.481 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.33 164.38 31.47 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.9 t -144.44 134.18 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.3 p -112.83 88.8 12.21 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.7 -22.88 8.73 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.489 2.126 . . . . 0.0 112.699 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -82.48 -28.45 31.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.923 0.489 . . . . 0.0 110.518 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 75.75 4.29 75.84 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -69.73 -9.05 52.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.301 0.64 . . . . 0.0 112.702 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -18.66 64.96 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.0 0.92 . . . . 0.0 113.221 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.62 -53.01 9.27 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 110.705 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.73 -34.35 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.169 0.588 . . . . 0.0 111.301 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -117.39 174.34 6.2 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.718 0.807 . . . . 0.0 110.819 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -98.92 111.02 23.54 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.512 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.6 ptm -125.8 158.74 64.36 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 121.921 -0.487 . . . . 0.0 110.644 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 2.5 Cg_endo -83.57 125.73 3.91 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.765 2.31 . . . . 0.0 110.826 164.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.22 154.75 22.95 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -74.76 111.21 9.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.053 0.541 . . . . 0.0 110.35 -171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -109.88 117.12 32.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.228 1.011 . . . . 0.0 110.328 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -107.49 135.23 49.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.505 1.122 . . . . 0.0 110.424 -167.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.2 118.95 35.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 109.424 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -123.62 103.49 8.45 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.47 169.47 36.99 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 138.06 58.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.011 0.525 . . . . 0.0 111.734 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -52.48 -32.06 38.02 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.643 1.577 . . . . 0.0 113.071 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.34 -10.1 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.738 . . . . 0.0 112.697 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.57 4.13 20.05 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.841 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -61.06 -33.52 73.44 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.377 0.99 . . . . 0.0 111.756 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -33.19 69.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.239 0.616 . . . . 0.0 110.769 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -76.7 -38.31 54.61 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.615 0.766 . . . . 0.0 110.575 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 122' ' ' ILE . 64.3 t -64.34 -47.65 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.141 0.976 . . . . 0.0 110.27 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.5 p -68.45 -29.87 68.61 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.881 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -43.13 99.38 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.38 0.672 . . . . 0.0 111.253 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 12.1 mm100 -63.15 -37.26 86.53 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.958 0.786 . . . . 0.0 110.485 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -48.38 51.01 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.223 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -66.07 -25.7 67.15 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.408 1.083 . . . . 0.0 111.611 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -67.04 -44.01 81.32 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.939 0.895 . . . . 0.0 111.293 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -110.09 3.94 20.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.903 0.481 . . . . 0.0 110.893 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.21 66.7 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.24 140.2 41.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.125 0.57 . . . . 0.0 110.373 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -169.57 145.78 3.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 171' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.326 0 C-N-CA 123.533 0.733 . . . . 0.0 110.133 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.446 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -62.29 -43.57 98.52 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.111 0.964 . . . . 0.0 111.528 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.23 -37.2 76.92 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.687 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -48.02 66.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -77.32 -22.96 51.11 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.984 0.514 . . . . 0.0 112.286 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.85 -27.6 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 109.494 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.5 -16.97 60.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.642 0.777 . . . . 0.0 110.954 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -70.39 146.03 50.7 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.829 0.452 . . . . 0.0 109.976 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG21 ' HG2' ' A' ' 154' ' ' GLU . 24.0 m -141.14 161.13 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.932 1.293 . . . . 0.0 110.021 -174.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.94 111.37 16.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.0 m-85 -74.02 -38.63 63.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.862 0.465 . . . . 0.0 110.905 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.8 -166.66 29.3 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.179 -169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.0 p -111.11 178.7 4.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.186 0.517 . . . . 0.0 111.474 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 47.6 tp -151.28 146.58 26.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.477 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -94.11 93.94 8.11 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.76 0.79 . . . . 0.0 109.399 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.83 102.85 2.61 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.829 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -78.66 105.7 10.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.363 0.581 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG11 ' HD2' ' A' ' 71' ' ' ARG . 10.8 t -89.56 147.33 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 112' ' ' LYS . 31.4 m -80.62 167.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.26 -20.0 68.9 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.996 -1.002 . . . . 0.0 114.093 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.19 -17.78 30.62 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.468 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.73 ' HD3' ' HB2' ' A' ' 139' ' ' ASN . 68.7 ttt180 -56.26 -42.0 76.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.21 1.004 . . . . 0.0 112.98 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.557 ' HA ' HG13 ' A' ' 76' ' ' VAL . 16.0 p90 -75.06 -16.78 60.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.167 0.439 . . . . 0.0 111.583 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -83.44 -28.92 28.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.702 0.801 . . . . 0.0 110.289 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.1 m -75.22 -27.9 59.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.271 0.628 . . . . 0.0 111.152 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.54 53.98 0.31 Allowed Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.407 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 72' ' ' TYR . 3.3 m -41.45 169.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.599 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 9.2 m -115.53 -179.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.004 -176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.15 -166.7 0.52 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.559 1.144 . . . . 0.0 110.673 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -77.82 141.0 39.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.165 0.586 . . . . 0.0 110.894 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 8.0 t30 58.46 32.8 22.52 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.712 1.205 . . . . 0.0 112.447 170.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mm-40 -82.65 141.52 32.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.673 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.553 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.4 mtp -88.02 142.2 27.97 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 32.9 m -132.83 150.9 33.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.846 0.858 . . . . 0.0 110.246 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -107.69 157.15 18.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.264 1.026 . . . . 0.0 109.568 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.92 146.06 39.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.374 0.67 . . . . 0.0 110.003 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -155.35 130.61 9.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 13.2 ptm180 -66.89 146.03 54.83 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.11 0.481 . . . . 0.0 111.267 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -99.29 106.85 41.49 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.173 0.989 . . . . 0.0 108.445 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -83.7 3.56 7.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.802 2.335 . . . . 0.0 112.851 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -119.8 -11.21 9.4 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.661 0.784 . . . . 0.0 111.518 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 92' ' ' PRO . 5.1 t-20 -63.06 121.78 71.12 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.944 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 33.8 Cg_endo -59.49 -19.78 53.62 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.883 3.055 . . . . 0.0 114.355 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -72.14 -50.58 26.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.415 0.686 . . . . 0.0 110.524 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 96' ' ' ASN . 21.9 p-10 177.74 157.04 0.38 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.276 0.985 . . . . 0.0 110.66 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -64.03 -23.22 67.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.265 176.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 10.8 m-20 -75.61 -2.23 28.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.746 0.818 . . . . 0.0 112.499 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.5 33.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.499 0.32 . . . . 0.0 110.158 169.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.0 mt -133.75 126.34 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.024 0.929 . . . . 0.0 109.739 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -82.27 134.08 35.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 168.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.58 134.85 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.287 0.635 . . . . 0.0 109.355 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.0 p30 -121.93 171.16 9.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.8 p30 -107.51 -169.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.482 1.037 . . . . 0.0 109.803 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.36 -29.89 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -78.47 -11.95 59.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.041 0.936 . . . . 0.0 111.692 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.17 -1.89 77.89 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 122.9 0.286 . . . . 0.0 113.382 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.8 t-20 -73.9 128.41 35.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.721 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.08 114.86 3.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.616 0.766 . . . . 0.0 110.409 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' ASN . 35.6 m -126.56 13.87 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.855 0.862 . . . . 0.0 111.974 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.36 -170.29 43.08 Favored Glycine 0 C--N 1.355 1.636 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.02 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -166.26 123.47 1.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.07 0.948 . . . . 0.0 109.123 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 115' ' ' LEU . 95.6 mt -80.34 7.26 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.1 0.96 . . . . 0.0 113.168 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HG3' ' H ' ' A' ' 113' ' ' LYS . 16.1 tptm 64.08 -156.44 0.31 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.632 1.173 . . . . 0.0 109.972 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 16.5 ttmm -79.03 -48.61 14.1 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 118.987 0.812 . . . . 0.0 110.882 170.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.06 -59.47 4.71 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.073 0.858 . . . . 0.0 112.572 -162.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 HD13 ' A' ' 111' ' ' LEU . 1.9 tm? -72.45 -46.54 54.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.618 0.723 . . . . 0.0 109.206 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -64.57 -29.47 70.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.713 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -65.71 -35.67 91.32 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 123.503 0.573 . . . . 0.0 112.63 -173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.71 -51.39 49.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.797 0.808 . . . . 0.0 109.486 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.68 -15.92 62.76 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.673 -1.148 . . . . 0.0 112.559 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.02 86.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.615 1.166 . . . . 0.0 112.689 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -73.76 -33.83 64.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 127' ' ' LEU . 56.8 mt -67.31 -33.5 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.419 0.688 . . . . 0.0 110.241 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.5 tpp -73.7 -43.36 59.5 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.005 1.322 . . . . 0.0 110.497 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.59 -50.47 30.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.803 -174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -91.05 2.03 56.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.483 -173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 56.03 44.13 25.98 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.714 1.205 . . . . 0.0 111.58 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.527 ' HB2' HG23 ' A' ' 122' ' ' ILE . 73.4 mt -70.18 -40.86 74.4 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.213 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.96 139.3 14.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.96 112.48 7.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.091 0.956 . . . . 0.0 109.529 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.14 120.33 48.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.38 166.8 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.88 150.36 21.94 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 82' ' ' MET . 64.8 t -142.08 116.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.26 92.74 0.93 Allowed Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 11.7 Cg_exo -69.65 -53.56 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.845 2.363 . . . . 0.0 113.498 -162.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.81 -26.31 57.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.631 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.99 79.43 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.939 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.78 -1.97 18.64 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.73 ' HB2' ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -63.17 -18.52 63.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.427 1.491 . . . . 0.0 113.84 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -82.22 -41.84 19.74 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.256 0.622 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.16 -58.42 3.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.809 0.444 . . . . 0.0 110.336 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -137.74 -163.15 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 110.294 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 p -95.2 127.02 40.92 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.6 ptm -129.36 151.29 77.61 Favored Pre-proline 0 C--O 1.249 1.059 0 C-N-CA 123.171 0.588 . . . . 0.0 109.51 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 139.82 25.92 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 121.968 1.778 . . . . 0.0 110.521 166.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -106.05 144.78 32.28 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -69.8 110.48 4.97 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 24.9 mtp -102.94 158.75 16.07 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -150.5 139.59 21.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 90.2 m-85 -101.83 133.2 46.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.078 0.951 . . . . 0.0 109.973 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -131.36 100.52 5.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.24 1.016 . . . . 0.0 108.805 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.56 169.39 37.82 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.46 145.91 52.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.943 0.497 . . . . 0.0 111.715 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' HG21 ' A' ' 58' ' ' VAL . 37.6 mt-10 -59.87 -28.5 67.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.035 0.934 . . . . 0.0 112.731 -172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.61 -21.83 62.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.877 0.471 . . . . 0.0 111.945 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -89.1 -8.6 53.52 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.046 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.278 0.49 . . . . 0.0 110.692 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.4 pptp? -65.16 -34.83 79.33 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.297 0.373 . . . . 0.0 110.749 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.57 -33.58 28.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.621 0.769 . . . . 0.0 110.87 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.05 -49.99 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.457 0.703 . . . . 0.0 110.265 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.4 t -66.24 -29.75 70.06 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.648 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 26.7 t70 -56.85 -44.79 82.51 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.522 0.729 . . . . 0.0 109.957 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 17.8 mm100 -71.24 -38.54 71.96 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.876 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.58 -55.66 25.16 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.587 0.554 . . . . 0.0 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -64.35 -22.94 67.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.97 0.908 . . . . 0.0 112.13 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -62.31 -40.87 97.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.968 0.907 . . . . 0.0 110.907 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -107.36 -0.98 22.03 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 15.86 61.57 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 114.342 0.497 . . . . 0.0 114.342 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 63' ' ' LEU . 31.1 m-85 -75.03 161.14 29.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.955 0.902 . . . . 0.0 112.126 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -170.06 153.82 4.82 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.811 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.566 1.564 0 C-N-CA 123.55 0.74 . . . . 0.0 112.946 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 p -84.84 -0.63 54.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.072 0.549 . . . . 0.0 112.425 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.29 -16.93 38.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.905 0.482 . . . . 0.0 111.448 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.65 -38.33 86.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.232 0.613 . . . . 0.0 110.924 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.72 -28.46 67.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.545 0.738 . . . . 0.0 111.625 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.89 -38.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.375 0.67 . . . . 0.0 109.372 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.31 -21.35 56.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.051 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -67.11 139.71 57.54 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.107 0.563 . . . . 0.0 110.724 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.45 169.0 17.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 109.144 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.26 126.64 35.59 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.39 -43.16 11.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.759 . . . . 0.0 110.053 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.58 -177.42 20.79 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.468 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -111.74 120.4 41.89 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.944 0.498 . . . . 0.0 110.219 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 169' ' ' PHE . 55.4 tp -77.14 148.16 36.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.835 1.254 . . . . 0.0 110.897 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -75.33 80.51 2.41 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.055 0.931 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -79.45 93.33 1.34 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.831 -171.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -70.56 92.37 0.84 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.34 138.33 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 70' ' ' LEU . 39.9 t -71.07 144.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.17 74.82 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.395 -0.669 . . . . 0.0 114.006 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' H ' HG12 ' A' ' 68' ' ' VAL . 39.2 tp -51.91 -23.04 4.39 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.859 1.264 . . . . 0.0 112.965 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 108' ' ' VAL . 20.3 ptt85 -56.88 -6.63 0.36 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.889 1.676 . . . . 0.0 114.349 173.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -54.66 -35.88 63.99 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.11 0.564 . . . . 0.0 111.949 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.98 -26.81 60.66 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.919 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.9 m -75.64 -21.64 57.51 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.831 0.852 . . . . 0.0 111.32 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.69 50.1 0.45 Allowed Glycine 0 C--N 1.356 1.646 0 CA-C-O 119.865 -0.408 . . . . 0.0 113.981 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -52.84 171.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.9 m -114.04 176.85 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.559 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.23 -164.49 1.09 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.809 1.243 . . . . 0.0 110.247 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -82.7 157.37 23.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.314 0.645 . . . . 0.0 111.172 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 67.71 10.97 8.14 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.177 1.391 . . . . 0.0 112.463 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 29.6 mm-40 -84.11 149.37 26.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.499 0.72 . . . . 0.0 110.73 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.593 ' HG2' HG22 ' A' ' 133' ' ' VAL . 60.3 mtp -107.73 152.22 24.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.905 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.5 162.09 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.374 1.069 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.36 145.82 51.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.521 1.128 . . . . 0.0 108.924 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HE1' ' A' ' 148' ' ' MET . 6.9 mp -101.04 135.13 42.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.187 0.595 . . . . 0.0 110.5 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.19 132.81 7.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.016 0.926 . . . . 0.0 108.697 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.737 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 2.5 ptp180 -57.1 147.39 24.67 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 112.086 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.18 127.33 59.59 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.512 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -20.09 65.61 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.248 2.632 . . . . 0.0 112.513 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -91.7 47.73 1.39 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.111 0.964 . . . . 0.0 109.147 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.1 p-10 -63.38 120.18 59.85 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.927 0.891 . . . . 0.0 111.365 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 18.2 Cg_exo -68.67 -50.89 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.912 2.408 . . . . 0.0 113.027 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.45 -50.33 4.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.202 0.601 . . . . 0.0 110.777 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -168.02 165.63 13.47 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -15.21 3.55 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.577 1.151 . . . . 0.0 113.062 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 29.5 p-10 -62.68 -21.92 66.09 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.687 0.795 . . . . 0.0 111.893 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.35 109.17 1.26 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.942 0.897 . . . . 0.0 109.926 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.737 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 98.7 mt -108.61 132.66 55.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 109.891 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 5.1 ttpm? -98.68 146.58 25.72 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.503 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.6 124.86 63.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 109.593 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -110.63 153.83 24.64 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -90.54 -172.83 3.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.541 0.337 . . . . 0.0 110.13 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.52 -23.85 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.889 0.475 . . . . 0.0 112.066 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.191 0.596 . . . . 0.0 110.412 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.94 -0.83 86.54 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 122.778 0.228 . . . . 0.0 113.447 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -74.02 133.2 42.93 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.123 0.969 . . . . 0.0 108.975 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -64.3 106.38 1.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.674 0.75 . . . . 0.0 110.065 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 35.3 m -114.57 12.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.086 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.84 178.25 48.09 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 114.673 0.629 . . . . 0.0 114.673 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -161.34 113.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 86.2 mt -68.59 -13.13 62.14 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 83.0 tttt 70.71 149.18 0.08 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.124 0.97 . . . . 0.0 110.59 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -21.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.253 1.021 . . . . 0.0 112.476 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.506 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tp10 -56.74 -64.69 0.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.289 1.036 . . . . 0.0 111.461 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 111' ' ' LEU . 59.9 tp -85.51 -49.66 7.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -60.04 -24.63 64.68 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.209 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.49 -34.36 89.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.456 0.472 . . . . 0.0 113.443 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.64 -45.08 26.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.438 0.695 . . . . 0.0 109.98 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.42 HD12 HD13 ' A' ' 111' ' ' LEU . 46.2 mt -70.73 -16.62 62.79 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.932 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.46 -53.91 32.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -68.9 -31.92 71.18 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.941 0.775 . . . . 0.0 110.761 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.23 -37.59 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.435 0.694 . . . . 0.0 110.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 44.9 ttm -79.32 -45.19 20.13 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.875 0.87 . . . . 0.0 110.962 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB2' HH22 ' A' ' 87' ' ' ARG . 29.3 t70 -67.39 -46.62 72.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.067 0.947 . . . . 0.0 110.851 -172.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -92.18 1.36 57.26 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.09 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.18 37.95 17.13 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.376 1.07 . . . . 0.0 111.917 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.26 -42.5 93.2 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.818 0.847 . . . . 0.0 111.351 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.07 137.98 17.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.65 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.2 116.89 18.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.126 0.97 . . . . 0.0 108.642 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.35 123.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -107.07 178.66 4.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.76 155.04 25.92 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.5 t -142.67 141.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.269 1.028 . . . . 0.0 108.281 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 137' ' ' GLY . 3.8 p -122.83 86.23 50.13 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.783 0.833 . . . . 0.0 109.153 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.52 -22.41 21.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.216 2.611 . . . . 0.0 113.9 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.35 0.66 . . . . 0.0 110.797 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 64.5 33.96 88.64 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.514 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -82.27 12.41 4.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.914 0.486 . . . . 0.0 111.446 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -52.85 -37.69 60.55 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.61 -44.7 63.95 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.423 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.86 3.56 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.374 0.669 . . . . 0.0 112.169 -168.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -122.51 170.73 9.69 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.544 0.738 . . . . 0.0 110.688 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 t -95.13 109.07 21.19 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.1 ptm -119.25 134.66 23.71 Favored Pre-proline 0 C--O 1.243 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 110.142 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.66 123.81 12.26 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.172 1.915 . . . . 0.0 110.795 164.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -98.12 156.64 16.57 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -82.12 107.49 14.86 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.547 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 11.8 mtp -105.16 112.54 25.7 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 m -101.79 120.41 40.32 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.077 0.551 . . . . 0.0 110.213 -163.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -94.89 124.19 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.056 0.942 . . . . 0.0 110.18 -172.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -124.29 111.56 15.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.574 1.15 . . . . 0.0 108.232 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.41 166.87 36.73 Favored Glycine 0 N--CA 1.463 0.485 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -68.89 146.88 52.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.021 0.528 . . . . 0.0 111.898 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.4 -24.75 67.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.274 1.029 . . . . 0.0 112.962 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.41 -13.39 59.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.669 0.387 . . . . 0.0 111.877 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.79 0.02 16.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -25.12 67.08 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.339 0.518 . . . . 0.0 112.165 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -36.43 83.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -80.47 -36.08 33.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.457 0.703 . . . . 0.0 110.923 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.79 -53.02 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.524 0.73 . . . . 0.0 109.799 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.9 t -70.71 -25.16 62.83 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.108 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.6 t70 -60.8 -49.53 77.1 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.0 mm100 -66.14 -38.51 88.31 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.159 0.912 . . . . 0.0 111.638 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.53 -62.66 1.39 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.715 0.635 . . . . 0.0 110.012 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.68 -19.1 65.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.38 1.072 . . . . 0.0 112.635 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 23.8 ttmm -51.39 -46.63 62.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.914 0.885 . . . . 0.0 110.889 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -95.94 -23.7 16.74 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.522 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 8.27 11.15 Favored Glycine 0 N--CA 1.475 1.263 0 N-CA-C 113.669 0.228 . . . . 0.0 113.669 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB3' HD11 ' A' ' 63' ' ' LEU . 49.8 m-85 -75.57 142.93 42.63 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -159.3 136.6 9.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 CA--C 1.555 1.148 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.418 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.0 p -65.53 -15.24 62.48 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.393 1.077 . . . . 0.0 112.582 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.01 -49.6 74.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.941 0.497 . . . . 0.0 110.448 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 45.4 mt-10 -65.68 -32.36 73.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.233 1.013 . . . . 0.0 113.374 -167.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.11 -37.72 72.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.135 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -75.79 -31.51 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.057 0.943 . . . . 0.0 109.855 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 8.5 t70 -70.44 -44.29 68.16 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.312 1.445 . . . . 0.0 110.841 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -85.7 122.64 30.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.47 165.02 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.816 1.246 . . . . 0.0 110.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' GLY . 5.9 tt -82.75 111.35 18.61 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -74.65 -36.02 62.86 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.491 0.717 . . . . 0.0 111.132 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 163.94 177.32 36.62 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.54 -171.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 p -112.83 149.32 33.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.303 0.641 . . . . 0.0 110.552 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.12 146.52 50.68 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.604 0.762 . . . . 0.0 110.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' PRO . 98.1 mtt180 -86.08 90.28 8.07 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.272 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.73 1.59 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.977 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -79.07 100.42 7.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.041 0.536 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.58 142.03 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 O-C-N 123.618 0.574 . . . . 0.0 109.541 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.04 154.23 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.944 0.898 . . . . 0.0 112.062 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.78 82.0 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.258 0.349 . . . . 0.0 113.66 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.09 -17.57 53.29 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.901 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.549 HH12 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -61.51 -14.49 29.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.363 1.065 . . . . 0.0 113.53 -177.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.777 ' HA ' HG13 ' A' ' 76' ' ' VAL . 44.9 p90 -60.21 -39.7 87.49 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.223 0.535 . . . . 0.0 111.509 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -71.71 -20.2 61.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.12 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 m -99.23 6.36 46.34 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.651 0.781 . . . . 0.0 111.502 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.27 55.84 0.59 Allowed Glycine 0 C--N 1.367 2.299 0 C-N-CA 120.362 -0.923 . . . . 0.0 115.398 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 72' ' ' TYR . 8.1 m -40.46 155.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 134' ' ' VAL . 19.5 m -115.57 159.78 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.335 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -85.27 -167.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.33 1.052 . . . . 0.0 111.659 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -73.83 151.65 40.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.305 0.642 . . . . 0.0 111.562 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 61.24 8.19 1.96 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.723 1.209 . . . . 0.0 113.595 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.68 133.29 40.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.59 0.756 . . . . 0.0 110.754 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 76.9 mtp -94.09 150.01 20.72 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.413 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.02 166.18 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.761 1.224 . . . . 0.0 109.354 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.68 140.88 48.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.635 1.174 . . . . 0.0 108.567 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.486 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.7 mp -97.12 132.41 42.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -150.32 133.36 16.15 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.6 ptt180 -69.98 145.27 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.097 0.475 . . . . 0.0 110.115 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -89.6 125.12 62.35 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.883 0.873 . . . . 0.0 111.288 -167.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.43 -19.84 24.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.203 2.602 . . . . 0.0 113.283 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -93.9 18.79 9.86 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.181 0.992 . . . . 0.0 110.315 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.6 p30 -51.37 137.06 30.82 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.142 1.377 . . . . 0.0 113.528 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 2.9 Cg_exo -79.01 -41.22 0.23 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.471 2.114 . . . . 0.0 112.453 172.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.32 -53.1 4.23 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.981 0.512 . . . . 0.0 111.448 -168.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -173.3 159.69 3.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.379 1.072 . . . . 0.0 108.476 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 18.4 ptpt -57.68 -25.6 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.55 4.71 23.44 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.37 103.85 1.73 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 64.6 mt -82.91 121.6 36.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.043 -172.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 37.6 ttmt -100.09 127.93 46.24 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.092 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.18 130.68 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.058 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -120.87 154.41 35.87 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -90.1 -171.52 3.16 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.026 0.83 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.97 -34.07 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.814 0.846 . . . . 0.0 112.505 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -77.68 -22.79 49.99 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.933 0.893 . . . . 0.0 111.065 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.37 4.36 58.38 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.74 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.57 125.36 24.0 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.426 0.691 . . . . 0.0 110.013 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.576 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 75.8 mt-30 -71.0 100.86 2.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.021 0.928 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' HB ' HH12 ' A' ' 71' ' ' ARG . 34.1 m -91.71 -2.66 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.381 0.672 . . . . 0.0 112.188 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.75 165.68 12.21 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 123.239 0.337 . . . . 0.0 112.553 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.8 m-70 -76.21 150.4 37.08 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.812 0.445 . . . . 0.0 110.125 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -70.7 -52.99 17.44 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 5.0 tmtp? 162.54 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -30.17 68.9 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.609 0.763 . . . . 0.0 112.81 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 38.8 tt0 -75.04 -54.92 6.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.88 0.872 . . . . 0.0 110.852 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.578 0.751 . . . . 0.0 109.784 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.83 92.24 Favored 'General case' 0 C--O 1.208 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.665 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.52 -35.61 80.95 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 124.141 0.901 . . . . 0.0 113.89 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.49 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . . . -67.53 -50.15 60.03 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.199 0.523 . . . . 0.0 110.06 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -77.94 -14.03 59.68 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.4 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.76 -47.3 64.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.378 1.471 . . . . 0.0 113.23 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -68.83 -32.33 71.95 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.705 0.802 . . . . 0.0 110.548 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.456 HD13 HG13 ' A' ' 160' ' ' VAL . 51.4 mt -66.03 -42.58 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.002 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.7 tpp -74.15 -37.55 64.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.678 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.95 -44.87 46.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.643 1.177 . . . . 0.0 110.863 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -99.07 5.45 46.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.057 0.543 . . . . 0.0 111.884 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 59.19 33.87 22.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.173 0.989 . . . . 0.0 112.057 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.23 -36.59 84.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.05 155.68 16.42 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.822 0.849 . . . . 0.0 110.833 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -82.01 139.44 34.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.779 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.53 125.16 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.76 148.46 43.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.205 1.002 . . . . 0.0 109.597 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -129.89 176.25 18.75 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 122.946 0.153 . . . . 0.0 113.381 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 12.4 t -142.79 141.63 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.092 1.357 . . . . 0.0 108.121 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 77' ' ' VAL . 6.5 m -103.98 86.06 1.17 Allowed Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.015 0.926 . . . . 0.0 108.977 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.24 -51.32 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.666 2.244 . . . . 0.0 113.408 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 138' ' ' ALA . 37.7 t80 -70.86 -26.71 63.38 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.91 0.484 . . . . 0.0 110.501 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.67 19.53 79.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.513 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' ' HD2' ' A' ' 136' ' ' PHE . . . -61.4 -17.48 54.35 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.283 0.633 . . . . 0.0 111.442 175.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 77' ' ' VAL . 5.2 t30 -48.44 -31.8 6.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.012 1.725 . . . . 0.0 112.847 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.44 -44.96 81.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 0.0 111.002 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.17 -64.35 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.172 0.589 . . . . 0.0 111.529 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -119.54 143.59 47.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.267 1.027 . . . . 0.0 109.741 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 p -93.48 109.18 20.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.025 0.917 . . . . 0.0 109.129 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 165.84 12.68 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.343 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 20.2 Cg_exo -67.24 122.05 9.27 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 121.486 1.457 . . . . 0.0 110.676 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.96 149.9 22.97 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.586 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 58.2 mtt -103.34 164.08 11.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 0.0 109.524 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -148.79 144.59 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.301 1.04 . . . . 0.0 109.07 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -105.18 128.38 53.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.806 0.842 . . . . 0.0 109.394 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -129.06 102.81 6.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.379 1.072 . . . . 0.0 109.631 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.32 178.95 37.93 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.57 142.91 58.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 117.48 0.64 . . . . 0.0 111.895 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.64 -34.78 27.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 113.631 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.51 -26.72 61.01 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -85.55 2.86 43.16 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.845 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -34.89 79.09 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.981 0.355 . . . . 0.0 110.26 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -26.78 56.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.88 0.872 . . . . 0.0 111.309 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -73.7 -52.32 13.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 122' ' ' ILE . 49.9 t -57.02 -43.12 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.928 1.291 . . . . 0.0 111.777 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.6 p -64.95 -33.94 77.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.921 0.489 . . . . 0.0 111.385 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 20.5 t70 -67.26 -32.94 74.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.688 0.618 . . . . 0.0 110.48 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 8.1 mm100 -73.33 -25.81 60.78 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 95.9 mt -76.51 -39.51 52.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.531 0.733 . . . . 0.0 110.253 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 8.7 mtpm? -59.96 -22.22 62.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.297 1.039 . . . . 0.0 111.992 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 118' ' ' ALA . 40.2 ttmt -54.0 -49.95 67.7 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 111.24 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -100.18 0.1 39.84 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.686 0.394 . . . . 0.0 111.082 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.59 35.95 24.32 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 116.802 -0.181 . . . . 0.0 112.82 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 25.8 m-85 -79.54 174.63 11.38 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.576 0.75 . . . . 0.0 110.808 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.88 152.64 23.42 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.442 1.097 . . . . 0.0 110.253 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.939 177.135 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.288 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 p -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.02 0.928 . . . . 0.0 111.876 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.5 -41.61 72.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.248 0.619 . . . . 0.0 110.213 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 43.4 mt-10 -75.62 -30.15 59.43 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.688 0.795 . . . . 0.0 112.396 -171.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.38 -36.32 74.04 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.075 0.234 . . . . 0.0 110.688 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.04 -37.06 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.405 0.682 . . . . 0.0 109.809 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 13.4 t70 -63.65 -34.86 78.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.535 1.134 . . . . 0.0 111.018 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -79.39 130.32 35.31 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.234 0.614 . . . . 0.0 109.487 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.19 156.42 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.843 0.857 . . . . 0.0 111.873 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 61' ' ' GLY . 6.0 tt -81.08 105.6 12.42 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.7 m-85 -73.66 -30.36 62.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.943 0.497 . . . . 0.0 110.601 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 148.46 -170.61 28.96 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -175.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.6 m -129.19 118.39 22.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.07 175.04 10.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HB2' ' HB2' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -126.64 97.89 5.18 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.828 0.823 . . . . 0.0 108.848 174.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.08 124.81 7.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.691 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -88.6 119.41 29.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.741 0.817 . . . . 0.0 110.358 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.73 140.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 46.8 t -72.35 139.49 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.82 58.43 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.253 -0.43 . . . . 0.0 113.895 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -23.43 67.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 111.276 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' THR . 3.5 mpt_? -75.52 -1.2 23.17 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.28 1.032 . . . . 0.0 111.817 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -45.33 -32.9 2.21 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.16 -18.03 65.1 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.792 1.237 . . . . 0.0 112.565 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 71' ' ' ARG . 14.7 t -73.78 -20.62 60.43 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.122 0.569 . . . . 0.0 110.973 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.63 48.6 0.54 Allowed Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.55 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.14 165.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 121.489 0.662 . . . . 0.0 111.524 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 18.1 m -115.52 171.84 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.238 -171.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -104.83 -166.78 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -63.19 149.52 45.19 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.569 0.747 . . . . 0.0 111.446 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 8.6 t30 77.17 -18.54 0.48 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.55 1.54 . . . . 0.0 112.337 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.3 mm-40 -62.56 141.78 58.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.4 mtp -105.06 143.74 32.82 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.969 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 18.2 m -129.57 132.32 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 109.795 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.42 142.25 28.75 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 109.686 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.624 HD11 ' SD ' ' A' ' 148' ' ' MET . 5.7 mp -90.68 121.14 32.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.858 0.863 . . . . 0.0 108.948 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -125.91 121.54 33.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -60.62 121.91 13.38 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -70.45 122.77 87.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.133 -163.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -20.35 36.71 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.693 2.262 . . . . 0.0 112.243 172.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -101.36 24.9 8.93 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.149 0.979 . . . . 0.0 110.667 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.81 126.75 72.74 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.588 0.755 . . . . 0.0 111.67 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.0 -24.17 6.03 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.462 2.108 . . . . 0.0 113.862 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.52 -56.08 1.99 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.228 -0.295 . . . . 0.0 111.362 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 6.4 m-20 -150.49 153.63 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.29 -14.65 57.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.863 0.865 . . . . 0.0 112.476 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.574 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 16.4 p-10 -70.3 -20.24 63.03 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.614 0.766 . . . . 0.0 111.638 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.99 109.38 3.44 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.293 0.637 . . . . 0.0 109.311 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 86.7 mt -85.09 119.51 33.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.685 0.794 . . . . 0.0 109.867 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -83.48 116.53 22.58 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG12 ' HB ' ' A' ' 83' ' ' VAL . 10.3 t -85.56 128.56 39.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -122.98 143.15 50.11 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 28.3 p-10 -82.72 -167.94 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.248 0.931 . . . . 0.0 111.259 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.34 -31.18 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.464 1.106 . . . . 0.0 112.773 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -83.93 -27.41 28.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.532 0.733 . . . . 0.0 111.05 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.18 6.53 48.16 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.582 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -66.5 120.96 14.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.801 0.84 . . . . 0.0 110.26 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -60.18 107.42 0.64 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 110.833 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.58 2.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 0.0 111.449 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 134.13 -145.69 17.73 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 173.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.13 158.51 43.46 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.034 0.934 . . . . 0.0 109.862 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD11 ' HE3' ' A' ' 148' ' ' MET . 29.1 mt -87.89 8.46 26.0 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.813 0.845 . . . . 0.0 112.456 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 69.63 129.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.558 1.143 . . . . 0.0 110.074 -172.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -44.13 -39.16 4.1 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.188 1.395 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -62.22 -54.61 38.44 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.334 1.054 . . . . 0.0 112.281 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 10.4 tt -75.08 -47.81 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.444 0.64 . . . . 0.0 110.031 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.437 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -54.92 -34.47 63.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.579 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -55.07 -37.41 63.28 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.024 0.828 . . . . 0.0 115.004 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.74 -51.49 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.976 0.51 . . . . 0.0 110.523 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 122' ' ' ILE . 30.1 mt -73.77 -20.06 60.6 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.745 -172.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.43 64.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.766 0.826 . . . . 0.0 111.896 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.22 -36.77 77.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.493 HD13 HG13 ' A' ' 160' ' ' VAL . 64.1 mt -61.82 -37.11 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 110.763 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.3 ttm -79.23 -51.17 9.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.452 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.0 -39.38 69.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.379 1.072 . . . . 0.0 111.108 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -90.57 1.64 56.55 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 62.74 43.1 7.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.413 1.085 . . . . 0.0 111.768 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 122' ' ' ILE . 45.6 mt -76.75 -48.05 19.88 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.642 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.47 149.68 27.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.198 0.599 . . . . 0.0 110.721 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -89.45 106.69 18.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.045 0.938 . . . . 0.0 109.309 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -93.89 124.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.98 160.84 14.72 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.47 144.81 15.6 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.3 t -137.7 126.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.65 90.42 5.04 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 64.9 Cg_endo -83.82 -18.7 5.35 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.519 2.146 . . . . 0.0 113.003 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -79.44 -32.63 42.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.762 0.425 . . . . 0.0 110.816 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.85 17.07 20.31 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.853 0.721 . . . . 0.0 114.599 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -84.26 0.74 47.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.608 0.763 . . . . 0.0 111.384 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -64.11 -26.4 68.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.653 1.181 . . . . 0.0 110.878 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -73.51 -30.35 63.05 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.695 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.5 11.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.277 0.631 . . . . 0.0 111.718 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -158.35 -168.64 2.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.545 0.738 . . . . 0.0 110.289 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.8 p -94.55 120.6 35.04 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.516 0.727 . . . . 0.0 109.066 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 ppp? -147.45 156.88 45.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.006 0.922 . . . . 0.0 109.743 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.581 ' HB2' ' HB2' ' A' ' 64' ' ' ARG . 26.9 Cg_endo -92.84 144.36 2.37 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.516 2.144 . . . . 0.0 113.531 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -107.38 153.91 22.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -79.73 109.57 14.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.759 0.314 . . . . 0.0 111.223 -170.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.624 ' SD ' HD11 ' A' ' 85' ' ' LEU . 22.0 mmt -89.85 110.23 21.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.896 0.878 . . . . 0.0 108.837 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m -103.46 125.25 49.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 31.5 m-85 -89.05 120.44 30.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 109.251 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.47 101.76 7.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.88 159.66 29.46 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.19 145.58 46.6 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.267 0.627 . . . . 0.0 112.614 -175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.45 -30.78 61.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.014 1.326 . . . . 0.0 113.468 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.34 -29.62 65.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.914 0.485 . . . . 0.0 111.472 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -88.66 9.8 22.92 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.285 0.634 . . . . 0.0 111.933 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 158' ' ' LYS . 11.7 ptp180 -54.93 -45.18 74.8 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.591 0.356 . . . . 0.0 111.601 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -78.94 -26.57 43.62 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.631 0.372 . . . . 0.0 111.333 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.24 89.76 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.041 0.536 . . . . 0.0 110.325 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 HD13 ' A' ' 122' ' ' ILE . 70.1 t -70.45 -45.29 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.489 1.116 . . . . 0.0 110.726 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.515 ' HB3' ' HE3' ' A' ' 165' ' ' LYS . 67.2 m -64.52 -32.15 73.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.26 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.98 -42.43 76.3 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.774 0.83 . . . . 0.0 110.865 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.05 -38.23 78.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.857 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.11 -55.43 16.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.798 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 161' ' ' SER . 93.7 mttt -56.9 -29.04 62.66 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.749 1.22 . . . . 0.0 111.993 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.08 -41.02 97.75 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.855 0.862 . . . . 0.0 111.54 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.13 3.6 25.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.768 0.427 . . . . 0.0 110.615 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.95 20.65 77.55 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.932 -0.371 . . . . 0.0 113.364 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 32.2 m-85 -67.82 146.08 54.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.939 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -156.21 139.38 15.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.48 170.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.423 ' H ' ' HG ' ' A' ' 171' ' ' LEU . 2.1 pp . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 124.324 1.049 . . . . 0.0 111.317 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.062 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.6 m -64.38 -14.08 54.49 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.618 0.767 . . . . 0.0 112.439 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.46 -31.47 61.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.725 1.21 . . . . 0.0 111.955 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.14 -40.78 67.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.848 0.459 . . . . 0.0 111.363 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 51' ' ' SER . 11.7 pt-20 -84.86 -15.59 44.18 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.708 0.403 . . . . 0.0 111.639 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 51' ' ' SER . 85.3 t -70.55 -34.76 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 168.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -47.19 48.54 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.928 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.2 m -82.69 115.04 21.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.648 0.779 . . . . 0.0 111.005 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 154' ' ' GLU . 14.3 m -107.71 162.94 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.256 1.022 . . . . 0.0 110.978 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.14 116.19 22.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.118 0.567 . . . . 0.0 109.793 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -79.43 -24.78 42.25 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.923 0.489 . . . . 0.0 110.567 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.03 -170.39 24.58 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.26 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.44 ' HB3' HG22 ' A' ' 149' ' ' THR . 22.5 p -123.1 121.35 35.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.073 0.549 . . . . 0.0 110.383 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.8 tp -80.12 145.87 32.15 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 109.876 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -76.16 85.87 3.01 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -74.2 163.96 54.61 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -141.32 91.75 2.41 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.529 1.165 . . . . 0.0 110.088 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 108' ' ' VAL . 98.9 t -76.51 127.77 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 167.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 24.9 t -68.32 141.73 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 123.737 0.648 . . . . 0.0 110.542 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.79 -44.98 23.47 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.539 0.524 . . . . 0.0 113.747 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.85 -15.79 55.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.473 0.709 . . . . 0.0 112.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HG2' ' HB ' ' A' ' 68' ' ' VAL . 36.6 mmt180 -73.81 -0.46 15.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.924 0.889 . . . . 0.0 112.54 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.484 ' HA ' HG13 ' A' ' 76' ' ' VAL . 42.5 p90 -50.72 -23.83 2.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.376 1.071 . . . . 0.0 113.843 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.72 -7.65 22.51 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.424 1.089 . . . . 0.0 112.71 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 p -73.23 -33.48 65.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.265 0.626 . . . . 0.0 109.912 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.59 48.05 0.52 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 72' ' ' TYR . 27.5 m -55.3 167.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.626 0.77 . . . . 0.0 112.268 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 m -114.12 163.88 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.27 0.628 . . . . 0.0 110.796 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -74.67 -172.19 1.47 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.312 1.045 . . . . 0.0 111.711 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -65.14 149.04 50.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.871 . . . . 0.0 111.95 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 64.88 10.75 6.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.957 1.303 . . . . 0.0 113.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.74 143.11 32.06 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.13 0.423 . . . . 0.0 111.154 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.2 mtp -83.08 145.5 29.23 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.705 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 146' ' ' LEU . 29.4 m -134.27 145.0 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.017 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.98 125.02 53.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.675 0.79 . . . . 0.0 109.895 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -90.14 138.42 31.53 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.982 0.913 . . . . 0.0 109.749 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -147.73 138.7 23.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.6 ptm180 -67.09 158.33 31.4 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.579 0.228 . . . . 0.0 110.568 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -87.99 116.06 65.0 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 123.103 0.561 . . . . 0.0 110.647 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.28 -39.06 5.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.275 1.983 . . . . 0.0 110.493 168.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -88.88 71.14 8.63 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 170.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.44 134.49 86.7 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.34 -42.16 4.11 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.961 2.44 . . . . 0.0 112.519 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -126.3 -52.79 1.5 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.461 0.704 . . . . 0.0 110.014 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -146.85 165.74 28.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.704 0.802 . . . . 0.0 109.95 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.12 -5.49 18.08 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.237 1.015 . . . . 0.0 112.581 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 1.9 m-20 -77.13 9.69 2.88 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.594 1.158 . . . . 0.0 112.586 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -93.39 139.37 30.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.479 0.712 . . . . 0.0 110.208 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 54.5 mt -127.07 120.42 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.36 1.064 . . . . 0.0 109.133 175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -87.47 115.37 24.85 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.439 0.695 . . . . 0.0 109.854 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' HG ' ' A' ' 85' ' ' LEU . 53.0 t -87.1 126.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 14.9 m-80 -117.65 164.67 14.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -95.7 -170.77 2.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.69 -22.59 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -86.64 -3.08 58.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.219 1.008 . . . . 0.0 111.908 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.68 86.08 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 122.945 0.307 . . . . 0.0 113.491 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -76.84 134.17 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.633 0.773 . . . . 0.0 108.986 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.9 pt20 -71.58 127.42 32.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 122.303 1.049 . . . . 0.0 111.662 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 67' ' ' VAL . 93.0 t -78.06 -24.79 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.177 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.41 -168.19 28.48 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.99 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -117.23 148.97 41.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 52.2 mt -75.33 -6.29 49.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.233 0.613 . . . . 0.0 112.26 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 68.74 141.86 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.262 1.025 . . . . 0.0 110.229 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -21.29 3.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -62.57 -63.03 1.35 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.071 0.948 . . . . 0.0 110.702 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.1 tt -80.36 -50.56 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.094 0.557 . . . . 0.0 109.597 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -52.8 -33.37 48.72 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.049 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -55.49 -43.48 85.43 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.105 0.878 . . . . 0.0 114.814 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.97 -48.74 72.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.23 0.538 . . . . 0.0 110.624 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.95 -18.24 60.91 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.625 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.48 91.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.12 0.968 . . . . 0.0 111.788 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -68.06 -40.78 82.7 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.549 0.531 . . . . 0.0 109.618 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 127' ' ' LEU . 55.3 mt -63.79 -37.41 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.587 0.755 . . . . 0.0 110.75 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.6 tpp -70.75 -52.61 19.7 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.16 -32.51 73.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.619 1.567 . . . . 0.0 111.689 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -99.28 -2.57 36.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.026 0.531 . . . . 0.0 111.278 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 61.13 32.51 19.62 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.898 0.879 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 122' ' ' ILE . 67.0 mt -63.39 -44.66 94.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.515 0.726 . . . . 0.0 110.145 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.45 142.23 21.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.288 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.03 107.85 5.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.479 1.112 . . . . 0.0 109.281 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.8 mt -99.36 104.83 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.4 178.72 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.21 168.76 32.01 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.466 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 63.9 t -141.36 125.73 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.43 100.66 2.43 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.46 -44.33 2.35 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.837 2.358 . . . . 0.0 113.812 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.47 -23.9 14.96 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 0.0 111.285 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.48 27.66 71.2 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.304 0.377 . . . . 0.0 113.547 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -81.29 4.82 19.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.475 0.71 . . . . 0.0 112.174 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 93.4 m-20 -63.43 -9.51 12.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.078 0.951 . . . . 0.0 112.004 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -64.42 -42.14 96.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.916 0.887 . . . . 0.0 111.008 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.8 -60.9 1.47 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.827 0.851 . . . . 0.0 111.147 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 84.6 m-85 -139.48 -173.62 3.66 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.875 . . . . 0.0 109.444 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 t -93.04 134.91 34.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 4.4 ppp? -137.95 153.12 73.32 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.706 0.802 . . . . 0.0 109.96 -172.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 21.4 Cg_exo -67.46 122.09 9.27 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.17 1.914 . . . . 0.0 112.637 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.496 HD22 ' HE2' ' A' ' 148' ' ' MET . 6.5 tt -100.91 124.54 46.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -80.17 110.16 15.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -172.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.597 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -112.81 116.32 29.88 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -171.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 62' ' ' SER . 37.8 p -102.71 133.68 47.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.95 1.3 . . . . 0.0 110.306 -165.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -100.95 117.76 35.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.834 0.853 . . . . 0.0 109.166 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -119.19 99.05 6.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.417 0.687 . . . . 0.0 109.508 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 163.44 31.73 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 146.47 24.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 111.655 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG2' HG21 ' A' ' 58' ' ' VAL . 44.6 mt-10 -58.97 -18.78 37.09 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.36 -32.31 43.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.087 0.403 . . . . 0.0 111.296 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -77.9 -6.92 55.88 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -57.95 -27.79 63.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.219 0.463 . . . . 0.0 110.791 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.78 -53.2 59.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.12 0.968 . . . . 0.0 109.138 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.88 -30.97 65.96 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.97 0.908 . . . . 0.0 112.081 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD13 ' A' ' 122' ' ' ILE . 56.1 t -71.13 -55.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.157 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.2 t -66.1 -22.69 66.41 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.903 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.22 -44.56 92.3 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.085 0.554 . . . . 0.0 110.307 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -79.51 -30.14 41.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.237 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.69 -61.01 2.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.85 -21.1 65.7 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.752 1.221 . . . . 0.0 112.101 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -53.45 -46.51 69.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.653 0.781 . . . . 0.0 110.493 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -99.72 -16.91 17.98 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.129 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.47 16.77 21.61 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 116.554 -0.294 . . . . 0.0 113.177 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -79.52 145.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.825 0.45 . . . . 0.0 110.095 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -172.81 138.56 0.82 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 108.755 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 171' ' ' LEU . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.548 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 p -68.07 -47.96 66.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.081 0.953 . . . . 0.0 111.806 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.39 -14.54 60.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.819 0.847 . . . . 0.0 112.144 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -62.58 -45.4 93.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.946 0.898 . . . . 0.0 112.186 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.56 -29.66 67.27 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.432 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.42 -22.16 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.642 0.777 . . . . 0.0 110.444 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -72.94 -46.65 51.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.271 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -80.19 113.88 18.69 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 154' ' ' GLU . 13.8 m -107.19 156.43 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.148 0.979 . . . . 0.0 111.327 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.79 109.6 14.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.445 0.698 . . . . 0.0 109.762 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 26.6 m-85 -74.38 -36.23 63.53 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 110.972 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.64 -176.03 36.44 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.769 0.668 . . . . 0.0 112.558 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 148' ' ' MET . 49.4 p -115.92 122.35 45.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.119 0.968 . . . . 0.0 110.532 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 169' ' ' PHE . 48.2 tp -99.86 137.46 38.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.941 0.496 . . . . 0.0 109.711 173.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -90.78 83.98 5.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -75.21 153.07 44.43 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.469 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -116.47 111.05 19.43 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.832 1.316 . . . . 0.0 109.978 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 111' ' ' LEU . 2.5 t -94.68 157.32 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.083 0.953 . . . . 0.0 109.118 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' HIS . 30.5 m -76.05 161.94 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.83 -17.74 74.34 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.326 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.7 -18.42 30.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.308 1.043 . . . . 0.0 111.431 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.683 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 63.8 mtp180 -49.86 -33.31 16.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.394 1.078 . . . . 0.0 113.204 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.27 -43.87 92.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.217 0.607 . . . . 0.0 110.628 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -71.62 -35.49 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.457 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -74.95 -16.93 60.62 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.089 0.555 . . . . 0.0 111.798 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.76 54.3 0.54 Allowed Glycine 0 C--N 1.357 1.713 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.282 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.3 m -40.9 164.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 19.3 m -114.51 167.16 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.527 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.38 -79.27 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.309 0.644 . . . . 0.0 111.825 -170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.6 154.15 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.789 0.835 . . . . 0.0 110.308 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.4 t30 52.79 28.56 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.943 1.297 . . . . 0.0 111.83 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 49.8 mm-40 -87.25 142.82 27.62 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.327 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 78.0 mtp -99.76 127.88 45.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 102' ' ' ASN . 35.6 m -118.04 163.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.294 1.038 . . . . 0.0 108.997 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.48 128.41 47.98 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' A' ' 98' ' ' ILE . 12.8 mt -80.18 112.01 17.09 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -123.78 115.12 20.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 108.316 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 37.2 ptt180 -57.03 133.82 55.28 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 121.106 0.479 . . . . 0.0 110.925 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.2 118.94 57.86 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.138 -161.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.667 2.245 . . . . 0.0 112.039 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -111.08 32.38 5.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.422 1.089 . . . . 0.0 109.73 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.41 127.3 65.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.877 0.871 . . . . 0.0 111.773 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.37 -48.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.033 1.822 . . . . 0.0 113.011 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -99.04 -50.5 4.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.792 0.437 . . . . 0.0 110.524 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -159.59 156.57 28.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.17 0.588 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -7.26 12.63 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.519 1.528 . . . . 0.0 113.559 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.582 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 26.1 p-10 -64.13 -30.7 71.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.003 0.521 . . . . 0.0 111.584 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.06 125.85 25.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.892 0.745 . . . . 0.0 109.239 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 70.5 mt -113.2 127.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 109.647 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 151.17 32.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 172.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.1 t -110.58 120.46 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.748 1.219 . . . . 0.0 107.854 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -119.06 127.46 53.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HA ' HG12 ' A' ' 83' ' ' VAL . 35.4 p-10 -71.93 -173.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.392 0.677 . . . . 0.0 112.385 -175.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.78 -31.9 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 C-N-CA 124.147 0.979 . . . . 0.0 112.293 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.73 -31.83 63.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.642 0.777 . . . . 0.0 111.053 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.68 -3.38 42.32 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.342 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -67.72 136.54 54.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.117 0.967 . . . . 0.0 110.836 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.5 pm0 -67.1 117.74 9.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.19 -2.38 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.385 0.674 . . . . 0.0 111.644 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 71' ' ' ARG . . . 152.59 -177.15 30.48 Favored Glycine 0 C--N 1.36 1.913 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 172.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 68' ' ' VAL . 55.6 m-70 -108.95 151.32 26.46 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HA ' HG13 ' A' ' 67' ' ' VAL . 52.0 mt -72.58 -55.03 7.54 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.581 0.628 . . . . 0.0 112.386 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 147.31 143.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.241 1.816 . . . . 0.0 106.104 -162.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.506 ' HG2' HD21 ' A' ' 96' ' ' ASN . 5.5 tmmm? -65.83 -41.41 91.83 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.861 0.464 . . . . 0.0 109.97 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.63 -52.67 42.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.802 0.841 . . . . 0.0 111.384 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 111' ' ' LEU . 62.6 tp -59.78 -57.12 14.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.12 70.15 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.994 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -60.69 -42.54 99.38 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.631 0.582 . . . . 0.0 113.307 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.73 71.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.36 0.664 . . . . 0.0 110.163 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 130' ' ' ILE . 61.3 mt -71.79 -17.79 62.15 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.17 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.33 77.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.372 1.069 . . . . 0.0 112.042 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.07 -35.76 64.28 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.063 0.545 . . . . 0.0 109.629 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 127' ' ' LEU . 51.6 mt -65.1 -36.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.39 0.614 . . . . 0.0 110.02 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 123' ' ' MET . 41.1 tpp -70.23 -44.21 69.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.913 1.285 . . . . 0.0 111.099 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.65 -48.71 24.73 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.263 -173.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -91.05 5.83 47.32 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.619 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 60.62 34.66 20.11 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.048 0.939 . . . . 0.0 111.641 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' HB2' HG23 ' A' ' 122' ' ' ILE . 81.8 mt -65.92 -41.56 91.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.583 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.66 141.39 8.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 110.269 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.23 107.48 14.06 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 HD22 ' A' ' 119' ' ' LEU . 18.6 mt -92.49 117.82 36.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -85.79 166.21 16.25 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -130.53 143.86 15.21 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 170.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.85 130.85 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.697 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.4 p -118.15 85.71 24.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.48 -38.68 0.67 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.642 2.228 . . . . 0.0 113.535 -171.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.38 -29.73 65.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.964 0.506 . . . . 0.0 110.384 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.31 17.23 68.1 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.57 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.99 9.94 4.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.111 0.965 . . . . 0.0 112.39 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 140' ' ' ASN . 0.2 OUTLIER -66.0 -21.27 66.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.699 0.799 . . . . 0.0 111.547 172.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 139' ' ' ASN . 5.3 t30 -75.66 -46.74 29.66 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 110.014 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.82 12.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.336 0.655 . . . . 0.0 111.663 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.11 -166.26 1.74 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.171 0.988 . . . . 0.0 110.129 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p -96.11 117.8 31.44 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.697 ' SD ' HG23 ' A' ' 134' ' ' VAL . 22.3 ptm -115.56 157.56 43.94 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.838 0.455 . . . . 0.0 111.27 -173.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.7 Cg_endo -71.1 124.84 10.87 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.319 2.012 . . . . 0.0 112.835 173.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.416 HD23 ' HE2' ' A' ' 148' ' ' MET . 24.6 tp -85.9 117.62 24.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.324 1.05 . . . . 0.0 108.792 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -75.33 107.77 7.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' SER . 64.4 mtt -106.23 137.74 43.65 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.964 0.906 . . . . 0.0 109.961 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.6 p -126.35 116.9 21.92 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -85.4 118.6 25.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.795 0.838 . . . . 0.0 109.292 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -122.68 101.41 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.665 0.786 . . . . 0.0 109.139 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.62 31.21 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.799 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 138.43 29.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.588 1.155 . . . . 0.0 112.427 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.471 ' HG2' HG21 ' A' ' 58' ' ' VAL . 42.0 mt-10 -58.92 -22.17 59.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 112.988 -175.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.34 -18.03 64.99 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.195 0.598 . . . . 0.0 112.056 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -44.0 75.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -167.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -24.64 51.32 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.578 0.351 . . . . 0.0 111.211 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.11 -35.21 61.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.839 0.455 . . . . 0.0 110.52 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.0 -50.63 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.032 0.933 . . . . 0.0 110.375 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p -66.94 -31.82 72.66 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.153 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.46 -39.7 67.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.215 0.606 . . . . 0.0 111.531 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -69.25 -37.35 77.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.946 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.2 mt -69.33 -55.48 10.3 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.587 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -54.64 -32.57 59.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.258 1.423 . . . . 0.0 112.134 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.08 -44.34 83.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -98.66 -15.3 19.47 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.434 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.31 9.48 50.89 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.8 m-85 -63.95 133.33 53.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.332 0.653 . . . . 0.0 110.713 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -166.0 152.89 9.71 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.187 0.595 . . . . 0.0 110.638 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 CA-C-O 120.067 -0.296 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 m -68.61 -17.0 64.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.088 0.955 . . . . 0.0 112.21 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.46 -20.43 65.48 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.911 0.485 . . . . 0.0 111.663 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.56 -43.97 97.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.711 0.804 . . . . 0.0 111.658 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.54 -25.24 57.0 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.208 0.603 . . . . 0.0 111.501 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 -30.69 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.39 -26.93 52.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.665 1.186 . . . . 0.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -61.78 149.39 40.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.787 0.835 . . . . 0.0 112.142 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.23 162.63 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.603 1.161 . . . . 0.0 110.064 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 tp -85.81 117.13 24.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.948 0.499 . . . . 0.0 110.22 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 24.8 m-85 -82.18 -34.03 29.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.994 0.518 . . . . 0.0 110.71 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.93 -166.63 33.04 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.932 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.9 p -115.1 169.22 9.27 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.666 0.787 . . . . 0.0 110.837 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 tp -147.8 139.04 23.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.293 0.637 . . . . 0.0 109.394 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -76.35 93.73 3.51 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.077 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.43 81.3 1.23 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.484 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -71.75 114.32 9.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -107.45 135.61 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.915 0.886 . . . . 0.0 109.189 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.82 151.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 124.506 1.122 . . . . 0.0 111.277 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.87 -21.7 31.26 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.19 -16.52 45.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.873 0.869 . . . . 0.0 112.067 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.746 HH12 HG22 ' A' ' 143' ' ' THR . 34.1 ptt-85 -49.74 -27.94 5.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.777 1.631 . . . . 0.0 113.227 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -63.31 -48.53 77.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.864 0.466 . . . . 0.0 110.262 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.26 -28.98 67.68 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.575 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.6 m -74.66 -24.86 58.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.811 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.88 53.76 0.33 Allowed Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.483 -0.62 . . . . 0.0 114.583 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -43.71 165.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.595 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.2 m -115.96 178.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.756 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.91 -82.05 0.38 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.872 0.469 . . . . 0.0 109.757 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -159.34 165.29 33.65 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.948 0.899 . . . . 0.0 109.732 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.581 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 1.9 m-20 64.38 7.6 3.71 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.875 1.27 . . . . 0.0 112.293 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.7 mm-40 -84.87 124.25 31.4 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.332 0.653 . . . . 0.0 110.788 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.6 mtm -88.16 130.35 35.07 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 25.3 m -125.26 126.53 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.753 0.821 . . . . 0.0 110.78 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.66 136.62 33.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.263 1.025 . . . . 0.0 110.229 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.544 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -87.57 141.56 28.52 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.49 0.716 . . . . 0.0 109.596 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -154.05 133.5 12.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 26.9 ptt180 -60.24 131.6 51.3 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 15.5 t70 -84.64 125.1 72.23 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' ASP . 37.6 Cg_exo -61.04 -37.55 75.15 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.307 2.671 . . . . 0.0 113.523 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.92 36.59 4.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.626 0.77 . . . . 0.0 109.732 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 88' ' ' ASP . 21.5 t-20 -63.41 127.73 91.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.95 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.25 -23.32 33.24 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.9 2.4 . . . . 0.0 113.636 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -79.62 -52.15 8.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.7 t70 177.98 156.77 0.39 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.427 1.091 . . . . 0.0 109.951 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -57.14 -33.48 67.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.865 1.266 . . . . 0.0 113.599 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.4 -12.99 58.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.296 0.639 . . . . 0.0 111.883 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.1 128.77 37.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.176 0.591 . . . . 0.0 111.315 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.1 mt -92.95 125.04 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.991 0.917 . . . . 0.0 110.532 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -96.38 126.18 41.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.432 HG12 ' HB ' ' A' ' 83' ' ' VAL . 14.3 t -93.89 143.4 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -127.86 147.3 50.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.629 1.172 . . . . 0.0 108.111 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p-10 -78.8 169.03 18.86 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.047 0.84 . . . . 0.0 110.051 170.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.67 -10.47 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.499 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.1 t-20 -73.12 -22.84 60.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 110.374 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 40.93 5.1 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -122.41 133.09 54.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.788 0.835 . . . . 0.0 109.788 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -63.47 131.35 47.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.332 0.653 . . . . 0.0 110.791 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.29 -32.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.399 0.68 . . . . 0.0 111.817 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.53 -171.65 44.73 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -128.65 139.78 52.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.022 0.929 . . . . 0.0 109.861 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.44 1.98 56.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.499 0.72 . . . . 0.0 111.8 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 67.74 -176.88 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.545 1.138 . . . . 0.0 110.382 -167.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -39.86 45.24 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -51.48 -63.25 1.19 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.279 0.987 . . . . 0.0 112.325 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.21 -39.08 88.9 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.518 0.675 . . . . 0.0 110.748 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.15 -21.62 63.99 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.348 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.22 -15.53 70.06 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.191 0.424 . . . . 0.0 113.412 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.11 -51.99 6.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.931 0.872 . . . . 0.0 109.062 165.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.4 HD22 HD13 ' A' ' 130' ' ' ILE . 60.2 mt -70.44 -17.46 63.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.72 -169.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.71 90.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.276 1.03 . . . . 0.0 111.895 -173.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -75.07 -33.73 61.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.949 0.5 . . . . 0.0 109.9 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.455 HD13 HG13 ' A' ' 160' ' ' VAL . 31.6 mt -70.15 -31.73 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.074 0.549 . . . . 0.0 110.115 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.9 tpp -79.43 -43.3 23.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.026 1.33 . . . . 0.0 110.798 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.25 -50.29 28.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.811 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -88.97 -0.62 57.57 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.427 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 59.59 32.45 21.59 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.653 1.181 . . . . 0.0 111.846 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 122' ' ' ILE . 68.0 mt -59.12 -39.39 82.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.142 0.977 . . . . 0.0 111.405 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.08 132.33 11.89 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.599 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.27 105.64 2.6 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.991 0.916 . . . . 0.0 109.266 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.4 HD13 HD22 ' A' ' 119' ' ' LEU . 12.2 mt -89.83 108.22 19.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.44 146.12 36.44 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -123.31 162.66 17.11 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -149.2 140.59 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.517 1.127 . . . . 0.0 108.033 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.06 87.31 34.0 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 57.4 Cg_endo -88.6 0.2 6.52 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.045 2.496 . . . . 0.0 112.907 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.25 -31.3 20.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.977 0.511 . . . . 0.0 112.009 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.58 -6.52 23.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.64 9.03 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.028 0.914 . . . . 0.0 112.715 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.48 -15.59 61.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.674 1.19 . . . . 0.0 111.367 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.29 -55.19 5.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.945 0.898 . . . . 0.0 111.071 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.71 -61.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.452 0.701 . . . . 0.0 111.641 -171.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 -178.63 3.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.538 0.735 . . . . 0.0 109.823 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.746 HG22 HH12 ' A' ' 71' ' ' ARG . 15.9 p -92.29 109.05 20.42 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -112.24 120.44 41.59 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.716 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.58 125.12 8.73 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.025 1.816 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 148' ' ' MET . 4.5 pp -89.37 146.94 24.34 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -73.36 107.36 5.62 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.127 0.571 . . . . 0.0 110.611 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.546 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 63.2 mtt -97.82 166.81 11.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.751 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.8 p -154.36 146.52 23.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.23 1.012 . . . . 0.0 109.634 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -109.19 120.39 42.39 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.134 0.974 . . . . 0.0 109.477 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -123.87 98.78 5.96 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.637 0.775 . . . . 0.0 109.647 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.31 162.46 30.63 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -55.57 142.57 33.0 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.647 0.779 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.34 -37.9 17.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.774 1.23 . . . . 0.0 113.465 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 158' ' ' LYS . 12.7 pt-20 -65.94 -29.78 70.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.213 0.605 . . . . 0.0 112.171 -174.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.22 4.19 13.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -61.71 -40.5 95.25 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 118.156 0.435 . . . . 0.0 111.31 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -69.31 -25.45 64.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.43 0.692 . . . . 0.0 111.192 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.6 -45.61 15.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.58 0.752 . . . . 0.0 110.567 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 122' ' ' ILE . 67.6 t -65.95 -45.68 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.449 1.1 . . . . 0.0 110.983 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.5 p -66.94 -32.01 72.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.151 0.58 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.46 -47.11 82.73 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.599 0.562 . . . . 0.0 110.838 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.0 mm100 -63.28 -44.27 95.57 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.37 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.23 -52.81 29.93 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.775 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.44 -22.69 66.79 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.798 0.839 . . . . 0.0 112.193 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -53.02 -46.56 68.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.157 0.983 . . . . 0.0 111.141 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -108.24 -11.9 15.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.114 0.966 . . . . 0.0 111.247 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.87 30.58 25.87 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.885 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -77.55 126.62 31.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -172.3 147.53 1.99 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 CA--C 1.554 1.12 0 O-C-N 123.498 0.499 . . . . 0.0 110.881 -179.457 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 -0.22 23.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.652 0.781 . . . . 0.0 112.012 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.66 -43.55 22.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.571 0.348 . . . . 0.0 110.567 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.58 -31.97 71.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.899 0.479 . . . . 0.0 111.936 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.74 -32.53 69.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.96 0.504 . . . . 0.0 111.265 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.59 -31.62 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.801 0.84 . . . . 0.0 109.645 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.92 -12.13 57.61 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.056 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.7 m -63.7 133.39 53.5 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.135 0.493 . . . . 0.0 110.717 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.2 m -129.18 163.62 33.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 124.84 1.256 . . . . 0.0 109.061 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.524 HD11 HG22 ' A' ' 149' ' ' THR . 40.3 tp -86.82 117.31 25.48 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -82.72 -31.42 28.48 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.65 -151.89 23.83 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.464 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -132.49 178.96 6.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.484 0.713 . . . . 0.0 110.684 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 39.0 tp -159.01 154.37 25.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.264 0.626 . . . . 0.0 110.186 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 94.69 5.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.978 0.911 . . . . 0.0 108.729 174.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.64 121.33 5.83 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -93.24 100.4 12.77 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.169 0.984 . . . . 0.0 109.751 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 7.9 p -82.88 145.68 8.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.368 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.8 m -65.72 156.02 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.18 0.992 . . . . 0.0 111.472 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 143' ' ' THR . . . -73.18 -23.42 77.6 Favored Glycine 0 N--CA 1.47 0.915 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.091 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt -51.29 -18.2 0.9 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.37 1.468 . . . . 0.0 112.678 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.628 HH12 HG21 ' A' ' 134' ' ' VAL . 13.8 ttt180 -47.19 -32.63 4.56 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.155 1.782 . . . . 0.0 112.755 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 26.0 p90 -63.22 -41.03 99.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.288 0.566 . . . . 0.0 110.933 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -69.53 -27.85 65.52 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.577 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 107' ' ' GLN . 6.0 m -101.48 -4.11 27.39 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.825 -170.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.32 52.56 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.965 172.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -44.42 156.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.2 175.88 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.087 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.78 -173.77 4.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.85 0.86 . . . . 0.0 111.157 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.3 151.45 39.82 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.933 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.57 -0.57 1.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.01 1.324 . . . . 0.0 113.883 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -73.33 128.48 35.61 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.272 0.487 . . . . 0.0 112.303 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.46 ' HG2' HG22 ' A' ' 133' ' ' VAL . 77.4 mtp -79.63 148.22 31.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.719 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.49 HG11 HH22 ' A' ' 71' ' ' ARG . 23.1 m -143.74 146.82 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.617 1.167 . . . . 0.0 108.8 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -97.5 156.07 16.66 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.177 0.991 . . . . 0.0 110.084 175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD12 ' HB ' ' A' ' 130' ' ' ILE . 27.7 mt -89.0 161.58 16.51 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.535 . . . . 0.0 109.636 168.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.56 144.88 18.45 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -80.68 123.28 28.04 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -60.53 109.0 1.68 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.79 -15.17 46.5 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.789 2.326 . . . . 0.0 113.123 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.54 90.81 3.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.03 115.88 22.83 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.12 -51.56 5.43 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.976 2.451 . . . . 0.0 112.624 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.8 -47.28 1.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.68 0.792 . . . . 0.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -122.98 137.92 54.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.522 0.729 . . . . 0.0 109.736 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -57.82 -27.12 62.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.792 1.237 . . . . 0.0 113.232 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.433 HD22 ' HA2' ' A' ' 117' ' ' GLY . 28.3 p-10 -84.86 -1.79 56.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.424 0.689 . . . . 0.0 112.827 -173.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.92 111.08 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.876 0.87 . . . . 0.0 111.19 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 119' ' ' LEU . 66.0 mt -96.03 108.62 21.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 C-N-CA 123.259 0.624 . . . . 0.0 110.118 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 32.2 ttpt -88.91 142.16 27.89 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.393 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.96 143.87 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.761 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 5.7 p30 -130.0 150.98 51.04 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.089 1.356 . . . . 0.0 107.878 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HA ' HG12 ' A' ' 83' ' ' VAL . 28.6 p-10 -90.51 -176.92 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.854 0.752 . . . . 0.0 111.04 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 m -57.83 -29.18 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.581 0.753 . . . . 0.0 112.649 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.84 -18.04 41.82 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.947 0.499 . . . . 0.0 111.245 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.04 50.17 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.042 0.353 . . . . 0.0 113.556 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.38 114.53 4.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.958 0.903 . . . . 0.0 109.174 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 74' ' ' THR . 22.9 pt20 -59.85 105.15 0.35 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.34 -17.81 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.392 0.677 . . . . 0.0 111.376 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.14 158.5 9.94 Favored Glycine 0 N--CA 1.473 1.107 0 O-C-N 122.954 0.159 . . . . 0.0 112.957 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 6.9 p-80 -81.86 154.59 25.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.3 0.64 . . . . 0.0 112.666 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 45.9 mt -70.73 -51.44 27.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.907 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 24.4 ttmm 156.65 145.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.642 1.577 . . . . 0.0 107.204 -166.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -23.59 55.33 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.755 0.707 . . . . 0.0 111.196 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.528 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 37.5 tt0 -74.24 -42.39 59.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.937 0.495 . . . . 0.0 110.569 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -47.54 85.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.93 67.61 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.866 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA2' HD22 ' A' ' 96' ' ' ASN . . . -53.86 -37.57 57.95 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.139 0.4 . . . . 0.0 113.746 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.05 -55.54 4.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.125 0.57 . . . . 0.0 110.475 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 122' ' ' ILE . 11.7 mt -68.16 -17.38 64.32 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.249 -171.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 96' ' ' ASN . . . -56.16 -54.35 46.16 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.556 1.142 . . . . 0.0 111.62 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.54 -29.11 69.12 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.183 0.927 . . . . 0.0 110.76 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 HG13 ' A' ' 160' ' ' VAL . 48.3 mt -68.59 -40.35 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.332 0.653 . . . . 0.0 110.143 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 52.0 ttm -80.1 -28.13 39.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.638 0.775 . . . . 0.0 111.446 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.96 -48.61 20.47 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.536 0.734 . . . . 0.0 110.614 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -95.43 5.25 52.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.547 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 57.45 37.26 27.76 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.44 1.096 . . . . 0.0 111.344 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 70.6 mt -61.01 -52.77 63.59 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.332 -177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 160' ' ' VAL . . . -146.14 161.49 40.08 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.615 0.766 . . . . 0.0 111.023 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -101.18 107.28 18.64 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.129 0.972 . . . . 0.0 108.556 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HD12 ' A' ' 85' ' ' LEU . 27.7 mt -96.56 112.11 28.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -93.4 173.55 7.65 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.74 154.82 24.53 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 82' ' ' MET . 93.7 t -141.87 129.58 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.628 HG21 HH12 ' A' ' 71' ' ' ARG . 61.7 t -99.62 87.16 0.64 Allowed Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 4.5 Cg_exo -76.25 -51.11 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.52 -165.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.416 ' HD2' ' HE3' ' A' ' 144' ' ' MET . 22.7 m-85 -71.81 -27.16 62.74 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.798 0.839 . . . . 0.0 110.844 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.76 18.45 72.28 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.356 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.64 1.95 27.8 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.834 0.853 . . . . 0.0 112.134 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -57.5 -25.73 60.24 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.53 1.532 . . . . 0.0 114.304 -176.199 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -86.65 -38.65 16.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.606 0.762 . . . . 0.0 111.386 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.65 -20.15 21.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.534 0.734 . . . . 0.0 112.039 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.73 173.08 16.58 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.297 0.639 . . . . 0.0 109.717 -167.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 69' ' ' GLY . 44.7 p -94.36 109.68 21.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE3' ' HD2' ' A' ' 136' ' ' PHE . 23.0 ptm -113.73 155.72 44.66 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 122.935 0.494 . . . . 0.0 111.004 -170.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.89 127.53 4.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.349 2.033 . . . . 0.0 111.369 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -92.75 143.23 26.5 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -69.9 107.41 3.55 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 16.3 mtp -94.78 150.24 20.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.09 130.38 22.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 113.7 25.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.391 0.676 . . . . 0.0 109.574 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.22 100.6 6.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.6 160.35 28.44 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -53.65 143.88 19.14 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.676 0.79 . . . . 0.0 112.496 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 2.3 tm-20 -50.77 -46.4 59.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.128 1.371 . . . . 0.0 111.454 -173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -58.94 -18.28 32.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 127' ' ' LEU . 1.4 t-20 -100.51 0.22 39.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -166.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 3.4 ppt_? -52.17 -37.28 54.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -171.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -81.72 -30.18 32.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.58 0.352 . . . . 0.0 111.366 -177.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.83 -43.31 46.59 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.086 0.554 . . . . 0.0 111.237 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 122' ' ' ILE . 61.9 t -62.7 -42.64 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.851 0.86 . . . . 0.0 110.73 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.0 t -64.24 -35.38 80.62 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.02 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -57.0 -41.16 77.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.959 0.904 . . . . 0.0 110.934 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.44 -36.32 78.86 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.723 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.4 mt -68.71 -44.35 74.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.021 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -59.37 -27.71 66.21 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.611 1.164 . . . . 0.0 111.879 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -54.62 -52.17 63.08 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 111.954 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -93.59 -23.68 18.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.472 0.709 . . . . 0.0 110.34 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.89 16.82 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.528 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.42 144.22 54.78 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.463 0.705 . . . . 0.0 110.53 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -176.42 152.66 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.716 1.206 . . . . 0.0 107.782 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.559 1.289 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 42.0 m -69.36 -7.78 40.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.403 0.681 . . . . 0.0 112.078 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.17 -31.42 63.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.357 1.063 . . . . 0.0 111.254 173.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 47.5 mt-10 -60.09 -23.97 64.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.978 . . . . 0.0 113.463 -175.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 51' ' ' SER . 13.0 pt-20 -70.25 -32.89 70.94 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.918 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.55 -29.4 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.133 0.973 . . . . 0.0 109.811 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 32.6 t70 -78.94 -24.9 43.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 0.0 111.004 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -78.69 122.77 26.41 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.203 0.601 . . . . 0.0 109.822 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 154' ' ' GLU . 27.0 m -124.16 175.87 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.873 1.269 . . . . 0.0 110.196 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.43 121.41 30.79 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.426 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.0 m-85 -85.26 -40.3 16.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.097 0.559 . . . . 0.0 110.042 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.19 -151.54 23.4 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.605 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.518 ' H ' HD13 ' A' ' 171' ' ' LEU . 73.9 p -123.56 -179.82 4.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.914 0.886 . . . . 0.0 111.073 -174.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 26.7 tp -156.28 155.78 32.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -93.53 90.59 6.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.962 0.905 . . . . 0.0 108.72 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.21 88.89 1.37 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -70.31 93.9 0.89 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.174 0.487 . . . . 0.0 110.398 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 32.4 t -95.14 143.48 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 109.723 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.07 143.2 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.162 0.585 . . . . 0.0 111.563 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 143' ' ' THR . . . -80.44 -19.91 67.8 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 113.051 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.1 tp -59.94 -22.62 62.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.23 1.012 . . . . 0.0 112.146 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.463 ' HE ' HG23 ' A' ' 108' ' ' VAL . 13.9 ptt-85 -74.4 0.26 15.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.493 1.117 . . . . 0.0 112.567 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -42.56 -40.3 2.62 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.483 1.513 . . . . 0.0 114.094 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -56.85 -24.78 53.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.408 1.083 . . . . 0.0 113.218 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 m -75.56 -7.16 53.49 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.749 0.82 . . . . 0.0 111.626 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.3 2.74 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 140' ' ' ASN . 31.6 m -62.54 169.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 28.2 m -114.29 149.32 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.932 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -97.17 -97.14 0.2 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -107.94 144.11 35.66 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.192 0.597 . . . . 0.0 111.606 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 t30 59.19 10.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.39 1.476 . . . . 0.0 112.634 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.614 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 68.3 mm-40 -79.83 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 122.782 0.433 . . . . 0.0 110.611 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -88.43 117.62 27.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 23.2 m -113.86 135.06 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.142 0.977 . . . . 0.0 109.923 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.1 55.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.688 0.795 . . . . 0.0 109.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.3 mp -81.88 141.06 33.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.629 0.771 . . . . 0.0 109.216 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -151.55 148.47 28.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.127 0.571 . . . . 0.0 109.929 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -58.81 144.41 44.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.186 0.994 . . . . 0.0 112.144 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.36 93.03 22.88 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.39 -24.62 12.05 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.708 2.272 . . . . 0.0 112.978 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.68 59.02 2.79 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.21 1.005 . . . . 0.0 110.469 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 15.1 m120 -108.32 143.09 26.74 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.768 164.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.58 -19.15 32.6 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.379 2.053 . . . . 0.0 111.156 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -77.59 -53.32 7.72 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.269 0.628 . . . . 0.0 110.467 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 4.8 t70 -177.04 152.04 0.87 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.815 0.697 . . . . 0.0 109.444 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.38 -19.14 64.61 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.331 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -77.37 -1.81 31.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.575 1.15 . . . . 0.0 113.006 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 138.68 46.44 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.98 123.69 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.934 0.894 . . . . 0.0 109.838 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.18 116.58 24.46 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.748 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.48 131.85 33.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -119.05 165.69 13.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 107.645 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.2 p-10 -98.29 -165.5 1.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.321 0.51 . . . . 0.0 110.056 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.69 -32.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.164 0.586 . . . . 0.0 112.109 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.755 0.822 . . . . 0.0 110.934 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -0.27 82.13 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.89 118.02 9.1 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.032 0.933 . . . . 0.0 109.155 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -62.27 122.16 14.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.8 0.687 . . . . 0.0 110.377 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG23 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -89.08 -12.79 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.097 173.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.93 -164.84 24.41 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -84.21 157.37 21.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.174 0.59 . . . . 0.0 110.015 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 4.0 tt -80.71 -55.27 4.95 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 158.21 127.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -163.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -58.22 9.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.369 0.668 . . . . 0.0 110.707 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -54.3 -48.38 71.36 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.376 1.071 . . . . 0.0 112.291 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.37 -40.24 77.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.83 -34.05 76.52 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.705 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.33 -32.28 80.29 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.913 0.758 . . . . 0.0 113.539 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.06 -59.16 2.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.397 0.618 . . . . 0.0 109.962 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.6 -15.04 63.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.38 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.82 72.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.116 1.366 . . . . 0.0 112.631 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -69.25 -32.95 72.5 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.586 0.554 . . . . 0.0 110.02 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 127' ' ' LEU . 50.3 mt -70.72 -34.29 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.461 0.705 . . . . 0.0 110.336 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 39.0 tpp -80.25 -39.36 29.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.612 1.165 . . . . 0.0 111.268 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -83.04 -37.43 23.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.194 0.998 . . . . 0.0 110.426 -171.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.55 6.31 47.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 53.58 39.2 29.77 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.509 1.124 . . . . 0.0 112.724 171.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.433 ' HB2' HG23 ' A' ' 122' ' ' ILE . 75.6 mt -66.06 -40.98 91.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.893 0.877 . . . . 0.0 111.09 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -151.62 138.11 18.62 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.102 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -77.23 107.03 9.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.604 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.29 110.95 24.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.25 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.57 179.0 4.99 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.586 0.754 . . . . 0.0 109.34 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -160.18 160.62 31.84 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 82' ' ' MET . 61.0 t -142.66 120.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 2.4 p -95.08 100.48 5.69 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.173 0.589 . . . . 0.0 109.901 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.74 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.832 2.355 . . . . 0.0 113.397 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.65 -27.63 45.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.587 0.755 . . . . 0.0 111.833 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.95 79.34 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.066 0.387 . . . . 0.0 114.066 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -75.92 -15.17 60.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.017 0.527 . . . . 0.0 111.348 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -9.57 33.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.594 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.8 m-20 -73.64 -56.92 4.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.818 0.447 . . . . 0.0 110.664 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.94 -42.38 7.16 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.169 0.587 . . . . 0.0 111.082 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.24 161.38 13.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.086 0.954 . . . . 0.0 111.468 -171.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 69' ' ' GLY . 67.1 p -95.73 109.02 21.38 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 22.8 ptm -131.75 151.0 77.82 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 122.59 0.356 . . . . 0.0 111.168 -169.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.06 129.13 4.53 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.618 2.212 . . . . 0.0 111.592 164.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -114.24 156.29 24.59 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.135 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -75.56 107.68 7.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.799 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.585 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 61.3 mtt -97.84 160.12 14.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.357 1.063 . . . . 0.0 109.008 173.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.27 135.03 30.24 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -169.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.594 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 96.9 m-85 -100.76 120.41 40.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.923 0.889 . . . . 0.0 110.144 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.89 110.17 12.75 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.9 39.98 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -64.19 141.31 58.82 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.955 0.502 . . . . 0.0 111.768 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.2 mt-10 -55.14 -31.05 61.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -171.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.49 -20.89 66.15 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.275 0.63 . . . . 0.0 112.199 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.09 -1.0 46.19 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.087 -0.959 . . . . 0.0 113.151 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -64.92 -29.73 70.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 119.593 1.088 . . . . 0.0 111.118 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -29.56 65.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.389 0.676 . . . . 0.0 111.082 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.63 -42.58 19.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.292 0.637 . . . . 0.0 110.271 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.46 -47.15 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.769 1.227 . . . . 0.0 110.83 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.5 t -61.85 -39.93 93.58 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.2 t70 -56.28 -41.29 75.64 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.837 0.71 . . . . 0.0 111.248 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 72.8 mm-40 -72.0 -35.6 69.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.643 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.35 -51.64 34.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.106 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.95 -33.23 72.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.613 1.165 . . . . 0.0 111.717 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 29.4 ttmt -54.8 -44.87 74.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.06 1.344 . . . . 0.0 111.43 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 -17.71 17.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.217 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.83 30.77 16.97 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.882 -0.399 . . . . 0.0 113.916 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' LEU . 53.7 m-85 -88.63 126.74 35.44 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.402 0.601 . . . . 0.0 109.532 172.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 169' ' ' PHE . 1.4 mptm? -131.38 150.11 52.28 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 108.967 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.251 1.181 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.882 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.1 t -80.47 -8.87 59.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.086 0.954 . . . . 0.0 112.143 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 7.2 p-10 -58.3 -19.17 32.55 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.512 1.125 . . . . 0.0 113.411 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -59.82 -61.04 2.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.258 0.623 . . . . 0.0 110.13 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.9 -17.62 55.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.536 0.734 . . . . 0.0 111.724 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 74.2 t -70.94 -29.99 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.941 0.496 . . . . 0.0 110.125 170.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.09 -9.46 27.97 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.425 0.69 . . . . 0.0 110.937 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -71.28 116.06 11.16 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.41 165.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.774 1.229 . . . . 0.0 110.421 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.44 117.44 23.07 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.161 0.584 . . . . 0.0 110.087 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.416 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.1 m-85 -84.68 -24.79 28.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.53 -158.7 27.07 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.472 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.2 p -112.22 178.78 4.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.327 0.651 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 37.3 tp -152.91 147.93 26.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.074 0.549 . . . . 0.0 109.844 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -84.27 87.5 7.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.709 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.36 93.83 0.91 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.926 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -67.42 111.91 4.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.749 0.82 . . . . 0.0 110.965 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG12 HD23 ' A' ' 111' ' ' LEU . 19.6 m -113.24 145.81 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.689 0.796 . . . . 0.0 109.119 172.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 143' ' ' THR . 26.2 m -96.58 153.33 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.173 0.589 . . . . 0.0 111.447 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.07 -19.88 68.81 Favored Glycine 0 N--CA 1.477 1.41 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.29 -17.57 58.99 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.504 0.669 . . . . 0.0 112.028 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.558 ' NH2' HG23 ' A' ' 108' ' ' VAL . 15.3 mtp180 -69.48 -2.38 11.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.38 1.472 . . . . 0.0 113.611 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -52.05 -42.84 63.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.6 0.76 . . . . 0.0 112.493 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -83.46 -6.47 59.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.862 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -75.17 -26.14 58.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 109.695 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.96 49.79 0.45 Allowed Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.389 -0.369 . . . . 0.0 112.704 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' ND2' ' A' ' 139' ' ' ASN . 15.7 m -59.79 170.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.46 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 6.0 m -115.54 178.56 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.657 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -85.03 -165.95 1.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.658 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.48 159.93 22.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.17 0.588 . . . . 0.0 110.411 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 63.47 9.02 3.88 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.083 1.353 . . . . 0.0 112.912 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 28.4 mm-40 -84.33 144.27 28.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.139 0.576 . . . . 0.0 110.731 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.441 ' HG2' HG22 ' A' ' 133' ' ' VAL . 72.1 mtm -92.84 132.88 36.61 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.89 152.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.993 0.917 . . . . 0.0 110.116 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.76 157.1 30.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.517 0.727 . . . . 0.0 110.489 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 98' ' ' ILE . 8.4 mp -100.43 134.65 43.07 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.304 0.642 . . . . 0.0 110.037 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -139.73 110.78 6.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.441 1.097 . . . . 0.0 108.238 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 127.37 32.93 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -118.18 96.64 49.99 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.892 -169.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.14 -24.88 76.76 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.993 2.462 . . . . 0.0 112.821 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.824 0.85 . . . . 0.0 111.826 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 94' ' ' ASP . 5.7 t-20 -57.83 117.89 22.37 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.735 0.814 . . . . 0.0 111.375 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.34 -14.13 22.87 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.964 2.443 . . . . 0.0 112.516 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -73.11 -49.48 28.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.114 0.966 . . . . 0.0 109.713 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 16.2 t70 -173.09 138.27 0.74 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.626 0.771 . . . . 0.0 109.829 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -69.54 -30.43 68.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.37 0.668 . . . . 0.0 111.62 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.95 -12.88 54.68 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.012 0.525 . . . . 0.0 110.508 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -59.77 109.14 0.86 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 124.267 0.979 . . . . 0.0 109.826 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 111' ' ' LEU . 73.2 mt -72.38 104.33 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.99 -172.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 39.6 ttmt -61.94 110.9 1.7 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.516 168.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.82 110.87 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.68 173.94 6.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.056 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -105.67 -167.87 1.38 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.02 -29.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.48 -31.69 63.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.781 0.832 . . . . 0.0 110.81 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.88 -2.34 41.47 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.191 -172.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.52 122.89 18.25 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.844 0.858 . . . . 0.0 109.45 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 18.5 pm0 -62.07 111.26 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.091 0.869 . . . . 0.0 109.761 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG23 ' NH2' ' A' ' 71' ' ' ARG . 16.0 m -91.36 -0.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.35 -148.68 20.21 Favored Glycine 0 C--N 1.366 2.228 0 C-N-CA 123.535 0.588 . . . . 0.0 113.513 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -137.28 146.13 44.33 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.085 1.354 . . . . 0.0 108.732 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 115' ' ' LEU . 43.4 mt -63.63 -57.1 11.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 117.955 0.343 . . . . 0.0 111.609 -176.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 115' ' ' LEU . 32.1 mmmt 173.98 169.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 128.078 2.551 . . . . 0.0 105.033 -167.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 -27.25 33.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 119.292 0.951 . . . . 0.0 109.327 160.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 169' ' ' PHE . 28.9 tt0 -69.7 -59.93 2.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.756 1.222 . . . . 0.0 111.085 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 HD13 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -58.2 -40.14 80.8 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.167 0.987 . . . . 0.0 109.044 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.99 97.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.831 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.17 -36.0 35.09 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 124.215 0.947 . . . . 0.0 113.928 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -61.34 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.444 0.698 . . . . 0.0 111.548 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 mt -71.38 -18.92 62.33 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.583 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.55 81.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.902 0.881 . . . . 0.0 110.417 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -65.4 -36.51 84.18 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.182 0.926 . . . . 0.0 110.331 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.401 HG23 ' HB2' ' A' ' 127' ' ' LEU . 67.5 mt -65.98 -42.06 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.0 -32.2 51.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.249 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -48.78 11.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.916 0.887 . . . . 0.0 111.021 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -85.93 7.01 25.92 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.141 0.576 . . . . 0.0 111.231 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 63.14 32.36 15.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 156' ' ' ASN . 56.7 mt -67.5 -44.17 79.12 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.895 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -156.33 150.38 25.21 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -77.77 134.92 37.95 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.409 ' HB ' HD22 ' A' ' 85' ' ' LEU . 31.3 mt -127.73 129.55 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.1 168.13 18.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.544 1.137 . . . . 0.0 108.516 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -137.02 166.96 24.8 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 82' ' ' MET . 62.6 t -147.91 131.35 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 137' ' ' GLY . 2.5 p -102.45 99.27 12.56 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.169 0.588 . . . . 0.0 110.251 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.11 -27.58 4.4 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.761 2.308 . . . . 0.0 112.766 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -75.23 -31.29 60.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.066 0.546 . . . . 0.0 111.784 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 63.18 11.69 40.49 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 114.222 0.449 . . . . 0.0 114.222 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -88.92 5.63 43.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.674 0.789 . . . . 0.0 111.397 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 3.6 p-10 -63.69 -19.42 64.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.597 1.159 . . . . 0.0 112.188 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -69.71 -60.73 2.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.744 0.818 . . . . 0.0 111.146 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.56 -32.04 11.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -171.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -113.58 162.56 16.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 112.196 -167.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 72.9 p -97.51 109.71 22.41 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE1' ' HB3' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -149.75 158.43 37.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -167.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.66 127.18 1.9 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.772 2.314 . . . . 0.0 113.035 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.482 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 3.7 pp -94.23 152.16 18.9 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -73.26 108.82 6.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.594 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.49 ' HE3' HD21 ' A' ' 111' ' ' LEU . 47.7 mtt -99.03 166.39 11.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.692 0.797 . . . . 0.0 110.346 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.4 p -143.69 156.17 44.46 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.304 1.042 . . . . 0.0 109.707 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 81.1 m-85 -117.41 117.24 28.94 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.715 0.806 . . . . 0.0 108.856 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -124.26 100.37 6.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.78 167.06 29.86 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -73.55 145.25 45.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.599 0.36 . . . . 0.0 111.307 -171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.34 -30.34 66.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 113.874 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.04 -6.51 54.8 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 127' ' ' LEU . 4.0 m-20 -118.24 7.55 12.1 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.248 0.619 . . . . 0.0 110.543 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -37.04 86.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.144 0.578 . . . . 0.0 112.11 -169.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -26.03 61.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.157 0.286 . . . . 0.0 110.765 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -77.93 -34.59 51.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.072 0.549 . . . . 0.0 110.335 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 156' ' ' ASN . 66.0 t -62.8 -50.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.33 0.652 . . . . 0.0 109.993 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.4 p -66.36 -32.21 73.45 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.735 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.26 -43.31 82.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.296 0.638 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 9.8 mm100 -70.05 -30.84 68.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.786 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.15 -52.34 35.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.19 0.596 . . . . 0.0 110.103 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.04 -25.07 67.67 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.447 1.099 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.929 1.292 . . . . 0.0 111.805 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -103.77 -28.37 11.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.293 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.11 29.88 5.3 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.552 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 114' ' ' GLU . 62.5 m-85 -78.17 129.93 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.733 0.766 . . . . 0.0 110.858 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -153.4 146.58 24.68 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.339 0 C-N-CA 123.709 0.804 . . . . 0.0 110.794 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 112.884 -0.086 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.1 t -66.69 -21.74 66.09 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.006 0.922 . . . . 0.0 111.646 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.9 -14.23 62.63 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.643 1.177 . . . . 0.0 112.483 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.19 -48.61 70.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.615 0.766 . . . . 0.0 112.021 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -15.29 59.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.196 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -35.3 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.925 0.89 . . . . 0.0 109.726 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -84.83 -15.44 44.75 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.749 1.219 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -80.42 143.39 33.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.523 0.729 . . . . 0.0 111.704 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.31 161.31 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.296 1.438 . . . . 0.0 110.474 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.7 tp -85.36 110.89 19.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 34.7 m-85 -73.17 -39.22 65.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.341 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.57 -160.86 30.56 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.1 p -111.79 179.14 4.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.516 0.726 . . . . 0.0 110.858 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 169' ' ' PHE . 33.7 tp -154.73 153.39 31.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.371 0.668 . . . . 0.0 109.983 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -87.29 92.71 9.17 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.64 125.21 8.39 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.456 ' H ' ' HG ' ' A' ' 115' ' ' LEU . 77.0 m80 -114.65 109.95 19.01 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.606 0.762 . . . . 0.0 110.286 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.39 139.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 66.4 t -71.97 142.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.998 0.519 . . . . 0.0 110.397 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.88 -44.45 68.68 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.727 -0.67 . . . . 0.0 114.328 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.1 -17.77 42.24 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.067 0.947 . . . . 0.0 112.065 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' A' ' 68' ' ' VAL . 2.3 mpt_? -74.35 1.4 11.72 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.452 1.101 . . . . 0.0 111.739 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -57.25 -28.83 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.845 0.458 . . . . 0.0 110.611 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.66 -31.89 72.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.051 0.94 . . . . 0.0 111.015 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -74.46 -27.06 60.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.392 0.677 . . . . 0.0 110.207 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.8 46.63 0.51 Allowed Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.756 -0.656 . . . . 0.0 114.288 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.676 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 93.7 t -56.49 154.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 122.816 0.446 . . . . 0.0 110.452 171.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.54 159.4 7.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.538 0.735 . . . . 0.0 111.061 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -96.02 -115.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.07 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -93.96 139.94 30.31 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.63 0.772 . . . . 0.0 111.745 -163.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 74.03 -22.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.37 1.468 . . . . 0.0 113.656 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.02 129.69 43.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.52 1.128 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.525 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.7 mtp -94.25 142.74 27.06 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 30.0 m -114.64 147.04 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.101 0.56 . . . . 0.0 110.463 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.76 53.75 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.042 0.937 . . . . 0.0 108.803 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -88.37 151.32 22.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.405 0.682 . . . . 0.0 110.319 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -159.76 153.68 23.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.073 0.949 . . . . 0.0 109.101 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.402 HH22 ' HB2' ' A' ' 124' ' ' ASP . 32.9 ttm180 -71.88 137.13 47.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.703 0.401 . . . . 0.0 110.334 172.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.78 117.17 67.61 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.4 0.68 . . . . 0.0 109.813 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.4 -29.76 53.68 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.781 2.321 . . . . 0.0 112.797 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.33 52.49 2.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.431 0.693 . . . . 0.0 109.599 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.25 108.16 1.06 Allowed Pre-proline 0 CA--C 1.566 1.564 0 C-N-CA 124.579 1.151 . . . . 0.0 112.498 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.86 -34.94 70.32 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 123.284 2.656 . . . . 0.0 113.543 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -126.0 -44.04 1.79 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.412 0.685 . . . . 0.0 111.197 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -162.94 162.7 26.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.142 0.577 . . . . 0.0 109.924 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.23 -14.52 26.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.417 1.087 . . . . 0.0 112.53 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 47.3 m-80 -73.33 4.08 5.09 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.74 116.96 18.68 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.248 0.619 . . . . 0.0 109.955 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.537 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 44.9 mt -97.98 118.79 45.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 C-N-CA 123.614 0.766 . . . . 0.0 109.649 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.731 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 17.3 ttmm -71.53 140.04 49.74 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.288 165.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 t -109.84 124.62 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -108.09 168.65 9.14 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -108.4 -165.77 1.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.988 0.515 . . . . 0.0 110.217 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.75 -33.14 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.742 . . . . 0.0 111.537 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -76.14 -19.99 58.0 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.991 0.916 . . . . 0.0 111.112 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.04 6.88 78.41 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -69.96 135.09 49.06 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 109.62 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.731 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 26.1 mp0 -73.81 98.64 3.0 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.825 0.85 . . . . 0.0 109.0 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 11.8 m -79.77 -25.82 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.51 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.7 -142.18 8.36 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 121.587 -0.34 . . . . 0.0 112.914 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -140.32 157.4 45.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.334 1.054 . . . . 0.0 109.571 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.58 HD13 HD12 ' A' ' 115' ' ' LEU . 65.9 mt -81.64 -5.06 57.71 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.422 176.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? 71.6 151.5 0.11 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 109.937 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -37.42 -42.06 0.48 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.41 -56.12 5.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.383 0.273 . . . . 0.0 111.122 -170.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.58 HD12 HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -72.43 -44.46 62.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -175.216 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.537 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -58.6 -51.6 69.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.412 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -60.44 -27.4 65.73 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.497 0.498 . . . . 0.0 114.071 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -61.59 1.73 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.954 0.502 . . . . 0.0 109.918 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 130' ' ' ILE . 18.1 mt -69.88 -16.07 63.18 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.971 -172.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.11 -24.15 65.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.967 0.907 . . . . 0.0 113.231 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -76.32 -35.87 58.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 127' ' ' LEU . 48.1 mt -67.64 -29.65 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.92 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.2 tpp -79.08 -41.71 28.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.463 1.105 . . . . 0.0 110.558 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HH22 ' A' ' 87' ' ' ARG . 20.7 t70 -67.66 -50.8 56.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.53 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -93.54 1.16 56.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.849 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 54.52 44.65 28.44 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.015 0.926 . . . . 0.0 111.642 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 122' ' ' ILE . 62.3 mt -68.79 -40.18 79.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.992 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -155.58 135.38 12.72 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.261 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -68.21 114.43 6.69 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 119' ' ' LEU . 13.7 mt -101.08 124.03 54.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.07 139.6 44.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.815 0.846 . . . . 0.0 108.944 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -116.95 168.16 12.74 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.343 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 82' ' ' MET . 44.1 t -138.94 133.6 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 146' ' ' LEU . 11.0 t -103.34 94.12 5.47 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.17 -56.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.179 1.92 . . . . 0.0 112.951 -172.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -75.8 -30.99 59.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.943 0.497 . . . . 0.0 110.976 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 49.47 34.62 19.91 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 124.0 0.812 . . . . 0.0 114.435 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -89.89 17.77 6.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.753 0.821 . . . . 0.0 112.278 -168.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -52.14 -36.46 51.47 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.293 1.037 . . . . 0.0 112.094 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -53.92 -49.14 69.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.819 0.848 . . . . 0.0 111.397 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.85 -51.59 11.01 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.722 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -157.49 166.42 33.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.416 1.087 . . . . 0.0 109.555 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.8 p -94.59 110.71 22.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.03 141.49 26.36 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 124.245 1.018 . . . . 0.0 110.562 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.29 130.26 18.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.951 2.434 . . . . 0.0 112.261 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.418 HD22 HG22 ' A' ' 134' ' ' VAL . 4.5 pp -87.52 152.97 21.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -91.13 110.73 22.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 122.1 -0.375 . . . . 0.0 110.502 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.572 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 54.7 mtt -92.5 169.45 10.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.217 1.007 . . . . 0.0 111.065 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 p -149.72 147.53 28.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.702 1.201 . . . . 0.0 109.062 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 91.8 m-85 -109.34 120.56 42.89 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.847 0.859 . . . . 0.0 109.515 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -124.17 97.68 5.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.22 166.34 35.73 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.75 139.76 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.373 0.669 . . . . 0.0 111.942 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -51.07 -37.28 44.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.753 1.221 . . . . 0.0 112.997 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.46 -12.29 59.92 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.679 0.791 . . . . 0.0 113.133 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -97.22 -0.98 45.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -30.24 69.61 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -33.59 71.62 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.16 0.505 . . . . 0.0 110.929 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.74 -33.97 30.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.48 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.37 -48.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.878 0.871 . . . . 0.0 110.777 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 72.9 p -64.34 -34.41 78.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 111.555 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.61 -42.76 75.35 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.674 0.609 . . . . 0.0 111.394 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mm100 -66.8 -38.94 87.46 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.326 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -70.17 -53.18 18.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.525 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.94 -25.61 68.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.888 0.875 . . . . 0.0 112.074 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.37 -48.12 82.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 111.389 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -102.89 -1.1 30.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.601 0.761 . . . . 0.0 111.046 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.73 63.65 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.368 0.418 . . . . 0.0 113.988 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 63' ' ' LEU . 24.8 m-85 -74.54 147.54 41.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.372 0.669 . . . . 0.0 111.05 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -164.16 152.58 13.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.787 0.835 . . . . 0.0 109.709 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 123.76 0.824 . . . . 0.0 112.882 174.456 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.0 p -80.35 -17.21 52.63 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.814 0.446 . . . . 0.0 111.913 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.07 -41.26 71.3 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.453 1.101 . . . . 0.0 111.537 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.86 -47.06 66.88 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.18 -22.01 60.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.387 0.275 . . . . 0.0 111.488 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.99 -31.94 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.827 0.851 . . . . 0.0 109.625 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.38 -13.73 42.6 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.715 0.806 . . . . 0.0 110.788 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.4 m -74.41 113.94 12.22 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 122.997 0.519 . . . . 0.0 110.497 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.29 158.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 0.0 110.898 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 tt -81.27 114.92 20.39 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.76 0.824 . . . . 0.0 108.962 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.05 -36.03 59.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.188 0.595 . . . . 0.0 110.062 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.48 175.9 38.98 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.756 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 p -110.67 155.23 22.73 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.106 0.962 . . . . 0.0 108.735 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.01 147.05 52.58 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.774 0.429 . . . . 0.0 110.285 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -78.42 78.56 4.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.797 0.808 . . . . 0.0 109.118 171.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -70.43 143.06 36.57 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.186 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -132.79 105.58 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.192 0.597 . . . . 0.0 109.546 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 71' ' ' ARG . 3.8 t -78.65 159.56 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.7 m -63.49 152.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.174 -0.329 . . . . 0.0 111.312 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 143' ' ' THR . . . -65.1 -35.56 91.92 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.03 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.34 -15.07 3.44 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.212 1.405 . . . . 0.0 113.269 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.691 HH12 HG22 ' A' ' 77' ' ' VAL . 1.9 tmm_? -56.95 -17.59 10.22 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.206 1.003 . . . . 0.0 112.42 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HA ' HG13 ' A' ' 76' ' ' VAL . 40.6 p90 -59.07 -41.31 87.68 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 123.062 0.545 . . . . 0.0 110.859 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -72.0 -31.18 65.99 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.251 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 71' ' ' ARG . 46.4 p -95.82 3.56 53.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.793 0.437 . . . . 0.0 111.561 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.9 52.2 0.51 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 140' ' ' ASN . 3.1 m -48.91 152.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 118.334 1.067 . . . . 0.0 113.186 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.691 HG22 HH12 ' A' ' 71' ' ' ARG . 28.8 m -114.47 164.7 10.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.884 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -84.39 -169.17 2.48 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.548 0.739 . . . . 0.0 111.231 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.66 157.89 37.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.64 0.776 . . . . 0.0 111.279 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 67.88 8.08 6.2 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.122 0.969 . . . . 0.0 112.186 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.6 mm-40 -76.93 140.63 40.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.482 0.658 . . . . 0.0 111.132 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.475 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.9 mtp -107.2 149.49 27.65 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 132' ' ' GLY . 13.4 m -132.04 163.5 37.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.248 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.38 125.71 23.3 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.76 160.38 26.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -157.05 126.75 6.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.002 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HD2' ' HB2' ' A' ' 95' ' ' LYS . 64.7 ttp85 -67.34 130.76 44.11 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.2 117.6 21.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 123.628 0.58 . . . . 0.0 110.733 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.35 -39.88 34.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.33 2.02 . . . . 0.0 110.237 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -95.26 76.1 3.42 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 7.5 p30 -67.4 127.9 93.54 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.968 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.54 -39.39 28.22 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.998 2.465 . . . . 0.0 113.021 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -127.35 -50.97 1.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.764 0.426 . . . . 0.0 110.43 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 8.8 p30 -150.38 170.58 18.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 110.031 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -64.9 -8.24 14.67 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.459 1.103 . . . . 0.0 113.09 -173.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.26 -12.25 39.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.587 0.755 . . . . 0.0 112.567 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 109.4 7.57 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.049 0.54 . . . . 0.0 110.303 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 120' ' ' ALA . 59.7 mt -118.8 115.82 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -85.22 163.21 18.82 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.467 0.651 . . . . 0.0 110.223 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.53 121.32 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.5 1.12 . . . . 0.0 109.237 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -109.76 130.97 55.46 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -75.85 -170.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.932 0.787 . . . . 0.0 110.994 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.43 -33.78 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.894 0.878 . . . . 0.0 112.87 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.13 -31.62 34.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.818 0.447 . . . . 0.0 110.885 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.49 6.4 25.34 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 116.323 -0.399 . . . . 0.0 113.266 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -66.7 119.25 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.858 0.863 . . . . 0.0 110.251 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -72.8 90.16 1.41 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.828 0.823 . . . . 0.0 110.279 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.5 -14.19 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.988 1.315 . . . . 0.0 113.307 -172.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.13 -157.4 27.62 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 118.024 0.375 . . . . 0.0 112.363 -176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -132.15 149.43 52.4 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.47 0.708 . . . . 0.0 110.269 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 71.5 mt -76.23 -0.85 23.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.685 0.794 . . . . 0.0 113.004 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.5 tttt 71.45 130.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -19.21 5.99 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.597 1.159 . . . . 0.0 113.865 -170.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -67.01 -55.09 15.9 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.481 0.713 . . . . 0.0 111.395 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.69 -44.97 12.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.354 0.662 . . . . 0.0 110.184 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -61.89 -24.28 66.84 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.179 0.991 . . . . 0.0 111.967 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.64 64.62 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.17 0.294 . . . . 0.0 113.538 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -65.97 -44.5 84.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.53 -16.41 56.02 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.742 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.496 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -56.53 -44.75 81.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 112.053 -174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -70.58 -32.74 70.25 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.09 0.869 . . . . 0.0 110.298 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 160' ' ' VAL . 62.5 mt -65.36 -41.63 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.194 0.598 . . . . 0.0 110.02 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.45 -37.93 50.5 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.918 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.35 -42.9 58.6 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.485 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -98.02 6.38 47.7 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.396 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.37 34.72 20.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.702 1.201 . . . . 0.0 111.654 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD13 ' HB1' ' A' ' 159' ' ' ALA . 75.8 mt -64.0 -43.44 95.66 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.484 0.714 . . . . 0.0 111.231 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.2 159.93 26.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.071 0.549 . . . . 0.0 111.109 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.8 mt -129.69 118.5 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.47 166.18 18.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.96 102.37 0.24 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' HG2' ' A' ' 82' ' ' MET . 43.0 t -103.58 114.96 44.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.9 p -101.3 91.29 2.01 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.263 1.025 . . . . 0.0 108.71 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 2.7 Cg_exo -78.54 -23.92 8.03 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.128 2.552 . . . . 0.0 112.93 -172.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.26 -28.82 19.66 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.21 0.604 . . . . 0.0 110.926 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.56 62.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 113.863 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.08 -2.38 33.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.631 0.772 . . . . 0.0 112.347 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -24.69 65.44 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.448 ' HA ' HG21 ' A' ' 76' ' ' VAL . 55.6 t30 -57.28 -34.3 68.52 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.056 0.942 . . . . 0.0 111.262 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.78 53.25 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.133 0.573 . . . . 0.0 110.816 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -167.99 -66.3 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.474 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 8.9 t -160.32 169.06 23.92 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.693 0.797 . . . . 0.0 110.17 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.581 ' SD ' HG23 ' A' ' 134' ' ' VAL . 5.5 ppp? -167.34 156.28 9.16 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.289 1.036 . . . . 0.0 109.484 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.1 Cg_endo -76.63 120.45 5.55 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.418 1.412 . . . . 0.0 112.063 170.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 146' ' ' LEU . 2.6 pt? -102.73 149.4 24.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -85.39 108.2 17.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -171.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 38.1 mtp -107.36 116.38 31.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.316 0.646 . . . . 0.0 109.873 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.7 p -113.06 126.49 55.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.763 0.425 . . . . 0.0 110.008 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -92.19 115.32 27.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.685 0.794 . . . . 0.0 109.537 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -114.54 110.97 20.63 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.503 1.121 . . . . 0.0 109.724 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.52 168.74 38.29 Favored Glycine 0 C--O 1.236 0.235 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -63.47 152.25 38.92 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.207 1.003 . . . . 0.0 111.304 -178.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.72 -27.78 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.065 0.946 . . . . 0.0 113.511 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 153' ' ' LYS . 12.8 pt-20 -78.08 -28.21 48.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.89 -5.02 46.74 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.797 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -59.01 -41.91 88.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.754 0.422 . . . . 0.0 110.228 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -70.49 -27.75 64.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.444 0.697 . . . . 0.0 111.738 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.71 -45.03 60.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.589 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 122' ' ' ILE . 70.4 t -64.41 -40.97 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.31 1.044 . . . . 0.0 111.14 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.4 m -58.58 -45.07 89.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.075 0.95 . . . . 0.0 110.62 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.14 -41.4 71.71 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.878 0.871 . . . . 0.0 111.542 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 49.6 mm-40 -75.34 -27.26 59.15 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.038 -174.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 76.1 mt -73.0 -44.26 61.22 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.824 173.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.46 -28.63 67.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.404 1.082 . . . . 0.0 111.356 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.57 -50.12 70.9 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.094 0.958 . . . . 0.0 111.34 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -81.43 -28.14 34.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.363 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.49 12.02 10.01 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-O 119.87 -0.406 . . . . 0.0 113.332 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.602 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 46.8 m-85 -70.09 168.23 16.01 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.231 0.612 . . . . 0.0 111.331 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 160.45 23.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.619 1.168 . . . . 0.0 112.475 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 126.941 2.097 . . . . 0.0 109.111 178.047 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 p -70.44 -34.66 72.72 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.081 0.552 . . . . 0.0 110.752 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -65.41 -24.06 67.11 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.242 1.017 . . . . 0.0 111.563 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.389 1.076 . . . . 0.0 112.528 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.41 -33.24 73.36 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.555 0.342 . . . . 0.0 111.246 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.88 -35.3 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.601 0.761 . . . . 0.0 109.474 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.35 -17.58 63.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.194 0.997 . . . . 0.0 111.104 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -73.71 116.66 14.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.313 0.645 . . . . 0.0 109.863 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.86 165.83 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.526 1.13 . . . . 0.0 110.859 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 149' ' ' THR . 24.6 tp -82.13 121.67 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.873 0.469 . . . . 0.0 110.177 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 19.7 m-85 -86.87 -38.58 16.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.169 0.588 . . . . 0.0 110.088 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 -172.18 28.92 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.724 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -112.6 166.5 11.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.464 0.706 . . . . 0.0 111.363 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.481 ' HB2' ' HE2' ' A' ' 150' ' ' PHE . 33.8 tp -145.32 150.6 36.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.933 0.893 . . . . 0.0 109.319 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -75.94 98.36 4.22 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.418 0.628 . . . . 0.0 109.964 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.09 73.98 2.5 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 52.9 t-80 -65.62 85.82 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.981 0.912 . . . . 0.0 110.351 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 111' ' ' LEU . 14.4 m -81.61 144.33 10.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.166 173.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.3 m -65.61 148.07 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.39 175.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.86 -22.12 62.15 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -61.85 -19.12 62.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.929 1.292 . . . . 0.0 111.804 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 34.4 ptt85 -72.52 0.14 11.18 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.387 1.075 . . . . 0.0 112.549 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -53.85 -35.63 61.71 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.811 0.844 . . . . 0.0 112.658 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -67.86 -23.23 65.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.884 0.874 . . . . 0.0 111.641 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -73.02 -24.18 60.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.072 0.549 . . . . 0.0 111.023 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.82 49.11 0.52 Allowed Glycine 0 C--N 1.354 1.533 0 O-C-N 122.309 -0.244 . . . . 0.0 113.49 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 43.4 t -63.47 160.09 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.634 0.774 . . . . 0.0 111.747 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.06 157.05 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.454 1.102 . . . . 0.0 109.3 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -78.91 -164.64 0.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.989 0.916 . . . . 0.0 113.024 -165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -67.05 145.89 54.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.691 0.797 . . . . 0.0 110.825 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 73.72 -15.52 0.57 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.198 1.399 . . . . 0.0 112.713 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -73.2 130.02 39.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.57 0.748 . . . . 0.0 111.113 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 79.7 mtp -84.77 149.42 25.76 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.068 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 16.4 m -134.75 -170.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.709 1.204 . . . . 0.0 109.836 177.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.92 154.5 22.08 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.595 1.158 . . . . 0.0 108.432 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -99.15 146.83 25.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.909 0.385 . . . . 0.0 110.817 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -155.83 127.77 7.49 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 108.845 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -63.05 142.23 58.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 174.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.24 110.79 2.83 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.753 0.821 . . . . 0.0 110.347 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -31.61 44.84 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.488 2.125 . . . . 0.0 111.271 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.27 68.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 170.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 6.9 p30 -74.85 119.03 74.82 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.059 0.544 . . . . 0.0 110.551 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 15.4 Cg_exo -69.61 -38.68 7.79 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 0.0 113.554 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -119.88 -51.39 2.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.304 0.641 . . . . 0.0 111.677 -167.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.25 146.82 35.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.375 0.67 . . . . 0.0 109.792 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.506 ' HB2' HH21 ' A' ' 87' ' ' ARG . 14.7 ptmm? -74.05 -5.1 39.47 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.932 0.893 . . . . 0.0 111.1 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -76.63 -6.03 50.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.204 1.002 . . . . 0.0 111.98 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.03 125.56 27.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.081 0.952 . . . . 0.0 110.646 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.9 mt -123.65 120.18 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.64 0.776 . . . . 0.0 110.657 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 39.5 mttp -77.7 162.79 26.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.554 1.141 . . . . 0.0 111.009 167.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.3 t -123.3 127.02 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -122.32 144.22 49.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.622 1.169 . . . . 0.0 108.737 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 29.6 p30 -74.29 179.01 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.883 0.765 . . . . 0.0 112.285 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.85 -25.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.167 0.987 . . . . 0.0 113.492 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -73.16 -17.2 61.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.376 0.67 . . . . 0.0 110.968 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.81 37.25 10.49 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.825 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.99 131.47 54.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.573 0.749 . . . . 0.0 109.185 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.92 104.76 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 124.167 0.917 . . . . 0.0 111.16 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 28.8 m -87.5 -0.24 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.012 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 151.89 -159.24 28.21 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.457 -0.338 . . . . 0.0 113.057 170.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 56.6 t-80 -122.83 150.11 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.3 tt -75.07 -57.07 4.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.122 0.169 . . . . 0.0 111.006 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.3 tptt 142.53 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -162.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -22.5 62.43 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.777 1.171 . . . . 0.0 112.192 -175.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.78 -47.56 68.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.289 1.035 . . . . 0.0 110.571 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 8.9 tt -72.04 -48.69 42.66 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.434 0.694 . . . . 0.0 109.273 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -21.91 65.9 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.041 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.8 -28.36 60.3 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 123.296 0.373 . . . . 0.0 113.691 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.13 -56.26 4.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.315 0.646 . . . . 0.0 109.896 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 122' ' ' ILE . 31.3 mt -63.67 -16.5 61.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.059 0.944 . . . . 0.0 112.396 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.22 65.36 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.518 1.527 . . . . 0.0 112.046 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -70.07 -30.55 67.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.35 1.031 . . . . 0.0 110.618 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.488 ' HA ' HD12 ' A' ' 127' ' ' LEU . 60.2 mt -67.79 -34.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.22 0.608 . . . . 0.0 110.143 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -80.8 -33.22 34.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.068 0.947 . . . . 0.0 110.723 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.85 -40.34 54.92 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.505 1.122 . . . . 0.0 111.467 -173.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.08 -2.38 40.27 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 57.84 41.58 24.6 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.236 1.015 . . . . 0.0 111.03 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.1 mt -61.3 -43.95 98.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.436 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -149.66 138.37 20.93 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.246 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.92 105.24 5.86 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.59 104.69 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.11 176.28 9.34 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.589 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.59 158.97 27.89 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.61 -0.268 . . . . 0.0 112.522 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 55.6 t -148.38 129.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 146' ' ' LEU . 21.8 t -96.68 93.41 1.36 Allowed Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 7.1 Cg_exo -74.25 -49.24 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.404 2.069 . . . . 0.0 112.24 -171.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.88 -27.48 33.44 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.563 0.745 . . . . 0.0 111.263 -172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.66 60.64 Favored Glycine 0 C--N 1.354 1.551 0 O-C-N 123.465 0.478 . . . . 0.0 114.27 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.99 9.27 10.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.415 0.686 . . . . 0.0 112.694 -170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.71 -20.5 66.36 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.611 0.765 . . . . 0.0 111.659 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.23 -47.96 82.07 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 0.0 110.077 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.61 -53.99 4.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.492 0.717 . . . . 0.0 111.747 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -146.88 -165.77 2.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.665 0.786 . . . . 0.0 111.504 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -95.94 122.73 39.06 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.809 0.844 . . . . 0.0 109.662 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -131.66 147.02 64.37 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.271 0.628 . . . . 0.0 111.223 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 88.2 Cg_endo -79.2 125.5 6.47 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.52 2.146 . . . . 0.0 112.252 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.581 HD22 HG22 ' A' ' 134' ' ' VAL . 3.3 pp -100.37 154.59 18.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.21 107.48 4.24 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.333 0.653 . . . . 0.0 110.559 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 85' ' ' LEU . 62.3 mtt -107.12 149.66 27.41 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -144.34 135.97 25.83 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -171.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 83.1 m-85 -99.53 123.56 43.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.241 1.016 . . . . 0.0 110.655 -174.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.68 105.25 7.69 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.1 0.96 . . . . 0.0 108.561 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.78 166.76 35.09 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -58.37 143.13 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.77 -41.04 61.33 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.068 0.947 . . . . 0.0 113.135 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.57 -21.11 66.61 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.37 -3.51 56.66 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.731 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -61.65 -32.25 72.4 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.146 0.885 . . . . 0.0 111.162 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.37 -46.68 85.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.751 0.82 . . . . 0.0 109.754 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -75.44 -30.59 60.06 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.652 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 122' ' ' ILE . 53.7 t -67.01 -49.71 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.535 0.734 . . . . 0.0 109.235 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.6 t -61.45 -34.14 74.93 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.449 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.1 t70 -55.54 -47.84 75.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.17 0.588 . . . . 0.0 110.43 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.8 mm100 -66.89 -41.27 87.48 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 124.774 1.296 . . . . 0.0 111.578 -176.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -62.39 1.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.797 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -57.05 -33.4 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.321 1.048 . . . . 0.0 111.846 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 20.9 ttmm -55.55 -53.3 58.1 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.333 1.053 . . . . 0.0 111.394 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.97 -16.29 38.83 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.435 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.79 26.76 7.83 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.626 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 74.4 m-85 -78.61 177.78 8.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.536 0.734 . . . . 0.0 110.126 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -48.03 145.34 3.11 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.211 1.004 . . . . 0.0 110.672 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.576 1.959 0 C-N-CA 124.987 1.315 . . . . 0.0 113.23 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 m -75.22 -0.94 21.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.16 0.984 . . . . 0.0 112.221 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -74.86 -24.85 58.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.248 1.019 . . . . 0.0 111.529 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -60.88 -44.78 96.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.577 0.751 . . . . 0.0 112.296 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.18 -33.32 74.23 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.116 0.566 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -72.34 -27.48 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.446 1.098 . . . . 0.0 110.038 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -85.93 -26.12 25.72 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.426 1.09 . . . . 0.0 110.645 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LYS . 70.2 m -82.15 135.36 35.29 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 110.835 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.13 164.17 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.08 1.352 . . . . 0.0 110.763 -172.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.428 HD11 HG22 ' A' ' 149' ' ' THR . 18.7 tp -87.55 112.62 22.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.082 0.553 . . . . 0.0 110.362 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 24.6 m-85 -78.17 -37.83 44.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.518 0.727 . . . . 0.0 111.408 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.85 -154.3 25.42 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -133.8 179.89 5.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.327 0.651 . . . . 0.0 111.176 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 171' ' ' LEU . 50.1 tp -158.57 150.75 21.57 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.614 1.165 . . . . 0.0 108.887 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -87.27 101.82 13.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 148' ' ' MET . . . -72.33 85.81 0.51 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.265 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -70.35 99.3 1.54 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.52 0.728 . . . . 0.0 109.286 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 71' ' ' ARG . 7.1 p -119.24 131.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.681 0.792 . . . . 0.0 109.825 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 70' ' ' LEU . 65.1 t -56.93 143.41 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.774 1.23 . . . . 0.0 111.719 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.45 66.25 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.532 ' H ' HG12 ' A' ' 68' ' ' VAL . 42.0 tp -61.56 -17.82 56.62 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.069 0.947 . . . . 0.0 111.803 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 67' ' ' VAL . 28.6 ptt-85 -63.89 -5.17 4.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.673 1.189 . . . . 0.0 113.442 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -53.33 -35.88 60.69 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.611 0.764 . . . . 0.0 112.616 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.44 -24.83 65.67 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 111.511 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -77.36 -6.57 53.77 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.952 0.901 . . . . 0.0 111.6 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.86 53.2 0.86 Allowed Glycine 0 C--N 1.359 1.834 0 O-C-N 121.81 -0.556 . . . . 0.0 113.301 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 29.0 m -68.41 171.38 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 24.1 m -114.71 162.1 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.411 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -89.96 -87.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.874 0.469 . . . . 0.0 111.811 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.92 149.23 36.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.847 0.459 . . . . 0.0 111.41 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.0 9.46 3.07 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.31 1.444 . . . . 0.0 113.141 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 56.6 mm-40 -82.11 132.52 35.25 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.904 0.383 . . . . 0.0 111.481 -174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.7 mtm -80.31 132.81 35.87 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.604 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 102' ' ' ASN . 27.0 m -131.66 163.35 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 124.098 0.959 . . . . 0.0 109.141 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.25 24.7 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.892 0.877 . . . . 0.0 108.735 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -85.23 148.79 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.478 0.711 . . . . 0.0 110.026 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.458 ' HA ' ' SD ' ' A' ' 123' ' ' MET . 52.5 tp60 -159.89 137.86 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.842 0.857 . . . . 0.0 108.776 175.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 22.5 ptt85 -66.92 152.48 45.6 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.237 0.541 . . . . 0.0 110.085 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 32.1 t70 -102.33 116.59 62.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.825 -168.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.92 -18.0 41.23 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.855 2.37 . . . . 0.0 112.808 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.03 15.64 4.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.259 0.623 . . . . 0.0 110.644 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -53.98 128.22 55.5 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.643 0.777 . . . . 0.0 111.461 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.37 -26.89 1.24 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.326 2.018 . . . . 0.0 113.793 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -108.68 -52.18 2.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.136 0.574 . . . . 0.0 110.934 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -166.67 157.56 12.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.307 0.643 . . . . 0.0 109.671 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' HH11 ' A' ' 87' ' ' ARG . 16.5 ptpt -62.35 -7.79 4.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.228 1.411 . . . . 0.0 112.81 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -54.04 -32.48 54.59 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.278 1.031 . . . . 0.0 112.232 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.89 109.15 1.36 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.402 0.439 . . . . 0.0 110.181 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.5 mt -107.92 149.59 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.634 1.174 . . . . 0.0 108.231 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -122.29 144.44 48.99 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.53 0.681 . . . . 0.0 110.972 171.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -77.83 130.38 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.155 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 23.2 m-80 -114.95 144.14 44.05 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.603 0.761 . . . . 0.0 109.124 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HA ' HG12 ' A' ' 83' ' ' VAL . 22.3 p30 -77.31 -169.69 1.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.445 0.566 . . . . 0.0 111.123 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.85 -25.87 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.188 0.595 . . . . 0.0 112.468 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -74.58 -21.1 59.66 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.213 174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.26 5.0 64.05 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.601 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.5 125.51 31.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.128 0.971 . . . . 0.0 108.781 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 12.0 pt20 -67.26 126.68 30.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.175 0.512 . . . . 0.0 111.701 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 16.9 m -89.47 -23.13 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.968 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 71' ' ' ARG . . . 165.06 165.27 22.07 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' A' ' 99' ' ' LYS . 23.1 m170 -92.0 150.87 20.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.091 0.956 . . . . 0.0 111.403 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 115' ' ' LEU . 29.8 mt -96.37 29.78 2.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.602 1.561 . . . . 0.0 112.316 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 65.09 -172.1 0.18 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.775 0.83 . . . . 0.0 110.737 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -80.42 -49.35 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.944 0.498 . . . . 0.0 110.839 171.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.38 -57.35 9.56 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.817 -166.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 111' ' ' LEU . 10.1 tt -67.67 -47.15 70.32 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.859 0.838 . . . . 0.0 109.314 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -62.34 -29.55 70.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.591 -1.641 . . . . 0.0 111.675 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.9 -38.85 94.65 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.544 0.527 . . . . 0.0 114.078 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -51.97 49.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.225 0.536 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.11 -16.83 64.17 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.928 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -61.32 -38.44 86.87 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.378 1.071 . . . . 0.0 112.887 -177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -71.36 -33.71 69.81 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.488 HD13 HG13 ' A' ' 160' ' ' VAL . 44.2 mt -68.66 -34.95 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.484 0.714 . . . . 0.0 110.322 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 86' ' ' GLN . 38.4 tpp -79.84 -52.26 8.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.095 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.54 -45.17 91.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.679 1.192 . . . . 0.0 110.654 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.86 2.76 54.6 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.59 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 56.35 36.93 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.308 1.043 . . . . 0.0 111.886 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.9 mt -65.86 -43.93 86.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.837 0.855 . . . . 0.0 111.322 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -148.71 140.27 23.5 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.477 0.711 . . . . 0.0 110.603 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.97 102.91 6.62 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -89.07 106.22 16.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.14 179.84 5.46 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.875 0.87 . . . . 0.0 109.382 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -162.96 172.97 39.11 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.634 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 78.0 t -149.28 138.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 107.512 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.36 90.76 1.49 Allowed Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.76 -23.53 2.59 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.054 1.836 . . . . 0.0 113.871 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -77.87 -28.73 50.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.379 0.672 . . . . 0.0 112.49 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.12 31.2 75.9 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 123.229 0.33 . . . . 0.0 113.771 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -85.6 17.13 3.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.04 0.936 . . . . 0.0 111.655 -178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.3 -26.24 68.31 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.624 1.17 . . . . 0.0 111.72 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.01 -37.0 69.88 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.553 0.741 . . . . 0.0 110.914 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.07 -64.64 0.82 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.652 0.381 . . . . 0.0 110.362 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 37.6 t80 171.75 -89.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.304 1.442 . . . . 0.0 108.497 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 67' ' ' VAL . 62.6 m -103.24 144.64 31.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.184 0.994 . . . . 0.0 109.852 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 1.4 pmm? -147.79 148.56 30.76 Favored Pre-proline 0 C--O 1.243 0.741 0 C-N-CA 123.308 0.643 . . . . 0.0 109.747 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.7 124.71 4.66 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.023 1.815 . . . . 0.0 109.985 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.2 145.58 27.88 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -74.79 106.81 6.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.6 ' SD ' HD21 ' A' ' 85' ' ' LEU . 60.3 mtt -95.67 161.07 14.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.019 0.928 . . . . 0.0 109.554 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -150.73 132.4 14.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -171.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 82.3 m-85 -97.66 117.27 31.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.744 0.817 . . . . 0.0 109.911 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -124.31 115.78 21.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.53 168.41 40.55 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -65.83 147.01 54.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.435 0.636 . . . . 0.0 112.693 -173.665 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -53.64 -32.5 51.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.406 1.482 . . . . 0.0 114.083 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.43 -23.93 60.18 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.902 0.481 . . . . 0.0 111.608 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -92.55 3.26 55.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.294 0.637 . . . . 0.0 111.722 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.37 76.48 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.091 0.556 . . . . 0.0 111.919 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -35.36 69.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.25 0.62 . . . . 0.0 110.872 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -78.11 -41.14 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.443 0.697 . . . . 0.0 110.63 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG13 HD13 ' A' ' 122' ' ' ILE . 78.1 t -61.12 -47.97 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.834 0.854 . . . . 0.0 110.347 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.4 m -73.11 -24.26 60.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.675 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 35.6 t70 -63.52 -39.81 95.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.83 0.452 . . . . 0.0 110.5 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.3 mm100 -64.47 -35.11 79.86 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.666 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.18 -40.23 59.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.653 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 10.3 mtmp? -67.06 -38.43 85.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.851 0.461 . . . . 0.0 110.908 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -59.47 -43.11 93.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.118 0.967 . . . . 0.0 111.691 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -96.78 -26.73 15.03 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.13 21.65 10.7 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.259 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 115' ' ' LEU . 67.3 m-85 -66.65 144.36 56.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.662 . . . . 0.0 110.462 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.0 152.89 28.68 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.968 173.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 28.2 m -85.99 -13.49 47.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.233 0.613 . . . . 0.0 111.888 173.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.24 -14.37 55.18 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.693 0.797 . . . . 0.0 112.982 -174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' NZ ' ' A' ' 153' ' ' LYS . 3.0 mp0 -55.25 -47.59 75.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.275 1.03 . . . . 0.0 111.629 171.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 51' ' ' SER . 11.1 pt-20 -72.76 -27.81 62.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.26 0.224 . . . . 0.0 111.338 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.52 -35.09 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.535 0.734 . . . . 0.0 109.619 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.5 t70 -76.4 -12.53 60.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.718 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -67.64 114.89 6.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.303 0.641 . . . . 0.0 111.685 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 56' ' ' ASP . 23.9 m -119.5 160.95 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.996 1.318 . . . . 0.0 110.821 -174.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.4 tp -81.37 112.41 18.63 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.439 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 22.2 m-85 -74.39 -29.12 61.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.96 0.504 . . . . 0.0 110.584 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.4 -176.75 29.71 Favored Glycine 0 C--O 1.246 0.851 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.703 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.7 p -110.81 119.83 40.38 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -100.84 133.21 45.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -73.09 96.21 2.16 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -76.48 -179.83 47.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 173.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -139.18 110.32 6.88 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.245 1.023 . . . . 0.0 109.942 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 146' ' ' LEU . 96.8 t -103.65 132.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 70' ' ' LEU . 93.2 t -82.84 141.27 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.317 0.647 . . . . 0.0 109.608 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.31 69.11 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.432 0.458 . . . . 0.0 113.609 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' H ' HG12 ' A' ' 68' ' ' VAL . 70.8 mt -64.13 -18.69 64.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.005 0.922 . . . . 0.0 111.367 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.444 ' HD2' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.15 0.65 18.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.828 1.251 . . . . 0.0 112.295 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 140' ' ' ASN . 11.1 p90 -55.98 -31.02 62.64 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.252 0.621 . . . . 0.0 111.762 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.36 -20.4 63.84 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.127 0.971 . . . . 0.0 111.91 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -74.97 -25.01 58.54 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.875 0.47 . . . . 0.0 110.059 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.55 50.41 0.45 Allowed Glycine 0 C--N 1.355 1.597 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.487 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.771 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 27.7 m -57.28 168.4 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.55 0.69 . . . . 0.0 112.673 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 m -114.41 166.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.543 -171.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.1 156.85 11.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.619 ' HB3' ' HA3' ' A' ' 137' ' ' GLY . 12.2 p30 -68.14 69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.157 1.383 . . . . 0.0 111.674 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -178.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.396 1.078 . . . . 0.0 109.37 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -65.18 149.41 49.96 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.121 -164.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 81.4 mtp -89.17 149.77 22.99 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.802 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.0 m -121.06 151.64 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.729 0.811 . . . . 0.0 110.933 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -108.12 166.45 10.73 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.498 1.119 . . . . 0.0 109.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -122.68 119.41 30.64 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.564 0.746 . . . . 0.0 109.336 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.01 135.83 50.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.255 1.022 . . . . 0.0 108.985 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.459 HH21 ' HG3' ' A' ' 95' ' ' LYS . 69.1 ttt180 -77.49 125.33 29.17 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.157 0.583 . . . . 0.0 109.882 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 91' ' ' ASN . 15.7 t70 -108.02 115.58 58.35 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 49.7 Cg_endo -83.55 -2.75 10.56 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.948 2.432 . . . . 0.0 114.26 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -107.53 21.63 17.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.267 0.627 . . . . 0.0 111.749 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 88' ' ' ASP . 50.9 m-80 -86.28 142.22 35.49 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 121.609 -0.682 . . . . 0.0 111.313 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.67 -12.55 33.3 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.063 2.509 . . . . 0.0 112.284 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -77.76 -53.4 7.57 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.131 0.572 . . . . 0.0 109.528 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 170.78 163.91 0.08 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.874 1.359 . . . . 0.0 109.784 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 89' ' ' PRO . 8.3 ptpp? -59.41 -22.55 61.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.345 1.458 . . . . 0.0 113.243 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -78.44 -12.3 60.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.495 0.718 . . . . 0.0 112.885 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.18 110.44 3.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.838 0.455 . . . . 0.0 110.72 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.4 mt -75.86 120.8 26.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 124.012 0.925 . . . . 0.0 110.657 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 5.5 tppp? -75.07 117.14 16.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.02 167.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 111' ' ' LEU . 15.1 t -77.18 130.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 12.8 m120 -112.62 175.73 5.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.01 173.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.9 p30 -110.54 -167.9 1.24 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.713 0.688 . . . . 0.0 109.92 169.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.48 -27.28 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.409 0.683 . . . . 0.0 112.525 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.31 -21.86 60.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.723 0.809 . . . . 0.0 110.641 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 -5.58 60.68 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.837 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -78.05 131.84 37.49 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.187 0.595 . . . . 0.0 110.746 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -57.44 127.47 32.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.613 1.165 . . . . 0.0 112.042 177.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.771 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 30.3 m -113.27 -19.52 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 111.228 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.96 -145.93 9.58 Favored Glycine 0 C--N 1.358 1.786 0 C-N-CA 121.594 -0.336 . . . . 0.0 113.756 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -139.96 156.53 46.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.526 1.13 . . . . 0.0 109.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 100' ' ' VAL . 53.9 mt -93.54 4.84 53.32 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.976 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 69.15 146.3 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.707 1.203 . . . . 0.0 110.815 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -56.12 -20.53 17.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.364 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.89 -59.43 5.14 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.135 0.974 . . . . 0.0 111.702 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 111' ' ' LEU . 3.9 pp -85.6 -22.03 28.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.615 0.366 . . . . 0.0 111.358 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -64.18 -37.8 88.77 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.48 0.712 . . . . 0.0 111.763 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.14 -29.48 74.51 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.851 0.72 . . . . 0.0 112.906 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.58 5.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 109.632 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.26 -15.92 63.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.977 0.911 . . . . 0.0 112.348 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -52.72 -44.92 66.71 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.41 1.084 . . . . 0.0 113.042 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -70.98 -32.23 69.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.911 0.386 . . . . 0.0 110.207 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.36 -35.44 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.421 0.689 . . . . 0.0 110.334 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.6 tpp -79.8 -33.53 40.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.671 1.188 . . . . 0.0 111.065 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.67 -51.14 10.27 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.169 0.988 . . . . 0.0 110.097 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -88.21 2.06 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.845 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 59.42 34.5 22.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.641 1.177 . . . . 0.0 111.354 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.54 -40.65 95.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.915 0.886 . . . . 0.0 111.894 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.73 134.88 13.13 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.474 0.71 . . . . 0.0 110.311 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.67 104.49 12.11 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.08 123.07 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.724 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.05 149.3 42.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.35 174.71 19.2 Favored Glycine 0 C--O 1.239 0.438 0 O-C-N 123.486 0.491 . . . . 0.0 112.869 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 14.4 p -151.18 143.58 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.869 0.868 . . . . 0.0 110.107 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.81 84.66 32.08 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.716 0.807 . . . . 0.0 110.029 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.62 -17.69 12.47 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.87 2.38 . . . . 0.0 112.647 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -83.22 -30.66 27.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.188 0.595 . . . . 0.0 111.174 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 79' ' ' ASN . . . 57.46 34.18 68.17 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.772 0.67 . . . . 0.0 114.339 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.16 0.31 57.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 0.0 110.548 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.87 -9.12 57.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.059 1.344 . . . . 0.0 112.582 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 72' ' ' TYR . 9.4 p30 -102.51 -22.25 14.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.327 0.651 . . . . 0.0 111.206 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.66 -41.53 7.66 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.629 0.772 . . . . 0.0 112.619 -167.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -160.0 -178.3 6.92 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 -164.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 22.5 p -90.19 108.75 19.94 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 ptm -112.06 148.87 39.96 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.97 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 96.6 Cg_endo -78.77 146.62 21.1 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.925 1.75 . . . . 0.0 110.14 160.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 67' ' ' VAL . 2.6 pt? -137.36 155.61 49.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.022 0.439 . . . . 0.0 110.134 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -74.22 108.08 6.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.118 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' ' 85' ' ' LEU . 24.8 mmt -102.48 153.59 19.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -143.24 124.72 14.78 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.034 0.934 . . . . 0.0 108.853 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.06 117.53 30.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.814 0.846 . . . . 0.0 109.665 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -119.76 100.62 7.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.83 157.28 27.2 Favored Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.495 ' NZ ' ' HG3' ' A' ' 53' ' ' GLU . 13.1 ptmt -61.42 144.44 54.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.751 0.42 . . . . 0.0 111.487 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.32 -34.38 57.19 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.83 -30.31 70.75 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.144 0.429 . . . . 0.0 111.961 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -85.74 -9.84 56.51 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.431 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.9 ppt_? -60.69 -29.25 69.2 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 118.899 0.772 . . . . 0.0 112.152 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.99 -37.76 86.03 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.097 0.559 . . . . 0.0 110.536 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 158' ' ' LYS . . . -82.68 -46.17 13.56 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.829 0.852 . . . . 0.0 110.505 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.54 -50.61 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.38 1.072 . . . . 0.0 111.458 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.9 p -65.0 -39.25 93.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.905 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.94 -38.9 76.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.981 0.912 . . . . 0.0 111.632 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.5 mm100 -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.377 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.58 -56.72 7.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.189 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -55.03 -32.16 61.63 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.336 1.454 . . . . 0.0 112.128 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.15 -39.03 77.75 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -107.16 -11.52 15.59 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.429 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.75 42.17 6.51 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.639 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.83 137.21 38.61 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.455 0.702 . . . . 0.0 110.104 171.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -168.18 151.42 5.73 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 123.631 0.772 . . . . 0.0 111.88 177.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.18 0.038 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.84 -42.44 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -76.04 -25.64 55.82 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.3 m -75.72 117.61 17.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.655 0.382 . . . . 0.0 110.022 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 m -116.0 156.64 17.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.556 1.142 . . . . 0.0 111.273 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.26 104.93 11.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -74.29 -33.07 63.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.97 -178.54 33.32 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.554 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -111.01 160.54 16.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.433 0.693 . . . . 0.0 109.926 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.507 HD22 HD21 ' A' ' 119' ' ' LEU . 29.7 tp -126.93 154.24 44.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 110.206 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -99.05 86.14 3.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.126 1.371 . . . . 0.0 108.128 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.98 87.28 0.87 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -70.98 80.6 0.65 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.848 0.859 . . . . 0.0 109.818 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.76 138.1 20.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.4 137.37 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 123.78 0.675 . . . . 0.0 109.654 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 142' ' ' PHE . . . -81.51 -31.17 34.28 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.219 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.5 tp -62.45 -18.81 62.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.978 0.911 . . . . 0.0 111.465 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.488 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 2.7 mmp_? -76.94 0.84 19.55 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.141 0.977 . . . . 0.0 112.582 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HA ' HG13 ' A' ' 76' ' ' VAL . 28.2 p90 -51.11 -34.22 29.64 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.436 1.095 . . . . 0.0 112.37 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -62.96 -34.51 77.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.394 1.078 . . . . 0.0 111.971 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.1 p -78.68 2.33 19.9 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 49.14 0.65 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.952 165.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.729 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 32.7 m -65.66 162.6 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.64 1.22 . . . . 0.0 111.366 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.08 166.5 8.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.92 0.888 . . . . 0.0 110.913 -170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.431 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -80.95 -170.83 2.89 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.797 0.839 . . . . 0.0 112.177 -170.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.11 145.86 55.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.995 0.918 . . . . 0.0 111.592 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 m120 66.25 10.17 6.94 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.326 1.45 . . . . 0.0 113.398 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.13 143.84 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.245 0.618 . . . . 0.0 110.141 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 80.6 mtp -96.65 142.0 29.22 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.5 m -126.2 145.81 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.361 1.064 . . . . 0.0 110.237 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -105.79 153.56 21.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.101 0.96 . . . . 0.0 110.461 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.94 125.97 53.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.584 0.754 . . . . 0.0 109.691 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -140.8 112.86 7.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.718 0.807 . . . . 0.0 109.396 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' HB3' HG12 ' A' ' 98' ' ' ILE . 5.8 ppt_? -87.54 151.35 23.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.52 0.328 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 1.8 m-20 -90.88 149.61 40.57 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 123.59 0.756 . . . . 0.0 111.626 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.92 -43.11 57.35 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.609 2.206 . . . . 0.0 111.634 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -153.38 93.83 1.74 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.685 1.194 . . . . 0.0 108.962 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 1.3 t-20 -89.05 151.74 47.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.02 -29.43 44.56 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.618 2.879 . . . . 0.0 113.614 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.51 -51.63 22.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t0 172.1 162.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.366 1.467 . . . . 0.0 108.319 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -65.01 -15.09 61.93 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.64 1.176 . . . . 0.0 112.266 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -87.78 -15.92 35.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.364 0.666 . . . . 0.0 111.881 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.41 118.82 9.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.526 0.73 . . . . 0.0 111.665 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 87' ' ' ARG . 63.1 mt -92.03 120.06 40.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.573 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 34.0 mtmm -81.14 123.4 28.39 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 164.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.27 126.16 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 6.5 p30 -115.29 173.76 6.35 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 124.598 1.159 . . . . 0.0 107.92 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -103.94 -170.38 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 118.666 0.666 . . . . 0.0 110.2 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -57.47 -33.06 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.57 -11.32 59.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.594 0.758 . . . . 0.0 111.564 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.16 14.57 78.81 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.521 -0.308 . . . . 0.0 112.888 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -78.5 120.57 23.4 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.95 0.9 . . . . 0.0 108.586 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.17 99.67 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.517 0.727 . . . . 0.0 109.499 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 23.0 m -71.77 -27.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.199 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.39 176.64 38.34 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.404 0.44 . . . . 0.0 113.41 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.602 ' HD2' ' HG2' ' A' ' 99' ' ' LYS . 31.6 m80 -92.46 133.96 35.41 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 1.3 tt -66.35 -54.08 28.72 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.68 0.612 . . . . 0.0 110.307 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 53.9 mmtt 150.85 133.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 -160.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -70.86 -42.02 70.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.06 -52.03 65.59 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.128 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.84 -40.46 91.75 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.178 0.591 . . . . 0.0 110.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.03 69.85 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.239 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.79 -31.79 64.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.5 0.5 . . . . 0.0 113.125 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.58 5.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.552 0.741 . . . . 0.0 110.414 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 63' ' ' LEU . 21.1 mt -73.3 -18.58 61.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -170.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.78 -29.7 65.97 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.412 0.685 . . . . 0.0 110.885 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.86 -35.33 64.74 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 127' ' ' LEU . 58.8 mt -70.86 -33.64 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.275 0.63 . . . . 0.0 110.765 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.2 tpp -74.34 -56.2 5.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.419 1.088 . . . . 0.0 110.659 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.38 -44.78 62.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.267 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.33 5.07 32.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.695 0.398 . . . . 0.0 111.403 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 60.98 33.54 19.72 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.377 1.071 . . . . 0.0 112.592 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HB2' HG23 ' A' ' 122' ' ' ILE . 64.2 mt -67.68 -38.56 83.89 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.662 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -166.67 145.89 5.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 111.173 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -78.26 116.87 19.0 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.998 0.919 . . . . 0.0 109.279 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -98.92 112.83 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.144 0.578 . . . . 0.0 109.812 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 10.9 pt-20 -83.41 167.66 17.29 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -143.27 152.34 23.98 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 35.5 t -149.16 128.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.475 1.11 . . . . 0.0 108.479 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.31 96.69 1.32 Allowed Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 123.646 0.778 . . . . 0.0 109.449 167.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.39 -31.34 9.22 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.591 2.194 . . . . 0.0 113.316 -176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.09 -20.94 12.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.989 0.916 . . . . 0.0 110.916 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.87 29.96 75.74 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.34 0.4 . . . . 0.0 113.468 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -76.79 3.24 12.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.953 0.901 . . . . 0.0 113.315 -170.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -67.43 -26.63 66.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.171 0.589 . . . . 0.0 110.274 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.84 -37.46 73.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.694 0.797 . . . . 0.0 110.569 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.14 -55.23 9.92 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.695 0.798 . . . . 0.0 110.867 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 74.7 t80 -151.34 -77.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 p -158.3 165.76 33.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.012 1.725 . . . . 0.0 107.85 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 14.3 ptt? -167.12 152.37 7.15 Favored Pre-proline 0 C--O 1.246 0.921 0 O-C-N 123.43 0.456 . . . . 0.0 110.398 168.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.67 126.44 10.81 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.996 1.797 . . . . 0.0 110.339 162.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.59 156.23 16.9 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.984 0.514 . . . . 0.0 109.959 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.44 107.02 3.17 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.373 0.42 . . . . 0.0 110.305 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.463 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 65.4 mtt -104.07 160.26 14.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 131' ' ' GLU . 19.2 m -154.34 143.3 21.06 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.477 0.58 . . . . 0.0 110.029 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 76.6 m-85 -104.19 117.8 35.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.28 1.032 . . . . 0.0 109.851 -174.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -121.04 100.62 7.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.276 1.03 . . . . 0.0 108.811 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.52 167.67 33.07 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -65.69 147.87 52.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.12 -19.88 48.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.681 1.192 . . . . 0.0 114.046 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.0 -22.08 56.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -93.06 -0.19 57.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.083 0.553 . . . . 0.0 112.478 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 7.6 ppt_? -52.83 -38.11 60.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -79.98 -27.62 39.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.793 0.437 . . . . 0.0 110.79 -175.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.96 55.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.424 0.69 . . . . 0.0 110.752 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.83 -51.79 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.885 0.874 . . . . 0.0 110.133 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.3 p -65.89 -30.41 71.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.589 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -54.89 -42.54 72.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.898 0.879 . . . . 0.0 111.728 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -67.68 -34.41 76.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.299 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.28 -45.39 55.88 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.913 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -61.12 -31.73 71.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.03 1.332 . . . . 0.0 111.372 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -58.34 -42.35 86.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.804 1.242 . . . . 0.0 111.296 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -97.62 -15.05 20.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.099 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.32 19.18 31.06 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 113.585 0.194 . . . . 0.0 113.585 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 123.717 0.807 . . . . 0.0 110.997 171.24 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.655 0.264 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.53 -33.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.384 0.674 . . . . 0.0 109.561 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.38 -25.71 59.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.015 0.926 . . . . 0.0 110.411 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -72.47 134.83 45.53 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.071 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.5 158.53 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.384 1.073 . . . . 0.0 110.469 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.73 102.6 12.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.436 1.094 . . . . 0.0 108.292 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 41.8 m-85 -74.44 -23.24 58.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.108 0.563 . . . . 0.0 111.422 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.35 177.2 14.76 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.032 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -111.22 120.6 42.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.171 0.588 . . . . 0.0 110.267 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -86.76 137.71 32.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.539 1.136 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 100.73 4.13 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -90.73 -170.84 43.43 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 166.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -165.43 127.04 2.0 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 100' ' ' VAL . 48.1 t -98.59 134.63 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 70' ' ' LEU . 23.7 t -69.98 143.93 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 O-C-N 123.92 0.763 . . . . 0.0 110.325 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.39 -22.52 78.58 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.233 0.333 . . . . 0.0 113.008 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' H ' HG12 ' A' ' 68' ' ' VAL . 35.0 tp -62.77 -18.15 62.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.429 1.092 . . . . 0.0 111.379 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 3.5 mmp_? -76.66 1.77 16.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.957 0.903 . . . . 0.0 112.823 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 76' ' ' VAL . 86.7 t80 -48.69 -36.63 16.56 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.92 0.888 . . . . 0.0 112.546 174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -62.44 -40.91 98.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.703 0.801 . . . . 0.0 111.609 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 p -78.51 -4.5 48.87 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.03 49.67 1.45 Allowed Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 72' ' ' TYR . 17.4 m -53.55 164.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG23 HG21 ' A' ' 134' ' ' VAL . 14.8 m -114.6 163.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.792 -164.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -92.52 -166.37 1.53 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.996 1.318 . . . . 0.0 111.266 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.17 147.13 48.65 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.496 0.718 . . . . 0.0 111.6 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 63.98 8.87 4.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 0.0 113.637 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -77.04 136.91 38.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.977 0.418 . . . . 0.0 110.31 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.541 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.8 mtp -100.24 150.08 22.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.163 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 102' ' ' ASN . 29.8 m -135.11 174.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.537 1.135 . . . . 0.0 109.553 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.33 133.7 16.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 107.714 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -84.62 146.34 27.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.17 0.588 . . . . 0.0 109.986 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -151.2 130.31 12.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.141 0.977 . . . . 0.0 108.598 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' A' ' 95' ' ' LYS . 34.1 ptt85 -74.27 146.81 42.93 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -80.46 118.04 70.56 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.101 0.561 . . . . 0.0 110.894 -167.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 -32.63 24.86 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.14 2.56 . . . . 0.0 112.187 173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.75 33.95 2.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.913 0.885 . . . . 0.0 109.925 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -53.89 119.0 17.02 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.586 1.154 . . . . 0.0 112.987 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.88 -28.27 16.72 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.961 2.441 . . . . 0.0 113.155 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -116.45 -51.68 2.59 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.38 0.672 . . . . 0.0 111.328 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -167.67 155.64 8.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.841 0.456 . . . . 0.0 110.651 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HB2' HH11 ' A' ' 87' ' ' ARG . 8.3 ptpp? -53.43 -23.17 9.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.179 1.791 . . . . 0.0 113.373 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 81.2 m-20 -78.98 18.86 0.58 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.775 0.83 . . . . 0.0 112.796 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.04 111.66 23.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 108.948 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 120' ' ' ALA . 29.7 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 123.592 0.757 . . . . 0.0 110.513 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 16.5 ptpt -85.66 164.37 17.72 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.503 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 67' ' ' VAL . 60.7 t -117.27 117.34 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -110.25 131.39 55.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.936 0.894 . . . . 0.0 108.816 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' HG12 ' A' ' 83' ' ' VAL . 26.3 p-10 -75.71 -168.92 0.94 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 118.307 0.503 . . . . 0.0 111.507 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -52.11 -33.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 124.4 1.08 . . . . 0.0 112.96 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.24 -20.32 25.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.178 0.591 . . . . 0.0 111.553 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.53 4.2 54.92 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-N 116.447 -0.342 . . . . 0.0 112.843 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.15 127.46 31.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 110.061 175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -77.3 92.16 3.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.925 0.89 . . . . 0.0 109.863 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 4.9 m -75.49 -14.89 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.231 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.24 -143.57 10.69 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 123.587 0.554 . . . . 0.0 112.426 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 51.9 m80 -135.83 166.75 22.57 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.407 1.083 . . . . 0.0 108.461 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 148' ' ' MET . 5.2 mp -78.13 -53.13 7.71 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.557 0.694 . . . . 0.0 109.819 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 170.72 166.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 127.013 2.125 . . . . 0.0 106.771 -167.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -78.67 -44.98 22.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HB3' ' NE2' ' A' ' 167' ' ' HIS . 19.5 mm-40 -66.74 -45.33 78.95 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.85 0.86 . . . . 0.0 111.935 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 65' ' ' GLY . 1.5 tt -64.4 -44.03 92.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.525 0.73 . . . . 0.0 110.007 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.16 85.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.645 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -59.63 -30.33 68.6 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.97 0.793 . . . . 0.0 113.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -73.1 -61.29 1.87 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.394 0.678 . . . . 0.0 110.058 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.12 -15.79 63.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.932 0.893 . . . . 0.0 113.202 -171.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -59.12 -39.55 82.63 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.413 1.085 . . . . 0.0 113.168 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.01 -32.95 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.079 0.552 . . . . 0.0 110.241 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.449 ' HA ' HD12 ' A' ' 127' ' ' LEU . 68.5 mt -66.78 -33.9 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.551 0.74 . . . . 0.0 110.081 174.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.4 tpp -78.01 -38.99 43.58 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.19 -47.66 34.21 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.196 0.998 . . . . 0.0 110.406 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -88.71 -1.49 58.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.099 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.87 31.45 18.24 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.264 1.025 . . . . 0.0 111.532 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 122' ' ' ILE . 77.6 mt -58.52 -43.62 89.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.157 0.983 . . . . 0.0 111.845 -174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.72 131.53 11.6 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.972 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.17 107.19 13.76 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.494 1.118 . . . . 0.0 108.492 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.1 mt -93.35 111.36 24.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.236 0.615 . . . . 0.0 109.948 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.92 179.7 7.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.801 0.84 . . . . 0.0 109.156 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.26 156.34 27.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 82' ' ' MET . 38.8 t -141.76 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.949 0.9 . . . . 0.0 109.69 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.521 HG13 ' HG ' ' A' ' 146' ' ' LEU . 1.7 m -103.73 94.99 6.83 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.447 1.099 . . . . 0.0 108.622 166.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.09 -48.76 3.27 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.537 2.158 . . . . 0.0 111.927 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.78 -27.79 40.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.604 0.762 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' ' HB ' ' A' ' 134' ' ' VAL . . . 63.6 30.08 76.58 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 113.733 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.07 -1.25 19.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.14 0.976 . . . . 0.0 111.507 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.63 -26.93 66.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.724 0.81 . . . . 0.0 111.09 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 9.9 t-20 -69.07 -29.6 67.76 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.417 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.28 -49.24 4.77 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.646 0.778 . . . . 0.0 110.715 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.99 -162.46 1.25 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.845 1.258 . . . . 0.0 110.087 -170.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -103.09 114.5 28.85 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.9 ptm -112.29 157.11 40.91 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.063 0.545 . . . . 0.0 110.307 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.91 124.81 13.2 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.252 1.968 . . . . 0.0 110.898 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HG ' HG13 ' A' ' 134' ' ' VAL . 4.7 tt -109.1 121.21 44.67 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.64 110.3 16.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.932 0.493 . . . . 0.0 109.676 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.52 ' SD ' HD21 ' A' ' 85' ' ' LEU . 47.6 mtt -115.82 113.36 23.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.409 1.084 . . . . 0.0 110.53 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -103.97 129.41 51.55 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.134 0.574 . . . . 0.0 110.472 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 3.9 m-85 -88.4 125.51 34.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.094 0.958 . . . . 0.0 109.478 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -126.73 99.2 5.67 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.98 161.71 31.69 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.72 145.41 54.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.392 0.677 . . . . 0.0 112.282 -175.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 157' ' ' ARG . 44.5 mt-10 -57.59 -31.74 66.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.253 1.021 . . . . 0.0 113.425 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.53 -23.77 66.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.28 2.41 56.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.261 0.624 . . . . 0.0 112.404 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.444 HH21 ' HB3' ' A' ' 154' ' ' GLU . 15.5 ptp180 -57.99 -37.97 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.844 0.457 . . . . 0.0 111.514 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.67 -43.42 89.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.226 1.01 . . . . 0.0 110.387 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.97 -36.29 67.08 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.358 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.39 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.848 0.859 . . . . 0.0 110.443 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.0 p -67.57 -26.78 66.46 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.086 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.13 -37.61 88.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.106 0.562 . . . . 0.0 110.951 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.1 mm100 -74.49 -38.43 62.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.012 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.68 -61.73 2.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.47 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.63 -21.99 66.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.749 1.219 . . . . 0.0 112.761 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -53.74 -52.34 60.47 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.882 0.873 . . . . 0.0 111.018 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.449 ' NE2' ' HB3' ' A' ' 114' ' ' GLU . 66.3 t-80 -96.25 -17.27 20.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.418 -177.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.1 34.32 5.43 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.734 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 . . . . . 0 N--CA 1.482 1.125 0 C-N-CA 123.609 0.764 . . . . 0.0 109.878 169.323 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.998 0.428 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.79 -30.96 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.684 0.794 . . . . 0.0 109.584 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -77.77 -18.07 56.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.767 0.827 . . . . 0.0 110.415 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.96 133.5 50.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.995 0.518 . . . . 0.0 110.879 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.2 m -132.62 162.77 39.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 125.015 1.326 . . . . 0.0 109.797 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 tp -83.89 111.58 19.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 23.0 m-85 -73.51 -25.86 60.62 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.287 0.565 . . . . 0.0 110.611 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -144.25 14.41 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -132.52 179.74 5.95 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.635 0.774 . . . . 0.0 110.271 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 169' ' ' PHE . 49.2 tp -143.35 146.76 33.8 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.571 0.748 . . . . 0.0 109.516 172.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -71.24 81.81 0.73 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.221 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -74.1 74.72 1.18 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -68.08 87.64 0.27 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 111' ' ' LEU . 36.6 t -87.42 147.97 4.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.696 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 87.6 t -61.46 140.96 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.274 1.029 . . . . 0.0 110.727 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.59 -38.18 15.02 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -17.55 31.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.871 1.269 . . . . 0.0 113.248 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.562 ' NH1' HG23 ' A' ' 108' ' ' VAL . 13.1 ptt180 -69.22 -2.29 10.16 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.491 0.717 . . . . 0.0 112.506 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -51.93 -36.84 50.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.071 0.948 . . . . 0.0 112.928 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.08 -30.58 71.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.746 0.818 . . . . 0.0 111.535 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 m -74.38 -6.31 47.44 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.758 0.823 . . . . 0.0 111.786 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.02 45.77 1.24 Allowed Glycine 0 C--N 1.35 1.327 0 O-C-N 122.388 -0.195 . . . . 0.0 113.486 169.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 HG23 ' ND2' ' A' ' 140' ' ' ASN . 28.9 m -64.96 172.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 170.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.08 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.68 -146.26 0.4 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.247 0.619 . . . . 0.0 109.769 -172.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 150.91 41.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.286 1.034 . . . . 0.0 112.666 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 68.83 -5.44 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.592 1.557 . . . . 0.0 113.208 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.16 146.49 29.53 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.042 0.537 . . . . 0.0 110.622 -172.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.469 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.5 mtp -97.43 143.56 28.04 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.518 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.13 145.78 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.36 1.064 . . . . 0.0 108.912 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -99.03 156.01 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -115.41 124.49 51.31 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -132.98 116.8 16.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.969 0.908 . . . . 0.0 109.679 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -67.91 119.21 12.21 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.621 ' HB3' HD21 ' A' ' 91' ' ' ASN . 18.5 t70 -66.6 132.65 94.16 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.571 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.79 -42.52 11.87 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.272 3.314 . . . . 0.0 114.079 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -167.38 106.95 0.58 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 123.138 0.273 . . . . 0.0 110.551 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.621 HD21 ' HB3' ' A' ' 88' ' ' ASP . 24.5 m-80 -96.7 146.26 30.99 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.05 -22.14 48.2 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.765 2.31 . . . . 0.0 114.003 -170.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -125.94 -46.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.713 0.405 . . . . 0.0 110.858 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.428 ' HB3' ' ND2' ' A' ' 96' ' ' ASN . 33.7 m-20 -117.14 92.7 3.93 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -55.86 -33.16 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.728 0.811 . . . . 0.0 111.686 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.585 ' H ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -72.3 -8.29 54.08 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 113.1 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 108.41 2.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.237 0.615 . . . . 0.0 111.375 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.32 125.95 45.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 124.081 0.952 . . . . 0.0 110.213 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 32.4 mmtp -86.8 123.91 32.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.106 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.61 112.67 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.0 m-20 -91.53 170.36 10.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.188 0.995 . . . . 0.0 108.849 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -108.11 -171.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.843 0.457 . . . . 0.0 110.248 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.69 -28.38 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.637 0.775 . . . . 0.0 112.24 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.9 -30.48 63.95 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.176 0.591 . . . . 0.0 110.357 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.19 -4.34 30.03 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.485 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.81 137.4 41.87 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.278 0.539 . . . . 0.0 110.026 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.78 95.37 0.89 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.562 HG23 ' NH1' ' A' ' 71' ' ' ARG . 27.8 m -86.95 16.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.861 0.865 . . . . 0.0 112.012 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 148.01 -175.72 27.19 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.925 169.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -102.68 148.83 25.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.11 0.964 . . . . 0.0 108.972 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.2 tt -73.89 -56.09 5.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? 152.12 121.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -165.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -61.11 -49.47 77.13 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 118.802 0.728 . . . . 0.0 112.072 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.33 -41.56 93.81 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.821 0.7 . . . . 0.0 110.82 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.77 -40.08 66.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.831 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.32 -24.54 65.75 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.008 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.28 -33.82 88.29 Favored Glycine 0 C--N 1.351 1.361 0 O-C-N 123.603 0.565 . . . . 0.0 112.958 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -56.84 4.78 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.413 0.625 . . . . 0.0 109.802 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 63' ' ' LEU . 22.5 mt -70.5 -18.12 62.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.506 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.96 67.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.881 0.873 . . . . 0.0 111.153 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -66.03 -35.5 80.72 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.184 0.928 . . . . 0.0 110.44 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.507 ' HA ' HD12 ' A' ' 127' ' ' LEU . 83.9 mt -62.62 -44.55 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 0.0 110.585 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 85' ' ' LEU . 30.1 ttm -81.19 -21.46 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.644 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.31 -51.05 10.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 0.0 109.72 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -89.71 4.16 50.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.224 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 59.71 36.63 22.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.533 1.133 . . . . 0.0 111.594 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 122' ' ' ILE . 66.0 mt -62.22 -40.83 97.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.44 1.096 . . . . 0.0 111.54 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.504 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.15 140.86 9.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.13 0.572 . . . . 0.0 111.093 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -76.52 133.51 39.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.1 113.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.39 132.75 54.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.35 154.78 18.53 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.773 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 82' ' ' MET . 67.3 t -137.99 137.26 44.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.23 84.88 4.98 Favored Pre-proline 0 CA--C 1.555 1.17 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.47 -35.78 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.656 2.237 . . . . 0.0 111.74 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.25 -26.13 58.61 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.966 0.907 . . . . 0.0 110.59 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.76 -6.08 14.18 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 115.835 1.094 . . . . 0.0 115.835 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.12 1.8 30.22 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.481 0.641 . . . . 0.0 112.723 -172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.602 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 3.4 t-20 -75.32 -18.4 60.03 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.116 0.484 . . . . 0.0 110.315 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' HG23 ' A' ' 76' ' ' VAL . 20.6 t-20 -61.89 -34.23 75.66 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.092 0.957 . . . . 0.0 110.663 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.94 -56.39 2.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.828 0.851 . . . . 0.0 112.579 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -126.8 -178.25 4.32 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.542 1.137 . . . . 0.0 110.573 -161.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p -93.8 125.46 38.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.087 0.955 . . . . 0.0 109.631 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 139' ' ' ASN . 3.3 ppp? -156.61 160.93 30.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.172 0.989 . . . . 0.0 109.302 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.96 121.5 7.36 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.791 1.661 . . . . 0.0 111.147 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 67' ' ' VAL . 6.5 tt -100.34 124.88 46.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -74.33 108.84 7.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.627 ' SD ' HD21 ' A' ' 85' ' ' LEU . 58.5 mtt -116.05 121.74 43.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.76 0.824 . . . . 0.0 109.581 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -108.99 140.53 42.36 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.373 1.069 . . . . 0.0 110.206 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 43.5 m-85 -104.15 121.01 42.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.923 0.889 . . . . 0.0 109.684 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -124.5 112.88 17.4 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.48 164.45 37.97 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -54.26 137.69 40.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.534 0.734 . . . . 0.0 110.541 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -53.93 -39.0 65.47 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 123.854 0.721 . . . . 0.0 112.551 -169.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.42 -18.03 35.67 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.319 1.048 . . . . 0.0 113.759 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -92.51 -8.22 45.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.79 -33.62 66.84 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.056 0.542 . . . . 0.0 112.398 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 46.7 pttt -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.674 0.789 . . . . 0.0 111.381 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -68.65 -34.7 76.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.62 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.96 -44.24 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.657 0.783 . . . . 0.0 110.466 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -72.67 -25.97 61.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.543 0.737 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 32.7 t70 -58.77 -39.92 82.43 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.15 0.5 . . . . 0.0 110.286 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 166' ' ' LYS . 14.7 mm100 -73.19 -39.49 65.53 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.12 -175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.51 -57.54 4.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.32 -21.29 59.52 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.654 1.181 . . . . 0.0 112.484 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 163' ' ' GLN . 21.8 ttmm -56.23 -50.38 71.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.989 0.916 . . . . 0.0 111.177 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -111.59 18.7 18.82 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.174 0.59 . . . . 0.0 110.545 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.0 14.07 76.05 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.584 ' HB3' HD11 ' A' ' 63' ' ' LEU . 28.4 m-85 . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 123.883 0.873 . . . . 0.0 110.892 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.0 t -72.54 -31.44 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.4 t70 -77.4 -14.0 59.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.285 0.634 . . . . 0.0 111.126 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 m -70.66 109.29 4.82 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.464 0.65 . . . . 0.0 110.519 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 56' ' ' ASP . 16.9 m -116.61 162.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.853 1.261 . . . . 0.0 110.293 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.76 118.49 22.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 27.8 m-85 -83.31 -31.5 26.83 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.322 0.582 . . . . 0.0 110.167 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.1 -167.94 29.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.873 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 147' ' ' HIS . 77.6 p -125.58 138.98 53.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.889 0.476 . . . . 0.0 110.102 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 33.6 tp -99.09 140.95 32.48 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 109.761 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -75.37 78.87 2.44 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.928 0.87 . . . . 0.0 110.486 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -71.68 141.23 31.66 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.419 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -122.01 100.72 7.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.45 0.7 . . . . 0.0 109.776 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.96 131.23 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.93 0.769 . . . . 0.0 108.974 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.66 142.32 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.741 0.816 . . . . 0.0 111.594 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.63 -27.29 57.35 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.64 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.85 -19.57 65.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.444 0.698 . . . . 0.0 110.072 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 4.1 mmp_? -78.1 0.27 25.39 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.47 1.108 . . . . 0.0 112.807 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.05 -36.66 65.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.473 0.709 . . . . 0.0 112.12 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.82 -32.23 73.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.701 0.8 . . . . 0.0 111.85 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 p -87.22 15.5 6.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.13 0.572 . . . . 0.0 112.399 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.04 49.95 1.41 Allowed Glycine 0 C--N 1.356 1.653 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 163.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.47 169.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.093 0.947 . . . . 0.0 111.585 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 HG11 ' A' ' 134' ' ' VAL . 27.6 m -115.64 158.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.769 0.828 . . . . 0.0 111.902 -164.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -74.32 -173.95 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.136 0.974 . . . . 0.0 110.758 -179.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -72.44 153.23 41.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.44 8.74 5.96 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 125.019 1.328 . . . . 0.0 112.229 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -88.11 145.41 25.96 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.7 -0.625 . . . . 0.0 111.553 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.578 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -95.36 147.37 23.58 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.123 177.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.82 142.09 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.556 1.142 . . . . 0.0 108.853 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -115.01 124.69 52.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.721 0.808 . . . . 0.0 109.56 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.9 mt -76.83 158.84 30.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.681 0.393 . . . . 0.0 110.707 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.03 121.59 4.89 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.425 0.69 . . . . 0.0 110.116 -174.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.28 134.61 56.14 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.471 0.708 . . . . 0.0 110.835 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' A' ' 91' ' ' ASN . 3.5 m-20 -68.74 118.28 59.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.319 0.647 . . . . 0.0 109.319 169.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.75 -29.57 90.07 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.918 2.412 . . . . 0.0 112.866 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -144.42 98.99 3.29 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 97' ' ' ALA . 14.7 m120 -65.64 138.69 96.79 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.583 0.753 . . . . 0.0 110.632 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.46 -54.41 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.434 2.089 . . . . 0.0 113.139 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -128.61 -50.72 1.26 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.754 0.822 . . . . 0.0 109.768 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.71 101.25 13.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.019 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.25 -4.96 28.6 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 3.6 p-10 -99.37 -2.14 37.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.282 1.033 . . . . 0.0 111.784 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 91' ' ' ASN . . . -68.71 144.24 54.47 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.021 0.528 . . . . 0.0 111.384 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.19 126.18 55.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.145 0.978 . . . . 0.0 108.931 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.17 152.93 43.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.506 0.722 . . . . 0.0 111.209 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.31 134.08 64.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -121.05 166.48 13.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.429 1.091 . . . . 0.0 108.084 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -99.34 -172.64 2.3 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.11 -19.28 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.227 0.611 . . . . 0.0 112.582 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -84.92 -10.93 56.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.354 0.662 . . . . 0.0 110.919 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.3 19.9 59.77 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.648 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.88 127.68 35.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 109.762 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.01 110.49 3.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 110.239 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 4.3 m -84.3 -10.51 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.943 0.497 . . . . 0.0 110.643 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.96 -141.52 12.86 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -106.05 173.76 6.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.733 0.813 . . . . 0.0 110.072 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.431 HD11 ' SD ' ' A' ' 148' ' ' MET . 2.3 tt -84.71 -52.32 6.16 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 172.01 168.77 0.1 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -79.06 -63.77 1.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.26 -36.55 74.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 0.0 112.379 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.483 HD11 ' HA2' ' A' ' 65' ' ' GLY . 4.9 tt -73.05 -46.02 54.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.896 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.03 67.44 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.838 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -61.48 -40.04 98.14 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.592 0.558 . . . . 0.0 113.347 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -49.55 39.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.38 0.609 . . . . 0.0 109.86 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 122' ' ' ILE . 17.1 mt -69.31 -16.74 63.62 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.819 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.84 -57.95 9.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.381 1.072 . . . . 0.0 111.543 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -64.07 -31.0 72.03 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.909 0.756 . . . . 0.0 110.687 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 127' ' ' LEU . 73.5 mt -67.34 -40.61 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.509 0.723 . . . . 0.0 111.203 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.7 ttm -80.36 -36.31 34.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.232 0.613 . . . . 0.0 110.971 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.13 -41.41 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.272 1.029 . . . . 0.0 111.101 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -99.67 7.98 44.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.648 0.779 . . . . 0.0 111.096 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 63.08 35.77 12.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.33 1.052 . . . . 0.0 111.762 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 122' ' ' ILE . 64.1 mt -69.5 -50.22 47.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.009 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -152.11 145.0 24.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.89 134.66 33.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 108.599 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.2 mt -121.4 117.42 52.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.721 0.296 . . . . 0.0 110.301 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -117.37 121.25 40.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.252 1.021 . . . . 0.0 108.451 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -90.14 155.52 24.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.582 -0.281 . . . . 0.0 112.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 82' ' ' MET . 53.3 t -138.68 128.02 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG23 ' A' ' 77' ' ' VAL . 5.0 p -96.01 102.27 10.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.711 0.805 . . . . 0.0 109.301 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -53.56 0.18 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.296 1.997 . . . . 0.0 113.574 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -84.98 -27.59 26.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.035 0.534 . . . . 0.0 110.941 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.35 81.84 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 113.718 0.247 . . . . 0.0 113.718 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.652 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -75.93 -7.75 55.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.423 0.689 . . . . 0.0 112.277 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.78 -16.65 63.86 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.864 0.865 . . . . 0.0 110.973 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -73.12 -25.66 60.93 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.622 0.769 . . . . 0.0 111.29 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.07 -60.61 2.19 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -141.5 -83.49 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.1 m -157.5 140.62 15.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.652 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -153.06 149.38 21.69 Favored Pre-proline 0 C--O 1.243 0.758 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 173.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.75 124.4 14.49 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.326 2.017 . . . . 0.0 112.815 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.485 HD22 ' HB ' ' A' ' 134' ' ' VAL . 4.3 pp -117.77 146.25 43.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.043 0.937 . . . . 0.0 108.858 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.5 m80 -86.55 109.85 19.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.612 0.365 . . . . 0.0 111.139 -166.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.649 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 40.3 mtt -99.76 111.77 24.07 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.188 0.995 . . . . 0.0 109.468 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 49.5 p -93.99 128.22 40.21 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.154 0.982 . . . . 0.0 109.653 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 24.7 m-85 -91.13 117.25 29.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.261 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -120.44 99.18 6.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.89 166.55 31.45 Favored Glycine 0 CA--C 1.501 -0.832 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.342 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.03 149.3 45.04 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.58 -48.02 7.51 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.78 1.632 . . . . 0.0 113.613 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.14 -9.89 55.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -171.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 127' ' ' LEU . 98.9 m-20 -107.62 -4.36 18.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 8.9 ptp85 -63.44 -29.24 70.56 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.216 0.916 . . . . 0.0 112.228 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.16 -42.52 86.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.67 0.788 . . . . 0.0 109.847 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.06 -34.12 29.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.467 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.89 -57.75 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.654 0.782 . . . . 0.0 110.517 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 m -62.95 -25.45 68.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.098 0.959 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.4 t70 -60.57 -48.65 80.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.526 0.33 . . . . 0.0 110.375 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.9 mm100 -64.06 -35.22 80.02 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.956 0.785 . . . . 0.0 111.155 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 -62.46 1.45 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.342 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -58.91 -26.98 64.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.497 0.719 . . . . 0.0 111.694 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 37.1 ttmt -56.06 -50.09 71.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.645 1.178 . . . . 0.0 111.793 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -87.15 -13.46 44.02 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.02 10.85 23.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.916 -0.38 . . . . 0.0 113.548 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 123.078 0.551 . . . . 0.0 110.106 171.885 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.92 -32.05 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.44 0.696 . . . . 0.0 109.605 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.97 -33.26 75.62 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.349 1.06 . . . . 0.0 110.48 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -78.53 127.49 32.22 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.753 0.821 . . . . 0.0 110.693 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.85 166.78 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.786 1.234 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.51 117.59 23.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.497 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 20.7 m-85 -81.12 -28.86 34.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.058 0.543 . . . . 0.0 110.648 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.93 -153.26 25.19 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -126.47 178.61 5.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.414 0.685 . . . . 0.0 110.559 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -150.96 141.56 22.62 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.913 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -71.74 84.14 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.494 0.718 . . . . 0.0 109.717 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.513 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.37 87.25 1.38 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.168 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 18.2 t60 -73.79 94.28 2.24 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.203 0.601 . . . . 0.0 110.213 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.55 HG11 ' HD2' ' A' ' 71' ' ' ARG . 38.3 t -82.22 142.68 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.431 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.74 154.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.892 0.877 . . . . 0.0 113.072 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.46 -19.95 72.85 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.387 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.3 tp -57.23 -23.85 50.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.973 1.309 . . . . 0.0 111.489 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.55 ' HD2' HG11 ' A' ' 67' ' ' VAL . 70.8 ttt180 -54.85 -21.83 12.62 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.241 1.416 . . . . 0.0 113.15 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -49.91 -49.6 49.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.165 0.986 . . . . 0.0 111.95 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -75.45 -25.94 57.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.056 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 m -80.46 -9.23 59.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.011 0.524 . . . . 0.0 110.53 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.31 50.18 0.73 Allowed Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.309 170.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.19 158.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 33.1 m -112.99 152.19 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.222 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.75 -76.84 0.11 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.338 0.399 . . . . 0.0 110.789 -164.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -164.07 159.22 20.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.065 0.946 . . . . 0.0 109.617 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 70.7 -7.6 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.486 1.114 . . . . 0.0 111.892 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.648 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 72.4 mm-40 -75.25 144.0 42.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.758 0.823 . . . . 0.0 111.965 -167.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.568 ' HG2' HG22 ' A' ' 133' ' ' VAL . 73.4 mtm -95.04 144.53 25.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.46 170.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.93 160.79 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.084 0.954 . . . . 0.0 109.083 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.68 25.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.6 mp -85.38 134.06 34.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.045 0.538 . . . . 0.0 109.575 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -142.78 130.7 21.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.3 0.64 . . . . 0.0 109.486 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -80.76 124.32 28.95 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -99.16 137.18 20.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.385 0.674 . . . . 0.0 111.446 -177.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.54 -28.7 6.51 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.622 2.215 . . . . 0.0 112.025 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -80.65 83.72 6.36 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 3.9 p-10 -89.92 127.91 52.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.334 -166.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 10.1 Cg_exo -74.47 -26.92 11.56 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.553 2.168 . . . . 0.0 112.408 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -120.84 -53.38 2.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.254 0.621 . . . . 0.0 111.578 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -168.1 154.0 7.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.01 -13.38 2.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.162 0.985 . . . . 0.0 113.636 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 90.0 m-20 -95.19 27.68 3.15 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.065 0.946 . . . . 0.0 111.48 174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.7 34.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.057 0.543 . . . . 0.0 110.687 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mt -116.36 123.87 71.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 C-N-CA 123.967 0.907 . . . . 0.0 109.437 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -81.84 150.13 27.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.591 0.71 . . . . 0.0 110.465 170.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -101.11 109.95 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -89.91 167.73 12.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -107.1 -165.6 1.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.298 0.499 . . . . 0.0 110.482 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -59.04 -31.24 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.847 0.859 . . . . 0.0 112.034 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.08 -11.96 57.53 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.196 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.37 85.82 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 113.169 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 133.66 36.23 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 109.746 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -61.64 92.45 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 O-C-N 124.283 0.99 . . . . 0.0 110.816 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.92 -1.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.738 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HG3' ' A' ' 71' ' ' ARG . . . 172.76 -159.34 29.9 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.554 0.533 . . . . 0.0 113.83 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 11.6 p-80 -142.01 150.48 41.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.887 1.275 . . . . 0.0 107.632 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.51 -53.84 12.53 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -178.47 -179.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.988 1.715 . . . . 0.0 108.104 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -81.0 -61.41 1.97 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 162.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.22 -39.21 23.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.712 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -67.08 -44.89 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.78 70.75 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.508 -1.223 . . . . 0.0 111.13 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -61.44 -42.82 99.86 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.876 0.735 . . . . 0.0 114.353 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.75 -47.95 67.82 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.389 0.614 . . . . 0.0 110.534 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.49 -18.97 63.74 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.55 87.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.117 0.967 . . . . 0.0 111.861 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -70.04 -32.87 71.21 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.699 0.625 . . . . 0.0 109.584 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 160' ' ' VAL . 66.5 mt -67.63 -37.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.654 0.782 . . . . 0.0 110.782 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.91 -44.9 21.69 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.797 0.839 . . . . 0.0 111.075 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.74 -46.7 52.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.653 1.181 . . . . 0.0 110.791 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.97 6.86 33.81 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.806 0.443 . . . . 0.0 111.243 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 59.92 33.56 21.53 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.806 1.242 . . . . 0.0 111.733 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 122' ' ' ILE . 68.9 mt -65.71 -42.59 90.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -158.34 151.17 22.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -86.39 132.11 34.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -113.81 113.44 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -102.99 179.27 4.32 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.208 1.003 . . . . 0.0 108.481 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.33 164.38 31.47 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.9 t -144.44 134.18 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.3 p -112.83 88.8 12.21 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.7 -22.88 8.73 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.489 2.126 . . . . 0.0 112.699 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -82.48 -28.45 31.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.923 0.489 . . . . 0.0 110.518 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 75.75 4.29 75.84 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -69.73 -9.05 52.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.301 0.64 . . . . 0.0 112.702 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -18.66 64.96 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.0 0.92 . . . . 0.0 113.221 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.62 -53.01 9.27 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 110.705 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.73 -34.35 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.169 0.588 . . . . 0.0 111.301 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -117.39 174.34 6.2 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.718 0.807 . . . . 0.0 110.819 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -98.92 111.02 23.54 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.512 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.6 ptm -125.8 158.74 64.36 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 121.921 -0.487 . . . . 0.0 110.644 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 2.5 Cg_endo -83.57 125.73 3.91 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.765 2.31 . . . . 0.0 110.826 164.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.22 154.75 22.95 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -74.76 111.21 9.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.053 0.541 . . . . 0.0 110.35 -171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -109.88 117.12 32.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.228 1.011 . . . . 0.0 110.328 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -107.49 135.23 49.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.505 1.122 . . . . 0.0 110.424 -167.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.2 118.95 35.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 109.424 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -123.62 103.49 8.45 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.47 169.47 36.99 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 138.06 58.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.011 0.525 . . . . 0.0 111.734 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -52.48 -32.06 38.02 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.643 1.577 . . . . 0.0 113.071 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.34 -10.1 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.738 . . . . 0.0 112.697 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.57 4.13 20.05 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.841 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -61.06 -33.52 73.44 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.377 0.99 . . . . 0.0 111.756 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -33.19 69.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.239 0.616 . . . . 0.0 110.769 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -76.7 -38.31 54.61 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.615 0.766 . . . . 0.0 110.575 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 122' ' ' ILE . 64.3 t -64.34 -47.65 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.141 0.976 . . . . 0.0 110.27 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.5 p -68.45 -29.87 68.61 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.881 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -43.13 99.38 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.38 0.672 . . . . 0.0 111.253 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 12.1 mm100 -63.15 -37.26 86.53 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.958 0.786 . . . . 0.0 110.485 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -48.38 51.01 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.223 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -66.07 -25.7 67.15 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.408 1.083 . . . . 0.0 111.611 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -67.04 -44.01 81.32 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.939 0.895 . . . . 0.0 111.293 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -110.09 3.94 20.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.903 0.481 . . . . 0.0 110.893 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.21 66.7 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 123.125 0.57 . . . . 0.0 110.373 173.132 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.85 -27.6 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 109.494 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.5 -16.97 60.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.642 0.777 . . . . 0.0 110.954 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -70.39 146.03 50.7 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.829 0.452 . . . . 0.0 109.976 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG21 ' HG2' ' A' ' 154' ' ' GLU . 24.0 m -141.14 161.13 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.932 1.293 . . . . 0.0 110.021 -174.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.94 111.37 16.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.0 m-85 -74.02 -38.63 63.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.862 0.465 . . . . 0.0 110.905 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.8 -166.66 29.3 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.179 -169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.0 p -111.11 178.7 4.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.186 0.517 . . . . 0.0 111.474 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 47.6 tp -151.28 146.58 26.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.477 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -94.11 93.94 8.11 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.76 0.79 . . . . 0.0 109.399 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.83 102.85 2.61 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.829 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -78.66 105.7 10.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.363 0.581 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG11 ' HD2' ' A' ' 71' ' ' ARG . 10.8 t -89.56 147.33 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 112' ' ' LYS . 31.4 m -80.62 167.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.26 -20.0 68.9 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.996 -1.002 . . . . 0.0 114.093 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.19 -17.78 30.62 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.468 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.73 ' HD3' ' HB2' ' A' ' 139' ' ' ASN . 68.7 ttt180 -56.26 -42.0 76.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.21 1.004 . . . . 0.0 112.98 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.557 ' HA ' HG13 ' A' ' 76' ' ' VAL . 16.0 p90 -75.06 -16.78 60.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.167 0.439 . . . . 0.0 111.583 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -83.44 -28.92 28.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.702 0.801 . . . . 0.0 110.289 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.1 m -75.22 -27.9 59.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.271 0.628 . . . . 0.0 111.152 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.54 53.98 0.31 Allowed Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.407 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 72' ' ' TYR . 3.3 m -41.45 169.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.599 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 9.2 m -115.53 -179.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.004 -176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.15 -166.7 0.52 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.559 1.144 . . . . 0.0 110.673 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -77.82 141.0 39.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.165 0.586 . . . . 0.0 110.894 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 8.0 t30 58.46 32.8 22.52 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.712 1.205 . . . . 0.0 112.447 170.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mm-40 -82.65 141.52 32.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.673 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.553 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.4 mtp -88.02 142.2 27.97 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 32.9 m -132.83 150.9 33.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.846 0.858 . . . . 0.0 110.246 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -107.69 157.15 18.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.264 1.026 . . . . 0.0 109.568 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.92 146.06 39.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.374 0.67 . . . . 0.0 110.003 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -155.35 130.61 9.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 13.2 ptm180 -66.89 146.03 54.83 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.11 0.481 . . . . 0.0 111.267 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -99.29 106.85 41.49 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.173 0.989 . . . . 0.0 108.445 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -83.7 3.56 7.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.802 2.335 . . . . 0.0 112.851 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -119.8 -11.21 9.4 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.661 0.784 . . . . 0.0 111.518 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 92' ' ' PRO . 5.1 t-20 -63.06 121.78 71.12 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.944 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 33.8 Cg_endo -59.49 -19.78 53.62 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.883 3.055 . . . . 0.0 114.355 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -72.14 -50.58 26.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.415 0.686 . . . . 0.0 110.524 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 96' ' ' ASN . 21.9 p-10 177.74 157.04 0.38 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.276 0.985 . . . . 0.0 110.66 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -64.03 -23.22 67.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.265 176.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 10.8 m-20 -75.61 -2.23 28.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.746 0.818 . . . . 0.0 112.499 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.5 33.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.499 0.32 . . . . 0.0 110.158 169.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.0 mt -133.75 126.34 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.024 0.929 . . . . 0.0 109.739 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -82.27 134.08 35.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 168.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.58 134.85 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.287 0.635 . . . . 0.0 109.355 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.0 p30 -121.93 171.16 9.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.8 p30 -107.51 -169.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.482 1.037 . . . . 0.0 109.803 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.36 -29.89 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.47 -11.95 59.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.041 0.936 . . . . 0.0 111.692 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.17 -1.89 77.89 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 122.9 0.286 . . . . 0.0 113.382 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.8 t-20 -73.9 128.41 35.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.721 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.08 114.86 3.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.616 0.766 . . . . 0.0 110.409 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' ASN . 35.6 m -126.56 13.87 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.855 0.862 . . . . 0.0 111.974 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.36 -170.29 43.08 Favored Glycine 0 C--N 1.355 1.636 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.02 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -166.26 123.47 1.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.07 0.948 . . . . 0.0 109.123 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 115' ' ' LEU . 95.6 mt -80.34 7.26 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.1 0.96 . . . . 0.0 113.168 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HG3' ' H ' ' A' ' 113' ' ' LYS . 16.1 tptm 64.08 -156.44 0.31 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.632 1.173 . . . . 0.0 109.972 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 16.5 ttmm -79.03 -48.61 14.1 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 118.987 0.812 . . . . 0.0 110.882 170.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.06 -59.47 4.71 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.073 0.858 . . . . 0.0 112.572 -162.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 HD13 ' A' ' 111' ' ' LEU . 1.9 tm? -72.45 -46.54 54.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.618 0.723 . . . . 0.0 109.206 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -64.57 -29.47 70.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.713 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -65.71 -35.67 91.32 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 123.503 0.573 . . . . 0.0 112.63 -173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.71 -51.39 49.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.797 0.808 . . . . 0.0 109.486 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.68 -15.92 62.76 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.673 -1.148 . . . . 0.0 112.559 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.02 86.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.615 1.166 . . . . 0.0 112.689 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -73.76 -33.83 64.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 127' ' ' LEU . 56.8 mt -67.31 -33.5 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.419 0.688 . . . . 0.0 110.241 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.5 tpp -73.7 -43.36 59.5 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.005 1.322 . . . . 0.0 110.497 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.59 -50.47 30.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.803 -174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -91.05 2.03 56.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.483 -173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 56.03 44.13 25.98 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.714 1.205 . . . . 0.0 111.58 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.527 ' HB2' HG23 ' A' ' 122' ' ' ILE . 73.4 mt -70.18 -40.86 74.4 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.213 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.96 139.3 14.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.96 112.48 7.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.091 0.956 . . . . 0.0 109.529 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.14 120.33 48.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.38 166.8 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.88 150.36 21.94 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 82' ' ' MET . 64.8 t -142.08 116.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.26 92.74 0.93 Allowed Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 11.7 Cg_exo -69.65 -53.56 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.845 2.363 . . . . 0.0 113.498 -162.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.81 -26.31 57.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.631 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.99 79.43 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.939 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.78 -1.97 18.64 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.73 ' HB2' ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -63.17 -18.52 63.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.427 1.491 . . . . 0.0 113.84 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -82.22 -41.84 19.74 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.256 0.622 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.16 -58.42 3.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.809 0.444 . . . . 0.0 110.336 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -137.74 -163.15 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 110.294 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 p -95.2 127.02 40.92 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.6 ptm -129.36 151.29 77.61 Favored Pre-proline 0 C--O 1.249 1.059 0 C-N-CA 123.171 0.588 . . . . 0.0 109.51 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 139.82 25.92 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 121.968 1.778 . . . . 0.0 110.521 166.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -106.05 144.78 32.28 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -69.8 110.48 4.97 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 24.9 mtp -102.94 158.75 16.07 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -150.5 139.59 21.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 90.2 m-85 -101.83 133.2 46.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.078 0.951 . . . . 0.0 109.973 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -131.36 100.52 5.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.24 1.016 . . . . 0.0 108.805 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.56 169.39 37.82 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.46 145.91 52.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.943 0.497 . . . . 0.0 111.715 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' HG21 ' A' ' 58' ' ' VAL . 37.6 mt-10 -59.87 -28.5 67.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.035 0.934 . . . . 0.0 112.731 -172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.61 -21.83 62.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.877 0.471 . . . . 0.0 111.945 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -89.1 -8.6 53.52 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.046 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.278 0.49 . . . . 0.0 110.692 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.4 pptp? -65.16 -34.83 79.33 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.297 0.373 . . . . 0.0 110.749 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.57 -33.58 28.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.621 0.769 . . . . 0.0 110.87 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.05 -49.99 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.457 0.703 . . . . 0.0 110.265 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.4 t -66.24 -29.75 70.06 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.648 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 26.7 t70 -56.85 -44.79 82.51 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.522 0.729 . . . . 0.0 109.957 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 17.8 mm100 -71.24 -38.54 71.96 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.876 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.58 -55.66 25.16 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.587 0.554 . . . . 0.0 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -64.35 -22.94 67.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.97 0.908 . . . . 0.0 112.13 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -62.31 -40.87 97.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.968 0.907 . . . . 0.0 110.907 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -107.36 -0.98 22.03 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 15.86 61.57 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 114.342 0.497 . . . . 0.0 114.342 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 63' ' ' LEU . 31.1 m-85 . . . . . 0 N--CA 1.482 1.166 0 C-N-CA 123.955 0.902 . . . . 0.0 112.126 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.765 0.317 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.89 -38.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.375 0.67 . . . . 0.0 109.372 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.31 -21.35 56.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.051 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -67.11 139.71 57.54 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.107 0.563 . . . . 0.0 110.724 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.45 169.0 17.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 109.144 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.26 126.64 35.59 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.39 -43.16 11.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.759 . . . . 0.0 110.053 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.58 -177.42 20.79 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.468 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -111.74 120.4 41.89 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.944 0.498 . . . . 0.0 110.219 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 169' ' ' PHE . 55.4 tp -77.14 148.16 36.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.835 1.254 . . . . 0.0 110.897 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -75.33 80.51 2.41 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.055 0.931 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -79.45 93.33 1.34 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.831 -171.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -70.56 92.37 0.84 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.34 138.33 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 70' ' ' LEU . 39.9 t -71.07 144.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.17 74.82 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.395 -0.669 . . . . 0.0 114.006 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.45 ' H ' HG12 ' A' ' 68' ' ' VAL . 39.2 tp -51.91 -23.04 4.39 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.859 1.264 . . . . 0.0 112.965 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 108' ' ' VAL . 20.3 ptt85 -56.88 -6.63 0.36 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.889 1.676 . . . . 0.0 114.349 173.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -54.66 -35.88 63.99 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.11 0.564 . . . . 0.0 111.949 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.98 -26.81 60.66 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.919 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.9 m -75.64 -21.64 57.51 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.831 0.852 . . . . 0.0 111.32 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.69 50.1 0.45 Allowed Glycine 0 C--N 1.356 1.646 0 CA-C-O 119.865 -0.408 . . . . 0.0 113.981 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -52.84 171.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.9 m -114.04 176.85 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.559 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.23 -164.49 1.09 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.809 1.243 . . . . 0.0 110.247 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -82.7 157.37 23.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.314 0.645 . . . . 0.0 111.172 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 67.71 10.97 8.14 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.177 1.391 . . . . 0.0 112.463 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 29.6 mm-40 -84.11 149.37 26.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.499 0.72 . . . . 0.0 110.73 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.593 ' HG2' HG22 ' A' ' 133' ' ' VAL . 60.3 mtp -107.73 152.22 24.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.905 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.5 162.09 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.374 1.069 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.36 145.82 51.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.521 1.128 . . . . 0.0 108.924 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HE1' ' A' ' 148' ' ' MET . 6.9 mp -101.04 135.13 42.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.187 0.595 . . . . 0.0 110.5 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.19 132.81 7.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.016 0.926 . . . . 0.0 108.697 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.737 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 2.5 ptp180 -57.1 147.39 24.67 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 112.086 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.18 127.33 59.59 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.512 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -20.09 65.61 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.248 2.632 . . . . 0.0 112.513 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -91.7 47.73 1.39 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.111 0.964 . . . . 0.0 109.147 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.1 p-10 -63.38 120.18 59.85 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.927 0.891 . . . . 0.0 111.365 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 18.2 Cg_exo -68.67 -50.89 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.912 2.408 . . . . 0.0 113.027 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.45 -50.33 4.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.202 0.601 . . . . 0.0 110.777 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -168.02 165.63 13.47 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -15.21 3.55 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.577 1.151 . . . . 0.0 113.062 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 29.5 p-10 -62.68 -21.92 66.09 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.687 0.795 . . . . 0.0 111.893 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -62.35 109.17 1.26 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.942 0.897 . . . . 0.0 109.926 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.737 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 98.7 mt -108.61 132.66 55.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 109.891 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 5.1 ttpm? -98.68 146.58 25.72 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.503 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.6 124.86 63.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 109.593 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -110.63 153.83 24.64 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -90.54 -172.83 3.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.541 0.337 . . . . 0.0 110.13 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.52 -23.85 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.889 0.475 . . . . 0.0 112.066 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.191 0.596 . . . . 0.0 110.412 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.94 -0.83 86.54 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 122.778 0.228 . . . . 0.0 113.447 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -74.02 133.2 42.93 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.123 0.969 . . . . 0.0 108.975 175.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.497 ' N ' HD22 ' A' ' 106' ' ' ASN . 26.5 pt20 -64.3 106.38 1.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.674 0.75 . . . . 0.0 110.065 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 35.3 m -114.57 12.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.086 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.84 178.25 48.09 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 114.673 0.629 . . . . 0.0 114.673 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.533 ' HE1' ' HB1' ' A' ' 97' ' ' ALA . 78.9 t60 -161.34 113.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 86.2 mt -68.59 -13.13 62.14 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 83.0 tttt 70.71 149.18 0.08 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.124 0.97 . . . . 0.0 110.59 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -21.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.253 1.021 . . . . 0.0 112.476 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.506 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tp10 -56.74 -64.69 0.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.289 1.036 . . . . 0.0 111.461 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 111' ' ' LEU . 59.9 tp -85.51 -49.66 7.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -60.04 -24.63 64.68 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.209 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.49 -34.36 89.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.456 0.472 . . . . 0.0 113.443 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.64 -45.08 26.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.438 0.695 . . . . 0.0 109.98 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.42 HD12 HD13 ' A' ' 111' ' ' LEU . 46.2 mt -70.73 -16.62 62.79 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.932 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.46 -53.91 32.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -68.9 -31.92 71.18 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.941 0.775 . . . . 0.0 110.761 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.23 -37.59 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.435 0.694 . . . . 0.0 110.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 44.9 ttm -79.32 -45.19 20.13 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.875 0.87 . . . . 0.0 110.962 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB2' HH22 ' A' ' 87' ' ' ARG . 29.3 t70 -67.39 -46.62 72.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.067 0.947 . . . . 0.0 110.851 -172.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -92.18 1.36 57.26 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.09 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.18 37.95 17.13 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.376 1.07 . . . . 0.0 111.917 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.26 -42.5 93.2 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.818 0.847 . . . . 0.0 111.351 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.07 137.98 17.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.65 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.2 116.89 18.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.126 0.97 . . . . 0.0 108.642 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.35 123.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -107.07 178.66 4.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.76 155.04 25.92 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.5 t -142.67 141.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.269 1.028 . . . . 0.0 108.281 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 137' ' ' GLY . 3.8 p -122.83 86.23 50.13 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.783 0.833 . . . . 0.0 109.153 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.52 -22.41 21.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.216 2.611 . . . . 0.0 113.9 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.35 0.66 . . . . 0.0 110.797 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 64.5 33.96 88.64 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.514 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -82.27 12.41 4.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.914 0.486 . . . . 0.0 111.446 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -52.85 -37.69 60.55 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.61 -44.7 63.95 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.423 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.86 3.56 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.374 0.669 . . . . 0.0 112.169 -168.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -122.51 170.73 9.69 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.544 0.738 . . . . 0.0 110.688 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 t -95.13 109.07 21.19 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.1 ptm -119.25 134.66 23.71 Favored Pre-proline 0 C--O 1.243 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 110.142 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.66 123.81 12.26 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.172 1.915 . . . . 0.0 110.795 164.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -98.12 156.64 16.57 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -82.12 107.49 14.86 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.547 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 11.8 mtp -105.16 112.54 25.7 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 m -101.79 120.41 40.32 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.077 0.551 . . . . 0.0 110.213 -163.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -94.89 124.19 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.056 0.942 . . . . 0.0 110.18 -172.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -124.29 111.56 15.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.574 1.15 . . . . 0.0 108.232 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.41 166.87 36.73 Favored Glycine 0 N--CA 1.463 0.485 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -68.89 146.88 52.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.021 0.528 . . . . 0.0 111.898 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.4 -24.75 67.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.274 1.029 . . . . 0.0 112.962 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.41 -13.39 59.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.669 0.387 . . . . 0.0 111.877 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.79 0.02 16.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -25.12 67.08 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.339 0.518 . . . . 0.0 112.165 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -36.43 83.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -80.47 -36.08 33.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.457 0.703 . . . . 0.0 110.923 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.79 -53.02 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.524 0.73 . . . . 0.0 109.799 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.9 t -70.71 -25.16 62.83 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.108 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.6 t70 -60.8 -49.53 77.1 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.0 mm100 -66.14 -38.51 88.31 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.159 0.912 . . . . 0.0 111.638 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.53 -62.66 1.39 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.715 0.635 . . . . 0.0 110.012 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.68 -19.1 65.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.38 1.072 . . . . 0.0 112.635 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 23.8 ttmm -51.39 -46.63 62.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.914 0.885 . . . . 0.0 110.889 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -95.94 -23.7 16.74 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.522 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 8.27 11.15 Favored Glycine 0 N--CA 1.475 1.263 0 N-CA-C 113.669 0.228 . . . . 0.0 113.669 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB3' HD11 ' A' ' 63' ' ' LEU . 49.8 m-85 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -75.79 -31.51 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.057 0.943 . . . . 0.0 109.855 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -70.44 -44.29 68.16 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.312 1.445 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -85.7 122.64 30.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.47 165.02 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.816 1.246 . . . . 0.0 110.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' GLY . 5.9 tt -82.75 111.35 18.61 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -74.65 -36.02 62.86 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.491 0.717 . . . . 0.0 111.132 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 163.94 177.32 36.62 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.54 -171.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 p -112.83 149.32 33.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.303 0.641 . . . . 0.0 110.552 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.12 146.52 50.68 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.604 0.762 . . . . 0.0 110.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' PRO . 98.1 mtt180 -86.08 90.28 8.07 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.272 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.73 1.59 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.977 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -79.07 100.42 7.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.041 0.536 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.58 142.03 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 O-C-N 123.618 0.574 . . . . 0.0 109.541 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.04 154.23 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.944 0.898 . . . . 0.0 112.062 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.78 82.0 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.258 0.349 . . . . 0.0 113.66 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.09 -17.57 53.29 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.901 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.549 HH12 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -61.51 -14.49 29.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.363 1.065 . . . . 0.0 113.53 -177.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.777 ' HA ' HG13 ' A' ' 76' ' ' VAL . 44.9 p90 -60.21 -39.7 87.49 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.223 0.535 . . . . 0.0 111.509 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -71.71 -20.2 61.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.12 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 m -99.23 6.36 46.34 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.651 0.781 . . . . 0.0 111.502 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.27 55.84 0.59 Allowed Glycine 0 C--N 1.367 2.299 0 C-N-CA 120.362 -0.923 . . . . 0.0 115.398 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 72' ' ' TYR . 8.1 m -40.46 155.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 134' ' ' VAL . 19.5 m -115.57 159.78 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.335 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -85.27 -167.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.33 1.052 . . . . 0.0 111.659 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -73.83 151.65 40.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.305 0.642 . . . . 0.0 111.562 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 61.24 8.19 1.96 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.723 1.209 . . . . 0.0 113.595 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.68 133.29 40.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.59 0.756 . . . . 0.0 110.754 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 76.9 mtp -94.09 150.01 20.72 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.413 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.02 166.18 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.761 1.224 . . . . 0.0 109.354 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.68 140.88 48.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.635 1.174 . . . . 0.0 108.567 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.486 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.7 mp -97.12 132.41 42.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -150.32 133.36 16.15 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.6 ptt180 -69.98 145.27 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.097 0.475 . . . . 0.0 110.115 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -89.6 125.12 62.35 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.883 0.873 . . . . 0.0 111.288 -167.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.43 -19.84 24.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.203 2.602 . . . . 0.0 113.283 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -93.9 18.79 9.86 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.181 0.992 . . . . 0.0 110.315 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.6 p30 -51.37 137.06 30.82 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.142 1.377 . . . . 0.0 113.528 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 2.9 Cg_exo -79.01 -41.22 0.23 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.471 2.114 . . . . 0.0 112.453 172.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.32 -53.1 4.23 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.981 0.512 . . . . 0.0 111.448 -168.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -173.3 159.69 3.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.379 1.072 . . . . 0.0 108.476 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 18.4 ptpt -57.68 -25.6 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.55 4.71 23.44 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.37 103.85 1.73 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 64.6 mt -82.91 121.6 36.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.043 -172.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 37.6 ttmt -100.09 127.93 46.24 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.092 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.18 130.68 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.058 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -120.87 154.41 35.87 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -90.1 -171.52 3.16 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.026 0.83 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.97 -34.07 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.814 0.846 . . . . 0.0 112.505 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -77.68 -22.79 49.99 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.933 0.893 . . . . 0.0 111.065 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.37 4.36 58.38 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.74 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.57 125.36 24.0 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.426 0.691 . . . . 0.0 110.013 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.576 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 75.8 mt-30 -71.0 100.86 2.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.021 0.928 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.549 ' HB ' HH12 ' A' ' 71' ' ' ARG . 34.1 m -91.71 -2.66 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.381 0.672 . . . . 0.0 112.188 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.75 165.68 12.21 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 123.239 0.337 . . . . 0.0 112.553 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.8 m-70 -76.21 150.4 37.08 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.812 0.445 . . . . 0.0 110.125 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -70.7 -52.99 17.44 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 5.0 tmtp? 162.54 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -30.17 68.9 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.609 0.763 . . . . 0.0 112.81 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 38.8 tt0 -75.04 -54.92 6.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.88 0.872 . . . . 0.0 110.852 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.578 0.751 . . . . 0.0 109.784 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.83 92.24 Favored 'General case' 0 C--O 1.208 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.665 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.52 -35.61 80.95 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 124.141 0.901 . . . . 0.0 113.89 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.49 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . . . -67.53 -50.15 60.03 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.199 0.523 . . . . 0.0 110.06 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -77.94 -14.03 59.68 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.4 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.76 -47.3 64.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.378 1.471 . . . . 0.0 113.23 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -68.83 -32.33 71.95 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.705 0.802 . . . . 0.0 110.548 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.456 HD13 HG13 ' A' ' 160' ' ' VAL . 51.4 mt -66.03 -42.58 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.002 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.7 tpp -74.15 -37.55 64.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.678 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.95 -44.87 46.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.643 1.177 . . . . 0.0 110.863 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -99.07 5.45 46.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.057 0.543 . . . . 0.0 111.884 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 59.19 33.87 22.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.173 0.989 . . . . 0.0 112.057 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.23 -36.59 84.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.05 155.68 16.42 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.822 0.849 . . . . 0.0 110.833 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -82.01 139.44 34.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.779 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.53 125.16 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.76 148.46 43.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.205 1.002 . . . . 0.0 109.597 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -129.89 176.25 18.75 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 122.946 0.153 . . . . 0.0 113.381 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 12.4 t -142.79 141.63 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.092 1.357 . . . . 0.0 108.121 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 77' ' ' VAL . 6.5 m -103.98 86.06 1.17 Allowed Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.015 0.926 . . . . 0.0 108.977 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.24 -51.32 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.666 2.244 . . . . 0.0 113.408 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 138' ' ' ALA . 37.7 t80 -70.86 -26.71 63.38 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.91 0.484 . . . . 0.0 110.501 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.67 19.53 79.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.513 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' ' HD2' ' A' ' 136' ' ' PHE . . . -61.4 -17.48 54.35 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.283 0.633 . . . . 0.0 111.442 175.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 77' ' ' VAL . 5.2 t30 -48.44 -31.8 6.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.012 1.725 . . . . 0.0 112.847 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.44 -44.96 81.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 0.0 111.002 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.17 -64.35 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.172 0.589 . . . . 0.0 111.529 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -119.54 143.59 47.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.267 1.027 . . . . 0.0 109.741 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 p -93.48 109.18 20.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.025 0.917 . . . . 0.0 109.129 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 165.84 12.68 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.343 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 20.2 Cg_exo -67.24 122.05 9.27 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 121.486 1.457 . . . . 0.0 110.676 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.96 149.9 22.97 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.586 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 58.2 mtt -103.34 164.08 11.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 0.0 109.524 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -148.79 144.59 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.301 1.04 . . . . 0.0 109.07 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -105.18 128.38 53.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.806 0.842 . . . . 0.0 109.394 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -129.06 102.81 6.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.379 1.072 . . . . 0.0 109.631 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.32 178.95 37.93 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.57 142.91 58.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 117.48 0.64 . . . . 0.0 111.895 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.64 -34.78 27.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 113.631 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.51 -26.72 61.01 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -85.55 2.86 43.16 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.845 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -34.89 79.09 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.981 0.355 . . . . 0.0 110.26 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -26.78 56.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.88 0.872 . . . . 0.0 111.309 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -73.7 -52.32 13.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 122' ' ' ILE . 49.9 t -57.02 -43.12 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.928 1.291 . . . . 0.0 111.777 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.6 p -64.95 -33.94 77.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.921 0.489 . . . . 0.0 111.385 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 20.5 t70 -67.26 -32.94 74.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.688 0.618 . . . . 0.0 110.48 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 8.1 mm100 -73.33 -25.81 60.78 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 95.9 mt -76.51 -39.51 52.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.531 0.733 . . . . 0.0 110.253 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 8.7 mtpm? -59.96 -22.22 62.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.297 1.039 . . . . 0.0 111.992 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 118' ' ' ALA . 40.2 ttmt -54.0 -49.95 67.7 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 111.24 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -100.18 0.1 39.84 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.686 0.394 . . . . 0.0 111.082 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.59 35.95 24.32 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 116.802 -0.181 . . . . 0.0 112.82 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 25.8 m-85 . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 123.576 0.75 . . . . 0.0 110.808 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.688 -0.116 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.04 -37.06 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.405 0.682 . . . . 0.0 109.809 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.65 -34.86 78.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.535 1.134 . . . . 0.0 111.018 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -79.39 130.32 35.31 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.234 0.614 . . . . 0.0 109.487 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.19 156.42 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.843 0.857 . . . . 0.0 111.873 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 61' ' ' GLY . 6.0 tt -81.08 105.6 12.42 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.7 m-85 -73.66 -30.36 62.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.943 0.497 . . . . 0.0 110.601 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 148.46 -170.61 28.96 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -175.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.6 m -129.19 118.39 22.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.07 175.04 10.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HB2' ' HB2' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -126.64 97.89 5.18 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.828 0.823 . . . . 0.0 108.848 174.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.08 124.81 7.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.691 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -88.6 119.41 29.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.741 0.817 . . . . 0.0 110.358 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.73 140.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 46.8 t -72.35 139.49 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.82 58.43 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.253 -0.43 . . . . 0.0 113.895 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -23.43 67.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 111.276 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' THR . 3.5 mpt_? -75.52 -1.2 23.17 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.28 1.032 . . . . 0.0 111.817 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -45.33 -32.9 2.21 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.16 -18.03 65.1 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.792 1.237 . . . . 0.0 112.565 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 71' ' ' ARG . 14.7 t -73.78 -20.62 60.43 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.122 0.569 . . . . 0.0 110.973 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.63 48.6 0.54 Allowed Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.55 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.14 165.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 121.489 0.662 . . . . 0.0 111.524 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 18.1 m -115.52 171.84 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.238 -171.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -104.83 -166.78 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -63.19 149.52 45.19 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.569 0.747 . . . . 0.0 111.446 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 8.6 t30 77.17 -18.54 0.48 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.55 1.54 . . . . 0.0 112.337 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.3 mm-40 -62.56 141.78 58.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.4 mtp -105.06 143.74 32.82 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.969 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 18.2 m -129.57 132.32 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 109.795 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.42 142.25 28.75 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 109.686 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.624 HD11 ' SD ' ' A' ' 148' ' ' MET . 5.7 mp -90.68 121.14 32.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.858 0.863 . . . . 0.0 108.948 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -125.91 121.54 33.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -60.62 121.91 13.38 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -70.45 122.77 87.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.133 -163.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -20.35 36.71 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.693 2.262 . . . . 0.0 112.243 172.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -101.36 24.9 8.93 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.149 0.979 . . . . 0.0 110.667 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.81 126.75 72.74 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.588 0.755 . . . . 0.0 111.67 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.0 -24.17 6.03 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.462 2.108 . . . . 0.0 113.862 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.52 -56.08 1.99 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.228 -0.295 . . . . 0.0 111.362 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 6.4 m-20 -150.49 153.63 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.29 -14.65 57.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.863 0.865 . . . . 0.0 112.476 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.574 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 16.4 p-10 -70.3 -20.24 63.03 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.614 0.766 . . . . 0.0 111.638 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.99 109.38 3.44 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.293 0.637 . . . . 0.0 109.311 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 86.7 mt -85.09 119.51 33.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.685 0.794 . . . . 0.0 109.867 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -83.48 116.53 22.58 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG12 ' HB ' ' A' ' 83' ' ' VAL . 10.3 t -85.56 128.56 39.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -122.98 143.15 50.11 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 28.3 p-10 -82.72 -167.94 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.248 0.931 . . . . 0.0 111.259 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.34 -31.18 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.464 1.106 . . . . 0.0 112.773 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -83.93 -27.41 28.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.532 0.733 . . . . 0.0 111.05 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.18 6.53 48.16 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.582 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -66.5 120.96 14.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.801 0.84 . . . . 0.0 110.26 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -60.18 107.42 0.64 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 110.833 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.58 2.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 0.0 111.449 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 134.13 -145.69 17.73 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 173.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.13 158.51 43.46 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.034 0.934 . . . . 0.0 109.862 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD11 ' HE3' ' A' ' 148' ' ' MET . 29.1 mt -87.89 8.46 26.0 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.813 0.845 . . . . 0.0 112.456 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 69.63 129.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.558 1.143 . . . . 0.0 110.074 -172.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -44.13 -39.16 4.1 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.188 1.395 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -62.22 -54.61 38.44 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.334 1.054 . . . . 0.0 112.281 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.424 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 10.4 tt -75.08 -47.81 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.444 0.64 . . . . 0.0 110.031 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.437 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -54.92 -34.47 63.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.579 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -55.07 -37.41 63.28 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.024 0.828 . . . . 0.0 115.004 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.74 -51.49 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.976 0.51 . . . . 0.0 110.523 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 122' ' ' ILE . 30.1 mt -73.77 -20.06 60.6 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.745 -172.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.43 64.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.766 0.826 . . . . 0.0 111.896 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.22 -36.77 77.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.493 HD13 HG13 ' A' ' 160' ' ' VAL . 64.1 mt -61.82 -37.11 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 110.763 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.3 ttm -79.23 -51.17 9.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.452 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.0 -39.38 69.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.379 1.072 . . . . 0.0 111.108 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -90.57 1.64 56.55 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 62.74 43.1 7.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.413 1.085 . . . . 0.0 111.768 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 122' ' ' ILE . 45.6 mt -76.75 -48.05 19.88 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.642 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.47 149.68 27.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.198 0.599 . . . . 0.0 110.721 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -89.45 106.69 18.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.045 0.938 . . . . 0.0 109.309 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -93.89 124.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.98 160.84 14.72 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.47 144.81 15.6 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.3 t -137.7 126.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.65 90.42 5.04 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 64.9 Cg_endo -83.82 -18.7 5.35 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.519 2.146 . . . . 0.0 113.003 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -79.44 -32.63 42.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.762 0.425 . . . . 0.0 110.816 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.85 17.07 20.31 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.853 0.721 . . . . 0.0 114.599 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -84.26 0.74 47.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.608 0.763 . . . . 0.0 111.384 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -64.11 -26.4 68.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.653 1.181 . . . . 0.0 110.878 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.51 -30.35 63.05 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.695 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.5 11.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.277 0.631 . . . . 0.0 111.718 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -158.35 -168.64 2.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.545 0.738 . . . . 0.0 110.289 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.8 p -94.55 120.6 35.04 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.516 0.727 . . . . 0.0 109.066 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 ppp? -147.45 156.88 45.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.006 0.922 . . . . 0.0 109.743 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.581 ' HB2' ' HB2' ' A' ' 64' ' ' ARG . 26.9 Cg_endo -92.84 144.36 2.37 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.516 2.144 . . . . 0.0 113.531 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -107.38 153.91 22.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -79.73 109.57 14.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.759 0.314 . . . . 0.0 111.223 -170.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.624 ' SD ' HD11 ' A' ' 85' ' ' LEU . 22.0 mmt -89.85 110.23 21.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.896 0.878 . . . . 0.0 108.837 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m -103.46 125.25 49.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 31.5 m-85 -89.05 120.44 30.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 109.251 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.47 101.76 7.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.88 159.66 29.46 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.19 145.58 46.6 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.267 0.627 . . . . 0.0 112.614 -175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.45 -30.78 61.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.014 1.326 . . . . 0.0 113.468 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.34 -29.62 65.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.914 0.485 . . . . 0.0 111.472 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -88.66 9.8 22.92 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.285 0.634 . . . . 0.0 111.933 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 158' ' ' LYS . 11.7 ptp180 -54.93 -45.18 74.8 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.591 0.356 . . . . 0.0 111.601 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -78.94 -26.57 43.62 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.631 0.372 . . . . 0.0 111.333 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.24 89.76 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.041 0.536 . . . . 0.0 110.325 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 HD13 ' A' ' 122' ' ' ILE . 70.1 t -70.45 -45.29 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.489 1.116 . . . . 0.0 110.726 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.515 ' HB3' ' HE3' ' A' ' 165' ' ' LYS . 67.2 m -64.52 -32.15 73.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.26 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.98 -42.43 76.3 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.774 0.83 . . . . 0.0 110.865 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.05 -38.23 78.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.857 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.11 -55.43 16.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.798 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 161' ' ' SER . 93.7 mttt -56.9 -29.04 62.66 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.749 1.22 . . . . 0.0 111.993 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.08 -41.02 97.75 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.855 0.862 . . . . 0.0 111.54 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.13 3.6 25.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.768 0.427 . . . . 0.0 110.615 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.95 20.65 77.55 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.932 -0.371 . . . . 0.0 113.364 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.424 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 32.2 m-85 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.939 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -70.55 -34.76 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 168.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -47.19 48.54 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.928 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.2 m -82.69 115.04 21.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.648 0.779 . . . . 0.0 111.005 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 154' ' ' GLU . 14.3 m -107.71 162.94 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.256 1.022 . . . . 0.0 110.978 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.14 116.19 22.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.118 0.567 . . . . 0.0 109.793 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -79.43 -24.78 42.25 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.923 0.489 . . . . 0.0 110.567 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.03 -170.39 24.58 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.26 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.44 ' HB3' HG22 ' A' ' 149' ' ' THR . 22.5 p -123.1 121.35 35.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.073 0.549 . . . . 0.0 110.383 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.8 tp -80.12 145.87 32.15 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 109.876 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -76.16 85.87 3.01 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -74.2 163.96 54.61 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -141.32 91.75 2.41 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.529 1.165 . . . . 0.0 110.088 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 108' ' ' VAL . 98.9 t -76.51 127.77 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 167.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 24.9 t -68.32 141.73 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 123.737 0.648 . . . . 0.0 110.542 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.79 -44.98 23.47 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.539 0.524 . . . . 0.0 113.747 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.85 -15.79 55.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.473 0.709 . . . . 0.0 112.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HG2' ' HB ' ' A' ' 68' ' ' VAL . 36.6 mmt180 -73.81 -0.46 15.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.924 0.889 . . . . 0.0 112.54 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.484 ' HA ' HG13 ' A' ' 76' ' ' VAL . 42.5 p90 -50.72 -23.83 2.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.376 1.071 . . . . 0.0 113.843 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.72 -7.65 22.51 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.424 1.089 . . . . 0.0 112.71 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 p -73.23 -33.48 65.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.265 0.626 . . . . 0.0 109.912 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.59 48.05 0.52 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 72' ' ' TYR . 27.5 m -55.3 167.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.626 0.77 . . . . 0.0 112.268 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 m -114.12 163.88 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.27 0.628 . . . . 0.0 110.796 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -74.67 -172.19 1.47 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.312 1.045 . . . . 0.0 111.711 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -65.14 149.04 50.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.871 . . . . 0.0 111.95 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 64.88 10.75 6.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.957 1.303 . . . . 0.0 113.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.74 143.11 32.06 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.13 0.423 . . . . 0.0 111.154 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.2 mtp -83.08 145.5 29.23 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.705 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 146' ' ' LEU . 29.4 m -134.27 145.0 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.017 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.98 125.02 53.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.675 0.79 . . . . 0.0 109.895 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -90.14 138.42 31.53 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.982 0.913 . . . . 0.0 109.749 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -147.73 138.7 23.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.6 ptm180 -67.09 158.33 31.4 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.579 0.228 . . . . 0.0 110.568 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -87.99 116.06 65.0 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 123.103 0.561 . . . . 0.0 110.647 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.28 -39.06 5.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.275 1.983 . . . . 0.0 110.493 168.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -88.88 71.14 8.63 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 170.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.44 134.49 86.7 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.34 -42.16 4.11 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.961 2.44 . . . . 0.0 112.519 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -126.3 -52.79 1.5 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.461 0.704 . . . . 0.0 110.014 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -146.85 165.74 28.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.704 0.802 . . . . 0.0 109.95 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.12 -5.49 18.08 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.237 1.015 . . . . 0.0 112.581 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 1.9 m-20 -77.13 9.69 2.88 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.594 1.158 . . . . 0.0 112.586 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -93.39 139.37 30.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.479 0.712 . . . . 0.0 110.208 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 54.5 mt -127.07 120.42 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.36 1.064 . . . . 0.0 109.133 175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -87.47 115.37 24.85 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.439 0.695 . . . . 0.0 109.854 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' HG ' ' A' ' 85' ' ' LEU . 53.0 t -87.1 126.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 14.9 m-80 -117.65 164.67 14.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -95.7 -170.77 2.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.69 -22.59 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -86.64 -3.08 58.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.219 1.008 . . . . 0.0 111.908 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.68 86.08 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 122.945 0.307 . . . . 0.0 113.491 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -76.84 134.17 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.633 0.773 . . . . 0.0 108.986 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.9 pt20 -71.58 127.42 32.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 122.303 1.049 . . . . 0.0 111.662 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 67' ' ' VAL . 93.0 t -78.06 -24.79 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.177 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.41 -168.19 28.48 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.99 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -117.23 148.97 41.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 52.2 mt -75.33 -6.29 49.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.233 0.613 . . . . 0.0 112.26 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 68.74 141.86 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.262 1.025 . . . . 0.0 110.229 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -21.29 3.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -62.57 -63.03 1.35 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.071 0.948 . . . . 0.0 110.702 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.1 tt -80.36 -50.56 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.094 0.557 . . . . 0.0 109.597 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -52.8 -33.37 48.72 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.049 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -55.49 -43.48 85.43 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.105 0.878 . . . . 0.0 114.814 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.97 -48.74 72.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.23 0.538 . . . . 0.0 110.624 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.95 -18.24 60.91 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.625 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.48 91.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.12 0.968 . . . . 0.0 111.788 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -68.06 -40.78 82.7 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.549 0.531 . . . . 0.0 109.618 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 127' ' ' LEU . 55.3 mt -63.79 -37.41 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.587 0.755 . . . . 0.0 110.75 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.6 tpp -70.75 -52.61 19.7 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.16 -32.51 73.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.619 1.567 . . . . 0.0 111.689 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.28 -2.57 36.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.026 0.531 . . . . 0.0 111.278 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 61.13 32.51 19.62 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.898 0.879 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 122' ' ' ILE . 67.0 mt -63.39 -44.66 94.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.515 0.726 . . . . 0.0 110.145 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.45 142.23 21.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.288 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.03 107.85 5.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.479 1.112 . . . . 0.0 109.281 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.8 mt -99.36 104.83 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.4 178.72 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.21 168.76 32.01 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.466 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 63.9 t -141.36 125.73 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.43 100.66 2.43 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.46 -44.33 2.35 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.837 2.358 . . . . 0.0 113.812 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.47 -23.9 14.96 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 0.0 111.285 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.48 27.66 71.2 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.304 0.377 . . . . 0.0 113.547 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -81.29 4.82 19.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.475 0.71 . . . . 0.0 112.174 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 93.4 m-20 -63.43 -9.51 12.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.078 0.951 . . . . 0.0 112.004 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -64.42 -42.14 96.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.916 0.887 . . . . 0.0 111.008 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.8 -60.9 1.47 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.827 0.851 . . . . 0.0 111.147 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 84.6 m-85 -139.48 -173.62 3.66 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.875 . . . . 0.0 109.444 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 t -93.04 134.91 34.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 4.4 ppp? -137.95 153.12 73.32 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.706 0.802 . . . . 0.0 109.96 -172.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 21.4 Cg_exo -67.46 122.09 9.27 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.17 1.914 . . . . 0.0 112.637 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.496 HD22 ' HE2' ' A' ' 148' ' ' MET . 6.5 tt -100.91 124.54 46.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -80.17 110.16 15.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -172.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.597 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -112.81 116.32 29.88 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -171.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 62' ' ' SER . 37.8 p -102.71 133.68 47.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.95 1.3 . . . . 0.0 110.306 -165.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -100.95 117.76 35.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.834 0.853 . . . . 0.0 109.166 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -119.19 99.05 6.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.417 0.687 . . . . 0.0 109.508 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 163.44 31.73 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 146.47 24.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 111.655 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG2' HG21 ' A' ' 58' ' ' VAL . 44.6 mt-10 -58.97 -18.78 37.09 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.36 -32.31 43.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.087 0.403 . . . . 0.0 111.296 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -77.9 -6.92 55.88 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -57.95 -27.79 63.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.219 0.463 . . . . 0.0 110.791 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.78 -53.2 59.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.12 0.968 . . . . 0.0 109.138 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.88 -30.97 65.96 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.97 0.908 . . . . 0.0 112.081 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD13 ' A' ' 122' ' ' ILE . 56.1 t -71.13 -55.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.157 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.2 t -66.1 -22.69 66.41 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.903 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.22 -44.56 92.3 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.085 0.554 . . . . 0.0 110.307 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -79.51 -30.14 41.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.237 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.69 -61.01 2.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.85 -21.1 65.7 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.752 1.221 . . . . 0.0 112.101 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -53.45 -46.51 69.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.653 0.781 . . . . 0.0 110.493 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -99.72 -16.91 17.98 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.129 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.47 16.77 21.61 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 116.554 -0.294 . . . . 0.0 113.177 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 122.825 0.45 . . . . 0.0 110.095 170.792 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.952 0.406 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.42 -22.16 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.642 0.777 . . . . 0.0 110.444 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -72.94 -46.65 51.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.271 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -80.19 113.88 18.69 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 154' ' ' GLU . 13.8 m -107.19 156.43 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.148 0.979 . . . . 0.0 111.327 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.79 109.6 14.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.445 0.698 . . . . 0.0 109.762 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 26.6 m-85 -74.38 -36.23 63.53 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 110.972 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.64 -176.03 36.44 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.769 0.668 . . . . 0.0 112.558 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 148' ' ' MET . 49.4 p -115.92 122.35 45.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.119 0.968 . . . . 0.0 110.532 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 169' ' ' PHE . 48.2 tp -99.86 137.46 38.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.941 0.496 . . . . 0.0 109.711 173.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -90.78 83.98 5.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -75.21 153.07 44.43 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.469 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -116.47 111.05 19.43 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.832 1.316 . . . . 0.0 109.978 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 111' ' ' LEU . 2.5 t -94.68 157.32 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.083 0.953 . . . . 0.0 109.118 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' HIS . 30.5 m -76.05 161.94 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.83 -17.74 74.34 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.326 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.7 -18.42 30.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.308 1.043 . . . . 0.0 111.431 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.683 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 63.8 mtp180 -49.86 -33.31 16.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.394 1.078 . . . . 0.0 113.204 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.27 -43.87 92.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.217 0.607 . . . . 0.0 110.628 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -71.62 -35.49 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.457 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -74.95 -16.93 60.62 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.089 0.555 . . . . 0.0 111.798 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.76 54.3 0.54 Allowed Glycine 0 C--N 1.357 1.713 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.282 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.3 m -40.9 164.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 19.3 m -114.51 167.16 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.527 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.38 -79.27 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.309 0.644 . . . . 0.0 111.825 -170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.6 154.15 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.789 0.835 . . . . 0.0 110.308 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.79 28.56 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.943 1.297 . . . . 0.0 111.83 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 49.8 mm-40 -87.25 142.82 27.62 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.327 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 78.0 mtp -99.76 127.88 45.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 102' ' ' ASN . 35.6 m -118.04 163.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.294 1.038 . . . . 0.0 108.997 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.48 128.41 47.98 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' A' ' 98' ' ' ILE . 12.8 mt -80.18 112.01 17.09 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -123.78 115.12 20.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 108.316 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 37.2 ptt180 -57.03 133.82 55.28 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 121.106 0.479 . . . . 0.0 110.925 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.2 118.94 57.86 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.138 -161.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.667 2.245 . . . . 0.0 112.039 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -111.08 32.38 5.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.422 1.089 . . . . 0.0 109.73 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.41 127.3 65.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.877 0.871 . . . . 0.0 111.773 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.37 -48.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.033 1.822 . . . . 0.0 113.011 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -99.04 -50.5 4.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.792 0.437 . . . . 0.0 110.524 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -159.59 156.57 28.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.17 0.588 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -7.26 12.63 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.519 1.528 . . . . 0.0 113.559 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.582 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 26.1 p-10 -64.13 -30.7 71.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.003 0.521 . . . . 0.0 111.584 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.06 125.85 25.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.892 0.745 . . . . 0.0 109.239 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 70.5 mt -113.2 127.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 109.647 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 151.17 32.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 172.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.1 t -110.58 120.46 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.748 1.219 . . . . 0.0 107.854 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -119.06 127.46 53.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HA ' HG12 ' A' ' 83' ' ' VAL . 35.4 p-10 -71.93 -173.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.392 0.677 . . . . 0.0 112.385 -175.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.78 -31.9 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 C-N-CA 124.147 0.979 . . . . 0.0 112.293 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.73 -31.83 63.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.642 0.777 . . . . 0.0 111.053 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.68 -3.38 42.32 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.342 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -67.72 136.54 54.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.117 0.967 . . . . 0.0 110.836 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.5 pm0 -67.1 117.74 9.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.19 -2.38 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.385 0.674 . . . . 0.0 111.644 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 71' ' ' ARG . . . 152.59 -177.15 30.48 Favored Glycine 0 C--N 1.36 1.913 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 172.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 68' ' ' VAL . 55.6 m-70 -108.95 151.32 26.46 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HA ' HG13 ' A' ' 67' ' ' VAL . 52.0 mt -72.58 -55.03 7.54 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.581 0.628 . . . . 0.0 112.386 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 147.31 143.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.241 1.816 . . . . 0.0 106.104 -162.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.506 ' HG2' HD21 ' A' ' 96' ' ' ASN . 5.5 tmmm? -65.83 -41.41 91.83 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.861 0.464 . . . . 0.0 109.97 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.63 -52.67 42.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.802 0.841 . . . . 0.0 111.384 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 111' ' ' LEU . 62.6 tp -59.78 -57.12 14.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.12 70.15 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.994 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -60.69 -42.54 99.38 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.631 0.582 . . . . 0.0 113.307 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.73 71.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.36 0.664 . . . . 0.0 110.163 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 130' ' ' ILE . 61.3 mt -71.79 -17.79 62.15 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.17 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.33 77.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.372 1.069 . . . . 0.0 112.042 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.07 -35.76 64.28 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.063 0.545 . . . . 0.0 109.629 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 127' ' ' LEU . 51.6 mt -65.1 -36.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.39 0.614 . . . . 0.0 110.02 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 123' ' ' MET . 41.1 tpp -70.23 -44.21 69.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.913 1.285 . . . . 0.0 111.099 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.65 -48.71 24.73 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.263 -173.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -91.05 5.83 47.32 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.619 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 60.62 34.66 20.11 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.048 0.939 . . . . 0.0 111.641 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' HB2' HG23 ' A' ' 122' ' ' ILE . 81.8 mt -65.92 -41.56 91.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.583 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.66 141.39 8.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 110.269 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.23 107.48 14.06 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 HD22 ' A' ' 119' ' ' LEU . 18.6 mt -92.49 117.82 36.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -85.79 166.21 16.25 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -130.53 143.86 15.21 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 170.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.85 130.85 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.697 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.4 p -118.15 85.71 24.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.48 -38.68 0.67 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.642 2.228 . . . . 0.0 113.535 -171.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.38 -29.73 65.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.964 0.506 . . . . 0.0 110.384 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.31 17.23 68.1 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.57 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.99 9.94 4.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.111 0.965 . . . . 0.0 112.39 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 140' ' ' ASN . 0.2 OUTLIER -66.0 -21.27 66.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.699 0.799 . . . . 0.0 111.547 172.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 139' ' ' ASN . 5.3 t30 -75.66 -46.74 29.66 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 110.014 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.82 12.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.336 0.655 . . . . 0.0 111.663 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.11 -166.26 1.74 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.171 0.988 . . . . 0.0 110.129 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p -96.11 117.8 31.44 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.697 ' SD ' HG23 ' A' ' 134' ' ' VAL . 22.3 ptm -115.56 157.56 43.94 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.838 0.455 . . . . 0.0 111.27 -173.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.7 Cg_endo -71.1 124.84 10.87 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.319 2.012 . . . . 0.0 112.835 173.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.416 HD23 ' HE2' ' A' ' 148' ' ' MET . 24.6 tp -85.9 117.62 24.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.324 1.05 . . . . 0.0 108.792 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -75.33 107.77 7.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' SER . 64.4 mtt -106.23 137.74 43.65 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.964 0.906 . . . . 0.0 109.961 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.6 p -126.35 116.9 21.92 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -85.4 118.6 25.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.795 0.838 . . . . 0.0 109.292 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -122.68 101.41 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.665 0.786 . . . . 0.0 109.139 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.62 31.21 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.799 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 138.43 29.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.588 1.155 . . . . 0.0 112.427 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.471 ' HG2' HG21 ' A' ' 58' ' ' VAL . 42.0 mt-10 -58.92 -22.17 59.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 112.988 -175.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.34 -18.03 64.99 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.195 0.598 . . . . 0.0 112.056 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -44.0 75.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -167.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -24.64 51.32 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.578 0.351 . . . . 0.0 111.211 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.11 -35.21 61.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.839 0.455 . . . . 0.0 110.52 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.0 -50.63 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.032 0.933 . . . . 0.0 110.375 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p -66.94 -31.82 72.66 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.153 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.46 -39.7 67.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.215 0.606 . . . . 0.0 111.531 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -69.25 -37.35 77.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.946 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.2 mt -69.33 -55.48 10.3 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.587 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -54.64 -32.57 59.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.258 1.423 . . . . 0.0 112.134 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.08 -44.34 83.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -98.66 -15.3 19.47 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.434 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.31 9.48 50.89 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.8 m-85 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.332 0.653 . . . . 0.0 110.713 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 -30.69 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.39 -26.93 52.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.665 1.186 . . . . 0.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -61.78 149.39 40.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.787 0.835 . . . . 0.0 112.142 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.23 162.63 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.603 1.161 . . . . 0.0 110.064 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 tp -85.81 117.13 24.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.948 0.499 . . . . 0.0 110.22 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 24.8 m-85 -82.18 -34.03 29.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.994 0.518 . . . . 0.0 110.71 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.93 -166.63 33.04 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.932 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.9 p -115.1 169.22 9.27 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.666 0.787 . . . . 0.0 110.837 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 tp -147.8 139.04 23.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.293 0.637 . . . . 0.0 109.394 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -76.35 93.73 3.51 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.077 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.43 81.3 1.23 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.484 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -71.75 114.32 9.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -107.45 135.61 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.915 0.886 . . . . 0.0 109.189 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.82 151.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 124.506 1.122 . . . . 0.0 111.277 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.87 -21.7 31.26 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.19 -16.52 45.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.873 0.869 . . . . 0.0 112.067 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.746 HH12 HG22 ' A' ' 143' ' ' THR . 34.1 ptt-85 -49.74 -27.94 5.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.777 1.631 . . . . 0.0 113.227 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -63.31 -48.53 77.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.864 0.466 . . . . 0.0 110.262 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.26 -28.98 67.68 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.575 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.6 m -74.66 -24.86 58.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.811 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.88 53.76 0.33 Allowed Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.483 -0.62 . . . . 0.0 114.583 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -43.71 165.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.595 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.2 m -115.96 178.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.756 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.448 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -94.91 -82.05 0.38 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.872 0.469 . . . . 0.0 109.757 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -159.34 165.29 33.65 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.948 0.899 . . . . 0.0 109.732 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.581 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 1.9 m-20 64.38 7.6 3.71 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.875 1.27 . . . . 0.0 112.293 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.7 mm-40 -84.87 124.25 31.4 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.332 0.653 . . . . 0.0 110.788 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.6 mtm -88.16 130.35 35.07 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 25.3 m -125.26 126.53 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.753 0.821 . . . . 0.0 110.78 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.66 136.62 33.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.263 1.025 . . . . 0.0 110.229 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.544 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -87.57 141.56 28.52 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.49 0.716 . . . . 0.0 109.596 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -154.05 133.5 12.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 26.9 ptt180 -60.24 131.6 51.3 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 15.5 t70 -84.64 125.1 72.23 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' ASP . 37.6 Cg_exo -61.04 -37.55 75.15 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.307 2.671 . . . . 0.0 113.523 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.92 36.59 4.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.626 0.77 . . . . 0.0 109.732 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 88' ' ' ASP . 21.5 t-20 -63.41 127.73 91.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.95 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.25 -23.32 33.24 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.9 2.4 . . . . 0.0 113.636 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -79.62 -52.15 8.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.7 t70 177.98 156.77 0.39 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.427 1.091 . . . . 0.0 109.951 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -57.14 -33.48 67.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.865 1.266 . . . . 0.0 113.599 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.4 -12.99 58.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.296 0.639 . . . . 0.0 111.883 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.1 128.77 37.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.176 0.591 . . . . 0.0 111.315 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.1 mt -92.95 125.04 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.991 0.917 . . . . 0.0 110.532 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -96.38 126.18 41.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.432 HG12 ' HB ' ' A' ' 83' ' ' VAL . 14.3 t -93.89 143.4 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -127.86 147.3 50.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.629 1.172 . . . . 0.0 108.111 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p-10 -78.8 169.03 18.86 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.047 0.84 . . . . 0.0 110.051 170.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.67 -10.47 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.499 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.1 t-20 -73.12 -22.84 60.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 110.374 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 40.93 5.1 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -122.41 133.09 54.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.788 0.835 . . . . 0.0 109.788 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -63.47 131.35 47.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.332 0.653 . . . . 0.0 110.791 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.29 -32.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.399 0.68 . . . . 0.0 111.817 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.53 -171.65 44.73 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -128.65 139.78 52.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.022 0.929 . . . . 0.0 109.861 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.44 1.98 56.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.499 0.72 . . . . 0.0 111.8 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 67.74 -176.88 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.545 1.138 . . . . 0.0 110.382 -167.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -39.86 45.24 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -51.48 -63.25 1.19 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.279 0.987 . . . . 0.0 112.325 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.21 -39.08 88.9 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.518 0.675 . . . . 0.0 110.748 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.15 -21.62 63.99 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.348 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.22 -15.53 70.06 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.191 0.424 . . . . 0.0 113.412 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.11 -51.99 6.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.931 0.872 . . . . 0.0 109.062 165.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.4 HD22 HD13 ' A' ' 130' ' ' ILE . 60.2 mt -70.44 -17.46 63.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.72 -169.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.71 90.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.276 1.03 . . . . 0.0 111.895 -173.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -75.07 -33.73 61.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.949 0.5 . . . . 0.0 109.9 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.455 HD13 HG13 ' A' ' 160' ' ' VAL . 31.6 mt -70.15 -31.73 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.074 0.549 . . . . 0.0 110.115 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.9 tpp -79.43 -43.3 23.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.026 1.33 . . . . 0.0 110.798 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.25 -50.29 28.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.811 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -88.97 -0.62 57.57 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.427 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 59.59 32.45 21.59 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.653 1.181 . . . . 0.0 111.846 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 122' ' ' ILE . 68.0 mt -59.12 -39.39 82.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.142 0.977 . . . . 0.0 111.405 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.08 132.33 11.89 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.599 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.27 105.64 2.6 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.991 0.916 . . . . 0.0 109.266 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.4 HD13 HD22 ' A' ' 119' ' ' LEU . 12.2 mt -89.83 108.22 19.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.44 146.12 36.44 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -123.31 162.66 17.11 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -149.2 140.59 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.517 1.127 . . . . 0.0 108.033 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.06 87.31 34.0 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 57.4 Cg_endo -88.6 0.2 6.52 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.045 2.496 . . . . 0.0 112.907 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.25 -31.3 20.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.977 0.511 . . . . 0.0 112.009 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.58 -6.52 23.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.64 9.03 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.028 0.914 . . . . 0.0 112.715 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.48 -15.59 61.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.674 1.19 . . . . 0.0 111.367 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.29 -55.19 5.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.945 0.898 . . . . 0.0 111.071 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.71 -61.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.452 0.701 . . . . 0.0 111.641 -171.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 -178.63 3.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.538 0.735 . . . . 0.0 109.823 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.746 HG22 HH12 ' A' ' 71' ' ' ARG . 15.9 p -92.29 109.05 20.42 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -112.24 120.44 41.59 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.716 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.58 125.12 8.73 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.025 1.816 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 148' ' ' MET . 4.5 pp -89.37 146.94 24.34 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -73.36 107.36 5.62 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.127 0.571 . . . . 0.0 110.611 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.546 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 63.2 mtt -97.82 166.81 11.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.751 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.8 p -154.36 146.52 23.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.23 1.012 . . . . 0.0 109.634 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -109.19 120.39 42.39 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.134 0.974 . . . . 0.0 109.477 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -123.87 98.78 5.96 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.637 0.775 . . . . 0.0 109.647 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.31 162.46 30.63 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -55.57 142.57 33.0 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.647 0.779 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.34 -37.9 17.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.774 1.23 . . . . 0.0 113.465 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 158' ' ' LYS . 12.7 pt-20 -65.94 -29.78 70.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.213 0.605 . . . . 0.0 112.171 -174.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.22 4.19 13.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -61.71 -40.5 95.25 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 118.156 0.435 . . . . 0.0 111.31 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -69.31 -25.45 64.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.43 0.692 . . . . 0.0 111.192 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.6 -45.61 15.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.58 0.752 . . . . 0.0 110.567 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 122' ' ' ILE . 67.6 t -65.95 -45.68 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.449 1.1 . . . . 0.0 110.983 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.5 p -66.94 -32.01 72.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.151 0.58 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.46 -47.11 82.73 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.599 0.562 . . . . 0.0 110.838 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.0 mm100 -63.28 -44.27 95.57 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.37 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.23 -52.81 29.93 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.775 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.44 -22.69 66.79 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.798 0.839 . . . . 0.0 112.193 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -53.02 -46.56 68.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.157 0.983 . . . . 0.0 111.141 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -108.24 -11.9 15.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.114 0.966 . . . . 0.0 111.247 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.87 30.58 25.87 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.885 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.759 0.314 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.59 -31.62 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.801 0.84 . . . . 0.0 109.645 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.92 -12.13 57.61 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.056 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.7 m -63.7 133.39 53.5 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.135 0.493 . . . . 0.0 110.717 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.2 m -129.18 163.62 33.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 124.84 1.256 . . . . 0.0 109.061 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.524 HD11 HG22 ' A' ' 149' ' ' THR . 40.3 tp -86.82 117.31 25.48 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -82.72 -31.42 28.48 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.65 -151.89 23.83 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.464 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -132.49 178.96 6.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.484 0.713 . . . . 0.0 110.684 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 39.0 tp -159.01 154.37 25.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.264 0.626 . . . . 0.0 110.186 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 94.69 5.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.978 0.911 . . . . 0.0 108.729 174.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.64 121.33 5.83 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -93.24 100.4 12.77 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.169 0.984 . . . . 0.0 109.751 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 7.9 p -82.88 145.68 8.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.368 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.8 m -65.72 156.02 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.18 0.992 . . . . 0.0 111.472 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 143' ' ' THR . . . -73.18 -23.42 77.6 Favored Glycine 0 N--CA 1.47 0.915 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.091 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt -51.29 -18.2 0.9 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.37 1.468 . . . . 0.0 112.678 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.628 HH12 HG21 ' A' ' 134' ' ' VAL . 13.8 ttt180 -47.19 -32.63 4.56 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.155 1.782 . . . . 0.0 112.755 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 26.0 p90 -63.22 -41.03 99.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.288 0.566 . . . . 0.0 110.933 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -69.53 -27.85 65.52 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.577 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 107' ' ' GLN . 6.0 m -101.48 -4.11 27.39 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.825 -170.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.32 52.56 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.965 172.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -44.42 156.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.2 175.88 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.087 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.78 -173.77 4.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.85 0.86 . . . . 0.0 111.157 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.3 151.45 39.82 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.933 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.57 -0.57 1.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.01 1.324 . . . . 0.0 113.883 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -73.33 128.48 35.61 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.272 0.487 . . . . 0.0 112.303 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.46 ' HG2' HG22 ' A' ' 133' ' ' VAL . 77.4 mtp -79.63 148.22 31.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.719 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.49 HG11 HH22 ' A' ' 71' ' ' ARG . 23.1 m -143.74 146.82 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.617 1.167 . . . . 0.0 108.8 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -97.5 156.07 16.66 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.177 0.991 . . . . 0.0 110.084 175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD12 ' HB ' ' A' ' 130' ' ' ILE . 27.7 mt -89.0 161.58 16.51 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.535 . . . . 0.0 109.636 168.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.56 144.88 18.45 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -80.68 123.28 28.04 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -60.53 109.0 1.68 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.79 -15.17 46.5 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.789 2.326 . . . . 0.0 113.123 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.54 90.81 3.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.03 115.88 22.83 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.12 -51.56 5.43 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.976 2.451 . . . . 0.0 112.624 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.8 -47.28 1.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.68 0.792 . . . . 0.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -122.98 137.92 54.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.522 0.729 . . . . 0.0 109.736 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -57.82 -27.12 62.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.792 1.237 . . . . 0.0 113.232 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.433 HD22 ' HA2' ' A' ' 117' ' ' GLY . 28.3 p-10 -84.86 -1.79 56.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.424 0.689 . . . . 0.0 112.827 -173.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.92 111.08 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.876 0.87 . . . . 0.0 111.19 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 119' ' ' LEU . 66.0 mt -96.03 108.62 21.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 C-N-CA 123.259 0.624 . . . . 0.0 110.118 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 32.2 ttpt -88.91 142.16 27.89 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.393 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.96 143.87 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.761 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 5.7 p30 -130.0 150.98 51.04 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.089 1.356 . . . . 0.0 107.878 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HA ' HG12 ' A' ' 83' ' ' VAL . 28.6 p-10 -90.51 -176.92 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.854 0.752 . . . . 0.0 111.04 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 m -57.83 -29.18 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.581 0.753 . . . . 0.0 112.649 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.84 -18.04 41.82 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.947 0.499 . . . . 0.0 111.245 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.04 50.17 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.042 0.353 . . . . 0.0 113.556 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.38 114.53 4.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.958 0.903 . . . . 0.0 109.174 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 74' ' ' THR . 22.9 pt20 -59.85 105.15 0.35 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.34 -17.81 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.392 0.677 . . . . 0.0 111.376 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.14 158.5 9.94 Favored Glycine 0 N--CA 1.473 1.107 0 O-C-N 122.954 0.159 . . . . 0.0 112.957 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 6.9 p-80 -81.86 154.59 25.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.3 0.64 . . . . 0.0 112.666 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 45.9 mt -70.73 -51.44 27.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.907 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 24.4 ttmm 156.65 145.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.642 1.577 . . . . 0.0 107.204 -166.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -23.59 55.33 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.755 0.707 . . . . 0.0 111.196 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.528 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 37.5 tt0 -74.24 -42.39 59.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.937 0.495 . . . . 0.0 110.569 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -47.54 85.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.93 67.61 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.866 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA2' HD22 ' A' ' 96' ' ' ASN . . . -53.86 -37.57 57.95 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.139 0.4 . . . . 0.0 113.746 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.05 -55.54 4.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.125 0.57 . . . . 0.0 110.475 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 122' ' ' ILE . 11.7 mt -68.16 -17.38 64.32 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.249 -171.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 96' ' ' ASN . . . -56.16 -54.35 46.16 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.556 1.142 . . . . 0.0 111.62 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.54 -29.11 69.12 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.183 0.927 . . . . 0.0 110.76 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 HG13 ' A' ' 160' ' ' VAL . 48.3 mt -68.59 -40.35 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.332 0.653 . . . . 0.0 110.143 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 52.0 ttm -80.1 -28.13 39.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.638 0.775 . . . . 0.0 111.446 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.96 -48.61 20.47 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.536 0.734 . . . . 0.0 110.614 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -95.43 5.25 52.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.547 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 57.45 37.26 27.76 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.44 1.096 . . . . 0.0 111.344 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 70.6 mt -61.01 -52.77 63.59 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.332 -177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 160' ' ' VAL . . . -146.14 161.49 40.08 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.615 0.766 . . . . 0.0 111.023 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -101.18 107.28 18.64 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.129 0.972 . . . . 0.0 108.556 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HD12 ' A' ' 85' ' ' LEU . 27.7 mt -96.56 112.11 28.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -93.4 173.55 7.65 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.74 154.82 24.53 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 82' ' ' MET . 93.7 t -141.87 129.58 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.628 HG21 HH12 ' A' ' 71' ' ' ARG . 61.7 t -99.62 87.16 0.64 Allowed Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 4.5 Cg_exo -76.25 -51.11 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.52 -165.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.416 ' HD2' ' HE3' ' A' ' 144' ' ' MET . 22.7 m-85 -71.81 -27.16 62.74 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.798 0.839 . . . . 0.0 110.844 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.76 18.45 72.28 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.356 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.64 1.95 27.8 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.834 0.853 . . . . 0.0 112.134 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -57.5 -25.73 60.24 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.53 1.532 . . . . 0.0 114.304 -176.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -86.65 -38.65 16.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.606 0.762 . . . . 0.0 111.386 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.65 -20.15 21.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.534 0.734 . . . . 0.0 112.039 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.73 173.08 16.58 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.297 0.639 . . . . 0.0 109.717 -167.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 69' ' ' GLY . 44.7 p -94.36 109.68 21.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE3' ' HD2' ' A' ' 136' ' ' PHE . 23.0 ptm -113.73 155.72 44.66 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 122.935 0.494 . . . . 0.0 111.004 -170.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.89 127.53 4.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.349 2.033 . . . . 0.0 111.369 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -92.75 143.23 26.5 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -69.9 107.41 3.55 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 16.3 mtp -94.78 150.24 20.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.09 130.38 22.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 113.7 25.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.391 0.676 . . . . 0.0 109.574 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.22 100.6 6.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.6 160.35 28.44 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -53.65 143.88 19.14 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.676 0.79 . . . . 0.0 112.496 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 2.3 tm-20 -50.77 -46.4 59.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.128 1.371 . . . . 0.0 111.454 -173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -58.94 -18.28 32.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 127' ' ' LEU . 1.4 t-20 -100.51 0.22 39.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -166.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 3.4 ppt_? -52.17 -37.28 54.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -171.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -81.72 -30.18 32.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.58 0.352 . . . . 0.0 111.366 -177.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.83 -43.31 46.59 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.086 0.554 . . . . 0.0 111.237 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 122' ' ' ILE . 61.9 t -62.7 -42.64 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.851 0.86 . . . . 0.0 110.73 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.0 t -64.24 -35.38 80.62 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.02 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -57.0 -41.16 77.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.959 0.904 . . . . 0.0 110.934 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.44 -36.32 78.86 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.723 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.4 mt -68.71 -44.35 74.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.021 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -59.37 -27.71 66.21 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.611 1.164 . . . . 0.0 111.879 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -54.62 -52.17 63.08 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 111.954 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -93.59 -23.68 18.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.472 0.709 . . . . 0.0 110.34 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.89 16.82 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.528 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 123.463 0.705 . . . . 0.0 110.53 174.366 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.904 0.383 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.55 -29.4 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.133 0.973 . . . . 0.0 109.811 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.94 -24.9 43.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 0.0 111.004 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -78.69 122.77 26.41 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.203 0.601 . . . . 0.0 109.822 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 154' ' ' GLU . 27.0 m -124.16 175.87 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.873 1.269 . . . . 0.0 110.196 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.43 121.41 30.79 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.426 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.0 m-85 -85.26 -40.3 16.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.097 0.559 . . . . 0.0 110.042 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.19 -151.54 23.4 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.605 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.9 p -123.56 -179.82 4.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.914 0.886 . . . . 0.0 111.073 -174.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 26.7 tp -156.28 155.78 32.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -93.53 90.59 6.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.962 0.905 . . . . 0.0 108.72 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.21 88.89 1.37 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -70.31 93.9 0.89 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.174 0.487 . . . . 0.0 110.398 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 32.4 t -95.14 143.48 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 109.723 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.07 143.2 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.162 0.585 . . . . 0.0 111.563 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 143' ' ' THR . . . -80.44 -19.91 67.8 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 113.051 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.1 tp -59.94 -22.62 62.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.23 1.012 . . . . 0.0 112.146 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.463 ' HE ' HG23 ' A' ' 108' ' ' VAL . 13.9 ptt-85 -74.4 0.26 15.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.493 1.117 . . . . 0.0 112.567 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -42.56 -40.3 2.62 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.483 1.513 . . . . 0.0 114.094 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -56.85 -24.78 53.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.408 1.083 . . . . 0.0 113.218 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 m -75.56 -7.16 53.49 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.749 0.82 . . . . 0.0 111.626 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.3 2.74 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 140' ' ' ASN . 31.6 m -62.54 169.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 28.2 m -114.29 149.32 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.932 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -97.17 -97.14 0.2 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -107.94 144.11 35.66 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.192 0.597 . . . . 0.0 111.606 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 t30 59.19 10.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.39 1.476 . . . . 0.0 112.634 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.614 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 68.3 mm-40 -79.83 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 122.782 0.433 . . . . 0.0 110.611 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -88.43 117.62 27.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 23.2 m -113.86 135.06 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.142 0.977 . . . . 0.0 109.923 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.1 55.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.688 0.795 . . . . 0.0 109.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.3 mp -81.88 141.06 33.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.629 0.771 . . . . 0.0 109.216 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -151.55 148.47 28.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.127 0.571 . . . . 0.0 109.929 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -58.81 144.41 44.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.186 0.994 . . . . 0.0 112.144 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.36 93.03 22.88 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.39 -24.62 12.05 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.708 2.272 . . . . 0.0 112.978 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.68 59.02 2.79 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.21 1.005 . . . . 0.0 110.469 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 97' ' ' ALA . 37.4 m-80 -108.32 143.09 26.74 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.768 164.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.58 -19.15 32.6 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.379 2.053 . . . . 0.0 111.156 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -77.59 -53.32 7.72 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.269 0.628 . . . . 0.0 110.467 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 4.8 t70 -177.04 152.04 0.87 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.815 0.697 . . . . 0.0 109.444 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.38 -19.14 64.61 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.331 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.37 -1.81 31.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.575 1.15 . . . . 0.0 113.006 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . . . -72.86 138.68 46.44 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.98 123.69 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.934 0.894 . . . . 0.0 109.838 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.18 116.58 24.46 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.748 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.48 131.85 33.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -119.05 165.69 13.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 107.645 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.2 p-10 -98.29 -165.5 1.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.321 0.51 . . . . 0.0 110.056 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.69 -32.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.164 0.586 . . . . 0.0 112.109 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.755 0.822 . . . . 0.0 110.934 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -0.27 82.13 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.89 118.02 9.1 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.032 0.933 . . . . 0.0 109.155 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -62.27 122.16 14.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.8 0.687 . . . . 0.0 110.377 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG23 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -89.08 -12.79 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.097 173.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.93 -164.84 24.41 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -84.21 157.37 21.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.174 0.59 . . . . 0.0 110.015 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 4.0 tt -80.71 -55.27 4.95 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 158.21 127.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -163.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -58.22 9.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.369 0.668 . . . . 0.0 110.707 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -54.3 -48.38 71.36 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.376 1.071 . . . . 0.0 112.291 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.37 -40.24 77.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.83 -34.05 76.52 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.705 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.33 -32.28 80.29 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.913 0.758 . . . . 0.0 113.539 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.06 -59.16 2.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.397 0.618 . . . . 0.0 109.962 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.6 -15.04 63.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.38 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.82 72.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.116 1.366 . . . . 0.0 112.631 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -69.25 -32.95 72.5 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.586 0.554 . . . . 0.0 110.02 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 127' ' ' LEU . 50.3 mt -70.72 -34.29 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.461 0.705 . . . . 0.0 110.336 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 39.0 tpp -80.25 -39.36 29.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.612 1.165 . . . . 0.0 111.268 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -83.04 -37.43 23.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.194 0.998 . . . . 0.0 110.426 -171.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.55 6.31 47.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 53.58 39.2 29.77 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.509 1.124 . . . . 0.0 112.724 171.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.433 ' HB2' HG23 ' A' ' 122' ' ' ILE . 75.6 mt -66.06 -40.98 91.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.893 0.877 . . . . 0.0 111.09 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -151.62 138.11 18.62 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.102 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -77.23 107.03 9.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.604 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.29 110.95 24.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.25 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.57 179.0 4.99 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.586 0.754 . . . . 0.0 109.34 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -160.18 160.62 31.84 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 82' ' ' MET . 61.0 t -142.66 120.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 2.4 p -95.08 100.48 5.69 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.173 0.589 . . . . 0.0 109.901 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.74 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.832 2.355 . . . . 0.0 113.397 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.65 -27.63 45.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.587 0.755 . . . . 0.0 111.833 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.95 79.34 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.066 0.387 . . . . 0.0 114.066 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -75.92 -15.17 60.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.017 0.527 . . . . 0.0 111.348 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -9.57 33.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.594 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.8 m-20 -73.64 -56.92 4.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.818 0.447 . . . . 0.0 110.664 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.94 -42.38 7.16 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.169 0.587 . . . . 0.0 111.082 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.24 161.38 13.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.086 0.954 . . . . 0.0 111.468 -171.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 69' ' ' GLY . 67.1 p -95.73 109.02 21.38 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 22.8 ptm -131.75 151.0 77.82 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 122.59 0.356 . . . . 0.0 111.168 -169.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.06 129.13 4.53 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.618 2.212 . . . . 0.0 111.592 164.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -114.24 156.29 24.59 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -75.56 107.68 7.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.799 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.585 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 61.3 mtt -97.84 160.12 14.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.357 1.063 . . . . 0.0 109.008 173.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.27 135.03 30.24 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -169.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.594 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 96.9 m-85 -100.76 120.41 40.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.923 0.889 . . . . 0.0 110.144 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.89 110.17 12.75 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.9 39.98 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -64.19 141.31 58.82 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.955 0.502 . . . . 0.0 111.768 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.2 mt-10 -55.14 -31.05 61.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -171.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.49 -20.89 66.15 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.275 0.63 . . . . 0.0 112.199 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.09 -1.0 46.19 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.087 -0.959 . . . . 0.0 113.151 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -64.92 -29.73 70.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 119.593 1.088 . . . . 0.0 111.118 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -29.56 65.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.389 0.676 . . . . 0.0 111.082 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.63 -42.58 19.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.292 0.637 . . . . 0.0 110.271 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.46 -47.15 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.769 1.227 . . . . 0.0 110.83 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.5 t -61.85 -39.93 93.58 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.2 t70 -56.28 -41.29 75.64 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.837 0.71 . . . . 0.0 111.248 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.1 mm100 -72.0 -35.6 69.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.643 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.35 -51.64 34.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.106 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.95 -33.23 72.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.613 1.165 . . . . 0.0 111.717 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 29.4 ttmt -54.8 -44.87 74.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.06 1.344 . . . . 0.0 111.43 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 -17.71 17.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.217 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.83 30.77 16.97 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.882 -0.399 . . . . 0.0 113.916 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' LEU . 53.7 m-85 . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 117.402 0.601 . . . . 0.0 109.532 172.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.94 -29.99 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.941 0.496 . . . . 0.0 110.125 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.09 -9.46 27.97 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.425 0.69 . . . . 0.0 110.937 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -71.28 116.06 11.16 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.41 165.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.774 1.229 . . . . 0.0 110.421 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.44 117.44 23.07 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.161 0.584 . . . . 0.0 110.087 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.416 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.1 m-85 -84.68 -24.79 28.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.53 -158.7 27.07 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.472 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.2 p -112.22 178.78 4.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.327 0.651 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 37.3 tp -152.91 147.93 26.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.074 0.549 . . . . 0.0 109.844 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -84.27 87.5 7.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.709 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.36 93.83 0.91 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.926 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -67.42 111.91 4.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.749 0.82 . . . . 0.0 110.965 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG12 HD23 ' A' ' 111' ' ' LEU . 19.6 m -113.24 145.81 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.689 0.796 . . . . 0.0 109.119 172.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 143' ' ' THR . 26.2 m -96.58 153.33 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.173 0.589 . . . . 0.0 111.447 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.07 -19.88 68.81 Favored Glycine 0 N--CA 1.477 1.41 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.29 -17.57 58.99 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.504 0.669 . . . . 0.0 112.028 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.558 ' NH2' HG23 ' A' ' 108' ' ' VAL . 15.3 mtp180 -69.48 -2.38 11.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.38 1.472 . . . . 0.0 113.611 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -52.05 -42.84 63.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.6 0.76 . . . . 0.0 112.493 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -83.46 -6.47 59.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.862 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -75.17 -26.14 58.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 109.695 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.96 49.79 0.45 Allowed Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.389 -0.369 . . . . 0.0 112.704 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' ND2' ' A' ' 139' ' ' ASN . 15.7 m -59.79 170.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.46 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 6.0 m -115.54 178.56 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.657 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -85.03 -165.95 1.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.658 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -82.48 159.93 22.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.17 0.588 . . . . 0.0 110.411 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER 63.47 9.02 3.88 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.083 1.353 . . . . 0.0 112.912 -179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 28.4 mm-40 -84.33 144.27 28.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.139 0.576 . . . . 0.0 110.731 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.441 ' HG2' HG22 ' A' ' 133' ' ' VAL . 72.1 mtm -92.84 132.88 36.61 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.89 152.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.993 0.917 . . . . 0.0 110.116 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.76 157.1 30.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.517 0.727 . . . . 0.0 110.489 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 98' ' ' ILE . 8.4 mp -100.43 134.65 43.07 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.304 0.642 . . . . 0.0 110.037 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -139.73 110.78 6.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.441 1.097 . . . . 0.0 108.238 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 127.37 32.93 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -118.18 96.64 49.99 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.892 -169.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.14 -24.88 76.76 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.993 2.462 . . . . 0.0 112.821 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.824 0.85 . . . . 0.0 111.826 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.593 HD22 ' HB3' ' A' ' 97' ' ' ALA . 66.0 t30 -57.83 117.89 22.37 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.735 0.814 . . . . 0.0 111.375 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.34 -14.13 22.87 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.964 2.443 . . . . 0.0 112.516 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.507 ' HB3' HD21 ' A' ' 91' ' ' ASN . 28.9 t80 -73.11 -49.48 28.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.114 0.966 . . . . 0.0 109.713 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 16.2 t70 -173.09 138.27 0.74 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.626 0.771 . . . . 0.0 109.829 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -69.54 -30.43 68.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.37 0.668 . . . . 0.0 111.62 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -83.95 -12.88 54.68 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.012 0.525 . . . . 0.0 110.508 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 91' ' ' ASN . . . -59.77 109.14 0.86 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 124.267 0.979 . . . . 0.0 109.826 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 111' ' ' LEU . 73.2 mt -72.38 104.33 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.99 -172.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 39.6 ttmt -61.94 110.9 1.7 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.516 168.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.82 110.87 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.68 173.94 6.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.056 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -105.67 -167.87 1.38 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.02 -29.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.48 -31.69 63.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.781 0.832 . . . . 0.0 110.81 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.88 -2.34 41.47 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.191 -172.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.52 122.89 18.25 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.844 0.858 . . . . 0.0 109.45 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 18.5 pm0 -62.07 111.26 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.091 0.869 . . . . 0.0 109.761 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.558 HG23 ' NH2' ' A' ' 71' ' ' ARG . 16.0 m -91.36 -0.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.35 -148.68 20.21 Favored Glycine 0 C--N 1.366 2.228 0 C-N-CA 123.535 0.588 . . . . 0.0 113.513 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -137.28 146.13 44.33 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.085 1.354 . . . . 0.0 108.732 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 115' ' ' LEU . 43.4 mt -63.63 -57.1 11.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 117.955 0.343 . . . . 0.0 111.609 -176.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 115' ' ' LEU . 32.1 mmmt 173.98 169.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 128.078 2.551 . . . . 0.0 105.033 -167.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 -27.25 33.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 119.292 0.951 . . . . 0.0 109.327 160.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 169' ' ' PHE . 28.9 tt0 -69.7 -59.93 2.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.756 1.222 . . . . 0.0 111.085 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 HD13 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -58.2 -40.14 80.8 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.167 0.987 . . . . 0.0 109.044 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.99 97.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.831 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.17 -36.0 35.09 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 124.215 0.947 . . . . 0.0 113.928 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -61.34 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.444 0.698 . . . . 0.0 111.548 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 mt -71.38 -18.92 62.33 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.583 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.55 81.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.902 0.881 . . . . 0.0 110.417 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -65.4 -36.51 84.18 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.182 0.926 . . . . 0.0 110.331 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.401 HG23 ' HB2' ' A' ' 127' ' ' LEU . 67.5 mt -65.98 -42.06 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.0 -32.2 51.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.249 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -48.78 11.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.916 0.887 . . . . 0.0 111.021 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -85.93 7.01 25.92 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.141 0.576 . . . . 0.0 111.231 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 63.14 32.36 15.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 156' ' ' ASN . 56.7 mt -67.5 -44.17 79.12 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.895 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -156.33 150.38 25.21 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -77.77 134.92 37.95 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.409 ' HB ' HD22 ' A' ' 85' ' ' LEU . 31.3 mt -127.73 129.55 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.1 168.13 18.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.544 1.137 . . . . 0.0 108.516 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -137.02 166.96 24.8 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 82' ' ' MET . 62.6 t -147.91 131.35 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 137' ' ' GLY . 2.5 p -102.45 99.27 12.56 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.169 0.588 . . . . 0.0 110.251 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.11 -27.58 4.4 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.761 2.308 . . . . 0.0 112.766 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -75.23 -31.29 60.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.066 0.546 . . . . 0.0 111.784 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 63.18 11.69 40.49 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 114.222 0.449 . . . . 0.0 114.222 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -88.92 5.63 43.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.674 0.789 . . . . 0.0 111.397 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 3.6 p-10 -63.69 -19.42 64.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.597 1.159 . . . . 0.0 112.188 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -69.71 -60.73 2.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.744 0.818 . . . . 0.0 111.146 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.56 -32.04 11.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -171.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -113.58 162.56 16.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 112.196 -167.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 72.9 p -97.51 109.71 22.41 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE1' ' HB3' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -149.75 158.43 37.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -167.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.66 127.18 1.9 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.772 2.314 . . . . 0.0 113.035 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.482 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 3.7 pp -94.23 152.16 18.9 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -73.26 108.82 6.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.594 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.49 ' HE3' HD21 ' A' ' 111' ' ' LEU . 47.7 mtt -99.03 166.39 11.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.692 0.797 . . . . 0.0 110.346 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.4 p -143.69 156.17 44.46 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.304 1.042 . . . . 0.0 109.707 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 81.1 m-85 -117.41 117.24 28.94 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.715 0.806 . . . . 0.0 108.856 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -124.26 100.37 6.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.78 167.06 29.86 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -73.55 145.25 45.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.599 0.36 . . . . 0.0 111.307 -171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.34 -30.34 66.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 113.874 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.04 -6.51 54.8 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 127' ' ' LEU . 4.0 m-20 -118.24 7.55 12.1 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.248 0.619 . . . . 0.0 110.543 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -37.04 86.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.144 0.578 . . . . 0.0 112.11 -169.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -26.03 61.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.157 0.286 . . . . 0.0 110.765 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -77.93 -34.59 51.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.072 0.549 . . . . 0.0 110.335 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 156' ' ' ASN . 66.0 t -62.8 -50.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.33 0.652 . . . . 0.0 109.993 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.4 p -66.36 -32.21 73.45 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.735 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.26 -43.31 82.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.296 0.638 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 9.8 mm100 -70.05 -30.84 68.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.786 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.15 -52.34 35.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.19 0.596 . . . . 0.0 110.103 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.04 -25.07 67.67 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.447 1.099 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.929 1.292 . . . . 0.0 111.805 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -103.77 -28.37 11.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.293 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.11 29.88 5.3 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.552 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 114' ' ' GLU . 62.5 m-85 . . . . . 0 N--CA 1.483 1.19 0 CA-C-N 117.733 0.766 . . . . 0.0 110.858 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -35.3 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.925 0.89 . . . . 0.0 109.726 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -84.83 -15.44 44.75 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.749 1.219 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -80.42 143.39 33.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.523 0.729 . . . . 0.0 111.704 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.31 161.31 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.296 1.438 . . . . 0.0 110.474 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.7 tp -85.36 110.89 19.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 34.7 m-85 -73.17 -39.22 65.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.341 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.57 -160.86 30.56 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.1 p -111.79 179.14 4.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.516 0.726 . . . . 0.0 110.858 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 169' ' ' PHE . 33.7 tp -154.73 153.39 31.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.371 0.668 . . . . 0.0 109.983 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -87.29 92.71 9.17 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.64 125.21 8.39 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.456 ' H ' ' HG ' ' A' ' 115' ' ' LEU . 77.0 m80 -114.65 109.95 19.01 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.606 0.762 . . . . 0.0 110.286 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.39 139.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 66.4 t -71.97 142.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.998 0.519 . . . . 0.0 110.397 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.88 -44.45 68.68 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.727 -0.67 . . . . 0.0 114.328 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.1 -17.77 42.24 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.067 0.947 . . . . 0.0 112.065 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' A' ' 68' ' ' VAL . 2.3 mpt_? -74.35 1.4 11.72 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.452 1.101 . . . . 0.0 111.739 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -57.25 -28.83 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.845 0.458 . . . . 0.0 110.611 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.66 -31.89 72.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.051 0.94 . . . . 0.0 111.015 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -74.46 -27.06 60.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.392 0.677 . . . . 0.0 110.207 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.8 46.63 0.51 Allowed Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.756 -0.656 . . . . 0.0 114.288 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.676 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 93.7 t -56.49 154.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 122.816 0.446 . . . . 0.0 110.452 171.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.54 159.4 7.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.538 0.735 . . . . 0.0 111.061 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -96.02 -115.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.07 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -93.96 139.94 30.31 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.63 0.772 . . . . 0.0 111.745 -163.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 74.03 -22.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.37 1.468 . . . . 0.0 113.656 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.02 129.69 43.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.52 1.128 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.525 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.7 mtp -94.25 142.74 27.06 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 30.0 m -114.64 147.04 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.101 0.56 . . . . 0.0 110.463 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.76 53.75 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.042 0.937 . . . . 0.0 108.803 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -88.37 151.32 22.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.405 0.682 . . . . 0.0 110.319 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -159.76 153.68 23.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.073 0.949 . . . . 0.0 109.101 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.402 HH22 ' HB2' ' A' ' 124' ' ' ASP . 32.9 ttm180 -71.88 137.13 47.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.703 0.401 . . . . 0.0 110.334 172.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.78 117.17 67.61 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.4 0.68 . . . . 0.0 109.813 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.4 -29.76 53.68 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.781 2.321 . . . . 0.0 112.797 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.33 52.49 2.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.431 0.693 . . . . 0.0 109.599 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.25 108.16 1.06 Allowed Pre-proline 0 CA--C 1.566 1.564 0 C-N-CA 124.579 1.151 . . . . 0.0 112.498 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.86 -34.94 70.32 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 123.284 2.656 . . . . 0.0 113.543 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -126.0 -44.04 1.79 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.412 0.685 . . . . 0.0 111.197 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -162.94 162.7 26.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.142 0.577 . . . . 0.0 109.924 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.23 -14.52 26.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.417 1.087 . . . . 0.0 112.53 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.477 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 47.3 m-80 -73.33 4.08 5.09 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.74 116.96 18.68 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.248 0.619 . . . . 0.0 109.955 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.537 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 44.9 mt -97.98 118.79 45.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 C-N-CA 123.614 0.766 . . . . 0.0 109.649 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.731 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 17.3 ttmm -71.53 140.04 49.74 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.288 165.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 t -109.84 124.62 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -108.09 168.65 9.14 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -108.4 -165.77 1.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.988 0.515 . . . . 0.0 110.217 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.75 -33.14 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.742 . . . . 0.0 111.537 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -76.14 -19.99 58.0 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.991 0.916 . . . . 0.0 111.112 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.04 6.88 78.41 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -69.96 135.09 49.06 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 109.62 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.731 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 26.1 mp0 -73.81 98.64 3.0 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.825 0.85 . . . . 0.0 109.0 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 11.8 m -79.77 -25.82 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.51 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.7 -142.18 8.36 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 121.587 -0.34 . . . . 0.0 112.914 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -140.32 157.4 45.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.334 1.054 . . . . 0.0 109.571 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.58 HD13 HD12 ' A' ' 115' ' ' LEU . 65.9 mt -81.64 -5.06 57.71 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.422 176.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? 71.6 151.5 0.11 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 109.937 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -37.42 -42.06 0.48 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.41 -56.12 5.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.383 0.273 . . . . 0.0 111.122 -170.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.58 HD12 HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -72.43 -44.46 62.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -175.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.537 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -58.6 -51.6 69.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.412 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -60.44 -27.4 65.73 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.497 0.498 . . . . 0.0 114.071 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -61.59 1.73 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.954 0.502 . . . . 0.0 109.918 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 130' ' ' ILE . 18.1 mt -69.88 -16.07 63.18 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.971 -172.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.11 -24.15 65.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.967 0.907 . . . . 0.0 113.231 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -76.32 -35.87 58.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 127' ' ' LEU . 48.1 mt -67.64 -29.65 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.92 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.2 tpp -79.08 -41.71 28.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.463 1.105 . . . . 0.0 110.558 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HH22 ' A' ' 87' ' ' ARG . 20.7 t70 -67.66 -50.8 56.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.53 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -93.54 1.16 56.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.849 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 54.52 44.65 28.44 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.015 0.926 . . . . 0.0 111.642 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 122' ' ' ILE . 62.3 mt -68.79 -40.18 79.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.992 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -155.58 135.38 12.72 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.261 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -68.21 114.43 6.69 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 119' ' ' LEU . 13.7 mt -101.08 124.03 54.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.07 139.6 44.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.815 0.846 . . . . 0.0 108.944 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -116.95 168.16 12.74 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.343 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 82' ' ' MET . 44.1 t -138.94 133.6 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 146' ' ' LEU . 11.0 t -103.34 94.12 5.47 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.17 -56.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.179 1.92 . . . . 0.0 112.951 -172.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -75.8 -30.99 59.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.943 0.497 . . . . 0.0 110.976 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 49.47 34.62 19.91 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 124.0 0.812 . . . . 0.0 114.435 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -89.89 17.77 6.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.753 0.821 . . . . 0.0 112.278 -168.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -52.14 -36.46 51.47 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.293 1.037 . . . . 0.0 112.094 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -53.92 -49.14 69.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.819 0.848 . . . . 0.0 111.397 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.85 -51.59 11.01 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.722 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -157.49 166.42 33.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.416 1.087 . . . . 0.0 109.555 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.8 p -94.59 110.71 22.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.03 141.49 26.36 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 124.245 1.018 . . . . 0.0 110.562 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.29 130.26 18.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.951 2.434 . . . . 0.0 112.261 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.418 HD22 HG22 ' A' ' 134' ' ' VAL . 4.5 pp -87.52 152.97 21.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -91.13 110.73 22.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 122.1 -0.375 . . . . 0.0 110.502 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.572 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 54.7 mtt -92.5 169.45 10.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.217 1.007 . . . . 0.0 111.065 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 p -149.72 147.53 28.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.702 1.201 . . . . 0.0 109.062 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 91.8 m-85 -109.34 120.56 42.89 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.847 0.859 . . . . 0.0 109.515 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -124.17 97.68 5.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.22 166.34 35.73 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.75 139.76 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.373 0.669 . . . . 0.0 111.942 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -51.07 -37.28 44.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.753 1.221 . . . . 0.0 112.997 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.46 -12.29 59.92 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.679 0.791 . . . . 0.0 113.133 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -97.22 -0.98 45.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -30.24 69.61 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -33.59 71.62 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.16 0.505 . . . . 0.0 110.929 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.74 -33.97 30.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.48 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.37 -48.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.878 0.871 . . . . 0.0 110.777 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 72.9 p -64.34 -34.41 78.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 111.555 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.61 -42.76 75.35 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.674 0.609 . . . . 0.0 111.394 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mm100 -66.8 -38.94 87.46 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.326 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -70.17 -53.18 18.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.525 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.94 -25.61 68.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.888 0.875 . . . . 0.0 112.074 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.37 -48.12 82.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 111.389 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -102.89 -1.1 30.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.601 0.761 . . . . 0.0 111.046 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.73 63.65 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.368 0.418 . . . . 0.0 113.988 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 63' ' ' LEU . 24.8 m-85 . . . . . 0 N--CA 1.481 1.106 0 C-N-CA 123.372 0.669 . . . . 0.0 111.05 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.99 -31.94 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.827 0.851 . . . . 0.0 109.625 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.38 -13.73 42.6 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.715 0.806 . . . . 0.0 110.788 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.4 m -74.41 113.94 12.22 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 122.997 0.519 . . . . 0.0 110.497 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.29 158.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 0.0 110.898 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 tt -81.27 114.92 20.39 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.76 0.824 . . . . 0.0 108.962 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.05 -36.03 59.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.188 0.595 . . . . 0.0 110.062 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.48 175.9 38.98 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.756 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 p -110.67 155.23 22.73 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.106 0.962 . . . . 0.0 108.735 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.01 147.05 52.58 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.774 0.429 . . . . 0.0 110.285 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -78.42 78.56 4.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.797 0.808 . . . . 0.0 109.118 171.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -70.43 143.06 36.57 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.186 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -132.79 105.58 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.192 0.597 . . . . 0.0 109.546 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 71' ' ' ARG . 3.8 t -78.65 159.56 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.7 m -63.49 152.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.174 -0.329 . . . . 0.0 111.312 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 143' ' ' THR . . . -65.1 -35.56 91.92 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.03 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.34 -15.07 3.44 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.212 1.405 . . . . 0.0 113.269 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.691 HH12 HG22 ' A' ' 77' ' ' VAL . 1.9 tmm_? -56.95 -17.59 10.22 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.206 1.003 . . . . 0.0 112.42 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HA ' HG13 ' A' ' 76' ' ' VAL . 40.6 p90 -59.07 -41.31 87.68 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 123.062 0.545 . . . . 0.0 110.859 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -72.0 -31.18 65.99 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.251 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 71' ' ' ARG . 46.4 p -95.82 3.56 53.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.793 0.437 . . . . 0.0 111.561 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.9 52.2 0.51 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 140' ' ' ASN . 3.1 m -48.91 152.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 118.334 1.067 . . . . 0.0 113.186 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.691 HG22 HH12 ' A' ' 71' ' ' ARG . 28.8 m -114.47 164.7 10.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.884 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -84.39 -169.17 2.48 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.548 0.739 . . . . 0.0 111.231 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.66 157.89 37.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.64 0.776 . . . . 0.0 111.279 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 67.88 8.08 6.2 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.122 0.969 . . . . 0.0 112.186 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.6 mm-40 -76.93 140.63 40.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.482 0.658 . . . . 0.0 111.132 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.475 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.9 mtp -107.2 149.49 27.65 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 132' ' ' GLY . 13.4 m -132.04 163.5 37.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.248 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.38 125.71 23.3 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.76 160.38 26.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -157.05 126.75 6.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.002 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HD2' ' HB2' ' A' ' 95' ' ' LYS . 64.7 ttp85 -67.34 130.76 44.11 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.2 117.6 21.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 123.628 0.58 . . . . 0.0 110.733 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.35 -39.88 34.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.33 2.02 . . . . 0.0 110.237 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.26 76.1 3.42 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 7.5 p30 -67.4 127.9 93.54 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.968 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.54 -39.39 28.22 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.998 2.465 . . . . 0.0 113.021 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -127.35 -50.97 1.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.764 0.426 . . . . 0.0 110.43 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 8.8 p30 -150.38 170.58 18.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 110.031 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -64.9 -8.24 14.67 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.459 1.103 . . . . 0.0 113.09 -173.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.26 -12.25 39.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.587 0.755 . . . . 0.0 112.567 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 109.4 7.57 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.049 0.54 . . . . 0.0 110.303 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 120' ' ' ALA . 59.7 mt -118.8 115.82 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -85.22 163.21 18.82 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.467 0.651 . . . . 0.0 110.223 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.53 121.32 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.5 1.12 . . . . 0.0 109.237 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -109.76 130.97 55.46 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -75.85 -170.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.932 0.787 . . . . 0.0 110.994 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.43 -33.78 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.894 0.878 . . . . 0.0 112.87 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.13 -31.62 34.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.818 0.447 . . . . 0.0 110.885 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.49 6.4 25.34 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 116.323 -0.399 . . . . 0.0 113.266 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -66.7 119.25 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.858 0.863 . . . . 0.0 110.251 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -72.8 90.16 1.41 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.828 0.823 . . . . 0.0 110.279 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.5 -14.19 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.988 1.315 . . . . 0.0 113.307 -172.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.13 -157.4 27.62 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 118.024 0.375 . . . . 0.0 112.363 -176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -132.15 149.43 52.4 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.47 0.708 . . . . 0.0 110.269 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 71.5 mt -76.23 -0.85 23.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.685 0.794 . . . . 0.0 113.004 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.5 tttt 71.45 130.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -19.21 5.99 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.597 1.159 . . . . 0.0 113.865 -170.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG3' ' HE1' ' A' ' 167' ' ' HIS . 12.2 tp10 -67.01 -55.09 15.9 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.481 0.713 . . . . 0.0 111.395 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.69 -44.97 12.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.354 0.662 . . . . 0.0 110.184 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -61.89 -24.28 66.84 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.179 0.991 . . . . 0.0 111.967 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.64 64.62 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.17 0.294 . . . . 0.0 113.538 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -65.97 -44.5 84.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.53 -16.41 56.02 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.742 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.496 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -56.53 -44.75 81.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 112.053 -174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -70.58 -32.74 70.25 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.09 0.869 . . . . 0.0 110.298 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 160' ' ' VAL . 62.5 mt -65.36 -41.63 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.194 0.598 . . . . 0.0 110.02 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.45 -37.93 50.5 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.918 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.35 -42.9 58.6 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.485 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -98.02 6.38 47.7 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.396 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.37 34.72 20.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.702 1.201 . . . . 0.0 111.654 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD13 ' HB1' ' A' ' 159' ' ' ALA . 75.8 mt -64.0 -43.44 95.66 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.484 0.714 . . . . 0.0 111.231 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.2 159.93 26.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.071 0.549 . . . . 0.0 111.109 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.8 mt -129.69 118.5 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.47 166.18 18.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.96 102.37 0.24 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' HG2' ' A' ' 82' ' ' MET . 43.0 t -103.58 114.96 44.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.9 p -101.3 91.29 2.01 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.263 1.025 . . . . 0.0 108.71 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 2.7 Cg_exo -78.54 -23.92 8.03 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.128 2.552 . . . . 0.0 112.93 -172.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.26 -28.82 19.66 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.21 0.604 . . . . 0.0 110.926 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.56 62.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 113.863 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.08 -2.38 33.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.631 0.772 . . . . 0.0 112.347 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -24.69 65.44 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.448 ' HA ' HG21 ' A' ' 76' ' ' VAL . 55.6 t30 -57.28 -34.3 68.52 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.056 0.942 . . . . 0.0 111.262 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.78 53.25 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.133 0.573 . . . . 0.0 110.816 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -167.99 -66.3 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.474 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 8.9 t -160.32 169.06 23.92 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.693 0.797 . . . . 0.0 110.17 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.581 ' SD ' HG23 ' A' ' 134' ' ' VAL . 5.5 ppp? -167.34 156.28 9.16 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.289 1.036 . . . . 0.0 109.484 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.1 Cg_endo -76.63 120.45 5.55 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.418 1.412 . . . . 0.0 112.063 170.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 146' ' ' LEU . 2.6 pt? -102.73 149.4 24.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -85.39 108.2 17.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -171.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 38.1 mtp -107.36 116.38 31.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.316 0.646 . . . . 0.0 109.873 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.7 p -113.06 126.49 55.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.763 0.425 . . . . 0.0 110.008 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -92.19 115.32 27.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.685 0.794 . . . . 0.0 109.537 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -114.54 110.97 20.63 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.503 1.121 . . . . 0.0 109.724 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.52 168.74 38.29 Favored Glycine 0 C--O 1.236 0.235 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -63.47 152.25 38.92 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.207 1.003 . . . . 0.0 111.304 -178.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.72 -27.78 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.065 0.946 . . . . 0.0 113.511 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 153' ' ' LYS . 12.8 pt-20 -78.08 -28.21 48.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.89 -5.02 46.74 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.797 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -59.01 -41.91 88.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.754 0.422 . . . . 0.0 110.228 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -70.49 -27.75 64.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.444 0.697 . . . . 0.0 111.738 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.71 -45.03 60.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.589 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 122' ' ' ILE . 70.4 t -64.41 -40.97 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.31 1.044 . . . . 0.0 111.14 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.4 m -58.58 -45.07 89.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.075 0.95 . . . . 0.0 110.62 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.14 -41.4 71.71 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.878 0.871 . . . . 0.0 111.542 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.2 mm100 -75.34 -27.26 59.15 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.038 -174.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 76.1 mt -73.0 -44.26 61.22 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.824 173.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.46 -28.63 67.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.404 1.082 . . . . 0.0 111.356 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.57 -50.12 70.9 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.094 0.958 . . . . 0.0 111.34 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . 0.47 ' HE1' ' HG3' ' A' ' 114' ' ' GLU . 20.6 t60 -81.43 -28.14 34.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.363 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.49 12.02 10.01 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-O 119.87 -0.406 . . . . 0.0 113.332 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.602 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 46.8 m-85 . . . . . 0 CA--C 1.558 1.274 0 C-N-CA 123.231 0.612 . . . . 0.0 111.331 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.7 0.286 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.88 -35.3 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.601 0.761 . . . . 0.0 109.474 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.35 -17.58 63.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.194 0.997 . . . . 0.0 111.104 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -73.71 116.66 14.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.313 0.645 . . . . 0.0 109.863 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.86 165.83 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.526 1.13 . . . . 0.0 110.859 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 149' ' ' THR . 24.6 tp -82.13 121.67 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.873 0.469 . . . . 0.0 110.177 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 19.7 m-85 -86.87 -38.58 16.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.169 0.588 . . . . 0.0 110.088 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 -172.18 28.92 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.724 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -112.6 166.5 11.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.464 0.706 . . . . 0.0 111.363 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.481 ' HB2' ' HE2' ' A' ' 150' ' ' PHE . 33.8 tp -145.32 150.6 36.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.933 0.893 . . . . 0.0 109.319 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -75.94 98.36 4.22 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.418 0.628 . . . . 0.0 109.964 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.09 73.98 2.5 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 52.9 t-80 -65.62 85.82 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.981 0.912 . . . . 0.0 110.351 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 111' ' ' LEU . 14.4 m -81.61 144.33 10.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.166 173.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.3 m -65.61 148.07 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.39 175.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.86 -22.12 62.15 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -61.85 -19.12 62.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.929 1.292 . . . . 0.0 111.804 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 34.4 ptt85 -72.52 0.14 11.18 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.387 1.075 . . . . 0.0 112.549 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -53.85 -35.63 61.71 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.811 0.844 . . . . 0.0 112.658 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -67.86 -23.23 65.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.884 0.874 . . . . 0.0 111.641 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -73.02 -24.18 60.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.072 0.549 . . . . 0.0 111.023 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.82 49.11 0.52 Allowed Glycine 0 C--N 1.354 1.533 0 O-C-N 122.309 -0.244 . . . . 0.0 113.49 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 43.4 t -63.47 160.09 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.634 0.774 . . . . 0.0 111.747 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.06 157.05 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.454 1.102 . . . . 0.0 109.3 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -78.91 -164.64 0.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.989 0.916 . . . . 0.0 113.024 -165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -67.05 145.89 54.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.691 0.797 . . . . 0.0 110.825 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 73.72 -15.52 0.57 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.198 1.399 . . . . 0.0 112.713 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -73.2 130.02 39.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.57 0.748 . . . . 0.0 111.113 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 79.7 mtp -84.77 149.42 25.76 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.068 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 16.4 m -134.75 -170.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.709 1.204 . . . . 0.0 109.836 177.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.92 154.5 22.08 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.595 1.158 . . . . 0.0 108.432 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -99.15 146.83 25.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.909 0.385 . . . . 0.0 110.817 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -155.83 127.77 7.49 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 108.845 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -63.05 142.23 58.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 174.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.24 110.79 2.83 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.753 0.821 . . . . 0.0 110.347 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -31.61 44.84 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.488 2.125 . . . . 0.0 111.271 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.27 68.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 170.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 6.9 p30 -74.85 119.03 74.82 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.059 0.544 . . . . 0.0 110.551 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 15.4 Cg_exo -69.61 -38.68 7.79 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 0.0 113.554 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -119.88 -51.39 2.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.304 0.641 . . . . 0.0 111.677 -167.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.25 146.82 35.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.375 0.67 . . . . 0.0 109.792 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.506 ' HB2' HH21 ' A' ' 87' ' ' ARG . 14.7 ptmm? -74.05 -5.1 39.47 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.932 0.893 . . . . 0.0 111.1 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -76.63 -6.03 50.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.204 1.002 . . . . 0.0 111.98 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.426 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -71.03 125.56 27.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.081 0.952 . . . . 0.0 110.646 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.9 mt -123.65 120.18 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.64 0.776 . . . . 0.0 110.657 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 39.5 mttp -77.7 162.79 26.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.554 1.141 . . . . 0.0 111.009 167.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.3 t -123.3 127.02 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -122.32 144.22 49.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.622 1.169 . . . . 0.0 108.737 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -74.29 179.01 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.883 0.765 . . . . 0.0 112.285 177.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.85 -25.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.167 0.987 . . . . 0.0 113.492 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -73.16 -17.2 61.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.376 0.67 . . . . 0.0 110.968 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.81 37.25 10.49 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.825 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.536 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.8 t-20 -121.99 131.47 54.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.573 0.749 . . . . 0.0 109.185 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.92 104.76 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 124.167 0.917 . . . . 0.0 111.16 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 28.8 m -87.5 -0.24 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.012 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 151.89 -159.24 28.21 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.457 -0.338 . . . . 0.0 113.057 170.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 64.0 t60 -122.83 150.11 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.3 tt -75.07 -57.07 4.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.122 0.169 . . . . 0.0 111.006 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.3 tptt 142.53 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -162.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -22.5 62.43 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.777 1.171 . . . . 0.0 112.192 -175.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.78 -47.56 68.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.289 1.035 . . . . 0.0 110.571 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 8.9 tt -72.04 -48.69 42.66 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.434 0.694 . . . . 0.0 109.273 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -21.91 65.9 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.041 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.8 -28.36 60.3 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 123.296 0.373 . . . . 0.0 113.691 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.13 -56.26 4.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.315 0.646 . . . . 0.0 109.896 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 122' ' ' ILE . 31.3 mt -63.67 -16.5 61.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.059 0.944 . . . . 0.0 112.396 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.22 65.36 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.518 1.527 . . . . 0.0 112.046 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -70.07 -30.55 67.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.35 1.031 . . . . 0.0 110.618 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.488 ' HA ' HD12 ' A' ' 127' ' ' LEU . 60.2 mt -67.79 -34.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.22 0.608 . . . . 0.0 110.143 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -80.8 -33.22 34.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.068 0.947 . . . . 0.0 110.723 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.85 -40.34 54.92 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.505 1.122 . . . . 0.0 111.467 -173.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.08 -2.38 40.27 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.221 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 57.84 41.58 24.6 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.236 1.015 . . . . 0.0 111.03 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.1 mt -61.3 -43.95 98.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.436 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -149.66 138.37 20.93 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.246 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.92 105.24 5.86 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.59 104.69 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.11 176.28 9.34 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.589 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.59 158.97 27.89 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.61 -0.268 . . . . 0.0 112.522 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 55.6 t -148.38 129.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 146' ' ' LEU . 21.8 t -96.68 93.41 1.36 Allowed Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 7.1 Cg_exo -74.25 -49.24 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.404 2.069 . . . . 0.0 112.24 -171.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.88 -27.48 33.44 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.563 0.745 . . . . 0.0 111.263 -172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.66 60.64 Favored Glycine 0 C--N 1.354 1.551 0 O-C-N 123.465 0.478 . . . . 0.0 114.27 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.99 9.27 10.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.415 0.686 . . . . 0.0 112.694 -170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.71 -20.5 66.36 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.611 0.765 . . . . 0.0 111.659 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.23 -47.96 82.07 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 0.0 110.077 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.61 -53.99 4.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.492 0.717 . . . . 0.0 111.747 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -146.88 -165.77 2.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.665 0.786 . . . . 0.0 111.504 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -95.94 122.73 39.06 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.809 0.844 . . . . 0.0 109.662 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -131.66 147.02 64.37 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.271 0.628 . . . . 0.0 111.223 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 88.2 Cg_endo -79.2 125.5 6.47 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.52 2.146 . . . . 0.0 112.252 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.581 HD22 HG22 ' A' ' 134' ' ' VAL . 3.3 pp -100.37 154.59 18.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.21 107.48 4.24 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.333 0.653 . . . . 0.0 110.559 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 85' ' ' LEU . 62.3 mtt -107.12 149.66 27.41 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -144.34 135.97 25.83 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -171.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 83.1 m-85 -99.53 123.56 43.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.241 1.016 . . . . 0.0 110.655 -174.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.68 105.25 7.69 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.1 0.96 . . . . 0.0 108.561 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.78 166.76 35.09 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -58.37 143.13 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.77 -41.04 61.33 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.068 0.947 . . . . 0.0 113.135 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.57 -21.11 66.61 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.37 -3.51 56.66 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.731 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -61.65 -32.25 72.4 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.146 0.885 . . . . 0.0 111.162 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.37 -46.68 85.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.751 0.82 . . . . 0.0 109.754 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -75.44 -30.59 60.06 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.652 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 122' ' ' ILE . 53.7 t -67.01 -49.71 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.535 0.734 . . . . 0.0 109.235 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.6 t -61.45 -34.14 74.93 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.449 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.1 t70 -55.54 -47.84 75.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.17 0.588 . . . . 0.0 110.43 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.8 mm100 -66.89 -41.27 87.48 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 124.774 1.296 . . . . 0.0 111.578 -176.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -62.39 1.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.797 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -57.05 -33.4 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.321 1.048 . . . . 0.0 111.846 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 20.9 ttmm -55.55 -53.3 58.1 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.333 1.053 . . . . 0.0 111.394 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.97 -16.29 38.83 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.435 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.79 26.76 7.83 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.626 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 74.4 m-85 . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 123.536 0.734 . . . . 0.0 110.126 168.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -72.34 -27.48 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.446 1.098 . . . . 0.0 110.038 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -85.93 -26.12 25.72 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.426 1.09 . . . . 0.0 110.645 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LYS . 70.2 m -82.15 135.36 35.29 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 110.835 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.13 164.17 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.08 1.352 . . . . 0.0 110.763 -172.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.428 HD11 HG22 ' A' ' 149' ' ' THR . 18.7 tp -87.55 112.62 22.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.082 0.553 . . . . 0.0 110.362 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 24.6 m-85 -78.17 -37.83 44.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.518 0.727 . . . . 0.0 111.408 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.85 -154.3 25.42 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -133.8 179.89 5.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.327 0.651 . . . . 0.0 111.176 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.57 150.75 21.57 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.614 1.165 . . . . 0.0 108.887 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -87.27 101.82 13.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 148' ' ' MET . . . -72.33 85.81 0.51 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.265 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -70.35 99.3 1.54 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.52 0.728 . . . . 0.0 109.286 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 71' ' ' ARG . 7.1 p -119.24 131.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.681 0.792 . . . . 0.0 109.825 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 70' ' ' LEU . 65.1 t -56.93 143.41 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.774 1.23 . . . . 0.0 111.719 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.45 66.25 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.532 ' H ' HG12 ' A' ' 68' ' ' VAL . 42.0 tp -61.56 -17.82 56.62 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.069 0.947 . . . . 0.0 111.803 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 67' ' ' VAL . 28.6 ptt-85 -63.89 -5.17 4.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.673 1.189 . . . . 0.0 113.442 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -53.33 -35.88 60.69 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.611 0.764 . . . . 0.0 112.616 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.44 -24.83 65.67 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 111.511 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -77.36 -6.57 53.77 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.952 0.901 . . . . 0.0 111.6 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.86 53.2 0.86 Allowed Glycine 0 C--N 1.359 1.834 0 O-C-N 121.81 -0.556 . . . . 0.0 113.301 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 29.0 m -68.41 171.38 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 24.1 m -114.71 162.1 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.411 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -89.96 -87.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.874 0.469 . . . . 0.0 111.811 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.92 149.23 36.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.847 0.459 . . . . 0.0 111.41 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.0 9.46 3.07 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.31 1.444 . . . . 0.0 113.141 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 56.6 mm-40 -82.11 132.52 35.25 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.904 0.383 . . . . 0.0 111.481 -174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.7 mtm -80.31 132.81 35.87 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.604 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 102' ' ' ASN . 27.0 m -131.66 163.35 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 124.098 0.959 . . . . 0.0 109.141 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.25 24.7 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.892 0.877 . . . . 0.0 108.735 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -85.23 148.79 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.478 0.711 . . . . 0.0 110.026 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.458 ' HA ' ' SD ' ' A' ' 123' ' ' MET . 52.5 tp60 -159.89 137.86 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.842 0.857 . . . . 0.0 108.776 175.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 22.5 ptt85 -66.92 152.48 45.6 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.237 0.541 . . . . 0.0 110.085 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 32.1 t70 -102.33 116.59 62.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.825 -168.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.92 -18.0 41.23 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.855 2.37 . . . . 0.0 112.808 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.03 15.64 4.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.259 0.623 . . . . 0.0 110.644 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -53.98 128.22 55.5 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.643 0.777 . . . . 0.0 111.461 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.37 -26.89 1.24 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.326 2.018 . . . . 0.0 113.793 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -108.68 -52.18 2.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.136 0.574 . . . . 0.0 110.934 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -166.67 157.56 12.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.307 0.643 . . . . 0.0 109.671 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' HH11 ' A' ' 87' ' ' ARG . 16.5 ptpt -62.35 -7.79 4.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.228 1.411 . . . . 0.0 112.81 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -54.04 -32.48 54.59 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.278 1.031 . . . . 0.0 112.232 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.89 109.15 1.36 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.402 0.439 . . . . 0.0 110.181 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.5 mt -107.92 149.59 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.634 1.174 . . . . 0.0 108.231 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -122.29 144.44 48.99 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.53 0.681 . . . . 0.0 110.972 171.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -77.83 130.38 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.155 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 23.2 m-80 -114.95 144.14 44.05 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.603 0.761 . . . . 0.0 109.124 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -77.31 -169.69 1.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.445 0.566 . . . . 0.0 111.123 177.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.85 -25.87 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.188 0.595 . . . . 0.0 112.468 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.409 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 24.8 t-20 -74.58 -21.1 59.66 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.213 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.26 5.0 64.05 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.601 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 2.2 t30 -82.5 125.51 31.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.128 0.971 . . . . 0.0 108.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 12.0 pt20 -67.26 126.68 30.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.175 0.512 . . . . 0.0 111.701 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 16.9 m -89.47 -23.13 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.968 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 71' ' ' ARG . . . 165.06 165.27 22.07 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' A' ' 99' ' ' LYS . 23.1 m170 -92.0 150.87 20.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.091 0.956 . . . . 0.0 111.403 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 115' ' ' LEU . 29.8 mt -96.37 29.78 2.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.602 1.561 . . . . 0.0 112.316 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 65.09 -172.1 0.18 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.775 0.83 . . . . 0.0 110.737 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -80.42 -49.35 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.944 0.498 . . . . 0.0 110.839 171.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.38 -57.35 9.56 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.817 -166.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 111' ' ' LEU . 10.1 tt -67.67 -47.15 70.32 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.859 0.838 . . . . 0.0 109.314 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -62.34 -29.55 70.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.591 -1.641 . . . . 0.0 111.675 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.9 -38.85 94.65 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.544 0.527 . . . . 0.0 114.078 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -51.97 49.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.225 0.536 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.11 -16.83 64.17 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.928 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -61.32 -38.44 86.87 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.378 1.071 . . . . 0.0 112.887 -177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -71.36 -33.71 69.81 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.488 HD13 HG13 ' A' ' 160' ' ' VAL . 44.2 mt -68.66 -34.95 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.484 0.714 . . . . 0.0 110.322 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 86' ' ' GLN . 38.4 tpp -79.84 -52.26 8.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.095 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.54 -45.17 91.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.679 1.192 . . . . 0.0 110.654 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.86 2.76 54.6 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.59 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 56.35 36.93 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.308 1.043 . . . . 0.0 111.886 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.9 mt -65.86 -43.93 86.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.837 0.855 . . . . 0.0 111.322 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -148.71 140.27 23.5 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.477 0.711 . . . . 0.0 110.603 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.97 102.91 6.62 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -89.07 106.22 16.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.14 179.84 5.46 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.875 0.87 . . . . 0.0 109.382 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -162.96 172.97 39.11 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.634 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 78.0 t -149.28 138.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 107.512 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.36 90.76 1.49 Allowed Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.76 -23.53 2.59 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.054 1.836 . . . . 0.0 113.871 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -77.87 -28.73 50.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.379 0.672 . . . . 0.0 112.49 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.12 31.2 75.9 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 123.229 0.33 . . . . 0.0 113.771 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -85.6 17.13 3.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.04 0.936 . . . . 0.0 111.655 -178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.3 -26.24 68.31 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.624 1.17 . . . . 0.0 111.72 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.01 -37.0 69.88 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.553 0.741 . . . . 0.0 110.914 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.07 -64.64 0.82 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.652 0.381 . . . . 0.0 110.362 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 37.6 t80 171.75 -89.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.304 1.442 . . . . 0.0 108.497 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 67' ' ' VAL . 62.6 m -103.24 144.64 31.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.184 0.994 . . . . 0.0 109.852 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 1.4 pmm? -147.79 148.56 30.76 Favored Pre-proline 0 C--O 1.243 0.741 0 C-N-CA 123.308 0.643 . . . . 0.0 109.747 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.7 124.71 4.66 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.023 1.815 . . . . 0.0 109.985 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.2 145.58 27.88 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -74.79 106.81 6.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.6 ' SD ' HD21 ' A' ' 85' ' ' LEU . 60.3 mtt -95.67 161.07 14.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.019 0.928 . . . . 0.0 109.554 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -150.73 132.4 14.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -171.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 82.3 m-85 -97.66 117.27 31.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.744 0.817 . . . . 0.0 109.911 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -124.31 115.78 21.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.53 168.41 40.55 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -65.83 147.01 54.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.435 0.636 . . . . 0.0 112.693 -173.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -53.64 -32.5 51.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.406 1.482 . . . . 0.0 114.083 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.43 -23.93 60.18 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.902 0.481 . . . . 0.0 111.608 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -92.55 3.26 55.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.294 0.637 . . . . 0.0 111.722 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.37 76.48 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.091 0.556 . . . . 0.0 111.919 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -35.36 69.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.25 0.62 . . . . 0.0 110.872 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -78.11 -41.14 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.443 0.697 . . . . 0.0 110.63 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.488 HG13 HD13 ' A' ' 122' ' ' ILE . 78.1 t -61.12 -47.97 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.834 0.854 . . . . 0.0 110.347 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.4 m -73.11 -24.26 60.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.675 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 35.6 t70 -63.52 -39.81 95.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.83 0.452 . . . . 0.0 110.5 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.3 mm100 -64.47 -35.11 79.86 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.666 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.18 -40.23 59.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.653 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 10.3 mtmp? -67.06 -38.43 85.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.851 0.461 . . . . 0.0 110.908 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -59.47 -43.11 93.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.118 0.967 . . . . 0.0 111.691 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -96.78 -26.73 15.03 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.13 21.65 10.7 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.259 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 115' ' ' LEU . 67.3 m-85 . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.662 . . . . 0.0 110.462 171.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.479 0.181 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.52 -35.09 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.535 0.734 . . . . 0.0 109.619 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.5 t70 -76.4 -12.53 60.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.718 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -67.64 114.89 6.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.303 0.641 . . . . 0.0 111.685 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 56' ' ' ASP . 23.9 m -119.5 160.95 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.996 1.318 . . . . 0.0 110.821 -174.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.4 tp -81.37 112.41 18.63 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 22.2 m-85 -74.39 -29.12 61.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.96 0.504 . . . . 0.0 110.584 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.4 -176.75 29.71 Favored Glycine 0 C--O 1.246 0.851 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.703 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.7 p -110.81 119.83 40.38 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -100.84 133.21 45.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -73.09 96.21 2.16 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -76.48 -179.83 47.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 173.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -139.18 110.32 6.88 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.245 1.023 . . . . 0.0 109.942 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 146' ' ' LEU . 96.8 t -103.65 132.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 70' ' ' LEU . 93.2 t -82.84 141.27 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.317 0.647 . . . . 0.0 109.608 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.31 69.11 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.432 0.458 . . . . 0.0 113.609 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' H ' HG12 ' A' ' 68' ' ' VAL . 70.8 mt -64.13 -18.69 64.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.005 0.922 . . . . 0.0 111.367 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.444 ' HD2' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.15 0.65 18.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.828 1.251 . . . . 0.0 112.295 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 140' ' ' ASN . 11.1 p90 -55.98 -31.02 62.64 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.252 0.621 . . . . 0.0 111.762 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.36 -20.4 63.84 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.127 0.971 . . . . 0.0 111.91 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -74.97 -25.01 58.54 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.875 0.47 . . . . 0.0 110.059 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.55 50.41 0.45 Allowed Glycine 0 C--N 1.355 1.597 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.487 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.771 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 27.7 m -57.28 168.4 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.55 0.69 . . . . 0.0 112.673 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 m -114.41 166.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.543 -171.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.1 156.85 11.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.619 ' HB3' ' HA3' ' A' ' 137' ' ' GLY . 12.2 p30 -68.14 69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.157 1.383 . . . . 0.0 111.674 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -178.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.396 1.078 . . . . 0.0 109.37 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -65.18 149.41 49.96 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.121 -164.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 81.4 mtp -89.17 149.77 22.99 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.802 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.0 m -121.06 151.64 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.729 0.811 . . . . 0.0 110.933 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -108.12 166.45 10.73 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.498 1.119 . . . . 0.0 109.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -122.68 119.41 30.64 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.564 0.746 . . . . 0.0 109.336 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.01 135.83 50.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.255 1.022 . . . . 0.0 108.985 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.459 HH21 ' HG3' ' A' ' 95' ' ' LYS . 69.1 ttt180 -77.49 125.33 29.17 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.157 0.583 . . . . 0.0 109.882 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 91' ' ' ASN . 15.7 t70 -108.02 115.58 58.35 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 49.7 Cg_endo -83.55 -2.75 10.56 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.948 2.432 . . . . 0.0 114.26 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -107.53 21.63 17.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.267 0.627 . . . . 0.0 111.749 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 88' ' ' ASP . 50.9 m-80 -86.28 142.22 35.49 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 121.609 -0.682 . . . . 0.0 111.313 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.67 -12.55 33.3 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.063 2.509 . . . . 0.0 112.284 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -77.76 -53.4 7.57 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.131 0.572 . . . . 0.0 109.528 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 170.78 163.91 0.08 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.874 1.359 . . . . 0.0 109.784 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 89' ' ' PRO . 8.3 ptpp? -59.41 -22.55 61.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.345 1.458 . . . . 0.0 113.243 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -78.44 -12.3 60.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.495 0.718 . . . . 0.0 112.885 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.18 110.44 3.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.838 0.455 . . . . 0.0 110.72 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.4 mt -75.86 120.8 26.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 124.012 0.925 . . . . 0.0 110.657 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 5.5 tppp? -75.07 117.14 16.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.02 167.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 111' ' ' LEU . 15.1 t -77.18 130.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 12.8 m120 -112.62 175.73 5.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.01 173.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.9 p30 -110.54 -167.9 1.24 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.713 0.688 . . . . 0.0 109.92 169.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.48 -27.28 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.409 0.683 . . . . 0.0 112.525 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -73.31 -21.86 60.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.723 0.809 . . . . 0.0 110.641 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 -5.58 60.68 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.837 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 131.84 37.49 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.187 0.595 . . . . 0.0 110.746 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -57.44 127.47 32.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.613 1.165 . . . . 0.0 112.042 177.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.771 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 30.3 m -113.27 -19.52 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 111.228 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.96 -145.93 9.58 Favored Glycine 0 C--N 1.358 1.786 0 C-N-CA 121.594 -0.336 . . . . 0.0 113.756 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -139.96 156.53 46.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.526 1.13 . . . . 0.0 109.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 100' ' ' VAL . 53.9 mt -93.54 4.84 53.32 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.976 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 69.15 146.3 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.707 1.203 . . . . 0.0 110.815 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -56.12 -20.53 17.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.89 -59.43 5.14 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.135 0.974 . . . . 0.0 111.702 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 111' ' ' LEU . 3.9 pp -85.6 -22.03 28.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.615 0.366 . . . . 0.0 111.358 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -64.18 -37.8 88.77 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.48 0.712 . . . . 0.0 111.763 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.14 -29.48 74.51 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.851 0.72 . . . . 0.0 112.906 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.58 5.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 109.632 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.26 -15.92 63.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.977 0.911 . . . . 0.0 112.348 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -52.72 -44.92 66.71 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.41 1.084 . . . . 0.0 113.042 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -70.98 -32.23 69.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.911 0.386 . . . . 0.0 110.207 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.36 -35.44 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.421 0.689 . . . . 0.0 110.334 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.6 tpp -79.8 -33.53 40.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.671 1.188 . . . . 0.0 111.065 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.67 -51.14 10.27 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.169 0.988 . . . . 0.0 110.097 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -88.21 2.06 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.845 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 59.42 34.5 22.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.641 1.177 . . . . 0.0 111.354 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.54 -40.65 95.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.915 0.886 . . . . 0.0 111.894 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.73 134.88 13.13 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.474 0.71 . . . . 0.0 110.311 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.67 104.49 12.11 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.08 123.07 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.724 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.05 149.3 42.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.35 174.71 19.2 Favored Glycine 0 C--O 1.239 0.438 0 O-C-N 123.486 0.491 . . . . 0.0 112.869 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 14.4 p -151.18 143.58 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.869 0.868 . . . . 0.0 110.107 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.81 84.66 32.08 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.716 0.807 . . . . 0.0 110.029 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.62 -17.69 12.47 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.87 2.38 . . . . 0.0 112.647 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -83.22 -30.66 27.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.188 0.595 . . . . 0.0 111.174 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 79' ' ' ASN . . . 57.46 34.18 68.17 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.772 0.67 . . . . 0.0 114.339 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.16 0.31 57.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 0.0 110.548 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.87 -9.12 57.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.059 1.344 . . . . 0.0 112.582 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 72' ' ' TYR . 9.4 p30 -102.51 -22.25 14.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.327 0.651 . . . . 0.0 111.206 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.66 -41.53 7.66 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.629 0.772 . . . . 0.0 112.619 -167.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -160.0 -178.3 6.92 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 -164.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 22.5 p -90.19 108.75 19.94 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 ptm -112.06 148.87 39.96 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.97 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 96.6 Cg_endo -78.77 146.62 21.1 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.925 1.75 . . . . 0.0 110.14 160.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 67' ' ' VAL . 2.6 pt? -137.36 155.61 49.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.022 0.439 . . . . 0.0 110.134 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -74.22 108.08 6.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.118 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' ' 85' ' ' LEU . 24.8 mmt -102.48 153.59 19.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -143.24 124.72 14.78 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.034 0.934 . . . . 0.0 108.853 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.06 117.53 30.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.814 0.846 . . . . 0.0 109.665 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -119.76 100.62 7.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.83 157.28 27.2 Favored Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -61.42 144.44 54.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.751 0.42 . . . . 0.0 111.487 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.32 -34.38 57.19 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.83 -30.31 70.75 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.144 0.429 . . . . 0.0 111.961 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -85.74 -9.84 56.51 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.431 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.9 ppt_? -60.69 -29.25 69.2 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 118.899 0.772 . . . . 0.0 112.152 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.99 -37.76 86.03 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.097 0.559 . . . . 0.0 110.536 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 158' ' ' LYS . . . -82.68 -46.17 13.56 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.829 0.852 . . . . 0.0 110.505 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.54 -50.61 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.38 1.072 . . . . 0.0 111.458 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.9 p -65.0 -39.25 93.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.905 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.94 -38.9 76.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.981 0.912 . . . . 0.0 111.632 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.5 mm100 -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.377 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.58 -56.72 7.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.189 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -55.03 -32.16 61.63 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.336 1.454 . . . . 0.0 112.128 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.15 -39.03 77.75 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -107.16 -11.52 15.59 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.429 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.75 42.17 6.51 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.639 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.455 0.702 . . . . 0.0 110.104 171.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -76.83 -18.04 58.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.45 0.7 . . . . 0.0 111.482 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.42 -22.59 66.97 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.952 0.901 . . . . 0.0 111.643 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -65.79 -41.48 91.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.43 0.692 . . . . 0.0 111.793 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -74.62 -23.78 58.75 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.682 0.219 . . . . 0.0 111.034 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.84 -42.44 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -76.04 -25.64 55.82 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.3 m -75.72 117.61 17.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.655 0.382 . . . . 0.0 110.022 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 m -116.0 156.64 17.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.556 1.142 . . . . 0.0 111.273 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.26 104.93 11.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -74.29 -33.07 63.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 120.955 0.407 . . . . 0.0 110.604 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HE2' ' A' ' 170' ' ' LYS . . . 156.97 -178.54 33.32 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.554 -173.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -111.01 160.54 16.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.433 0.693 . . . . 0.0 109.926 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.507 HD22 HD21 ' A' ' 119' ' ' LEU . 29.7 tp -126.93 154.24 44.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.491 0.662 . . . . 0.0 110.206 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -99.05 86.14 3.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.126 1.371 . . . . 0.0 108.128 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.98 87.28 0.87 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -70.98 80.6 0.65 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.848 0.859 . . . . 0.0 109.818 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.76 138.1 20.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.4 137.37 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 123.78 0.675 . . . . 0.0 109.654 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 142' ' ' PHE . . . -81.51 -31.17 34.28 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.219 -173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 39.5 tp -62.45 -18.81 62.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.978 0.911 . . . . 0.0 111.465 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.488 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 2.7 mmp_? -76.94 0.84 19.55 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.141 0.977 . . . . 0.0 112.582 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.446 ' HA ' HG13 ' A' ' 76' ' ' VAL . 28.2 p90 -51.11 -34.22 29.64 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.436 1.095 . . . . 0.0 112.37 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -62.96 -34.51 77.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.394 1.078 . . . . 0.0 111.971 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 34.1 p -78.68 2.33 19.9 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.79 49.14 0.65 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.952 165.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.729 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 32.7 m -65.66 162.6 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.64 1.22 . . . . 0.0 111.366 174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.08 166.5 8.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.92 0.888 . . . . 0.0 110.913 -170.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.431 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -80.95 -170.83 2.89 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.797 0.839 . . . . 0.0 112.177 -170.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.11 145.86 55.74 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.995 0.918 . . . . 0.0 111.592 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.0 m120 66.25 10.17 6.94 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.326 1.45 . . . . 0.0 113.398 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -84.13 143.84 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.245 0.618 . . . . 0.0 110.141 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.455 ' HG2' HG22 ' A' ' 133' ' ' VAL . 80.6 mtp -96.65 142.0 29.22 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.5 m -126.2 145.81 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.361 1.064 . . . . 0.0 110.237 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -105.79 153.56 21.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.101 0.96 . . . . 0.0 110.461 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mp -109.94 125.97 53.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.584 0.754 . . . . 0.0 109.691 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -140.8 112.86 7.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.718 0.807 . . . . 0.0 109.396 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' HB3' HG12 ' A' ' 98' ' ' ILE . 5.8 ppt_? -87.54 151.35 23.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.52 0.328 . . . . 0.0 110.126 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 91' ' ' ASN . 1.8 m-20 -90.88 149.61 40.57 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 123.59 0.756 . . . . 0.0 111.626 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.92 -43.11 57.35 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.609 2.206 . . . . 0.0 111.634 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -153.38 93.83 1.74 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.685 1.194 . . . . 0.0 108.962 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 1.3 t-20 -89.05 151.74 47.32 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.02 -29.43 44.56 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.618 2.879 . . . . 0.0 113.614 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -71.51 -51.63 22.59 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t0 172.1 162.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.366 1.467 . . . . 0.0 108.319 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -65.01 -15.09 61.93 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.64 1.176 . . . . 0.0 112.266 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -87.78 -15.92 35.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.364 0.666 . . . . 0.0 111.881 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.41 118.82 9.28 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 123.526 0.73 . . . . 0.0 111.665 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 87' ' ' ARG . 63.1 mt -92.03 120.06 40.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.573 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 34.0 mtmm -81.14 123.4 28.39 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 164.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -83.27 126.16 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 6.5 p30 -115.29 173.76 6.35 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 124.598 1.159 . . . . 0.0 107.92 173.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -103.94 -170.38 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 118.666 0.666 . . . . 0.0 110.2 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -57.47 -33.06 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.609 0.764 . . . . 0.0 112.435 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.57 -11.32 59.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.594 0.758 . . . . 0.0 111.564 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.16 14.57 78.81 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.521 -0.308 . . . . 0.0 112.888 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -78.5 120.57 23.4 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.95 0.9 . . . . 0.0 108.586 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.17 99.67 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.517 0.727 . . . . 0.0 109.499 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 23.0 m -71.77 -27.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.199 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.39 176.64 38.34 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.404 0.44 . . . . 0.0 113.41 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.602 ' HD2' ' HG2' ' A' ' 99' ' ' LYS . 31.6 m80 -92.46 133.96 35.41 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 1.3 tt -66.35 -54.08 28.72 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.68 0.612 . . . . 0.0 110.307 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 111' ' ' LEU . 53.9 mmtt 150.85 133.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 -160.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -70.86 -42.02 70.65 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.06 -52.03 65.59 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.128 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -65.84 -40.46 91.75 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.178 0.591 . . . . 0.0 110.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.03 69.85 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.239 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.79 -31.79 64.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.5 0.5 . . . . 0.0 113.125 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.85 -55.58 5.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.552 0.741 . . . . 0.0 110.414 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 63' ' ' LEU . 21.1 mt -73.3 -18.58 61.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -170.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.78 -29.7 65.97 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.412 0.685 . . . . 0.0 110.885 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.86 -35.33 64.74 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 127' ' ' LEU . 58.8 mt -70.86 -33.64 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.275 0.63 . . . . 0.0 110.765 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.2 tpp -74.34 -56.2 5.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.419 1.088 . . . . 0.0 110.659 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.38 -44.78 62.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.267 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.33 5.07 32.22 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.695 0.398 . . . . 0.0 111.403 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 60.98 33.54 19.72 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.377 1.071 . . . . 0.0 112.592 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HB2' HG23 ' A' ' 122' ' ' ILE . 64.2 mt -67.68 -38.56 83.89 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.662 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -166.67 145.89 5.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 111.173 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -78.26 116.87 19.0 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.998 0.919 . . . . 0.0 109.279 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -98.92 112.83 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.144 0.578 . . . . 0.0 109.812 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.43 ' HG2' ' HB ' ' A' ' 149' ' ' THR . 10.9 pt-20 -83.41 167.66 17.29 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -143.27 152.34 23.98 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.455 HG22 ' HG2' ' A' ' 82' ' ' MET . 35.5 t -149.16 128.06 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.475 1.11 . . . . 0.0 108.479 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.31 96.69 1.32 Allowed Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 123.646 0.778 . . . . 0.0 109.449 167.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.39 -31.34 9.22 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.591 2.194 . . . . 0.0 113.316 -176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.09 -20.94 12.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.989 0.916 . . . . 0.0 110.916 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 62.87 29.96 75.74 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.34 0.4 . . . . 0.0 113.468 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.442 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -76.79 3.24 12.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.953 0.901 . . . . 0.0 113.315 -170.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -67.43 -26.63 66.51 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.171 0.589 . . . . 0.0 110.274 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.84 -37.46 73.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.694 0.797 . . . . 0.0 110.569 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.14 -55.23 9.92 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.695 0.798 . . . . 0.0 110.867 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 74.7 t80 -151.34 -77.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.7 p -158.3 165.76 33.99 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.012 1.725 . . . . 0.0 107.85 172.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 14.3 ptt? -167.12 152.37 7.15 Favored Pre-proline 0 C--O 1.246 0.921 0 O-C-N 123.43 0.456 . . . . 0.0 110.398 168.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.67 126.44 10.81 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.996 1.797 . . . . 0.0 110.339 162.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.59 156.23 16.9 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.984 0.514 . . . . 0.0 109.959 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.44 107.02 3.17 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.373 0.42 . . . . 0.0 110.305 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.463 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 65.4 mtt -104.07 160.26 14.99 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.43 ' HB ' ' HG2' ' A' ' 131' ' ' GLU . 19.2 m -154.34 143.3 21.06 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.477 0.58 . . . . 0.0 110.029 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 76.6 m-85 -104.19 117.8 35.1 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.28 1.032 . . . . 0.0 109.851 -174.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -121.04 100.62 7.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.276 1.03 . . . . 0.0 108.811 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.52 167.67 33.07 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -65.69 147.87 52.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -174.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.12 -19.88 48.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.681 1.192 . . . . 0.0 114.046 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.0 -22.08 56.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -93.06 -0.19 57.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.083 0.553 . . . . 0.0 112.478 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 7.6 ppt_? -52.83 -38.11 60.98 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -79.98 -27.62 39.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.793 0.437 . . . . 0.0 110.79 -175.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.85 -39.96 55.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.424 0.69 . . . . 0.0 110.752 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.83 -51.79 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.885 0.874 . . . . 0.0 110.133 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.3 p -65.89 -30.41 71.0 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.589 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -54.89 -42.54 72.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.898 0.879 . . . . 0.0 111.728 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -67.68 -34.41 76.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.299 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.28 -45.39 55.88 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.913 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -61.12 -31.73 71.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.03 1.332 . . . . 0.0 111.372 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -58.34 -42.35 86.64 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.804 1.242 . . . . 0.0 111.296 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -97.62 -15.05 20.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.099 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.32 19.18 31.06 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 113.585 0.194 . . . . 0.0 113.585 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.43 165.94 22.76 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.717 0.807 . . . . 0.0 110.997 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -57.61 147.77 26.23 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.03 0.932 . . . . 0.0 110.82 170.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 124.681 1.192 . . . . 0.0 110.451 -176.765 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.4 m -61.19 -37.11 81.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.631 0.772 . . . . 0.0 111.732 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -86.68 -29.83 22.17 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.014 0.525 . . . . 0.0 111.015 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.38 -39.51 90.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.969 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.31 -27.16 61.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.892 0.477 . . . . 0.0 111.286 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.53 -33.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.384 0.674 . . . . 0.0 109.561 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.38 -25.71 59.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.015 0.926 . . . . 0.0 110.411 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -72.47 134.83 45.53 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.071 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.5 158.53 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.384 1.073 . . . . 0.0 110.469 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tt -83.73 102.6 12.39 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.436 1.094 . . . . 0.0 108.292 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 41.8 m-85 -74.44 -23.24 58.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.108 0.563 . . . . 0.0 111.422 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.35 177.2 14.76 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.032 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -111.22 120.6 42.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.171 0.588 . . . . 0.0 110.267 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.5 tp -86.76 137.71 32.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.539 1.136 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 100.73 4.13 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -90.73 -170.84 43.43 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 166.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -165.43 127.04 2.0 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 100' ' ' VAL . 48.1 t -98.59 134.63 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 70' ' ' LEU . 23.7 t -69.98 143.93 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 O-C-N 123.92 0.763 . . . . 0.0 110.325 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.39 -22.52 78.58 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.233 0.333 . . . . 0.0 113.008 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' H ' HG12 ' A' ' 68' ' ' VAL . 35.0 tp -62.77 -18.15 62.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.429 1.092 . . . . 0.0 111.379 174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 3.5 mmp_? -76.66 1.77 16.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.957 0.903 . . . . 0.0 112.823 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 76' ' ' VAL . 86.7 t80 -48.69 -36.63 16.56 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.92 0.888 . . . . 0.0 112.546 174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -62.44 -40.91 98.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.703 0.801 . . . . 0.0 111.609 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 p -78.51 -4.5 48.87 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.03 49.67 1.45 Allowed Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.898 0.719 . . . . 0.0 114.898 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 72' ' ' TYR . 17.4 m -53.55 164.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG23 HG21 ' A' ' 134' ' ' VAL . 14.8 m -114.6 163.7 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.792 -164.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -92.52 -166.37 1.53 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.996 1.318 . . . . 0.0 111.266 -173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -71.17 147.13 48.65 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.496 0.718 . . . . 0.0 111.6 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 63.98 8.87 4.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.288 1.435 . . . . 0.0 113.637 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -77.04 136.91 38.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.977 0.418 . . . . 0.0 110.31 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.541 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.8 mtp -100.24 150.08 22.91 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.163 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 102' ' ' ASN . 29.8 m -135.11 174.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.537 1.135 . . . . 0.0 109.553 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.33 133.7 16.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.928 1.291 . . . . 0.0 107.714 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.52 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -84.62 146.34 27.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.17 0.588 . . . . 0.0 109.986 -174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -151.2 130.31 12.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.141 0.977 . . . . 0.0 108.598 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.496 HH11 ' HB2' ' A' ' 95' ' ' LYS . 34.1 ptt85 -74.27 146.81 42.93 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -80.46 118.04 70.56 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.101 0.561 . . . . 0.0 110.894 -167.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 -32.63 24.86 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.14 2.56 . . . . 0.0 112.187 173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.75 33.95 2.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.913 0.885 . . . . 0.0 109.925 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -53.89 119.0 17.02 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.586 1.154 . . . . 0.0 112.987 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.88 -28.27 16.72 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.961 2.441 . . . . 0.0 113.155 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -116.45 -51.68 2.59 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.38 0.672 . . . . 0.0 111.328 -176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -167.67 155.64 8.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.841 0.456 . . . . 0.0 110.651 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.496 ' HB2' HH11 ' A' ' 87' ' ' ARG . 8.3 ptpp? -53.43 -23.17 9.17 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.179 1.791 . . . . 0.0 113.373 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 81.2 m-20 -78.98 18.86 0.58 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.775 0.83 . . . . 0.0 112.796 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.04 111.66 23.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 108.948 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 120' ' ' ALA . 29.7 mt -103.82 122.27 56.33 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 C-N-CA 123.592 0.757 . . . . 0.0 110.513 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 16.5 ptpt -85.66 164.37 17.72 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.503 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 67' ' ' VAL . 60.7 t -117.27 117.34 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -110.25 131.39 55.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.936 0.894 . . . . 0.0 108.816 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' HG12 ' A' ' 83' ' ' VAL . 26.3 p-10 -75.71 -168.92 0.94 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 118.307 0.503 . . . . 0.0 111.507 -175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -52.11 -33.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 124.4 1.08 . . . . 0.0 112.96 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.24 -20.32 25.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.178 0.591 . . . . 0.0 111.553 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.53 4.2 54.92 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-N 116.447 -0.342 . . . . 0.0 112.843 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.15 127.46 31.34 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 110.061 175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -77.3 92.16 3.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.925 0.89 . . . . 0.0 109.863 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 4.9 m -75.49 -14.89 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.231 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.24 -143.57 10.69 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 123.587 0.554 . . . . 0.0 112.426 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 51.9 m80 -135.83 166.75 22.57 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.407 1.083 . . . . 0.0 108.461 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 148' ' ' MET . 5.2 mp -78.13 -53.13 7.71 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.557 0.694 . . . . 0.0 109.819 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 170.72 166.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 127.013 2.125 . . . . 0.0 106.771 -167.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -78.67 -44.98 22.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HB3' ' NE2' ' A' ' 167' ' ' HIS . 19.5 mm-40 -66.74 -45.33 78.95 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.85 0.86 . . . . 0.0 111.935 -176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.493 HD11 ' HA2' ' A' ' 65' ' ' GLY . 1.5 tt -64.4 -44.03 92.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.525 0.73 . . . . 0.0 110.007 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.16 85.49 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.645 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -59.63 -30.33 68.6 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.97 0.793 . . . . 0.0 113.389 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -73.1 -61.29 1.87 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.394 0.678 . . . . 0.0 110.058 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.12 -15.79 63.74 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.932 0.893 . . . . 0.0 113.202 -171.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -59.12 -39.55 82.63 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.413 1.085 . . . . 0.0 113.168 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.01 -32.95 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.079 0.552 . . . . 0.0 110.241 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.449 ' HA ' HD12 ' A' ' 127' ' ' LEU . 68.5 mt -66.78 -33.9 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.551 0.74 . . . . 0.0 110.081 174.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 36.4 tpp -78.01 -38.99 43.58 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.19 -47.66 34.21 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.196 0.998 . . . . 0.0 110.406 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -88.71 -1.49 58.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.099 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.87 31.45 18.24 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.264 1.025 . . . . 0.0 111.532 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 122' ' ' ILE . 77.6 mt -58.52 -43.62 89.23 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.157 0.983 . . . . 0.0 111.845 -174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.72 131.53 11.6 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.972 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -81.17 107.19 13.76 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.494 1.118 . . . . 0.0 108.492 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.1 mt -93.35 111.36 24.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.236 0.615 . . . . 0.0 109.948 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.92 179.7 7.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.801 0.84 . . . . 0.0 109.156 169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.26 156.34 27.16 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 82' ' ' MET . 38.8 t -141.76 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.949 0.9 . . . . 0.0 109.69 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.521 HG13 ' HG ' ' A' ' 146' ' ' LEU . 1.7 m -103.73 94.99 6.83 Favored Pre-proline 0 N--CA 1.484 1.246 0 C-N-CA 124.447 1.099 . . . . 0.0 108.622 166.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.09 -48.76 3.27 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.537 2.158 . . . . 0.0 111.927 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.78 -27.79 40.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.604 0.762 . . . . 0.0 110.553 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' ' HB ' ' A' ' 134' ' ' VAL . . . 63.6 30.08 76.58 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 113.733 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.07 -1.25 19.32 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.14 0.976 . . . . 0.0 111.507 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.63 -26.93 66.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.724 0.81 . . . . 0.0 111.09 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 9.9 t-20 -69.07 -29.6 67.76 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.417 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.28 -49.24 4.77 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.646 0.778 . . . . 0.0 110.715 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -133.99 -162.46 1.25 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.845 1.258 . . . . 0.0 110.087 -170.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -103.09 114.5 28.85 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 170.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.9 ptm -112.29 157.11 40.91 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.063 0.545 . . . . 0.0 110.307 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.91 124.81 13.2 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.252 1.968 . . . . 0.0 110.898 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.521 ' HG ' HG13 ' A' ' 134' ' ' VAL . 4.7 tt -109.1 121.21 44.67 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.64 110.3 16.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.932 0.493 . . . . 0.0 109.676 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.52 ' SD ' HD21 ' A' ' 85' ' ' LEU . 47.6 mtt -115.82 113.36 23.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.409 1.084 . . . . 0.0 110.53 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -103.97 129.41 51.55 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.134 0.574 . . . . 0.0 110.472 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 3.9 m-85 -88.4 125.51 34.75 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.094 0.958 . . . . 0.0 109.478 -177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -126.73 99.2 5.67 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.98 161.71 31.69 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.72 145.41 54.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.392 0.677 . . . . 0.0 112.282 -175.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 157' ' ' ARG . 44.5 mt-10 -57.59 -31.74 66.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.253 1.021 . . . . 0.0 113.425 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.53 -23.77 66.28 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -91.28 2.41 56.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.261 0.624 . . . . 0.0 112.404 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.444 HH21 ' HB3' ' A' ' 154' ' ' GLU . 15.5 ptp180 -57.99 -37.97 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 122.844 0.457 . . . . 0.0 111.514 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.67 -43.42 89.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.226 1.01 . . . . 0.0 110.387 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.97 -36.29 67.08 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.358 -177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.39 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.848 0.859 . . . . 0.0 110.443 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.0 p -67.57 -26.78 66.46 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.086 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.13 -37.61 88.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.106 0.562 . . . . 0.0 110.951 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.1 mm100 -74.49 -38.43 62.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.012 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.68 -61.73 2.22 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.47 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -62.63 -21.99 66.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.749 1.219 . . . . 0.0 112.761 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -53.74 -52.34 60.47 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.882 0.873 . . . . 0.0 111.018 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.449 ' NE2' ' HB3' ' A' ' 114' ' ' GLU . 66.3 t-80 -96.25 -17.27 20.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.418 -177.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.1 34.32 5.43 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.734 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.16 152.15 20.68 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.609 0.764 . . . . 0.0 109.878 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -166.41 150.31 7.44 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.798 0.839 . . . . 0.0 109.753 -177.641 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -85.12 36.33 0.62 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.92 0.888 . . . . 0.0 111.93 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.23 -30.64 64.77 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.104 0.962 . . . . 0.0 112.264 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -66.82 -13.01 61.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.813 1.245 . . . . 0.0 113.588 -177.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.55 -28.73 69.54 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.555 0.742 . . . . 0.0 111.18 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.79 -30.96 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.684 0.794 . . . . 0.0 109.584 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -77.77 -18.07 56.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.767 0.827 . . . . 0.0 110.415 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.96 133.5 50.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.995 0.518 . . . . 0.0 110.879 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.2 m -132.62 162.77 39.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 125.015 1.326 . . . . 0.0 109.797 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.3 tp -83.89 111.58 19.36 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 23.0 m-85 -73.51 -25.86 60.62 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.287 0.565 . . . . 0.0 110.611 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.94 -144.25 14.41 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.2 m -132.52 179.74 5.95 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.635 0.774 . . . . 0.0 110.271 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 169' ' ' PHE . 49.2 tp -143.35 146.76 33.8 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.571 0.748 . . . . 0.0 109.516 172.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -71.24 81.81 0.73 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.221 168.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -74.1 74.72 1.18 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -68.08 87.64 0.27 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.529 HG13 ' HA ' ' A' ' 111' ' ' LEU . 36.6 t -87.42 147.97 4.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.696 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 87.6 t -61.46 140.96 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.274 1.029 . . . . 0.0 110.727 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.59 -38.18 15.02 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -17.55 31.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.871 1.269 . . . . 0.0 113.248 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.562 ' NH1' HG23 ' A' ' 108' ' ' VAL . 13.1 ptt180 -69.22 -2.29 10.16 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.491 0.717 . . . . 0.0 112.506 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -51.93 -36.84 50.53 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.071 0.948 . . . . 0.0 112.928 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.08 -30.58 71.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.746 0.818 . . . . 0.0 111.535 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 m -74.38 -6.31 47.44 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.758 0.823 . . . . 0.0 111.786 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.02 45.77 1.24 Allowed Glycine 0 C--N 1.35 1.327 0 O-C-N 122.388 -0.195 . . . . 0.0 113.486 169.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 HG23 ' ND2' ' A' ' 140' ' ' ASN . 28.9 m -64.96 172.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 170.7 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.08 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.68 -146.26 0.4 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.247 0.619 . . . . 0.0 109.769 -172.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 150.91 41.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.286 1.034 . . . . 0.0 112.666 -176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 68.83 -5.44 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.592 1.557 . . . . 0.0 113.208 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.16 146.49 29.53 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.042 0.537 . . . . 0.0 110.622 -172.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.469 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.5 mtp -97.43 143.56 28.04 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.518 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.13 145.78 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 124.36 1.064 . . . . 0.0 108.912 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -99.03 156.01 17.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -115.41 124.49 51.31 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -132.98 116.8 16.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.969 0.908 . . . . 0.0 109.679 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' ' SD ' ' A' ' 123' ' ' MET . 0.0 OUTLIER -67.91 119.21 12.21 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.621 ' HB3' HD21 ' A' ' 91' ' ' ASN . 18.5 t70 -66.6 132.65 94.16 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.571 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.79 -42.52 11.87 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.272 3.314 . . . . 0.0 114.079 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -167.38 106.95 0.58 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 123.138 0.273 . . . . 0.0 110.551 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.621 HD21 ' HB3' ' A' ' 88' ' ' ASP . 24.5 m-80 -96.7 146.26 30.99 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.05 -22.14 48.2 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.765 2.31 . . . . 0.0 114.003 -170.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -125.94 -46.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.713 0.405 . . . . 0.0 110.858 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.428 ' HB3' ' ND2' ' A' ' 96' ' ' ASN . 33.7 m-20 -117.14 92.7 3.93 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.011 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -55.86 -33.16 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.728 0.811 . . . . 0.0 111.686 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.585 ' H ' HD22 ' A' ' 96' ' ' ASN . 0.0 OUTLIER -72.3 -8.29 54.08 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 113.1 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 108.41 2.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.237 0.615 . . . . 0.0 111.375 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.32 125.95 45.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 124.081 0.952 . . . . 0.0 110.213 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 32.4 mmtp -86.8 123.91 32.46 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.106 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.61 112.67 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.0 m-20 -91.53 170.36 10.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.188 0.995 . . . . 0.0 108.849 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -108.11 -171.99 1.97 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.843 0.457 . . . . 0.0 110.248 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.69 -28.38 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.637 0.775 . . . . 0.0 112.24 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.9 -30.48 63.95 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.176 0.591 . . . . 0.0 110.357 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.19 -4.34 30.03 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.485 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -74.81 137.4 41.87 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.278 0.539 . . . . 0.0 110.026 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.78 95.37 0.89 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.562 HG23 ' NH1' ' A' ' 71' ' ' ARG . 27.8 m -86.95 16.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.861 0.865 . . . . 0.0 112.012 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 148.01 -175.72 27.19 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.925 169.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -102.68 148.83 25.09 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.11 0.964 . . . . 0.0 108.972 175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.2 tt -73.89 -56.09 5.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? 152.12 121.83 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -165.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -61.11 -49.47 77.13 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 118.802 0.728 . . . . 0.0 112.072 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.33 -41.56 93.81 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.821 0.7 . . . . 0.0 110.82 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.77 -40.08 66.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.831 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.32 -24.54 65.75 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.008 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.28 -33.82 88.29 Favored Glycine 0 C--N 1.351 1.361 0 O-C-N 123.603 0.565 . . . . 0.0 112.958 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.43 -56.84 4.78 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.413 0.625 . . . . 0.0 109.802 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.425 HD21 HD22 ' A' ' 63' ' ' LEU . 22.5 mt -70.5 -18.12 62.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.506 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.96 67.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.881 0.873 . . . . 0.0 111.153 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -66.03 -35.5 80.72 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.184 0.928 . . . . 0.0 110.44 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.507 ' HA ' HD12 ' A' ' 127' ' ' LEU . 83.9 mt -62.62 -44.55 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 0.0 110.585 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.505 ' HE1' ' HB3' ' A' ' 85' ' ' LEU . 30.1 ttm -81.19 -21.46 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.644 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.31 -51.05 10.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.251 0.62 . . . . 0.0 109.72 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -89.71 4.16 50.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.224 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 59.71 36.63 22.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.533 1.133 . . . . 0.0 111.594 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 122' ' ' ILE . 66.0 mt -62.22 -40.83 97.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.44 1.096 . . . . 0.0 111.54 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.504 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.15 140.86 9.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.13 0.572 . . . . 0.0 111.093 176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -76.52 133.51 39.72 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.4 mt -117.1 113.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.39 132.75 54.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -102.35 154.78 18.53 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.773 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 82' ' ' MET . 67.3 t -137.99 137.26 44.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.23 84.88 4.98 Favored Pre-proline 0 CA--C 1.555 1.17 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.47 -35.78 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.656 2.237 . . . . 0.0 111.74 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.25 -26.13 58.61 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.966 0.907 . . . . 0.0 110.59 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.76 -6.08 14.18 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 115.835 1.094 . . . . 0.0 115.835 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.12 1.8 30.22 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.481 0.641 . . . . 0.0 112.723 -172.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.602 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 3.4 t-20 -75.32 -18.4 60.03 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.116 0.484 . . . . 0.0 110.315 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' HG23 ' A' ' 76' ' ' VAL . 20.6 t-20 -61.89 -34.23 75.66 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.092 0.957 . . . . 0.0 110.663 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -101.94 -56.39 2.28 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.828 0.851 . . . . 0.0 112.579 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -126.8 -178.25 4.32 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.542 1.137 . . . . 0.0 110.573 -161.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p -93.8 125.46 38.43 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.087 0.955 . . . . 0.0 109.631 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 139' ' ' ASN . 3.3 ppp? -156.61 160.93 30.41 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.172 0.989 . . . . 0.0 109.302 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.96 121.5 7.36 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.791 1.661 . . . . 0.0 111.147 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 67' ' ' VAL . 6.5 tt -100.34 124.88 46.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -74.33 108.84 7.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.627 ' SD ' HD21 ' A' ' 85' ' ' LEU . 58.5 mtt -116.05 121.74 43.11 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.76 0.824 . . . . 0.0 109.581 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.2 p -108.99 140.53 42.36 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.373 1.069 . . . . 0.0 110.206 -168.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 43.5 m-85 -104.15 121.01 42.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.923 0.889 . . . . 0.0 109.684 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -124.5 112.88 17.4 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.48 164.45 37.97 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 53' ' ' GLU . 7.9 ptpp? -54.26 137.69 40.68 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.534 0.734 . . . . 0.0 110.541 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -53.93 -39.0 65.47 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 123.854 0.721 . . . . 0.0 112.551 -169.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.42 -18.03 35.67 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.319 1.048 . . . . 0.0 113.759 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -92.51 -8.22 45.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.79 -33.62 66.84 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.056 0.542 . . . . 0.0 112.398 -175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 46.7 pttt -61.89 -49.93 74.24 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.674 0.789 . . . . 0.0 111.381 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -68.65 -34.7 76.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.62 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.96 -44.24 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.657 0.783 . . . . 0.0 110.466 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.5 m -72.67 -25.97 61.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.543 0.737 . . . . 0.0 111.005 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 32.7 t70 -58.77 -39.92 82.43 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.15 0.5 . . . . 0.0 110.286 176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 166' ' ' LYS . 14.7 mm100 -73.19 -39.49 65.53 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.12 -175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.51 -57.54 4.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.32 -21.29 59.52 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.654 1.181 . . . . 0.0 112.484 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 163' ' ' GLN . 21.8 ttmm -56.23 -50.38 71.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.989 0.916 . . . . 0.0 111.177 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -111.59 18.7 18.82 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.174 0.59 . . . . 0.0 110.545 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 72.0 14.07 76.05 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.584 ' HB3' HD11 ' A' ' 63' ' ' LEU . 28.4 m-85 -66.1 137.55 57.13 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.883 0.873 . . . . 0.0 110.892 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -166.54 151.0 7.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.467 1.107 . . . . 0.0 108.022 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.564 1.507 0 C-N-CA 123.435 0.694 . . . . 0.0 111.628 174.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 120.096 -0.28 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.2 t -60.31 -35.5 75.74 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.246 1.019 . . . . 0.0 111.372 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -73.73 -40.09 63.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.196 0.598 . . . . 0.0 110.874 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -67.62 -42.05 82.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.101 0.961 . . . . 0.0 111.588 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.39 -36.78 71.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.328 0.651 . . . . 0.0 111.993 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.0 t -72.54 -31.44 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 58' ' ' VAL . 14.4 t70 -77.4 -14.0 59.8 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.285 0.634 . . . . 0.0 111.126 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 m -70.66 109.29 4.82 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.464 0.65 . . . . 0.0 110.519 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 56' ' ' ASP . 16.9 m -116.61 162.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.853 1.261 . . . . 0.0 110.293 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.76 118.49 22.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 157' ' ' ARG . 27.8 m-85 -83.31 -31.5 26.83 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.322 0.582 . . . . 0.0 110.167 174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.1 -167.94 29.49 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.873 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 147' ' ' HIS . 77.6 p -125.58 138.98 53.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.889 0.476 . . . . 0.0 110.102 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 33.6 tp -99.09 140.95 32.48 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.075 0.95 . . . . 0.0 109.761 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -75.37 78.87 2.44 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.928 0.87 . . . . 0.0 110.486 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA2' HD11 ' A' ' 115' ' ' LEU . . . -71.68 141.23 31.66 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.419 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -122.01 100.72 7.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.45 0.7 . . . . 0.0 109.776 -176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.96 131.23 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.93 0.769 . . . . 0.0 108.974 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.66 142.32 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.741 0.816 . . . . 0.0 111.594 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.63 -27.29 57.35 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.64 -175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.85 -19.57 65.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.444 0.698 . . . . 0.0 110.072 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 4.1 mmp_? -78.1 0.27 25.39 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.47 1.108 . . . . 0.0 112.807 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.05 -36.66 65.8 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.473 0.709 . . . . 0.0 112.12 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.82 -32.23 73.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.701 0.8 . . . . 0.0 111.85 -174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 p -87.22 15.5 6.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.13 0.572 . . . . 0.0 112.399 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.04 49.95 1.41 Allowed Glycine 0 C--N 1.356 1.653 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 163.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.47 169.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.093 0.947 . . . . 0.0 111.585 171.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 HG11 ' A' ' 134' ' ' VAL . 27.6 m -115.64 158.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.769 0.828 . . . . 0.0 111.902 -164.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -74.32 -173.95 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.136 0.974 . . . . 0.0 110.758 -179.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -72.44 153.23 41.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.44 8.74 5.96 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 125.019 1.328 . . . . 0.0 112.229 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -88.11 145.41 25.96 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.7 -0.625 . . . . 0.0 111.553 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.578 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -95.36 147.37 23.58 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.123 177.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.82 142.09 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.556 1.142 . . . . 0.0 108.853 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -115.01 124.69 52.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.721 0.808 . . . . 0.0 109.56 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.9 mt -76.83 158.84 30.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.681 0.393 . . . . 0.0 110.707 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.03 121.59 4.89 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.425 0.69 . . . . 0.0 110.116 -174.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -63.28 134.61 56.14 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.471 0.708 . . . . 0.0 110.835 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' A' ' 91' ' ' ASN . 3.5 m-20 -68.74 118.28 59.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.319 0.647 . . . . 0.0 109.319 169.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.75 -29.57 90.07 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.918 2.412 . . . . 0.0 112.866 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -144.42 98.99 3.29 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 97' ' ' ALA . 14.7 m120 -65.64 138.69 96.79 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.583 0.753 . . . . 0.0 110.632 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.46 -54.41 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.434 2.089 . . . . 0.0 113.139 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -128.61 -50.72 1.26 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.754 0.822 . . . . 0.0 109.768 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.71 101.25 13.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.019 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.25 -4.96 28.6 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.528 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 3.6 p-10 -99.37 -2.14 37.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.282 1.033 . . . . 0.0 111.784 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 91' ' ' ASN . . . -68.71 144.24 54.47 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.021 0.528 . . . . 0.0 111.384 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.8 mt -132.19 126.18 55.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.145 0.978 . . . . 0.0 108.931 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.17 152.93 43.74 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.506 0.722 . . . . 0.0 111.209 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.31 134.08 64.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -121.05 166.48 13.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.429 1.091 . . . . 0.0 108.084 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -99.34 -172.64 2.3 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 171.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.11 -19.28 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 C-N-CA 123.227 0.611 . . . . 0.0 112.582 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -84.92 -10.93 56.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.354 0.662 . . . . 0.0 110.919 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.3 19.9 59.77 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.565 -0.288 . . . . 0.0 113.648 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.88 127.68 35.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.12 0.968 . . . . 0.0 109.762 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -68.01 110.49 3.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.091 0.956 . . . . 0.0 110.239 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 4.3 m -84.3 -10.51 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.943 0.497 . . . . 0.0 110.643 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.96 -141.52 12.86 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -106.05 173.76 6.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.733 0.813 . . . . 0.0 110.072 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.431 HD11 ' SD ' ' A' ' 148' ' ' MET . 2.3 tt -84.71 -52.32 6.16 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.8 tptp 172.01 168.77 0.1 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -79.06 -63.77 1.34 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.26 -36.55 74.53 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.98 0.912 . . . . 0.0 112.379 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.483 HD11 ' HA2' ' A' ' 65' ' ' GLY . 4.9 tt -73.05 -46.02 54.18 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.896 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.03 67.44 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.838 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -61.48 -40.04 98.14 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.592 0.558 . . . . 0.0 113.347 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.57 -49.55 39.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.38 0.609 . . . . 0.0 109.86 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 122' ' ' ILE . 17.1 mt -69.31 -16.74 63.62 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.819 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.84 -57.95 9.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.381 1.072 . . . . 0.0 111.543 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -64.07 -31.0 72.03 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.909 0.756 . . . . 0.0 110.687 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.539 ' HA ' HD12 ' A' ' 127' ' ' LEU . 73.5 mt -67.34 -40.61 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.509 0.723 . . . . 0.0 111.203 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 45.7 ttm -80.36 -36.31 34.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.232 0.613 . . . . 0.0 110.971 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.13 -41.41 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.272 1.029 . . . . 0.0 111.101 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -99.67 7.98 44.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.648 0.779 . . . . 0.0 111.096 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 63.08 35.77 12.75 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.33 1.052 . . . . 0.0 111.762 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 122' ' ' ILE . 64.1 mt -69.5 -50.22 47.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.009 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -152.11 145.0 24.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.225 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -87.89 134.66 33.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 108.599 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 55.2 mt -121.4 117.42 52.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 120.721 0.296 . . . . 0.0 110.301 -173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -117.37 121.25 40.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.252 1.021 . . . . 0.0 108.451 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -90.14 155.52 24.48 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 116.582 -0.281 . . . . 0.0 112.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 82' ' ' MET . 53.3 t -138.68 128.02 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.56 HG11 HG23 ' A' ' 77' ' ' VAL . 5.0 p -96.01 102.27 10.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.711 0.805 . . . . 0.0 109.301 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.36 -53.56 0.18 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.296 1.997 . . . . 0.0 113.574 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -84.98 -27.59 26.36 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.035 0.534 . . . . 0.0 110.941 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.35 81.84 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 113.718 0.247 . . . . 0.0 113.718 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.652 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -75.93 -7.75 55.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.423 0.689 . . . . 0.0 112.277 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.78 -16.65 63.86 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.864 0.865 . . . . 0.0 110.973 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -73.12 -25.66 60.93 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.622 0.769 . . . . 0.0 111.29 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.07 -60.61 2.19 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -141.5 -83.49 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.1 m -157.5 140.62 15.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.652 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -153.06 149.38 21.69 Favored Pre-proline 0 C--O 1.243 0.758 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 173.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.75 124.4 14.49 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.326 2.017 . . . . 0.0 112.815 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.485 HD22 ' HB ' ' A' ' 134' ' ' VAL . 4.3 pp -117.77 146.25 43.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.043 0.937 . . . . 0.0 108.858 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 34.5 m80 -86.55 109.85 19.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.612 0.365 . . . . 0.0 111.139 -166.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.649 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 40.3 mtt -99.76 111.77 24.07 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.188 0.995 . . . . 0.0 109.468 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 49.5 p -93.99 128.22 40.21 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.154 0.982 . . . . 0.0 109.653 -166.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.403 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 24.7 m-85 -91.13 117.25 29.45 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.261 -177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -120.44 99.18 6.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.89 166.55 31.45 Favored Glycine 0 CA--C 1.501 -0.832 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.342 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.03 149.3 45.04 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -43.58 -48.02 7.51 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.78 1.632 . . . . 0.0 113.613 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.14 -9.89 55.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -171.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 127' ' ' LEU . 98.9 m-20 -107.62 -4.36 18.36 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 8.9 ptp85 -63.44 -29.24 70.56 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.216 0.916 . . . . 0.0 112.228 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -58.16 -42.52 86.14 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.67 0.788 . . . . 0.0 109.847 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.06 -34.12 29.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.467 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.89 -57.75 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.654 0.782 . . . . 0.0 110.517 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 m -62.95 -25.45 68.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.098 0.959 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.4 t70 -60.57 -48.65 80.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.526 0.33 . . . . 0.0 110.375 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.9 mm100 -64.06 -35.22 80.02 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.956 0.785 . . . . 0.0 111.155 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.05 -62.46 1.45 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.342 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -58.91 -26.98 64.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.497 0.719 . . . . 0.0 111.694 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 37.1 ttmt -56.06 -50.09 71.95 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.645 1.178 . . . . 0.0 111.793 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -87.15 -13.46 44.02 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.02 10.85 23.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-O 119.916 -0.38 . . . . 0.0 113.548 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -73.71 168.97 18.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.078 0.551 . . . . 0.0 110.106 171.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 151.48 46.88 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 122.67 0.388 . . . . 0.0 110.216 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.8 pt? . . . . . 0 CA--C 1.565 1.542 0 C-N-CA 123.019 0.528 . . . . 0.0 110.153 170.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 t -65.68 -35.2 80.1 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.724 0.809 . . . . 0.0 110.464 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.78 -28.01 69.29 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.386 1.474 . . . . 0.0 113.742 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 50' ' ' GLY . 15.8 pt-20 -70.4 -31.25 68.39 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.755 0.422 . . . . 0.0 111.82 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -27.56 21.51 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.768 0.427 . . . . 0.0 110.471 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.92 -32.05 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.44 0.696 . . . . 0.0 109.605 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.97 -33.26 75.62 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.349 1.06 . . . . 0.0 110.48 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.0 m -78.53 127.49 32.22 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.753 0.821 . . . . 0.0 110.693 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.85 166.78 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.786 1.234 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.8 tp -84.51 117.59 23.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.497 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 20.7 m-85 -81.12 -28.86 34.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.058 0.543 . . . . 0.0 110.648 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.93 -153.26 25.19 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 171' ' ' LEU . 35.0 p -126.47 178.61 5.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.414 0.685 . . . . 0.0 110.559 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.4 tp -150.96 141.56 22.62 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.913 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -71.74 84.14 0.9 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.494 0.718 . . . . 0.0 109.717 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.37 87.25 1.38 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.168 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 18.2 t60 -73.79 94.28 2.24 Favored 'General case' 0 C--N 1.348 0.539 0 C-N-CA 123.203 0.601 . . . . 0.0 110.213 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.55 HG11 ' HD2' ' A' ' 71' ' ' ARG . 38.3 t -82.22 142.68 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.431 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.74 154.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.892 0.877 . . . . 0.0 113.072 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.46 -19.95 72.85 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.387 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.3 tp -57.23 -23.85 50.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.973 1.309 . . . . 0.0 111.489 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.55 ' HD2' HG11 ' A' ' 67' ' ' VAL . 70.8 ttt180 -54.85 -21.83 12.62 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.241 1.416 . . . . 0.0 113.15 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -49.91 -49.6 49.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.165 0.986 . . . . 0.0 111.95 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -75.45 -25.94 57.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.056 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.1 m -80.46 -9.23 59.76 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.011 0.524 . . . . 0.0 110.53 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.31 50.18 0.73 Allowed Glycine 0 C--N 1.355 1.601 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.309 170.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 m -42.19 158.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 33.1 m -112.99 152.19 14.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.222 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.75 -76.84 0.11 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.338 0.399 . . . . 0.0 110.789 -164.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -164.07 159.22 20.28 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.065 0.946 . . . . 0.0 109.617 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 70.7 -7.6 1.04 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.486 1.114 . . . . 0.0 111.892 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.648 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 72.4 mm-40 -75.25 144.0 42.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.758 0.823 . . . . 0.0 111.965 -167.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.568 ' HG2' HG22 ' A' ' 133' ' ' VAL . 73.4 mtm -95.04 144.53 25.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.46 170.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.93 160.79 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.084 0.954 . . . . 0.0 109.083 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.68 25.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.6 mp -85.38 134.06 34.1 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.045 0.538 . . . . 0.0 109.575 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -142.78 130.7 21.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.3 0.64 . . . . 0.0 109.486 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -80.76 124.32 28.95 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB3' ' HE2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -99.16 137.18 20.38 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.385 0.674 . . . . 0.0 111.446 -177.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.54 -28.7 6.51 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.622 2.215 . . . . 0.0 112.025 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -80.65 83.72 6.36 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 3.9 p-10 -89.92 127.91 52.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.334 -166.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 10.1 Cg_exo -74.47 -26.92 11.56 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.553 2.168 . . . . 0.0 112.408 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -120.84 -53.38 2.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.254 0.621 . . . . 0.0 111.578 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -168.1 154.0 7.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.01 -13.38 2.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.162 0.985 . . . . 0.0 113.636 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.505 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 90.0 m-20 -95.19 27.68 3.15 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.065 0.946 . . . . 0.0 111.48 174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.7 34.15 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.057 0.543 . . . . 0.0 110.687 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.3 mt -116.36 123.87 71.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 C-N-CA 123.967 0.907 . . . . 0.0 109.437 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -81.84 150.13 27.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.591 0.71 . . . . 0.0 110.465 170.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -101.11 109.95 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -89.91 167.73 12.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -107.1 -165.6 1.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 118.298 0.499 . . . . 0.0 110.482 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.9 m -59.04 -31.24 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.847 0.859 . . . . 0.0 112.034 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.08 -11.96 57.53 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.196 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.12 5.37 85.82 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 113.169 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 133.66 36.23 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 109.746 177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -61.64 92.45 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 O-C-N 124.283 0.99 . . . . 0.0 110.816 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.92 -1.7 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.738 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.494 ' HA3' ' HG3' ' A' ' 71' ' ' ARG . . . 172.76 -159.34 29.9 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.554 0.533 . . . . 0.0 113.83 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 11.6 p-80 -142.01 150.48 41.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.887 1.275 . . . . 0.0 107.632 171.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.51 -53.84 12.53 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -173.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -178.47 -179.32 0.66 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.988 1.715 . . . . 0.0 108.104 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -81.0 -61.41 1.97 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 162.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.22 -39.21 23.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.712 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tt -67.08 -44.89 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.78 70.75 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.508 -1.223 . . . . 0.0 111.13 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -61.44 -42.82 99.86 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.876 0.735 . . . . 0.0 114.353 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.75 -47.95 67.82 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.389 0.614 . . . . 0.0 110.534 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.49 -18.97 63.74 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.55 87.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.117 0.967 . . . . 0.0 111.861 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -70.04 -32.87 71.21 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.699 0.625 . . . . 0.0 109.584 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.466 HD13 HG13 ' A' ' 160' ' ' VAL . 66.5 mt -67.63 -37.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.654 0.782 . . . . 0.0 110.782 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.91 -44.9 21.69 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.797 0.839 . . . . 0.0 111.075 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.74 -46.7 52.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.653 1.181 . . . . 0.0 110.791 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.97 6.86 33.81 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.806 0.443 . . . . 0.0 111.243 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 59.92 33.56 21.53 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.806 1.242 . . . . 0.0 111.733 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 122' ' ' ILE . 68.9 mt -65.71 -42.59 90.93 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -158.34 151.17 22.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -86.39 132.11 34.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 169.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.5 mt -113.81 113.44 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -102.99 179.27 4.32 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.208 1.003 . . . . 0.0 108.481 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -154.33 164.38 31.47 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.9 t -144.44 134.18 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 137' ' ' GLY . 5.3 p -112.83 88.8 12.21 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.7 -22.88 8.73 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.489 2.126 . . . . 0.0 112.699 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -82.48 -28.45 31.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.923 0.489 . . . . 0.0 110.518 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 75.75 4.29 75.84 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -69.73 -9.05 52.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.301 0.64 . . . . 0.0 112.702 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.74 -18.66 64.96 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.0 0.92 . . . . 0.0 113.221 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.62 -53.01 9.27 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.703 0.627 . . . . 0.0 110.705 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.73 -34.35 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.169 0.588 . . . . 0.0 111.301 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -117.39 174.34 6.2 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.718 0.807 . . . . 0.0 110.819 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 t -98.92 111.02 23.54 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.512 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.6 ptm -125.8 158.74 64.36 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 121.921 -0.487 . . . . 0.0 110.644 -175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 2.5 Cg_endo -83.57 125.73 3.91 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.765 2.31 . . . . 0.0 110.826 164.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.3 pp -110.22 154.75 22.95 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -74.76 111.21 9.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.053 0.541 . . . . 0.0 110.35 -171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -109.88 117.12 32.98 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.228 1.011 . . . . 0.0 110.328 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -107.49 135.23 49.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.505 1.122 . . . . 0.0 110.424 -167.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.2 118.95 35.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 109.424 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -123.62 103.49 8.45 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.47 169.47 36.99 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 138.06 58.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.011 0.525 . . . . 0.0 111.734 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -52.48 -32.06 38.02 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.643 1.577 . . . . 0.0 113.071 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.34 -10.1 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.546 0.738 . . . . 0.0 112.697 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -110.57 4.13 20.05 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.841 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -61.06 -33.52 73.44 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.377 0.99 . . . . 0.0 111.756 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -33.19 69.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.239 0.616 . . . . 0.0 110.769 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -76.7 -38.31 54.61 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.615 0.766 . . . . 0.0 110.575 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD13 ' A' ' 122' ' ' ILE . 64.3 t -64.34 -47.65 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.141 0.976 . . . . 0.0 110.27 175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.5 p -68.45 -29.87 68.61 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.881 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -61.23 -43.13 99.38 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.38 0.672 . . . . 0.0 111.253 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 12.1 mm100 -63.15 -37.26 86.53 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.958 0.786 . . . . 0.0 110.485 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -48.38 51.01 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.223 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -66.07 -25.7 67.15 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.408 1.083 . . . . 0.0 111.611 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -67.04 -44.01 81.32 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.939 0.895 . . . . 0.0 111.293 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -110.09 3.94 20.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.903 0.481 . . . . 0.0 110.893 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.21 66.7 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.523 0.569 . . . . 0.0 114.523 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.24 140.2 41.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.125 0.57 . . . . 0.0 110.373 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -169.57 145.78 3.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 171' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.326 0 C-N-CA 123.533 0.733 . . . . 0.0 110.133 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.446 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.3 t -62.29 -43.57 98.52 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.111 0.964 . . . . 0.0 111.528 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.23 -37.2 76.92 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.687 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -48.02 66.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.713 0.805 . . . . 0.0 110.781 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -77.32 -22.96 51.11 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.984 0.514 . . . . 0.0 112.286 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.85 -27.6 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.498 0.719 . . . . 0.0 109.494 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.5 -16.97 60.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.642 0.777 . . . . 0.0 110.954 172.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -70.39 146.03 50.7 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 122.829 0.452 . . . . 0.0 109.976 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG21 ' HG2' ' A' ' 154' ' ' GLU . 24.0 m -141.14 161.13 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.932 1.293 . . . . 0.0 110.021 -174.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.94 111.37 16.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.0 m-85 -74.02 -38.63 63.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.862 0.465 . . . . 0.0 110.905 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.8 -166.66 29.3 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.179 -169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.0 p -111.11 178.7 4.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.186 0.517 . . . . 0.0 111.474 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 47.6 tp -151.28 146.58 26.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.477 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -94.11 93.94 8.11 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.76 0.79 . . . . 0.0 109.399 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.83 102.85 2.61 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.829 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -78.66 105.7 10.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.363 0.581 . . . . 0.0 109.975 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG11 ' HD2' ' A' ' 71' ' ' ARG . 10.8 t -89.56 147.33 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 112' ' ' LYS . 31.4 m -80.62 167.88 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.26 -20.0 68.9 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 114.996 -1.002 . . . . 0.0 114.093 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.19 -17.78 30.62 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.265 0.626 . . . . 0.0 111.468 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.73 ' HD3' ' HB2' ' A' ' 139' ' ' ASN . 68.7 ttt180 -56.26 -42.0 76.71 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.21 1.004 . . . . 0.0 112.98 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.557 ' HA ' HG13 ' A' ' 76' ' ' VAL . 16.0 p90 -75.06 -16.78 60.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.167 0.439 . . . . 0.0 111.583 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -83.44 -28.92 28.48 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.702 0.801 . . . . 0.0 110.289 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.1 m -75.22 -27.9 59.73 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.271 0.628 . . . . 0.0 111.152 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.54 53.98 0.31 Allowed Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.407 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 72' ' ' TYR . 3.3 m -41.45 169.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.599 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 9.2 m -115.53 -179.64 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.004 -176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.15 -166.7 0.52 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.559 1.144 . . . . 0.0 110.673 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -77.82 141.0 39.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.165 0.586 . . . . 0.0 110.894 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 8.0 t30 58.46 32.8 22.52 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.712 1.205 . . . . 0.0 112.447 170.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.599 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mm-40 -82.65 141.52 32.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.673 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.553 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.4 mtp -88.02 142.2 27.97 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 32.9 m -132.83 150.9 33.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.846 0.858 . . . . 0.0 110.246 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -107.69 157.15 18.34 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.264 1.026 . . . . 0.0 109.568 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.92 146.06 39.65 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.374 0.67 . . . . 0.0 110.003 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -155.35 130.61 9.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 13.2 ptm180 -66.89 146.03 54.83 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.11 0.481 . . . . 0.0 111.267 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -99.29 106.85 41.49 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.173 0.989 . . . . 0.0 108.445 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -83.7 3.56 7.59 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.802 2.335 . . . . 0.0 112.851 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -119.8 -11.21 9.4 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.661 0.784 . . . . 0.0 111.518 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 92' ' ' PRO . 5.1 t-20 -63.06 121.78 71.12 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-O 118.578 -0.725 . . . . 0.0 109.944 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 33.8 Cg_endo -59.49 -19.78 53.62 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.883 3.055 . . . . 0.0 114.355 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -72.14 -50.58 26.78 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.415 0.686 . . . . 0.0 110.524 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 96' ' ' ASN . 21.9 p-10 177.74 157.04 0.38 Allowed 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.276 0.985 . . . . 0.0 110.66 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -64.03 -23.22 67.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.265 176.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 10.8 m-20 -75.61 -2.23 28.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.746 0.818 . . . . 0.0 112.499 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.5 33.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.499 0.32 . . . . 0.0 110.158 169.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.0 mt -133.75 126.34 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.024 0.929 . . . . 0.0 109.739 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -82.27 134.08 35.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 168.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.58 134.85 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.287 0.635 . . . . 0.0 109.355 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.0 p30 -121.93 171.16 9.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 172.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.8 p30 -107.51 -169.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.482 1.037 . . . . 0.0 109.803 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.36 -29.89 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.47 -11.95 59.98 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.041 0.936 . . . . 0.0 111.692 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.17 -1.89 77.89 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 122.9 0.286 . . . . 0.0 113.382 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.8 t-20 -73.9 128.41 35.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.829 0.852 . . . . 0.0 109.721 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.08 114.86 3.98 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.616 0.766 . . . . 0.0 110.409 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' ASN . 35.6 m -126.56 13.87 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.855 0.862 . . . . 0.0 111.974 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.36 -170.29 43.08 Favored Glycine 0 C--N 1.355 1.636 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.02 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -166.26 123.47 1.37 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.07 0.948 . . . . 0.0 109.123 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 115' ' ' LEU . 95.6 mt -80.34 7.26 9.97 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.1 0.96 . . . . 0.0 113.168 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HG3' ' H ' ' A' ' 113' ' ' LYS . 16.1 tptm 64.08 -156.44 0.31 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.632 1.173 . . . . 0.0 109.972 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 16.5 ttmm -79.03 -48.61 14.1 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 118.987 0.812 . . . . 0.0 110.882 170.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.06 -59.47 4.71 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.073 0.858 . . . . 0.0 112.572 -162.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.513 HD12 HD13 ' A' ' 111' ' ' LEU . 1.9 tm? -72.45 -46.54 54.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.618 0.723 . . . . 0.0 109.206 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -64.57 -29.47 70.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.713 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -65.71 -35.67 91.32 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 123.503 0.573 . . . . 0.0 112.63 -173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.71 -51.39 49.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.797 0.808 . . . . 0.0 109.486 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.68 -15.92 62.76 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.673 -1.148 . . . . 0.0 112.559 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.02 86.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.615 1.166 . . . . 0.0 112.689 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -73.76 -33.83 64.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 127' ' ' LEU . 56.8 mt -67.31 -33.5 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.419 0.688 . . . . 0.0 110.241 174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 47.5 tpp -73.7 -43.36 59.5 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.005 1.322 . . . . 0.0 110.497 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.59 -50.47 30.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.803 -174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -91.05 2.03 56.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.483 -173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt 56.03 44.13 25.98 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.714 1.205 . . . . 0.0 111.58 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.527 ' HB2' HG23 ' A' ' 122' ' ' ILE . 73.4 mt -70.18 -40.86 74.4 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.213 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -156.96 139.3 14.74 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -70.96 112.48 7.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.091 0.956 . . . . 0.0 109.529 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.3 mt -99.14 120.33 48.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.38 166.8 11.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 170.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.88 150.36 21.94 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 82' ' ' MET . 64.8 t -142.08 116.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.26 92.74 0.93 Allowed Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 11.7 Cg_exo -69.65 -53.56 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.845 2.363 . . . . 0.0 113.498 -162.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -75.81 -26.31 57.13 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.631 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 72.67 19.99 79.43 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.939 -176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.78 -1.97 18.64 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.73 ' HB2' ' HD3' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -63.17 -18.52 63.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.427 1.491 . . . . 0.0 113.84 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -82.22 -41.84 19.74 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.256 0.622 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.16 -58.42 3.29 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.809 0.444 . . . . 0.0 110.336 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -137.74 -163.15 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.791 0.836 . . . . 0.0 110.294 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.0 p -95.2 127.02 40.92 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.6 ptm -129.36 151.29 77.61 Favored Pre-proline 0 C--O 1.249 1.059 0 C-N-CA 123.171 0.588 . . . . 0.0 109.51 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.59 139.82 25.92 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 121.968 1.778 . . . . 0.0 110.521 166.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -106.05 144.78 32.28 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -69.8 110.48 4.97 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 24.9 mtp -102.94 158.75 16.07 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -150.5 139.59 21.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 90.2 m-85 -101.83 133.2 46.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.078 0.951 . . . . 0.0 109.973 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -131.36 100.52 5.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.24 1.016 . . . . 0.0 108.805 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.56 169.39 37.82 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.46 145.91 52.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.943 0.497 . . . . 0.0 111.715 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HG2' HG21 ' A' ' 58' ' ' VAL . 37.6 mt-10 -59.87 -28.5 67.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.035 0.934 . . . . 0.0 112.731 -172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.61 -21.83 62.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.877 0.471 . . . . 0.0 111.945 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -89.1 -8.6 53.52 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.046 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -31.29 72.42 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.278 0.49 . . . . 0.0 110.692 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 2.4 pptp? -65.16 -34.83 79.33 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.297 0.373 . . . . 0.0 110.749 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -82.57 -33.58 28.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.621 0.769 . . . . 0.0 110.87 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.05 -49.99 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.457 0.703 . . . . 0.0 110.265 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.4 t -66.24 -29.75 70.06 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.648 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 158' ' ' LYS . 26.7 t70 -56.85 -44.79 82.51 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.522 0.729 . . . . 0.0 109.957 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 17.8 mm100 -71.24 -38.54 71.96 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.876 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.58 -55.66 25.16 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.587 0.554 . . . . 0.0 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -64.35 -22.94 67.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.97 0.908 . . . . 0.0 112.13 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -62.31 -40.87 97.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.968 0.907 . . . . 0.0 110.907 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -107.36 -0.98 22.03 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.798 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 15.86 61.57 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 114.342 0.497 . . . . 0.0 114.342 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 63' ' ' LEU . 31.1 m-85 -75.03 161.14 29.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.955 0.902 . . . . 0.0 112.126 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -170.06 153.82 4.82 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.811 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.566 1.564 0 C-N-CA 123.55 0.74 . . . . 0.0 112.946 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 p -84.84 -0.63 54.6 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.072 0.549 . . . . 0.0 112.425 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.29 -16.93 38.44 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.905 0.482 . . . . 0.0 111.448 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.65 -38.33 86.65 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.232 0.613 . . . . 0.0 110.924 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.72 -28.46 67.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.545 0.738 . . . . 0.0 111.625 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -73.89 -38.79 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.375 0.67 . . . . 0.0 109.372 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.31 -21.35 56.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.051 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -67.11 139.71 57.54 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.107 0.563 . . . . 0.0 110.724 175.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.0 m -125.45 169.0 17.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.907 1.283 . . . . 0.0 109.144 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.26 126.64 35.59 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.39 -43.16 11.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.596 0.759 . . . . 0.0 110.053 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.58 -177.42 20.79 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.468 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 p -111.74 120.4 41.89 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.944 0.498 . . . . 0.0 110.219 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 169' ' ' PHE . 55.4 tp -77.14 148.16 36.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.835 1.254 . . . . 0.0 110.897 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -75.33 80.51 2.41 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.055 0.931 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -79.45 93.33 1.34 Allowed Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.831 -171.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -70.56 92.37 0.84 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 0.0 110.844 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.34 138.33 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 168.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 70' ' ' LEU . 39.9 t -71.07 144.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.32 -19.17 74.82 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.395 -0.669 . . . . 0.0 114.006 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' H ' HG12 ' A' ' 68' ' ' VAL . 39.2 tp -51.91 -23.04 4.39 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.859 1.264 . . . . 0.0 112.965 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 108' ' ' VAL . 20.3 ptt85 -56.88 -6.63 0.36 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.889 1.676 . . . . 0.0 114.349 173.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -54.66 -35.88 63.99 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.11 0.564 . . . . 0.0 111.949 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.98 -26.81 60.66 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.919 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.9 m -75.64 -21.64 57.51 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.831 0.852 . . . . 0.0 111.32 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.69 50.1 0.45 Allowed Glycine 0 C--N 1.356 1.646 0 CA-C-O 119.865 -0.408 . . . . 0.0 113.981 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.1 m -52.84 171.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.9 m -114.04 176.85 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.559 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -87.23 -164.49 1.09 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.809 1.243 . . . . 0.0 110.247 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -82.7 157.37 23.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.314 0.645 . . . . 0.0 111.172 173.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 67.71 10.97 8.14 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.177 1.391 . . . . 0.0 112.463 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 29.6 mm-40 -84.11 149.37 26.25 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.499 0.72 . . . . 0.0 110.73 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.593 ' HG2' HG22 ' A' ' 133' ' ' VAL . 60.3 mtp -107.73 152.22 24.64 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.905 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.5 162.09 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.374 1.069 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -129.36 145.82 51.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.521 1.128 . . . . 0.0 108.924 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.481 HD21 ' HE1' ' A' ' 148' ' ' MET . 6.9 mp -101.04 135.13 42.99 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.187 0.595 . . . . 0.0 110.5 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.19 132.81 7.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.016 0.926 . . . . 0.0 108.697 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.737 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 2.5 ptp180 -57.1 147.39 24.67 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 112.086 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.18 127.33 59.59 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.512 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.51 -20.09 65.61 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.248 2.632 . . . . 0.0 112.513 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -91.7 47.73 1.39 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.111 0.964 . . . . 0.0 109.147 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 4.1 p-10 -63.38 120.18 59.85 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.927 0.891 . . . . 0.0 111.365 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 18.2 Cg_exo -68.67 -50.89 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.912 2.408 . . . . 0.0 113.027 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.45 -50.33 4.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.202 0.601 . . . . 0.0 110.777 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -168.02 165.63 13.47 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.447 1.099 . . . . 0.0 108.657 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.26 -15.21 3.55 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.577 1.151 . . . . 0.0 113.062 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 29.5 p-10 -62.68 -21.92 66.09 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.687 0.795 . . . . 0.0 111.893 175.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -62.35 109.17 1.26 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 123.942 0.897 . . . . 0.0 109.926 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.737 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 98.7 mt -108.61 132.66 55.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 123.506 0.722 . . . . 0.0 109.891 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 99' ' ' LYS . 5.1 ttpm? -98.68 146.58 25.72 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.503 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.6 124.86 63.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.73 0.812 . . . . 0.0 109.593 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -110.63 153.83 24.64 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -90.54 -172.83 3.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.541 0.337 . . . . 0.0 110.13 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.52 -23.85 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.889 0.475 . . . . 0.0 112.066 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.191 0.596 . . . . 0.0 110.412 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.94 -0.83 86.54 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 122.778 0.228 . . . . 0.0 113.447 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -74.02 133.2 42.93 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.123 0.969 . . . . 0.0 108.975 175.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.497 ' N ' HD22 ' A' ' 106' ' ' ASN . 26.5 pt20 -64.3 106.38 1.09 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.674 0.75 . . . . 0.0 110.065 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 35.3 m -114.57 12.02 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.086 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.84 178.25 48.09 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 114.673 0.629 . . . . 0.0 114.673 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.533 ' HE1' ' HB1' ' A' ' 97' ' ' ALA . 78.9 t60 -161.34 113.62 1.85 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 86.2 mt -68.59 -13.13 62.14 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 83.0 tttt 70.71 149.18 0.08 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.124 0.97 . . . . 0.0 110.59 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -21.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.253 1.021 . . . . 0.0 112.476 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.506 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tp10 -56.74 -64.69 0.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.289 1.036 . . . . 0.0 111.461 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 111' ' ' LEU . 59.9 tp -85.51 -49.66 7.88 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.442 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -60.04 -24.63 64.68 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.209 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -63.49 -34.36 89.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.456 0.472 . . . . 0.0 113.443 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -77.64 -45.08 26.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.438 0.695 . . . . 0.0 109.98 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.42 HD12 HD13 ' A' ' 111' ' ' LEU . 46.2 mt -70.73 -16.62 62.79 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.932 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.46 -53.91 32.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -68.9 -31.92 71.18 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.941 0.775 . . . . 0.0 110.761 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 67.1 mt -69.23 -37.59 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.435 0.694 . . . . 0.0 110.802 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 44.9 ttm -79.32 -45.19 20.13 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.875 0.87 . . . . 0.0 110.962 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB2' HH22 ' A' ' 87' ' ' ARG . 29.3 t70 -67.39 -46.62 72.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.067 0.947 . . . . 0.0 110.851 -172.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -92.18 1.36 57.26 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.09 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.18 37.95 17.13 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.376 1.07 . . . . 0.0 111.917 171.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.26 -42.5 93.2 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.818 0.847 . . . . 0.0 111.351 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.07 137.98 17.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.65 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.2 116.89 18.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.126 0.97 . . . . 0.0 108.642 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.35 123.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -107.07 178.66 4.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -151.76 155.04 25.92 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 82' ' ' MET . 58.5 t -142.67 141.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.269 1.028 . . . . 0.0 108.281 175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 137' ' ' GLY . 3.8 p -122.83 86.23 50.13 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 123.783 0.833 . . . . 0.0 109.153 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.52 -22.41 21.24 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.216 2.611 . . . . 0.0 113.9 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.35 0.66 . . . . 0.0 110.797 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 64.5 33.96 88.64 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.514 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -82.27 12.41 4.4 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.914 0.486 . . . . 0.0 111.446 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -52.85 -37.69 60.55 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.61 -44.7 63.95 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.423 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.86 3.56 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.374 0.669 . . . . 0.0 112.169 -168.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -122.51 170.73 9.69 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.544 0.738 . . . . 0.0 110.688 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 t -95.13 109.07 21.19 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 19.1 ptm -119.25 134.66 23.71 Favored Pre-proline 0 C--O 1.243 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 110.142 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.66 123.81 12.26 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.172 1.915 . . . . 0.0 110.795 164.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -98.12 156.64 16.57 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -82.12 107.49 14.86 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.547 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 11.8 mtp -105.16 112.54 25.7 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 m -101.79 120.41 40.32 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.077 0.551 . . . . 0.0 110.213 -163.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -94.89 124.19 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.056 0.942 . . . . 0.0 110.18 -172.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -124.29 111.56 15.97 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.574 1.15 . . . . 0.0 108.232 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.41 166.87 36.73 Favored Glycine 0 N--CA 1.463 0.485 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -68.89 146.88 52.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.021 0.528 . . . . 0.0 111.898 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.4 -24.75 67.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.274 1.029 . . . . 0.0 112.962 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -77.41 -13.39 59.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.669 0.387 . . . . 0.0 111.877 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.79 0.02 16.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -25.12 67.08 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 118.339 0.518 . . . . 0.0 112.165 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -36.43 83.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -80.47 -36.08 33.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.457 0.703 . . . . 0.0 110.923 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.79 -53.02 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.524 0.73 . . . . 0.0 109.799 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.9 t -70.71 -25.16 62.83 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.108 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.6 t70 -60.8 -49.53 77.1 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.0 mm100 -66.14 -38.51 88.31 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.159 0.912 . . . . 0.0 111.638 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.53 -62.66 1.39 Allowed 'General case' 0 C--O 1.244 0.766 0 O-C-N 123.715 0.635 . . . . 0.0 110.012 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.68 -19.1 65.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.38 1.072 . . . . 0.0 112.635 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 23.8 ttmm -51.39 -46.63 62.89 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.914 0.885 . . . . 0.0 110.889 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -95.94 -23.7 16.74 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.522 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 8.27 11.15 Favored Glycine 0 N--CA 1.475 1.263 0 N-CA-C 113.669 0.228 . . . . 0.0 113.669 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB3' HD11 ' A' ' 63' ' ' LEU . 49.8 m-85 -75.57 142.93 42.63 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -159.3 136.6 9.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 CA--C 1.555 1.148 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.418 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.0 p -65.53 -15.24 62.48 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.393 1.077 . . . . 0.0 112.582 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.01 -49.6 74.02 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.941 0.497 . . . . 0.0 110.448 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 45.4 mt-10 -65.68 -32.36 73.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.233 1.013 . . . . 0.0 113.374 -167.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.11 -37.72 72.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.135 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -75.79 -31.51 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.057 0.943 . . . . 0.0 109.855 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 8.5 t70 -70.44 -44.29 68.16 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.312 1.445 . . . . 0.0 110.841 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -85.7 122.64 30.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 -175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.47 165.02 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 124.816 1.246 . . . . 0.0 110.458 -174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' GLY . 5.9 tt -82.75 111.35 18.61 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -74.65 -36.02 62.86 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.491 0.717 . . . . 0.0 111.132 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 163.94 177.32 36.62 Favored Glycine 0 C--O 1.245 0.826 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.54 -171.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 p -112.83 149.32 33.25 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.303 0.641 . . . . 0.0 110.552 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.6 tp -128.12 146.52 50.68 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.604 0.762 . . . . 0.0 110.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' PRO . 98.1 mtt180 -86.08 90.28 8.07 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.272 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.55 88.73 1.59 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.977 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -79.07 100.42 7.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.041 0.536 . . . . 0.0 109.636 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.58 142.03 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 O-C-N 123.618 0.574 . . . . 0.0 109.541 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.04 154.23 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.944 0.898 . . . . 0.0 112.062 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.78 82.0 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.258 0.349 . . . . 0.0 113.66 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.09 -17.57 53.29 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.469 1.507 . . . . 0.0 112.901 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.549 HH12 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -61.51 -14.49 29.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.363 1.065 . . . . 0.0 113.53 -177.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.777 ' HA ' HG13 ' A' ' 76' ' ' VAL . 44.9 p90 -60.21 -39.7 87.49 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.223 0.535 . . . . 0.0 111.509 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -71.71 -20.2 61.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.12 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 m -99.23 6.36 46.34 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.651 0.781 . . . . 0.0 111.502 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.27 55.84 0.59 Allowed Glycine 0 C--N 1.367 2.299 0 C-N-CA 120.362 -0.923 . . . . 0.0 115.398 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 72' ' ' TYR . 8.1 m -40.46 155.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 134' ' ' VAL . 19.5 m -115.57 159.78 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.335 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -85.27 -167.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.33 1.052 . . . . 0.0 111.659 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -73.83 151.65 40.47 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.305 0.642 . . . . 0.0 111.562 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 61.24 8.19 1.96 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.723 1.209 . . . . 0.0 113.595 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.68 133.29 40.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.59 0.756 . . . . 0.0 110.754 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 76.9 mtp -94.09 150.01 20.72 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.413 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.02 166.18 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.761 1.224 . . . . 0.0 109.354 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.68 140.88 48.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.635 1.174 . . . . 0.0 108.567 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.486 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.7 mp -97.12 132.41 42.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -150.32 133.36 16.15 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 38.6 ptt180 -69.98 145.27 51.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.097 0.475 . . . . 0.0 110.115 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -89.6 125.12 62.35 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.883 0.873 . . . . 0.0 111.288 -167.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.43 -19.84 24.68 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.203 2.602 . . . . 0.0 113.283 170.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -93.9 18.79 9.86 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.181 0.992 . . . . 0.0 110.315 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 8.6 p30 -51.37 137.06 30.82 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.142 1.377 . . . . 0.0 113.528 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 2.9 Cg_exo -79.01 -41.22 0.23 Allowed 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.471 2.114 . . . . 0.0 112.453 172.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.32 -53.1 4.23 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.981 0.512 . . . . 0.0 111.448 -168.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -173.3 159.69 3.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.379 1.072 . . . . 0.0 108.476 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 18.4 ptpt -57.68 -25.6 60.49 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.55 4.71 23.44 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.37 103.85 1.73 Allowed 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 64.6 mt -82.91 121.6 36.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.043 -172.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 37.6 ttmt -100.09 127.93 46.24 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.092 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.18 130.68 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.058 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -120.87 154.41 35.87 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -90.1 -171.52 3.16 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.026 0.83 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -55.97 -34.07 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.814 0.846 . . . . 0.0 112.505 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -77.68 -22.79 49.99 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.933 0.893 . . . . 0.0 111.065 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.37 4.36 58.38 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.74 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.57 125.36 24.0 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.426 0.691 . . . . 0.0 110.013 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.576 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 75.8 mt-30 -71.0 100.86 2.07 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.021 0.928 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' HB ' HH12 ' A' ' 71' ' ' ARG . 34.1 m -91.71 -2.66 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.381 0.672 . . . . 0.0 112.188 -174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 124.75 165.68 12.21 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 123.239 0.337 . . . . 0.0 112.553 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 65.8 m-70 -76.21 150.4 37.08 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.812 0.445 . . . . 0.0 110.125 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tt -70.7 -52.99 17.44 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 5.0 tmtp? 162.54 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -30.17 68.9 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.609 0.763 . . . . 0.0 112.81 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 38.8 tt0 -75.04 -54.92 6.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.88 0.872 . . . . 0.0 110.852 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.578 0.751 . . . . 0.0 109.784 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.83 92.24 Favored 'General case' 0 C--O 1.208 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.665 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.52 -35.61 80.95 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 124.141 0.901 . . . . 0.0 113.89 176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.49 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . . . -67.53 -50.15 60.03 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.199 0.523 . . . . 0.0 110.06 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -77.94 -14.03 59.68 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.4 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -51.76 -47.3 64.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.378 1.471 . . . . 0.0 113.23 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -68.83 -32.33 71.95 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.705 0.802 . . . . 0.0 110.548 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.456 HD13 HG13 ' A' ' 160' ' ' VAL . 51.4 mt -66.03 -42.58 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.637 0.775 . . . . 0.0 110.002 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.7 tpp -74.15 -37.55 64.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.678 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.95 -44.87 46.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.643 1.177 . . . . 0.0 110.863 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -99.07 5.45 46.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.057 0.543 . . . . 0.0 111.884 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 59.19 33.87 22.9 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.173 0.989 . . . . 0.0 112.057 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.23 -36.59 84.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.545 0.738 . . . . 0.0 111.052 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.05 155.68 16.42 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.822 0.849 . . . . 0.0 110.833 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -82.01 139.44 34.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.779 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.53 125.16 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.76 148.46 43.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.205 1.002 . . . . 0.0 109.597 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -129.89 176.25 18.75 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 122.946 0.153 . . . . 0.0 113.381 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 12.4 t -142.79 141.63 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.092 1.357 . . . . 0.0 108.121 174.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 77' ' ' VAL . 6.5 m -103.98 86.06 1.17 Allowed Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.015 0.926 . . . . 0.0 108.977 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.24 -51.32 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.666 2.244 . . . . 0.0 113.408 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 138' ' ' ALA . 37.7 t80 -70.86 -26.71 63.38 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.91 0.484 . . . . 0.0 110.501 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.67 19.53 79.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.513 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' HB2' ' HD2' ' A' ' 136' ' ' PHE . . . -61.4 -17.48 54.35 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.283 0.633 . . . . 0.0 111.442 175.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 77' ' ' VAL . 5.2 t30 -48.44 -31.8 6.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.012 1.725 . . . . 0.0 112.847 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.44 -44.96 81.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.632 0.773 . . . . 0.0 111.002 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.17 -64.35 1.12 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.172 0.589 . . . . 0.0 111.529 -176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -119.54 143.59 47.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.267 1.027 . . . . 0.0 109.741 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 p -93.48 109.18 20.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.025 0.917 . . . . 0.0 109.129 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 165.84 12.68 Favored Pre-proline 0 C--O 1.245 0.833 0 CA-C-N 113.65 -1.613 . . . . 0.0 109.343 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 64' ' ' ARG . 20.2 Cg_exo -67.24 122.05 9.27 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 121.486 1.457 . . . . 0.0 110.676 170.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.96 149.9 22.97 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.243 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.586 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 58.2 mtt -103.34 164.08 11.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 0.0 109.524 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -148.79 144.59 27.1 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.301 1.04 . . . . 0.0 109.07 -173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -105.18 128.38 53.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.806 0.842 . . . . 0.0 109.394 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -129.06 102.81 6.66 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.379 1.072 . . . . 0.0 109.631 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.32 178.95 37.93 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.57 142.91 58.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 117.48 0.64 . . . . 0.0 111.895 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -50.64 -34.78 27.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.837 1.255 . . . . 0.0 113.631 -175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.51 -26.72 61.01 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -85.55 2.86 43.16 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 119.35 -0.357 . . . . 0.0 111.845 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -34.89 79.09 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.981 0.355 . . . . 0.0 110.26 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -26.78 56.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.88 0.872 . . . . 0.0 111.309 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -73.7 -52.32 13.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.456 HG13 HD13 ' A' ' 122' ' ' ILE . 49.9 t -57.02 -43.12 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.928 1.291 . . . . 0.0 111.777 176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.6 p -64.95 -33.94 77.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.921 0.489 . . . . 0.0 111.385 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 20.5 t70 -67.26 -32.94 74.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.688 0.618 . . . . 0.0 110.48 177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 8.1 mm100 -73.33 -25.81 60.78 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 95.9 mt -76.51 -39.51 52.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.531 0.733 . . . . 0.0 110.253 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 8.7 mtpm? -59.96 -22.22 62.23 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.297 1.039 . . . . 0.0 111.992 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 118' ' ' ALA . 40.2 ttmt -54.0 -49.95 67.7 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 111.24 175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -100.18 0.1 39.84 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.686 0.394 . . . . 0.0 111.082 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.59 35.95 24.32 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 116.802 -0.181 . . . . 0.0 112.82 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 25.8 m-85 -79.54 174.63 11.38 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.576 0.75 . . . . 0.0 110.808 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.88 152.64 23.42 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.442 1.097 . . . . 0.0 110.253 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.939 177.135 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.288 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 p -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.02 0.928 . . . . 0.0 111.876 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.5 -41.61 72.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.248 0.619 . . . . 0.0 110.213 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 43.4 mt-10 -75.62 -30.15 59.43 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.688 0.795 . . . . 0.0 112.396 -171.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.38 -36.32 74.04 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.075 0.234 . . . . 0.0 110.688 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.04 -37.06 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.405 0.682 . . . . 0.0 109.809 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 13.4 t70 -63.65 -34.86 78.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.535 1.134 . . . . 0.0 111.018 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.6 m -79.39 130.32 35.31 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.234 0.614 . . . . 0.0 109.487 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.19 156.42 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.843 0.857 . . . . 0.0 111.873 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 61' ' ' GLY . 6.0 tt -81.08 105.6 12.42 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.7 m-85 -73.66 -30.36 62.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.943 0.497 . . . . 0.0 110.601 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' HD23 ' A' ' 59' ' ' LEU . . . 148.46 -170.61 28.96 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -175.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.6 m -129.19 118.39 22.32 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 19.7 tp -79.07 175.04 10.95 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HB2' ' HB2' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -126.64 97.89 5.18 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.828 0.823 . . . . 0.0 108.848 174.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.08 124.81 7.05 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.691 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -88.6 119.41 29.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.741 0.817 . . . . 0.0 110.358 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.73 140.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 46.8 t -72.35 139.49 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.82 58.43 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.253 -0.43 . . . . 0.0 113.895 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -23.43 67.13 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 111.276 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' THR . 3.5 mpt_? -75.52 -1.2 23.17 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.28 1.032 . . . . 0.0 111.817 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -45.33 -32.9 2.21 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.16 -18.03 65.1 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.792 1.237 . . . . 0.0 112.565 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 71' ' ' ARG . 14.7 t -73.78 -20.62 60.43 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.122 0.569 . . . . 0.0 110.973 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.63 48.6 0.54 Allowed Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.55 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.14 165.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 121.489 0.662 . . . . 0.0 111.524 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 18.1 m -115.52 171.84 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.238 -171.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -104.83 -166.78 1.27 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 -170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -63.19 149.52 45.19 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.569 0.747 . . . . 0.0 111.446 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 8.6 t30 77.17 -18.54 0.48 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.55 1.54 . . . . 0.0 112.337 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.3 mm-40 -62.56 141.78 58.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.4 mtp -105.06 143.74 32.82 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.969 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 18.2 m -129.57 132.32 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.07 0.948 . . . . 0.0 109.795 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.42 142.25 28.75 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 109.686 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.624 HD11 ' SD ' ' A' ' 148' ' ' MET . 5.7 mp -90.68 121.14 32.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.858 0.863 . . . . 0.0 108.948 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -125.91 121.54 33.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -60.62 121.91 13.38 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -70.45 122.77 87.5 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.133 -163.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -20.35 36.71 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.693 2.262 . . . . 0.0 112.243 172.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -101.36 24.9 8.93 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.149 0.979 . . . . 0.0 110.667 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.81 126.75 72.74 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.588 0.755 . . . . 0.0 111.67 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.0 -24.17 6.03 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.462 2.108 . . . . 0.0 113.862 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.52 -56.08 1.99 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 122.228 -0.295 . . . . 0.0 111.362 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 6.4 m-20 -150.49 153.63 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.29 -14.65 57.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.863 0.865 . . . . 0.0 112.476 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.574 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 16.4 p-10 -70.3 -20.24 63.03 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.614 0.766 . . . . 0.0 111.638 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.99 109.38 3.44 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.293 0.637 . . . . 0.0 109.311 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 86.7 mt -85.09 119.51 33.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.685 0.794 . . . . 0.0 109.867 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -83.48 116.53 22.58 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 165.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG12 ' HB ' ' A' ' 83' ' ' VAL . 10.3 t -85.56 128.56 39.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -122.98 143.15 50.11 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 28.3 p-10 -82.72 -167.94 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.248 0.931 . . . . 0.0 111.259 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.34 -31.18 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.464 1.106 . . . . 0.0 112.773 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -83.93 -27.41 28.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.532 0.733 . . . . 0.0 111.05 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.18 6.53 48.16 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.582 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -66.5 120.96 14.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.801 0.84 . . . . 0.0 110.26 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -60.18 107.42 0.64 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 110.833 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.58 2.23 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 0.0 111.449 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 134.13 -145.69 17.73 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 173.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.13 158.51 43.46 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.034 0.934 . . . . 0.0 109.862 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD11 ' HE3' ' A' ' 148' ' ' MET . 29.1 mt -87.89 8.46 26.0 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.813 0.845 . . . . 0.0 112.456 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 69.63 129.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.558 1.143 . . . . 0.0 110.074 -172.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -44.13 -39.16 4.1 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.188 1.395 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -62.22 -54.61 38.44 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.334 1.054 . . . . 0.0 112.281 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 10.4 tt -75.08 -47.81 26.98 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.444 0.64 . . . . 0.0 110.031 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.437 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -54.92 -34.47 63.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.579 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -55.07 -37.41 63.28 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.024 0.828 . . . . 0.0 115.004 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.74 -51.49 33.73 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.976 0.51 . . . . 0.0 110.523 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 122' ' ' ILE . 30.1 mt -73.77 -20.06 60.6 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.745 -172.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.43 64.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.766 0.826 . . . . 0.0 111.896 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.22 -36.77 77.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.493 HD13 HG13 ' A' ' 160' ' ' VAL . 64.1 mt -61.82 -37.11 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.82 0.848 . . . . 0.0 110.763 176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 14.3 ttm -79.23 -51.17 9.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.452 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.0 -39.38 69.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.379 1.072 . . . . 0.0 111.108 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -90.57 1.64 56.55 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 62.74 43.1 7.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.413 1.085 . . . . 0.0 111.768 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 122' ' ' ILE . 45.6 mt -76.75 -48.05 19.88 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.642 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -154.47 149.68 27.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.198 0.599 . . . . 0.0 110.721 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -89.45 106.69 18.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.045 0.938 . . . . 0.0 109.309 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -93.89 124.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -104.98 160.84 14.72 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -128.47 144.81 15.6 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 82' ' ' MET . 40.3 t -137.7 126.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.65 90.42 5.04 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 64.9 Cg_endo -83.82 -18.7 5.35 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.519 2.146 . . . . 0.0 113.003 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -79.44 -32.63 42.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.762 0.425 . . . . 0.0 110.816 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.85 17.07 20.31 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.853 0.721 . . . . 0.0 114.599 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -84.26 0.74 47.79 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.608 0.763 . . . . 0.0 111.384 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -64.11 -26.4 68.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.653 1.181 . . . . 0.0 110.878 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.51 -30.35 63.05 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.695 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.5 11.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.277 0.631 . . . . 0.0 111.718 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -158.35 -168.64 2.52 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.545 0.738 . . . . 0.0 110.289 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.8 p -94.55 120.6 35.04 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.516 0.727 . . . . 0.0 109.066 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 ppp? -147.45 156.88 45.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.006 0.922 . . . . 0.0 109.743 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.581 ' HB2' ' HB2' ' A' ' 64' ' ' ARG . 26.9 Cg_endo -92.84 144.36 2.37 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 122.516 2.144 . . . . 0.0 113.531 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -107.38 153.91 22.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -79.73 109.57 14.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.759 0.314 . . . . 0.0 111.223 -170.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.624 ' SD ' HD11 ' A' ' 85' ' ' LEU . 22.0 mmt -89.85 110.23 21.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.896 0.878 . . . . 0.0 108.837 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m -103.46 125.25 49.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 31.5 m-85 -89.05 120.44 30.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 109.251 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.47 101.76 7.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.88 159.66 29.46 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.19 145.58 46.6 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.267 0.627 . . . . 0.0 112.614 -175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.45 -30.78 61.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.014 1.326 . . . . 0.0 113.468 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.34 -29.62 65.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.914 0.485 . . . . 0.0 111.472 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -88.66 9.8 22.92 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.285 0.634 . . . . 0.0 111.933 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 158' ' ' LYS . 11.7 ptp180 -54.93 -45.18 74.8 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.591 0.356 . . . . 0.0 111.601 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -78.94 -26.57 43.62 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.631 0.372 . . . . 0.0 111.333 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.05 -42.24 89.76 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.041 0.536 . . . . 0.0 110.325 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 HD13 ' A' ' 122' ' ' ILE . 70.1 t -70.45 -45.29 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.489 1.116 . . . . 0.0 110.726 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.515 ' HB3' ' HE3' ' A' ' 165' ' ' LYS . 67.2 m -64.52 -32.15 73.66 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.26 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -55.98 -42.43 76.3 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.774 0.83 . . . . 0.0 110.865 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.05 -38.23 78.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.857 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.11 -55.43 16.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.798 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HE3' ' HB3' ' A' ' 161' ' ' SER . 93.7 mttt -56.9 -29.04 62.66 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.749 1.22 . . . . 0.0 111.993 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -62.08 -41.02 97.75 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.855 0.862 . . . . 0.0 111.54 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.13 3.6 25.92 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.768 0.427 . . . . 0.0 110.615 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.95 20.65 77.55 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.932 -0.371 . . . . 0.0 113.364 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 32.2 m-85 -67.82 146.08 54.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.939 172.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -156.21 139.38 15.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.48 170.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.423 ' H ' ' HG ' ' A' ' 171' ' ' LEU . 2.1 pp . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 124.324 1.049 . . . . 0.0 111.317 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.062 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.6 m -64.38 -14.08 54.49 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.618 0.767 . . . . 0.0 112.439 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.46 -31.47 61.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.725 1.21 . . . . 0.0 111.955 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -72.14 -40.78 67.8 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.848 0.459 . . . . 0.0 111.363 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 51' ' ' SER . 11.7 pt-20 -84.86 -15.59 44.18 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.708 0.403 . . . . 0.0 111.639 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 51' ' ' SER . 85.3 t -70.55 -34.76 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 168.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.82 -47.19 48.54 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.928 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.2 m -82.69 115.04 21.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.648 0.779 . . . . 0.0 111.005 -173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 154' ' ' GLU . 14.3 m -107.71 162.94 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.256 1.022 . . . . 0.0 110.978 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.14 116.19 22.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.118 0.567 . . . . 0.0 109.793 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -79.43 -24.78 42.25 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.923 0.489 . . . . 0.0 110.567 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.03 -170.39 24.58 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.26 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.44 ' HB3' HG22 ' A' ' 149' ' ' THR . 22.5 p -123.1 121.35 35.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.073 0.549 . . . . 0.0 110.383 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.8 tp -80.12 145.87 32.15 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.363 1.065 . . . . 0.0 109.876 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -76.16 85.87 3.01 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -74.2 163.96 54.61 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -141.32 91.75 2.41 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.529 1.165 . . . . 0.0 110.088 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 108' ' ' VAL . 98.9 t -76.51 127.77 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 167.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 24.9 t -68.32 141.73 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 O-C-N 123.737 0.648 . . . . 0.0 110.542 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.79 -44.98 23.47 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.539 0.524 . . . . 0.0 113.747 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.85 -15.79 55.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.473 0.709 . . . . 0.0 112.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' HG2' ' HB ' ' A' ' 68' ' ' VAL . 36.6 mmt180 -73.81 -0.46 15.88 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.924 0.889 . . . . 0.0 112.54 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.484 ' HA ' HG13 ' A' ' 76' ' ' VAL . 42.5 p90 -50.72 -23.83 2.96 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.376 1.071 . . . . 0.0 113.843 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.72 -7.65 22.51 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.424 1.089 . . . . 0.0 112.71 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 p -73.23 -33.48 65.35 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.265 0.626 . . . . 0.0 109.912 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.59 48.05 0.52 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 72' ' ' TYR . 27.5 m -55.3 167.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.626 0.77 . . . . 0.0 112.268 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.5 m -114.12 163.88 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.27 0.628 . . . . 0.0 110.796 -174.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -74.67 -172.19 1.47 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.312 1.045 . . . . 0.0 111.711 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -65.14 149.04 50.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.871 . . . . 0.0 111.95 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 64.88 10.75 6.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.957 1.303 . . . . 0.0 113.973 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.74 143.11 32.06 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 118.13 0.423 . . . . 0.0 111.154 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.52 ' HG2' HG22 ' A' ' 133' ' ' VAL . 83.2 mtp -83.08 145.5 29.23 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.705 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 146' ' ' LEU . 29.4 m -134.27 145.0 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.017 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.98 125.02 53.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.675 0.79 . . . . 0.0 109.895 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -90.14 138.42 31.53 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.982 0.913 . . . . 0.0 109.749 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -147.73 138.7 23.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.6 ptm180 -67.09 158.33 31.4 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.579 0.228 . . . . 0.0 110.568 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -87.99 116.06 65.0 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 123.103 0.561 . . . . 0.0 110.647 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.28 -39.06 5.88 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.275 1.983 . . . . 0.0 110.493 168.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -88.88 71.14 8.63 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 170.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.44 134.49 86.7 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.766 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.34 -42.16 4.11 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.961 2.44 . . . . 0.0 112.519 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -126.3 -52.79 1.5 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.461 0.704 . . . . 0.0 110.014 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -146.85 165.74 28.81 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.704 0.802 . . . . 0.0 109.95 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -68.12 -5.49 18.08 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.237 1.015 . . . . 0.0 112.581 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.474 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 1.9 m-20 -77.13 9.69 2.88 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.594 1.158 . . . . 0.0 112.586 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -93.39 139.37 30.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.479 0.712 . . . . 0.0 110.208 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 54.5 mt -127.07 120.42 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.36 1.064 . . . . 0.0 109.133 175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -87.47 115.37 24.85 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.439 0.695 . . . . 0.0 109.854 171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.502 HG22 ' HG ' ' A' ' 85' ' ' LEU . 53.0 t -87.1 126.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 14.9 m-80 -117.65 164.67 14.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -95.7 -170.77 2.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.69 -22.59 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -86.64 -3.08 58.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.219 1.008 . . . . 0.0 111.908 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.68 86.08 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 122.945 0.307 . . . . 0.0 113.491 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -76.84 134.17 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.633 0.773 . . . . 0.0 108.986 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 25.9 pt20 -71.58 127.42 32.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 122.303 1.049 . . . . 0.0 111.662 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 67' ' ' VAL . 93.0 t -78.06 -24.79 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.177 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.41 -168.19 28.48 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.99 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -117.23 148.97 41.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 52.2 mt -75.33 -6.29 49.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.233 0.613 . . . . 0.0 112.26 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 68.74 141.86 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.262 1.025 . . . . 0.0 110.229 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -21.29 3.06 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -172.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -62.57 -63.03 1.35 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.071 0.948 . . . . 0.0 110.702 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.1 tt -80.36 -50.56 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.094 0.557 . . . . 0.0 109.597 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -52.8 -33.37 48.72 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.049 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -55.49 -43.48 85.43 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.105 0.878 . . . . 0.0 114.814 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.97 -48.74 72.93 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.23 0.538 . . . . 0.0 110.624 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.9 mt -73.95 -18.24 60.91 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.625 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.48 91.18 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.12 0.968 . . . . 0.0 111.788 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -68.06 -40.78 82.7 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.549 0.531 . . . . 0.0 109.618 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 127' ' ' LEU . 55.3 mt -63.79 -37.41 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.587 0.755 . . . . 0.0 110.75 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.6 tpp -70.75 -52.61 19.7 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.139 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.16 -32.51 73.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.619 1.567 . . . . 0.0 111.689 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -99.28 -2.57 36.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.026 0.531 . . . . 0.0 111.278 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 61.13 32.51 19.62 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.898 0.879 . . . . 0.0 111.542 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 122' ' ' ILE . 67.0 mt -63.39 -44.66 94.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.515 0.726 . . . . 0.0 110.145 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.45 142.23 21.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.288 173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -73.03 107.85 5.61 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.479 1.112 . . . . 0.0 109.281 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.8 mt -99.36 104.83 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.4 178.72 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.21 168.76 32.01 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.466 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 82' ' ' MET . 63.9 t -141.36 125.73 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.43 100.66 2.43 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.46 -44.33 2.35 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.837 2.358 . . . . 0.0 113.812 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -99.47 -23.9 14.96 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 0.0 111.285 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.48 27.66 71.2 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.304 0.377 . . . . 0.0 113.547 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.493 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -81.29 4.82 19.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.475 0.71 . . . . 0.0 112.174 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 93.4 m-20 -63.43 -9.51 12.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.078 0.951 . . . . 0.0 112.004 173.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -64.42 -42.14 96.21 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.916 0.887 . . . . 0.0 111.008 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.8 -60.9 1.47 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.827 0.851 . . . . 0.0 111.147 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 84.6 m-85 -139.48 -173.62 3.66 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.875 . . . . 0.0 109.444 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 t -93.04 134.91 34.7 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 138' ' ' ALA . 4.4 ppp? -137.95 153.12 73.32 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.706 0.802 . . . . 0.0 109.96 -172.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 21.4 Cg_exo -67.46 122.09 9.27 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.17 1.914 . . . . 0.0 112.637 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.496 HD22 ' HE2' ' A' ' 148' ' ' MET . 6.5 tt -100.91 124.54 46.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -80.17 110.16 15.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -172.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.597 ' SD ' HD21 ' A' ' 85' ' ' LEU . 59.6 mtt -112.81 116.32 29.88 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.033 0.933 . . . . 0.0 110.505 -171.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 62' ' ' SER . 37.8 p -102.71 133.68 47.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.95 1.3 . . . . 0.0 110.306 -165.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -100.95 117.76 35.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.834 0.853 . . . . 0.0 109.166 -175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -119.19 99.05 6.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.417 0.687 . . . . 0.0 109.508 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 163.44 31.73 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.46 146.47 24.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 111.655 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.436 ' HG2' HG21 ' A' ' 58' ' ' VAL . 44.6 mt-10 -58.97 -18.78 37.09 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -172.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.36 -32.31 43.15 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.087 0.403 . . . . 0.0 111.296 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -77.9 -6.92 55.88 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -57.95 -27.79 63.72 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.219 0.463 . . . . 0.0 110.791 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -61.78 -53.2 59.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.12 0.968 . . . . 0.0 109.138 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.88 -30.97 65.96 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.97 0.908 . . . . 0.0 112.081 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD13 ' A' ' 122' ' ' ILE . 56.1 t -71.13 -55.09 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.157 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.2 t -66.1 -22.69 66.41 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.903 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -59.22 -44.56 92.3 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.085 0.554 . . . . 0.0 110.307 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -79.51 -30.14 41.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.237 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.69 -61.01 2.59 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.85 -21.1 65.7 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.752 1.221 . . . . 0.0 112.101 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -53.45 -46.51 69.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.653 0.781 . . . . 0.0 110.493 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -99.72 -16.91 17.98 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.129 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.47 16.77 21.61 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 116.554 -0.294 . . . . 0.0 113.177 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -79.52 145.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.825 0.45 . . . . 0.0 110.095 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -172.81 138.56 0.82 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 108.755 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 171' ' ' LEU . 1.9 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.548 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.3 p -68.07 -47.96 66.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.081 0.953 . . . . 0.0 111.806 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.39 -14.54 60.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.819 0.847 . . . . 0.0 112.144 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -62.58 -45.4 93.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.946 0.898 . . . . 0.0 112.186 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.56 -29.66 67.27 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.432 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.42 -22.16 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.642 0.777 . . . . 0.0 110.444 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -72.94 -46.65 51.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.822 1.249 . . . . 0.0 110.271 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 m -80.19 113.88 18.69 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.364 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 154' ' ' GLU . 13.8 m -107.19 156.43 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.148 0.979 . . . . 0.0 111.327 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.79 109.6 14.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.445 0.698 . . . . 0.0 109.762 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 26.6 m-85 -74.38 -36.23 63.53 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 110.972 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.64 -176.03 36.44 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.769 0.668 . . . . 0.0 112.558 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 148' ' ' MET . 49.4 p -115.92 122.35 45.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.119 0.968 . . . . 0.0 110.532 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 169' ' ' PHE . 48.2 tp -99.86 137.46 38.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.941 0.496 . . . . 0.0 109.711 173.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -90.78 83.98 5.79 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -75.21 153.07 44.43 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-O 119.187 -0.785 . . . . 0.0 111.469 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -116.47 111.05 19.43 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.832 1.316 . . . . 0.0 109.978 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG13 ' HA ' ' A' ' 111' ' ' LEU . 2.5 t -94.68 157.32 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.083 0.953 . . . . 0.0 109.118 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' HIS . 30.5 m -76.05 161.94 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.83 -17.74 74.34 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.326 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.7 -18.42 30.98 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.308 1.043 . . . . 0.0 111.431 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.683 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 63.8 mtp180 -49.86 -33.31 16.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.394 1.078 . . . . 0.0 113.204 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.27 -43.87 92.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.217 0.607 . . . . 0.0 110.628 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -71.62 -35.49 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.457 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.0 m -74.95 -16.93 60.62 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.089 0.555 . . . . 0.0 111.798 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.76 54.3 0.54 Allowed Glycine 0 C--N 1.357 1.713 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.282 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.3 m -40.9 164.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 19.3 m -114.51 167.16 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.527 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -70.38 -79.27 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.309 0.644 . . . . 0.0 111.825 -170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.6 154.15 1.97 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.789 0.835 . . . . 0.0 110.308 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.79 28.56 6.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.943 1.297 . . . . 0.0 111.83 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 49.8 mm-40 -87.25 142.82 27.62 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.327 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 78.0 mtp -99.76 127.88 45.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 109.254 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 102' ' ' ASN . 35.6 m -118.04 163.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 124.294 1.038 . . . . 0.0 108.997 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.48 128.41 47.98 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.434 ' HB3' HG21 ' A' ' 98' ' ' ILE . 12.8 mt -80.18 112.01 17.09 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -123.78 115.12 20.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 108.316 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 37.2 ptt180 -57.03 133.82 55.28 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 121.106 0.479 . . . . 0.0 110.925 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.2 118.94 57.86 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.138 -161.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.667 2.245 . . . . 0.0 112.039 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -111.08 32.38 5.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.422 1.089 . . . . 0.0 109.73 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.41 127.3 65.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.877 0.871 . . . . 0.0 111.773 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.37 -48.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.033 1.822 . . . . 0.0 113.011 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -99.04 -50.5 4.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.792 0.437 . . . . 0.0 110.524 -173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -159.59 156.57 28.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.17 0.588 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.33 -7.26 12.63 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.519 1.528 . . . . 0.0 113.559 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.582 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 26.1 p-10 -64.13 -30.7 71.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.003 0.521 . . . . 0.0 111.584 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.06 125.85 25.3 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.892 0.745 . . . . 0.0 109.239 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 70.5 mt -113.2 127.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.824 . . . . 0.0 109.647 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 151.17 32.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.73 172.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.1 t -110.58 120.46 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.748 1.219 . . . . 0.0 107.854 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -119.06 127.46 53.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.537 ' HA ' HG12 ' A' ' 83' ' ' VAL . 35.4 p-10 -71.93 -173.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.392 0.677 . . . . 0.0 112.385 -175.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.9 m -55.78 -31.9 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 C-N-CA 124.147 0.979 . . . . 0.0 112.293 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.73 -31.83 63.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.642 0.777 . . . . 0.0 111.053 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.68 -3.38 42.32 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 112.342 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -67.72 136.54 54.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.117 0.967 . . . . 0.0 110.836 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.5 pm0 -67.1 117.74 9.55 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.8 m -111.19 -2.38 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.385 0.674 . . . . 0.0 111.644 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.683 ' HA3' ' HG2' ' A' ' 71' ' ' ARG . . . 152.59 -177.15 30.48 Favored Glycine 0 C--N 1.36 1.913 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 172.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 68' ' ' VAL . 55.6 m-70 -108.95 151.32 26.46 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.614 ' HA ' HG13 ' A' ' 67' ' ' VAL . 52.0 mt -72.58 -55.03 7.54 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.581 0.628 . . . . 0.0 112.386 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt 147.31 143.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.241 1.816 . . . . 0.0 106.104 -162.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.506 ' HG2' HD21 ' A' ' 96' ' ' ASN . 5.5 tmmm? -65.83 -41.41 91.83 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.861 0.464 . . . . 0.0 109.97 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.63 -52.67 42.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.802 0.841 . . . . 0.0 111.384 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 111' ' ' LEU . 62.6 tp -59.78 -57.12 14.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.12 70.15 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.994 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 96' ' ' ASN . . . -60.69 -42.54 99.38 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.631 0.582 . . . . 0.0 113.307 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.73 71.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.36 0.664 . . . . 0.0 110.163 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 130' ' ' ILE . 61.3 mt -71.79 -17.79 62.15 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.17 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.33 77.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.372 1.069 . . . . 0.0 112.042 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -74.07 -35.76 64.28 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.063 0.545 . . . . 0.0 109.629 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 127' ' ' LEU . 51.6 mt -65.1 -36.21 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.39 0.614 . . . . 0.0 110.02 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 123' ' ' MET . 41.1 tpp -70.23 -44.21 69.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.913 1.285 . . . . 0.0 111.099 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.65 -48.71 24.73 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.263 -173.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -91.05 5.83 47.32 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.619 -173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 60.62 34.66 20.11 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.048 0.939 . . . . 0.0 111.641 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' HB2' HG23 ' A' ' 122' ' ' ILE . 81.8 mt -65.92 -41.56 91.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.583 -177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -162.66 141.39 8.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 110.269 176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.23 107.48 14.06 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD13 HD22 ' A' ' 119' ' ' LEU . 18.6 mt -92.49 117.82 36.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -85.79 166.21 16.25 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -130.53 143.86 15.21 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 170.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.85 130.85 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.697 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.4 p -118.15 85.71 24.96 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.48 -38.68 0.67 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.642 2.228 . . . . 0.0 113.535 -171.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.38 -29.73 65.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.964 0.506 . . . . 0.0 110.384 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 67.31 17.23 68.1 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.57 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -79.99 9.94 4.85 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.111 0.965 . . . . 0.0 112.39 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 140' ' ' ASN . 0.2 OUTLIER -66.0 -21.27 66.39 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.699 0.799 . . . . 0.0 111.547 172.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 139' ' ' ASN . 5.3 t30 -75.66 -46.74 29.66 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.376 1.07 . . . . 0.0 110.014 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.82 12.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.336 0.655 . . . . 0.0 111.663 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.11 -166.26 1.74 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.171 0.988 . . . . 0.0 110.129 -172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 78.2 p -96.11 117.8 31.44 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.697 ' SD ' HG23 ' A' ' 134' ' ' VAL . 22.3 ptm -115.56 157.56 43.94 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.838 0.455 . . . . 0.0 111.27 -173.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 60.7 Cg_endo -71.1 124.84 10.87 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.319 2.012 . . . . 0.0 112.835 173.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.416 HD23 ' HE2' ' A' ' 148' ' ' MET . 24.6 tp -85.9 117.62 24.87 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.324 1.05 . . . . 0.0 108.792 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -75.33 107.77 7.67 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' SER . 64.4 mtt -106.23 137.74 43.65 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.964 0.906 . . . . 0.0 109.961 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.6 p -126.35 116.9 21.92 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -85.4 118.6 25.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.795 0.838 . . . . 0.0 109.292 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -122.68 101.41 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.665 0.786 . . . . 0.0 109.139 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.62 31.21 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.799 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.82 138.43 29.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.588 1.155 . . . . 0.0 112.427 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.471 ' HG2' HG21 ' A' ' 58' ' ' VAL . 42.0 mt-10 -58.92 -22.17 59.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 112.988 -175.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.34 -18.03 64.99 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -103.83 0.66 30.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.195 0.598 . . . . 0.0 112.056 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.38 -44.0 75.65 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -167.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -24.64 51.32 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.578 0.351 . . . . 0.0 111.211 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.11 -35.21 61.74 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.839 0.455 . . . . 0.0 110.52 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.0 -50.63 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.032 0.933 . . . . 0.0 110.375 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.0 p -66.94 -31.82 72.66 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.153 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.46 -39.7 67.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.215 0.606 . . . . 0.0 111.531 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -69.25 -37.35 77.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.946 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.2 mt -69.33 -55.48 10.3 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.587 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -54.64 -32.57 59.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.258 1.423 . . . . 0.0 112.134 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.08 -44.34 83.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.559 1.144 . . . . 0.0 111.587 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -98.66 -15.3 19.47 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.434 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.31 9.48 50.89 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.569 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.8 m-85 -63.95 133.33 53.03 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.332 0.653 . . . . 0.0 110.713 175.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -166.0 152.89 9.71 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 123.187 0.595 . . . . 0.0 110.638 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 CA-C-O 120.067 -0.296 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.3 m -68.61 -17.0 64.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.088 0.955 . . . . 0.0 112.21 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.46 -20.43 65.48 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.911 0.485 . . . . 0.0 111.663 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.56 -43.97 97.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.711 0.804 . . . . 0.0 111.658 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.54 -25.24 57.0 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.208 0.603 . . . . 0.0 111.501 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.47 -30.69 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.39 -26.93 52.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.665 1.186 . . . . 0.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -61.78 149.39 40.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.787 0.835 . . . . 0.0 112.142 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.23 162.63 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.603 1.161 . . . . 0.0 110.064 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 tp -85.81 117.13 24.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.948 0.499 . . . . 0.0 110.22 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 24.8 m-85 -82.18 -34.03 29.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.994 0.518 . . . . 0.0 110.71 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.93 -166.63 33.04 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.932 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.9 p -115.1 169.22 9.27 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.666 0.787 . . . . 0.0 110.837 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 tp -147.8 139.04 23.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.293 0.637 . . . . 0.0 109.394 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 ptt85 -76.35 93.73 3.51 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.077 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.43 81.3 1.23 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.484 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -71.75 114.32 9.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -107.45 135.61 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.915 0.886 . . . . 0.0 109.189 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.82 151.68 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 124.506 1.122 . . . . 0.0 111.277 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.87 -21.7 31.26 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 115.988 1.155 . . . . 0.0 115.988 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.19 -16.52 45.72 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.873 0.869 . . . . 0.0 112.067 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.746 HH12 HG22 ' A' ' 143' ' ' THR . 34.1 ptt-85 -49.74 -27.94 5.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.777 1.631 . . . . 0.0 113.227 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -63.31 -48.53 77.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.864 0.466 . . . . 0.0 110.262 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -68.26 -28.98 67.68 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.575 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.6 m -74.66 -24.86 58.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.045 0.538 . . . . 0.0 110.811 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.88 53.76 0.33 Allowed Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.483 -0.62 . . . . 0.0 114.583 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -43.71 165.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.595 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 16.2 m -115.96 178.82 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.756 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.448 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -94.91 -82.05 0.38 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.872 0.469 . . . . 0.0 109.757 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -159.34 165.29 33.65 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.948 0.899 . . . . 0.0 109.732 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.581 ' H ' ' HA ' ' A' ' 135' ' ' PRO . 1.9 m-20 64.38 7.6 3.71 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.875 1.27 . . . . 0.0 112.293 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.7 mm-40 -84.87 124.25 31.4 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.332 0.653 . . . . 0.0 110.788 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.6 mtm -88.16 130.35 35.07 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 25.3 m -125.26 126.53 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.753 0.821 . . . . 0.0 110.78 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.66 136.62 33.76 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.263 1.025 . . . . 0.0 110.229 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.544 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.2 mp -87.57 141.56 28.52 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.49 0.716 . . . . 0.0 109.596 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -154.05 133.5 12.77 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 26.9 ptt180 -60.24 131.6 51.3 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 15.5 t70 -84.64 125.1 72.23 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' ASP . 37.6 Cg_exo -61.04 -37.55 75.15 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.307 2.671 . . . . 0.0 113.523 -173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.92 36.59 4.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.626 0.77 . . . . 0.0 109.732 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 88' ' ' ASP . 21.5 t-20 -63.41 127.73 91.59 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.95 -173.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.25 -23.32 33.24 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.9 2.4 . . . . 0.0 113.636 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -79.62 -52.15 8.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.7 t70 177.98 156.77 0.39 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.427 1.091 . . . . 0.0 109.951 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -57.14 -33.48 67.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.865 1.266 . . . . 0.0 113.599 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.4 -12.99 58.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.296 0.639 . . . . 0.0 111.883 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.1 128.77 37.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.176 0.591 . . . . 0.0 111.315 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.1 mt -92.95 125.04 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.991 0.917 . . . . 0.0 110.532 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -96.38 126.18 41.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 168.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.432 HG12 ' HB ' ' A' ' 83' ' ' VAL . 14.3 t -93.89 143.4 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -127.86 147.3 50.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.629 1.172 . . . . 0.0 108.111 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 7.0 p-10 -78.8 169.03 18.86 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.047 0.84 . . . . 0.0 110.051 170.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 m -66.67 -10.47 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -172.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.499 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 28.1 t-20 -73.12 -22.84 60.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 110.374 171.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 40.93 5.1 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -122.41 133.09 54.63 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.788 0.835 . . . . 0.0 109.788 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -63.47 131.35 47.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.332 0.653 . . . . 0.0 110.791 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.29 -32.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.399 0.68 . . . . 0.0 111.817 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.53 -171.65 44.73 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.063 0.385 . . . . 0.0 114.063 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -128.65 139.78 52.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.022 0.929 . . . . 0.0 109.861 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.44 1.98 56.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.499 0.72 . . . . 0.0 111.8 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 67.74 -176.88 0.2 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.545 1.138 . . . . 0.0 110.382 -167.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.45 -39.86 45.24 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -51.48 -63.25 1.19 Allowed 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.279 0.987 . . . . 0.0 112.325 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.21 -39.08 88.9 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.518 0.675 . . . . 0.0 110.748 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.15 -21.62 63.99 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.348 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.22 -15.53 70.06 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.191 0.424 . . . . 0.0 113.412 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -84.11 -51.99 6.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.931 0.872 . . . . 0.0 109.062 165.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.4 HD22 HD13 ' A' ' 130' ' ' ILE . 60.2 mt -70.44 -17.46 63.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.72 -169.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.71 90.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.276 1.03 . . . . 0.0 111.895 -173.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -75.07 -33.73 61.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.949 0.5 . . . . 0.0 109.9 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.455 HD13 HG13 ' A' ' 160' ' ' VAL . 31.6 mt -70.15 -31.73 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.074 0.549 . . . . 0.0 110.115 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.9 tpp -79.43 -43.3 23.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.026 1.33 . . . . 0.0 110.798 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.25 -50.29 28.45 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.811 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -88.97 -0.62 57.57 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.427 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 59.59 32.45 21.59 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.653 1.181 . . . . 0.0 111.846 171.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' HB2' HG23 ' A' ' 122' ' ' ILE . 68.0 mt -59.12 -39.39 82.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.142 0.977 . . . . 0.0 111.405 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.08 132.33 11.89 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.599 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.27 105.64 2.6 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.991 0.916 . . . . 0.0 109.266 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.4 HD13 HD22 ' A' ' 119' ' ' LEU . 12.2 mt -89.83 108.22 19.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -110.44 146.12 36.44 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -123.31 162.66 17.11 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -149.2 140.59 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.517 1.127 . . . . 0.0 108.033 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.06 87.31 34.0 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' ASN . 57.4 Cg_endo -88.6 0.2 6.52 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.045 2.496 . . . . 0.0 112.907 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.25 -31.3 20.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.977 0.511 . . . . 0.0 112.009 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.58 -6.52 23.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.64 9.03 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.028 0.914 . . . . 0.0 112.715 -174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.48 -15.59 61.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.674 1.19 . . . . 0.0 111.367 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -77.29 -55.19 5.62 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.945 0.898 . . . . 0.0 111.071 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.71 -61.66 1.9 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.452 0.701 . . . . 0.0 111.641 -171.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 -178.63 3.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.538 0.735 . . . . 0.0 109.823 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.746 HG22 HH12 ' A' ' 71' ' ' ARG . 15.9 p -92.29 109.05 20.42 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -112.24 120.44 41.59 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.716 -168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.58 125.12 8.73 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.025 1.816 . . . . 0.0 110.401 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.437 HD11 ' HE3' ' A' ' 148' ' ' MET . 4.5 pp -89.37 146.94 24.34 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -73.36 107.36 5.62 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.127 0.571 . . . . 0.0 110.611 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.546 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 63.2 mtt -97.82 166.81 11.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.802 0.841 . . . . 0.0 109.751 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.8 p -154.36 146.52 23.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.23 1.012 . . . . 0.0 109.634 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -109.19 120.39 42.39 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.134 0.974 . . . . 0.0 109.477 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -123.87 98.78 5.96 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.637 0.775 . . . . 0.0 109.647 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.31 162.46 30.63 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -55.57 142.57 33.0 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.647 0.779 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -48.34 -37.9 17.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.774 1.23 . . . . 0.0 113.465 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.422 ' O ' ' HE3' ' A' ' 158' ' ' LYS . 12.7 pt-20 -65.94 -29.78 70.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.213 0.605 . . . . 0.0 112.171 -174.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.22 4.19 13.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -61.71 -40.5 95.25 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 118.156 0.435 . . . . 0.0 111.31 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -69.31 -25.45 64.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.43 0.692 . . . . 0.0 111.192 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.6 -45.61 15.59 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.58 0.752 . . . . 0.0 110.567 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 122' ' ' ILE . 67.6 t -65.95 -45.68 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.449 1.1 . . . . 0.0 110.983 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 80.5 p -66.94 -32.01 72.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.151 0.58 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.46 -47.11 82.73 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.599 0.562 . . . . 0.0 110.838 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.0 mm100 -63.28 -44.27 95.57 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.37 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.23 -52.81 29.93 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.775 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -65.44 -22.69 66.79 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.798 0.839 . . . . 0.0 112.193 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -53.02 -46.56 68.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.157 0.983 . . . . 0.0 111.141 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -108.24 -11.9 15.16 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.114 0.966 . . . . 0.0 111.247 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.87 30.58 25.87 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.885 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -77.55 126.62 31.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -172.3 147.53 1.99 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 CA--C 1.554 1.12 0 O-C-N 123.498 0.499 . . . . 0.0 110.881 -179.457 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 -0.22 23.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.652 0.781 . . . . 0.0 112.012 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.66 -43.55 22.56 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.571 0.348 . . . . 0.0 110.567 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.58 -31.97 71.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.899 0.479 . . . . 0.0 111.936 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.74 -32.53 69.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.96 0.504 . . . . 0.0 111.265 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.59 -31.62 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.801 0.84 . . . . 0.0 109.645 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -82.92 -12.13 57.61 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.056 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.7 m -63.7 133.39 53.5 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.135 0.493 . . . . 0.0 110.717 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.2 m -129.18 163.62 33.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 124.84 1.256 . . . . 0.0 109.061 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.524 HD11 HG22 ' A' ' 149' ' ' THR . 40.3 tp -86.82 117.31 25.48 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -82.72 -31.42 28.48 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.65 -151.89 23.83 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.464 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.0 p -132.49 178.96 6.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.484 0.713 . . . . 0.0 110.684 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 148' ' ' MET . 39.0 tp -159.01 154.37 25.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.264 0.626 . . . . 0.0 110.186 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 94.69 5.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.978 0.911 . . . . 0.0 108.729 174.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.64 121.33 5.83 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -93.24 100.4 12.77 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.169 0.984 . . . . 0.0 109.751 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 7.9 p -82.88 145.68 8.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.368 176.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.8 m -65.72 156.02 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.18 0.992 . . . . 0.0 111.472 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 143' ' ' THR . . . -73.18 -23.42 77.6 Favored Glycine 0 N--CA 1.47 0.915 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.091 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.8 mt -51.29 -18.2 0.9 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.37 1.468 . . . . 0.0 112.678 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.628 HH12 HG21 ' A' ' 134' ' ' VAL . 13.8 ttt180 -47.19 -32.63 4.56 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.155 1.782 . . . . 0.0 112.755 174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 69' ' ' GLY . 26.0 p90 -63.22 -41.03 99.07 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.288 0.566 . . . . 0.0 110.933 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -69.53 -27.85 65.52 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.577 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 107' ' ' GLN . 6.0 m -101.48 -4.11 27.39 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.825 -170.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.32 52.56 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-O 119.199 -0.778 . . . . 0.0 114.965 172.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 m -44.42 156.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.2 175.88 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.087 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.78 -173.77 4.64 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.85 0.86 . . . . 0.0 111.157 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -74.3 151.45 39.82 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.933 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.57 -0.57 1.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.01 1.324 . . . . 0.0 113.883 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -73.33 128.48 35.61 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.272 0.487 . . . . 0.0 112.303 -172.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.46 ' HG2' HG22 ' A' ' 133' ' ' VAL . 77.4 mtp -79.63 148.22 31.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.719 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.49 HG11 HH22 ' A' ' 71' ' ' ARG . 23.1 m -143.74 146.82 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.617 1.167 . . . . 0.0 108.8 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB3' ' OD1' ' A' ' 101' ' ' ASN . . . -97.5 156.07 16.66 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.177 0.991 . . . . 0.0 110.084 175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD12 ' HB ' ' A' ' 130' ' ' ILE . 27.7 mt -89.0 161.58 16.51 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.535 . . . . 0.0 109.636 168.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.56 144.88 18.45 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -80.68 123.28 28.04 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -60.53 109.0 1.68 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.79 -15.17 46.5 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.789 2.326 . . . . 0.0 113.123 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -123.54 90.81 3.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.03 115.88 22.83 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.12 -51.56 5.43 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.976 2.451 . . . . 0.0 112.624 -176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.8 -47.28 1.68 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.68 0.792 . . . . 0.0 109.999 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -122.98 137.92 54.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.522 0.729 . . . . 0.0 109.736 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -57.82 -27.12 62.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.792 1.237 . . . . 0.0 113.232 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.433 HD22 ' HA2' ' A' ' 117' ' ' GLY . 28.3 p-10 -84.86 -1.79 56.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.424 0.689 . . . . 0.0 112.827 -173.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.92 111.08 0.6 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.876 0.87 . . . . 0.0 111.19 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 119' ' ' LEU . 66.0 mt -96.03 108.62 21.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 C-N-CA 123.259 0.624 . . . . 0.0 110.118 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 32.2 ttpt -88.91 142.16 27.89 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.393 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.96 143.87 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.761 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 5.7 p30 -130.0 150.98 51.04 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.089 1.356 . . . . 0.0 107.878 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' HA ' HG12 ' A' ' 83' ' ' VAL . 28.6 p-10 -90.51 -176.92 4.91 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.854 0.752 . . . . 0.0 111.04 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 m -57.83 -29.18 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.581 0.753 . . . . 0.0 112.649 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.84 -18.04 41.82 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.947 0.499 . . . . 0.0 111.245 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.04 50.17 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.042 0.353 . . . . 0.0 113.556 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.38 114.53 4.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.958 0.903 . . . . 0.0 109.174 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 74' ' ' THR . 22.9 pt20 -59.85 105.15 0.35 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.34 -17.81 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.392 0.677 . . . . 0.0 111.376 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.14 158.5 9.94 Favored Glycine 0 N--CA 1.473 1.107 0 O-C-N 122.954 0.159 . . . . 0.0 112.957 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 6.9 p-80 -81.86 154.59 25.78 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.3 0.64 . . . . 0.0 112.666 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 45.9 mt -70.73 -51.44 27.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.907 -177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.528 ' HG2' ' H ' ' A' ' 114' ' ' GLU . 24.4 ttmm 156.65 145.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.642 1.577 . . . . 0.0 107.204 -166.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -23.59 55.33 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.755 0.707 . . . . 0.0 111.196 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.528 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 37.5 tt0 -74.24 -42.39 59.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.937 0.495 . . . . 0.0 110.569 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 -47.54 85.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.93 67.61 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.866 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' HA2' HD22 ' A' ' 96' ' ' ASN . . . -53.86 -37.57 57.95 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.139 0.4 . . . . 0.0 113.746 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.05 -55.54 4.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.125 0.57 . . . . 0.0 110.475 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 122' ' ' ILE . 11.7 mt -68.16 -17.38 64.32 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.249 -171.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 96' ' ' ASN . . . -56.16 -54.35 46.16 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.556 1.142 . . . . 0.0 111.62 -177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.54 -29.11 69.12 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.183 0.927 . . . . 0.0 110.76 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.445 HD13 HG13 ' A' ' 160' ' ' VAL . 48.3 mt -68.59 -40.35 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.332 0.653 . . . . 0.0 110.143 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 52.0 ttm -80.1 -28.13 39.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.638 0.775 . . . . 0.0 111.446 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.96 -48.61 20.47 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.536 0.734 . . . . 0.0 110.614 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -95.43 5.25 52.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.547 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm 57.45 37.26 27.76 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.44 1.096 . . . . 0.0 111.344 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB3' ' OD1' ' A' ' 156' ' ' ASN . 70.6 mt -61.01 -52.77 63.59 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.332 -177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 160' ' ' VAL . . . -146.14 161.49 40.08 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.615 0.766 . . . . 0.0 111.023 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -101.18 107.28 18.64 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.129 0.972 . . . . 0.0 108.556 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HD12 ' A' ' 85' ' ' LEU . 27.7 mt -96.56 112.11 28.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -93.4 173.55 7.65 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -140.74 154.82 24.53 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 82' ' ' MET . 93.7 t -141.87 129.58 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.628 HG21 HH12 ' A' ' 71' ' ' ARG . 61.7 t -99.62 87.16 0.64 Allowed Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 4.5 Cg_exo -76.25 -51.11 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.52 -165.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.416 ' HD2' ' HE3' ' A' ' 144' ' ' MET . 22.7 m-85 -71.81 -27.16 62.74 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.798 0.839 . . . . 0.0 110.844 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 68.76 18.45 72.28 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.356 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.64 1.95 27.8 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.834 0.853 . . . . 0.0 112.134 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -57.5 -25.73 60.24 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.53 1.532 . . . . 0.0 114.304 -176.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -86.65 -38.65 16.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.606 0.762 . . . . 0.0 111.386 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.65 -20.15 21.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.534 0.734 . . . . 0.0 112.039 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -159.73 173.08 16.58 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.297 0.639 . . . . 0.0 109.717 -167.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 69' ' ' GLY . 44.7 p -94.36 109.68 21.51 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE3' ' HD2' ' A' ' 136' ' ' PHE . 23.0 ptm -113.73 155.72 44.66 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 122.935 0.494 . . . . 0.0 111.004 -170.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.89 127.53 4.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.349 2.033 . . . . 0.0 111.369 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -92.75 143.23 26.5 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -69.9 107.41 3.55 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 16.3 mtp -94.78 150.24 20.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.09 130.38 22.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 113.7 25.28 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.391 0.676 . . . . 0.0 109.574 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.22 100.6 6.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.6 160.35 28.44 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -53.65 143.88 19.14 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.676 0.79 . . . . 0.0 112.496 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 2.3 tm-20 -50.77 -46.4 59.42 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.128 1.371 . . . . 0.0 111.454 -173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -58.94 -18.28 32.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 127' ' ' LEU . 1.4 t-20 -100.51 0.22 39.15 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -166.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 3.4 ppt_? -52.17 -37.28 54.21 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -171.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -81.72 -30.18 32.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.58 0.352 . . . . 0.0 111.366 -177.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.83 -43.31 46.59 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.086 0.554 . . . . 0.0 111.237 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 122' ' ' ILE . 61.9 t -62.7 -42.64 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.851 0.86 . . . . 0.0 110.73 171.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.0 t -64.24 -35.38 80.62 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.02 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -57.0 -41.16 77.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.959 0.904 . . . . 0.0 110.934 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.44 -36.32 78.86 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.723 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 81.4 mt -68.71 -44.35 74.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.021 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -59.37 -27.71 66.21 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.611 1.164 . . . . 0.0 111.879 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -54.62 -52.17 63.08 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.439 1.096 . . . . 0.0 111.954 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -93.59 -23.68 18.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.472 0.709 . . . . 0.0 110.34 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.89 16.82 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.528 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.42 144.22 54.78 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.463 0.705 . . . . 0.0 110.53 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -176.42 152.66 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.716 1.206 . . . . 0.0 107.782 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.559 1.289 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 42.0 m -69.36 -7.78 40.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.403 0.681 . . . . 0.0 112.078 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.17 -31.42 63.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.357 1.063 . . . . 0.0 111.254 173.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 47.5 mt-10 -60.09 -23.97 64.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.144 0.978 . . . . 0.0 113.463 -175.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 51' ' ' SER . 13.0 pt-20 -70.25 -32.89 70.94 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.634 0.652 . . . . 0.0 110.918 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.55 -29.4 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.133 0.973 . . . . 0.0 109.811 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.542 ' HB3' ' HA ' ' A' ' 53' ' ' GLU . 32.6 t70 -78.94 -24.9 43.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 0.0 111.004 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -78.69 122.77 26.41 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.203 0.601 . . . . 0.0 109.822 174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 154' ' ' GLU . 27.0 m -124.16 175.87 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.873 1.269 . . . . 0.0 110.196 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.43 121.41 30.79 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.426 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.0 m-85 -85.26 -40.3 16.76 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.097 0.559 . . . . 0.0 110.042 174.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.19 -151.54 23.4 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.605 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.518 ' H ' HD13 ' A' ' 171' ' ' LEU . 73.9 p -123.56 -179.82 4.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.914 0.886 . . . . 0.0 111.073 -174.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.594 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 26.7 tp -156.28 155.78 32.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 172.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -93.53 90.59 6.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.962 0.905 . . . . 0.0 108.72 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.21 88.89 1.37 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -70.31 93.9 0.89 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.174 0.487 . . . . 0.0 110.398 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' LEU . 32.4 t -95.14 143.48 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 109.723 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.07 143.2 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.162 0.585 . . . . 0.0 111.563 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 143' ' ' THR . . . -80.44 -19.91 67.8 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 113.051 173.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 34.1 tp -59.94 -22.62 62.69 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.23 1.012 . . . . 0.0 112.146 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.463 ' HE ' HG23 ' A' ' 108' ' ' VAL . 13.9 ptt-85 -74.4 0.26 15.06 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.493 1.117 . . . . 0.0 112.567 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -42.56 -40.3 2.62 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.483 1.513 . . . . 0.0 114.094 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -56.85 -24.78 53.82 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.408 1.083 . . . . 0.0 113.218 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 m -75.56 -7.16 53.49 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.749 0.82 . . . . 0.0 111.626 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.3 2.74 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 140' ' ' ASN . 31.6 m -62.54 169.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.614 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 28.2 m -114.29 149.32 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 114.42 -1.263 . . . . 0.0 108.932 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -97.17 -97.14 0.2 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -167.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -107.94 144.11 35.66 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.192 0.597 . . . . 0.0 111.606 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 t30 59.19 10.39 1.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.39 1.476 . . . . 0.0 112.634 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.614 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 68.3 mm-40 -79.83 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 122.782 0.433 . . . . 0.0 110.611 -174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG2' HG22 ' A' ' 133' ' ' VAL . 85.1 mtp -88.43 117.62 27.49 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 23.2 m -113.86 135.06 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.142 0.977 . . . . 0.0 109.923 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.95 130.1 55.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.688 0.795 . . . . 0.0 109.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.524 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.3 mp -81.88 141.06 33.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.629 0.771 . . . . 0.0 109.216 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -151.55 148.47 28.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.127 0.571 . . . . 0.0 109.929 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -58.81 144.41 44.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.186 0.994 . . . . 0.0 112.144 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.36 93.03 22.88 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.39 -24.62 12.05 Favored 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.708 2.272 . . . . 0.0 112.978 -175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.68 59.02 2.79 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 122.21 1.005 . . . . 0.0 110.469 -174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 97' ' ' ALA . 37.4 m-80 -108.32 143.09 26.74 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.768 164.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.58 -19.15 32.6 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.379 2.053 . . . . 0.0 111.156 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -77.59 -53.32 7.72 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.269 0.628 . . . . 0.0 110.467 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 4.8 t70 -177.04 152.04 0.87 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.815 0.697 . . . . 0.0 109.444 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -68.38 -19.14 64.61 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.331 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.37 -1.81 31.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.575 1.15 . . . . 0.0 113.006 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . . . -72.86 138.68 46.44 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.4 mt -106.98 123.69 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.934 0.894 . . . . 0.0 109.838 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -86.18 116.58 24.46 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.748 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.6 t -85.48 131.85 33.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -119.05 165.69 13.81 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 107.645 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 37.2 p-10 -98.29 -165.5 1.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.321 0.51 . . . . 0.0 110.056 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.69 -32.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.164 0.586 . . . . 0.0 112.109 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.96 -19.93 59.89 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.755 0.822 . . . . 0.0 110.934 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -0.27 82.13 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -65.89 118.02 9.1 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.032 0.933 . . . . 0.0 109.155 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -62.27 122.16 14.95 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.8 0.687 . . . . 0.0 110.377 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG23 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -89.08 -12.79 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.097 173.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.93 -164.84 24.41 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -84.21 157.37 21.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.174 0.59 . . . . 0.0 110.015 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 4.0 tt -80.71 -55.27 4.95 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 158.21 127.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -163.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -58.22 9.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.369 0.668 . . . . 0.0 110.707 -175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -54.3 -48.38 71.36 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.376 1.071 . . . . 0.0 112.291 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.37 -40.24 77.58 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.279 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.83 -34.05 76.52 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.705 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.33 -32.28 80.29 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.913 0.758 . . . . 0.0 113.539 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.06 -59.16 2.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.397 0.618 . . . . 0.0 109.962 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.7 mt -68.6 -15.04 63.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.38 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.82 72.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.116 1.366 . . . . 0.0 112.631 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -69.25 -32.95 72.5 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.586 0.554 . . . . 0.0 110.02 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 127' ' ' LEU . 50.3 mt -70.72 -34.29 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 123.461 0.705 . . . . 0.0 110.336 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 39.0 tpp -80.25 -39.36 29.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.612 1.165 . . . . 0.0 111.268 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -83.04 -37.43 23.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.194 0.998 . . . . 0.0 110.426 -171.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.55 6.31 47.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.77 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 53.58 39.2 29.77 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.509 1.124 . . . . 0.0 112.724 171.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.433 ' HB2' HG23 ' A' ' 122' ' ' ILE . 75.6 mt -66.06 -40.98 91.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.893 0.877 . . . . 0.0 111.09 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -151.62 138.11 18.62 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.102 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -77.23 107.03 9.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.604 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.29 110.95 24.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.25 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.57 179.0 4.99 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.586 0.754 . . . . 0.0 109.34 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -160.18 160.62 31.84 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 176.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' A' ' 82' ' ' MET . 61.0 t -142.66 120.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 146' ' ' LEU . 2.4 p -95.08 100.48 5.69 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.173 0.589 . . . . 0.0 109.901 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.74 -43.11 0.28 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.832 2.355 . . . . 0.0 113.397 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.65 -27.63 45.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.587 0.755 . . . . 0.0 111.833 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.95 79.34 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.066 0.387 . . . . 0.0 114.066 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 144' ' ' MET . . . -75.92 -15.17 60.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.017 0.527 . . . . 0.0 111.348 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -9.57 33.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.594 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.8 m-20 -73.64 -56.92 4.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.818 0.447 . . . . 0.0 110.664 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.94 -42.38 7.16 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.169 0.587 . . . . 0.0 111.082 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.24 161.38 13.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.086 0.954 . . . . 0.0 111.468 -171.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 69' ' ' GLY . 67.1 p -95.73 109.02 21.38 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 138' ' ' ALA . 22.8 ptm -131.75 151.0 77.82 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 122.59 0.356 . . . . 0.0 111.168 -169.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.06 129.13 4.53 Favored 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 122.618 2.212 . . . . 0.0 111.592 164.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -114.24 156.29 24.59 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -75.56 107.68 7.87 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.799 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.585 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 61.3 mtt -97.84 160.12 14.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.357 1.063 . . . . 0.0 109.008 173.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.27 135.03 30.24 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -169.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.594 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 96.9 m-85 -100.76 120.41 40.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.923 0.889 . . . . 0.0 110.144 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -126.89 110.17 12.75 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.96 168.9 39.98 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -64.19 141.31 58.82 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 122.955 0.502 . . . . 0.0 111.768 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 58' ' ' VAL . 34.2 mt-10 -55.14 -31.05 61.01 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -171.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.49 -20.89 66.15 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.275 0.63 . . . . 0.0 112.199 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.09 -1.0 46.19 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.087 -0.959 . . . . 0.0 113.151 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 154' ' ' GLU . 6.5 ppt_? -64.92 -29.73 70.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 119.593 1.088 . . . . 0.0 111.118 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -29.56 65.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.389 0.676 . . . . 0.0 111.082 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.63 -42.58 19.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.292 0.637 . . . . 0.0 110.271 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.46 -47.15 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.769 1.227 . . . . 0.0 110.83 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.5 t -61.85 -39.93 93.58 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.497 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 38.2 t70 -56.28 -41.29 75.64 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.837 0.71 . . . . 0.0 111.248 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.1 mm100 -72.0 -35.6 69.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.643 -176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.35 -51.64 34.9 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.106 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.95 -33.23 72.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.613 1.165 . . . . 0.0 111.717 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 29.4 ttmt -54.8 -44.87 74.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.06 1.344 . . . . 0.0 111.43 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 -17.71 17.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.217 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.83 30.77 16.97 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.882 -0.399 . . . . 0.0 113.916 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' A' ' 63' ' ' LEU . 53.7 m-85 -88.63 126.74 35.44 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.402 0.601 . . . . 0.0 109.532 172.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 169' ' ' PHE . 1.4 mptm? -131.38 150.11 52.28 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 108.967 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.251 1.181 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.882 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.1 t -80.47 -8.87 59.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.086 0.954 . . . . 0.0 112.143 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 7.2 p-10 -58.3 -19.17 32.55 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.512 1.125 . . . . 0.0 113.411 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -59.82 -61.04 2.91 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.258 0.623 . . . . 0.0 110.13 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -78.9 -17.62 55.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.536 0.734 . . . . 0.0 111.724 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 74.2 t -70.94 -29.99 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.941 0.496 . . . . 0.0 110.125 170.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.09 -9.46 27.97 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.425 0.69 . . . . 0.0 110.937 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 m -71.28 116.06 11.16 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.41 165.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.774 1.229 . . . . 0.0 110.421 -177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.44 117.44 23.07 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.161 0.584 . . . . 0.0 110.087 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.416 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 21.1 m-85 -84.68 -24.79 28.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.385 0.674 . . . . 0.0 110.55 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 142.53 -158.7 27.07 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.472 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.2 p -112.22 178.78 4.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.327 0.651 . . . . 0.0 110.589 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 150' ' ' PHE . 37.3 tp -152.91 147.93 26.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.074 0.549 . . . . 0.0 109.844 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -84.27 87.5 7.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.709 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.36 93.83 0.91 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.926 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -67.42 111.91 4.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.749 0.82 . . . . 0.0 110.965 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG12 HD23 ' A' ' 111' ' ' LEU . 19.6 m -113.24 145.81 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.689 0.796 . . . . 0.0 109.119 172.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HA ' HG22 ' A' ' 143' ' ' THR . 26.2 m -96.58 153.33 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.173 0.589 . . . . 0.0 111.447 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.07 -19.88 68.81 Favored Glycine 0 N--CA 1.477 1.41 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.29 -17.57 58.99 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.504 0.669 . . . . 0.0 112.028 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.558 ' NH2' HG23 ' A' ' 108' ' ' VAL . 15.3 mtp180 -69.48 -2.38 11.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.38 1.472 . . . . 0.0 113.611 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -52.05 -42.84 63.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.6 0.76 . . . . 0.0 112.493 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -83.46 -6.47 59.47 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.862 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -75.17 -26.14 58.85 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 109.695 173.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.96 49.79 0.45 Allowed Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.389 -0.369 . . . . 0.0 112.704 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HB ' ' ND2' ' A' ' 139' ' ' ASN . 15.7 m -59.79 170.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.46 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 6.0 m -115.54 178.56 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.657 -177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -85.03 -165.95 1.35 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.658 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -82.48 159.93 22.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.17 0.588 . . . . 0.0 110.411 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER 63.47 9.02 3.88 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.083 1.353 . . . . 0.0 112.912 -179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 28.4 mm-40 -84.33 144.27 28.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.139 0.576 . . . . 0.0 110.731 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.441 ' HG2' HG22 ' A' ' 133' ' ' VAL . 72.1 mtm -92.84 132.88 36.61 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.89 152.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.993 0.917 . . . . 0.0 110.116 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.76 157.1 30.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.517 0.727 . . . . 0.0 110.489 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 98' ' ' ILE . 8.4 mp -100.43 134.65 43.07 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.304 0.642 . . . . 0.0 110.037 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -139.73 110.78 6.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.441 1.097 . . . . 0.0 108.238 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.55 127.37 32.93 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -118.18 96.64 49.99 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.892 -169.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.14 -24.88 76.76 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.993 2.462 . . . . 0.0 112.821 176.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.824 0.85 . . . . 0.0 111.826 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.593 HD22 ' HB3' ' A' ' 97' ' ' ALA . 66.0 t30 -57.83 117.89 22.37 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.735 0.814 . . . . 0.0 111.375 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -74.34 -14.13 22.87 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.964 2.443 . . . . 0.0 112.516 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.507 ' HB3' HD21 ' A' ' 91' ' ' ASN . 28.9 t80 -73.11 -49.48 28.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.114 0.966 . . . . 0.0 109.713 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 16.2 t70 -173.09 138.27 0.74 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.626 0.771 . . . . 0.0 109.829 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -69.54 -30.43 68.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.37 0.668 . . . . 0.0 111.62 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -83.95 -12.88 54.68 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.012 0.525 . . . . 0.0 110.508 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 91' ' ' ASN . . . -59.77 109.14 0.86 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 124.267 0.979 . . . . 0.0 109.826 -173.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.431 ' HB ' HD12 ' A' ' 111' ' ' LEU . 73.2 mt -72.38 104.33 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.99 -172.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 107' ' ' GLN . 39.6 ttmt -61.94 110.9 1.7 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.516 168.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.82 110.87 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.68 173.94 6.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.056 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -105.67 -167.87 1.38 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.2 m -62.02 -29.71 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -73.48 -31.69 63.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.781 0.832 . . . . 0.0 110.81 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.88 -2.34 41.47 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.191 -172.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -65.52 122.89 18.25 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.844 0.858 . . . . 0.0 109.45 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 18.5 pm0 -62.07 111.26 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.091 0.869 . . . . 0.0 109.761 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG23 ' NH2' ' A' ' 71' ' ' ARG . 16.0 m -91.36 -0.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.35 -148.68 20.21 Favored Glycine 0 C--N 1.366 2.228 0 C-N-CA 123.535 0.588 . . . . 0.0 113.513 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -137.28 146.13 44.33 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.085 1.354 . . . . 0.0 108.732 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 115' ' ' LEU . 43.4 mt -63.63 -57.1 11.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 117.955 0.343 . . . . 0.0 111.609 -176.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 115' ' ' LEU . 32.1 mmmt 173.98 169.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 128.078 2.551 . . . . 0.0 105.033 -167.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 -27.25 33.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 119.292 0.951 . . . . 0.0 109.327 160.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 169' ' ' PHE . 28.9 tt0 -69.7 -59.93 2.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.756 1.222 . . . . 0.0 111.085 -177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 HD13 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -58.2 -40.14 80.8 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.167 0.987 . . . . 0.0 109.044 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.99 97.93 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.831 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -51.17 -36.0 35.09 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 124.215 0.947 . . . . 0.0 113.928 -176.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.3 -61.34 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.444 0.698 . . . . 0.0 111.548 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 mt -71.38 -18.92 62.33 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.583 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.55 81.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.902 0.881 . . . . 0.0 110.417 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -65.4 -36.51 84.18 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.182 0.926 . . . . 0.0 110.331 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.401 HG23 ' HB2' ' A' ' 127' ' ' LEU . 67.5 mt -65.98 -42.06 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 30.1 ttp -78.0 -32.2 51.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.249 -177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.32 -48.78 11.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.916 0.887 . . . . 0.0 111.021 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER -85.93 7.01 25.92 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.141 0.576 . . . . 0.0 111.231 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 63.14 32.36 15.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' A' ' 156' ' ' ASN . 56.7 mt -67.5 -44.17 79.12 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.895 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -156.33 150.38 25.21 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.999 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -77.77 134.92 37.95 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 166.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.409 ' HB ' HD22 ' A' ' 85' ' ' LEU . 31.3 mt -127.73 129.55 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.1 168.13 18.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.544 1.137 . . . . 0.0 108.516 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -137.02 166.96 24.8 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.929 -0.469 . . . . 0.0 111.929 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 82' ' ' MET . 62.6 t -147.91 131.35 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 137' ' ' GLY . 2.5 p -102.45 99.27 12.56 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.169 0.588 . . . . 0.0 110.251 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.11 -27.58 4.4 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.761 2.308 . . . . 0.0 112.766 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -75.23 -31.29 60.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.066 0.546 . . . . 0.0 111.784 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 134' ' ' VAL . . . 63.18 11.69 40.49 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 114.222 0.449 . . . . 0.0 114.222 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 144' ' ' MET . . . -88.92 5.63 43.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.674 0.789 . . . . 0.0 111.397 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 3.6 p-10 -63.69 -19.42 64.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.597 1.159 . . . . 0.0 112.188 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -69.71 -60.73 2.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.744 0.818 . . . . 0.0 111.146 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.56 -32.04 11.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -171.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -113.58 162.56 16.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.368 0.604 . . . . 0.0 112.196 -167.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 72.9 p -97.51 109.71 22.41 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.482 ' HE1' ' HB3' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -149.75 158.43 37.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -167.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -88.66 127.18 1.9 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.772 2.314 . . . . 0.0 113.035 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.482 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 3.7 pp -94.23 152.16 18.9 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -73.26 108.82 6.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.594 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.49 ' HE3' HD21 ' A' ' 111' ' ' LEU . 47.7 mtt -99.03 166.39 11.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.692 0.797 . . . . 0.0 110.346 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.4 p -143.69 156.17 44.46 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.304 1.042 . . . . 0.0 109.707 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HE1' ' HB2' ' A' ' 63' ' ' LEU . 81.1 m-85 -117.41 117.24 28.94 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.715 0.806 . . . . 0.0 108.856 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -124.26 100.37 6.66 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.78 167.06 29.86 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -73.55 145.25 45.67 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.599 0.36 . . . . 0.0 111.307 -171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -58.34 -30.34 66.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 113.874 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.04 -6.51 54.8 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 127' ' ' LEU . 4.0 m-20 -118.24 7.55 12.1 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.248 0.619 . . . . 0.0 110.543 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -37.04 86.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.144 0.578 . . . . 0.0 112.11 -169.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -26.03 61.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.157 0.286 . . . . 0.0 110.765 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -77.93 -34.59 51.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.072 0.549 . . . . 0.0 110.335 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 156' ' ' ASN . 66.0 t -62.8 -50.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.33 0.652 . . . . 0.0 109.993 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 83.4 p -66.36 -32.21 73.45 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.735 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -57.26 -43.31 82.93 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.296 0.638 . . . . 0.0 111.413 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 9.8 mm100 -70.05 -30.84 68.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.786 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 97.9 mt -68.15 -52.34 35.85 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.19 0.596 . . . . 0.0 110.103 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.04 -25.07 67.67 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.447 1.099 . . . . 0.0 111.585 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.929 1.292 . . . . 0.0 111.805 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -103.77 -28.37 11.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.293 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.11 29.88 5.3 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.552 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 114' ' ' GLU . 62.5 m-85 -78.17 129.93 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.733 0.766 . . . . 0.0 110.858 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -153.4 146.58 24.68 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.678 ' H ' HD23 ' A' ' 171' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.339 0 C-N-CA 123.709 0.804 . . . . 0.0 110.794 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 112.884 -0.086 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.1 t -66.69 -21.74 66.09 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.006 0.922 . . . . 0.0 111.646 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -69.9 -14.23 62.63 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.643 1.177 . . . . 0.0 112.483 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.19 -48.61 70.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.615 0.766 . . . . 0.0 112.021 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -15.29 59.22 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.196 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -35.3 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.925 0.89 . . . . 0.0 109.726 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -84.83 -15.44 44.75 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.749 1.219 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -80.42 143.39 33.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.523 0.729 . . . . 0.0 111.704 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.31 161.31 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.296 1.438 . . . . 0.0 110.474 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.7 tp -85.36 110.89 19.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 34.7 m-85 -73.17 -39.22 65.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.341 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.57 -160.86 30.56 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.1 p -111.79 179.14 4.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.516 0.726 . . . . 0.0 110.858 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 169' ' ' PHE . 33.7 tp -154.73 153.39 31.18 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.371 0.668 . . . . 0.0 109.983 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -87.29 92.71 9.17 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.64 125.21 8.39 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.456 ' H ' ' HG ' ' A' ' 115' ' ' LEU . 77.0 m80 -114.65 109.95 19.01 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.606 0.762 . . . . 0.0 110.286 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -104.39 139.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' HB ' ' HD3' ' A' ' 71' ' ' ARG . 66.4 t -71.97 142.87 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.998 0.519 . . . . 0.0 110.397 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.88 -44.45 68.68 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.727 -0.67 . . . . 0.0 114.328 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.1 -17.77 42.24 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.067 0.947 . . . . 0.0 112.065 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' A' ' 68' ' ' VAL . 2.3 mpt_? -74.35 1.4 11.72 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.452 1.101 . . . . 0.0 111.739 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -57.25 -28.83 63.3 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.845 0.458 . . . . 0.0 110.611 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.66 -31.89 72.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.051 0.94 . . . . 0.0 111.015 174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -74.46 -27.06 60.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.392 0.677 . . . . 0.0 110.207 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.8 46.63 0.51 Allowed Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.756 -0.656 . . . . 0.0 114.288 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.676 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 93.7 t -56.49 154.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 122.816 0.446 . . . . 0.0 110.452 171.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.54 159.4 7.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.538 0.735 . . . . 0.0 111.061 -170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -96.02 -115.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.07 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -93.96 139.94 30.31 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.63 0.772 . . . . 0.0 111.745 -163.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 74.03 -22.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.37 1.468 . . . . 0.0 113.656 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.02 129.69 43.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.52 1.128 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.525 ' HG2' HG22 ' A' ' 133' ' ' VAL . 74.7 mtp -94.25 142.74 27.06 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 30.0 m -114.64 147.04 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.101 0.56 . . . . 0.0 110.463 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.76 53.75 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.042 0.937 . . . . 0.0 108.803 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -88.37 151.32 22.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.405 0.682 . . . . 0.0 110.319 -173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -159.76 153.68 23.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.073 0.949 . . . . 0.0 109.101 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.402 HH22 ' HB2' ' A' ' 124' ' ' ASP . 32.9 ttm180 -71.88 137.13 47.23 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.703 0.401 . . . . 0.0 110.334 172.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.78 117.17 67.61 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.4 0.68 . . . . 0.0 109.813 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.4 -29.76 53.68 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.781 2.321 . . . . 0.0 112.797 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.33 52.49 2.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.431 0.693 . . . . 0.0 109.599 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.25 108.16 1.06 Allowed Pre-proline 0 CA--C 1.566 1.564 0 C-N-CA 124.579 1.151 . . . . 0.0 112.498 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.86 -34.94 70.32 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 123.284 2.656 . . . . 0.0 113.543 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -126.0 -44.04 1.79 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.412 0.685 . . . . 0.0 111.197 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -162.94 162.7 26.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.142 0.577 . . . . 0.0 109.924 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.23 -14.52 26.48 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.417 1.087 . . . . 0.0 112.53 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' HB3' ' HA2' ' A' ' 117' ' ' GLY . 47.3 m-80 -73.33 4.08 5.09 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.74 116.96 18.68 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.248 0.619 . . . . 0.0 109.955 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.537 ' H ' ' HB1' ' A' ' 116' ' ' ALA . 44.9 mt -97.98 118.79 45.09 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 C-N-CA 123.614 0.766 . . . . 0.0 109.649 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.731 ' HD3' ' HG3' ' A' ' 107' ' ' GLN . 17.3 ttmm -71.53 140.04 49.74 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.288 165.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.1 t -109.84 124.62 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -108.09 168.65 9.14 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 172.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 35.7 p-10 -108.4 -165.77 1.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.988 0.515 . . . . 0.0 110.217 173.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -59.75 -33.14 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.556 0.742 . . . . 0.0 111.537 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -76.14 -19.99 58.0 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.991 0.916 . . . . 0.0 111.112 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.04 6.88 78.41 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -69.96 135.09 49.06 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 109.62 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.731 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 26.1 mp0 -73.81 98.64 3.0 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.825 0.85 . . . . 0.0 109.0 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.676 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 11.8 m -79.77 -25.82 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.51 -175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.7 -142.18 8.36 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 121.587 -0.34 . . . . 0.0 112.914 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -140.32 157.4 45.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.334 1.054 . . . . 0.0 109.571 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.58 HD13 HD12 ' A' ' 115' ' ' LEU . 65.9 mt -81.64 -5.06 57.71 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.422 176.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? 71.6 151.5 0.11 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 109.937 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -37.42 -42.06 0.48 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.413 1.485 . . . . 0.0 114.653 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.41 -56.12 5.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.383 0.273 . . . . 0.0 111.122 -170.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.58 HD12 HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -72.43 -44.46 62.38 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -175.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.537 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -58.6 -51.6 69.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.412 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 96' ' ' ASN . . . -60.44 -27.4 65.73 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.497 0.498 . . . . 0.0 114.071 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.93 -61.59 1.73 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.954 0.502 . . . . 0.0 109.918 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 130' ' ' ILE . 18.1 mt -69.88 -16.07 63.18 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.971 -172.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.11 -24.15 65.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.967 0.907 . . . . 0.0 113.231 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -76.32 -35.87 58.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 127' ' ' LEU . 48.1 mt -67.64 -29.65 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.92 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.2 tpp -79.08 -41.71 28.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.463 1.105 . . . . 0.0 110.558 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HH22 ' A' ' 87' ' ' ARG . 20.7 t70 -67.66 -50.8 56.04 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.53 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -93.54 1.16 56.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.849 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 54.52 44.65 28.44 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.015 0.926 . . . . 0.0 111.642 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 122' ' ' ILE . 62.3 mt -68.79 -40.18 79.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.992 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -155.58 135.38 12.72 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.261 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -68.21 114.43 6.69 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 119' ' ' LEU . 13.7 mt -101.08 124.03 54.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -135.07 139.6 44.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.815 0.846 . . . . 0.0 108.944 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -116.95 168.16 12.74 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.343 -178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 82' ' ' MET . 44.1 t -138.94 133.6 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 146' ' ' LEU . 11.0 t -103.34 94.12 5.47 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.17 -56.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.179 1.92 . . . . 0.0 112.951 -172.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -75.8 -30.99 59.24 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.943 0.497 . . . . 0.0 110.976 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 49.47 34.62 19.91 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 124.0 0.812 . . . . 0.0 114.435 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -89.89 17.77 6.39 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.753 0.821 . . . . 0.0 112.278 -168.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -52.14 -36.46 51.47 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.293 1.037 . . . . 0.0 112.094 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -53.92 -49.14 69.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.819 0.848 . . . . 0.0 111.397 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.85 -51.59 11.01 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.722 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -157.49 166.42 33.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.416 1.087 . . . . 0.0 109.555 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.8 p -94.59 110.71 22.5 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.03 141.49 26.36 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 124.245 1.018 . . . . 0.0 110.562 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.29 130.26 18.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.951 2.434 . . . . 0.0 112.261 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.418 HD22 HG22 ' A' ' 134' ' ' VAL . 4.5 pp -87.52 152.97 21.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -91.13 110.73 22.01 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 122.1 -0.375 . . . . 0.0 110.502 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.572 ' HA ' ' HA2' ' A' ' 132' ' ' GLY . 54.7 mtt -92.5 169.45 10.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.217 1.007 . . . . 0.0 111.065 173.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 p -149.72 147.53 28.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.702 1.201 . . . . 0.0 109.062 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.442 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 91.8 m-85 -109.34 120.56 42.89 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.847 0.859 . . . . 0.0 109.515 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -124.17 97.68 5.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.22 166.34 35.73 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.75 139.76 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.373 0.669 . . . . 0.0 111.942 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -51.07 -37.28 44.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.753 1.221 . . . . 0.0 112.997 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.46 -12.29 59.92 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.679 0.791 . . . . 0.0 113.133 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -97.22 -0.98 45.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -30.24 69.61 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -33.59 71.62 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.16 0.505 . . . . 0.0 110.929 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -81.74 -33.97 30.74 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.48 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.37 -48.77 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.878 0.871 . . . . 0.0 110.777 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 72.9 p -64.34 -34.41 78.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 111.555 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.61 -42.76 75.35 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.674 0.609 . . . . 0.0 111.394 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.3 mm100 -66.8 -38.94 87.46 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.326 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -70.17 -53.18 18.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.525 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -62.94 -25.61 68.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.888 0.875 . . . . 0.0 112.074 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.37 -48.12 82.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 111.389 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -102.89 -1.1 30.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.601 0.761 . . . . 0.0 111.046 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.43 19.73 63.65 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.368 0.418 . . . . 0.0 113.988 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 63' ' ' LEU . 24.8 m-85 -74.54 147.54 41.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.372 0.669 . . . . 0.0 111.05 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -164.16 152.58 13.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.787 0.835 . . . . 0.0 109.709 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 123.76 0.824 . . . . 0.0 112.882 174.456 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.377 -0.289 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.0 p -80.35 -17.21 52.63 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.814 0.446 . . . . 0.0 111.913 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.07 -41.26 71.3 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.453 1.101 . . . . 0.0 111.537 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.86 -47.06 66.88 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.448 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -73.18 -22.01 60.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.387 0.275 . . . . 0.0 111.488 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.99 -31.94 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.827 0.851 . . . . 0.0 109.625 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.38 -13.73 42.6 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.715 0.806 . . . . 0.0 110.788 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.4 m -74.41 113.94 12.22 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 122.997 0.519 . . . . 0.0 110.497 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.29 158.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.397 1.079 . . . . 0.0 110.898 -175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 tt -81.27 114.92 20.39 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.76 0.824 . . . . 0.0 108.962 174.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.05 -36.03 59.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.188 0.595 . . . . 0.0 110.062 177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.48 175.9 38.98 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.756 -176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 p -110.67 155.23 22.73 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.106 0.962 . . . . 0.0 108.735 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -131.01 147.05 52.58 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.774 0.429 . . . . 0.0 110.285 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -78.42 78.56 4.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.797 0.808 . . . . 0.0 109.118 171.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -70.43 143.06 36.57 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.186 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -132.79 105.58 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.192 0.597 . . . . 0.0 109.546 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 71' ' ' ARG . 3.8 t -78.65 159.56 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.7 m -63.49 152.59 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.174 -0.329 . . . . 0.0 111.312 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 143' ' ' THR . . . -65.1 -35.56 91.92 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.03 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.34 -15.07 3.44 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.212 1.405 . . . . 0.0 113.269 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.691 HH12 HG22 ' A' ' 77' ' ' VAL . 1.9 tmm_? -56.95 -17.59 10.22 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.206 1.003 . . . . 0.0 112.42 -179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HA ' HG13 ' A' ' 76' ' ' VAL . 40.6 p90 -59.07 -41.31 87.68 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 123.062 0.545 . . . . 0.0 110.859 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -72.0 -31.18 65.99 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.251 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 71' ' ' ARG . 46.4 p -95.82 3.56 53.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.793 0.437 . . . . 0.0 111.561 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.9 52.2 0.51 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 115.713 1.045 . . . . 0.0 115.713 169.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 140' ' ' ASN . 3.1 m -48.91 152.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-N 118.334 1.067 . . . . 0.0 113.186 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.691 HG22 HH12 ' A' ' 71' ' ' ARG . 28.8 m -114.47 164.7 10.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.884 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -84.39 -169.17 2.48 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.548 0.739 . . . . 0.0 111.231 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -71.66 157.89 37.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.64 0.776 . . . . 0.0 111.279 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 67.88 8.08 6.2 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.122 0.969 . . . . 0.0 112.186 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.6 mm-40 -76.93 140.63 40.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.482 0.658 . . . . 0.0 111.132 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.475 ' HG2' HG22 ' A' ' 133' ' ' VAL . 78.9 mtp -107.2 149.49 27.65 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 132' ' ' GLY . 13.4 m -132.04 163.5 37.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.248 175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.38 125.71 23.3 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.76 160.38 26.22 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.086 0.47 . . . . 0.0 111.153 -172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -157.05 126.75 6.18 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.002 172.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HD2' ' HB2' ' A' ' 95' ' ' LYS . 64.7 ttp85 -67.34 130.76 44.11 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.2 117.6 21.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 123.628 0.58 . . . . 0.0 110.733 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.35 -39.88 34.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.33 2.02 . . . . 0.0 110.237 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.26 76.1 3.42 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 7.5 p30 -67.4 127.9 93.54 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.968 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.54 -39.39 28.22 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.998 2.465 . . . . 0.0 113.021 -173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -127.35 -50.97 1.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.764 0.426 . . . . 0.0 110.43 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 8.8 p30 -150.38 170.58 18.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.783 0.833 . . . . 0.0 110.031 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' ' HD2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -64.9 -8.24 14.67 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.459 1.103 . . . . 0.0 113.09 -173.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -64.26 -12.25 39.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.587 0.755 . . . . 0.0 112.567 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 109.4 7.57 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.049 0.54 . . . . 0.0 110.303 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 120' ' ' ALA . 59.7 mt -118.8 115.82 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -85.22 163.21 18.82 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.467 0.651 . . . . 0.0 110.223 172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.53 121.32 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.5 1.12 . . . . 0.0 109.237 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -109.76 130.97 55.46 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -75.85 -170.53 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.932 0.787 . . . . 0.0 110.994 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.43 -33.78 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.894 0.878 . . . . 0.0 112.87 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -81.13 -31.62 34.12 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.818 0.447 . . . . 0.0 110.885 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.49 6.4 25.34 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 116.323 -0.399 . . . . 0.0 113.266 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -66.7 119.25 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.858 0.863 . . . . 0.0 110.251 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -72.8 90.16 1.41 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.828 0.823 . . . . 0.0 110.279 176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.5 -14.19 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.988 1.315 . . . . 0.0 113.307 -172.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.13 -157.4 27.62 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 118.024 0.375 . . . . 0.0 112.363 -176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -132.15 149.43 52.4 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.47 0.708 . . . . 0.0 110.269 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 116' ' ' ALA . 71.5 mt -76.23 -0.85 23.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.685 0.794 . . . . 0.0 113.004 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.5 tttt 71.45 130.56 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.436 1.094 . . . . 0.0 110.556 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -19.21 5.99 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.597 1.159 . . . . 0.0 113.865 -170.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG3' ' HE1' ' A' ' 167' ' ' HIS . 12.2 tp10 -67.01 -55.09 15.9 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.481 0.713 . . . . 0.0 111.395 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.69 -44.97 12.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.354 0.662 . . . . 0.0 110.184 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . . . -61.89 -24.28 66.84 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.179 0.991 . . . . 0.0 111.967 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.47 -32.64 64.62 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.17 0.294 . . . . 0.0 113.538 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 163' ' ' GLN . . . -65.97 -44.5 84.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 171.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.53 -16.41 56.02 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.742 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.496 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -56.53 -44.75 81.15 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.34 1.056 . . . . 0.0 112.053 -174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -70.58 -32.74 70.25 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.09 0.869 . . . . 0.0 110.298 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 160' ' ' VAL . 62.5 mt -65.36 -41.63 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.194 0.598 . . . . 0.0 110.02 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -77.45 -37.93 50.5 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.918 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -74.35 -42.9 58.6 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.485 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -98.02 6.38 47.7 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.396 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 60.37 34.72 20.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.702 1.201 . . . . 0.0 111.654 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD13 ' HB1' ' A' ' 159' ' ' ALA . 75.8 mt -64.0 -43.44 95.66 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.484 0.714 . . . . 0.0 111.231 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -162.2 159.93 26.43 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.071 0.549 . . . . 0.0 111.109 175.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.8 mt -129.69 118.5 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.47 166.18 18.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.96 102.37 0.24 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' HG2' ' A' ' 82' ' ' MET . 43.0 t -103.58 114.96 44.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG23 ' SD ' ' A' ' 144' ' ' MET . 2.9 p -101.3 91.29 2.01 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.263 1.025 . . . . 0.0 108.71 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 2.7 Cg_exo -78.54 -23.92 8.03 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.128 2.552 . . . . 0.0 112.93 -172.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.26 -28.82 19.66 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.21 0.604 . . . . 0.0 110.926 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.56 62.3 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 113.863 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.08 -2.38 33.87 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.631 0.772 . . . . 0.0 112.347 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -24.69 65.44 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.448 ' HA ' HG21 ' A' ' 76' ' ' VAL . 55.6 t30 -57.28 -34.3 68.52 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.056 0.942 . . . . 0.0 111.262 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.78 53.25 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.133 0.573 . . . . 0.0 110.816 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -167.99 -66.3 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.474 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 8.9 t -160.32 169.06 23.92 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.693 0.797 . . . . 0.0 110.17 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.581 ' SD ' HG23 ' A' ' 134' ' ' VAL . 5.5 ppp? -167.34 156.28 9.16 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.289 1.036 . . . . 0.0 109.484 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 74.1 Cg_endo -76.63 120.45 5.55 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 121.418 1.412 . . . . 0.0 112.063 170.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 146' ' ' LEU . 2.6 pt? -102.73 149.4 24.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -85.39 108.2 17.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -171.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.669 ' SD ' ' HA3' ' A' ' 65' ' ' GLY . 38.1 mtp -107.36 116.38 31.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.316 0.646 . . . . 0.0 109.873 -171.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.7 p -113.06 126.49 55.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.763 0.425 . . . . 0.0 110.008 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -92.19 115.32 27.97 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.685 0.794 . . . . 0.0 109.537 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -114.54 110.97 20.63 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.503 1.121 . . . . 0.0 109.724 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.52 168.74 38.29 Favored Glycine 0 C--O 1.236 0.235 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -63.47 152.25 38.92 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 118.207 1.003 . . . . 0.0 111.304 -178.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -56.72 -27.78 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.065 0.946 . . . . 0.0 113.511 -171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 153' ' ' LYS . 12.8 pt-20 -78.08 -28.21 48.69 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.89 -5.02 46.74 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.797 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -59.01 -41.91 88.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.754 0.422 . . . . 0.0 110.228 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -70.49 -27.75 64.44 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.444 0.697 . . . . 0.0 111.738 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -72.71 -45.03 60.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.589 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 122' ' ' ILE . 70.4 t -64.41 -40.97 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.31 1.044 . . . . 0.0 111.14 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 66.4 m -58.58 -45.07 89.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.075 0.95 . . . . 0.0 110.62 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.14 -41.4 71.71 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.878 0.871 . . . . 0.0 111.542 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.2 mm100 -75.34 -27.26 59.15 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.038 -174.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 169' ' ' PHE . 76.1 mt -73.0 -44.26 61.22 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.824 173.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -59.46 -28.63 67.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.404 1.082 . . . . 0.0 111.356 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.57 -50.12 70.9 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.094 0.958 . . . . 0.0 111.34 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . 0.47 ' HE1' ' HG3' ' A' ' 114' ' ' GLU . 20.6 t60 -81.43 -28.14 34.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.363 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.49 12.02 10.01 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-O 119.87 -0.406 . . . . 0.0 113.332 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.602 ' HB2' ' HB3' ' A' ' 164' ' ' LEU . 46.8 m-85 -70.09 168.23 16.01 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.231 0.612 . . . . 0.0 111.331 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 160.45 23.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.619 1.168 . . . . 0.0 112.475 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 126.941 2.097 . . . . 0.0 109.111 178.047 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.12 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 p -70.44 -34.66 72.72 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.081 0.552 . . . . 0.0 110.752 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -65.41 -24.06 67.11 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.242 1.017 . . . . 0.0 111.563 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.389 1.076 . . . . 0.0 112.528 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -61.41 -33.24 73.36 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.555 0.342 . . . . 0.0 111.246 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.88 -35.3 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.601 0.761 . . . . 0.0 109.474 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.35 -17.58 63.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.194 0.997 . . . . 0.0 111.104 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -73.71 116.66 14.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.313 0.645 . . . . 0.0 109.863 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.86 165.83 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.526 1.13 . . . . 0.0 110.859 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 149' ' ' THR . 24.6 tp -82.13 121.67 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.873 0.469 . . . . 0.0 110.177 177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.455 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 19.7 m-85 -86.87 -38.58 16.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.169 0.588 . . . . 0.0 110.088 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 -172.18 28.92 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.724 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -112.6 166.5 11.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.464 0.706 . . . . 0.0 111.363 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.481 ' HB2' ' HE2' ' A' ' 150' ' ' PHE . 33.8 tp -145.32 150.6 36.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.933 0.893 . . . . 0.0 109.319 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -75.94 98.36 4.22 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.418 0.628 . . . . 0.0 109.964 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA3' ' SD ' ' A' ' 148' ' ' MET . . . -81.09 73.98 2.5 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 145' ' ' PRO . 52.9 t-80 -65.62 85.82 0.08 Allowed 'General case' 0 C--N 1.349 0.58 0 C-N-CA 123.981 0.912 . . . . 0.0 110.351 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 111' ' ' LEU . 14.4 m -81.61 144.33 10.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.166 173.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 71' ' ' ARG . 33.3 m -65.61 148.07 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.39 175.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.86 -22.12 62.15 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.1 tp -61.85 -19.12 62.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.929 1.292 . . . . 0.0 111.804 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 34.4 ptt85 -72.52 0.14 11.18 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.387 1.075 . . . . 0.0 112.549 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -53.85 -35.63 61.71 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.811 0.844 . . . . 0.0 112.658 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -67.86 -23.23 65.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.884 0.874 . . . . 0.0 111.641 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -73.02 -24.18 60.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.072 0.549 . . . . 0.0 111.023 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.82 49.11 0.52 Allowed Glycine 0 C--N 1.354 1.533 0 O-C-N 122.309 -0.244 . . . . 0.0 113.49 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 43.4 t -63.47 160.09 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.634 0.774 . . . . 0.0 111.747 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.06 157.05 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.454 1.102 . . . . 0.0 109.3 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -78.91 -164.64 0.62 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.989 0.916 . . . . 0.0 113.024 -165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -67.05 145.89 54.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.691 0.797 . . . . 0.0 110.825 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.8 t30 73.72 -15.52 0.57 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.198 1.399 . . . . 0.0 112.713 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -73.2 130.02 39.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.57 0.748 . . . . 0.0 111.113 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 79.7 mtp -84.77 149.42 25.76 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.068 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 16.4 m -134.75 -170.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.709 1.204 . . . . 0.0 109.836 177.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -160.92 154.5 22.08 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.595 1.158 . . . . 0.0 108.432 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -99.15 146.83 25.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.909 0.385 . . . . 0.0 110.817 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -155.83 127.77 7.49 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 108.845 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -63.05 142.23 58.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 174.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.24 110.79 2.83 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.753 0.821 . . . . 0.0 110.347 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -31.61 44.84 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.488 2.125 . . . . 0.0 111.271 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -107.27 68.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 170.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 6.9 p30 -74.85 119.03 74.82 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.059 0.544 . . . . 0.0 110.551 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 15.4 Cg_exo -69.61 -38.68 7.79 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 0.0 113.554 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -119.88 -51.39 2.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.304 0.641 . . . . 0.0 111.677 -167.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.25 146.82 35.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.375 0.67 . . . . 0.0 109.792 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.506 ' HB2' HH21 ' A' ' 87' ' ' ARG . 14.7 ptmm? -74.05 -5.1 39.47 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.932 0.893 . . . . 0.0 111.1 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -76.63 -6.03 50.32 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.204 1.002 . . . . 0.0 111.98 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.426 ' HB1' ' HE1' ' A' ' 110' ' ' HIS . . . -71.03 125.56 27.2 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.081 0.952 . . . . 0.0 110.646 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 60.9 mt -123.65 120.18 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.64 0.776 . . . . 0.0 110.657 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 110' ' ' HIS . 39.5 mttp -77.7 162.79 26.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.554 1.141 . . . . 0.0 111.009 167.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.3 t -123.3 127.02 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -122.32 144.22 49.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.622 1.169 . . . . 0.0 108.737 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -74.29 179.01 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.883 0.765 . . . . 0.0 112.285 177.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.85 -25.45 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.167 0.987 . . . . 0.0 113.492 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -73.16 -17.2 61.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.376 0.67 . . . . 0.0 110.968 177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.81 37.25 10.49 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.825 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.536 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 4.8 t-20 -121.99 131.47 54.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.573 0.749 . . . . 0.0 109.185 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -58.92 104.76 0.26 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 124.167 0.917 . . . . 0.0 111.16 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 28.8 m -87.5 -0.24 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.012 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' ' HD2' ' A' ' 71' ' ' ARG . . . 151.89 -159.24 28.21 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.457 -0.338 . . . . 0.0 113.057 170.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 99' ' ' LYS . 64.0 t60 -122.83 150.11 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.3 tt -75.07 -57.07 4.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.122 0.169 . . . . 0.0 111.006 -170.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.3 tptt 142.53 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -162.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -22.5 62.43 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.777 1.171 . . . . 0.0 112.192 -175.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.78 -47.56 68.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.289 1.035 . . . . 0.0 110.571 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HA ' ' HZ ' ' A' ' 169' ' ' PHE . 8.9 tt -72.04 -48.69 42.66 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.434 0.694 . . . . 0.0 109.273 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -21.91 65.9 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.041 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.8 -28.36 60.3 Favored Glycine 0 N--CA 1.476 1.33 0 O-C-N 123.296 0.373 . . . . 0.0 113.691 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.13 -56.26 4.35 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.315 0.646 . . . . 0.0 109.896 172.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 122' ' ' ILE . 31.3 mt -63.67 -16.5 61.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.059 0.944 . . . . 0.0 112.396 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.22 65.36 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.518 1.527 . . . . 0.0 112.046 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -70.07 -30.55 67.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.35 1.031 . . . . 0.0 110.618 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.488 ' HA ' HD12 ' A' ' 127' ' ' LEU . 60.2 mt -67.79 -34.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.22 0.608 . . . . 0.0 110.143 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 35.9 tpp -80.8 -33.22 34.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.068 0.947 . . . . 0.0 110.723 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -75.85 -40.34 54.92 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.505 1.122 . . . . 0.0 111.467 -173.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.08 -2.38 40.27 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.221 178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 57.84 41.58 24.6 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.236 1.015 . . . . 0.0 111.03 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.1 mt -61.3 -43.95 98.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.436 -178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -149.66 138.37 20.93 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.246 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.92 105.24 5.86 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.7 mt -89.59 104.69 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.11 176.28 9.34 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.589 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -149.59 158.97 27.89 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.61 -0.268 . . . . 0.0 112.522 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 55.6 t -148.38 129.75 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 146' ' ' LEU . 21.8 t -96.68 93.41 1.36 Allowed Pre-proline 0 N--CA 1.481 1.087 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 7.1 Cg_exo -74.25 -49.24 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.404 2.069 . . . . 0.0 112.24 -171.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.88 -27.48 33.44 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.563 0.745 . . . . 0.0 111.263 -172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.66 60.64 Favored Glycine 0 C--N 1.354 1.551 0 O-C-N 123.465 0.478 . . . . 0.0 114.27 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.99 9.27 10.51 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.415 0.686 . . . . 0.0 112.694 -170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -64.71 -20.5 66.36 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.611 0.765 . . . . 0.0 111.659 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.23 -47.96 82.07 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.671 0.788 . . . . 0.0 110.077 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.61 -53.99 4.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.492 0.717 . . . . 0.0 111.747 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -146.88 -165.77 2.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.665 0.786 . . . . 0.0 111.504 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 t -95.94 122.73 39.06 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.809 0.844 . . . . 0.0 109.662 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -131.66 147.02 64.37 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.271 0.628 . . . . 0.0 111.223 -170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . 88.2 Cg_endo -79.2 125.5 6.47 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.52 2.146 . . . . 0.0 112.252 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.581 HD22 HG22 ' A' ' 134' ' ' VAL . 3.3 pp -100.37 154.59 18.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.21 107.48 4.24 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.333 0.653 . . . . 0.0 110.559 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 85' ' ' LEU . 62.3 mtt -107.12 149.66 27.41 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 173.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -144.34 135.97 25.83 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -171.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.481 ' HE2' ' HB2' ' A' ' 63' ' ' LEU . 83.1 m-85 -99.53 123.56 43.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.241 1.016 . . . . 0.0 110.655 -174.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -130.68 105.25 7.69 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.1 0.96 . . . . 0.0 108.561 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.78 166.76 35.09 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -58.37 143.13 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.509 0.724 . . . . 0.0 111.626 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -51.77 -41.04 61.33 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.068 0.947 . . . . 0.0 113.135 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.57 -21.11 66.61 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.37 -3.51 56.66 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.731 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -61.65 -32.25 72.4 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.146 0.885 . . . . 0.0 111.162 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.37 -46.68 85.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.751 0.82 . . . . 0.0 109.754 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -75.44 -30.59 60.06 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.652 -174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 122' ' ' ILE . 53.7 t -67.01 -49.71 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.535 0.734 . . . . 0.0 109.235 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.6 t -61.45 -34.14 74.93 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.449 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 166' ' ' LYS . 35.1 t70 -55.54 -47.84 75.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.17 0.588 . . . . 0.0 110.43 178.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 15.8 mm100 -66.89 -41.27 87.48 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 124.774 1.296 . . . . 0.0 111.578 -176.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -62.39 1.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.797 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -57.05 -33.4 67.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.321 1.048 . . . . 0.0 111.846 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' ASP . 20.9 ttmm -55.55 -53.3 58.1 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.333 1.053 . . . . 0.0 111.394 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.97 -16.29 38.83 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.435 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.79 26.76 7.83 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.626 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' HZ ' ' HA ' ' A' ' 115' ' ' LEU . 74.4 m-85 -78.61 177.78 8.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.536 0.734 . . . . 0.0 110.126 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -48.03 145.34 3.11 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.211 1.004 . . . . 0.0 110.672 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.576 1.959 0 C-N-CA 124.987 1.315 . . . . 0.0 113.23 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.2 m -75.22 -0.94 21.13 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.16 0.984 . . . . 0.0 112.221 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -74.86 -24.85 58.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.248 1.019 . . . . 0.0 111.529 175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -60.88 -44.78 96.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.577 0.751 . . . . 0.0 112.296 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.18 -33.32 74.23 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.116 0.566 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -72.34 -27.48 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.446 1.098 . . . . 0.0 110.038 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -85.93 -26.12 25.72 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.426 1.09 . . . . 0.0 110.645 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LYS . 70.2 m -82.15 135.36 35.29 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 110.835 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.13 164.17 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.08 1.352 . . . . 0.0 110.763 -172.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.428 HD11 HG22 ' A' ' 149' ' ' THR . 18.7 tp -87.55 112.62 22.44 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.082 0.553 . . . . 0.0 110.362 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 24.6 m-85 -78.17 -37.83 44.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.518 0.727 . . . . 0.0 111.408 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.85 -154.3 25.42 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -133.8 179.89 5.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.327 0.651 . . . . 0.0 111.176 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 171' ' ' LEU . 50.1 tp -158.57 150.75 21.57 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.614 1.165 . . . . 0.0 108.887 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -87.27 101.82 13.9 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 148' ' ' MET . . . -72.33 85.81 0.51 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.265 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -70.35 99.3 1.54 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.52 0.728 . . . . 0.0 109.286 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 71' ' ' ARG . 7.1 p -119.24 131.66 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.681 0.792 . . . . 0.0 109.825 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 70' ' ' LEU . 65.1 t -56.93 143.41 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.774 1.23 . . . . 0.0 111.719 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.45 66.25 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.532 ' H ' HG12 ' A' ' 68' ' ' VAL . 42.0 tp -61.56 -17.82 56.62 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.069 0.947 . . . . 0.0 111.803 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 67' ' ' VAL . 28.6 ptt-85 -63.89 -5.17 4.0 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 124.673 1.189 . . . . 0.0 113.442 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -53.33 -35.88 60.69 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.611 0.764 . . . . 0.0 112.616 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.44 -24.83 65.67 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.325 1.05 . . . . 0.0 111.511 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 m -77.36 -6.57 53.77 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.952 0.901 . . . . 0.0 111.6 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.86 53.2 0.86 Allowed Glycine 0 C--N 1.359 1.834 0 O-C-N 121.81 -0.556 . . . . 0.0 113.301 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 29.0 m -68.41 171.38 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.436 ' HB ' ' HG3' ' A' ' 81' ' ' GLU . 24.1 m -114.71 162.1 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.411 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -89.96 -87.49 0.18 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.874 0.469 . . . . 0.0 111.811 -173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.92 149.23 36.54 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.847 0.459 . . . . 0.0 111.41 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.2 m120 62.0 9.46 3.07 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.31 1.444 . . . . 0.0 113.141 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 56.6 mm-40 -82.11 132.52 35.25 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.904 0.383 . . . . 0.0 111.481 -174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 61.7 mtm -80.31 132.81 35.87 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.604 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 102' ' ' ASN . 27.0 m -131.66 163.35 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 124.098 0.959 . . . . 0.0 109.141 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.81 134.25 24.7 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.892 0.877 . . . . 0.0 108.735 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.6 HD21 ' SD ' ' A' ' 148' ' ' MET . 6.4 mp -85.23 148.79 25.91 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.478 0.711 . . . . 0.0 110.026 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.458 ' HA ' ' SD ' ' A' ' 123' ' ' MET . 52.5 tp60 -159.89 137.86 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.842 0.857 . . . . 0.0 108.776 175.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 22.5 ptt85 -66.92 152.48 45.6 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.237 0.541 . . . . 0.0 110.085 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 32.1 t70 -102.33 116.59 62.74 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.825 -168.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.92 -18.0 41.23 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.855 2.37 . . . . 0.0 112.808 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -86.03 15.64 4.88 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.259 0.623 . . . . 0.0 110.644 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -53.98 128.22 55.5 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.643 0.777 . . . . 0.0 111.461 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.37 -26.89 1.24 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.326 2.018 . . . . 0.0 113.793 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -108.68 -52.18 2.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.136 0.574 . . . . 0.0 110.934 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -166.67 157.56 12.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.307 0.643 . . . . 0.0 109.671 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HB2' HH11 ' A' ' 87' ' ' ARG . 16.5 ptpt -62.35 -7.79 4.93 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.228 1.411 . . . . 0.0 112.81 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -54.04 -32.48 54.59 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.278 1.031 . . . . 0.0 112.232 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.89 109.15 1.36 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.402 0.439 . . . . 0.0 110.181 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 59.5 mt -107.92 149.59 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.634 1.174 . . . . 0.0 108.231 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER -122.29 144.44 48.99 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.53 0.681 . . . . 0.0 110.972 171.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.3 t -77.83 130.38 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.155 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 23.2 m-80 -114.95 144.14 44.05 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.603 0.761 . . . . 0.0 109.124 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -77.31 -169.69 1.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.445 0.566 . . . . 0.0 111.123 177.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.85 -25.87 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.188 0.595 . . . . 0.0 112.468 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 24.8 t-20 -74.58 -21.1 59.66 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.476 0.711 . . . . 0.0 111.213 174.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.26 5.0 64.05 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.601 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 2.2 t30 -82.5 125.51 31.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.128 0.971 . . . . 0.0 108.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 101' ' ' ASN . 12.0 pt20 -67.26 126.68 30.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.175 0.512 . . . . 0.0 111.701 -175.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 16.9 m -89.47 -23.13 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.968 178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 71' ' ' ARG . . . 165.06 165.27 22.07 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' A' ' 99' ' ' LYS . 23.1 m170 -92.0 150.87 20.76 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.091 0.956 . . . . 0.0 111.403 -174.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 115' ' ' LEU . 29.8 mt -96.37 29.78 2.76 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.602 1.561 . . . . 0.0 112.316 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 65.09 -172.1 0.18 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.775 0.83 . . . . 0.0 110.737 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -80.42 -49.35 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.944 0.498 . . . . 0.0 110.839 171.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.38 -57.35 9.56 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.817 -166.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 111' ' ' LEU . 10.1 tt -67.67 -47.15 70.32 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.859 0.838 . . . . 0.0 109.314 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' A' ' 98' ' ' ILE . . . -62.34 -29.55 70.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.591 -1.641 . . . . 0.0 111.675 176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.9 -38.85 94.65 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.544 0.527 . . . . 0.0 114.078 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -51.97 49.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.225 0.536 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.1 mt -68.11 -16.83 64.17 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.928 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 98' ' ' ILE . . . -61.32 -38.44 86.87 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.378 1.071 . . . . 0.0 112.887 -177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -71.36 -33.71 69.81 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.488 HD13 HG13 ' A' ' 160' ' ' VAL . 44.2 mt -68.66 -34.95 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.484 0.714 . . . . 0.0 110.322 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 86' ' ' GLN . 38.4 tpp -79.84 -52.26 8.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.095 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.54 -45.17 91.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.679 1.192 . . . . 0.0 110.654 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -89.86 2.76 54.6 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.59 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 56.35 36.93 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.308 1.043 . . . . 0.0 111.886 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 122' ' ' ILE . 82.9 mt -65.86 -43.93 86.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.837 0.855 . . . . 0.0 111.322 -178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' ' HE2' ' A' ' 60' ' ' PHE . . . -148.71 140.27 23.5 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.477 0.711 . . . . 0.0 110.603 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.97 102.91 6.62 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.5 mt -89.07 106.22 16.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.14 179.84 5.46 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.875 0.87 . . . . 0.0 109.382 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 148' ' ' MET . . . -162.96 172.97 39.11 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.634 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 78.0 t -149.28 138.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 107.512 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.36 90.76 1.49 Allowed Pre-proline 0 N--CA 1.484 1.242 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.76 -23.53 2.59 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.054 1.836 . . . . 0.0 113.871 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -77.87 -28.73 50.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.379 0.672 . . . . 0.0 112.49 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.12 31.2 75.9 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 123.229 0.33 . . . . 0.0 113.771 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -85.6 17.13 3.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.04 0.936 . . . . 0.0 111.655 -178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -62.3 -26.24 68.31 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.624 1.17 . . . . 0.0 111.72 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.01 -37.0 69.88 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.553 0.741 . . . . 0.0 110.914 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.07 -64.64 0.82 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.652 0.381 . . . . 0.0 110.362 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 37.6 t80 171.75 -89.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.304 1.442 . . . . 0.0 108.497 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 67' ' ' VAL . 62.6 m -103.24 144.64 31.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.184 0.994 . . . . 0.0 109.852 -175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 1.4 pmm? -147.79 148.56 30.76 Favored Pre-proline 0 C--O 1.243 0.741 0 C-N-CA 123.308 0.643 . . . . 0.0 109.747 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.7 124.71 4.66 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.023 1.815 . . . . 0.0 109.985 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.2 145.58 27.88 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -74.79 106.81 6.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.6 ' SD ' HD21 ' A' ' 85' ' ' LEU . 60.3 mtt -95.67 161.07 14.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.019 0.928 . . . . 0.0 109.554 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -150.73 132.4 14.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -171.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.429 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 82.3 m-85 -97.66 117.27 31.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.744 0.817 . . . . 0.0 109.911 -176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -124.31 115.78 21.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.53 168.41 40.55 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 1.0 OUTLIER -65.83 147.01 54.06 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.435 0.636 . . . . 0.0 112.693 -173.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -53.64 -32.5 51.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.406 1.482 . . . . 0.0 114.083 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.43 -23.93 60.18 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.902 0.481 . . . . 0.0 111.608 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -92.55 3.26 55.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.294 0.637 . . . . 0.0 111.722 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -37.37 76.48 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.091 0.556 . . . . 0.0 111.919 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -35.36 69.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.25 0.62 . . . . 0.0 110.872 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 163' ' ' GLN . . . -78.11 -41.14 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.443 0.697 . . . . 0.0 110.63 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG13 HD13 ' A' ' 122' ' ' ILE . 78.1 t -61.12 -47.97 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.834 0.854 . . . . 0.0 110.347 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.4 m -73.11 -24.26 60.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.675 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 35.6 t70 -63.52 -39.81 95.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.83 0.452 . . . . 0.0 110.5 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 14.3 mm100 -64.47 -35.11 79.86 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.666 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.18 -40.23 59.58 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.653 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 10.3 mtmp? -67.06 -38.43 85.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.851 0.461 . . . . 0.0 110.908 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -59.47 -43.11 93.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.118 0.967 . . . . 0.0 111.691 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -96.78 -26.73 15.03 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.13 21.65 10.7 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.259 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 115' ' ' LEU . 67.3 m-85 -66.65 144.36 56.44 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.354 0.662 . . . . 0.0 110.462 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.0 152.89 28.68 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.968 173.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 28.2 m -85.99 -13.49 47.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.233 0.613 . . . . 0.0 111.888 173.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.24 -14.37 55.18 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.693 0.797 . . . . 0.0 112.982 -174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' NZ ' ' A' ' 153' ' ' LYS . 3.0 mp0 -55.25 -47.59 75.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.275 1.03 . . . . 0.0 111.629 171.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 51' ' ' SER . 11.1 pt-20 -72.76 -27.81 62.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.26 0.224 . . . . 0.0 111.338 -178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.52 -35.09 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.535 0.734 . . . . 0.0 109.619 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.5 t70 -76.4 -12.53 60.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.718 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -67.64 114.89 6.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.303 0.641 . . . . 0.0 111.685 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 56' ' ' ASP . 23.9 m -119.5 160.95 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.996 1.318 . . . . 0.0 110.821 -174.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.4 tp -81.37 112.41 18.63 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.439 ' HE1' ' HB2' ' A' ' 128' ' ' ALA . 22.2 m-85 -74.39 -29.12 61.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.96 0.504 . . . . 0.0 110.584 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.4 -176.75 29.71 Favored Glycine 0 C--O 1.246 0.851 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.703 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.7 p -110.81 119.83 40.38 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -100.84 133.21 45.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.972 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -73.09 96.21 2.16 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 145' ' ' PRO . . . -76.48 -179.83 47.72 Favored Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 173.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -139.18 110.32 6.88 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.245 1.023 . . . . 0.0 109.942 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 146' ' ' LEU . 96.8 t -103.65 132.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 70' ' ' LEU . 93.2 t -82.84 141.27 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.317 0.647 . . . . 0.0 109.608 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.04 -26.31 69.11 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.432 0.458 . . . . 0.0 113.609 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' H ' HG12 ' A' ' 68' ' ' VAL . 70.8 mt -64.13 -18.69 64.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.005 0.922 . . . . 0.0 111.367 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.444 ' HD2' ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.15 0.65 18.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.828 1.251 . . . . 0.0 112.295 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 140' ' ' ASN . 11.1 p90 -55.98 -31.02 62.64 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.252 0.621 . . . . 0.0 111.762 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.36 -20.4 63.84 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.127 0.971 . . . . 0.0 111.91 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 m -74.97 -25.01 58.54 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.875 0.47 . . . . 0.0 110.059 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.55 50.41 0.45 Allowed Glycine 0 C--N 1.355 1.597 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.487 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.771 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 27.7 m -57.28 168.4 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.55 0.69 . . . . 0.0 112.673 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 m -114.41 166.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.543 -171.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.1 156.85 11.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.619 ' HB3' ' HA3' ' A' ' 137' ' ' GLY . 12.2 p30 -68.14 69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.157 1.383 . . . . 0.0 111.674 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -178.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.396 1.078 . . . . 0.0 109.37 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -65.18 149.41 49.96 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.121 -164.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 81.4 mtp -89.17 149.77 22.99 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.802 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 34.0 m -121.06 151.64 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.729 0.811 . . . . 0.0 110.933 -177.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 101' ' ' ASN . . . -108.12 166.45 10.73 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.498 1.119 . . . . 0.0 109.94 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 ' SD ' ' A' ' 148' ' ' MET . 7.0 mp -122.68 119.41 30.64 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.564 0.746 . . . . 0.0 109.336 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.01 135.83 50.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.255 1.022 . . . . 0.0 108.985 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.459 HH21 ' HG3' ' A' ' 95' ' ' LYS . 69.1 ttt180 -77.49 125.33 29.17 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.157 0.583 . . . . 0.0 109.882 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 91' ' ' ASN . 15.7 t70 -108.02 115.58 58.35 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 49.7 Cg_endo -83.55 -2.75 10.56 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.948 2.432 . . . . 0.0 114.26 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -107.53 21.63 17.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.267 0.627 . . . . 0.0 111.749 -168.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 88' ' ' ASP . 50.9 m-80 -86.28 142.22 35.49 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 121.609 -0.682 . . . . 0.0 111.313 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.67 -12.55 33.3 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.063 2.509 . . . . 0.0 112.284 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -77.76 -53.4 7.57 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.131 0.572 . . . . 0.0 109.528 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 170.78 163.91 0.08 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.874 1.359 . . . . 0.0 109.784 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 89' ' ' PRO . 8.3 ptpp? -59.41 -22.55 61.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.345 1.458 . . . . 0.0 113.243 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -78.44 -12.3 60.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.495 0.718 . . . . 0.0 112.885 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.18 110.44 3.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.838 0.455 . . . . 0.0 110.72 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.4 mt -75.86 120.8 26.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 124.012 0.925 . . . . 0.0 110.657 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 5.5 tppp? -75.07 117.14 16.58 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.02 167.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 111' ' ' LEU . 15.1 t -77.18 130.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 172.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 12.8 m120 -112.62 175.73 5.31 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.915 1.286 . . . . 0.0 108.01 173.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 1.9 p30 -110.54 -167.9 1.24 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.713 0.688 . . . . 0.0 109.92 169.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.48 -27.28 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.409 0.683 . . . . 0.0 112.525 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -73.31 -21.86 60.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.723 0.809 . . . . 0.0 110.641 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.44 -5.58 60.68 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.837 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 131.84 37.49 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.187 0.595 . . . . 0.0 110.746 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -57.44 127.47 32.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.613 1.165 . . . . 0.0 112.042 177.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.771 ' HB ' ' HA ' ' A' ' 76' ' ' VAL . 30.3 m -113.27 -19.52 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 111.228 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.96 -145.93 9.58 Favored Glycine 0 C--N 1.358 1.786 0 C-N-CA 121.594 -0.336 . . . . 0.0 113.756 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -139.96 156.53 46.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.526 1.13 . . . . 0.0 109.694 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 100' ' ' VAL . 53.9 mt -93.54 4.84 53.32 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.976 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 69.15 146.3 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.707 1.203 . . . . 0.0 110.815 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -56.12 -20.53 17.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.89 -59.43 5.14 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.135 0.974 . . . . 0.0 111.702 -170.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 111' ' ' LEU . 3.9 pp -85.6 -22.03 28.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.615 0.366 . . . . 0.0 111.358 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 113' ' ' LYS . . . -64.18 -37.8 88.77 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.48 0.712 . . . . 0.0 111.763 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.14 -29.48 74.51 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 123.851 0.72 . . . . 0.0 112.906 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.58 5.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 109.632 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.26 -15.92 63.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.977 0.911 . . . . 0.0 112.348 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -52.72 -44.92 66.71 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.41 1.084 . . . . 0.0 113.042 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -70.98 -32.23 69.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 120.911 0.386 . . . . 0.0 110.207 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.36 -35.44 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.421 0.689 . . . . 0.0 110.334 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.6 tpp -79.8 -33.53 40.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.671 1.188 . . . . 0.0 111.065 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.67 -51.14 10.27 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.169 0.988 . . . . 0.0 110.097 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -88.21 2.06 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.845 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 59.42 34.5 22.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.641 1.177 . . . . 0.0 111.354 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.54 -40.65 95.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.915 0.886 . . . . 0.0 111.894 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 60' ' ' PHE . . . -154.73 134.88 13.13 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.474 0.71 . . . . 0.0 110.311 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.67 104.49 12.11 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.08 123.07 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.724 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.05 149.3 42.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 109.315 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.35 174.71 19.2 Favored Glycine 0 C--O 1.239 0.438 0 O-C-N 123.486 0.491 . . . . 0.0 112.869 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 14.4 p -151.18 143.58 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.869 0.868 . . . . 0.0 110.107 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.81 84.66 32.08 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.716 0.807 . . . . 0.0 110.029 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.62 -17.69 12.47 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.87 2.38 . . . . 0.0 112.647 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -83.22 -30.66 27.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.188 0.595 . . . . 0.0 111.174 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 79' ' ' ASN . . . 57.46 34.18 68.17 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.772 0.67 . . . . 0.0 114.339 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.16 0.31 57.24 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 0.0 110.548 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -71.87 -9.12 57.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.059 1.344 . . . . 0.0 112.582 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 72' ' ' TYR . 9.4 p30 -102.51 -22.25 14.07 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.327 0.651 . . . . 0.0 111.206 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.66 -41.53 7.66 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.629 0.772 . . . . 0.0 112.619 -167.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -160.0 -178.3 6.92 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 -164.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 68' ' ' VAL . 22.5 p -90.19 108.75 19.94 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 ptm -112.06 148.87 39.96 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.97 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 96.6 Cg_endo -78.77 146.62 21.1 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 121.925 1.75 . . . . 0.0 110.14 160.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 67' ' ' VAL . 2.6 pt? -137.36 155.61 49.19 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.022 0.439 . . . . 0.0 110.134 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -74.22 108.08 6.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.118 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.475 ' SD ' HD11 ' A' ' 85' ' ' LEU . 24.8 mmt -102.48 153.59 19.91 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -143.24 124.72 14.78 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.034 0.934 . . . . 0.0 108.853 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.06 117.53 30.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.814 0.846 . . . . 0.0 109.665 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -119.76 100.62 7.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.83 157.28 27.2 Favored Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.495 ' NZ ' ' HG3' ' A' ' 53' ' ' GLU . 13.1 ptmt -61.42 144.44 54.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.751 0.42 . . . . 0.0 111.487 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.32 -34.38 57.19 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.83 -30.31 70.75 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.144 0.429 . . . . 0.0 111.961 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -85.74 -9.84 56.51 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.431 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.9 ppt_? -60.69 -29.25 69.2 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 118.899 0.772 . . . . 0.0 112.152 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -61.99 -37.76 86.03 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.097 0.559 . . . . 0.0 110.536 178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 158' ' ' LYS . . . -82.68 -46.17 13.56 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.829 0.852 . . . . 0.0 110.505 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.54 -50.61 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.38 1.072 . . . . 0.0 111.458 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 89.9 p -65.0 -39.25 93.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.905 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.94 -38.9 76.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.981 0.912 . . . . 0.0 111.632 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 10.5 mm100 -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.377 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 78.4 mt -68.58 -56.72 7.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.189 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -55.03 -32.16 61.63 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.336 1.454 . . . . 0.0 112.128 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -58.15 -39.03 77.75 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.165 0.986 . . . . 0.0 111.734 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -107.16 -11.52 15.59 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.429 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.75 42.17 6.51 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.639 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.83 137.21 38.61 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.455 0.702 . . . . 0.0 110.104 171.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -168.18 151.42 5.73 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.28 1.032 . . . . 0.0 108.461 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 123.631 0.772 . . . . 0.0 111.88 177.879 . . . . . . . . 0 0 . 1 stop_ save_